Citrus Sinensis ID: 002157
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 959 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | yes | no | 0.947 | 0.974 | 0.585 | 0.0 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.281 | 0.328 | 0.647 | 1e-101 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.286 | 0.213 | 0.431 | 4e-66 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.262 | 0.392 | 0.468 | 2e-64 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.272 | 0.378 | 0.441 | 2e-62 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.263 | 0.337 | 0.450 | 3e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.281 | 0.294 | 0.431 | 7e-61 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.271 | 0.156 | 0.361 | 8e-58 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.314 | 0.185 | 0.354 | 1e-56 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.272 | 0.158 | 0.383 | 2e-54 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1029 bits (2661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 563/962 (58%), Positives = 693/962 (72%), Gaps = 53/962 (5%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRTSSSSS--NAAPPS-----PSASA 52
M++IFKKLH G N E NRTN+ + +D NR S++ A P S P A A
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTNDA-----APPSDQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 53 ATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-N 111
++ +SPAP +S +R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL +
Sbjct: 56 TSSMASPAPTAAS-NRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGS 114
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
++R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL L
Sbjct: 115 HQRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
ESN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG
Sbjct: 175 ESNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSA 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
+D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGS
Sbjct: 235 EDSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P +
Sbjct: 295 HYTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQF 354
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
SND PK EGSS +S + S L+ + +E+ +S S+P S
Sbjct: 355 SNDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSP 406
Query: 412 SSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLN 471
SS + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLN
Sbjct: 407 SSVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLN 460
Query: 472 PFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYM 531
PFQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+
Sbjct: 461 PFQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYI 519
Query: 532 EGILPKINREPN-NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
E +LPK++R+P N +S +TSS++ + +N+ +D+ + + S
Sbjct: 520 ENLLPKLHRDPRYGNTQSSYATSSSNGAIS---------SNVHGRDNVTFVSPVAVPSSF 570
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRF-MGTN 640
S+ +Q P +VED++ N+ +E P ++ E HD RK T D G +
Sbjct: 571 TSTENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCD 629
Query: 641 LKLRDLESPSSSVDSSTSKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWN 698
+L+D ES SSS+DS++ + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+
Sbjct: 630 PRLKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWH 689
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
GTEVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRG
Sbjct: 690 GTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRG 749
Query: 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818
SL+RILHRP +DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV
Sbjct: 750 SLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVG 809
Query: 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW G
Sbjct: 810 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRG 869
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938
MNPMQVVGAVGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+
Sbjct: 870 MNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVL 929
Query: 939 PS 940
P+
Sbjct: 930 PT 931
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 176/272 (64%), Positives = 215/272 (79%), Gaps = 2/272 (0%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGM 787
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939
II CW +P RPSFA + L+PL + +P
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 122/283 (43%), Positives = 181/283 (63%), Gaps = 8/283 (2%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 703
+D + P ++ + +V++ F E E+P ++ +G RIG G YG+V+ W GTEVA
Sbjct: 822 KDHQFPVPTIPAKIIEVEKPF-----EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVA 876
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
VK + + + + + ++EV ++ +LRHPN+VLFMGA T P + I+TE+L RGSL I
Sbjct: 877 VKMLFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
L ++D R+++ D ARGM LH+ P I+HRDLK+ NLLVD +W VKV+DFGL+
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLA 996
Query: 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
+K +TF +K+ GT W+APEVL E EK DVYS+ ++LWEL T +P+ G N MQ
Sbjct: 997 TVKSHTF--AKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
VV ++ + RL +P P A ++ CW+TDP+ RPSF ++
Sbjct: 1055 VVRSID-RGERLPMPAWCPPKYAALMNRCWETDPTHRPSFPEI 1096
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 119/254 (46%), Positives = 167/254 (65%), Gaps = 2/254 (0%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+I + +G RIG G+YGEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPNV+ F+G+ PP++ I TE++PRGSL+ ILH Q+ IKM +D A+G+ LH
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLH 487
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 488 NSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 545
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R +P+ P +++ +
Sbjct: 546 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLID 605
Query: 912 CWQTDPSLRPSFAQ 925
C +PS RP+ Q
Sbjct: 606 CLNENPSHRPTMEQ 619
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 116/263 (44%), Positives = 169/263 (64%), Gaps = 2/263 (0%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+I + + +G RIG G++GEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPNV+ F+G+ P++ I TE++PRGSL+ ILH ++ +M +D A+G+ LH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 505 GSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 562
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R PK P +++ +
Sbjct: 563 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKD 622
Query: 912 CWQTDPSLRPSFAQLTVALKPLQ 934
C +PS RP+ Q L+ ++
Sbjct: 623 CLNENPSQRPTMEQCLEILESIE 645
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 237 bits (605), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 119/264 (45%), Positives = 163/264 (61%), Gaps = 11/264 (4%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFL-----DQDFSGAALLEFKREVKIMRRLR 731
++V+ RIG GS EV+ W G VA+KK D+DF L E +E IM +LR
Sbjct: 490 EIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDF----LNELAQEATIMSQLR 545
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+ F+G PP + I+ E++P GSL+RILH P +D R MALD+A+GMN LH
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLH 605
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 849
P ++HRDLKS NLLVD+++ VK+SDFGLS KH ++ + GTP W APEVLR
Sbjct: 606 CCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVLR 665
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
N+P EK DV+SF ++LWE+ T + P+ GM Q+V +VG R +P ++ R+I
Sbjct: 666 NDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRLI 725
Query: 910 WECWQTDPSLRPSFAQLTVALKPL 933
ECW DP RPSF ++ L+ +
Sbjct: 726 TECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 120/278 (43%), Positives = 178/278 (64%), Gaps = 8/278 (2%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF-L 708
S SV S+ Q F D EI + +L + ++G G++G VY W G+ VA+K+ +
Sbjct: 638 SGSVVEPPSQQQQYFSD----IEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 709 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
++D + L EF++E+ I+ RLRHPN+VL M A T PPNL ITE+LP GSL+ LH
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
+++ + K+A+ +A+GMN LH S ++HRD+KS NLL+D++ NVK+ DFGLS+LK
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLS--GVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSK 811
Query: 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
+ +KS G+P WM+PE+L E EK DVY+FG+ILWEL T +LP+ G++ +Q+ AV
Sbjct: 812 STEMTKSI-GSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAV 870
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
++ R IP ++ +I CW DP RPSF ++
Sbjct: 871 TTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEI 908
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 8e-58, Method: Compositional matrix adjust.
Identities = 95/263 (36%), Positives = 172/263 (65%), Gaps = 3/263 (1%)
Query: 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+C I ++++ +GE+IGLGSYG VY W +VA+KKF+ Q LL + E+ +
Sbjct: 1389 LCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFL 1448
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
++L HPN++ +GA + PN+ I+TE++ +G+L + +++ ++IK+ +++A+G+
Sbjct: 1449 KKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGI 1508
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
+ LH+ P I+HRD+K N+L+D+NWNVK++DFG +R+K + ++ GTP W APE+
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEI 1566
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+RN+ +EK DV+SFG+++WE+ T K P+IG N M++ + ++ R +IP++ A+
Sbjct: 1567 IRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAK 1625
Query: 908 IIWECWQTDPSLRPSFAQLTVAL 930
++ +CW + RP+ + + L
Sbjct: 1626 LMRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 115/324 (35%), Positives = 185/324 (57%), Gaps = 22/324 (6%)
Query: 625 YHDRRKCTHDRFMG--TNLKLRDLESPSSSVDSSTSKVDQIFDDD--------------- 667
Y + + +RF G T + D ++ S + D S +I D D
Sbjct: 1294 YEIKFEILKNRFFGGITYVNYND-DTDSGTADDSNYDSGKIIDIDYMADIDKEDSFLTSA 1352
Query: 668 -VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 726
+C I ++++ +G++IGLGSYG V++ W G +VAVKKF+ Q S LLEF+ E+
Sbjct: 1353 NMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAF 1412
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
+ L+H N+V F+GA + PN+ I+TE++ G+L +L P ++ ++K+ A G
Sbjct: 1413 LSELKHSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMG 1472
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
++ LH+S P IVHRD+K N+LVD+++NVK++DFG +R+K + ++ + GTP W APE
Sbjct: 1473 IDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPE 1530
Query: 847 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
V+R E EK DV+SFGV++WE+ T K P+ N M+V + + R IP + A
Sbjct: 1531 VIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFA 1589
Query: 907 RIIWECWQTDPSLRPSFAQLTVAL 930
++I +CW RP+ ++ L
Sbjct: 1590 KLIKKCWHAKAHKRPTMTEVVQQL 1613
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 102/266 (38%), Positives = 159/266 (59%), Gaps = 5/266 (1%)
Query: 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+C I ++D+ +G++IG+GSYG V W VAVKKF+ Q +LEF+ E+ +
Sbjct: 1384 LCRWIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFL 1443
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+LRHP+++L +GA + PN+ I+TEF+ GSL ++ + + K +IKM A G+
Sbjct: 1444 SQLRHPHIILMIGACLKRPNICIVTEFMGNGSLRNVIKTT--KPEWKLKIKMLYQTALGI 1501
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH S P I+HRD+K N+LVD + NVK++DFG +R+K S + GTP W APE+
Sbjct: 1502 GYLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEEN--SVMTRCGTPCWTAPEI 1559
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+R E EK DV+SFG+++WE+ T K P+ G N M+V + + R +IP + +
Sbjct: 1560 IRGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDI-LEGARPQIPSDCPIDFTK 1618
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPL 933
++ +CW P RPS + + L +
Sbjct: 1619 LMKQCWHAKPDKRPSMEDVIMGLNDM 1644
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 959 | ||||||
| 224125544 | 967 | predicted protein [Populus trichocarpa] | 0.983 | 0.975 | 0.683 | 0.0 | |
| 224130772 | 955 | predicted protein [Populus trichocarpa] | 0.964 | 0.968 | 0.685 | 0.0 | |
| 359487849 | 955 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.974 | 0.680 | 0.0 | |
| 255542402 | 958 | map3k delta-1 protein kinase, putative [ | 0.966 | 0.967 | 0.676 | 0.0 | |
| 356535135 | 930 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.967 | 0.655 | 0.0 | |
| 229335619 | 913 | EDR1 [Glycine max] | 0.938 | 0.985 | 0.656 | 0.0 | |
| 356576743 | 932 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.965 | 0.651 | 0.0 | |
| 262213688 | 871 | EDR1 [Glycine max] | 0.885 | 0.974 | 0.651 | 0.0 | |
| 449435758 | 935 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.952 | 0.976 | 0.635 | 0.0 | |
| 298204924 | 876 | unnamed protein product [Vitis vinifera] | 0.893 | 0.978 | 0.641 | 0.0 |
| >gi|224125544|ref|XP_002319612.1| predicted protein [Populus trichocarpa] gi|222857988|gb|EEE95535.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1316 bits (3407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 672/983 (68%), Positives = 781/983 (79%), Gaps = 40/983 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNETLASTTSCAT-----DHNRTSSSSSNAAPPSPSASAA 53
M++IFKKLHIGSNHES NRT+ A++ S D +++ +S A+PP S S A
Sbjct: 1 MKHIFKKLHIGSNHESSPNRTSNETATSASSPPPSGSSDQRASATINSPASPPLTSPSPA 60
Query: 54 TAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLN-- 111
T A + TDY TSEEEFQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 TTVQPSA----ISNLTDYFTSEEEFQVQLALAISASNSEFRDDTEKDQIRAATLLSLGGG 116
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
N R D+ R+K + E +SR YWEYNVLDY E+V+DGFYD+ L T + QGK+PSL L
Sbjct: 117 NNRVDVDREKGEEKVEDMSRYYWEYNVLDYGEKVMDGFYDV--LCTSSAVQGKMPSLTDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
E+N +SGFE VIVNR ID LEEL+Q+AQCIALD PAT+V +LVQQLA+LV GHMGGPV
Sbjct: 175 ETNASSSGFEAVIVNRKIDPTLEELMQIAQCIALDCPATNVAVLVQQLAELVTGHMGGPV 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
KDAN++LA+W+ERS+ELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLVKGS
Sbjct: 235 KDANLILAKWIERSSELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG+EDDAVNIIKL++EREFLVDLMAAPGTLIPAD+ SAKD+ FK IP LR+
Sbjct: 295 HYTGIEDDAVNIIKLKDEREFLVDLMAAPGTLIPADVPSAKDSTFK--------IPSLRS 346
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
+ND+G V+++P PL EG+SQ+S+VDG P N SE AESLP F S + G SSG+
Sbjct: 347 TNDTGVVFTRPNPLPGEGTSQSSSVDGISPFNSRLNSENAESLPFFSGSSSDAGVGSSGV 406
Query: 412 SSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
+++ P NQ +SS+ IGTS+YKG RG +AVGDG RMNVNVVPYG EDSK+LF+DL
Sbjct: 407 ANKAAPTNQFGNISSTAIGTSVYKGSRGGHAVGDGVRMNVNVVPYGPNSPEDSKNLFSDL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK+ +H P E+K+ EF + NPV G PP P++ KN++ YNEVPR+KE
Sbjct: 467 NPFQIKGTGKSFMHHKPVENKINEFPGRKNNPVPG-PPAPLVWKNRYAYNEVPRRKENEL 525
Query: 531 MEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
+EG+ P+INREPNN + ASTSS SE P FK S++ N S+K+S++R+ S +L
Sbjct: 526 VEGLYPRINREPNNYNQSLASTSS-SEKVYPQGFKSSSNFNPSNKESDTRNYASSVSSAL 584
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV-----------EDHEIGYHDRRKCTHDRF 636
+S SQ P VE+ +SN K+ + KN+ ED+EI +HDRRKCT+DRF
Sbjct: 585 SSDPSQCYSFPSVEEANSNFKENKLWDAKNLQNDSEAMAKEHEDNEIDFHDRRKCTYDRF 644
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
MGTNLKL+D ESPS+SVD + +VDQI DD EI WEDL++GERIGLGSYGEVYHAD
Sbjct: 645 MGTNLKLKDPESPSASVDPISHRVDQIMDDVDVGDEICWEDLIIGERIGLGSYGEVYHAD 704
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
WNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP
Sbjct: 705 WNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 764
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816
RGSL+RILHRP CQ+DEKRRI+MALDVARGMNCLH S PTIVHRDLKSPNLLVDKNW VK
Sbjct: 765 RGSLYRILHRPQCQIDEKRRIRMALDVARGMNCLHASIPTIVHRDLKSPNLLVDKNWTVK 824
Query: 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
V DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELAT++LPW
Sbjct: 825 VCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATIRLPW 884
Query: 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRL
Sbjct: 885 SGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRL 944
Query: 937 VIPSHPDQPSSALPQEISVNSTP 959
VIPSH DQPS L QEI+VNSTP
Sbjct: 945 VIPSHLDQPSPPLQQEIAVNSTP 967
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130772|ref|XP_002328373.1| predicted protein [Populus trichocarpa] gi|222838088|gb|EEE76453.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1293 bits (3346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 663/967 (68%), Positives = 768/967 (79%), Gaps = 42/967 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNE--------TLASTTSCATDHNRTSSSSSNAAPPSPSA 50
M++IFKKLHIGSN+ES NRT+ SC++DH + +S A PPS S
Sbjct: 1 MKHIFKKLHIGSNNESSPNRTSNDTATSASTPPPPPPSCSSDHRAAGTGNSPANPPSTSP 60
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
S AT A ++ G+RTDY SEE+FQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 SPATTAQP----LAFGNRTDYFASEEDFQVQLALAISASNSEFRDDTEKDQIRAATLLSL 116
Query: 111 N--NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSL 168
N R D+GR+K + E LSR YWEYNVLDY ERV+DGFYD++ T + QGK+PSL
Sbjct: 117 GGGNNRIDVGREKGEGKVEDLSRYYWEYNVLDYGERVMDGFYDVF--CTSSAVQGKMPSL 174
Query: 169 AHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMG 228
LE+N G SGFE VIVNR +D ALEEL+Q+AQCIALD ATDV ILVQQLA+LV GHMG
Sbjct: 175 MDLETNAGGSGFEAVIVNRKVDPALEELMQIAQCIALDWLATDVTILVQQLAELVTGHMG 234
Query: 229 GPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLV 288
GPVKDAN++LA+WM+RSTELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLV
Sbjct: 235 GPVKDANLILAKWMDRSTELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLV 294
Query: 289 KGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPI 348
KGSHYTG+EDDAVNIIKLE+EREFLVDLMAAPGTLIPAD+ SAKDT FK IP
Sbjct: 295 KGSHYTGIEDDAVNIIKLEDEREFLVDLMAAPGTLIPADVPSAKDTTFK--------IPA 346
Query: 349 LRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
R SN++G V+++ KPL EG+SQNS+VDG PL+ SE AESLPSF S G S
Sbjct: 347 PR-SNETGVVFARSKPLTGEGTSQNSSVDGISPLDRILCSENAESLPSFSGSSNNAGVGS 405
Query: 409 SGISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLF 467
SG+S++ P NQ ++S+ GTS+YKG RG +A+GDG RMNVNVVPY EDSK+LF
Sbjct: 406 SGVSNKTAPTNQLGNIASTAFGTSVYKGSRGVHAIGDGLRMNVNVVPYVPNTSEDSKNLF 465
Query: 468 ADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKE 527
ADLNPFQIKG GK+ +H P E+K+ EFQ + NPV PP P+M KN+ YNEVPR+K+
Sbjct: 466 ADLNPFQIKGTGKSFMHNKPAENKINEFQGRKNNPVPS-PPAPLMWKNRFAYNEVPRRKD 524
Query: 528 YSYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSG 587
+EG+ P+INREPNN +S +++S SE P FK S++ N S+++S++R++ S +
Sbjct: 525 NDNVEGLYPRINREPNNYNHSSLASTSLSEKVYPQGFKSSSNLNTSNRESDTRNSASSAS 584
Query: 588 PSLASSTSQLNGPPLVEDLSSNSKDE--NPKNV-----------EDHEIGYHDRRKCTHD 634
L+S T+Q P VE+++SN +++ + KN+ ED+EIG+HDRRKC HD
Sbjct: 585 SELSSYTNQGYSLPSVEEVNSNFEEKLWDAKNLQNDMEASVKESEDNEIGFHDRRKCIHD 644
Query: 635 RFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYH 694
RFMGTNLKL+ ESPS+SVDSST +VD+I DD EI WEDLV GERIGLGSYGEVYH
Sbjct: 645 RFMGTNLKLKGPESPSTSVDSSTHRVDRILDDVDVGDEICWEDLVFGERIGLGSYGEVYH 704
Query: 695 ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
ADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEF
Sbjct: 705 ADWNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEF 764
Query: 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814
LPRGSL+RILHRP CQ+DEKRRIKMALDVARGMNCLH STPTIVHRDLKSPNLLVD+NW
Sbjct: 765 LPRGSLYRILHRPQCQIDEKRRIKMALDVARGMNCLHASTPTIVHRDLKSPNLLVDENWT 824
Query: 815 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 874
VKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK
Sbjct: 825 VKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKS 884
Query: 875 PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
PW GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFA+L VAL PLQ
Sbjct: 885 PWSGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAELAVALMPLQ 944
Query: 935 RLVIPSH 941
RLV+PSH
Sbjct: 945 RLVVPSH 951
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487849|ref|XP_002271755.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1290 bits (3337), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/983 (68%), Positives = 776/983 (78%), Gaps = 52/983 (5%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTT- 58
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
FQVQLA+AISAS+S+ D SEKDQIRAATLLSL R+
Sbjct: 59 ----------------------FQVQLALAISASNSDFRDDSEKDQIRAATLLSLGRHRT 96
Query: 116 DLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNL 175
D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL LE+NL
Sbjct: 97 DSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLTDLETNL 155
Query: 176 GNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDAN 235
GNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGGPV+DAN
Sbjct: 156 GNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGGPVRDAN 215
Query: 236 IMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG 295
IML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVKGSHYTG
Sbjct: 216 IMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVKGSHYTG 275
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
VEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD++ K YNP +SKIP L+ S D
Sbjct: 276 VEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDSSLKSYNPKLSKIPTLQASKDP 335
Query: 356 GAVYSKPKPLHA--EGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
G VYS+PKPL EGSSQ ST++ SLP + ++SEK ESL SF S S + G +S IS
Sbjct: 336 GGVYSRPKPLLGDYEGSSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTSRISK 395
Query: 414 RVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFADLNP
Sbjct: 396 RVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFADLNP 455
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ+ G+ K S P E+KV+EFQ + + GRPP+P+M KN++ NEVPRKKE ++E
Sbjct: 456 FQMIGSSKASAQSKPMENKVDEFQREKNSAAPGRPPLPLMWKNRYANNEVPRKKENDFVE 515
Query: 533 GILPKINREPNN-NL-STSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
G+ PKINRE N+ NL S +++ ++TSE FK S +A +++K ++ +++ + L
Sbjct: 516 GLFPKINRETNDYNLPSLTSNNATTSEKVYSGVFKLSGNAYMNNKVNDDQNSSCNTTSML 575
Query: 591 ASSTSQLNGPPLVEDLSSNSKDENPKN-----------VEDH---EIGYHDRRKCTHDRF 636
A STSQ N L ED+++N ++ K+ ++H E G HD RK HD F
Sbjct: 576 APSTSQFNRLSLDEDVNANYNEKYHKDGKVFQSDMVDAAKEHDKNETGLHDHRKFRHDSF 635
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
M NL R+ ESP SSVDS KVDQ+F+D V ECEIPWEDLVLGERIGLGSYGEVYH D
Sbjct: 636 MENNL--REAESPCSSVDSDAGKVDQMFED-VGECEIPWEDLVLGERIGLGSYGEVYHGD 692
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
WNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP
Sbjct: 693 WNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 752
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816
RGSL+RILHRP CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVK
Sbjct: 753 RGSLYRILHRPSCQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVK 812
Query: 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
V DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW
Sbjct: 813 VCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPW 872
Query: 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
GMNPMQVVGAVGFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRL
Sbjct: 873 SGMNPMQVVGAVGFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRL 932
Query: 937 VIPSHPDQPSSALPQEISVNSTP 959
VIP H DQ S L QEISVNSTP
Sbjct: 933 VIPQHLDQQSLTLQQEISVNSTP 955
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542402|ref|XP_002512264.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223548225|gb|EEF49716.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1275 bits (3298), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 670/990 (67%), Positives = 780/990 (78%), Gaps = 63/990 (6%)
Query: 1 MRNIFKKLHIGSNHESN-RTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSP 59
M++IFKKLHIGS HE N R NET + + SC++DH RTSS
Sbjct: 1 MKHIFKKLHIGSGHEPNHRPNETPSPSQSCSSDH-RTSS--------------------- 38
Query: 60 APVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPE--DFSEKDQIRAATLLSL----NNR 113
V + S +S E++Q+QLA+A+SAS+SN E + E DQIRAATLLSL NN
Sbjct: 39 --VNAPASPPSTSSSPEDYQIQLALALSASASNSEFREDHENDQIRAATLLSLGGNHNNH 96
Query: 114 ------RSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPS 167
R D+ R+K ++AAE LSRQYWEYNVLDYEE+V+DGFYD++ S P Q K+PS
Sbjct: 97 THNPTHRIDMPRNKGELAAEALSRQYWEYNVLDYEEKVMDGFYDVF--SRSPVVQAKMPS 154
Query: 168 LAHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHM 227
L LE+N G+S FE V++NR +DHALEELVQVAQCIALD PATDVGILVQ+LA++V GHM
Sbjct: 155 LTELETNPGSSSFEAVVINRAMDHALEELVQVAQCIALDCPATDVGILVQRLAEVVTGHM 214
Query: 228 GGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRL 287
GGPVKDANIMLARWMERST+LR+SL TS LPIGSI+IGLSRHRALLFKVLAD+IR PCRL
Sbjct: 215 GGPVKDANIMLARWMERSTDLRKSLHTSALPIGSIDIGLSRHRALLFKVLADNIRFPCRL 274
Query: 288 VKGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIP 347
VKGSHYTG+EDDA+NIIKLE+EREFLVDLMA PGTLIPAD+LSAKDT FK YNP I+ I
Sbjct: 275 VKGSHYTGIEDDAINIIKLEDEREFLVDLMADPGTLIPADVLSAKDTTFKSYNPNINIIA 334
Query: 348 ILRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAA 407
L++ N+S +Y++ P EGSSQNS++DGSLPL+ S++E AESL SF S G
Sbjct: 335 GLQSPNESEIIYTRSSPSFGEGSSQNSSMDGSLPLDRRSSNETAESLASFSGASSNVGVG 394
Query: 408 SSGISSRV-TPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSL 466
SSG S+V + NQ +SS IG YKGGRG +AV D RMNVNV+PYGQ EDS++L
Sbjct: 395 SSGGPSKVASSNQHGNISSLAIG---YKGGRGTHAVADAVRMNVNVIPYGQNSLEDSRNL 451
Query: 467 FADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKK 526
F+DLNPFQIKG GK+ +H P E+KVE+F + N + GRPP P+ KN++ YNEVPRKK
Sbjct: 452 FSDLNPFQIKGTGKSFMHNKPAENKVEDFHGQKDNLLPGRPPAPLKWKNRYAYNEVPRKK 511
Query: 527 EYSYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALS 584
EY Y+EG+ P I+REPN N S ++S+S+ SE P S+ +N SS+D ++ ++ S
Sbjct: 512 EYDYIEGLFPGISREPNGYNQSSLASSSSTMSEKVYPQGLNSSSSSNTSSRDGDAWNSSS 571
Query: 585 GSGPSLASSTSQLNGPPLVEDLSSNSKDENPKNV--------------EDHEIGYHDRRK 630
G+ +LAS +Q LVE+ +S+ K E+P++ E++EIG+ DRRK
Sbjct: 572 GTNSALASGMNQCYKSSLVEEANSDFK-ESPRDAKNFQNDAEVTIRDDENNEIGFQDRRK 630
Query: 631 CTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSY 689
CTHDRFMG NLKL+ ES SSS+DS +KVDQIFDD DV ECEIPWEDL LGERIGLGSY
Sbjct: 631 CTHDRFMGINLKLK--ESSSSSIDSGKNKVDQIFDDVDVGECEIPWEDLDLGERIGLGSY 688
Query: 690 GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749
GEVYHADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLS
Sbjct: 689 GEVYHADWNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLS 748
Query: 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809
II+EFLPRGSL+RILHRPHCQ+DEKRRIKMALDVARGMNCLH+S PTIVHRDLKSPNLLV
Sbjct: 749 IISEFLPRGSLYRILHRPHCQIDEKRRIKMALDVARGMNCLHSSIPTIVHRDLKSPNLLV 808
Query: 810 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
DKNWNVKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL
Sbjct: 809 DKNWNVKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929
ATL+LPW GMNPMQVVGAVGFQNRRLEIPK++DP VA IIW+CWQ+DP+ RPSFA+LT A
Sbjct: 869 ATLRLPWSGMNPMQVVGAVGFQNRRLEIPKDIDPKVAMIIWQCWQSDPNARPSFAELTTA 928
Query: 930 LKPLQRLVIPSHPDQPSSALPQEISVNSTP 959
LKPLQRLVIPSH DQPSS L QEISVNSTP
Sbjct: 929 LKPLQRLVIPSHLDQPSSPLQQEISVNSTP 958
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535135|ref|XP_003536104.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1203 bits (3112), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/972 (65%), Positives = 739/972 (76%), Gaps = 72/972 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 77
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 134
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 135 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 193
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 194 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 248
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 249 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 308
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 309 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 366
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 367 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 424
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 425 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 483
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 484 NPFQIKGMGKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK----- 538
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 539 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQ 582
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+LA T ++ P HD+R CT+DRFMG+NLKL+D ES
Sbjct: 583 TLAQVTGSVSPP------------------------NHDQRNCTYDRFMGSNLKLKDPES 618
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKF
Sbjct: 619 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKF 678
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 767
LDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP
Sbjct: 679 LDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRP 738
Query: 768 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
+CQ+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 739 NCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 798
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 799 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGA 858
Query: 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947
VGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ +
Sbjct: 859 VGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAP 918
Query: 948 ALPQEISVNSTP 959
+PQEISVNSTP
Sbjct: 919 PMPQEISVNSTP 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229335619|gb|ACQ57002.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1201 bits (3106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/972 (65%), Positives = 740/972 (76%), Gaps = 72/972 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 1 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 60
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 61 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 117
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 118 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 176
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 177 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 231
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 232 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 291
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 292 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 349
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 350 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 407
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 408 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + VSGRPP+P+M KN+H YNE PRK
Sbjct: 467 NPFQIKGMGKAPVHNKPVENKPPELKSTKNYAVSGRPPVPLMWKNRHAYNEDPRK----- 521
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 522 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINNDVN----------- 563
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
A + +Q+ G +P N HD+R CT+DRFMG+NLKL+D ES
Sbjct: 564 --AQTLAQVTG------------SVSPPN--------HDQRNCTYDRFMGSNLKLKDPES 601
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKF
Sbjct: 602 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKF 661
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 767
LDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP
Sbjct: 662 LDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRP 721
Query: 768 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
+CQ+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 722 NCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 781
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 782 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGA 841
Query: 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947
VGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ +
Sbjct: 842 VGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQVAP 901
Query: 948 ALPQEISVNSTP 959
+PQEISVNSTP
Sbjct: 902 PMPQEISVNSTP 913
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576743|ref|XP_003556489.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1192 bits (3083), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 635/974 (65%), Positives = 730/974 (74%), Gaps = 74/974 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTS--CATDHNRTSSSSSNAAPPSPS--------A 50
M+NIFKKLHIGS+H+ +R+NE S CATD +++S+++ + +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEPSPPVPSPSCATDQSQSSAATPPSPSSASPSPSPSTLVV 77
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
+ + +PVV+ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 TPSCGGGGASPVVN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSL 134
Query: 111 NNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAH 170
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS
Sbjct: 135 GGHRIDSTRNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTD 193
Query: 171 LESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGP 230
LE+N G G E+VIVN+TID ALEEL+Q+AQCIALD P V LVQ+LA+LV HMGGP
Sbjct: 194 LEANPG--GSELVIVNQTIDPALEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGP 248
Query: 231 VKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKG 290
VKDA IMLARW E ELR SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRL+KG
Sbjct: 249 VKDAGIMLARWTETRAELRTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLLKG 308
Query: 291 SHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILR 350
SHYTGVEDDAVNIIKLE EREFLVDLMAAPGTLIPADILS KD+AFK YNP I +P L
Sbjct: 309 SHYTGVEDDAVNIIKLEGEREFLVDLMAAPGTLIPADILSTKDSAFKSYNPKI--LPSLP 366
Query: 351 TSNDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
++ D+ YS+P +P H EGSSQNS + D SLP NG EK+E PS S E G
Sbjct: 367 STKDNEFSYSRPIQPFHGEGSSQNSVIKDYSLPWNGKPYFEKSE--PSNLGLSRESGTGP 424
Query: 409 SGISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
S I ++ TPNQ D L + + G SLYKG G N VGDG R+NVNVVPY DS++LFA
Sbjct: 425 SKIPNKGTPNQLDNLPALS-GASLYKGTLGMNTVGDGTRLNVNVVPYTNISPNDSRNLFA 483
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+ YNE PRK
Sbjct: 484 DLNPFQIKGMGKAPVHNKPVENKPPELKSTKNNTVSGRPPVPLMWKNRPAYNEDPRK--- 540
Query: 529 SYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGS 586
N PN N ++ SSTSEN + S KP ++NI++ +
Sbjct: 541 ---------TNHNPNDYNPPLFVSNGSSTSENIDLSSSKPLYNSNINN---------DVN 582
Query: 587 GPSLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDL 646
+LA T ++ P HD+RKCT+DRFMG+NLKL+D
Sbjct: 583 AQTLAQVTGSVSPP------------------------NHDQRKCTYDRFMGSNLKLKDP 618
Query: 647 ESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK 705
ESPSSS+DS T+++D I DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVK
Sbjct: 619 ESPSSSIDSITNRIDPILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVK 678
Query: 706 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 765
KFLDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILH
Sbjct: 679 KFLDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILH 738
Query: 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825
R + Q+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRL
Sbjct: 739 RSNYQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRL 798
Query: 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW MN MQVV
Sbjct: 799 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSEMNTMQVV 858
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 945
GAVGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ
Sbjct: 859 GAVGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQV 918
Query: 946 SSALPQEISVNSTP 959
+ +PQEISVNSTP
Sbjct: 919 APPMPQEISVNSTP 932
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|262213688|gb|ACY36006.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1184 bits (3063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/964 (65%), Positives = 712/964 (73%), Gaps = 115/964 (11%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSPA 60
M+NIFKKLHIGS+H+ +R+NE SPS
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEA------------------------SPS----------- 42
Query: 61 PVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRSDLGRD 120
D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL R D R+
Sbjct: 43 ---------DFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGGHRIDSARN 93
Query: 121 KADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNLGNSGF 180
K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE+N G G
Sbjct: 94 KDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLEANPG--GS 150
Query: 181 EVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLAR 240
E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVKDA+IMLAR
Sbjct: 151 ELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVKDASIMLAR 207
Query: 241 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 300
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 208 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 267
Query: 301 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 360
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 268 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 325
Query: 361 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 418
+P +P H EGSSQNS V D SLP NG EK + G S I ++ TPN
Sbjct: 326 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEK------------DSGVGPSKIPNKGTPN 373
Query: 419 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 478
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 374 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 432
Query: 479 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 538
GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 433 GKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK------------T 480
Query: 539 NREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ 596
N PN N ++ SS SE + S KP ++NI++ + +LA T
Sbjct: 481 NHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGS 531
Query: 597 LNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSS 656
++ P HD+R CT+DRFMG+NLKL+D ESPSSS+DS
Sbjct: 532 VSPP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSI 567
Query: 657 TSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA 715
T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGA
Sbjct: 568 TNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGA 627
Query: 716 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR 775
AL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEKR
Sbjct: 628 ALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEKR 687
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKS
Sbjct: 688 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKS 747
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 895
TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRRL
Sbjct: 748 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRRL 807
Query: 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 955
+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ + +PQEISV
Sbjct: 808 DIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAPPMPQEISV 867
Query: 956 NSTP 959
NSTP
Sbjct: 868 NSTP 871
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435758|ref|XP_004135661.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1182 bits (3057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/981 (63%), Positives = 741/981 (75%), Gaps = 68/981 (6%)
Query: 1 MRNIFKKLHIGSNHESNRTNE-----TLASTTSCATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKK HIGSNHE NR+NE AS++ C +D NR + + + PP+
Sbjct: 1 MKHIFKKFHIGSNHEPNRSNENPSPVAAASSSPCVSD-NRGGNVTQVSVPPN-------- 51
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
R+DY +SEEEFQVQLA+AISAS+S+ D EKDQIRAATLLSL N R
Sbjct: 52 ------------RSDYFSSEEEFQVQLALAISASNSDFRDDPEKDQIRAATLLSLGNHRI 99
Query: 116 D-LGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESN 174
D RD+ D AAEVLSRQYWEYNVLDYEE+VV+GFYD+ LSTD + QGK+PSL+ +E++
Sbjct: 100 DSTARDQGD-AAEVLSRQYWEYNVLDYEEKVVNGFYDV--LSTDSAVQGKIPSLSDIEAS 156
Query: 175 LGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDA 234
G+SGFEVV+VN TID ALEELVQ+AQCIA D P T+V +LVQ+LA+LV GHMGGPVKDA
Sbjct: 157 FGSSGFEVVMVNMTIDPALEELVQIAQCIA-DCPGTEVRVLVQRLAELVMGHMGGPVKDA 215
Query: 235 NIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYT 294
+ MLARWMERSTELR SL TSVLPIGSINIGLSRHRALLFKVLADSI++PCRLVKGSHYT
Sbjct: 216 HFMLARWMERSTELRTSLHTSVLPIGSINIGLSRHRALLFKVLADSIKMPCRLVKGSHYT 275
Query: 295 GVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTA-FKPYNPLISKIPILRTSN 353
GVE+DAVNIIKLE+EREFLVDLMAAPGTL+PADI +AKDT FKPYNP +S+IP L SN
Sbjct: 276 GVEEDAVNIIKLEDEREFLVDLMAAPGTLLPADIFNAKDTTNFKPYNPKVSRIPSLHHSN 335
Query: 354 DSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
D G +KP EGSSQN + ++G + ES+PS SSG++
Sbjct: 336 DVGISSAKPTSGLEEGSSQNFGAEAISLMDGKLGYGRTESVPS-----------SSGVTC 384
Query: 414 RVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDG-ARMNVNVVPYGQTGQEDSKSLFADLNP 472
+ + LS GTS YKG GDG R+NVNVVP+GQ+ EDSK+LFADLNP
Sbjct: 385 XINSRLMENLSLLGTGTSRYKGAH----FGDGNVRLNVNVVPFGQS-SEDSKNLFADLNP 439
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
F I+G GK+ + +++K EE Q P G PP+P+ KN+ +N VP K EY YME
Sbjct: 440 FLIRGTGKSFIPNKFSDNKSEELQK----PTIGHPPVPLW-KNRFAFNAVPNKNEYDYME 494
Query: 533 GILPKINREPNN-NLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLA 591
G P+I+R PN+ N++ S+S S+ SE+ P SND + S + +E S+ S A
Sbjct: 495 GRFPRISRGPNDQNMALSSSNSTGSESVKPGGSGTSNDLSASVRSAEVGSSSSNMYAQPA 554
Query: 592 SSTSQLNGPPLVEDLSSNSKDENPKNVE------------DHEIGYHDRRKCTHDRFMGT 639
+ N P +++ + S E+ N + D+ I + +RRK T++R +GT
Sbjct: 555 FGMMEPNILPFIDEQNRKSNGEHSGNTDMEDEKVDAVDGRDNLIRFDNRRKFTYERSVGT 614
Query: 640 NLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWN 698
NL L+D +P V+ S+++ +Q++DD DV +CEI WEDLV+GERIGLGSYGEVYHADWN
Sbjct: 615 NLILKDSGNPGLLVNPSSNRFEQVYDDVDVGQCEIQWEDLVIGERIGLGSYGEVYHADWN 674
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
TEVAVKKFLDQDFSGAAL EFKREV IMR+LRHPN+VLFMGAVTRPPNLSI+TEFLPRG
Sbjct: 675 DTEVAVKKFLDQDFSGAALAEFKREVLIMRQLRHPNIVLFMGAVTRPPNLSIVTEFLPRG 734
Query: 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818
SL+RI+HRP+CQ+DEKRRIKMALDVARGMNCLHTS PTIVHRDLKSPNLLVDKNWNVKVS
Sbjct: 735 SLYRIIHRPNCQIDEKRRIKMALDVARGMNCLHTSNPTIVHRDLKSPNLLVDKNWNVKVS 794
Query: 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
DFGLSRLKHNTFLSSKST GTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELATL+LPW G
Sbjct: 795 DFGLSRLKHNTFLSSKSTGGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATLRLPWSG 854
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938
MNPMQVVGAVGF+N+RLEIPKE+DP VARIIWECWQTDP+LRPSF+QL LKPLQRLV+
Sbjct: 855 MNPMQVVGAVGFRNQRLEIPKEVDPTVARIIWECWQTDPNLRPSFSQLANILKPLQRLVL 914
Query: 939 PSHPDQPSSALPQEISVNSTP 959
P H DQPSS++ QEISVNSTP
Sbjct: 915 PPHSDQPSSSVLQEISVNSTP 935
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204924|emb|CBI34231.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1167 bits (3019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 620/966 (64%), Positives = 714/966 (73%), Gaps = 109/966 (11%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTTV 59
Query: 56 ASSPAPVV------SSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLS 109
+S+ A + ++ +R+DY SEEEFQVQLA+AISAS+S+ D SEKDQIRAATLLS
Sbjct: 60 SSTAASTLPTATSPAASNRSDYFLSEEEFQVQLALAISASNSDFRDDSEKDQIRAATLLS 119
Query: 110 LNNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLA 169
L R+D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL
Sbjct: 120 LGRHRTDSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLT 178
Query: 170 HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGG 229
LE+NLGNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGG
Sbjct: 179 DLETNLGNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGG 238
Query: 230 PVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVK 289
PV+DANIML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVK
Sbjct: 239 PVRDANIMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVK 298
Query: 290 GSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPIL 349
GSHYTGVEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD+
Sbjct: 299 GSHYTGVEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDS--------------- 343
Query: 350 RTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASS 409
SSQ ST++ SLP + ++SEK ESL SF S S + G +S
Sbjct: 344 --------------------SSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTS 383
Query: 410 GISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
IS RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFA
Sbjct: 384 RISKRVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFA 443
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQ+ G+ K S P E+KV+EFQ + S P
Sbjct: 444 DLNPFQMIGSSKASAQSKPMENKVDEFQREK---NSAAP--------------------- 479
Query: 529 SYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
+N + N++ +T++ + ++ FN S +AN + K
Sbjct: 480 ---------VNDDQNSSCNTTSMLAPSTSQFNRLSLDEDVNANYNEK------------- 517
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+G D+ +K E+ KN E G HD RK HD FM N LR+ ES
Sbjct: 518 ------YHKDGKVFQSDMVDAAK-EHDKN----ETGLHDHRKFRHDSFMENN--LREAES 564
Query: 649 PSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL 708
P SSVDS KVDQ+F +DV ECEIPWEDLVLGERIGLGSYGEVYH DWNGTEVAVKKFL
Sbjct: 565 PCSSVDSDAGKVDQMF-EDVGECEIPWEDLVLGERIGLGSYGEVYHGDWNGTEVAVKKFL 623
Query: 709 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
DQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+RILHRP
Sbjct: 624 DQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLYRILHRPS 683
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHN
Sbjct: 684 CQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHN 743
Query: 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
TFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW GMNPMQVVGAV
Sbjct: 744 TFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPWSGMNPMQVVGAV 803
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSA 948
GFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRLVIP H DQ S
Sbjct: 804 GFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRLVIPQHLDQQSLT 863
Query: 949 LPQEIS 954
L QEIS
Sbjct: 864 LQQEIS 869
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 959 | ||||||
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.949 | 0.976 | 0.563 | 1.3e-267 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.295 | 0.321 | 0.759 | 2.7e-180 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.299 | 0.278 | 0.717 | 1.1e-171 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.286 | 0.277 | 0.720 | 8.5e-162 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.281 | 0.328 | 0.647 | 3.4e-126 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.286 | 0.355 | 0.602 | 1.7e-89 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.276 | 0.360 | 0.615 | 1.2e-88 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.285 | 0.358 | 0.595 | 4.1e-88 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.263 | 0.377 | 0.623 | 1.4e-85 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.261 | 0.323 | 0.482 | 3.6e-84 |
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2574 (911.2 bits), Expect = 1.3e-267, P = 1.3e-267
Identities = 541/960 (56%), Positives = 654/960 (68%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRXXXXXX------XXXXXXXXXXXX 53
M++IFKKLH G N E NRTN+ A+ S D NR
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTND--AAPPS---DQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 54 XXXXXXXXXXXXGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-NN 112
+R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL ++
Sbjct: 56 TSSMASPAPTAASNRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGSH 115
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
+R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL LE
Sbjct: 116 QRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDLE 175
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
SN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG +
Sbjct: 176 SNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSAE 235
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGSH
Sbjct: 236 DSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGSH 295
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P + S
Sbjct: 296 YTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQFS 355
Query: 353 NDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGIS 412
ND PK EGSS +S + S L+ + +E+ +S S+P S S
Sbjct: 356 NDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSPS 407
Query: 413 SRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
S + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLNP
Sbjct: 408 SVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLNP 461
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+E
Sbjct: 462 FQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYIE 520
Query: 533 GILPKINREPNNNLXXXXXXXXXXENFNPHSFKPSNDANISSKDXXXXXXXXXXXXXXXX 592
+LPK++R+P ++ S + +N+ +D
Sbjct: 521 NLLPKLHRDPRYG--------NTQSSYATSSSNGAISSNVHGRDNVTFVSPVAVPSSFTS 572
Query: 593 XXXQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRFM-GTNLK 642
Q P +VED++ N+ +E P ++ E HD RK T D G + +
Sbjct: 573 TENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPR 631
Query: 643 LRDLEXXXXXXXXXXXKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT 700
L+D E + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+GT
Sbjct: 632 LKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGT 691
Query: 701 EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760
EVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRGSL
Sbjct: 692 EVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSL 751
Query: 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820
+RILHRP +DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV DF
Sbjct: 752 YRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDF 811
Query: 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMN
Sbjct: 812 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMN 871
Query: 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940
PMQVVGAVGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+P+
Sbjct: 872 PMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPT 931
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 2.7e-180, Sum P(2) = 2.7e-180
Identities = 215/283 (75%), Positives = 247/283 (87%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 726
+ + EI WEDL +GERIG+GSYGEVY A+WNGTEVAVKKFLDQDFSG AL +FK E++I
Sbjct: 598 EAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEI 657
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M RLRHPNVVLFMGAVTRPPN SI+TEFLPRGSL+R+LHRP+ Q+DEKRR++MALDVA+G
Sbjct: 658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKG 717
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
MN LHTS PT+VHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAPE
Sbjct: 718 MNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPE 777
Query: 847 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
VLRNEP+NEKCDVYSFGVILWELAT ++PW G+NPMQVVGAVGFQNRRLEIP ++D VA
Sbjct: 778 VLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVA 837
Query: 907 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 949
+II ECWQT+P LRPSF QL +LK LQ L I + + S +
Sbjct: 838 QIIRECWQTEPHLRPSFTQLMQSLKRLQGLNISNRANTSESLM 880
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 1.1e-171, Sum P(4) = 1.1e-171
Identities = 208/290 (71%), Positives = 249/290 (85%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
DDV +CEI WE++ +GERIGLGSYGEVY DW+GTEVAVKKFLDQD +G AL EF+ EV+
Sbjct: 736 DDVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVR 795
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
IM++LRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE+RR++MALD AR
Sbjct: 796 IMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAAR 855
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGT EWMAP
Sbjct: 856 GMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAP 915
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP +DP +
Sbjct: 916 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAI 975
Query: 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP---SSALPQE 952
A +I +CWQTD LRPSFA++ +LK LQ+ V S+ +P SS+LP E
Sbjct: 976 ADLISKCWQTDSKLRPSFAEIMASLKRLQKPVTGSNIPRPVPSSSSLPTE 1025
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 8.5e-162, Sum P(2) = 8.5e-162
Identities = 201/279 (72%), Positives = 240/279 (86%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
DDV ECEI WE++ + ERIGLGSYGEVY DW+GT VAVKKF+DQD +G AL EF+ EV+
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
+MRRLRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE++R++MALD AR
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+K +T+LSSKSTAGT EWMAP
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAP 882
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP+ +DP +
Sbjct: 883 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGI 942
Query: 906 ARIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPS 940
A II +CWQTDP LRPSF ++ +LK P+QR +PS
Sbjct: 943 ADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAAVPS 981
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 3.4e-126, Sum P(2) = 3.4e-126
Identities = 176/272 (64%), Positives = 215/272 (79%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGM 787
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939
II CW +P RPSFA + L+PL + +P
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 167/277 (60%), Positives = 213/277 (76%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D + E EI W+DL +GE++G GS G VYH W G++VAVK F Q++S +
Sbjct: 477 KVDT--DSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIE 534
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
FK+EV +M+RLRHPNV+LFMGAVT P L I++EFLPRGSLFR+L + ++D +RRI
Sbjct: 535 SFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIH 594
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838
MALD+ARGMN LH +P I+HRDLKS NLLVDKNW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 595 MALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKG 654
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF ++RLEIP
Sbjct: 655 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIP 714
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
K++DP ++ CW +D LRP+F +L L+ LQR
Sbjct: 715 KDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQR 751
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
Identities = 163/265 (61%), Positives = 205/265 (77%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
CEI WEDL LGE +G GS+ V+ WNG++VA+K + D D++ L E K+E+ IM++L
Sbjct: 461 CEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKL 520
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
RHPNV+LFMGAV +II E++PRGSLF+ILH + +D+KRR++MALDVARGMN L
Sbjct: 521 RHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNYL 580
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H P IVHRDLKS NLLVDKNWNVKV DFGLS+ K+ TFLS+KS GTP+WMAPEVLR+
Sbjct: 581 HRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRS 640
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
EPSNEKCDV+SFGVILWEL T +PW +N +QVVG VGF +RRL++P+ L+P +A II
Sbjct: 641 EPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASIIQ 700
Query: 911 ECWQTDPSLRPSFAQLTVALKPLQR 935
+CWQTDP+ RPSF +L + L R
Sbjct: 701 DCWQTDPAKRPSFEELISQMMSLFR 725
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 165/277 (59%), Positives = 208/277 (75%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D D + EI WEDL +GE+IG GS G VYH W G++VAVK F Q++S +
Sbjct: 470 KVDM--DSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIIT 527
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
FK+EV +M+RLRHPNV+LFMGAV P L I+TEFLPRGSLFR+L R ++D +RRI
Sbjct: 528 SFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIH 587
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838
MA D+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L++ G
Sbjct: 588 MASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR-G 646
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
TP+WMAPEVLRNE ++EK DVYSFGV+LWEL T K+PW +N MQV+GAVGF N+RLE+P
Sbjct: 647 TPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVP 706
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
K++DP ++ CW ++P RPSF +L L+ LQR
Sbjct: 707 KDVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQR 743
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 159/255 (62%), Positives = 199/255 (78%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D D E EI W+DL +GE+IG GS G VYH W G++VAVK F Q++S + +
Sbjct: 417 KVD--IDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIK 474
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F++EV +M+RLRHPNV+LFMGAVT P L I++EF+PRGSLFR+L R ++D +RRI
Sbjct: 475 SFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKLDWRRRIN 534
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838
MALD+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 535 MALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKG 594
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF N+RLEIP
Sbjct: 595 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIP 654
Query: 899 KELDPLVARIIWECW 913
K+ DP +I CW
Sbjct: 655 KDTDPDWISLIESCW 669
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 667 (239.9 bits), Expect = 3.6e-84, Sum P(3) = 3.6e-84
Identities = 125/259 (48%), Positives = 181/259 (69%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E +I + +L +G R+G+G +GEV+ WNGT+VA+K FL+QD + + +F E+ I+ R
Sbjct: 511 EWDIDFSELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSR 570
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGM 787
+RHPNVVLF+GA T+PP LS+ITE++ GSL+ ++H ++ RR++M D+ RG+
Sbjct: 571 VRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGL 630
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
C+H IVHRDLKS N LVDK+W VK+ DFGLSR+ + + S+AGTPEWMAPE+
Sbjct: 631 MCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPEL 688
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+RN P EKCD++S GVI+WEL+TL+ PW G+ P +VV AV + RLEIP PL ++
Sbjct: 689 IRNRPFTEKCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPD--GPL-SK 745
Query: 908 IIWECWQTDPSLRPSFAQL 926
+I +CW +P RP+ ++
Sbjct: 746 LIADCW-AEPEERPNCEEI 763
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FPR3 | EDR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5852 | 0.9478 | 0.9742 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00130329 | SubName- Full=Putative uncharacterized protein; (967 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 959 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 4e-99 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-73 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-71 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-65 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-56 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-50 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-48 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-46 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-45 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-44 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-43 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-41 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-40 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-40 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-40 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-39 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-39 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-39 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-37 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-37 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-37 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-36 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-35 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-35 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-35 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-34 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-34 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-34 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-33 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-33 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-33 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-33 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-32 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-31 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-31 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-31 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-31 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-31 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-30 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-30 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-30 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-29 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-29 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-28 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-27 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-26 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-24 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-23 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-20 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.002 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 308 bits (792), Expect = 4e-99
Identities = 114/206 (55%), Positives = 146/206 (70%), Gaps = 6/206 (2%)
Query: 123 DVAAEVLSRQYWEYNVLDYEERVVDGFYDIYG--LSTDPSTQGKLPSLAHLES-NLGNSG 179
+AE LS +YW Y L Y++++ DGFYDIYG +D G++PSL L++ G+S
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 180 FEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLA 239
FEVV+V+R D L+EL Q+A+C+ T+ LVQ+LA LV+ HMGGPVKDA MLA
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCG-TNTAALVQKLAGLVSDHMGGPVKDAESMLA 119
Query: 240 RWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDD 299
RW E S EL+ + V+P+GS+ IGL RHRALLFKVLADSI LPCRLVKG Y G +DD
Sbjct: 120 RWKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCGSDDD 177
Query: 300 AVNIIKLEEEREFLVDLMAAPGTLIP 325
A N++K ++ RE+LVDLM APGTLIP
Sbjct: 178 ASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 1e-73
Identities = 99/258 (38%), Positives = 146/258 (56%), Gaps = 13/258 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G T+VAVK L + S EF E IM++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+V +G T+ L I+TE++P G L L + ++ K ++MAL +A+GM L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 849
+ VHRDL + N LV +N VK+SDFGLSR + K G P +WMAPE L+
Sbjct: 120 SK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P+ + +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 909 IWECWQTDPSLRPSFAQL 926
+ +CW DP RP+F++L
Sbjct: 237 MLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 2e-71
Identities = 100/263 (38%), Positives = 141/263 (53%), Gaps = 16/263 (6%)
Query: 678 LVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPNVV +G T L I+ E++ G L L + ++ + AL +ARGM L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAPEVL 848
S +HRDL + N LV +N VK+SDFGLSR ++ G WMAPE L
Sbjct: 120 -SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRWMAPESL 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234
Query: 908 IIWECWQTDPSLRPSFAQLTVAL 930
++ +CW DP RP+F++L L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 5e-70
Identities = 99/258 (38%), Positives = 143/258 (55%), Gaps = 13/258 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCL 790
HPN+V +G T L I+ E++P G L L + + + + AL +ARGM L
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
S +HRDL + N LV +N VK+SDFGLSR ++ P WMAPE L+
Sbjct: 120 E-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
K DV+SFGV+LWE+ TL + P+ GM+ +V+ + + RL P P + ++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 909 IWECWQTDPSLRPSFAQL 926
+ +CW DP RP+F++L
Sbjct: 237 MLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 9e-65
Identities = 76/255 (29%), Positives = 124/255 (48%), Gaps = 17/255 (6%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E++G GS+G+VY A T VA+K + + RE+KI+++L+HPN+V
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L ++ E+ G LF +L + ++ E + + LH+ I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG--I 118
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
VHRDLK N+L+D++ +VK++DFGL+R + GTPE+MAPEVL + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 858 DVYSFGVILWELATLKLPWIGMNPMQVV------GAVGFQNRRLEIPKELDPLVARIIWE 911
D++S GVIL+EL T K P+ G + + + F +I E L+ +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK---- 233
Query: 912 CWQTDPSLRPSFAQL 926
DP R + +
Sbjct: 234 LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 3e-63
Identities = 92/267 (34%), Positives = 140/267 (52%), Gaps = 22/267 (8%)
Query: 682 ERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+++G G++GEVY G TEVAVK L +D S +F +E ++M++L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ------VDEKRRIKMALDVARGMN 788
+G T L ++ E++ G L L RP + K + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAP 845
L + VHRDL + N LV ++ VK+SDFGLSR + G WMAP
Sbjct: 120 YLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E L++ K DV+SFGV+LWE+ TL P+ G++ +V+ + + RL P+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDE 235
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALK 931
+ ++ CWQ DP RP+F++L L+
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 7e-62
Identities = 89/259 (34%), Positives = 136/259 (52%), Gaps = 15/259 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
L ++G GS+G VY A GT VAVK + +RE++I+RRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V + A +L ++ E+ G LF L R + E K+AL + RG+ LH++
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSN 854
I+HRDLK N+L+D+N VK++DFGL++ + S + GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 855 EKCDVYSFGVILWELATLKLPW---IGMNPMQVVGAVGFQNRRLEIPKELDPLVAR---- 907
K DV+S GVIL+EL T K P+ ++ +Q++ + LE + +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL--GPPLEFDEPKWSSGSEEAKD 235
Query: 908 IIWECWQTDPSLRPSFAQL 926
+I +C DPS RP+ ++
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 1e-60
Identities = 81/247 (32%), Positives = 124/247 (50%), Gaps = 40/247 (16%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G +G VY A G +VA+K ++ S + L E RE++I+++L HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
+L ++ E+ GSL +L ++ E +++ L + G+ LH S I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNG-IIHRD 117
Query: 802 LKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDV 859
LK N+L+D N VK++DFGLS+L + K+ GTP +MAPEVL + +EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 919
+S GVIL+EL LK +I + Q DP
Sbjct: 178 WSLGVILYELPELK---------------------------------DLIRKMLQKDPEK 204
Query: 920 RPSFAQL 926
RPS ++
Sbjct: 205 RPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 87/257 (33%), Positives = 133/257 (51%), Gaps = 10/257 (3%)
Query: 677 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+ GE +G GS+G VY A G +AVK S L +RE++I+ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 735 VVLFMGA-VTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V + G+ N L+I E++ GSL +L + ++ E K + G+ LH+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRN 850
+ IVHRD+K N+LVD + VK++DFG ++ + + S GTP WMAPEV+R
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARII 909
E D++S G + E+AT K PW + NPM + +G EIP+ L +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237
Query: 910 WECWQTDPSLRPSFAQL 926
+C + DP RP+ +L
Sbjct: 238 RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 96/262 (36%), Positives = 142/262 (54%), Gaps = 13/262 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++L LG IG G +G+V D+ G +VAVK D A F E +M LR
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTLR 58
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCL 790
HPN+V +G V + L I+TE++ +GSL L R + +++ ALDV GM L
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
VHRDL + N+LV ++ KVSDFGL++ S K P +W APE LR
Sbjct: 119 EEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPEALR 172
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + K DV+SFG++LWE+ + ++P+ + VV V + R+E P+ P V ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKV 231
Query: 909 IWECWQTDPSLRPSFAQLTVAL 930
+ +CW+ DP+ RP+F QL L
Sbjct: 232 MKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 89/265 (33%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNG T+VAVK S A L+ E +IM++L
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDV 783
RH +V + + I+TE++ +GSL L VD MA +
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQI 112
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EW 842
A GM L + +HRDL + N+LV +N K++DFGL+RL + +++ A P +W
Sbjct: 113 AEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
APE K DV+SFG++L E+ T ++P+ GM +V+ V + R+ P
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNC 229
Query: 902 DPLVARIIWECWQTDPSLRPSFAQL 926
+ ++ +CW DP RP+F L
Sbjct: 230 PEELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 98/267 (36%), Positives = 147/267 (55%), Gaps = 11/267 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ D+ + ++G G YGEVY W VAVK L +D + EF +E +M+
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKED--TMEVEEFLKEAAVMKE 58
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMN 788
++HPN+V +G TR P IITEF+ G+L L + Q V+ + MA ++ M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 847
L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W APE
Sbjct: 119 YLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
L + K DV++FGV+LWE+AT + P+ G++ QV + + R+E P+ P V
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235
Query: 907 RIIWECWQTDPSLRPSFAQLTVALKPL 933
++ CWQ +PS RPSFA++ A + +
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 79/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
LG+ IG G++G VY + G VA+K+ + AL +E+ +++ L+HPN+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
++G++ +L II E+ GSL +I+ + E V +G+ LH +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQ--GV 120
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
+HRD+K+ N+L K+ VK++DFG++ +L + S GTP WMAPEV+ ++
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 916
D++S G + EL T P+ +NPM + + Q+ +P+ + P + + +C+Q D
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD 238
Query: 917 PSLRPSFAQL 926
P+LRP+ QL
Sbjct: 239 PNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 8e-46
Identities = 74/252 (29%), Positives = 130/252 (51%), Gaps = 16/252 (6%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+G+VY +G +K+ + + AL EVKI+++L HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL----NEVKILKKLNHPNIIK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 794
+ + L I+ E+ G L +I + E++ + + + + LH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I+HRD+K N+ + N VK+ DFG+S++ +T +K+ GTP +++PE+ +N+P N
Sbjct: 124 --ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
K D++S G +L+EL TLK P+ G N +++ + IP + + ++ Q
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQ 240
Query: 915 TDPSLRPSFAQL 926
DP RPS AQ+
Sbjct: 241 KDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 86/268 (32%), Positives = 134/268 (50%), Gaps = 28/268 (10%)
Query: 684 IGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V ++ G +VAVK L+ +F+RE++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G +P +L +I E+LP GSL L R Q++ KR + + + +GM+ L +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEP 852
+HRDL + N+LV+ VK+SDFGL+++ + + K +P W APE LR
Sbjct: 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 853 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 898
+ DV+SFGV L+EL T L++ I M V + + RL P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQL 926
V ++ CW+ +P RPSFA L
Sbjct: 249 PSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 88/262 (33%), Positives = 133/262 (50%), Gaps = 8/262 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E P E+ L ++G G +GEV+ W VA+K L D +F++EV+ ++RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSD-DLLKQQDFQKEVQALKRL 59
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNC 789
RH +++ + + IITE + +GSL L P QV I MA VA GM
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
L +HRDL + N+LV ++ KV+DFGL+RL S +W APE
Sbjct: 120 LEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + K DV+SFG++L+E+ T ++P+ GMN +V + R+ P + + +I
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236
Query: 909 IWECWQTDPSLRPSFAQLTVAL 930
+ ECW +P RPSF L L
Sbjct: 237 MLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 84/261 (32%), Positives = 138/261 (52%), Gaps = 23/261 (8%)
Query: 675 WEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
+E L E+IG G +GEVY A G EVA+K + S + E++I+++ +H
Sbjct: 2 FEIL---EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKH 56
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLH 791
PN+V + G+ + L I+ EF GSL +L + Q + +I + ++ +G+ LH
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
++ I+HRD+K+ N+L+ + VK+ DFGLS +T + + GTP WMAPEV+ +
Sbjct: 116 SNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGK 172
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPKELDPLV 905
P + K D++S G+ ELA K P+ + PM+ G G +N P++
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEKWSDEF 227
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
+ +C Q +P RP+ QL
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 9e-44
Identities = 85/261 (32%), Positives = 130/261 (49%), Gaps = 14/261 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EI + L ++G G +GEV+ WN T VAVK +F E +IM++L
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGM 787
RHP ++ T + I+TE + GSL L ++ + I MA VA GM
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL--IDMAAQVASGM 116
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
L +HRDL + N+LV +N KV+DFGL+R +K + + + + +W APE
Sbjct: 117 AYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 847 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ K DV+SFG++L E+ T ++P+ GM +V+ V Q R+ P +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
I+ +CW+ DP RP+F L
Sbjct: 234 YDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 88/280 (31%), Positives = 144/280 (51%), Gaps = 23/280 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P E + L +G GS+G VY G T VA+K ++++ S +EF E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT-VNENASMRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP---HCQV----DEKR 775
+M+ +VV +G V+ ++ E + +G L L RP + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G P WMAPE L++ K DV+SFGV+LWE+ATL + P+ G++ +V+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932
L++P+ + ++ CWQ +P +RP+F ++ +LK
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 88/254 (34%), Positives = 130/254 (51%), Gaps = 14/254 (5%)
Query: 681 GERIGLGSYGEVYHADWN---GTEVAVK--KFLDQDFSG-AALLEFKREVKIMRRLRHPN 734
GE +G GS+G VY N G AVK D +G A+ + ++E+ ++ +L+HPN
Sbjct: 5 GELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V ++G NL I E +P GSL ++L + + E + G+ LH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE-P 852
VHRD+K N+LVD N VK++DFG++ K S +KS G+P WMAPEV+ +
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
D++S G + E+AT K PW + + V +G IP L I +C
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 913 WQTDPSLRPSFAQL 926
Q DPSLRP+ A+L
Sbjct: 239 LQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 89/258 (34%), Positives = 142/258 (55%), Gaps = 13/258 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ L LGE IG G +G V ++ G +VAVK + D + A LE E +M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQAFLE---ETAVMTKLHHKNL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTST 794
V +G + L I+ E + +G+L L R V + ++ +LDVA GM + +
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME--YLES 118
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
+VHRDL + N+LV ++ KVSDFGL+R+ +SK +W APE L+++ +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFS 175
Query: 855 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
K DV+S+GV+LWE+ + + P+ M+ +V V + R+E P+ V ++ CW
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCW 234
Query: 914 QTDPSLRPSFAQLTVALK 931
+T+P RPSF +L L+
Sbjct: 235 ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKRE 723
D+ P E E+IG G+ GEVY A T EVA+KK E
Sbjct: 9 KDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINE 65
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
+ IM+ +HPN+V + + L ++ E++ GSL I+ + +++E + + +V
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG----LSRLKHNTFLSSKSTAGT 839
+G+ LH+ ++HRD+KS N+L+ K+ +VK++DFG L++ K S GT
Sbjct: 126 LQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGT 179
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----R 894
P WMAPEV++ + K D++S G++ E+A + P++ P++ + F
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPP 235
Query: 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
L+ P++ P + +C DP RPS +L
Sbjct: 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 682 ERIGLGSYGEVYHADW---NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+++G GS+G V +W G VAVK L D + +F +E IM L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTP 795
G V P L ++TE P GSL L + + A+ +A GM L +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+HRDL + N+L+ + VK+ DFGL R + ++ + W APE LR
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ DV+ FGV LWE+ T + PW G++ Q++ + + RLE P+ + ++ +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 912 CWQTDPSLRPSFAQLT 927
CW +P+ RP+FA L
Sbjct: 237 CWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 85/259 (32%), Positives = 134/259 (51%), Gaps = 13/259 (5%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+L + +G G +G V+ W G +VA+K + S +F E K+M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V G T+ + I+TE++ G L L ++ + + M DV M L ++
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-- 119
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
+HRDL + N LV ++ VKVSDFGL+R + + + SS+ T +W PEV +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 855 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWE 911
K DV+SFGV++WE+ + K+P+ + +VV +V G+ RL PK V I++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMYS 236
Query: 912 CWQTDPSLRPSFAQLTVAL 930
CW P RP+F +L L
Sbjct: 237 CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 75/256 (29%), Positives = 130/256 (50%), Gaps = 9/256 (3%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P E + E++G GSYG VY A G VA+K L E +E+ I+++
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCD 56
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P +V + G+ + +L I+ E+ GS+ I+ + + E+ + +G+ LH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
++ +HRD+K+ N+L+++ K++DFG+S +T + GTP WMAPEV++
Sbjct: 117 SNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 910
N K D++S G+ E+A K P+ ++PM+ + + + L P++ P +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234
Query: 911 ECWQTDPSLRPSFAQL 926
+C DP RPS QL
Sbjct: 235 KCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 82/254 (32%), Positives = 134/254 (52%), Gaps = 8/254 (3%)
Query: 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
E+IG G++G+VY TEVAVK +F +E +I+++ HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIG 59
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ + I+ E +P GSL L + ++ K+ ++M+LD A GM L + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHR 117
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKSTAGTP-EWMAPEVLRNEPSNEKCD 858
DL + N LV +N +K+SDFG+SR + + S P +W APE L + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 859 VYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917
V+S+G++LWE +L P+ GM+ Q + R+ P+ + R++ +CW DP
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 918 SLRPSFAQLTVALK 931
RPSF+++ L+
Sbjct: 237 ENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 20/261 (7%)
Query: 680 LGERIGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G +IG G++G+VY A D G +AVK+ QD + E E+K++ L+HPN+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDVARGMNCLHTSTP 795
+ G + I E+ G+L +L H ++ ++ I++ L + G+ LH+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNT---FLSSKSTAGTPEWMAPEVLRNE 851
IVHRD+K N+ +D N +K+ DFG + +LK+NT +S AGTP +MAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 852 PSNEK---CDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPK--ELDPLV 905
D++S G ++ E+AT K PW + N Q++ VG ++ IP +L P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPEG 237
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
+ C ++DP RP+ ++L
Sbjct: 238 KDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 88/256 (34%), Positives = 127/256 (49%), Gaps = 13/256 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+DL + +G G +G V + W G +VA+K + S EF E K+M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V G T+ + I+TE++ G L L H Q + ++M DV GM L +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ--LLEMCKDVCEGMAYLES 118
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+HRDL + N LVD VKVSDFGLSR + + + SS + W PEVL
Sbjct: 119 K--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 852 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
+ K DV++FGV++WE+ +L K+P+ N + V V Q RL P V I++
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMY 235
Query: 911 ECWQTDPSLRPSFAQL 926
CW RP+F QL
Sbjct: 236 SCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 83/268 (30%), Positives = 132/268 (49%), Gaps = 37/268 (13%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E L E IG GS+GEVY A T VA+K +D + + + + ++E++ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ + G+ + L II E+ GS +L +P ++DE + +V G+ LH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KP-GKLDETYIAFILREVLLGLEYLHEE 117
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 847
+HRD+K+ N+L+ + +VK++DFG+S K NTF GTP WMAPEV
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGTPFWMAPEV 169
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
++ +EK D++S G+ ELA + P ++PM+V+ IPK P +
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEG 220
Query: 908 IIWE---------CWQTDPSLRPSFAQL 926
+ C DP RPS +L
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 7e-40
Identities = 94/264 (35%), Positives = 143/264 (54%), Gaps = 21/264 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L +++G G +GEV+ WNG T+VAVK S + LE E +IM++L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK------MALDVA 784
RH +V V+ P + I+TE++ +GSL L + E R +K MA VA
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-----KDGEGRALKLPNLVDMAAQVA 112
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 843
GM + +HRDL+S N+LV K++DFGL+RL + +++ A P +W
Sbjct: 113 AGM--AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE K DV+SFG++L EL T ++P+ GMN +V+ V + R+ P++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
+ ++ +CW+ DP RP+F L
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 90/285 (31%), Positives = 151/285 (52%), Gaps = 30/285 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
E+P + L LG+ +G G++G+V A+ G + VAVK L D + L + E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLVSEM 66
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP-------------H 768
++M+ + +H N++ +G T+ L ++ E+ G+L L RP
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
+ +K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R H+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 829 TFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVV 885
K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 243
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930
+ + R+E P+ + ++ +CW PS RP+F QL L
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 89/255 (34%), Positives = 139/255 (54%), Gaps = 15/255 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
++L L + IG G +G+V D+ G +VAVK + D + A F E +M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHSNL 61
Query: 736 VLFMGA-VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTS 793
V +G V L I+TE++ +GSL L R + +K +LDV M L +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEP 852
VHRDL + N+LV ++ KVSDFGL++ S++ T P +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKK 175
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ K DV+SFG++LWE+ + ++P+ + VV V + +++ P P+V ++ +
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQ 234
Query: 912 CWQTDPSLRPSFAQL 926
CW D + RPSF QL
Sbjct: 235 CWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 16/264 (6%)
Query: 674 PWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK--KFLDQDFSGAALLEFKREVKIMRR 729
P ED L +RIG G+YG+VY A G VA+K K D ++E+ +++
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKE 56
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
RHPN+V + G+ R L I+ E+ GSL I + E + + + +G+
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 848
LH + +HRD+K N+L+ ++ +VK++DFG+S T KS GTP WMAPEV
Sbjct: 117 LHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 849 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV---GAVGFQNRRLEIPKELDP 903
R + KCD+++ G+ ELA L+ P ++PM+ + F +L+ ++ P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234
Query: 904 LVARIIWECWQTDPSLRPSFAQLT 927
+ I +C DP RP+ +L
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 18/265 (6%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADWNGT-----EVAVKKFLDQDFSGAALLEFKREVKIM 727
I + + + IG G +GEV +VA+K S L+F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIM 59
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+ HPN++ G VT+ + IITE++ GSL + L + + + M +A GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TP-EWMA 844
L S VHRDL + N+LV+ N KVSDFGLSR ++ ++ +T G P W A
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EATYTTKGGKIPIRWTA 176
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKEL 901
PE + DV+SFG+++WE+ + + P+ M+ V+ AV G+ RL P +
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDC 233
Query: 902 DPLVARIIWECWQTDPSLRPSFAQL 926
+ +++ +CWQ D + RP+F+Q+
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 89/288 (30%), Positives = 145/288 (50%), Gaps = 31/288 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
EIP + E +G G++G+VY + G T VA+K L ++ EF++E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 779
++M L+HPN+V +G T+ ++ E+L G L F + + PH V +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 780 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829
+LD +A GM L S+ VHRDL + N LV + VK+SDFGLSR ++
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 830 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 886
+ +S + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 887 AVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ ++R+ L P++ V ++ ECW P+ RP F + L+
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 85/257 (33%), Positives = 131/257 (50%), Gaps = 9/257 (3%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+L + +G G +G V+ W +VA+K + S +F E K+M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V G T+ L I+TEF+ G L L + ++ + + M DV GM L +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSN 854
+ +HRDL + N LV VKVSDFG++R + +S S A P +W PEV +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 855 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
K DV+SFGV++WE+ T K+P+ + +VV + + RL PK V +++ CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCW 238
Query: 914 QTDPSLRPSFAQLTVAL 930
P RP+FA+L A+
Sbjct: 239 HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 17/258 (6%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKF-LDQDFSGAA--LLEFKREVKIMRRLRHP 733
G+ +G G++G VY D G E+AVK+ D D + + E+++++ L+H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V + G + LSI E++P GS+ L + R K + G+ LH++
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN 123
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLK----HNTFLSSKSTAGTPEWMAPEVL 848
IVHRD+K N+L D NVK+ DFG S RL+ T + KS GTP WM+PEV+
Sbjct: 124 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGTPYWMSPEVI 179
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
E K DV+S G + E+ T K PW M + + Q ++P + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 909 IWECWQTDPSLRPSFAQL 926
+ + + RPS +L
Sbjct: 240 LRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
+ + +VL +G G++G+V+ + + VAVK L + S A +F+RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR-------------PHCQV 771
+++ +H N+V F G T ++ E++ G L + L P ++
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 772 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-F 830
+ +++A+ +A GM L ++ VHRDL + N LV + VK+ DFG+SR + T +
Sbjct: 120 TLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 831 LSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 888
P WM PE + + DV+SFGV+LWE+ T K PW G++ +V+ +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 923
Q R L+ P+ V I+ CW+ DP R +
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 90/264 (34%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT VA+K S A L+ E ++M++L
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 789
RH +V V+ P + I+TE++ +GSL L + + + + MA +A GM
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM-- 115
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W APE
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 234
Query: 908 IIWECWQTDPSLRPSFAQLTVALK 931
++ +CW+ +P RP+F L L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 80/248 (32%), Positives = 132/248 (53%), Gaps = 7/248 (2%)
Query: 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
E +G G++GEV+ + T VAVK +D ++F E +I+++ HPN+V +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
T+ + I+ E +P G L + ++ K+ +K ALD A GM + + +HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGM--AYLESKNCIHR 117
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDV 859
DL + N LV +N +K+SDFG+SR + + SS P +W APE L + + DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 860 YSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918
+S+G++LWE +L + P+ GM Q V + R+ P++ V +++ CW P
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236
Query: 919 LRPSFAQL 926
RP F++L
Sbjct: 237 NRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 86/264 (32%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E+P E L L +++G G +GEV+ +NG T+VA+K S A L E +M++L
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 789
+HP +V VT+ P + IITE++ GSL L P ++ + I MA +A GM
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ +HRDL++ N+LV + K++DFGL+RL + +++ A P +W APE +
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P +
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYE 234
Query: 908 IIWECWQTDPSLRPSFAQLTVALK 931
++ CW+ P RP+F L L+
Sbjct: 235 LMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 80/259 (30%), Positives = 129/259 (49%), Gaps = 15/259 (5%)
Query: 682 ERIGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G++G V + +G EV V K L Q+ A EF RE +M +L HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+G V + L ++ E P G L + L + ++ ++A VA GM L +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH--F 116
Query: 798 VHRDLKSPN-LLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPS 853
VHRDL + N LLV+++ K+SDFG+SR + + + + P +W APE +
Sbjct: 117 VHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 854 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+ K DV+S+GV LWE + P+ M +V+ + RL P+E + I+ C
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234
Query: 913 WQTDPSLRPSFAQLTVALK 931
W+ P RP+F++L +
Sbjct: 235 WKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 29/264 (10%)
Query: 682 ERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRH 732
E IG GS+G V D G + K+ D+ + E ++ EV I+R L+H
Sbjct: 6 ETIGKGSFGTVRKVRRKSD--GKILVWKEI---DYGN--MTEKEKQQLVSEVNILRELKH 58
Query: 733 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMALDVAR 785
PN+V + + N L I+ E+ G L +++ + C+ ++E+ ++ +
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEFIWRILTQLLL 116
Query: 786 GMNCLHT---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ H T++HRDLK N+ +D N NVK+ DFGL+++ + +K+ GTP +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
M+PE L + +EK D++S G +++EL L P+ N +Q+ + + + IP
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYS 235
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
+ +I DP RPS +L
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 87/256 (33%), Positives = 137/256 (53%), Gaps = 11/256 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT +VA+K A L+ E +IM++L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 789
RH +V V+ P + I+TEF+ +GSL L + + + + MA +A GM
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ +HRDL++ N+LV N K++DFGL+RL + +++ A P +W APE
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P+ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234
Query: 908 IIWECWQTDPSLRPSF 923
++ CW+ DP RP+F
Sbjct: 235 LMKLCWKKDPDERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 89/267 (33%), Positives = 141/267 (52%), Gaps = 17/267 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L +++G G +GEV+ A +N T+VAVK S A L E +M+ L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNC 789
+H +V VT+ P + IITEF+ +GSL L + + I + +A GM
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM-- 115
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+HRDL++ N+LV + K++DFGL+R+ + +++ A P +W APE +
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDPL 904
K DV+SFG++L E+ T ++P+ GM+ +V+ A+ G++ R E P+EL
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL--- 232
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALK 931
I+ CW+ P RP+F + L
Sbjct: 233 -YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 84/256 (32%), Positives = 130/256 (50%), Gaps = 13/256 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+L L + IG G +G V+ W +VA+K + S +F E ++M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V G T + ++ EF+ G L L + ++ + M LDV GM L +S
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS- 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK-HNTFLSSKSTAGTPEWMAPEVLRNEPS 853
++HRDL + N LV +N VKVSDFG++R + + SS T +W +PEV
Sbjct: 120 -NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 854 NEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIW 910
+ K DV+SFGV++WE+ + K P+ + +VV + GF RL P+ V ++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 911 ECWQTDPSLRPSFAQL 926
CW+ P RPSF+ L
Sbjct: 236 HCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 83/261 (31%), Positives = 124/261 (47%), Gaps = 10/261 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA---DWNGTEVAVK-KFLDQDFSGAALLEFKREVKIM 727
EI ED+ LG IG G +G+VY ++AV K S + +F +E IM
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
R+ HP++V +G +T P + I+ E P G L L +D I + ++ +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 846
L + VHRD+ + N+LV VK+ DFGLSR + S P +WMAPE
Sbjct: 121 AYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 847 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ DV+ FGV +WE+ L P+ G+ V+G + RL +P P +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTL 237
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
++ +CW DPS RP F +L
Sbjct: 238 YSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 88/266 (33%), Positives = 142/266 (53%), Gaps = 16/266 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E + L +++G G +GEV+ + N T+VAVK S A LE E +M+ L
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 789
+H +V VT+ + IITE++ +GSL L +V + I + +A GM
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM-- 116
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ +HRDL++ N+LV ++ K++DFGL+R+ + +++ A P +W APE +
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDPL 904
K DV+SFG++L+E+ T K+P+ GM+ V+ A+ G++ R+E P EL
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL--- 233
Query: 905 VARIIWECWQTDPSLRPSFAQLTVAL 930
I+ CW+ RP+F L L
Sbjct: 234 -YDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 19/276 (6%)
Query: 678 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L + +G G++G VY W VA+K + + S A E E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP+VV +G + + +IT+ +P G L + + + + + +A+GM+ L
Sbjct: 68 HPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL- 125
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 849
+VHRDL + N+LV +VK++DFGL++L + G P +WMA E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV+S+GV +WEL T P+ G+ +++ + + RL P V +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMV 243
Query: 909 IWECWQTDPSLRPSFAQLT-----VALKPLQRLVIP 939
+ +CW D RP+F +L +A P + LVI
Sbjct: 244 LVKCWMIDAESRPTFKELINEFSKMARDPQRYLVIQ 279
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 4e-34
Identities = 87/285 (30%), Positives = 146/285 (51%), Gaps = 29/285 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVY--HADWNGTE----VAVKKFLDQDFSGAALLEFKREVK 725
E+P + E +G ++G++Y H G + VA+K D + + EF++E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEAS 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPH----CQVDEKRRIKM 779
+M L HPN+V +G VT+ + ++ E+L +G L F I+ PH C DE +K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 780 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829
+LD +A GM L S+ VH+DL + N+L+ + +VK+SD GLSR ++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 830 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 886
+ + + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
V + + L ++ P + ++ ECWQ PS RP F + L+
Sbjct: 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 684 IGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV+ A G E V VK EF+RE+ + R+L H NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE--------KRRIKMALDVARGMN 788
+G +I E+ G L + L + ++ K+++ + +A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 847
H S VHRDL + N LV VKVS LS+ +N+ A P W+APE
Sbjct: 132 --HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 848 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
++ + + K DV+SFGV++WE+ T +LP+ G++ +V+ + L +P+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 907 RIIWECWQTDPSLRPSFAQLTVAL 930
+++ CW +P RPSF++L AL
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-34
Identities = 84/263 (31%), Positives = 128/263 (48%), Gaps = 15/263 (5%)
Query: 682 ERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
E IG G +GEV VA+K L ++ +F E IM + HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
G VT+ + IITEF+ G+L L + Q + + M +A GM L S
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEMN 126
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNE 851
VHRDL + N+LV+ N KVSDFGLSR + T+ SS W APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 852 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
DV+S+G+++WE+ + + P+ M+ V+ A+ Q+ RL P + + +++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLML 245
Query: 911 ECWQTDPSLRPSFAQLTVALKPL 933
+CWQ D + RP F Q+ L +
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 93/299 (31%), Positives = 144/299 (48%), Gaps = 53/299 (17%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
E P + L E++G G +GEV+ + +G + VAVK L D S
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDAS 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
A +F +EVKI+ RL PN+ +G T P L +I E++ G L + L + H
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK-HVAETS 118
Query: 774 KRR-----------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822
+ MA +A GM + + VHRDL + N LV KN+ +K++DFG+
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMR--YLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 823 SR-LKHNTFLSSKSTAGTP-EWMAPE-VLRNEPSNEKCDVYSFGVILWELATL--KLPWI 877
SR L + + + A P WMA E VL + + K DV++FGV LWE+ TL + P+
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYE 235
Query: 878 GMNPMQVVGAVG--FQNRRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ QV+ G F++ +I PK+ + ++ ECW+ D RP+F ++
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 27/270 (10%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKF------LDQDFSG-----AALLEFKREVK 725
V GE IG G+YG VY A G +AVK+ + S AL + E++
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL---RSEIE 60
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
++ L H N+V ++G T LSI E++P GS+ L R + + +E+ V
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLE 119
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 843
G+ LH+ I+HRDLK+ NLLVD + K+SDFG+S+ + + + ++ + G+ WM
Sbjct: 120 GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 844 APEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
APEV+ + + K D++S G ++ E+ + PW + + +G + IP ++
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237
Query: 902 DPLVARI----IWECWQTDPSLRPSFAQLT 927
++ + + C+ +P RP+ +L
Sbjct: 238 SMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 88/279 (31%), Positives = 145/279 (51%), Gaps = 23/279 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 775
+M+ +VV +G V++ +I E + RG L L RP + + K+
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 121 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 836 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G WM+PE L++ DV+SFGV+LWE+ATL + P+ GM+ QV+ V +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 91/283 (32%), Positives = 139/283 (49%), Gaps = 30/283 (10%)
Query: 675 WEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
WED+ + IG G++G+V A D A+K L + S +F E++++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCKL 59
Query: 731 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEK 774
HPN++ +GA L I E+ P G+L L H + +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 775 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834
+ ++ A DVA GM L S +HRDL + N+LV +N K++DFGLSR + + K
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE---VYVK 174
Query: 835 STAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQ 891
T G WMA E L K DV+SFGV+LWE+ +L P+ GM ++ + Q
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 233
Query: 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
R+E P+ D V ++ +CW+ P RP FAQ++V L +
Sbjct: 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 71/261 (27%), Positives = 127/261 (48%), Gaps = 19/261 (7%)
Query: 681 GERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLRHPN 734
G+++G G++ Y A GT +AVK+ + + + ++E+++M RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
++ +GA + ++ E++ GS+ +L + + E I + RG++ LH +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 795 PTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKST-----AGTPEWMAPEVL 848
I+HRD+K NLL+D ++++DFG + + + GT +MAPEVL
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRLEIPKELDPLV 905
R E CDV+S G ++ E+AT K PW N + ++ + IP+ L P +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
+ C + P RP +L
Sbjct: 241 RDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 91/283 (32%), Positives = 151/283 (53%), Gaps = 32/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G +G+V A+ G T+VAVK L D + L +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLIS 72
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-----------HRPHCQ 770
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L + P
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 771 VDEKRRIK----MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
+E+ K A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H+ K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 249
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ + + R++ P + ++ +CW PS RP+F QL
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 4e-33
Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 44/288 (15%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLD-------QDFSGAALLEFK 721
+ W D+ + IG G++G+V A D + A+K+ + +DF+G
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG------- 56
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 765
E++++ +L HPN++ +GA L + E+ P G+L F I +
Sbjct: 57 -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115
Query: 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825
+ ++ + A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 826 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 882
+ + K T G WMA E L DV+S+GV+LWE+ +L P+ GM
Sbjct: 174 QE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230
Query: 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930
++ + Q RLE P D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 231 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 30/279 (10%)
Query: 678 LVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
L LG+ +G G +G V + + VAVK + + + EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 733 PNVVLFMG------AVTRPPNLSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMAL 781
PNV+ +G ++ + P +I F+ G L L + + +K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP 840
D+A GM L S +HRDL + N ++ ++ V V+DFGLS+ ++ + A P
Sbjct: 121 DIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 841 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-----AVGFQNRR 894
+W+A E L + K DV++FGV +WE+AT G P V R
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-----GQTPYPGVENHEIYDYLRHGNR 233
Query: 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
L+ P++ + +++ CW+ DP RP+F +L L+ +
Sbjct: 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 24/264 (9%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLR 731
DL + +G GS G VY G A+KK + LL RE+K +R
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P VV GA + +SI+ E++ GSL L + ++ E +A + +G++ LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAP 845
T I+HRD+K NLL++ VK++DFG+S++ + NTF+ GT +M+P
Sbjct: 117 T-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSP 169
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWI---GMNPMQVVGAVGFQNRRLEIPKELD 902
E ++ E + D++S G+ L E A K P++ + +++ A+ +E
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS 229
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
P I C Q DP RPS A+L
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-32
Identities = 83/253 (32%), Positives = 131/253 (51%), Gaps = 19/253 (7%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
ERIG G++GEV+ + T VAVK + L D +F +E +I+++ HPN+V
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA----KFLQEARILKQYSHPNIV 56
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+G T+ + I+ E + G L ++ K I+M + A GM L +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK--H 114
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WMAPEVLRNEP 852
+HRDL + N LV + +K+SDFG+SR + + + ST G + W APE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGMKQIPVKWTAPEALNYGR 172
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ + DV+SFG++LWE +L +P+ ++ Q A+ Q RL P+ V R++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMER 231
Query: 912 CWQTDPSLRPSFA 924
CW+ DP RPSF+
Sbjct: 232 CWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 30/277 (10%)
Query: 684 IGLGSYGEV----YH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G V Y D G VAVKK Q + L +F+RE++I++ L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G NL ++ E+LP GSL L + ++D ++ + A + +GM L +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--GSK 127
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPE-WMAPEVLRNEP 852
VHRDL + N+LV+ VK+ DFGL+++ + + + +P W APE L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 853 SNEKCDVYSFGVILWELAT----------LKLPWIGMN---PMQVVGAVGF--QNRRLEI 897
+ DV+SFGV+L+EL T + +G + M V + N RL
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA 247
Query: 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
P + I+ ECW DPS RPSF++L + ++ ++
Sbjct: 248 PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 82/255 (32%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 684 IGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G +G VYH D AVK L++ + +F +E IM+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 739 MGAVTRPPNLS-IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+G ++ ++ G L + K I L VA+GM L ++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--ASKKF 119
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTP-EWMAPEVLRNEPS 853
VHRDL + N ++D+++ VKV+DFGL+R K + + + A P +WMA E L+ +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 854 NEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKEL-DPLVARIIWE 911
K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ DPL ++
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLY-EVMLS 237
Query: 912 CWQTDPSLRPSFAQL 926
CW P +RP+F++L
Sbjct: 238 CWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 71/248 (28%), Positives = 120/248 (48%), Gaps = 10/248 (4%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G GSYG VY A+K+ S + E++I+ + HPN++ + A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPTIV 798
L I+ E+ P G L + + + + + E+ ++ + + RG+ LH I+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--IL 125
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
HRDLKS N+L+ N VK+ D G+S++ K+ GTP +MAPEV + P + K D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 859 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918
++S G +L+E+AT P+ + MQ + + + IP + I Q P
Sbjct: 184 IWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPK 242
Query: 919 LRPSFAQL 926
LRP+ ++
Sbjct: 243 LRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 88/290 (30%), Positives = 150/290 (51%), Gaps = 32/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E P + LVLG+ +G G +G+V A+ G + VAVK L + + L +
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLIS 66
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +G T+ L +I E+ +G+L F I
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H+ K++ G +WMAPE L + + DV+SFG+++WE+ TL P+ G+ P++
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + + R++ P + ++ ECW P+ RP+F QL AL +
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 64/253 (25%), Positives = 124/253 (49%), Gaps = 6/253 (2%)
Query: 677 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
D + +IG GS+G V+ + A+K+ + E E +++ +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTS 793
++ + + L+I+ E+ G L ++L + + E + + + + G+ LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I+HRD+KS NL +D NVK+ D G+++L + + + GTP +++PE+ ++P
Sbjct: 121 K--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
NEK DV++ GV+L+E T K P+ N ++ + + + + +A++I +C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 914 QTDPSLRPSFAQL 926
D RP QL
Sbjct: 238 TKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 41/294 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P ++ IG G++G V+ A G T VAVK L ++ S +F+RE
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREA 59
Query: 725 KIMRRLRHPNVVLFMG--AVTRPPNLSIITEFLPRGSLFRILHR---------------- 766
+M HPN+V +G AV +P + ++ E++ G L L
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 767 -----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ ++ +A VA GM + S VHRDL + N LV +N VK++DFG
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGM--AYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 822 LSRLKHNT--FLSSKSTAGTPEWMAPE-VLRNEPSNEKCDVYSFGVILWELATLKL-PWI 877
LSR ++ + +S++ A WM PE + N + E DV+++GV+LWE+ + + P+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYY 234
Query: 878 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
GM +V+ V N L P + ++ CW PS RPSFA + L+
Sbjct: 235 GMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/262 (29%), Positives = 136/262 (51%), Gaps = 21/262 (8%)
Query: 681 GERIGLGSYGEVY---HADWNGTEVAVKKF------LDQDFSGAALLE-FKREVKIMRRL 730
G IG GS+G VY +A +G +AVK+ ++L+ RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
+H N+V ++G+ +L+I E++P GS+ +L+ + +E + +G+N L
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYL 122
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK------STAGTPEWMA 844
H I+HRD+K N+LVD +K+SDFG+S+ LS+K S G+ WMA
Sbjct: 123 HNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
PEV++ K D++S G ++ E+ T K P+ +Q + +G +N EIP +
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSE 239
Query: 905 VARIIWECWQTDPSLRPSFAQL 926
+ + ++ D + RP+ A+L
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 88/263 (33%), Positives = 132/263 (50%), Gaps = 25/263 (9%)
Query: 681 GERIGLGSYGEVYHADWN-GTEVAVKKF-LDQDFSGAALLEFKR---EVKIMRRLRHPNV 735
GE +G G+YG VY N G +AVK+ LD AA E+++ EV +++ L+H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTS 793
V ++G +SI EF+P GS+ IL+R P + + K LD G+ LH +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNN 121
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--------LKHNTFLSSKSTAGTPEWMAP 845
+VHRD+K N+++ N +K+ DFG +R H+ L KS GTP WMAP
Sbjct: 122 C--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAP 177
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903
EV+ K D++S G ++E+AT K P M+ + + +G +R L +P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSA 236
Query: 904 LVARIIWECWQTDPSLRPSFAQL 926
+ C D RPS QL
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 29/269 (10%)
Query: 676 EDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 728
D+VL +G G++G+V+ A + + VAVK ++ S +A +F+RE +++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR---------- 776
L+H ++V F G T L ++ E++ G L R L H P ++
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 777 --IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLS 832
+ +A +A GM ++ ++ VHRDL + N LV + VK+ DFG+SR ++T +
Sbjct: 123 QMLAIASQIASGM--VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 891
T WM PE + + D++SFGV+LWE+ T K PW ++ + + + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 892 NRRLEIPKELDPLVARIIWECWQTDPSLR 920
R LE P+ P V I+ CWQ +P R
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 24/276 (8%)
Query: 678 LVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
LG +G G +G V A D + +VAVK FS + + EF RE M+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 733 PNVVLFMG------AVTRPPNLSIITEFLPRGSLF------RILHRPHCQVDEKRRIKMA 780
PNV+ +G A R P +I F+ G L RI P + + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTLVRFM 119
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
+D+A GM L S+ +HRDL + N ++++N V V+DFGLS+ + + +
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 897
P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ + + RL+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQ 236
Query: 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
P + V ++ +CW +P RPSF L L+ +
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 84/274 (30%), Positives = 137/274 (50%), Gaps = 43/274 (15%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T + A K + + S L +F E+ I+ +HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V A L I+ EF G+L I+ + E + + + +N LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 847
++HRDLK+ N+L+ + +VK++DFG+S K +TF+ GTP WMAPEV
Sbjct: 123 K--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174
Query: 848 L-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+ ++ P + K D++S G+ L ELA ++ P +NPM+V+ L+I K
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEP 225
Query: 903 PLVAR----------IIWECWQTDPSLRPSFAQL 926
P + + + C DP RP+ A+L
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 77/261 (29%), Positives = 126/261 (48%), Gaps = 38/261 (14%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFM 739
+IG G + VY A +G VA+KK + A A + +E+ ++++L HPNV+ ++
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPT 796
+ L+I+ E G L R++ Q + E+ K + + + +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-- 126
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRNE 851
I+HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQN-RRLEIP--------KE 900
N K D++S G +L+E+A L+ P+ G MN + + + + P +E
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEKCDYPPLPADHYSEE 236
Query: 901 LDPLVARIIWECWQTDPSLRP 921
L LV+R C DP RP
Sbjct: 237 LRDLVSR----CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 81/258 (31%), Positives = 128/258 (49%), Gaps = 11/258 (4%)
Query: 684 IGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G +GEV E+ V K L ++ +F E IM + HPN++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G VT+ + I+TE++ GSL L + Q + + M +A GM L S VH
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVH 129
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 856
RDL + N+LV+ N KVSDFGLSR+ + ++ +T G W APE +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 857 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+G+++WE+ + + P+ M+ V+ A+ + RL P + + +++ +CWQ
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQK 248
Query: 916 DPSLRPSFAQLTVALKPL 933
D + RP F Q+ L L
Sbjct: 249 DRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 90/296 (30%), Positives = 143/296 (48%), Gaps = 40/296 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE----------------VAVKKFLDQDFSGA 715
E P + L L E++G G +GEV+ + G VAVK L D +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKT 59
Query: 716 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----- 770
A +F +E+KIM RL++PN++ +G L +ITE++ G L + L + +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 771 ------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
V + MA+ +A GM L ++ VHRDL + N LV ++ +K++DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 825 -LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGMN 880
L + + A P WMA E + DV++FGV LWE+ TL + P+ ++
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
Query: 881 PMQVVGAVG--FQNRRLEIPKELDPL----VARIIWECWQTDPSLRPSFAQLTVAL 930
QV+ G F+N+ +I PL V +++ CW D RP+F ++ L
Sbjct: 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 32/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E + L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVS 69
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + I
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + VARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
+N K+T G +WMAPE L + + DV+SFGV++WE+ TL P+ G+ P++
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 246
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ + + R++ P + ++ +CW PS RP+F QL
Sbjct: 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 86/271 (31%), Positives = 138/271 (50%), Gaps = 30/271 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+D L E IG+G+ VY A N +VA+K+ +D + ++ E ++EV+ M + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLH 791
NVV + + L ++ +L GSL I+ P +DE + +V +G+ LH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----------RLKHNTFLSSKSTAGTPE 841
++ +HRD+K+ N+L+ ++ +VK++DFG+S R TF GTP
Sbjct: 120 SNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------VGTPC 171
Query: 842 WMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIP 898
WMAPEV+ + K D++SFG+ ELAT P+ PM+V+ + QN LE
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLETG 230
Query: 899 KELDP---LVARIIWECWQTDPSLRPSFAQL 926
+ ++I C Q DPS RP+ +L
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 84/260 (32%), Positives = 129/260 (49%), Gaps = 15/260 (5%)
Query: 684 IGLGSYGEVYHADWN---GTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G +GEV+ EVAV K L ++ +F E IM + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G VT+ IITE++ G+L + L + + + M +A GM L S VH
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVH 130
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 856
RDL + N+LV+ N KVSDFGLSR+ + + +T+G W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 857 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECW 913
DV+SFG+++WE+ + + P+ M+ +V+ A+ GF RL P + V +++ +CW
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQCW 247
Query: 914 QTDPSLRPSFAQLTVALKPL 933
Q D + RP F + L L
Sbjct: 248 QQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 92/283 (32%), Positives = 149/283 (52%), Gaps = 32/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E+ L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVS 66
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RP--------HCQV 771
E+++M+ + +H N++ +GA T+ L ++ E+ +G+L L RP C++
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 772 DE-----KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
E K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
HN K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 243
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ + + R++ P + I+ ECW PS RP+F QL
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 87/274 (31%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVY-----HADWNGTEVAVK-KFLDQDFSGAALLEFKREVK 725
E+P + + L +G G++GEVY D + E+ V K L + S +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 726 IMRRLRHPNVVLFMG-AVTRPPNLSIITEFLPRGSLFRILH--RPH----CQVDEKRRIK 778
IM + H N+V +G + R P I+ E + G L L RP + K +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPN-LLVDKNWN--VKVSDFGLSR-LKHNTFLSSK 834
A DVA+G L + +HRD+ + N LL K K++DFG++R + ++
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 835 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
A P +WM PE + K DV+SFGV+LWE+ +L +P+ G +V+ V
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
RL+ PK V RI+ +CWQ P RP+FA +
Sbjct: 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 17/280 (6%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVL 737
E IG G+YG VY T V K ++ D + + +REV ++ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ G+ + P L II E+ GS+ R L + + EK + +V + +H +
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP-IAEKYISVIIREVLVALKYIHKVG--V 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 856
+HRD+K+ N+LV NVK+ DFG++ L + + GTP WMAPEV+ + K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQT 915
D++S G+ ++E+AT P+ ++ + + + + RLE L+ + C
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVAACLDE 241
Query: 916 DPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 955
+P R S +L L+ I +H P S L + IS
Sbjct: 242 EPKERLSAEEL------LKSKWIKAHSKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 9e-30
Identities = 94/297 (31%), Positives = 144/297 (48%), Gaps = 41/297 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
E P + L E++G G +GEV+ + G E VAVK L +D +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDAN 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ- 770
A +F +E+KIM RL+ PN++ + L +ITE++ G L + L H P
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 771 VDEKRR-------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
I MA +A GM L S+ VHRDL + N LV KN+ +K++DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 824 R-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGM 879
R L + + A P WM+ E + DV++FGV LWE+ TL + P+ +
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237
Query: 880 NPMQVVGAVG-F---QNRRLEIPKE-LDP-LVARIIWECWQTDPSLRPSFAQLTVAL 930
+ QV+ G F Q R++ +PK L P + +++ CW+ + RPSF ++ L
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 34/266 (12%)
Query: 684 IGLGSYGEVYHA-----DWNGTE---VAVKKF----LDQDFSGAALLEFKREVKIMRRLR 731
+G G++GEVY G+ VAVK DQ+ EF +E +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-----EFLKEAHLMSNFN 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------VDEKRRIKMALDVAR 785
HPN+V +G II E + G L L + + K + + LDVA+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
G C++ +HRDL + N LV D + VK+ DFGL+R + + + +
Sbjct: 118 G--CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 897
P WMAPE L + + DV+SFGV++WE+ TL + P+ +N +V+ V RL+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234
Query: 898 PKELDPLVARIIWECWQTDPSLRPSF 923
P+ + +++ CW DPS RP+F
Sbjct: 235 PENCPDKIYQLMTNCWAQDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 86/278 (30%), Positives = 136/278 (48%), Gaps = 35/278 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSG--AALLEFKR 722
E P +L G+ +G G++G+V A G +VAVK S AL+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMA 780
E+KIM L H N+V +GA T + +ITE+ G L L R + + + +
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
VA+GM L ++ +HRDL + N+L+ VK+ DFGL+R + +++ K A
Sbjct: 148 YQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM-------NPMQVVGAVGF 890
P +WMAPE + N + DV+S+G++LWE+ +L P+ GM ++ G+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGY 261
Query: 891 QNRRLE-IPKELDPLVARIIWECWQTDPSLRPSFAQLT 927
+ + E P E + I+ CW DP RP+F Q+
Sbjct: 262 RMAQPEHAPAE----IYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 23/279 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + L +G GS+G VY + T VAVK +++ S +EF E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 775
+M+ +VV +G V++ ++ E + G L L RP + + +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L+ VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 836 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G WMAPE L++ D++SFGV+LWE+ +L + P+ G++ QV+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
L+ P V ++ CWQ +P +RP+F ++ LK
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 88/273 (32%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHAD-WNGTE------VAVKKFLDQDFSGAALLEFKREVK 725
I D+VL +G G++G+V+ A+ +N + VAVK D AA +F+RE +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAE 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ--VDEKRR----- 776
++ L+H ++V F G L ++ E++ G L + L H P VD + R
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 777 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 829
+ +A +A GM ++ ++ VHRDL + N LV N VK+ DFG+SR ++T
Sbjct: 120 LGLSQMLHIASQIASGM--VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 830 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGA 887
+ T WM PE + + DV+SFGVILWE+ T K PW ++ +V+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 920
+ Q R LE P+ V I+ CWQ +P R
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 90/293 (30%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
EI + E +G +G+VY GT VA+K D+ G EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 779
+ RL+HPN+V +G VT+ LS+I + L F ++ PH V D+ + +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 780 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR----- 824
L+ +A GM L S+ +VH+DL + N+LV NVK+SD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 825 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM 879
L N+ L + WM+PE + + D++S+GV+LWE+ + L P+ G
Sbjct: 178 DYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 880 NPMQVVGAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
+ V+ + +NR+ L P + V ++ ECW PS RP F + L+
Sbjct: 231 SNQDVIEMI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 37/290 (12%)
Query: 677 DLVLGERIGLGSYGEVYHA---DWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+LVLG+ +G G +G+V A G T VAVK L ++ S + L + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQ 59
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL---FRILHRPHCQ---------------- 770
+ HP+V+ GA ++ L +I E+ GSL R +
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 771 ----VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-- 824
+ I A ++RGM L + +VHRDL + N+LV + +K+SDFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQ 883
+ ++++ +WMA E L + + DV+SFGV+LWE+ TL P+ G+ P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + R+E P+ + ++ CW+ +P RP+FA ++ L+ +
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 8/216 (3%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
P ED L +RIG G+YG+VY A + N E+A K + + G ++E+ +M+ +H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKH 65
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N+V + G+ R L I EF GSL I H + E + ++ + +G+ LH+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS 124
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL---R 849
+HRD+K N+L+ N +VK++DFG+S T KS GTP WMAPEV R
Sbjct: 125 KGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
N+ CD+++ G+ ELA L+ P ++PM+ +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/244 (29%), Positives = 119/244 (48%), Gaps = 16/244 (6%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVV-L 737
+G GS+G+V D G A+K L + + E I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPT 796
T L ++ E+ P G LF L + E+R R A ++ + LH+
Sbjct: 59 HYAFQT-EEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAA-EIVLALEYLHSLG-- 113
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I++RDLK N+L+D + ++K++DFGL++ + + + GTPE++APEVL + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 916
D +S GV+L+E+ T K P+ + ++ + L P+ L P +I Q D
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQKD 231
Query: 917 PSLR 920
P+ R
Sbjct: 232 PTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 74/251 (29%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 737
++IG GS+G++Y A + +E V K + D + + E K+EV ++ +++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIK--EIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPT 796
F + L I+ E+ G L + ++R E + + + ++ G+ +H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-- 121
Query: 797 IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 855
I+HRD+KS N+ + KN V K+ DFG++R +++ + + GTP +++PE+ +N P N
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
K D++S G +L+EL TLK P+ G N Q+V + Q I + +I + ++
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLFKV 240
Query: 916 DPSLRPSFAQL 926
P RPS +
Sbjct: 241 SPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 86/269 (31%), Positives = 135/269 (50%), Gaps = 28/269 (10%)
Query: 684 IGLGSYGEVYHA--DWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739
IG G++G+V A +G + A K + + S +F E++++ +L HPN++ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 740 GAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEKRRIKMALDVA 784
GA L + E+ P G+L L + + ++ + A DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEW 842
RGM+ L S +HRDL + N+LV +N+ K++DFGLSR + + K T G W
Sbjct: 123 RGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRW 177
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E L DV+S+GV+LWE+ +L P+ GM ++ + Q RLE P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVAL 930
D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 27/285 (9%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVK 725
I ++VL +G G++G+V+ A+ + VAVK +D S A +F RE +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH------------RPHCQVDE 773
++ L+H ++V F G L ++ E++ G L + L ++ +
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 831
+ + +A +A GM ++ ++ VHRDL + N LV +N VK+ DFG+SR ++T +
Sbjct: 120 SQMLHIAQQIAAGM--VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
T WM PE + + DV+S GV+LWE+ T K PW ++ +V+ +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236
Query: 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
Q R L+ P+ V ++ CWQ +P +R + ++ L+ L +
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 77/254 (30%), Positives = 130/254 (51%), Gaps = 22/254 (8%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
ERIG GS+GEV+ N T+ V K +D + + + + ++E+ ++ + P V + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ + L II E+L GS +L DE + M ++ +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK--IHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 861 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA--------RIIWEC 912
S G+ ELA + P M+PM+V+ IPK P + I C
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 913 WQTDPSLRPSFAQL 926
DPS RP+ +L
Sbjct: 237 LNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 59/252 (23%), Positives = 122/252 (48%), Gaps = 6/252 (2%)
Query: 684 IGLGSYGE--VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G++GE +Y + + V K+ S + E+ I+ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 742 VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
L I E+ G+L+ +I+ + +E+ + + ++ +H + I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+K+ N+ + K +K+ DFG+S++ + + +++ GTP +M+PE+ + N K D++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 861 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 920
+ G +L+EL TLK + NP+ +V + Q + + ++ Q DP R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 921 PSFAQLTVALKP 932
P+ ++
Sbjct: 245 PTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 74/254 (29%), Positives = 131/254 (51%), Gaps = 22/254 (8%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
ERIG GS+GEVY N T EV K +D + + + + ++E+ ++ + P + + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ + L II E+L GS +L +P ++E + ++ +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPG-PLEETYIATILREILKGLDYLHSERK--IHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 861 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV--------ARIIWEC 912
S G+ ELA + P ++PM+V+ IPK P + + C
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKPFKEFVEAC 236
Query: 913 WQTDPSLRPSFAQL 926
DP RP+ +L
Sbjct: 237 LNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 75/230 (32%), Positives = 119/230 (51%), Gaps = 15/230 (6%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
LG+ +G G++GEVY AD G E+AVK+ D + + + E+++++ LRH
Sbjct: 6 LGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+V + G + P LSI E++P GS+ L + + + E + + +G++ LH
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 848
++ IVHRD+K N+L D NVK+ DFG S+ +S KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
E K DV+S + E+ T K PW M + + Q + +P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 21/272 (7%)
Query: 678 LVLGERIGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
L LG+ +G G +G V N + VAVK + + + +F E M+ HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 734 NVVLFMGAVTRP------PNLSIITEFLPRGSL--FRILHRPHCQ---VDEKRRIKMALD 782
NV+ +G + P+ +I F+ G L F + R + + +K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP- 840
+A GM L S+ + +HRDL + N ++++N NV V+DFGLS+ +N + A P
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 899
+W+A E L + K DV+SFGV +WE+AT + P+ G+ ++ + NR + P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238
Query: 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
LD L + ++ CW +P RPSF L L+
Sbjct: 239 CLDGLYS-LMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 682 ERIGLGSYGEVYHADWN---GTEVAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPN 734
E++G G+YG VY A + G VA+KK LD + AL RE+ +++ L+HPN
Sbjct: 5 EKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELKHPN 59
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHTS 793
+V + + L ++ E+ L + L + + IK + + RG+ H+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP-NLIKSIMYQLLRGLAYCHSH 117
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
I+HRDLK N+L++++ +K++DFGL+R T E W APE+L
Sbjct: 118 R--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+ T K
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 65/305 (21%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFK-----REV 724
+D G+ IG GS+ V A E A+K + L + E K E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--------EKKVKYVKIEK 52
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RRI 777
+++ RL HP ++ NL + E+ P G L + + + + +DEK I
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEI 111
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---- 833
+AL+ I+HRDLK N+L+DK+ ++K++DFG +++
Sbjct: 112 LLALEYLHSKG--------IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 834 ----------------KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877
S GT E+++PE+L +P+ + D+++ G I++++ T K P+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
Query: 878 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937
G N + P P +I + DP R + LK
Sbjct: 224 GSNEYLTFQKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK------ 275
Query: 938 IPSHP 942
+HP
Sbjct: 276 --AHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 21/271 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHP-NVVL 737
+ ++G GS+GEVY A + VA+K + S + +E F RE++I+ L HP N+V
Sbjct: 4 ILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTP 795
+L ++ E++ GSL +L + + E + + + + LH+
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 796 TIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVL 848
I+HRD+K N+L+D++ VK+ DFGL++L + +S A GTP +MAPEVL
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 849 R---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
++ D++S G+ L+EL T P+ G L P PL
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
+ +A P RL
Sbjct: 241 PSNPE----LISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 75/260 (28%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W G V + K L++ A +EF E IM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
+G V P + ++T+ +P G L +H + + + + +A+GM ++ +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM--MYLEERRLV 131
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--EWMAPEVLRNEPSNEK 856
HRDL + N+LV +VK++DFGL+RL + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 857 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+GV +WEL T P+ G+ P + + + + RL P V ++ +CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 916 DPSLRPSFAQLTVALKPLQR 935
D RP F +L + R
Sbjct: 251 DADSRPKFKELAAEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 28/268 (10%)
Query: 684 IGLGSYGEVY------HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V D G +VAVK L + G + + K+E++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 738 FMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G T I I EFLP GSL L R +++ K+++K A+ + +GM+ L +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNT-FLSSKSTAGTPE-WMAPEVLRNEP 852
VHRDL + N+LV+ VK+ DFGL++ ++ + + + K +P W APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 853 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 898
DV+SFGV L+EL T LK+ M V V + +RL P
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQL 926
V +++ +CW+ PS R +F L
Sbjct: 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 86/285 (30%), Positives = 138/285 (48%), Gaps = 35/285 (12%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T A K ++ S L ++ E++I+ HP
Sbjct: 14 WE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHP 69
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGS-------LFRILHRPHCQVDEKRRIKMALDVARG 786
+V +GA L I+ EF P G+ L R L P QV ++ ++
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-------A 122
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ LH+ I+HRDLK+ N+L+ + ++K++DFG+S T S GTP WMAPE
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 847 V-----LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKE 900
V +++ P + K D++S G+ L E+A ++ P +NPM+V+ + L P +
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQL--------TVALKPLQRLV 937
+ P RPS AQL + +PL+ LV
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 19/263 (7%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK---REVKIMRR 729
+DL +G G+ G V G +AVK L+ + K RE+ I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----EAIQKQILRELDILHK 55
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
P +V F GA ++SI E++ GSL +IL ++ E+ K+A+ V +G+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
LH I+HRD+K N+LV+ +K+ DFG+S N+ +K+ GT +MAPE ++
Sbjct: 116 LH-EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQ 172
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIG-----MNPMQVVGAVGFQNRRLEIPKELDPL 904
+ K D++S G+ L ELAT + P+ +++ + + + P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232
Query: 905 VARIIWECWQTDPSLRPSFAQLT 927
+ C DP RPS+ +L
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 86/303 (28%), Positives = 138/303 (45%), Gaps = 53/303 (17%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
+ P L+ E++G G +GEV+ + + VAVK L D +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDAN 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
A +F +EVKI+ RL+ PN++ +G L +ITE++ G L + L +D+
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDD 117
Query: 774 KRR--------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813
K + +AL +A GM L S+ VHRDL + N LV +N
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENL 175
Query: 814 NVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+K++DFG+SR L + + A P WMA E + DV++FGV LWE+
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 872 L--KLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE----CWQTDPSLRPSF 923
L + P+ + QV+ G F+++ ++ P + ++E CW D RPSF
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 924 AQL 926
+ +
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 82/262 (31%), Positives = 126/262 (48%), Gaps = 24/262 (9%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
LG+ +G G++G VY AD G E+AVK+ + + + + E+++++ L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 734 NVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+V + G + P LSI E +P GS+ L + + + E K + G++ LH
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 848
++ IVHRD+K N+L D NVK+ DFG S+ LS KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD----PL 904
E K D++S G + E+ T K PW M + + Q +P +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 905 VARIIWECWQTDPSLRPSFAQL 926
+ RI E LRPS +L
Sbjct: 242 LKRIFVEA-----KLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 16/251 (6%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G++G V+ + V +K+ + + L + E ++++ L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
L I+ E+ P G+L + R + +DE + + + ++ +HT I+HR
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHR 125
Query: 801 DLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTA----GTPEWMAPEVLRNEPSNE 855
DLK+ N+L+DK+ V K+ DFG+S++ LSSKS A GTP +++PE+ +P N+
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
K D+++ G +L+ELA+LK + N +V + I P + ++I
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 916 DPSLRPSFAQL 926
DPS RP +Q+
Sbjct: 240 DPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 74/258 (28%), Positives = 136/258 (52%), Gaps = 14/258 (5%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
P E E+IG GS+GEV+ N T+ V K +D + + + + ++E+ ++ +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+HRD+K+ N+L+ ++ VK++DFG++ +T + + GTP WMAPEV++
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE- 911
+ K D++S G+ ELA + P ++PM+V+ + N P L+ ++ + E
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYSKPLKEF 232
Query: 912 ---CWQTDPSLRPSFAQL 926
C +PS RP+ +L
Sbjct: 233 VEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 27/242 (11%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T V A K +D S L ++ E+ I+ HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCL 790
N+V + A NL I+ EF G++ + L RP + + K L+ +N L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYL 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-- 848
H + I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 849 ---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ L+I K P +
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTL 228
Query: 906 AR 907
A+
Sbjct: 229 AQ 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 10/233 (4%)
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
VA+ L S F E + + H N+V G +TR + I+TE++ G+L
Sbjct: 36 VAIHT-LRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
L + Q+ + + M +A GM L S VH+ L + +LV+ + K+S F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 822 -LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879
L K ++ S W APE ++ + DV+SFG+++WE+ + + P+ M
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 880 NPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930
+ V+ AV GF RL P+ L+ +++ +CWQ + RP F+Q+ L
Sbjct: 213 SGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 21/282 (7%)
Query: 684 IGLGSYGEVYHADWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W VK K L + S A E E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
+G + + +IT+ +P G L + + + + + +A+GMN L +V
Sbjct: 75 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 856
HRDL + N+LV +VK++DFGL++L + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 857 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+GV +WEL T P+ G+ P + ++ + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 916 DPSLRPSFAQLT-----VALKPLQRLVI----PSHPDQPSSA 948
D RP F +L +A P + LVI H P+ +
Sbjct: 251 DADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 292
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 27/268 (10%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLD----QDFSGAALLEFKREVKIMR 728
P D L +R+G G+YG+VY A + + E+A K + DFS ++E+ +++
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVK 61
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDVA 784
+H N+V + G+ L I E+ GSL I H Q+ + +
Sbjct: 62 ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQI-----AYVCRETL 116
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+G+ LH+ +HRD+K N+L+ N +VK++DFG++ T KS GTP WMA
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 845 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIP 898
PEV +N N+ CD+++ G+ ELA L+ P ++PM+ ++ FQ +L+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQL 926
+ + +P RP+ +L
Sbjct: 235 TKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 22/234 (9%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 740
I G+YG V+ A T A+K D ++ E I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL ++ E+LP G L +L ++ RI +A ++ + LH++ I+HR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSNG--IIHR 117
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRL--------KHNTFLSSKSTAGTPEWMAPEVLRNEP 852
DLK N+L+D N ++K++DFGLS++ ++ K GTP+++APEV+ +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDP 903
++ D +S G IL+E P+ G P ++ FQN ++E P++++
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 69/263 (26%), Positives = 125/263 (47%), Gaps = 41/263 (15%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFK------REVKIM 727
+D + +G GS+G V G+ A+K S A +++ K E +I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLNEKRIL 55
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEKRRIKMAL 781
+ +RHP +V G+ NL ++ E++P G LF L + P + A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF-------YAA 108
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTP 840
V + LH+ IV+RDLK NLL+D + +K++DFG + R+K T+ + GTP
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTP 162
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEI 897
E++APE++ ++ + D ++ G++++E+ P+ NP+Q+ ++ ++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKILEGKVRF 217
Query: 898 PKELDPLVARIIWECWQTDPSLR 920
P P +I Q D + R
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 54/196 (27%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 682 ERIGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
++IG GS+G+ V + +G + +K+ S E ++EV ++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ NL I+ ++ G L+ +I + E + + + + + +H I
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
+HRD+KS N+ + K+ +K+ DFG++R+ ++T +++ GTP +++PE+ N P N K
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 858 DVYSFGVILWELATLK 873
D+++ G +L+E+ TLK
Sbjct: 183 DIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 679 VLGERIGLGSYGEV--YHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
VLGE G +G+V Y D G VAVK L ++ +K+E+ I++ L H
Sbjct: 11 VLGE----GHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYH 65
Query: 733 PNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
N+V + G + L +I E++P GSL L P +++ + + A + GM L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEV 847
H+ +HRDL + N+L+D + VK+ DFGL++ H + + W A E
Sbjct: 124 HSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 848 LRNEPSNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGFQNRRL 895
L+ + DV+SFGV L+EL T ++ M VV + R +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 896 EIPKELD-PLVARIIWE-CWQTDPSLRPSFAQLTVALK 931
+P + P I+ + CW+T+ RP+F L LK
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 13/256 (5%)
Query: 684 IGLGSYGEV----YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G++G V Y + VAVK + + A E RE +M++L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G + + ++ E G L + L + V EK ++ V+ GM L + VH
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETN--FVH 118
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 856
RDL + N+L+ K+SDFGLS+ + +K+ P +W APE + + K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 857 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+SFGV++WE + P+ GM +V + R+E P+ P + ++ CW
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTY 237
Query: 916 DPSLRPSFAQLTVALK 931
RP FA + + L+
Sbjct: 238 GVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 49/277 (17%)
Query: 682 ERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR-----------EVKIM 727
E +G G++G VY + +A+K+ + A + KR EV I+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEI---NVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 728 R-RLRHPNVVLFMGAVTRPPNLSIITEFL---PRGSLFRILHRPHCQVDEKRRIKMALDV 783
+ +LRHPN+V + L I+ + + P G F L + E+R + + +
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH-NTFLSSKSTAGTPEW 842
+ LH IVHRDL N+++ ++ V ++DFGL++ K + L+S GT +
Sbjct: 123 VLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILY 179
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIP 898
PE+++NEP EK DV++FG IL+++ TL+ P+ N ++V AV
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV---------- 229
Query: 899 KELDPL--------VARIIWECWQTDPSLRPSFAQLT 927
+PL V +I C D RP Q++
Sbjct: 230 --YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 77/256 (30%), Positives = 126/256 (49%), Gaps = 9/256 (3%)
Query: 674 PWEDLVLGERIGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P L +IG GS G V G +VAVKK +D L F EV IMR +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFN-EVVIMRDYQ 74
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+V + L ++ EFL G+L I+ H +++E++ + L V + ++ LH
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLH 132
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
++HRD+KS ++L+ + VK+SDFG KS GTP WMAPEV+
Sbjct: 133 AQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDPLVARIIW 910
P + D++S G+++ E+ + P+ P+Q + + +L+ ++ P + +
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 911 ECWQTDPSLRPSFAQL 926
DP+ R + A+L
Sbjct: 251 RMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)
Query: 681 GERIGLGSYGEV---YHADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHPN 734
G+ +G G++G V Y D G E+A K+ + + + + E+++++ L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 735 VVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V + G + L+I E++P GS+ L + + + E K + GM+ LH+
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVLR 849
+ IVHRD+K N+L D NVK+ DFG S+ +S +S GTP WM+PEV+
Sbjct: 125 NM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----LV 905
E K DV+S G + E+ T K PW M + + Q ++P + +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 906 ARIIWECWQTDPS----LRPSFAQL 926
I E PS LR FAQL
Sbjct: 243 GCIFVEARHR-PSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/249 (28%), Positives = 129/249 (51%), Gaps = 11/249 (4%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR +HPN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ +DE + + + + + LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--VIH 138
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKCD 858
RD+KS N+L+ + +VK++DFG + S +ST GTP WMAPEV+ + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 859 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDP 917
++S G++ E+ + P++ NP++ + + L+ P++L + + C + D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 918 SLRPSFAQL 926
R S +L
Sbjct: 258 EKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 681 GERI--GLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
GER+ G G+YG VY A T+V A+K+ ++D L E+ + L+H N+V
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV 68
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTST 794
++G+ + I E +P GSL +L + +E+ I + G+ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 795 PTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
IVHRD+K N+LV+ V K+SDFG S+ +++ GT ++MAPEV+ P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 854 --NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
D++S G + E+AT K P+I + P + VG EIP+ L I
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 911 ECWQTDPSLRPSFAQL 926
C++ DP R S L
Sbjct: 247 RCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+IG G+YG VY A G VA+KK F + AL RE+K+++ L HPN+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ + +L ++ EF+ L++++ + E + +G+ H+
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRN 850
I+HRDLK NLL++ +K++DFGL+R S T W APE+L
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 851 EPS-NEKCDVYSFGVILWELATLKLPWIGMN 880
+ + D++S G I EL + + + G +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 84/278 (30%), Positives = 124/278 (44%), Gaps = 49/278 (17%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
L E IG G+YG+VY H G VA+K D E K E I+R+ HPN+
Sbjct: 10 LVEVIGEGTYGKVYKARHKK-TGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 736 VLFMGAVT--RPPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DV 783
F GA PP L ++ E GS+ ++ + +R+K +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRET 122
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 843
RG+ LH + ++HRD+K N+L+ KN VK+ DFG+S +T + GTP WM
Sbjct: 123 LRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 844 APEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
APEV+ + + + DV+S G+ ELA K P M+PM+ + F+ IP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-----IP 231
Query: 899 KELDPLVAR----------IIWECWQTDPSLRPSFAQL 926
+ P + I EC + RP +L
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 49/275 (17%)
Query: 687 GSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 737
G++G +++ EV VK D A+ ++ +E ++ L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 738 FMGAVTR---PP-------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+ PP N + FL + L + ++ + MA+ +A GM
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL--GEANNPQALSTQQLVHMAIQIACGM 130
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE-----W 842
+ LH ++H+D+ + N ++D+ VK++D LSR + F G E W
Sbjct: 131 SYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVKW 185
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE--- 896
MA E L N+ + DV+SFGV+LWEL TL + P++ ++P ++ + G+ RL
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPI 242
Query: 897 -IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930
P EL ++A CW DP RPSF+QL L
Sbjct: 243 NCPDELFAVMAC----CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 83/257 (32%), Positives = 122/257 (47%), Gaps = 29/257 (11%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 737
IG GS+G VY A T VA+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G R ++ E+ GS IL H+ Q E I +G+ LH+
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE- 135
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVL--RNE 851
+HRD+K+ N+L+ + VK++DFG + L N+F+ GTP WMAPEV+ +E
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188
Query: 852 PS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 909
+ K DV+S G+ ELA K P MN M + + QN + + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWSDYFRNFV 247
Query: 910 WECWQTDPSLRPSFAQL 926
C Q P RPS +L
Sbjct: 248 DSCLQKIPQDRPSSEEL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/247 (27%), Positives = 124/247 (50%), Gaps = 7/247 (2%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G GSYGEV +G + +KK ++ S ++E +++ +L+HPN+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 742 VTRPPN-LSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVH 799
L I+ F G L+ L ++ E + ++ + +A + LH I+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILH 125
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RDLK+ N+ + + +KV D G++R+ N + + GTP +M+PE+ N+P N K DV
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 919
++ G ++E+ATLK + + +V + + + +PK+ P + +I P
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKRPEK 244
Query: 920 RPSFAQL 926
RPS +
Sbjct: 245 RPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 18/208 (8%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLF 738
++IG G + EVY A +G VA+KK D A A + +E+ ++++L HPNV+ +
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTP 795
+ L+I+ E G L R++ Q + EK K + + + +H+
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRN 850
++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIG 878
N K D++S G +L+E+A L+ P+ G
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 70/248 (28%), Positives = 127/248 (51%), Gaps = 9/248 (3%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G V+ A G EVA+K+ Q L+ E+ +M+ L++PN+V F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ C +DE + + + + + LH + ++H
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTET-C-MDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 918
+S G++ E+ + P++ NP++ + + L+ P++L P+ + C + D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 919 LRPSFAQL 926
R S +L
Sbjct: 259 KRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 69/266 (25%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
LGE G GS + N + K + D + + RE++I + + P +V +
Sbjct: 9 LGEGAG-GSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 740 GAVTRPP--NLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTST 794
GA ++ I E+ GSL I + + + EK K+A V +G++ LH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I+HRD+K N+L+ + VK+ DFG+S N+ + + GT +MAPE ++ +P +
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYS 181
Query: 855 EKCDVYSFGVILWELATLKLPWI-----GMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
DV+S G+ L E+A + P+ + P++++ + + P+ D I
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEPGNGIK 237
Query: 910 W---------ECWQTDPSLRPSFAQL 926
W +C + DP+ RP+ +
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 58/238 (24%), Positives = 115/238 (48%), Gaps = 12/238 (5%)
Query: 692 VYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV----LFMGAVTRPP 746
+Y +N EV ++ F L++ + E+K +RR+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806
LS+I E+ RG L +L + + K ++ MA+D +G+ L+ T +++L S +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVS 153
Query: 807 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGV 864
LV +N+ +K+ GL ++ + K+ + + ++L + K D+YS GV
Sbjct: 154 FLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 865 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 922
+LWE+ T K+P+ + ++ + +N L++P + + I+ C D RP+
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-23
Identities = 69/260 (26%), Positives = 131/260 (50%), Gaps = 20/260 (7%)
Query: 679 VLGERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+L +R+G GS+G VY A +K+ + + ++ +E +++ +L HP
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQ--VDEKRRIKMALDVARGMNCL 790
+V F + IITE+ L ++ H + E + + + + G++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H I+HRDLK+ N+ + N +K+ DFG+SRL + + + GTP +M+PE L++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLVA 906
+ + K D++S G IL+E+ L + G N + VV + + +P ++L+ ++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQ 238
Query: 907 RIIWECWQTDPSLRPSFAQL 926
++ DPSLRPS A++
Sbjct: 239 SML----NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPNV 735
+IG G+YG+VY A T VA+KK ++ + F A+ RE+K++++LRHPN+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPNI 60
Query: 736 VLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 792
V VT SI + E++ L +L P + E + IK + G+ LH+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ-IKCYMKQLLEGLQYLHS 118
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
+ I+HRD+K N+L++ + +K++DFGL+R + S T W PE+
Sbjct: 119 NG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPEL 172
Query: 848 LRNEPS-NEKCDVYSFGVILWELAT 871
L + D++S G IL EL
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 4e-22
Identities = 76/280 (27%), Positives = 136/280 (48%), Gaps = 11/280 (3%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR ++PN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ C +DE + + + + ++ LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALDFLHSNQ--VIH 138
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 918
+S G++ E+ + P++ NP++ + + L+ P+ L + + C + D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 919 LRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 958
R S +L P +L P P +E NS+
Sbjct: 259 RRGSAKELL--QHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 8/205 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A G +VAVKK +D L F EV IMR H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFN-EVVIMRDYHHENVVDMYN 86
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L ++ EFL G+L I+ H +++E++ + L V R ++ LH ++HR
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQG--VIHR 142
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+KS ++L+ + +K+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+++ E+ + P+ P+Q +
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 76/279 (27%), Positives = 134/279 (48%), Gaps = 25/279 (8%)
Query: 677 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR 731
+L + +G G +G V+ W + ++ V QD SG E + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
H +V +G + +L ++T+ P GSL + + +D +R + + +A+GM L
Sbjct: 68 HAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTP-EWMAP 845
+VHR+L + N+L+ + V+++DFG++ L K + S TP +WMA
Sbjct: 127 EHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKTPIKWMAL 180
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E + + DV+S+GV +WE+ + P+ GM P +V + + RL P+
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239
Query: 905 VARIIWECWQTDPSLRPSFAQLT-----VALKPLQRLVI 938
V ++ +CW D ++RP+F +L +A P + LVI
Sbjct: 240 VYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYLVI 278
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-22
Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 12/260 (4%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W +G V + K L ++ S A E E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
+G + + ++T+ +P G L + ++ + + + +A+GM+ L +V
Sbjct: 75 LG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 856
HRDL + N+LV +VK++DFGL+RL + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 857 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+GV +WEL T P+ G+ P + + + + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 916 DPSLRPSFAQLTVALKPLQR 935
D RP F +L + R
Sbjct: 251 DSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 69/251 (27%), Positives = 123/251 (49%), Gaps = 13/251 (5%)
Query: 684 IGLGSYG----EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G++G VY +VA+K L + + E RE +IM +L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G V L ++ E G L + L ++ +++ V+ GM L VH
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVH 118
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 856
RDL + N+L+ K+SDFGLS+ +++ ++S P +W APE + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 857 CDVYSFGVILWE-LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+G+ +WE + + P+ M +V+ + Q +RL+ P E P + ++ +CW
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY 237
Query: 916 DPSLRPSFAQL 926
RP+FA++
Sbjct: 238 KWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 9/247 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A +G VAVKK +D L F EV IMR +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFN-EVVIMRDYQHENVVEMYN 84
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L ++ EFL G+L I+ H +++E++ + L V + ++ LH ++HR
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQG--VIHR 140
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+KS ++L+ + VK+SDFG KS GTP WMAPE++ P + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 861 SFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQTDPSL 919
S G+++ E+ + P+ P++ + + +L+ ++ P + + DP+
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 920 RPSFAQL 926
R + A+L
Sbjct: 261 RATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
RE++IM R P +V F GA N+ + EF+ GSL RI + + + K+A+
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAV 110
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
V G+ L+ + I+HRD+K N+LV+ +K+ DFG+S N+ + + GT
Sbjct: 111 AVVEGLTYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTST 167
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-----------F 890
+M+PE ++ K DV+S G+ + ELA K P+ + + G
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF-AFSNIDDDGQDDPMGILDLLQQIV 226
Query: 891 QNRRLEIPKELDPLVAR-IIWECWQTDPSLRPSFAQLT 927
Q +P P R + C DP+ RP+ QL
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 71/259 (27%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 677 DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 733
+ + ++IG G + EVY A + VA+KK + + A + +E+ ++++L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCL 790
NV+ ++ + L+I+ E G L +++ Q + E+ K + + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAP 845
H+ ++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+P
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSP 175
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LD 902
E + N K D++S G +L+E+A L+ P+ G MN + + Q +P E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYS 234
Query: 903 PLVARIIWECWQTDPSLRP 921
+ ++ C DP RP
Sbjct: 235 EKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 684 IGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G GS+G V H N + K + S +A+ + ++E ++ +++HPN+V F
Sbjct: 8 VGEGSFGRALLVQHV--NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ +L I+ E+ G L + + ++ E ++ + + G+ +H ++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLH 123
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+ + +N VK+ DFG +RL + + + GTP ++ PE+ N P N K D+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183
Query: 860 YSFGVILWELATLKLPW 876
+S G IL+EL TLK P+
Sbjct: 184 WSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 5e-21
Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 9/248 (3%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+++ Q L+ E+ +MR ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 83
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ C +DE + + + + + LH++ ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 918
+S G++ E+ + P++ NP++ + + L+ P++L + + C D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 919 LRPSFAQL 926
R S +L
Sbjct: 260 KRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-20
Identities = 78/263 (29%), Positives = 123/263 (46%), Gaps = 24/263 (9%)
Query: 676 EDLVLG-ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMR 728
E++ +G IG GS+G VY A + T VAVKK +SG E +EVK ++
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQ 76
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
+L+HPN + + G + ++ E+ L + +P +V+ AL +G
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QG 133
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ LH+ ++HRD+K+ N+L+ + VK++DFG + + S GTP WMAPE
Sbjct: 134 LAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPE 187
Query: 847 VLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
V+ + K DV+S G+ ELA K P MN M + + + E
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247
Query: 904 LVARIIWECWQTDPSLRPSFAQL 926
+ C Q P RP+ A+L
Sbjct: 248 SFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 61/288 (21%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G GSYG V H + G VA+KKFL+ + RE++++++LRH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
R L ++ EF+ L + P+ +DE R K + RG+ H+ I+HR
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN--IIHR 124
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT----PEWM-APEVLRNEPSNE 855
D+K N+LV ++ VK+ DFG +R L++ T W APE+L +
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 856 K-CDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVG-------------- 889
+ D+++ G ++ E+ T P+ ++ +G
Sbjct: 180 RAVDIWAVGCLVTEMLT-------GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 890 -FQNRRLEIPKELDPL----------VARIIWECWQTDPSLRPSFAQL 926
F RL KE++PL V + +C + DP RPS +QL
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-20
Identities = 90/340 (26%), Positives = 148/340 (43%), Gaps = 81/340 (23%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
E P + L LG+ +G G++G+V AD G + VAVK L + + + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSEL 61
Query: 725 KIMRRL-RHPNVVLFMGAVTRP--PNLSII----------------TEFLP---RGSLFR 762
KI+ + H NVV +GA T+P P + I+ EF+P + + FR
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFR 121
Query: 763 -------------------------------ILHRPHCQVDEKRR--------------- 776
+ + V+E+
Sbjct: 122 QGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL 181
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 835
I + VA+GM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 182 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 836 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNR 893
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 300 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 682 ERIGLGSYGEVYHADWN-GTEVA--VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+ IG G +G+V + + G A V K L + L F +EV+ R L HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRI--KMALDVARGMNCLHTST 794
+G ++ EF P G L L R ++ + +MA +VA G+ LH +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+H DL N + + +VK+ D+GL + + +++ A W+APE++
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 853 SN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK-ELD- 902
+ +K +++S GV +WEL T P+ ++ QV+ V + + +++PK +LD
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLDL 237
Query: 903 PLVAR---IIWECWQTDPSLRPS 922
R ++ CW DP RP+
Sbjct: 238 KYSDRWYEVMQFCW-LDPETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 679 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGA-------ALLEFKREVKIMRR 729
G+++G G+Y VY A D G VA+KK + A AL RE+K+++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQE 58
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALDVARG 786
L+HPN++ + N++++ EF+ L +++ D K + M L RG
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RG 114
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK----STAGTPEW 842
+ LH++ I+HRDLK NLL+ + +K++DFGL+R +F S T +
Sbjct: 115 LEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNRKMTHQVVTRWY 168
Query: 843 MAPEVLRNEPS-NEKCDVYSFGVILWEL 869
APE+L D++S G I EL
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 39/261 (14%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMR 728
D +GE +G GS+G V A GT A+K ++ +L+ K+ E I+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSILM 73
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--- 785
L HP +V M + + + EF+ G LF L ++ + DVA+
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFYH 124
Query: 786 -----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGT 839
LH+ I++RDLK NLL+D +VKV+DFG + ++ TF + GT
Sbjct: 125 AELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGT 178
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 899
PE++APEV++++ + D ++ GV+L+E P+ P ++ + RL+ P
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPN 236
Query: 900 ELDPLVARIIWECWQTDPSLR 920
D ++ QTD + R
Sbjct: 237 WFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 3e-20
Identities = 83/285 (29%), Positives = 129/285 (45%), Gaps = 26/285 (9%)
Query: 656 STSKVDQIFDDDVCEC---EIPWEDLVLGERIGLGSYGEVYHA-DWNGTEV-AVKKFLDQ 710
STS+ + D ++ E E P + IG GS+G VY A D EV A+KK
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM--- 58
Query: 711 DFSGAALLE----FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRIL 764
+SG E +EVK ++R++HPN + + G R ++ E+ L +
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH 118
Query: 765 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
+P +V+ AL +G+ LH+ ++HRD+K+ N+L+ + VK++DFG +
Sbjct: 119 KKPLQEVEIAAITHGAL---QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS 173
Query: 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNP 881
+ + S GTP WMAPEV+ + K DV+S G+ ELA K P MN
Sbjct: 174 IAS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
Query: 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
M + + E + C Q P RP+ +L
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 5e-20
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 41/214 (19%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV- 736
IG G+YG V A G +VA+KK F D + L RE+K++R LRH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENIIG 63
Query: 737 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
L + RPP+ I+TE + L +++ P D+ + + + RG+ L
Sbjct: 64 LL--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYL 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM------- 843
H++ ++HRDLK N+LV+ N ++K+ DFGL+R ++
Sbjct: 120 HSAN--VIHRDLKPSNILVNSNCDLKICDFGLAR-------GVDPDEDEKGFLTEYVVTR 170
Query: 844 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APE+L + + D++S G I EL T K
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 54/158 (34%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 835
I + VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 836 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 893
A P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + F R
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRR 288
Query: 894 -----RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
R+ P+ P + I+ +CW +P RP+F++L
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 55/235 (23%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKF-----LDQDFSGAALLEFKREVKIMR 728
+D + + IG G++GEV+ T A+K + ++ + E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 729 RLRHPNVV-LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALD 782
P +V L+ + +L ++ E++P G L +L R +E R + +ALD
Sbjct: 57 DADSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------------------- 823
+ +HRD+K N+L+D + ++K++DFGL
Sbjct: 116 SVHKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 824 ----------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 868
R + + ST GTP+++APEVLR P +CD +S GVIL+E
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 84/306 (27%), Positives = 123/306 (40%), Gaps = 52/306 (16%)
Query: 646 LESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAV 704
L PSSS SS+S +L RIG G+ G VY T +
Sbjct: 47 LPPPSSSSSSSSSSSAS---GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 705 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 764
K + + + RE++I+R + HPNVV + ++ EF+ GSL
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---- 159
Query: 765 HRPHCQVDEKRRIKMAL---DVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817
E I DVAR G+ LH IVHRD+K NLL++ NVK+
Sbjct: 160 --------EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKI 209
Query: 818 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC-----DVYSFGVILWELATL 872
+DFG+SR+ T S+ GT +M+PE + + ++ D++S GV + E
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 873 KLPWIGMNPMQVVGAVGFQ------------NRRLEIPKELDPLVARIIWECWQTDPSLR 920
+ P+ VG Q ++ E P I C Q +P+ R
Sbjct: 270 RFPF----------GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKR 319
Query: 921 PSFAQL 926
S QL
Sbjct: 320 WSAMQL 325
|
Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFM 739
I G++G VY A G A+K D + + K E IM P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 740 GAVTRPPNLSIITEFLPRG---SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L ++ E+L G SL + L + E + +V G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I+HRD+K NLL+D+ ++K++DFGLSR L +K GTP+++APE + ++
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKE 900
D +S G +++E P+ P V F N RR+ P+E
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 84/268 (31%), Positives = 120/268 (44%), Gaps = 34/268 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL-RHPNVV 736
E IG G+YG+VY +G+ AVK LD D E + E I++ L HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDE----EIEAEYNILQSLPNHPNVV 82
Query: 737 LFMGAVTRPPNLS-----IITEFLPRGS---LFRILHRPHCQVDEKRRIKMALDVARGMN 788
F G + L ++ E GS L + L ++DE + G+
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
LH + I+HRD+K N+L+ VK+ DFG+S +T L ++ GTP WMAPEV+
Sbjct: 143 HLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 849 RNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
E + +CDV+S G+ EL P M+P++ + F+ R P L P
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPPTLLHP 256
Query: 904 L-----VARIIWECWQTDPSLRPSFAQL 926
I +C D RPS L
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 50/138 (36%), Positives = 80/138 (57%), Gaps = 3/138 (2%)
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVL 848
H + ++HRD+KS N+L+ N VK+ DFG S++ T ++ GTP ++APE+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
R +P ++K D++S GV+L+EL TLK P+ G N M+ V R +P + P + I
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPSISPEMQEI 276
Query: 909 IWECWQTDPSLRPSFAQL 926
+ +DP RPS ++L
Sbjct: 277 VTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 27/268 (10%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRR 729
+DL + E +G G+YG V H GT +AVK+ S E KR ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQ----EQKRLLMDLDISMR 55
Query: 730 LRH-PNVVLFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARG 786
P V F GA+ R ++ I E + ++ ++ + E K+A+ + +
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ LH S +++HRD+K N+L+++N VK+ DFG+S ++ ++ AG +MAPE
Sbjct: 116 LEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPE 173
Query: 847 VLRNEPS----NEKCDVYSFGVILWELATLKLP---WIGMNPMQVVGAVGFQNRRLEIPK 899
+ E + + K DV+S G+ + ELAT + P W P Q + V + ++P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTPFQQLKQV-VEEPSPQLPA 230
Query: 900 E-LDPLVARIIWECWQTDPSLRPSFAQL 926
E P + +C + + RP++ +L
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 36/270 (13%)
Query: 680 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737
L E +G G+YG+VY T ++A K +D +G E K+E+ ++++ H N+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 738 FMGAVTR--PPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCL 790
+ GA + PP + ++ EF GS+ ++ ++ I + ++ RG++ L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 128 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 851 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ + + K D++S G+ E+A P M+PM+ + IP+ P +
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRL 236
Query: 906 ARIIW---------ECWQTDPSLRPSFAQL 926
W C + S RP+ QL
Sbjct: 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G+YG V T VA+KKF + + REVK++R+LRH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
A R L ++ E++ R +L +L + + + + H+ I+H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIH 123
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVLRNEPS 853
RD+K N+LV ++ +K+ DFG +R L ++ + T + APE+L + +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 854 NEK-CDVYSFGVILWELAT 871
K DV++ G I+ EL
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 5/157 (3%)
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 838
+ VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K +A
Sbjct: 180 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 839 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLE 896
P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
P+ P + RI+ CWQ DP RP+F+ L L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 676 EDLV-LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRL 730
EDL LGE IG G++G V H +GT +AVK+ + ++ +MR
Sbjct: 4 EDLKDLGE-IGRGAFGTVNKMLHKP-SGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVA 784
P +V F GA+ R + I E L SL + + K I K+A+
Sbjct: 61 DCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEV--LKSVIPEEILGKIAVATV 117
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ +N L I+HRD+K N+L+D+N N+K+ DFG+S ++ ++ AG +MA
Sbjct: 118 KALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMA 175
Query: 845 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRL--EI 897
PE + + + + DV+S G+ L+E+AT K P+ N + Q+ V L
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235
Query: 898 PKELDPLVARIIWECWQTDPSLRPSFAQL 926
+E P I C D S RP + +L
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 679 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLR-- 731
IG G+YG VY A D N G VA+KK L ++ + L RE+ ++++L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL---REIALLKQLESF 58
Query: 732 -HPNVVLFMG-----AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVA 784
HPN+V + R L+++ E + + L L + IK + +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 843
RG++ LH+ IVHRDLK N+LV + VK++DFGL+R+ +F + ++ W
Sbjct: 118 RGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATLK 873
APEVL D++S G I EL +
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A +G +VAVK +D L F EV IMR +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYK 85
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L ++ EFL G+L I+ + +++E++ + V + + LH+ ++HR
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHR 141
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+KS ++L+ + VK+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+++ E+ + P+ +P+Q +
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFL-DQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G +G V A+K E +I+ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GMNCLHT 792
+ ++ E+ G L+ IL R AR LH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---------RGLFDEYTARFYIACVVLAFEYLHN 111
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGL-----SRLKHNTFLSSKSTAGTPEWMAPEV 847
I++RDLK NLL+D N VK+ DFG S K TF GTPE++APE+
Sbjct: 112 RG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEI 163
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKELDP 903
+ N+ + D +S G++L+EL T + P+ +PM++ + N +LE P +D
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 53/158 (33%), Positives = 88/158 (55%), Gaps = 3/158 (1%)
Query: 721 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
K E I+ + HP +V A L +I +FL G LF L + +E + +A
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840
++A ++ LH+ I++RDLK N+L+D+ ++K++DFGLS+ + + S GT
Sbjct: 106 -ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
E+MAPEV+ + D +SFGV+++E+ T LP+ G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 61/249 (24%), Positives = 122/249 (48%), Gaps = 13/249 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+DL + +G G++G V+ + A+K + + E ++++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P ++ L ++ E++P G LF L R + + A ++ + LH+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 851
IV+RDLK N+L+DK ++K++DFG ++ L+ T+ + GTPE++APEV++++
Sbjct: 120 KE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQSK 173
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
N+ D ++ G++++E+ P+ NP + + +LE P+ LD +I +
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDLYAKDLIKK 231
Query: 912 CWQTDPSLR 920
D + R
Sbjct: 232 LLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 56/164 (34%), Positives = 87/164 (53%), Gaps = 23/164 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + ++G G++GEVY A G VA+KK L + + RE+KI+++L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 734 NVV-LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRPHCQVDEKRRIK-MA 780
NVV L AV RP RGS++ + L P ++ E + IK
Sbjct: 68 NVVPLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKCYM 121
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
L + G+N LH + I+HRD+K+ N+L+D +K++DFGL+R
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A +G+ AVK + +L+ K + IM + L+HP
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKK-----TILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L + +++ G LF L R C ++ + R A +VA + LH+
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN 116
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I++RDLK N+L+D +V ++DFGL + ++ + GTPE++APEVLR EP +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 855 EKCDVYSFGVILWEL 869
D + G +L+E+
Sbjct: 175 RTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVK-------IMRRLRH 732
++G G YG+V+ A T VA+K+ LL EV+ I+ +
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTKS 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V + A L + E++P G +L+ ++ R MA ++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+HRDLK N L+D + ++K++DFGLS+ + S G+P++MAPEVLR +
Sbjct: 120 LG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ D +S G +L+E P+ G P +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 675 WEDLVLGERIGLGSYGEVY--HADWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL 730
WE + E IG G+YG+V+ NG++ AVK LD D E + E I++ L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE----EIEAEYNILKAL 71
Query: 731 R-HPNVVLFMGA-----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
HPNVV F G V L ++ E GS+ ++ + + +A +
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 785 RG-MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 843
M H +HRD+K N+L+ VK+ DFG+S +T L ++ GTP WM
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 844 APEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
APEV+ E + +CDV+S G+ EL P ++PM+ + +IP
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIP 242
Query: 899 KELDPLVAR----------IIWECWQTDPSLRPSFAQL 926
+ P + + I +C D RP+ + L
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 21/249 (8%)
Query: 684 IGLGSYGEVYHA-DWNGTEV-AVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 737
IG GS+G VY A D +EV A+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 738 FMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ G R ++ E+ L S +H+ Q E + +G+ LH+
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG--ALQGLAYLHSH--N 135
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 855
++HRD+K+ N+L+ + VK+ DFG + + + GTP WMAPEV+ +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 856 --KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
K DV+S G+ ELA K P MN M + + + C
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 914 QTDPSLRPS 922
Q P RP+
Sbjct: 252 QKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 69/233 (29%), Positives = 118/233 (50%), Gaps = 40/233 (17%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM----------RRL--- 730
+G GS+G+V+ A+ GT +Q F+ AL K++V +M +R+
Sbjct: 3 LGKGSFGKVFLAELKGT--------NQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSL 51
Query: 731 --RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGM 787
HP + NL + E+L G L + H C + D R A ++ G+
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAP 845
LH+ IV+RDLK N+L+D + ++K++DFG+ K N +K+ GTP+++AP
Sbjct: 110 QFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAP 165
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
E+L + N D +SFGV+L+E+ + P+ G + ++ FQ+ R++ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKR----R 776
E +I++ L HP +V + N+ ++ + L G L + + + ++ +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE 108
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836
I +AL+ I+HRD+K N+L+D+ +V ++DF ++ L++ ST
Sbjct: 109 IVLALEYLHSKG--------IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-ST 159
Query: 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+GTP +MAPEVL + + D +S GV +E K P+
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A+ GT A+KK L+ D ++E R V + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE--RRVLALA-WEHPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+L + E+L G L + + DE R A ++ G+ LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG-- 116
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I++RDLK N+L+DK+ ++K++DFG+ + N + + GTP+++APE+L+ + NE
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
D +SFGV+L+E+ + P+ G + ++ F + + P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG VY A G VA+KK L+ + G A+ RE+ +++ L HPN+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----REISLLKELNHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMAL-DVARGMNCLHTS 793
V + V L ++ EFL L + + P +D IK L + +G+ H+
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHSH 118
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPE----WM-AP 845
++HRDLK NLL+D+ +K++DFGL+R + T+ T E W AP
Sbjct: 119 R--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--------THEVVTLWYRAP 168
Query: 846 EVLRNEPS-NEKCDVYSFGVILWELATLK 873
E+L + D++S G I E+ +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-18
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 21/197 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A E AVK + A+L+ K E IM + ++HP
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKK-----AILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L + +++ G LF L R C ++ + R A ++A + LH+
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IV+RDLK N+L+D ++ ++DFGL + ++HN ++ + GTPE++APEVL +P
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQP 172
Query: 853 SNEKCDVYSFGVILWEL 869
+ D + G +L+E+
Sbjct: 173 YDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-17
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 4/198 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + + L + E+ G LF L R +++ R A +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ ++ LH S +V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLS 220
Query: 903 PLVARIIWECWQTDPSLR 920
P ++ + DP R
Sbjct: 221 PEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 684 IGLGSYGEVYHADWNGT-EV----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A+ GT E+ +KK L D + E KR + + + HP +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE-KRVLALAGK--HPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + R + DE R A ++ G+ LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG-- 116
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+L+D ++K++DFG+ + +TF GTP+++APE+L
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDYIAPEILSY 170
Query: 851 EPSNEKCDVYSFGVILWEL 869
+P D ++ GV+L+E+
Sbjct: 171 QPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 3/154 (1%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + + L + E++ G LF L R +++ R A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ ++ LH+ IV+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+APEVL + D + GV+++E+ +LP+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ RIG G++G V+ A G VA+KK + G + RE+K ++ +HP VV
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTST 794
+ ++ E++P L +L RP + K ++M L G+ +H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----W-MAPEVLR 849
I+HRDLK NLL+ + +K++DFGL+RL F + + + W APE+L
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 850 NEPS-NEKCDVYSFGVILWEL 869
+ D+++ G I EL
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 52/268 (19%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-------FKREVKIMRRLRH-PNV 735
+G G+YG+V+ G A K + + A +++ + E +++ +R P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKR----RIKMALDVARGMNCL 790
V A L +I +++ G LF L R H E R I +ALD L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HL 121
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAP 845
H I++RD+K N+L+D +V ++DFGLS+ FL+ + S GT E+MAP
Sbjct: 122 HQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERAYSFCGTIEYMAP 175
Query: 846 EVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------ 897
EV+R ++ D +S GV+ +EL T G +P V G QN + EI
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT------GASPFTVDGE---QNSQSEISRRILK 226
Query: 898 -----PKELDPLVARIIWECWQTDPSLR 920
PK + I + + DP R
Sbjct: 227 SKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 5/198 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + A L + E+ G LF L R +E+ R A +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-E 103
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ + LH+ +V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE+
Sbjct: 104 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLS 219
Query: 903 PLVARIIWECWQTDPSLR 920
P ++ + DP R
Sbjct: 220 PEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
E VL E +G G+YG VY T V + K + + + + E+ I+ + P
Sbjct: 2 EIEVLDE-LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V F GA + + E++ GSL ++ + E ++ V +G+ L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE 851
I+HRD+K N+LV+ N VK+ DFG+S N S +K+ G +MAPE +++
Sbjct: 121 EH-NIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 852 PSNE------KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------EIPK 899
N+ + DV+S G+ + E+A + P+ P + + Q + +P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLPS 232
Query: 900 ELDPLVARIIWECWQTDPSLRPSFAQLT 927
+ +C P+ RP++AQL
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNVV 736
+IG G++GEV+ A VA+KK L + F AL RE+KI++ L+H NVV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL----REIKILQLLKHENVV 74
Query: 737 LFMGAVTRPPN--------LSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVAR 785
+ ++ EF L +L + + K+ +KM L+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN--- 130
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG------- 838
G+ +H + I+HRD+K+ N+L+ K+ +K++DFGL+R F SK++
Sbjct: 131 GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNRV 184
Query: 839 -TPEWMAPEVLRNEPS-NEKCDVYSFGVILWELAT 871
T + PE+L E D++ G I+ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 9/156 (5%)
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 840
VA GM L ++ VHRDL + N+L+ + VK+ DFGL+R ++ + ++S ST
Sbjct: 248 VANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---KLPWIGMNPMQVVGAVGFQNRRLEI 897
+WMAPE + N DV+SFG++LWE+ TL P + MN Q A+ + R+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNAIK-RGYRMAK 363
Query: 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
P + I+ +CW+ +RP F+QL + L
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY T VA+KK L+ + G RE+ +++ L+HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCL 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMAL-DVARGMNCLHTSTPT 796
+ + L +I EFL L + L P Q + +K L + +G+ H+
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 855
++HRDLK NLL+D +K++DFGL+R T + APEVL P +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 856 KCDVYSFGVILWELATLK 873
D++S G I E+AT K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 29/261 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+D+ E +G G+ G VY A + K + D + + E++I+ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVARGMN 788
++ F GA +SI TEF+ GSL D R+I ++A+ V +G+
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLT 109
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
L + I+HRD+K N+LV+ VK+ DFG+S N+ +K+ GT +MAPE +
Sbjct: 110 YLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERI 165
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWI-------GMNPMQVVGAVGFQNRRLEIPKEL 901
E DV+S G+ ELA + P+ + P+Q++ + ++ + +
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225
Query: 902 DPLVARIIWECWQTDPSLRPS 922
I +C + P RP+
Sbjct: 226 SEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-17
Identities = 55/159 (34%), Positives = 88/159 (55%), Gaps = 15/159 (9%)
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 840
VARGM L ++ VHRDL + N+L+ + VK+ DFGL+R + + ++S ST
Sbjct: 246 VARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR-----R 894
+WMAPE + + DV+S+G++LWE+ +L P+ GM +V + F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM----IVDST-FYNKIKSGYR 358
Query: 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ P V I+ +CW ++P RPSF L+ ++ L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A AVK A+L+ K + IM + ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L + +++ G LF L R + + R A ++A + LH+
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSLN 116
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEP 852
I++RDLK N+L+D +V ++DFGL K S ++ GTPE++APEVLR +P
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 853 SNEKCDVYSFGVILWEL 869
+ D + G +L+E+
Sbjct: 173 YDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
+ +++G G++G VY A G VA+KK + +S + REVK +R+L HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
V L + E++ G+L++ + R E + + +G+ +H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWM-APEV-LRN 850
HRDLK NLLV VK++DFGL+R + + ST W APE+ LR+
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST----RWYRAPEILLRS 173
Query: 851 EPSNEKCDVYSFGVILWELATLK 873
+ D+++ G I+ EL TL+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 30/273 (10%)
Query: 682 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G +G+V ++ + +V VK+ L S ++F E + R L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE-LRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV------DEKRRIKMALDVARGMNCLH 791
+G T ++ EF P G L L C+ D +MA ++A G+ LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRS--CRKAELMTPDPTTLQRMACEIALGL--LH 115
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLR 849
+H DL N L+ + VK+ D+GLS K+ + +++ W+APE++
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 850 NEPSN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVG-AVGFQNRRLEIPKE 900
N ++ +V+S GV +WEL L P+ ++ QV+ V Q +L P+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 901 LDPLVAR---IIWECWQTDPSLRPSFAQLTVAL 930
PL R ++ CW P RPS ++ + L
Sbjct: 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 39/208 (18%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A G +VA+KK F Q F L RE+KI+RR +H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENIIGI 68
Query: 739 MGAVTRPPNLS------IITEFLPRGSLFRI-----LHRPHCQVDEKRRIKMALDVARGM 787
+ + RPP+ I+ E + L+++ L H Q + RG+
Sbjct: 69 L-DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQILRGL 119
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPEW 842
+H++ ++HRDLK NLL++ N ++K+ DFGL+R+ H FL+ T +
Sbjct: 120 KYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT--EYVATRWY 175
Query: 843 MAPEVLRNEPSNEKC-DVYSFGVILWEL 869
APE++ N K D++S G IL E+
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 680 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737
L E +G G+YG+VY T ++A K +D + E K E+ ++++ H N+
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 738 FMGAVTR--PP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCL 790
+ GA + PP L ++ EF GS+ ++ ++ I + ++ RG+ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 138 HAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 851 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
+ + + + D++S G+ E+A P M+PM+ +
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 61/193 (31%), Positives = 105/193 (54%), Gaps = 18/193 (9%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVVLFMG 740
+G+G++G V A G VA+KK + + FS L + RE+K+++ LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM-KPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 741 AVTRP-PNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIK-MALDVARGMNCLHTSTPTI 797
P ++ +TE L L R+L RP EK+ I+ + RG+ +H++ +
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPL----EKQFIQYFLYQILRGLKYVHSAG--V 129
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEK 856
VHRDLK N+L+++N ++K+ DFGL+R++ ST + APE+ L + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR---YYRAPEIMLTWQKYDVE 186
Query: 857 CDVYSFGVILWEL 869
D++S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 61/194 (31%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V A++ T E+ K L + A +L+ KR + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
++ + E+ G L +H E R + A V G+ LH + I
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKST-AGTPEWMAPEVLRNEPSNE 855
V+RDLK NLL+D VK++DFGL K F ST GTPE++APEVL
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 856 KCDVYSFGVILWEL 869
D + GV+++E+
Sbjct: 181 AVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-- 731
DL IG G+ G+VY + G +AVK+ E KR I+ L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKR---ILMDLDVV 67
Query: 732 ---H--PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
H P +V G ++ I E L L ++L R + E KM + + +
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKS---TAGTPEW 842
++ L ++HRD+K N+L+D + NVK+ DFG+S RL + SK+ +AG +
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAAY 180
Query: 843 MAPEVLRNEPSNEK----CDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNR-RLE 896
MAPE + N K DV+S G+ L ELAT + P+ +V+ + + L
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240
Query: 897 IPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ P + C D RP + +L
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA--ALLEFKREVKIMRRLRHPNVVLFMG 740
+G G +GEV T ++ K + + A + F+ E I+ P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPTIVH 799
A NL ++ E+ P G L +L+R Q DE + +A ++ ++ +H VH
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG--YVH 125
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK-- 856
RD+K N+L+D+ ++K++DFG + RL N ++SK GTP+++APEVL + K
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 857 ----CDVYSFGVILWEL 869
CD +S GVI +E+
Sbjct: 186 YGVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 50/239 (20%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKF----------LDQDFSGAA 716
+ ++ +ED +G GS+G V A + + VA+K+F +D FS
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS--- 80
Query: 717 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR- 775
E KI+ + HP V G+ L ++ EF+ G F L R KR
Sbjct: 81 ------ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------NKRF 128
Query: 776 ----------RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825
+I + + + +N IV+RDLK NLL+DK+ +K++DFG +++
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLN--------IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
Query: 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ + GTPE++APE+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 181 VDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLD-------QDFSGAALLEFKREVKIMRRLRHPN 734
+G G +GEV G A KK LD + A E KI+ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALN-----EKKILEKVSSRF 54
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V A +L ++ + G L + I + E R I A + G+ LH
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IV+RDLK N+L+D + NV++SD GL+ LK K AGTP +MAPEVL+ E
Sbjct: 115 R--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEV 170
Query: 853 SNEKCDVYSFGVILWEL 869
+ D ++ G L+E+
Sbjct: 171 YDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-16
Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 5/179 (2%)
Query: 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810
++ + IL +D + + + VA+GM+ L ++ +HRDL + N+L+
Sbjct: 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLT 248
Query: 811 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWE 868
K+ DFGL+R +++++ K A P +WMAPE + N + DV+S+G++LWE
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 869 LATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ +L P+ GM + + R+ P+ + I+ CW DP RP+F Q+
Sbjct: 309 IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFK------------REVK 725
G +G G+YG+V A D G VA+KK + S + + RE+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 726 IMRRLRHPNVVLFMGAV---TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
IM ++H N+ MG V ++++ + + L +++ R + + + + L
Sbjct: 73 IMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQ 127
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG---- 838
+ G+N LH +HRDL N+ ++ K++DFGL+R S +
Sbjct: 128 ILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 839 -----TPE----WM-APEVLRN-EPSNEKCDVYSFGVILWELATLK 873
T + W APE+L E + D++S G I EL T K
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 683 RIGLGSYGEVYHA-DWNGTE-VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
RIG G+YG VY A D E VA+KK +D + G + RE+ ++ LRHPN+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 740 GAVT--RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
V ++ ++ E+ + L +L E + + L + RG+ LH + I
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--I 129
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEK 856
+HRDLK NLL+ +K++DFGL+R T + APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189
Query: 857 CDVYSFGVILWEL 869
D+++ G IL EL
Sbjct: 190 IDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK----REVKIMRRLRHPNVVL 737
+G G+YG+V A T +VA+KK L + F A RE+++++ + H NV+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK-LSRPFQSA---IHAKRTYRELRLLKHMDHENVIG 78
Query: 738 FMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNC 789
+ T +L ++T + L I+ CQ D+ + + + RG+
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK---CQKLSDDHIQF-LVYQILRGLKY 133
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEV 847
+H++ I+HRDLK N+ V+++ +K+ DFGL+R + T T + APE+
Sbjct: 134 IHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGA 887
+ N N+ D++S G I+ EL T K + G + M +VG
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 5/155 (3%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMAL 781
E ++++ RHP + + L + E+ G LF H +V E R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA 102
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ + LH+ +V+RDLK NL++DK+ ++K++DFGL + + + K+ GTPE
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
++APEVL + D + GV+++E+ +LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFK-----REVK--------IMRRL 730
IG GS+G+V A K+ LD +L+ K +E K +++ +
Sbjct: 3 IGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
+HP +V + L + +F+ G LF L R + + R A ++A + L
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYL 112
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H+ IV+RDLK N+L+D +V ++DFGL + ++ + GTPE++APEV+R
Sbjct: 113 HSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
+P + D + G +L+E+ G+ P + L P L P + W
Sbjct: 171 QPYDNTVDWWCLGAVLYEML------YGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
Query: 911 ECWQT 915
+
Sbjct: 225 SILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-15
Identities = 58/187 (31%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 699 GTEVAVKKFLDQDFSGAALL-EFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 756
G EVA+K F+RE + RL HPN+V L P L + E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 757 RGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DK 811
+L +L + R + LD + C H IVHRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAHNQG--IVHRDLKPQNIMVSQTGV 117
Query: 812 NWNVKVSDFGLSRLKHNTFLSSKSTA-------GTPEWMAPEVLRNEPSNEKCDVYSFGV 864
+ KV DFG+ L + +T GTP + APE LR EP D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 865 ILWELAT 871
I E T
Sbjct: 178 IFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
V K L D L F +M +L H ++V G R N+ ++ E++ G L
Sbjct: 34 VLKVLGSD--HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVF 90
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VK 816
LHR V ++ +A +A ++ L +VH ++ N+LV + +K
Sbjct: 91 LHREKNNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN--EKCDVYSFGVILWELAT-LK 873
+SD G+ T LS + W+APE +RN ++ D +SFG L E+ + +
Sbjct: 149 LSDPGIPI----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 874 LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
P ++ + F + +P +A +I +CW DP+ RPSF +
Sbjct: 205 EP---LSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-15
Identities = 65/253 (25%), Positives = 126/253 (49%), Gaps = 21/253 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 693
G N + DL+ P+ ++D+ ++ ++I + + ++ ED + + IG G++GEV
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRK-IRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 694 HADWNGTE-VAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
++ V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKYL 118
Query: 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808
++ E++P G L ++ + V EK +V ++ +H+ ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNML 174
Query: 809 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 863
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 864 VILWELATLKLPW 876
V L+E+ P+
Sbjct: 235 VFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 682 ERIGLGSYGEVY---HADWNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPN 734
+IG GSYG V+ + + G VA+KKF+ D AL RE++++++L+HPN
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPN 61
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + R L ++ E+ L + P V E K+ + +N H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
+HRD+K N+L+ K +K+ DFG +R+ T + APE+L +
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 854 NEKCDVYSFGVILWELATLKLPWIG 878
DV++ G + EL T + W G
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G+YG V T+ VA+KKF D + + RE+K++R L+ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
R L ++ E++ + L + P+ EK R + + ++ H + IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKND--IVHRD 125
Query: 802 LKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA------PEVLRNEPSNE 855
+K NLL+ N +K+ DFG +R LS S A E++A PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFAR-----NLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 856 KCDVYSFGVILWELA 870
D++S G IL EL+
Sbjct: 181 AVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 46/260 (17%)
Query: 684 IGLGSYGEV---YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G++GEV D G A+KK + + + E I+ +P VV
Sbjct: 9 IGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L +I E+LP G + +L + +E+ R +A + ++ +H +H
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIH 124
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLS-------------RLKHN----------TFLSSK-- 834
RD+K NLL+D ++K+SDFGL L H +SSK
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 835 -------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881
ST GTP+++APEV N++CD +S GVI++E+ P+ NP
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 882 MQVVGAVGFQNRRLEIPKEL 901
+ + L+ P E+
Sbjct: 245 QETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 684 IGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVL 737
IG G+YG+V+ A G VA+K+ Q L REV ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 738 FMGAVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
T R L+++ E + + + P V + M + RG++ LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+VHRDLK N+LV + +K++DFGL+R+ + S T + APEVL
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQSS 185
Query: 853 SNEKCDVYSFGVILWEL 869
D++S G I E+
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-14
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 59/237 (24%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNVVLFM 739
IG G GEVY + VA+KK + +D S LL+ F RE KI L HP +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIV--- 65
Query: 740 GAVTRPPNLSIITEFLP--------RG----SLFR------ILHRPHCQVDEKRRIKMAL 781
P SI ++ P G SL + L + EK + L
Sbjct: 66 ------PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---AEKTSVGAFL 116
Query: 782 ----DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH---------- 827
+ + +H+ ++HRDLK N+L+ V + D+G + K
Sbjct: 117 SIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 828 ---NTFLSSKST-----AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
S T GTP++MAPE L P++E D+Y+ GVIL+++ TL P+
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 39/222 (17%)
Query: 684 IGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G++G V W +G VA+KK + + + RE+K++ +H NV
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-- 61
Query: 738 FMGA--VTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 788
+ A + +PP++ ++TE + + L +I+ P + +K+ L + RG+
Sbjct: 62 -LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSD--HVKVFLYQILRGLK 117
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEW 842
LH++ I+HRD+K NLLV+ N +K+ DFGL+R+ KH T T +
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT-----QEVVTQYY 170
Query: 843 MAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
APE+L D++S G I EL ++ + +P+Q
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVV 736
E IG G+YG V A +G +VA+KK + KR E+KI+R +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRP-HCQVD-EKRRIKMAL-D 782
+I P G+ F+ LH H + I+ L
Sbjct: 68 ------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKST 836
+ RG+ +H++ ++HRDLK NLLV+++ +++ DFG++R +H F++
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 837 AGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 869
T + APE+L + P D++S G I E+
Sbjct: 174 --TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 57/228 (25%), Positives = 113/228 (49%), Gaps = 21/228 (9%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT+ + K + QD + KR + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQ 65
Query: 738 FMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQV---DEKRRIKMALDVARGMNCLHTS 793
L + E++ G L + I QV E + A ++A G+ LH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I++RDLK N+++D ++K++DFG+ + ++++ GTP+++APE++ +P
Sbjct: 121 G--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
+ D ++FGV+L+E+ + P+ G + ++ ++ N + PK L
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 60/242 (24%), Positives = 118/242 (48%), Gaps = 25/242 (10%)
Query: 644 RDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY---HAD 696
D + P+ ++D+ S+ ++ + + + + ED + + IG G++GEV H
Sbjct: 8 YDCDIPALRKNKNIDNFLSRYEKAAEK-ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS 66
Query: 697 WNGTEVAVKKFLDQD----FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752
+V K L + S +A F E IM +V A L ++
Sbjct: 67 SK--QVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122
Query: 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812
E++P G L ++ + + EK +V ++ +H+ +HRD+K N+L+DK+
Sbjct: 123 EYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS 178
Query: 813 WNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFGVILW 867
++K++DFG ++ N + + GTP++++PEVL+++ + +CD +S GV L+
Sbjct: 179 GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 868 EL 869
E+
Sbjct: 239 EM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
++G+ + T VAVKK S L ++E+ R+L+HPN++
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL---DVARGMNCLHTS 793
++ + L +++ + GS L + H + + +A DV ++ +H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDF--GLSRLKHN-----TFLSSKSTAGTPEWMAPE 846
+HR +K+ ++L+ + V +S +S +KH KS+ W++PE
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 847 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
VL+ NEK D+YS G+ ELA +P+ M Q
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 4/154 (2%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
RE+K++ P +V F GA +SI E + GSL ++L + ++ E K+++
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISI 106
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
V RG+ L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT
Sbjct: 107 AVLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRS 163
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
+M+PE L+ + D++S G+ L E+A + P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 11/157 (7%)
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 835
++ + VA+GM+ L ++ +HRD+ + N+L+ K+ DFGL+R + +++ K
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 836 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM---NPMQVVGAVGF 890
A P +WMAPE + + + DV+S+G++LWE+ +L K P+ G+ + + G+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY 332
Query: 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 927
Q R P P + I+ CW +P+ RP+F+Q++
Sbjct: 333 QMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 772 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831
E R + G+ LH I++RDLK N+L+D + NV++SD GL+ +
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+K AGTP +MAPE+L+ E + D ++ GV L+E+ + P+
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 38/190 (20%)
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806
NL +I EFLP G + +L + +E+ + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDN 131
Query: 807 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 834
LL+D +VK+SDFGL L H+ TF ++SK
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 835 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251
Query: 892 NRRLEIPKEL 901
L P E+
Sbjct: 252 KETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL-------EFKREVKIMRRLRHPNVV 736
+G G YG+V+ K F + A ++ K E I+ ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-----RRIKMALDVARGMNCLH 791
+ A L +I E+L G LF L R +++ I +AL+ H
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE--------H 115
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 849
I++RDLK N+L+D +VK++DFGL K + + + GT E+MAPE+L
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
+ D +S G +++++ T P+ N
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 683 RIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVV--- 736
RI G+YG VY A T VA+KK ++++ G + RE+ I+ +L+HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVK 70
Query: 737 -LFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ +G + + ++ E++ SL + +P Q + K + L G+ LH +
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---SGVAHLHDN 125
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTPEWMAPEVL 848
I+HRDLK+ NLL++ +K+ DFGL+R LK T T + APE+L
Sbjct: 126 W--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-----QLVVTLWYRAPELL 178
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I EL T K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY A G VA+KK LD + G RE+ +++ L HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKL 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DVARGMNCLHT 792
+ + L ++ EFL + + I + L + +G+ H+
Sbjct: 65 LDVIHTENKLYLVFEFLHQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 119 H--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 174
Query: 853 SNEKCDVYSFGVILWEL 869
C YS V +W L
Sbjct: 175 ----CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 3/149 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++ ++ P +V + P L ++ F+ G LF L R D R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAE 101
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ + LH +++RDLK N+L+D ++ + DFGL +L + + GTPE+
Sbjct: 102 LLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+APE+L + D ++ GV+L+E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 66/249 (26%), Positives = 114/249 (45%), Gaps = 16/249 (6%)
Query: 684 IGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V TE VKK L D ++ ++ V + HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
L + E++ G L + R +E R A +++ +N LH I+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--II 118
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 859 VYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 911
++ GV+++E+ + P+ +G NP Q FQ +++ IP+ L A ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 238
Query: 912 CWQTDPSLR 920
DP R
Sbjct: 239 FLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 38/190 (20%)
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806
NL +I EFLP G + +L + +E + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPDN 131
Query: 807 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 834
LL+D +VK+SDFGL L HN +F ++SK
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 835 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251
Query: 892 NRRLEIPKEL 901
L P E+
Sbjct: 252 KETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 684 IGLGSYGEVYHADW----NGTEVAVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPN 734
IG G+YG VY A +G E A+KKF S +A RE+ ++R L+H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALLRELKHEN 63
Query: 735 VVLFMGAVTRPPNLSI-----ITEFLPRGSLFRIL--HRPH--CQVDE---KRRIKMALD 782
VV + + S+ E L++I+ HR + K + L+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHN---TFLSSKS 835
G++ LH++ ++HRDLK N+LV + VK+ D GL+RL +
Sbjct: 120 ---GVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 836 TAGTPEWMAPEVLRNEPSNEKC-DVYSFGVILWELATLK 873
T + APE+L K D+++ G I EL TL+
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFM 739
+IG G++ EV A G A+K + + F + RE++ +RRL HPN++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 740 GAVTRPPN--LSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L+++ E L +L+ I R + EKR + + ++ +H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--------EWM-APEV 847
I HRD+K N+L+ + +K++DFG S + P W APE
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWYRAPEC 169
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
L + K D+++ G + +E+ +L
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT+ + K + QD + KR + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK--PPFLTQ 65
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L + E++ G L + + + E + A ++A G+ LH+ I
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKG--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
++RDLK N+++D ++K++DFG+ + +++K+ GTP+++APE++ +P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 858 DVYSFGVILWELATLKLPWIG 878
D ++FGV+L+E+ + P+ G
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 61/225 (27%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR------LRHPNVV 736
+G GS+G+V A+ G E K L +D L++ E ++ + +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD---VVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+L + EFL G L F I + + D R A ++ G+ LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPS 853
I++RDLK N+++D++ ++K++DFG+ K N F ++++ GTP+++APE+L+
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
D +SFGV+L+E+ + P+ G + ++ F++ R++ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 682 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G GSY VY + NG VA+K Q+ G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMAL-DVARGMNCLH 791
+ L+++ E++ H CQ +K +K+ L + RG++ +H
Sbjct: 70 DIIHTKETLTLVFEYV---------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
I+HRDLK NLL+ +K++DFGL+R K + + T + P+VL
Sbjct: 121 QRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 852 PSNEKC-DVYSFGVILWELATLKLPWIGMNPMQ 883
C D++ G I E+ + GM +Q
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I H +E R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ G+ LH IV+RDLK N+L+D + ++++SD GL+ + + K GT
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVG 166
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-E 900
+MAPEV++NE D ++ G +L+E+ + G FQ R+ +I + E
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEM--------------IAGQSPFQQRKKKIKREE 212
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
++ LV + E + S ++ + P +RL
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG G+YG+VY A G VA+KK LD + G + RE+KI+R+L H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHRNIVNLKE 73
Query: 741 AVT----------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
VT ++ E++ L +L E + G+N
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLR 849
H +HRD+K N+L++ +K++DFGL+RL ++ + W PE+L
Sbjct: 133 HKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190
Query: 850 NE----PSNEKCDVYSFGVILWELATLK 873
E P+ DV+S G IL EL T K
Sbjct: 191 GEERYGPA---IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G+ G V A G VA+KK F + + A RE+ +M+ + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY----RELVLMKLVNHKNIIG 79
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----------GM 787
+ T +L EF + ++ CQV I+M LD R G+
Sbjct: 80 LLNVFTPQKSLE---EFQDVYLVMELMDANLCQV-----IQMDLDHERMSYLLYQMLCGI 131
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV
Sbjct: 132 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 188
Query: 848 LRNEPSNEKCDVYSFGVILWEL 869
+ E D++S G I+ E+
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 64/253 (25%), Positives = 122/253 (48%), Gaps = 21/253 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 693
G + + DL+ P+ ++D+ ++ + + + + ED + + IG G++GEV
Sbjct: 2 GLDALVYDLDFPALRKNKNIDNFLNRYKDTINK-IRDLRMKAEDYEVVKVIGRGAFGEVQ 60
Query: 694 HADWNGT-EVAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
T +V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYL 118
Query: 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808
++ E++P G L ++ + V EK +V ++ +H+ +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNML 174
Query: 809 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 863
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 864 VILWELATLKLPW 876
V L+E+ P+
Sbjct: 235 VFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A + T +VA+KK D L RE+K++R L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---REIKLLRHLDHENVIA- 68
Query: 739 MGAVTRPPN------LSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARG 786
+ + PP+ + I+ E L L +I+ HCQ + RG
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQY-------FLYQLLRG 120
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ +H++ ++HRDLK NLL++ N ++K+ DFGL+R T + APE
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 847 VLRNEPSNE---KCDVYSFGVILWELATLK 873
+L N +E DV+S G I EL K
Sbjct: 179 LLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQDF----SGA--ALLEFKREVKIMRRLRHPNV 735
+G G +GEV G A KK LD+ SG ALLE +I+ ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLE----KEILEKVNSPFI 55
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
V A +L ++ + G L + I + ++ +R I + + G+ LH +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI--LHLHS 113
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
IV+RD+K N+L+D N ++SD GL+ LK ++ + AGT +MAPE+L+ EP
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEEPY 171
Query: 854 NEKCDVYSFGVILWELATLKLPW 876
+ D ++ G ++E+ + P+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-13
Identities = 50/174 (28%), Positives = 90/174 (51%), Gaps = 4/174 (2%)
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
+ +K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
++L ++ E+ K+++ V RG+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 92 QVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
+S ++ + S GT +M+PE L+ + + D++S G+ L ELA + P
Sbjct: 150 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 11/192 (5%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLD-----QDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT EV K L QD + KR + + + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L + E++ G L + R + DE R A +V + LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHG--V 117
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
++RDLK N+L+D + K++DFG+ + +++ + GTP+++APE+L+
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 858 DVYSFGVILWEL 869
D ++ GV+++E+
Sbjct: 178 DWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 738
IG+G+YG VY A +G VA+K Q L REV +++RL HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 739 MGAVT-----RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCL 790
M R ++++ E + + L L + P + + + RG++ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFL 124
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H + IVHRDLK N+LV VK++DFGL+R+ ++ ++ T + APEVL
Sbjct: 125 HANC--IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 851 EPSNEKCDVYSFGVILWEL 869
D++S G I E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 45/264 (17%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--------PNV 735
+G G+YG+V+ K + + AAL++ + V+ R R+ P +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR----RIKMALDVARGMNCL 790
V A L +I +++ G +F L+ R + DE R I +AL+
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE-------- 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAP 845
H IV+RD+K N+L+D +V ++DFGLS+ FLS + S GT E+MAP
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAP 175
Query: 846 EVLRNEPSNEKC-DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRL-----E 896
E++R + + K D +S G++++EL T G +P + G Q +RR+
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT------GASPFTLEGERNTQSEVSRRILKCDPP 229
Query: 897 IPKELDPLVARIIWECWQTDPSLR 920
P + P ++ + + DP R
Sbjct: 230 FPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 43/271 (15%)
Query: 682 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G +G+V + D V VK+ L + S EF ++ R L+HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKE-LKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-------IKMALDVARGMNCL 790
+G ++ E+ G L L Q RR +MA ++A G+ +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVL 848
H +H DL N + + VKV D+G+ SR K + + W+APE++
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 849 -----------RNEPSNEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAVGFQNRRLE 896
+ +PSN V++ GV LWEL P+ ++ +V+ V ++++++
Sbjct: 174 GEFHGGLITAEQTKPSN----VWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVK 228
Query: 897 IPK-ELD-PLVAR---IIWECWQTDPSLRPS 922
+ K +L+ P R ++ CW + P R +
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLS-PEKRAT 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 16/249 (6%)
Query: 684 IGLGSYGEVYHADWNGTEVA-----VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V + T +KK L D ++ ++ V HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
L + EF+ G L + R +E R A +++ +N LH I+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERG--II 118
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 859 VYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 911
++ GV+++E+ + P+ +GM NP Q FQ +++ IP+ L + ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG 238
Query: 912 CWQTDPSLR 920
DP R
Sbjct: 239 FLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G+YG V A G +VA+KK F + F+ A RE+++++ ++H NV+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMKHENVIG 78
Query: 738 FMGAVTRPPNLSIITEF---LP-----RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
+ T +L +F +P G L + H ++ E R + + +G+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKY 133
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
+H + I+HRDLK NL V+++ +K+ DFGL+R T T + APEV+
Sbjct: 134 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVIL 188
Query: 850 N-EPSNEKCDVYSFGVILWELATLK 873
N + D++S G I+ E+ T K
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 684 IGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G G+ G V+ + + +K + + A + RE++++ P +V F GA
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802
+SI E + GSL ++L + ++ E+ K+++ V +G+ L I+HRD+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDV 130
Query: 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 862
K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+ + + D++S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 863 GVILWELATLKLP 875
G+ L E+A + P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL---------------KHNTFLSSKSTAGTPE 841
IVHRDLK NLL+ ++K++DFGLS++ K K GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
++APEV+ + + D ++ G+IL+E +P+ G P ++ G V + +E P+
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEWPEGD 239
Query: 902 DPLVAR---IIWECWQTDPSLR 920
+ L A +I + +P R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG V+ A VA+K+ LD D G +AL RE+ +++ L+H N+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V + L+++ E+ + L + + +D + + +G+ H+
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SN 854
++HRDLK NLL++KN +K++DFGL+R + T + P+VL +
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178
Query: 855 EKCDVYSFGVILWELA 870
D++S G I ELA
Sbjct: 179 TSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREV-------KIMRR---LR 731
IG G++G+VY T A+K + K+EV I+ R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P +V + +L ++T+++ G LF L + + E R ++ + LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH 113
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
IV+RDLK N+L+D ++ + DFGLS+ ++ + GT E++APEVL +E
Sbjct: 114 KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 852 PSNEK-CDVYSFGVILWEL 869
K D +S GV+++E+
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E++G G+Y VY G VA+K+ LD + G RE+ +M+ L+H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAI-REISLMKELKHENIVRL 63
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L ++ E++ L + + H +D + +G+ H +
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 852
++HRDLK NLL++K +K++DFGL+R + NTF + T W AP+VL
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL----WYRAPDVLLGSR 176
Query: 853 S-NEKCDVYSFGVILWELAT 871
+ + D++S G I+ E+ T
Sbjct: 177 TYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 684 IGLGSYGEVYHA------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A +V K + QD + KR + + R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPT 796
P L + EF+ G L + H + DE R A ++ + LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I++RDLK N+L+D + K++DFG+ + ++ + GTP+++APE+L+
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 857 CDVYSFGVILWEL 869
D ++ GV+L+E+
Sbjct: 177 VDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 48/201 (23%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT+ + K + QD + KR + + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL--QDKPPFLTQ 65
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L + E++ G L + + + E + + A +++ G+ LH I
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRG--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
++RDLK N+++D ++K++DFG+ + +++++ GTP+++APE++ +P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 858 DVYSFGVILWELATLKLPWIG 878
D +++GV+L+E+ + P+ G
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 79/303 (26%), Positives = 120/303 (39%), Gaps = 81/303 (26%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRHPNVVL 737
E IG GSYG V A G +VA+KK D + S A RE+K++R LRHP++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA------------R 785
+ + PP+ EF +F ++ QV IK D+ R
Sbjct: 64 -IKHIMLPPSRR---EFKDIYVVFELMESDLHQV-----IKANDDLTPEHHQFFLYQLLR 114
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 843
+ +HT+ + HRDLK N+L + + +K+ DFGL+R+ N T W
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAIFWTDY 166
Query: 844 -------APEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN----------- 880
APE+ + P+ D++S G I E+ T K + G N
Sbjct: 167 VATRWYRAPELCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
Query: 881 ----PMQVVGAVG-------FQNRRLEIPKEL-------DPLVARIIWECWQTDPSLRPS 922
+ + V + R + P DPL R++ DP RP+
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 923 FAQ 925
+
Sbjct: 284 AEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 14/247 (5%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V + VKK L D ++ ++ V + +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHV-FEQASSNPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
L ++ E++ G L + R +E R A ++ +N LH I+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--II 118
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+RDLK N+L+D + ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 859 VYSFGVILWELATLKLPW--IGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECW 913
++ GV+++E+ + P+ I NP FQ + + IP+ L + ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238
Query: 914 QTDPSLR 920
DP R
Sbjct: 239 NKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 721 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKR--- 775
+ E +++ +R P +V A L +I +++ G LF + R + E +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 776 -RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-S 833
I +AL+ H I++RD+K N+L+D N +V ++DFGLS+ H + +
Sbjct: 112 GEIVLALE--------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 834 KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
S GT E+MAP+++R ++ D +S GV+++EL T G +P V G Q
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQ 217
Query: 892 ---NRRL-----EIPKELDPLVARIIWECWQTDPSLR 920
+RR+ P+E+ L II DP R
Sbjct: 218 AEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY A T +A+KK L+Q+ G RE+ +++ ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVRL 66
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTI 797
V L ++ E+L + P + R IK L + RG+ H+ +
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP-RLIKTYLYQILRGIAYCHSHR--V 123
Query: 798 VHRDLKSPNLLVDKNWN-VKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 852
+HRDLK NLL+D+ N +K++DFGL+R + TF T W APE+L
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAPEILLGSR 179
Query: 853 S-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+ K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-11
Identities = 44/140 (31%), Positives = 78/140 (55%), Gaps = 19/140 (13%)
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKSTAGTPEWMAPEVLRNEPS 853
++HRDLKS N+ + +K+ DFG S+ +++ +S + S GTP ++APE+ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------RLEIPKELDPLVA 906
++K D++S GVIL+EL TL P+ G + +++ V + + LDPL++
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308
Query: 907 RIIWECWQTDPSLRPSFAQL 926
+ +P+LRP+ QL
Sbjct: 309 K--------NPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 53/235 (22%), Positives = 110/235 (46%), Gaps = 11/235 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRH 732
ED + + IG G++GEV N +V K L+ + A F+ E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+ A NL ++ ++ G L +L + ++ E ++ ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L+
Sbjct: 121 LH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 852 PSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
+ +CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKR------------EVKIMRR 729
+G G +GEV G A KK LE KR E +I+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKK-----------LEKKRIKKRKGEAMALNEKQILEK 56
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMN 788
+ VV A L ++ + G L F I + + DE+R + A ++ G+
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEV 847
LH IV+RDLK N+L+D ++++SD GL+ + + + GT +MAPEV
Sbjct: 117 DLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRVGTVGYMAPEV 172
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKE 900
++NE Y+F W L L I G +P F+ R+ ++ +E
Sbjct: 173 VKNER-------YTFSPDWWGLGCLIYEMIEGKSP--------FRQRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVV---- 736
+G GS G V+ A + VAVKK L S L RE+KI+RRL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL---REIKIIRRLDHDNIVKVYE 69
Query: 737 -LFMGAVTRPPNLSIITEF--------LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
L ++ +TE L +L + E+ + RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGL 127
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRL-----KHNTFLSSKSTAGTPE 841
+H++ ++HRDLK N+ ++ V K+ DFGL+R+ H +LS T
Sbjct: 128 KYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKW 183
Query: 842 WMAPEVLRNEPSN--EKCDVYSFGVILWELATLKLPWIGMNPMQ 883
+ +P +L + P+N + D+++ G I E+ T K + G + ++
Sbjct: 184 YRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 49/246 (19%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG+G++GEV T A+K D K E I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL + +++P G + +L R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLS---RLKHN----------------------------- 828
D+K N+L+D++ ++K++DFGL R H+
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 829 -----------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877
+ S GTP ++APEVL + CD +S GVIL+E+ + P++
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
Query: 878 GMNPMQ 883
P +
Sbjct: 246 ADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 6e-11
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 49/212 (23%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGA--ALLEFKREVKIMRRLR-HPNVV 736
+++G G+YG V+ A VA+KK D F A A F RE+ ++ L HPN+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 737 LFMGAVTRPPN---LSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARG 786
+ V + N + ++ E++ R ++ +H KR I L A
Sbjct: 71 KLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--------KRYIMYQLLKA-- 119
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP------ 840
+ +H+ ++HRDLK N+L++ + VK++DFGL+R + + P
Sbjct: 120 LKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTDYV 173
Query: 841 --EWM-APEVLRNEPSNEKCDVYSFGVILWEL 869
W APE+L Y+ GV +W +
Sbjct: 174 ATRWYRAPEILLGSTR------YTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 687 GSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746
GS G V+ A G V + Q G L+E +++ + HP+V+ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQ--KGTTLIE----AMLLQNVNHPSVIRMKDTLVSGA 130
Query: 747 NLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804
++ LP L+ L + + + + + + G+ LH I+HRD+K+
Sbjct: 131 ITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKT 185
Query: 805 PNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 862
N+ ++ V + D G ++ FL AGT E APEVL + N K D++S
Sbjct: 186 ENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 863 GVILWEL 869
G++L+E+
Sbjct: 243 GIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+++G G+Y VY T+ VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMAL-DVARGMNCLHTSTPTI 797
+ +L+++ E+L + L + L C +K+ L + RG+N H +
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 856
+HRDLK NLL+++ +K++DFGL+R K + + T + P++L + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 857 CDVYSFGVILWELAT 871
D++ G I +E++T
Sbjct: 186 IDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK-FLDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG+VY A G VA+KK L+ D G AL RE+ +++ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIY 62
Query: 736 VLFMGAVTR------PPNLSIITEFLPRG-SLFRILHR--PHCQVDEKRRIKMALDVARG 786
++ + V P+L ++ E+L F + P + K + +G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
+ H ++HRDLK NLLVDK + K++D GL R S T + AP
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 846 EVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
EVL + D++S G I E++ + + G + +Q
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 53/235 (22%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG G++GEV G A+K L + F L K E ++ P VV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L +I EFLP G L +L + ++ R MA + + +H +HR
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVHKLG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------------------------ 830
D+K N+L+D+ ++K+SDFGLS H
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 831 --LSSK---------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 868
+SSK ST GTP+++APE+ + ++CD +S G I++E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-10
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-- 780
E I+R + HP+++ G T +I LPR ++ +C + KR I +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR---YKT--DLYCYLAAKRNIAICDI 184
Query: 781 ----LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----RLKHNTFLS 832
V R + LH + I+HRD+K+ N+ ++ +V + DFG + + N +
Sbjct: 185 LAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
AGT APE+L +P D++S G++L+E+AT
Sbjct: 243 ---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 699 GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
G VAVKK F +Q + A RE+ +++ + H N++ + T +L EF
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLE---EF 98
Query: 755 LPRGSLFRILHRPHCQV-----DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809
+ ++ CQV D +R + + G+ LH++ I+HRDLK N++V
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV 156
Query: 810 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
+ +K+ DFGL+R F+ + T + APEV+ E D++S G I+ EL
Sbjct: 157 KSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G G+Y V+ TE VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 740 GAVTRPPNLSIITEFLPR---------GSLFRILHRPHCQVDEKRRIKMAL-DVARGMNC 789
V +L+++ E+L + G++ + +K+ L + RG+
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-----------HNVKIFLYQILRGLAY 119
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
H ++HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 120 CHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 850 NEPS-NEKCDVYSFGVILWELAT 871
+ + D++ G I +E+A+
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 43/244 (17%)
Query: 702 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 45 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLE---EFQDV 97
Query: 758 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 807
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 98 YLVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 150
Query: 808 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 867
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 868 ELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 923
E+ K+ + G + + +V+ +G E K+L P V + RP +
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCP--EFMKKLQPTVRNYVEN--------RPKY 259
Query: 924 AQLT 927
A LT
Sbjct: 260 AGLT 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 7/199 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E V +++G G+Y V+ TE VA+K+ + GA REV +++ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHA 63
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V + L+++ E+L + + + +I M + RG++ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCHKR 122
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I+HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 123 K--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 854 -NEKCDVYSFGVILWELAT 871
+ D++ G IL+E+AT
Sbjct: 181 YSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 684 IGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFK-REVKIMRRLR-HPNVV- 736
+G G+YG V A T VA+KK + FS L + RE+K++R R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK-ITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 737 LF-MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTS 793
L+ M V N + E L L +I+ Q + + + G+ +H++
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS----KSTAGTPEWMAPEV-L 848
++HRDLK NLLV+ + +K+ DFGL+R + T + APE+ L
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 849 RNEPSNEKCDVYSFGVILWELATLK 873
+ + DV+S G IL EL K
Sbjct: 183 SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 23/200 (11%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 738
+G G+YG V A G VAVKK L + F +++ KR E+++++ ++H NV+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 739 MGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHT 792
+ T +L + L L I+ CQ ++ + + RG+ +H+
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-E 851
+ I+HRDLK NL V+++ +K+ DFGL+R +T T + APE++ N
Sbjct: 139 AD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 852 PSNEKCDVYSFGVILWELAT 871
N+ D++S G I+ EL T
Sbjct: 194 HYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G+YG V A G +VA+KK F + F+ A RE+ +++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHMQHENVIG 78
Query: 738 FMGAVTRPPNLSIITEF---LP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+ T + +F +P + L +I+ P + E + + + G+ +H+
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGLKYIHS 135
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 850
+ I+HRDLK NL V+++ +K+ DFGL+R T W APEV+ N
Sbjct: 136 AG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT----RWYRAPEVILNW 189
Query: 851 EPSNEKCDVYSFGVILWELATLK 873
N+ D++S G I+ E+ T K
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 702 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 52 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLE---EFQDV 104
Query: 758 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 807
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 105 YIVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 157
Query: 808 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 867
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 868 ELATLKLPWIGMN 880
E+ + + G +
Sbjct: 217 EMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRH----P 733
IG G +GEVY AD G A+K LD+ L +IM L P
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMK-CLDKKRIKMKQGETLALNE--RIMLSLVSTGDCP 57
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVL-RN 850
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL +
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 851 EPSNEKCDVYSFGVILWEL 869
+ D +S G +L++L
Sbjct: 171 VAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 57/279 (20%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G++GEV A T+ A+K +D + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL + +++P G + +L R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGL-------------------------------------- 822
D+K N+L+D++ ++K++DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 823 -SRLK---------HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL 872
RLK H L+ S GTP ++APEVL + CD +S GVIL+E+
Sbjct: 186 GDRLKPLERRAARQHQRCLA-HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 873 KLPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 909
+ P++ P++ V L IP + L P + +I
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 4/157 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I + + +E+R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ G+ LH V+RDLK N+L+D ++++SD GL+ +K S + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
+MAPEVL N+ D + G +++E+ + P+ G
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 55/278 (19%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G++GEV A T A+K +D + + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL + +++P G + +L R + R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLS---RLKHNTFLSSK----------------------- 834
D+K N+L+D + ++K++DFGL R HN+ K
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185
Query: 835 ---------------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 873
S GTP ++APEVL + + CD +S GVIL+E+ +
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
Query: 874 LPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 909
P++ P + V L IP + L P +I
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 687 GSYGEVY---HADWNGTEVAVKKFLD-QDFSGAALLEFKREV-KIMRRLRHPNVVLFMGA 741
G +G+V H ++ V+K + ++F+ +E V ++M+ +PN + +
Sbjct: 27 GKFGKVSVLKHKPTQ--KLFVQKIIKAKNFNA---IEPM--VHQLMKD--NPNFIKLYYS 77
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
VT +I +++ G LF +L + + E K+ + +N LH I+H D
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHN--IIHND 134
Query: 802 LKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEKCDV 859
+K N+L D + + D+GL ++ + S GT ++ +PE ++ + D
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDVSFDW 189
Query: 860 YSFGVILWELATLKLP 875
++ GV+ +EL T K P
Sbjct: 190 WAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G G V+ GT A+K K + + ++E I+ L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILATLDHPFLPTL 66
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L ++ ++ P G LFR+L R C +E R A +V + LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG-- 123
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS------------------------RLKHNTFLS 832
IV+RDLK N+L+ ++ ++ +SDF LS + TF
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 833 -----SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-09
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 44/232 (18%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHPNVV 736
++IG G +GEV+ T+ + F + S L E ++ EV +MR L+H N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 737 LFMGAVTRPPN--LSIITEFLPRGSLFRILHR---------PHCQVDEKRRIKMALDVAR 785
++ N L I+ EF G L R + + H VD R++ AL
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVD-------------KNWN----VKVSDFGLSRLKHN 828
+ + ++HRDLK N+ + N N K+ DFGLS+ N
Sbjct: 136 NLKD-GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---N 191
Query: 829 TFLSS--KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPW 876
+ S S GTP + +PE+L +E ++K D+++ G I++EL + K P+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 33/111 (29%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPS-- 853
VHRD+K N+L+D N +++++DFG S LK N + S GTP++++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 854 ---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
+CD +S GV ++E+ + P+ + ++ G + R + P +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 63/256 (24%), Positives = 116/256 (45%), Gaps = 32/256 (12%)
Query: 681 GERIGLGSYGEVYHADWNGTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVL 737
G R +G YGE++ TEV + K LD +++S + F +M +L H ++VL
Sbjct: 14 GIRREVGDYGELHK-----TEV-LLKVLDKSHRNYSES----FFEAASMMSQLSHKHLVL 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
G ++ E++ GSL L + ++ ++++A +A ++ L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--GL 121
Query: 798 VHRDLKSPNLLV-----DKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
H ++ + N+L+ K N +K+SD G+S T L + W+ PE +
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPECIE 177
Query: 850 NEPS-NEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
N + + D +SFG LWE+ + P ++ + + F R ++P +A
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPAPKWTELAN 234
Query: 908 IIWECWQTDPSLRPSF 923
+I +C +P RPSF
Sbjct: 235 LINQCMDYEPDFRPSF 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
GT V V+ ++ + L + EV + RHPN++ T L +I+ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 759 SLFRILHRPHCQVDEKRRIKMALDVA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817
S +L + + I L A RG+N LH + +HR++K+ ++L+ + V +
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSL 142
Query: 818 SDFGLSRL--------KHNTF--LSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVI 865
S GLS L K ST+ P W++PE+LR + N K D+YS G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGIT 199
Query: 866 LWELATLKLPWIGMNPMQVV 885
ELAT ++P+ M Q++
Sbjct: 200 ACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 4/155 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I + + DE+R I A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ G+ L IV+RDLK N+L+D ++++SD GL+ ++ + + GT
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVG 166
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+MAPEV+ NE D + G +++E+ + P+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 25/199 (12%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 738
+G G+YG V A +VAVKK L + F +L+ +R E+++++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQ--SLIHARRTYRELRLLKHMKHENVIGL 79
Query: 739 MGAVTRPPNLSIITEF-----LPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 792
+ T ++ E L L I+ CQ ++ + + RG+ +H+
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 850
+ I+HRDLK N+ V+++ +++ DFGL+R + +T W APE++ N
Sbjct: 137 AG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT----RWYRAPEIMLNW 190
Query: 851 EPSNEKCDVYSFGVILWEL 869
N+ D++S G I+ EL
Sbjct: 191 MHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 31/109 (28%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 855
VHRD+K N+L+DKN +++++DFG RL + + S GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 856 ----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
+CD +S GV ++E+ + P+ + ++ G + + P +
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----PNVV 736
IG G +GEVY AD G A+K + +IM L P +V
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
A P L I + + G L L + H EK A ++ G+ +H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPS- 853
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL+ +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAY 173
Query: 854 NEKCDVYSFGVILWEL 869
+ D +S G +L++L
Sbjct: 174 DSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 7/191 (3%)
Query: 682 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G GSY VY + NG VA+K + G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L+ + E++ ++ P R+ M + RG+ +H I+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHGQH--ILH 126
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCD 858
RDLK NLL+ +K++DFGL+R K + S T + P+VL + D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 859 VYSFGVILWEL 869
++ G I E+
Sbjct: 187 IWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+++G GSY VY G VA+K+ + GA RE +++ L+H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-------RRIKMAL-DVARGMNCLH 791
+ L+++ E+L Q + +++ L + RG+ H
Sbjct: 70 DIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
++HRDLK NLL+ + +K++DFGL+R K
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 681 GERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G ++G G+YG VY A + E A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 737 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
+ + F L+ I+ K+ +++ + + G+
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 788 NCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPE 841
+ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 842 WM-APEVLRNEPSNEKC-DVYSFGVILWELAT 871
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 737 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
+ + F L+ I+ K+ +++ + + G+
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 788 NCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPE 841
+ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 842 WM-APEVLRNEPSNEKC-DVYSFGVILWELAT 871
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-06
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E+ M +L+HPN+V +G +I E++ +L +L + +RR K+A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIG 788
Query: 783 VARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTFLSSKSTAGT 839
+A+ + LH +P +V +L +++D ++++S GL F+SS
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
++APE + EK D+Y FG+IL EL T K P
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 20/236 (8%)
Query: 698 NGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
NG E+ V K LD AL F +M ++ H ++ G R ++ EF+
Sbjct: 41 NGRELRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 813
G L L + +V +I +A +A ++ L +VH ++ + N+L+ +
Sbjct: 100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157
Query: 814 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWE 868
+K+SD G+S T LS + W+APE + S + D +SFG L E
Sbjct: 158 GTSPFIKLSDPGVSF----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 869 LA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 923
+ ++P P + F ++ +P+ +A +I +C +P+ RPSF
Sbjct: 214 ICFDGEVPLKERTPSE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF 266
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVK--KFLDQDFSGAALLEFKR 722
E+P ++LVLG +G G++G V A +G +VAVK K + AL+
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS--- 89
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
E+KIM L H N+V +GA T+ + IITE+ G L LHR
Sbjct: 90 ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 47/279 (16%)
Query: 616 KNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPW 675
+++ +E H K +F + KL + E ++ +++ D+D+ P
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS--PN 65
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK-REVKIMRRLRH 732
+ LG IG GS+G VY A T +VA+KK L QD ++K RE+ IM+ L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLNH 118
Query: 733 PNVVL-----FMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL--- 781
N++ + + L+++ EF+P+ H + R AL
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV--------HKYMKHYARNNHALPLF 170
Query: 782 -------DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLKHNTFLSS 833
+ R + +H+ I HRDLK NLL+D N + +K+ DFG ++ N
Sbjct: 171 LVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQ 225
Query: 834 KSTA--GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 869
+S + + + APE++ + D++S G I+ E+
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 718 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
L F +MR++ H ++VL G R ++ EF+ G L +HR + +
Sbjct: 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF 108
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGLSRLKHNTF 830
K+A +A ++ L +VH ++ + N+L+ + +K+SD G+ T
Sbjct: 109 KVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TV 162
Query: 831 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 869
LS + W+APE + + + + D +SFG LWE+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 723 EVKIMRRLRHPNVVLFM-----GAVT---RPPNLSIITEFLPRGSLFRILHRPHCQVDE- 773
E +++RRL HP V+ + G +T P S + +L G+ R L QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL--GARLRPLGLA--QVTAV 265
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833
R++ A+D G I+HRD+K+ N+LV+ ++ + DFG + ++ +
Sbjct: 266 ARQLLSAIDYIHGEG--------IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 834 --KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 870
AGT + APEVL +P D++S G++++E A
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 687 GSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
GS GEV+ H D +V VK +G RE+ I++ + H ++ + A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAV-----TGGKTPG--REIDILKTISHRAIINLIHAY 155
Query: 743 TRPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGM----NCLHTSTPT 796
S + +P + LF + R ++ A+ + R + LH
Sbjct: 156 R---WKSTVCMVMPKYKCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG-- 205
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I+HRD+K+ N+ +D+ N + DFG + +L H +GT E +PE+L +P
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 855 EKCDVYSFGVILWELATLKLPWIG 878
K D++S G++L+E++ + G
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-05
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 6/173 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
E+ V+ + I G++G+VY N AVK D ++ + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P +V ++ N+ ++ E+L G + +LH + DE+ +K +VA ++ LH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR 122
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
I+HRDLK N+L+ ++K++DFGLS++ N L+ TP P
Sbjct: 123 HG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPN 734
+ I G+ E+Y D+ G + +K + + + L E +RE +IM R R
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60
Query: 735 V----VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
V V F+ P N I+ E++ L +++ ++++ ++ R + L
Sbjct: 61 VNVPAVYFVD----PENFIIVMEYIEGEPLKDLINSN-----GMEELELSREIGRLVGKL 111
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
H++ I+H DL + N+++ + + DFGL+
Sbjct: 112 HSA--GIIHGDLTTSNMILSGG-KIYLIDFGLAEFSK 145
|
Length = 211 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
+HR KS N+L+ W+ + G F + + + P +MAPEV++ + EK
Sbjct: 33 LHRQAKSGNILL--TWDGLLKLDGSV-----AFKTPEQSRPDPYFMAPEVIQGQSYTEKA 85
Query: 858 DVYSFGVILWELATLKLPWIGMNPM 882
D+YS G+ L+E +LP+ +
Sbjct: 86 DIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 44/137 (32%), Positives = 62/137 (45%), Gaps = 12/137 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P + LVLG +G G++G+V G +VAVK L + E+
Sbjct: 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVK-MLKPTARSSEKQALMSEL 91
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMAL 781
KIM L H N+V +GA T+ + IITE+ G L LH R + + K L
Sbjct: 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDL 151
Query: 782 DVARGMNCLHTSTPTIV 798
D+ G+N ST + V
Sbjct: 152 DIF-GINPADESTRSYV 167
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 16/101 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFK--- 721
E P + L LG+ +G G++G+V A G E VAVK + GA E+K
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE----GATASEYKALM 58
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSL 760
E+KI+ + H NVV +GA T+P L +I E+ G+L
Sbjct: 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 698 NGTEVAVKKFLDQDFSGAALLEF-KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
G V V++ ++ + ++ F + E+ + + HPN+V + L ++T F+
Sbjct: 24 TGEYVTVRR-INLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 757 RGSLFRILHRPHCQ--VDEKRRIKMA---LDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811
GS ++ C +D + +A V + ++ +H VHR +K+ ++L+
Sbjct: 83 YGSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISV 136
Query: 812 NWNVKVSDF--GLSRLKHNTFLS-----SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSF 862
+ V +S LS + H L K + W++PEVL+ + + K D+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 863 GVILWELATLKLPWIGMNPMQV 884
G+ ELA +P+ M Q+
Sbjct: 197 GITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGA--ALLEFKR 722
E P ++L G+ +G G++G+V A + N VAVK + AL+
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS--- 90
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
E+KI+ L +H N+V +GA T + +ITE+ G L L +
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 37/154 (24%), Positives = 59/154 (38%), Gaps = 31/154 (20%)
Query: 684 IGLGSYGEVYHADWNGTEVAVK---------KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
I G+ +Y D+ G VK LD+ +RE +I+ + R
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREARILAKAREAG 60
Query: 735 V----VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
V V P N I+ E++ G L + E+ R + +V R + L
Sbjct: 61 VPVPIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKL 108
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
H + IVH DL + N+++ + DFGL
Sbjct: 109 HKA--GIVHGDLTTSNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 38/198 (19%), Positives = 56/198 (28%), Gaps = 58/198 (29%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-----PNVV 736
+ G+ Y +K A E +RE+ ++R L P V+
Sbjct: 3 RPLSGGASNRTYLVGTGDGRYVLKLAP----PAEAAEELRRELALLRHLAAAGIPVPRVL 58
Query: 737 LF------------------MGAVTRPPNLSIITEFLPR-GSLFRILHR-PHCQVDEKRR 776
+TRP + + L L LH P + RR
Sbjct: 59 AGGTDGGGLGLPFLLMEGLPGEVLTRPLDPAERGALLEALARLLARLHSVPPEALPLARR 118
Query: 777 IKMALDVARG----------------------------MNCLHTSTPTIVHRDLKSPNLL 808
++ L + R + L +VH DL NLL
Sbjct: 119 LRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLL 178
Query: 809 VDKNWNVK-VSDFGLSRL 825
VD V V DF + L
Sbjct: 179 VDPGGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 959 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 98.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.61 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| PF04473 | 153 | DUF553: Transglutaminase-like domain; InterPro: IP | 96.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.82 | |
| PLN02236 | 344 | choline kinase | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.58 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.58 | |
| COG1305 | 319 | Transglutaminase-like enzymes, putative cysteine p | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.44 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.42 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.82 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.78 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.57 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.07 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.86 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-63 Score=516.22 Aligned_cols=198 Identities=51% Similarity=0.882 Sum_probs=188.2
Q ss_pred hHHHHHHHHhhccccccCCcccCceeeeccCCC--C-CCCCCCCCChhhhhcc-cCCCCeEEEEEecccChHHHHHHHHH
Q 002157 125 AAEVLSRQYWEYNVLDYEERVVDGFYDIYGLST--D-PSTQGKLPSLAHLESN-LGNSGFEVVIVNRTIDHALEELVQVA 200 (959)
Q Consensus 125 ~~~~~s~~~w~~~~lsy~~~i~dGFY~i~~~~~--~-~~~~~~iPsl~~L~~~-~~~~~~EVIlVDr~~D~~L~~L~~~a 200 (959)
++|++|+|||++|+|+|+||||||||||||++. + ..+++|||+|++|++. ..+.++|||||||++|++|++|+++|
T Consensus 2 ~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~a 81 (204)
T PF14381_consen 2 SAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQRA 81 (204)
T ss_pred cHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHHH
Confidence 689999999999999999999999999999974 3 4799999999999995 67889999999999999999999999
Q ss_pred HHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHhhCCceeEeeeeccccchhhHHHHHHHhhc
Q 002157 201 QCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADS 280 (959)
Q Consensus 201 ~~l~~~l~~~~~~~~v~~LA~lV~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~g~~~~~a~lfk~l~d~ 280 (959)
+++++++. .+..+++++||+|||++|||++.+++....+|++++++||+ +++|+|||+|++|+|||||||||+|||+
T Consensus 82 ~~~~~~~~-~~~~~~v~~LA~lVa~~MGG~~~~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ 158 (204)
T PF14381_consen 82 HELSKGLS-TNTKELVQKLAKLVADRMGGPVSDAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADR 158 (204)
T ss_pred HHHHhccc-cCHHHHHHHHHHHHHHHhCCCCCcchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHh
Confidence 99998865 36789999999999999999999999999999999888988 7899999999999999999999999999
Q ss_pred cCCceEEeeccccCCC-CCCeeEEEEecCcceeeeecccCCCcccC
Q 002157 281 IRLPCRLVKGSHYTGV-EDDAVNIIKLEEEREFLVDLMAAPGTLIP 325 (959)
Q Consensus 281 ~~~~~~lv~G~~~~~~-~~~a~~~v~~~~~~~~~~Dlm~~pg~L~~ 325 (959)
+||||+||||+||||+ +++|||+|++.|+++||||||++||+|+|
T Consensus 159 iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 159 IGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred cCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 9999999999999999 88999999999999999999999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=433.52 Aligned_cols=270 Identities=47% Similarity=0.794 Sum_probs=248.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECCce-EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP- 746 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~-VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~- 746 (959)
..+.|.++++.+.+.||.|+||+||++.|+|+. ||||++............|.+|+.+|.+++|||||+|+|++.+..
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 456677788888899999999999999999998 999999887776666889999999999999999999999999988
Q ss_pred cEEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccc
Q 002157 747 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSR 824 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk 824 (959)
.++|||||+++|+|.+++++ ....++...++.|+.||++||+|||++++ ||||||||+||||+.++ ++||+|||+++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 46789999999999999999999999985 99999999999999998 99999999999
Q ss_pred cccCCcccCCCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~--g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls 902 (959)
.............||+.|||||++. ...|+.|+|||||||++|||++|..||.+..+.+....+.....++.+|..++
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 8765433344478999999999999 56899999999999999999999999999999888888888999999999999
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
+.+..||.+||..||.+||++.+|+..|+.+......
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 9999999999999999999999999999999886654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=426.06 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=226.3
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+..++|+++++||+|+||+||+++. +++.||+|++.+....+. .+.....|..||.+++||+||+++..|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999976 678899999988765443 567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||+||+.||+|+.+|++.+ .+.+..++.++.+|+.||.|||++| ||||||||||||||.+|||+|+|||+++....
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999998764 7888877778889999999999999 99999999999999999999999999997666
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
....+.++|||+.|||||++.+..|+..+||||||+++|||++|.+||.+.+..++...+.... ....|..++.+.++|
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHH
Confidence 6666778999999999999999999999999999999999999999999999999998885432 355666799999999
Q ss_pred HHHHhhcCCCCCC----CHHHHH
Q 002157 909 IWECWQTDPSLRP----SFAQLT 927 (959)
Q Consensus 909 I~kCL~~DP~kRP----Sa~EIL 927 (959)
|+++|+.||++|. ++.+|.
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhh
Confidence 9999999999996 455543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=419.63 Aligned_cols=251 Identities=32% Similarity=0.473 Sum_probs=227.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-E
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-L 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~-l 748 (959)
.+..++++.++.||+|..|+||+++| +++.+|+|++ .....+...+++.+|+++++..+|||||++||+|..+.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 36667888899999999999999988 5888999998 344567788899999999999999999999999999995 9
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
.|+||||++|+|.+++.+. .+++|...-.|+.+|++||.|||. ++ ||||||||.||||+..|+|||||||.++.+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999999999765 479999999999999999999996 77 9999999999999999999999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHhhhhccccccCCCCC-C
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIPKE-L 901 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~-----~~~ql~~~i~~~~~~~~iP~~-l 901 (959)
+. ...+++||..|||||.+.+..|+.++||||||+.++||..|++||... ++.+++..|. .+.++.+|.. +
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~f 307 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEF 307 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccC
Confidence 66 457899999999999999999999999999999999999999999874 6677888776 4457778886 9
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++++++||..||++||.+||+++|++++
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=432.36 Aligned_cols=249 Identities=28% Similarity=0.451 Sum_probs=231.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.+|+.++.||+|||..||+++. +|+.||+|++.+... .......+.+|++|.++|+|||||+|+++|++..+.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999976 799999999987544 3345667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+|..++|..+++++ ..++|.++++|++||+.||.|||+++ |||||||..||||+++.+|||+|||+|.........
T Consensus 98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999854 58999999999999999999999999 999999999999999999999999999998877677
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
..+.||||-|+|||++....++..+||||+||+||-||+|++||...+-.+.+..|.. ....+|..++.+.++||.+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--NEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--cCcccccccCHHHHHHHHHH
Confidence 8899999999999999999999999999999999999999999999999999988854 46677889999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|+.||.+||++.+|+.+
T Consensus 253 L~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDH 269 (592)
T ss_pred hcCCcccCCCHHHHhcC
Confidence 99999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=418.52 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=230.4
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~ 749 (959)
...||.+++.||.|+|++|++|+. .++.||||++.+..+. +..++.+.+|..+|.+| .||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 347899999999999999999976 6889999998776543 34456788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+|+||+++|+|.++|++. +.+++...+.++.+|+.||+|||++| ||||||||||||||.+|++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999999886 48999999999999999999999999 999999999999999999999999999976532
Q ss_pred cc-----------c--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC
Q 002157 830 FL-----------S--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 896 (959)
Q Consensus 830 ~~-----------~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~ 896 (959)
.. . ..+++||..|.+||++.....++.+|||+||||||.|+.|.+||.+.+...++++| ......
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALDYE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhccc
Confidence 11 1 15689999999999999999999999999999999999999999999998888877 445788
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHhhhh
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQR 935 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~l~k 935 (959)
+|..+++.+++||+++|..||.+|++..||.++ ++.+..
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 899999999999999999999999999999875 455544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=393.76 Aligned_cols=241 Identities=25% Similarity=0.449 Sum_probs=222.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
...++|++++.||.|+||+|.+++. ++..||+|++.++...+. ......+|.++|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 5678999999999999999999976 678899999987665433 4456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
|||||++||.|+.++++.+ ++++..++.++.||+.||+|||+++ |+||||||||||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998764 8999999999999999999999999 999999999999999999999999999987644
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
+.+.||||.|+|||++..+.|++++|||+|||++|||+.|.+||...++.+++++|. .....+|..++.++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHHH
Confidence 457899999999999999999999999999999999999999999999999999985 457888999999999999
Q ss_pred HHHhhcCCCCCC
Q 002157 910 WECWQTDPSLRP 921 (959)
Q Consensus 910 ~kCL~~DP~kRP 921 (959)
+++|+.|-.+|.
T Consensus 273 ~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 273 KKLLQVDLTKRF 284 (355)
T ss_pred HHHHhhhhHhhh
Confidence 999999999993
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=405.09 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=224.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
..+|.+.+.||.|+|++||+|++ ++..||||.+.+..+....++-+..|+.||+.++|||||.|++++..++++||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 6789999999988888888888999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC------CcEEEEecCccccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLK 826 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~------g~VKLiDFGlAk~~ 826 (959)
|||.||+|.+||++.+ .+++..++.++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998764 8999999999999999999999999 9999999999999764 46999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-CCCCCCcHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLV 905 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~-~iP~~ls~eL 905 (959)
... ....+.||++.|||||++..+.|+.|+|+||+|+|+|+|++|+.||...+..++...+....... .++..++..+
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 754 44567999999999999999999999999999999999999999999999999988776554443 3445677788
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.+|+...|+.++.+|-++.+-..
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhh
Confidence 89999999999999988776554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=408.25 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=213.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-----HHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-----~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
.+.|.+.+.||+|+||.|-+|.. +++.||||++.++..... ....+.+|++||++|+|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 36789999999999999999965 789999999987654332 22346799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecCccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR 824 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~---g~VKLiDFGlAk 824 (959)
.||||||+.||+|++++-.++ .+.+..-..+++||+.|+.|||+.| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999986654 6777777889999999999999999 9999999999999755 789999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccc--cCCC
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRR--LEIP 898 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~--~~iP 898 (959)
..+.. ....+.|||+.|.|||++.++. +..++|+|||||+||-+|+|.+||.+..... +.+.+..+... +..+
T Consensus 328 ~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 328 VSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred ccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 98743 5577899999999999998765 3458999999999999999999998866554 55555433222 2234
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++.+.++||.+||..||++||++.|+|+
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 568999999999999999999999999886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=392.85 Aligned_cols=259 Identities=27% Similarity=0.486 Sum_probs=229.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEee-eeecCCc-
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG-AVTRPPN- 747 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g-~~~~~~~- 747 (959)
.....+|+|.++||+|.||.||++.+ +|..||.|.+.-.............|+.+|++|+|||||++++ -|.++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 44567899999999999999999976 8999999998866667777788999999999999999999999 4555555
Q ss_pred EEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--EEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPT--IVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~--IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
++||||||.+|+|.++++ +.+..+++..+|+++.|++.||.++|..-++ |+||||||.||+|+.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 999999999999999885 4556899999999999999999999994334 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC-CCC
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KEL 901 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP-~~l 901 (959)
++.+........+.+|||+||+||++.+.+|+.++|||||||++|||..-+.||.+.+-.++..+|... ..+++| ...
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHh
Confidence 999887777778899999999999999999999999999999999999999999999888888887643 444567 678
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
+.+++.||..|+..||+.||+...++..+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 999999999999999999998655555444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=399.99 Aligned_cols=256 Identities=32% Similarity=0.483 Sum_probs=226.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~---~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~ 746 (959)
.....|.+++.||+|+||+|++|++ ++..||||++...... ......+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999976 6899999976654221 133456778999999998 999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk~ 825 (959)
.++||||||.||+|++++.+ ..++.+..+..+++||+.|++|||++| |+||||||||||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999988 568999999999999999999999999 9999999999999999 9999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC-C-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCC-c
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEP-S-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL-D 902 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~-~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~l-s 902 (959)
.........+.+||+.|+|||++.+.. | +.++||||+|++||.|++|+.||...+...++..+ ......+|..+ +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 743335567899999999999999977 7 58999999999999999999999998888888775 55678889999 9
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+++++||.+||..||.+|+++.+|+ .-.-++
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 9999999999999999999999998 433333
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=386.21 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=216.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++.|+.+.++|+|+||+||+|++ +|+.||||+|....-.+...+...||+++|++|+|+|+|.++++|.....++||+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 35788899999999999999976 6889999999877666666777899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|||+. ++.+-|++....++...+.++++|++.|+.|+|+++ +||||||||||||..+|.+||||||+|+.+..+...
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 99976 566666676778999999999999999999999999 999999999999999999999999999988766566
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-------------------cc
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------QN 892 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-------------------~~ 892 (959)
.+.++.|+||.|||.+.| ..|++.+|||++||++.||++|.+.|++....+.+..|.. .+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 677889999999999998 6799999999999999999999999999877655433321 11
Q ss_pred cccCCC----------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 RRLEIP----------KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 ~~~~iP----------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++-| ..++..+.+|+++||+.||++|++.+|++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 234567899999999999999999999885
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=400.62 Aligned_cols=273 Identities=38% Similarity=0.642 Sum_probs=236.3
Q ss_pred ccccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 668 ~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+++|..+++.++..||+|.||+||+|+|.| .||||++.......+..+.|++|+.+|++-+|.||+-|+|||..+..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 36788899999999999999999999999987 68999999999999999999999999999999999999999999877
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
.||+.+|.|-+|+.+|+....+++....+.|+.||++||.|||.++ |||||||..||||.+++.|||+|||++....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999988888999999999999999999999999 9999999999999999999999999997644
Q ss_pred CCc--ccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---ccccCCCC
Q 002157 828 NTF--LSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPK 899 (959)
Q Consensus 828 ~~~--~~~~t~~GT~~YmAPEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~---~~~~~iP~ 899 (959)
... .......|...|||||++.. .+|++.+|||||||++|||++|.+||...+..+++-.+..+ .....+-.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 221 11233457889999999974 45899999999999999999999999977777766555433 22233445
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCCC
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 945 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~~ 945 (959)
.+++++++|+..||..++++||.|.+|+..|+.+... .|...+.+
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~-~pki~RS~ 664 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS-LPKINRSA 664 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc-ccccccCc
Confidence 7788999999999999999999999999999888775 44444433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=410.47 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=225.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~ 746 (959)
..+..++|.++++||+|.||+|+++.. +++.||||++++... ..+.++....|.+|+... +||++++++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 356778999999999999999999977 567899999988754 455677888999999988 5999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++|+||||+.||++..+.+. ..+++..+..|+..|+.||.|||++| |||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999996555543 47999999999999999999999999 999999999999999999999999999976
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
......+.++||||.|||||++.+..|+..+|||+|||||||||.|+.||.+.+..++...|. .....+|.+++.+..
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAI 596 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHH
Confidence 655567789999999999999999999999999999999999999999999999999999884 557888999999999
Q ss_pred HHHHHHhhcCCCCCCCH
Q 002157 907 RIIWECWQTDPSLRPSF 923 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa 923 (959)
.+++++|.+||++|...
T Consensus 597 ~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhccCcccccCC
Confidence 99999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=402.76 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=222.5
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..++|++++.||+|+||.||+|+. +|..||+|++++... ....+..++.|..||....+|+||+|+..|++.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 367889999999999999999999965 788999999987643 44566778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+||||||++||++..+|.+. ..+++..+..++.+++.|++-||++| +|||||||+|+|||..|||||+||||+..+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999999765 47899988888899999999999999 9999999999999999999999999986321
Q ss_pred C-----------------------Ccc------------------------cCCCCCCCCCccCcccccCCCCCchhHHH
Q 002157 828 N-----------------------TFL------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860 (959)
Q Consensus 828 ~-----------------------~~~------------------------~~~t~~GT~~YmAPEvl~g~~~s~ksDIW 860 (959)
. ... .....+|||.|||||++.+..|+..+|||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 01245799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHHhhcCCCCCCC---HHHHHH
Q 002157 861 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTV 928 (959)
Q Consensus 861 SLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kRPS---a~EIL~ 928 (959)
|||||+||||.|.+||.+.++.+.+..|......+.+|. .++.+.+|||.+||. ||++|.. ++||..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999999999988876655566664 568999999999998 9999985 666654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=379.90 Aligned_cols=262 Identities=33% Similarity=0.533 Sum_probs=216.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~ 742 (959)
+++..++|++.++||+|+||.||+|.+ .++.||||++.... .......+.+|+.+|.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 467788999999999999999999974 23579999886432 333456788999999999 899999999988
Q ss_pred ecCC-cEEEEEeccCCCCHHHHhhCCC-----------------------------------------------------
Q 002157 743 TRPP-NLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (959)
Q Consensus 743 ~~~~-~l~LVmEy~~gGsL~dlL~k~~----------------------------------------------------- 768 (959)
...+ .+++||||+++|+|.+++.+..
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5889999999999999986431
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCC
Q 002157 769 --------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAG 838 (959)
Q Consensus 769 --------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~G 838 (959)
..+.+..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 23677788899999999999999998 9999999999999999999999999998643221 12223456
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 839 T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............|..+++++.+||.+||+.||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999997 9999988654433323323334455677889999999999999999
Q ss_pred CCCCCHHHHHHHHHhhhh
Q 002157 918 SLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 918 ~kRPSa~EIL~~Le~l~k 935 (959)
.+||++.+|++.|+.+.+
T Consensus 319 ~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 319 KERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=402.44 Aligned_cols=249 Identities=30% Similarity=0.473 Sum_probs=228.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeecc-CCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~-~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.-|++++.||+|+.|.|.+|++ +|+.+|||++.+. .........+.+|+-||+.+.||||+++|++|++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3478899999999999999987 8999999999876 555556677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++|.|++++-+.+ ++.+....++++||+.|+.|||..+ |+||||||||+|||..++|||+|||+|.+.... .-
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 9999999999997764 7888888899999999999999999 999999999999999999999999999876544 44
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
..+.||++.|.+||++.|.+| +.++||||.|||||.||+|.+||.+.+...++.++ +...+++|.+++.++++||.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 678999999999999999987 67999999999999999999999999999888877 556888999999999999999
Q ss_pred HhhcCCCCCCCHHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~L 930 (959)
||..||.+|.|+++|+.+-
T Consensus 246 ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HhccCccccccHHHHhhCc
Confidence 9999999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=397.12 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=229.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+++|.+.+.||+|+||.||+|++ +.+.||+|.+.+....+..+..+.+|++|++.++|||||.++++|+...++++|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 36788999999999999999976 5678999999888877778889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+.| +|+.+|... ..++|..+..|+.+++.||.|||+++ |+|||+||.|||++..|++||||||+|+........
T Consensus 81 e~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 99976 999999775 48999999999999999999999998 999999999999999999999999999988766555
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....|||.|||||++.+..|+..+|+||||||+|||+.|++||......++...|. ..+...|..++..++.|+..+
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHHH
Confidence 667789999999999999999999999999999999999999999988888888774 346666779999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|++||.+|.+..+++.+
T Consensus 235 L~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGH 251 (808)
T ss_pred hhcChhhcccHHHHhcC
Confidence 99999999999998865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=396.01 Aligned_cols=264 Identities=36% Similarity=0.615 Sum_probs=236.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECCc-eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~-~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..++|..+.+.+++.||+|-||.||+|+|++. +||||.++..... ...|.+|+++|++|+|+|||+|+++|..++.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 45677778899999999999999999999877 9999998765433 3467899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++||||||+.|+|.++|++ .+..+...+.+.|+.||++||+||++++ +|||||-.+||||++++.+||+|||+++..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999999986 5678899999999999999999999999 999999999999999999999999999976
Q ss_pred cCCccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.+..+. .....-...|.|||.+....++.|+|||||||+||||++ |+.||.++...+++..+. .+.+++.|..++.+
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDE 432 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHH
Confidence 555443 222334557999999999999999999999999999998 899999999998888775 66789999999999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
+.+++..||+.+|++||||+.+...|+.+.....
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 9999999999999999999999999998866543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=370.21 Aligned_cols=261 Identities=23% Similarity=0.400 Sum_probs=222.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999987 4889999998754332 234456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999999764 46889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. ....+|..++..+++||++|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCccCCHHHHHHHHHH
Confidence 2346799999999999999999999999999999999999999999888777666533 35667788899999999999
Q ss_pred hhcCCCCCCC-----HHHHHHH--HHhhhhhhCCCCCCC
Q 002157 913 WQTDPSLRPS-----FAQLTVA--LKPLQRLVIPSHPDQ 944 (959)
Q Consensus 913 L~~DP~kRPS-----a~EIL~~--Le~l~kl~~p~~p~~ 944 (959)
|+.||.+|++ +.+++++ ++.+.....++....
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~ 271 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLK 271 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCC
Confidence 9999999995 8888876 444444444433333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=381.15 Aligned_cols=258 Identities=32% Similarity=0.522 Sum_probs=218.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC--cEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~--~l~LV 751 (959)
.++..++.||+|+||.||++... |+.+|||.+..... .....+.+|+++|.+++|||||+++|...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45667888999999999999874 78999998765522 12667899999999999999999999744444 69999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCccccccC--
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN-- 828 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~~~~-- 828 (959)
|||+++|+|.+++.+.+..+++..++.++.||++||.|||++| ||||||||+||||+. +|.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999887668999999999999999999999999 999999999999999 79999999999987653
Q ss_pred -CcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 -TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 -~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.........||+.|||||++.+ .....++|||||||++.||++|..||.. .........+......+.+|..++.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122446789999999999995 3445699999999999999999999988 455554555555555568999999999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
++||.+||..||.+|||+.++|.+.-..+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999998876554444
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=374.20 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=219.4
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34568999999999999999999987 578899999876432 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999999999764 46888889999999999999999999 99999999999999999999999999986643
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++.++++|
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDL 245 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHH
Confidence 2 234679999999999999999999999999999999999999999988877766654 33566788899999999
Q ss_pred HHHHhhcCCCCCCC-----HHHHHHH
Q 002157 909 IWECWQTDPSLRPS-----FAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPS-----a~EIL~~ 929 (959)
|.+||+.||.+|++ +++|+.+
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999986 6888754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=362.73 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=217.1
Q ss_pred eEeeccCcEEEEEEEECCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCcEEEEEeccC
Q 002157 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLP 756 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~~l~LVmEy~~ 756 (959)
..||+|++|.||+|.++++.||||++....... .....+.+|+.+|++++|||||++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 569999999999999999999999987654322 335678899999999999999999999876 356899999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
+|+|.+++.+. ..+++...+.++.|++.||.|||.. + ++||||||+|||++.++.+||+|||+++..... ...
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~ 179 (283)
T PHA02988 106 RGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFK 179 (283)
T ss_pred CCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhccc---ccc
Confidence 99999999764 4688899999999999999999984 6 889999999999999999999999999865432 124
Q ss_pred CCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 836 TAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
..|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..++...+.....+..+|..++.++++||.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 568999999999976 678999999999999999999999999988877777665555667777788999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHhhhh
Q 002157 914 QTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+.||.+||++.+|++.|+.++.
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=390.69 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=227.7
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
...-....|....+||+|+.|.||.++. +++.||||++...... ...-+.+|+.+|+..+|+|||++++.|...+.
T Consensus 267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 3344556788889999999999999976 6788999998765433 23457899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|+||||++||+|-+++... .++|.++..|++++++||+|||.+| |||||||.+|||++.+|.+||+|||++..+.
T Consensus 345 LWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999999999764 5999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVA 906 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~ 906 (959)
.......+.+||++|||||++....|+.++|||||||+++||+.|++||...++.+.+..+...+ ..+..|..++++++
T Consensus 421 ~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 421 EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHH
Confidence 77667778999999999999999999999999999999999999999999888887777665443 34567789999999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+|+.+||+.|+.+|+++.|||++
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=372.29 Aligned_cols=243 Identities=24% Similarity=0.417 Sum_probs=212.3
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
+.||+|+||.||++++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.++|||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 678899999876432 2334556789999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~G 838 (959)
+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999999764 47899999999999999999999999 999999999999999999999999998764333333445679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCC
Q 002157 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918 (959)
Q Consensus 839 T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~ 918 (959)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.. ....+|..++.++++||.+||+.||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999998887766665533 35667888999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 002157 919 LRP-----SFAQLTVA 929 (959)
Q Consensus 919 kRP-----Sa~EIL~~ 929 (959)
+|| ++.+++.+
T Consensus 236 ~R~~~~~~~~~~ll~h 251 (323)
T cd05571 236 QRLGGGPEDAKEIMEH 251 (323)
T ss_pred HcCCCCCCCHHHHHcC
Confidence 999 79998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=375.09 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=225.9
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEECC--ceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~g--~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..+.|+++++||+|.-|+||+++.++ ..+|+|++.+.... .....++..|..||+.++||+++.||..|+.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 44667889999999999999999999865 68999999876543 4556678889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.|+|||||+||+|+.+++++ +..+++..++.++.+++.||+|||..| ||+||||||||||.++|||-|+||.++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999998764 567999999999999999999999999 999999999999999999999999987521
Q ss_pred cC-----------------------------------C---------------------cccCCCCCCCCCccCcccccC
Q 002157 827 HN-----------------------------------T---------------------FLSSKSTAGTPEWMAPEVLRN 850 (959)
Q Consensus 827 ~~-----------------------------------~---------------------~~~~~t~~GT~~YmAPEvl~g 850 (959)
.. . ......++||-+|+|||+|.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 011245779999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCC----HHHH
Q 002157 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS----FAQL 926 (959)
Q Consensus 851 ~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPS----a~EI 926 (959)
...+.++|||+|||++|||+.|..||.|.+..+.+..+..+.....--..++..++|||+++|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999998887654444433467899999999999999999998 6776
Q ss_pred HHH--HHhhhh
Q 002157 927 TVA--LKPLQR 935 (959)
Q Consensus 927 L~~--Le~l~k 935 (959)
.++ ++.+.+
T Consensus 390 K~HpFF~gVnW 400 (459)
T KOG0610|consen 390 KRHPFFEGVNW 400 (459)
T ss_pred hcCccccCCCh
Confidence 543 455544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=384.60 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=215.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCC-cE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP-NL 748 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~-~l 748 (959)
+..++|.++++||.|+||.||+|+. .++.||||++++.....+. ..-+||++-|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4467899999999999999999975 7889999998877655333 23368999999998 999999999999888 89
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||||||+. +|+++++.+++.+++..++.|+.||++||+|+|.+| +.|||||||||||..+..|||+|||+|+....
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 999999965 999999988889999999999999999999999999 99999999999999889999999999998754
Q ss_pred CcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------------
Q 002157 829 TFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 893 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-------------- 893 (959)
. ...+.++-|+||.|||++. ...|+.++|||++|||++|+.+-++.|.|.+..+.+.+|+.-..
T Consensus 163 k-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 K-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 4 2345688999999999986 46689999999999999999999999999887655544321110
Q ss_pred ---ccCCC-----------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ---RLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ---~~~iP-----------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+.+| ..++.++.+||.+||..||.+|||+.|.+++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 01111 2467899999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.08 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=219.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+..++|++.+.||+|+||.||+|.+ .+..||+|++.... .......+.+|+.++.+++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567899999999999999999975 25679999886543 33445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++|+|.+++.+....+++..++.++.||+.||+|||+++ ++||||||+||||+.++.+||+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999876567899999999999999999999998 9999999999999999999999999876543
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 828 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+. .......|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 221 11122345678999999999999999999999999999775 999999888776666553 233455678899999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.+++.+||+.+|.+||++.+|++.|.++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.29 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=214.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.++..++||||+++++++...+.++|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 5789999998765322 234557889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999999764 36889999999999999999999999 99999999999999999999999999986543 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC------CCcHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK------ELDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~------~ls~eL~ 906 (959)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.........|. .++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 3456799999999999999999999999999999999999999998887766555432222222222 4589999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+||.+||..+|.+||++.+++.+
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=369.11 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=216.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||+||+|++. ++.||||++....... .....+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999874 8899999987654322 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-- 830 (959)
||+++++|.+++.+. ..+++..++.++.||+.||+|||.+| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999775 57899999999999999999999998 9999999999999999999999999998654332
Q ss_pred ---------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002157 831 ---------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (959)
Q Consensus 831 ---------------------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q 883 (959)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12335679999999999999999999999999999999999999999988776
Q ss_pred HHhhhhccccccCCCC--CCcHHHHHHHHHHhhcCCCCCCC-HHHHHHH
Q 002157 884 VVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS-FAQLTVA 929 (959)
Q Consensus 884 l~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kRPS-a~EIL~~ 929 (959)
....+........+|. .+++++++||.+||. ||.+|++ +.+++.+
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 6655544223334443 359999999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.25 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=207.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.++||.|+||.||+|++ ++..||+|++...... .....+.+|+.++++++||||+++++++.....+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 47899999999999999999976 5788999988654321 22345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++ +|.+++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 899998766667889999999999999999999998 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------------cc
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------RR 894 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-----------------~~ 894 (959)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 345678999999999876 568999999999999999999999998877654433221000 00
Q ss_pred cCC-----------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 LEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ~~i-----------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+ ...++.++++||++||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 001 1246789999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.56 Aligned_cols=247 Identities=26% Similarity=0.461 Sum_probs=221.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.+|+|.+.||+|.||+|-+++. .|+.||||.+++... .++....+.+|++||..|+||||+++|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5799999999999999999964 789999999988765 4567788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||..+|.|++|+.+++ .+++...+.|++||+.|+.|||.++ ++|||||.+|||||.++++||+|||++.++... ..
T Consensus 133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 9999999999998764 8999999999999999999999999 999999999999999999999999999987655 44
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
..++||++.|.+||+++|.+| +..+|-||||++||.|+.|..||.|.+...++..|..+..+- +.-+.+..-||++
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRw 285 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRW 285 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHH
Confidence 678999999999999999987 678999999999999999999999999888887775433222 2345668899999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||..||++|.|+.+|..+
T Consensus 286 mLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASH 303 (668)
T ss_pred HHhcCcccchhHHHHhhh
Confidence 999999999999998765
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.85 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=212.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|++.+.||+|+||.||++.+ +++.||||++....... .....+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999976 68899999987654322 233467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ce
Confidence 99999999887543 346889999999999999999999998 999999999999999999999999999865432 22
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh--hccccccCCCCCCcHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i--~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+ ........++..++.++.+||.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 23467999999999999999999999999999999999999999876543221111 1123345567789999999999
Q ss_pred HHhhcCCCCCCC-----HHHHHHH--HHhh
Q 002157 911 ECWQTDPSLRPS-----FAQLTVA--LKPL 933 (959)
Q Consensus 911 kCL~~DP~kRPS-----a~EIL~~--Le~l 933 (959)
+||+.||.+||+ +.+++++ ++.+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999997 8888874 4444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.90 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=210.8
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
+.||+|+||.||+++. ++..||+|++..... .......+.+|+++++.++||||++++++|...+.++|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999976 678999999876432 2334556788999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~G 838 (959)
+|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 999988764 36899999999999999999999998 999999999999999999999999998754333233345679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCC
Q 002157 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918 (959)
Q Consensus 839 T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~ 918 (959)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ....+|..+++++++||.+||+.||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999998887766655532 34567788999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 002157 919 LRP-----SFAQLTVA 929 (959)
Q Consensus 919 kRP-----Sa~EIL~~ 929 (959)
+|+ ++.+++++
T Consensus 236 ~R~~~~~~~~~~~l~h 251 (323)
T cd05595 236 QRLGGGPSDAKEVMEH 251 (323)
T ss_pred HhCCCCCCCHHHHHcC
Confidence 998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=380.01 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=219.0
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~ 749 (959)
..+.|+.+++||+|+||.||+|++ +|+.||+|+++.....+.......+||.||++|.||||++|.+.+... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346789999999999999999987 788899999998877777777888999999999999999999998776 6799
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||+|||+. +|.-++...+-.+++.++..|+.||+.||+|||.+| |+|||||..|||||.+|.+||+|||+|+++...
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999976 899999888889999999999999999999999999 999999999999999999999999999977654
Q ss_pred ccc-CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------cccCCC-
Q 002157 830 FLS-SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------RRLEIP- 898 (959)
Q Consensus 830 ~~~-~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~--------~~~~iP- 898 (959)
... .+..+-|+||.|||.+.|. .|+.++|+||.||||.||+.|++.|.+.+..+.+..|-..- ....+|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 333 4566789999999999986 49999999999999999999999999988876655442100 000111
Q ss_pred ------------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 ------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ------------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++....+|+..||..||.+|.|+.+.++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 3567889999999999999999999988753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=354.52 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=210.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC------------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~------------------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN 734 (959)
++.++|++.++||+|+||.||+|.+. +..||||++.... .......+.+|+.+|.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 45678999999999999999999752 2369999886543 3445677899999999999999
Q ss_pred eeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 002157 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH------------------CQVDEKRRIKMALDVARGMNCLHTSTPT 796 (959)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~ 796 (959)
|+++++++.+.+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999985421 23567788999999999999999999
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--C
Q 002157 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--L 872 (959)
Q Consensus 797 IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt--G 872 (959)
|+||||||+||||+.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999997653321 11223456789999999998889999999999999999986 5
Q ss_pred CCCCCCCChHHHHhhhhc------cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 873 KLPWIGMNPMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 873 ~~PF~g~~~~ql~~~i~~------~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
..||.+....+....+.. .......|..++..+.+||.+||..||.+||++.+|...|+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 688888766554433211 11122345677899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.57 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=209.2
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999987 577899999875432 334456778999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCC
Q 002157 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (959)
Q Consensus 761 ~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~ 840 (959)
.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9999764 46899999999999999999999999 99999999999999999999999999986433333344567999
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCC
Q 002157 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 920 (959)
Q Consensus 841 ~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kR 920 (959)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++++||.+||+.||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999999999999999999999999999999888777666553 34667788899999999999999999999
Q ss_pred CC---HHHHHH
Q 002157 921 PS---FAQLTV 928 (959)
Q Consensus 921 PS---a~EIL~ 928 (959)
|+ +.+++.
T Consensus 236 ~~~~~~~e~l~ 246 (312)
T cd05585 236 LGYNGAQEIKN 246 (312)
T ss_pred CCCCCHHHHHc
Confidence 85 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.01 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=219.2
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC---CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~---g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..+..++|++.+.||+|+||.||+|++. +..||||++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4466789999999999999999999763 25799999875432 2334557889999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||+++..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999997653 6889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++......+.. ....+|..++..++
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPKFLDNNCK 256 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHH
Confidence 432 2356799999999999999899999999999999999999999999887766666543 34567888999999
Q ss_pred HHHHHHhhcCCCCCC-----CHHHHHHH
Q 002157 907 RIIWECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
+||++||+.||.+|+ ++++++.+
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999999999995 89988765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=368.03 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=211.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||+||+|++ +++.||||++.+... .......+.+|+.++.+++|+||+++++.+.+...++|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999977 578999999876433 2334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-- 830 (959)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999764 47899999999999999999999999 9999999999999999999999999987543210
Q ss_pred ---------------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002157 831 ---------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (959)
Q Consensus 831 ---------------------------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 877 (959)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHHhhcCCC---CCCCHHHHHHH
Q 002157 878 GMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPS---LRPSFAQLTVA 929 (959)
Q Consensus 878 g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~---kRPSa~EIL~~ 929 (959)
+.+..+....+........+|. .++.++++||.+|+. +|. .||++.+|+.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9888777766654333444554 468999999999775 444 56899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=365.71 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=211.9
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
+.||+|+||.||+++. +++.||||++..... .......+.+|+++++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 678999999876432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~G 838 (959)
+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 999998664 46899999999999999999999998 999999999999999999999999998764333233345679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCC
Q 002157 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918 (959)
Q Consensus 839 T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~ 918 (959)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++.+||.+||+.||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 999999999999999999999999999999999999999887776665553 335567889999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 002157 919 LRP-----SFAQLTVA 929 (959)
Q Consensus 919 kRP-----Sa~EIL~~ 929 (959)
+|+ ++.+++++
T Consensus 236 ~R~~~~~~~~~~il~h 251 (328)
T cd05593 236 KRLGGGPDDAKEIMRH 251 (328)
T ss_pred HcCCCCCCCHHHHhcC
Confidence 997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.25 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=210.6
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHH---HcCCCceeEEeeeeecCCcEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR---RLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~---~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|++++. .++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 578899999876432 2233455667766654 56799999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++++|..++.+ ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999998865 36899999999999999999999998 99999999999999999999999999875433333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ....+|..++.++.+||.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHH
Confidence 34457899999999999999999999999999999999999999999887776665533 3455778899999999999
Q ss_pred HhhcCCCCCC-----CHHHHHHH
Q 002157 912 CWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRP-----Sa~EIL~~ 929 (959)
||+.||.+|| ++.+++.+
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhC
Confidence 9999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.82 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=206.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||++++ +++.||||++............+.+|+.++++++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999987 46789999987654444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-cc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-~~ 832 (959)
|++++.|..+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 998876665543 3457899999999999999999999998 9999999999999999999999999998754322 12
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------------ccc
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------RRL 895 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-----------------~~~ 895 (959)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 234578999999999999889999999999999999999999998876543322111000 000
Q ss_pred C-------------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 E-------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ~-------------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ....++.++++||.+||+.||++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 11236788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.70 Aligned_cols=257 Identities=31% Similarity=0.573 Sum_probs=219.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.++.+++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 455789999999999999999997632 469999876443 344556789999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd 810 (959)
...+++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||.++ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 99999999999999999986531 35788889999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 002157 811 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (959)
Q Consensus 811 ~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~ 887 (959)
.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 12234457889999999998889999999999999999997 9999999888777666
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+.. ......|..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 239 i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 543 334456778999999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.24 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=212.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|.+...++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 578999999876432 2234456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999999764 36899999999999999999999999 99999999999999999999999999875422100
Q ss_pred -------------------------------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 002157 832 -------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 874 (959)
Q Consensus 832 -------------------------------------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~ 874 (959)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1113469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 002157 875 PWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 929 (959)
Q Consensus 875 PF~g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kRPS---a~EIL~~ 929 (959)
||.+.+..+....+........+|. .+++++++||.+||. +|.+|++ +.+++.+
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999887776655543333444444 468999999999996 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.42 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=227.5
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..++|++++.||+|.||.||+|+. ++-.||+|++.+.... .....++.+|+.|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 456779999999999999999999976 4567999999876542 2344578999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.||++||.++|+|+..|.. ...++++.....++.|++.||.|+|..+ ||||||||+|+|++..|.+||+|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999999973 3346899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
. .....+.|||..|++||+..+..++..+|+|++|++.||++.|.+||......+.+.++ ...+..+|..++.+++
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAA 250 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHH
Confidence 4 34456799999999999999999999999999999999999999999999988888877 4457788899999999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
|||.+||.++|.+|....|++++
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHhccCccccccHHHHhhh
Confidence 99999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=361.17 Aligned_cols=247 Identities=21% Similarity=0.369 Sum_probs=212.9
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999987 467899999876532 223345567788888887 5899999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998664 36889999999999999999999998 999999999999999999999999999754333333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+. .....+|..++.++++||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHH
Confidence 445779999999999999999999999999999999999999999988877776664 335567888999999999999
Q ss_pred hhcCCCCCCCH-----HHHHH
Q 002157 913 WQTDPSLRPSF-----AQLTV 928 (959)
Q Consensus 913 L~~DP~kRPSa-----~EIL~ 928 (959)
|+.||.+|++. .+++.
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhc
Confidence 99999999974 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=383.84 Aligned_cols=255 Identities=36% Similarity=0.643 Sum_probs=230.1
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+...++|+++.+.-++-||.|+.|.||+|+..++.||||+++... ..+|+-|++|+|+||+.|.|+|....
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 334578888888888999999999999999999999999754321 35788999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++||||||..|-|..+|+.. +.+.......+..+|+.||+|||.+. |||||||.-||||..+..|||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999999999999764 57888888999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
.+. .....++||..|||||+|..++.+.|+|||||||+|||||||..||.+.+...+.--+..+...+..|..++..++
T Consensus 263 ~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 263 SDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 554 4456799999999999999999999999999999999999999999998877776666666778889999999999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
-||++||+..|..||+|.+|+.+|+...
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 9999999999999999999999998653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.78 Aligned_cols=270 Identities=23% Similarity=0.327 Sum_probs=225.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|...++||+|.||.||+|++ +|+.||||+++.....+-......||+++|+.++|+||+.++++|-+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999987 78999999998776665556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|++ .+|...++.....+....+..++.++++||+|||.+. |+||||||+|+||+.+|.+||+|||+++.+.......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 996 5999999988889999999999999999999999999 9999999999999999999999999999988776655
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-----------------
Q 002157 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 895 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~----------------- 895 (959)
...+-|.+|.|||.+.|. .|+..+|+||.|||+.||+-|.+.|.|.++.+.+..+-.....+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 556889999999999885 48999999999999999999999999987765554331100000
Q ss_pred -CCC--------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCCCC
Q 002157 896 -EIP--------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 949 (959)
Q Consensus 896 -~iP--------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~~~~~~ 949 (959)
.+| ...+.++.+|+.+||..||.+|+++.|.+++= -+.....|..|...|-..
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCcCCc
Confidence 011 23466789999999999999999999998642 223355555555544433
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=359.94 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=212.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCcEEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~H-pNIVkL~g~~~~~~~l~LVm 752 (959)
+|++++.||+|+||.||+|++ +++.||||++..... .......+..|++++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999987 456899999876432 23345667889999999966 56889999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999998764 36889999999999999999999998 999999999999999999999999998754322233
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999988777766663 345667888999999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 002157 913 WQTDPSLRPSF-----AQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa-----~EIL~~ 929 (959)
|..||.+|++. .+++++
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=364.22 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=210.9
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
+.||+|+||.||++++ +++.||||++..... .......+.+|+++++.++||||+++++++...+.++|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 678999999876533 2334556788999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
+|..++.+. ..+++..+..++.||+.||.|||+ .| |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999998764 468999999999999999999997 67 99999999999999999999999999875433323334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..+++++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999888776665553 33556788899999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 002157 918 SLRP-----SFAQLTVA 929 (959)
Q Consensus 918 ~kRP-----Sa~EIL~~ 929 (959)
.+|+ ++.+++++
T Consensus 236 ~~R~~~~~~~~~~il~h 252 (325)
T cd05594 236 KQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhCCCCCCCHHHHhcC
Confidence 9997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.88 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=209.8
Q ss_pred eEeeccCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 682 k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~--~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+.||+|+||.||+++. .++.||||++...... ......+.+|+.+|+.++||||++++++|..++.+++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 4678999998764321 22334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++.+. ..+.+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 9999999999765 36788888889999999999999999 99999999999999999999999999875433333344
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ....+|..+++++++||.+||+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHcc
Confidence 56799999999999998899999999999999999999999999887766665532 3556788899999999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 002157 915 TDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 915 ~DP~kRP-----Sa~EIL~~ 929 (959)
.||.+|| ++.+++.+
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcC
Confidence 9999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.03 Aligned_cols=270 Identities=24% Similarity=0.407 Sum_probs=236.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+.+++|.++++||+|.||+|.+++. .++.||||++++... .++.+.....|-++|+..+||++..|...|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 35678999999999999999999975 688999999887654 344555667899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||..||.|+-+|.+. +.+++...+.+..+|+.||.|||+.+ ||+||||.+|+|+|++|||||+|||+++....
T Consensus 244 CFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999999999774 57888888889999999999999998 99999999999999999999999999997666
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
......++||||.|+|||++....|+.++|||.+|+++|||+||++||...+...++..|... .+.+|..++++.+.|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--d~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--DLKFPRTLSPEAKTL 398 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--hccCCccCCHHHHHH
Confidence 667788999999999999999999999999999999999999999999999998888887544 677899999999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHHH--H------HhhhhhhCCCCCCCCC
Q 002157 909 IWECWQTDPSLRP-----SFAQLTVA--L------KPLQRLVIPSHPDQPS 946 (959)
Q Consensus 909 I~kCL~~DP~kRP-----Sa~EIL~~--L------e~l~kl~~p~~p~~~~ 946 (959)
+..+|.+||.+|. +++||.++ + .-+.+.+.|+.++|-.
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 9999999999996 46676543 2 2335566666655543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=369.26 Aligned_cols=262 Identities=27% Similarity=0.464 Sum_probs=217.2
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+.+..++|++++.||+|+||.||+|++. +..||||++..... ......+.+|+.+++.+ +|+|||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 34567789999999999999999999752 24699999875433 33456788999999999 89999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-----------------------------------------------------
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~----------------------------------------------------- 768 (959)
|...+.+++||||+++|+|.+++.+..
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985421
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 769 ----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 769 ----------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
..+++..+++|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24677888999999999999999998 99999999999999999999999999976533211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 832 -~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.....................|...++++++||
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1122335678999999998889999999999999999997 99999876654433333333334556677899999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 910 WECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
.+||+.||.+||++.+|++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.21 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=211.3
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+..++|++.+.||+|+||.||++++ ++..||+|++... ........+.+|+++|++++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4568899999999999999999987 4778999988654 234456678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999999999764 36889999999999999999999853 3999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------------
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------- 890 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-------------------- 890 (959)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 22346799999999999999999999999999999999999999977655443221110
Q ss_pred -------------------------cccccCCC-CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 891 -------------------------QNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 891 -------------------------~~~~~~iP-~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
.......+ ..++.++++||.+||+.||++||++.+|+.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00011111 24678999999999999999999999998763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.81 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=210.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||+||++++ +++.||||++.+... .......+.+|++++++++||||++++++|.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999976 678999999875432 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999764 46889999999999999999999999 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 002157 832 ----------------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVI 865 (959)
Q Consensus 832 ----------------------------------------------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiL 865 (959)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHHhhcCCCCC---CCHHHHHHH
Q 002157 866 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLR---PSFAQLTVA 929 (959)
Q Consensus 866 LyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kR---PSa~EIL~~ 929 (959)
+|||++|..||.+.+..+....+........+|. .++.++++||.+||+ +|.+| +++.+++.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999998887666655543333444454 578999999999997 67765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=367.62 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=209.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999987 677899999976543 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc---
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--- 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--- 830 (959)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||..| |+||||||+||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999999764 36888999999999999999999998 9999999999999999999999999975321000
Q ss_pred --------------------------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 002157 831 --------------------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866 (959)
Q Consensus 831 --------------------------------------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLL 866 (959)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHHhh--cCCCCCCCHHHHHHH
Q 002157 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQ--TDPSLRPSFAQLTVA 929 (959)
Q Consensus 867 yELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~--~DP~kRPSa~EIL~~ 929 (959)
|||++|..||...+..+....+........+|. .+++++++||.+||. .++..|+++.+|+.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999998877665555443333344443 579999999999654 455569999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=353.06 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=203.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+|+.+++.++||||+++++++.++..+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 5788999998654322 12345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. ++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9995 6888888766667899999999999999999999999 999999999999999999999999998765433333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhc--cc----------------
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGF--QN---------------- 892 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~--~~---------------- 892 (959)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+.. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 345678999999999876 458899999999999999999999998764422 1111100 00
Q ss_pred ---cccCCCC---------CCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 ---RRLEIPK---------ELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 ---~~~~iP~---------~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....+. ..+.++++||.+||+.||.+|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000011 23467899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=367.79 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=214.2
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+.+..++|+++++||+|+||.||+|++ .+..||||++..... ......+.+|+.+|..+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3456677999999999999999999964 245799998864432 23345788999999999 89999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-----------------------------------------------------
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~----------------------------------------------------- 768 (959)
|...+..++||||+++|+|.+++.+..
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986422
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 769 ---------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 769 ---------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 24677888999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 828 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 828 ~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....................|...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 3221 1122345678999999999999999999999999999997 889998765433222222233344556677899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
+++||.+||+.||++||++.+|++.|++
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 9999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.53 Aligned_cols=251 Identities=33% Similarity=0.556 Sum_probs=215.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.++|++.+.||+|+||.||+++++ +..+|+|.+...... ...+.+|+.+|++++||||+++++++.....+++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 4567999999999999999999884 458999987644332 346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999999765556889999999999999999999999 999999999999999999999999998765332211
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 833 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 833 -~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... .....|...+.++.+|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHH
Confidence 122345668999999998889999999999999999999 89999988877776666432 344556778899999999
Q ss_pred HHhhcCCCCCCCHHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~L 930 (959)
+||+.+|.+||++.+|++.|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=365.93 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=214.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH------------HHHHHHHHHHHHHHcCCCceeE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVL 737 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~------------~~~ef~~Ei~IL~~L~HpNIVk 737 (959)
....++|++++.||+|.||.|.+|+. +++.||||++.+..+... ..+.+.+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34568999999999999999999987 688999999976443221 1357899999999999999999
Q ss_pred EeeeeecC--CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcE
Q 002157 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815 (959)
Q Consensus 738 L~g~~~~~--~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~V 815 (959)
|+++..+. +.+|||+|||..|.+...=.. ..-+.+.++++|+++++.||+|||.+| ||||||||.|+||+.+|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcE
Confidence 99999775 469999999998877653221 222899999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccC-----CcccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh
Q 002157 816 KVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 886 (959)
Q Consensus 816 KLiDFGlAk~~~~-----~~~~~~t~~GT~~YmAPEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~ 886 (959)
||+|||.+..... ........+|||.|+|||...++. .+.+.||||||++||.|++|+.||.+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 9999999886521 112223468999999999987732 3678999999999999999999999999999998
Q ss_pred hhhccccccCCCCC--CcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 887 AVGFQNRRLEIPKE--LDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 887 ~i~~~~~~~~iP~~--ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
+|. +.++.+|.. +.+++++||.+||.+||++|.++.+|..+.
T Consensus 330 KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 330 KIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 884 556777755 789999999999999999999999987665
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.11 Aligned_cols=239 Identities=28% Similarity=0.437 Sum_probs=208.7
Q ss_pred eEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 682 k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
+.||+|+||.||+++. .++.||||++............+.+|+++|++++||||+++++++...+.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 57889999987654444445567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~ 836 (959)
+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999764 46899999999999999999999999 9999999999999999999999999998654443334456
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcC
Q 002157 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 916 (959)
Q Consensus 837 ~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~D 916 (959)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++++||.+||+.|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999889999999999999999999999999888776666553 3345678889999999999999999
Q ss_pred CCCCCCHHH
Q 002157 917 PSLRPSFAQ 925 (959)
Q Consensus 917 P~kRPSa~E 925 (959)
|.+||++.+
T Consensus 237 P~~R~~a~~ 245 (318)
T cd05582 237 PANRLGAGP 245 (318)
T ss_pred HhHcCCCCC
Confidence 999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=356.33 Aligned_cols=247 Identities=29% Similarity=0.408 Sum_probs=205.3
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..++|+++++||+|+||.||+|++ +++.||||++.... .......+.+|+++++.++|+||+++++++...+.+++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 346788889999999999999987 57899999986543 334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+.+++|.... ...+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999986532 3567788889999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhhccccccCCCCCCcH
Q 002157 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---l~~~i~~~~~~~~iP~~ls~ 903 (959)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ....+. .......+..++.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCH
Confidence 3445679999999999843 334578999999999999999999997433221 222221 2334556678899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++++||.+||+.||++||++.||+++
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=361.44 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=214.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||+||++++ +++.||||++..... .......+.+|+.+++.++|+||+++++++.+.+.++|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999976 678999999876543 2334566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999876568999999999999999999999999 99999999999999999999999999986543221
Q ss_pred cCCCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcH
Q 002157 832 SSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDP 903 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~--~ls~ 903 (959)
......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+........+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457999999999987 45678899999999999999999999998877666655543333333443 5789
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++++||.+||+ +|.+||++.+++.+
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 99999999997 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.96 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=227.1
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
=|.+.+.||+|-|..|-++++ +|++||||++.+..+.......+.+|+++|+.++|||||+||++...+..+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 377788999999999999976 899999999999888877778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
-++|+|++||-+....+.+....+++.||+.|+.|+|+.. +||||||||||.+. +-|-|||+|||++..+... ...
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL 175 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL 175 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence 9999999999887788999999999999999999999998 99999999999886 5699999999999877554 556
Q ss_pred CCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s-~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.+.||+..|-|||++.|..|+ +++||||||+|||-|+||++||...+..+.+-.| -.....+|..++.++++||..|
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHHH
Confidence 789999999999999998885 5789999999999999999999999988887776 3457778999999999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTV 928 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~ 928 (959)
|..||.+|.++++|..
T Consensus 254 LvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVS 269 (864)
T ss_pred HhcCchhhccHHHHhc
Confidence 9999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=339.62 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=218.6
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|.+++|++.++||+|+||.||+|.. ++..||+|.+..... ....+.+|+.++++++|+||+++++.+...+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 357788999999999999999999986 556799998754322 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++|||+++++|.+++.+. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999998653 356888899999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 829 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 829 ~~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 3211 122345678999999998889999999999999999998 9999988777666555432 233444567889999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+|+.+||+.+|++||++++|++.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=358.92 Aligned_cols=237 Identities=25% Similarity=0.375 Sum_probs=206.1
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||.||+|++ +++.||||++.+... .......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578899999875432 233455677888888877 699999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999998765 46899999999999999999999999 99999999999999999999999999876433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..++.++++||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999988877776653 33556778899999999999999999
Q ss_pred CCCCCH
Q 002157 918 SLRPSF 923 (959)
Q Consensus 918 ~kRPSa 923 (959)
.+||++
T Consensus 236 ~~R~~~ 241 (320)
T cd05590 236 TMRLGS 241 (320)
T ss_pred HHCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=366.67 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=218.2
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
...++..++|++.+.||+|+||.||++++ +++.||||++.+... .......+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34556778999999999999999999987 578899999875432 222344577899999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..+++||||+++|+|.+++... .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999999999753 5788888899999999999999998 99999999999999999999999999976
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC-
Q 002157 826 KHNTF-LSSKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK- 899 (959)
Q Consensus 826 ~~~~~-~~~~t~~GT~~YmAPEvl~g~----~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~- 899 (959)
..... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+........+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 54322 123456799999999998754 378899999999999999999999999887766666654433445554
Q ss_pred -CCcHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 900 -ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 900 -~ls~eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
.++.++++||.+||+.+|.+ |+++.+++.+
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57899999999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.78 Aligned_cols=256 Identities=32% Similarity=0.533 Sum_probs=219.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
..++|++.+.||+|+||.||+|++. ...||||++.... .......+.+|+.++++++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4578999999999999999999873 3479999876543 344556788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+....+++..++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999999776667899999999999999999999998 99999999999999999999999999987642
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 ~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHH
Confidence 11 11222345678999999999889999999999999999997 9999988777666655532 23445567789999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.+|+.+||+.+|++||++.+|++.|+++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=339.04 Aligned_cols=257 Identities=24% Similarity=0.449 Sum_probs=215.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||+|++ +++.||||++.... ........+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6799999999999999999976 68899999876533 33445567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988742 3345788999999999999999999998 999999999999999999999999998876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+.....+...+...+..+++
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3323345688999999999988899999999999999999999999976532 33333332222222223457788999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
||.+||+.+|.+||++.+|++.|+.++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=366.90 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=209.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||+++. +++.||||++..... .......+.+|+.+|++++|+||+++++.|.+.+.++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3799999999999999999986 578899999865432 2223456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC---
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~--- 829 (959)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999765 36888888999999999999999999 999999999999999999999999997532100
Q ss_pred ----------------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHH
Q 002157 830 ----------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869 (959)
Q Consensus 830 ----------------------------------------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyEL 869 (959)
.......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHHhhcCCCCCC---CHHHHHHH
Q 002157 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRP---SFAQLTVA 929 (959)
Q Consensus 870 LtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dLI~kCL~~DP~kRP---Sa~EIL~~ 929 (959)
++|+.||.+.+..+....+........+| ..+++++.+||.+|+ .+|.+|+ ++.+++.+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999988766555443322233333 367899999999987 5999999 89999866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=335.52 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=219.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|.+.+.||+|+||.||++++ +++.|++|.+............+.+|+.++++++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588899999999999999987 678999999876665566677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 457889999999999999999999998 9999999999999999999999999988765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+. ......++..++.+++++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 45678999999999999989999999999999999999999998887666555443 23344556678899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.+|++||++.+|++.
T Consensus 238 ~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 238 TKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.13 Aligned_cols=257 Identities=30% Similarity=0.434 Sum_probs=220.5
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..+.+..++|++..+||.|..++||+|++ .++.||||++..+..... ...+.+|++.|..++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34566778999999999999999999987 689999999987765544 788999999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+|+||.||.+|++.++++.. ...++|..+..|+++++.||.|||++| .||||||+.||||+.+|.|||+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence 999999999999999999642 346999999999999999999999999 99999999999999999999999998765
Q ss_pred ccCCccc----CCCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc----
Q 002157 826 KHNTFLS----SKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---- 895 (959)
Q Consensus 826 ~~~~~~~----~~t~~GT~~YmAPEvl~--g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~---- 895 (959)
+...... ..+++||++|||||++. ...|+.|+|||||||+..||.+|..||....+++++.... ++.++
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 4332211 15679999999999954 3569999999999999999999999999999988765432 22222
Q ss_pred -CCC----CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 -EIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 -~iP----~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.++ +.++..++.||..||++||.+||++.+++.+
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111 3467789999999999999999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=358.22 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=209.6
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
++||+|+||.||+|++ +++.||||++..... .......+..|.+++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 467899999876432 233445677889999876 899999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|..++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999998764 46889999999999999999999999 99999999999999999999999999876433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.. ....+|..++.++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhccCH
Confidence 99999999999999999999999999999999999999999888777766643 3455677889999999999999999
Q ss_pred CCCC-------CHHHHHHH
Q 002157 918 SLRP-------SFAQLTVA 929 (959)
Q Consensus 918 ~kRP-------Sa~EIL~~ 929 (959)
.+|+ ++.+++.+
T Consensus 236 ~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 236 NKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHcCCCCCCCCCHHHHhcC
Confidence 9999 77888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=365.85 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=209.5
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|+++++||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++|+|||++++.|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 589999999999999999987 678899999876432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC----
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 829 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~---- 829 (959)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999999765 36888999999999999999999998 999999999999999999999999997532100
Q ss_pred -------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 002157 830 -------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866 (959)
Q Consensus 830 -------------------------------------------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLL 866 (959)
.......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 002157 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPS---FAQLTVA 929 (959)
Q Consensus 867 yELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dLI~kCL~~DP~kRPS---a~EIL~~ 929 (959)
|||++|+.||.+.++.+....+........+| ..+++++.+||.+|+ .+|.+|++ +.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999988776665554333333444 467899999999987 59999997 8887753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.47 Aligned_cols=242 Identities=25% Similarity=0.423 Sum_probs=206.8
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
++||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999876432 223344556677777755 899999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999998764 36899999999999999999999998 99999999999999999999999999986543333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+. .....+|..++.++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988877766653 34566788899999999999999999
Q ss_pred CCCCCHH-HHHH
Q 002157 918 SLRPSFA-QLTV 928 (959)
Q Consensus 918 ~kRPSa~-EIL~ 928 (959)
.+||++. ++++
T Consensus 236 ~~R~~~~~~l~~ 247 (316)
T cd05592 236 TKRLGVDGDIRQ 247 (316)
T ss_pred HHcCCChHHHHc
Confidence 9999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=338.26 Aligned_cols=256 Identities=36% Similarity=0.627 Sum_probs=219.7
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++...+|.+.+.||.|+||.||+|.+ .++.||+|++.... .....+.+|++++++++|+||+++++++..+..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 56678899999999999999999976 57889999876442 23457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999998653 345889999999999999999999998 99999999999999999999999999986544
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 829 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 829 ~~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+. .......+..++.++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 3221 112234668999999999999999999999999999998 999998877766655543 2335567788999999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+||.+||+.||.+||++.++++.|+.+
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.53 Aligned_cols=255 Identities=33% Similarity=0.599 Sum_probs=220.4
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
...+|+++++||.|+||.||+|.+ .+..+|+|++..... .....+.+|+.+++.++|+||+++++++.....+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 446799999999999999999987 467899998765432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
||+++++|.+++.+. +..+.+..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999999753 346889999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......++..|++||++.+..++.++||||||+++|+|++ |+.||.+....+....+. ...+...+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHH
Confidence 3334456778999999998889999999999999999998 899998887776666554 33455667788999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHhh
Q 002157 911 ECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+||+.||.+||++.+|++.|+.+
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.80 Aligned_cols=256 Identities=29% Similarity=0.552 Sum_probs=216.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+.+++|++.+.||+|+||+||+|.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568899999999999999999974 34679999886533 3445567889999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 002157 747 NLSIITEFLPRGSLFRILHRP----------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~----------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd 810 (959)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 999999999999999998532 124778888999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 002157 811 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (959)
Q Consensus 811 ~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~ 887 (959)
.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 11233446778999999998889999999999999999998 9999988776655554
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
+. .......+..++.++++++.+||+.||.+||++.+|++.|+.
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 43 233455677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.38 Aligned_cols=248 Identities=36% Similarity=0.631 Sum_probs=210.2
Q ss_pred eEEeEeeccCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 679 VLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~~------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++.+.||.|.||.||+|++. +..|+||++.. .........+.+|++++++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 57789999999999999886 57799998844 344555788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC--C
Q 002157 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--T 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~--~ 829 (959)
||+++|+|.++|... ...+++..++.|+.||+.||.|||+++ |+|+||++.|||++.++.+||+|||++..... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999875 567999999999999999999999998 99999999999999999999999999987622 1
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+ ....+...+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 122233456778999999999889999999999999999999 78999998887777666 3455667788899999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~L 930 (959)
|.+||..||.+||++.+|++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.24 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=200.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----CcEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~l~ 749 (959)
+|++.++||+|+||.||+|.+ ++..||||++............+.+|+.++++++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999986 578999998875433333445788999999999999999999987543 2489
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+. ++|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 6899988654 36899999999999999999999999 999999999999999999999999999754322
Q ss_pred c---ccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------
Q 002157 830 F---LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 890 (959)
Q Consensus 830 ~---~~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-------------- 890 (959)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234679999999999876 5789999999999999999999999987664332211100
Q ss_pred ------------cccccC---CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 891 ------------QNRRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 891 ------------~~~~~~---iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...... ....+++++.+||.+||+.||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.05 Aligned_cols=256 Identities=33% Similarity=0.554 Sum_probs=218.4
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++..++|++.+.||+|+||.||+|.+ .++.||||.+..... ...++.+|+.++++++|+||+++++++...+.+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 56678899999999999999999986 456799998865432 24568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999996543 56899999999999999999999998 999999999999999999999999999876532
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+. .......+..++..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHH
Confidence 211 111223457999999999899999999999999999998 999999888776665553 23344566778899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
++.+||+.+|.+||++.+|+..|+.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.13 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=206.0
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
++||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999987 577899999876432 122344566788888765 899999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999998764 46889999999999999999999998 99999999999999999999999999875332223334577
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+. .....+|..++.++++||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777766553 23456777899999999999999999
Q ss_pred CCCCCHH-HHH
Q 002157 918 SLRPSFA-QLT 927 (959)
Q Consensus 918 ~kRPSa~-EIL 927 (959)
.+|+++. +++
T Consensus 236 ~~R~~~~~~~~ 246 (316)
T cd05620 236 TRRLGVVGNIR 246 (316)
T ss_pred HHcCCChHHHH
Confidence 9999974 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=346.50 Aligned_cols=265 Identities=32% Similarity=0.537 Sum_probs=222.7
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~ 739 (959)
.+++..++|.+++.||+|+||.||++++. ...||+|.+.... ......++.+|+.+++++ +|+||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 45677789999999999999999999752 2469999887543 334456788999999999 799999999
Q ss_pred eeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
+++...+.+++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999996532 24788899999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~~~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
+|||++.++.+||+|||++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998765432111 112234568999999999889999999999999999998 8899988777
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
.++...+. .......|..++.++++||.+||..+|.+||++.+|++.|+.+.....
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 66655543 333456777889999999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=355.69 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=207.1
Q ss_pred CeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~--~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
+|++++.||+|+||+||+++. +++.||+|++.+... .......+.+|+.+++++ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999975 578899999875432 122345678899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999998664 36889999999999999999999998 99999999999999999999999999976433
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCCc
Q 002157 829 TF-LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELD 902 (959)
Q Consensus 829 ~~-~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~~~iP~~ls 902 (959)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ..+...+ ......+|..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 21 2233467999999999998754 78899999999999999999999965322 2222222 233456778899
Q ss_pred HHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 002157 903 PLVARIIWECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
..+++||.+||+.||.+|| ++++++++
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=373.39 Aligned_cols=259 Identities=26% Similarity=0.375 Sum_probs=221.9
Q ss_pred ccccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 668 ~~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
....+...++|++.+.||+|+||+||++++ +++.||||++............+.+|+.++..++|+||+++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344455568999999999999999999976 688999999987766667777889999999999999999998877543
Q ss_pred C--------cEEEEEeccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 746 P--------NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 746 ~--------~l~LVmEy~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
. .+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCC
Confidence 2 367999999999999998642 346889999999999999999999998 999999999999999999
Q ss_pred EEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc
Q 002157 815 VKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 815 VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~ 892 (959)
+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. .
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-G 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-C
Confidence 9999999998654321 123456799999999999999999999999999999999999999998887766665543 2
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....+|..+++++.+||.+||+.||.+||++.+++.+
T Consensus 261 ~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3445678899999999999999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.72 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=206.1
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||+||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 467899999876432 122344566788888765 899999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999764 46888999999999999999999998 99999999999999999999999999875432222334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ...+|..++.++++||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCH
Confidence 999999999999999999999999999999999999999998877776665432 345677899999999999999999
Q ss_pred CCCCCHH-HHHH
Q 002157 918 SLRPSFA-QLTV 928 (959)
Q Consensus 918 ~kRPSa~-EIL~ 928 (959)
.+||++. +++.
T Consensus 236 ~~R~~~~~~l~~ 247 (316)
T cd05619 236 ERRLGVKGDIRQ 247 (316)
T ss_pred hhcCCChHHHHc
Confidence 9999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.20 Aligned_cols=259 Identities=31% Similarity=0.536 Sum_probs=220.1
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
|.+++|.+.+.||+|+||+||++.. ++..+|+|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5678999999999999999999974 2345889987543 234456788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g 813 (959)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999986432 24899999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhc
Q 002157 814 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 890 (959)
Q Consensus 814 ~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~ 890 (959)
.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997553221 11223446778999999999999999999999999999998 9999988877666655542
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
......+..++.++.+|+.+||+.||.+||++.+++..|+++.+.
T Consensus 238 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 -GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 333455667889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=338.63 Aligned_cols=257 Identities=32% Similarity=0.544 Sum_probs=219.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~ 743 (959)
+++..++|++.+.||+|+||.||++.+. +..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 3567789999999999999999999763 2579999875443 2334567889999999999999999999999
Q ss_pred cCCcEEEEEeccCCCCHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 744 RPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k~~---------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
.....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 9999999999999999999986421 24677889999999999999999998 999999999999999999
Q ss_pred EEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc
Q 002157 815 VKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (959)
Q Consensus 815 VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~ 891 (959)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 9999999987654321 11233456789999999988889999999999999999998 999999888777666554 4
Q ss_pred ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 892 ~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.....+|..++.++.+||.+||+.+|.+||++.+|+..|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 4456677888999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=371.75 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=222.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
..|...++||+|.||.||+|.+ .++.||+|++..... +..+..+.+|+.+|.+++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4577778999999999999976 678899999876543 3456788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
||.||++.++++.. ..+.+..+..|+++++.||.|||.++ .+|||||+.||||..+|.+||+|||.+.+........
T Consensus 92 y~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999999764 35588888889999999999999998 9999999999999999999999999999888777777
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
.+++||+.|||||++.+..|+.|+|||||||+.+||.+|.+||.+..++..+..|. ...++.+-..+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999999977665554 33455555688999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
++||+.||++.+++.+
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9999999999988753
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=361.31 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=211.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||++++ +++.||||++..... .......+.+|+.++.+++|+||+++++.+.+.+.++|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 578899999875432 2334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-- 830 (959)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999764 46899999999999999999999999 9999999999999999999999999987542110
Q ss_pred ---------------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002157 831 ---------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (959)
Q Consensus 831 ---------------------------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 877 (959)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 002157 878 GMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 929 (959)
Q Consensus 878 g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kRPS---a~EIL~~ 929 (959)
+.++......+........+|. .++.++++||.+|+ .||.+|++ +.+++.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9888777666543333444454 36899999999987 59999985 6676655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.01 Aligned_cols=242 Identities=21% Similarity=0.363 Sum_probs=209.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVm 752 (959)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|+.++..+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999987 578899999876432 2234456778899998885 578889999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999998764 36899999999999999999999998 999999999999999999999999998764333333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. ....+|..++.++++|+.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHH
Confidence 4456799999999999999999999999999999999999999999888777666543 35567888999999999999
Q ss_pred hhcCCCCCCCH
Q 002157 913 WQTDPSLRPSF 923 (959)
Q Consensus 913 L~~DP~kRPSa 923 (959)
|+.+|.+|++.
T Consensus 236 l~~~p~~R~~~ 246 (323)
T cd05615 236 MTKHPSKRLGC 246 (323)
T ss_pred cccCHhhCCCC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.44 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=209.8
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 567899999876532 223455677899999888 799999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999998765 37899999999999999999999998 99999999999999999999999999875333223334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .....+|..++.++++||.+||+.||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777666553 33556778899999999999999999
Q ss_pred CCCCCH-----HHHHHH
Q 002157 918 SLRPSF-----AQLTVA 929 (959)
Q Consensus 918 ~kRPSa-----~EIL~~ 929 (959)
.+||++ .+++.+
T Consensus 236 ~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 236 EKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.85 Aligned_cols=238 Identities=26% Similarity=0.409 Sum_probs=202.8
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~-IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||+||+|++ +++.||||++...... ......+..|.. +++.++||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987 6789999998764322 222344555554 56778999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999998764 47889999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....++..++.++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999988777666553 23455667889999999999999999
Q ss_pred CCCCCHH
Q 002157 918 SLRPSFA 924 (959)
Q Consensus 918 ~kRPSa~ 924 (959)
.+||++.
T Consensus 236 ~~R~~~~ 242 (323)
T cd05575 236 TKRLGAK 242 (323)
T ss_pred HhCCCCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=340.45 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=216.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|.+.+.||+|+||.||+|++. +..||||++.... .......+.+|+++|++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34577899999999999999999752 3679999886543 233457889999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH-------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~-------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~ 812 (959)
...++||||+++++|.+++...+ ..+++..+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 99999999999999999996532 34778889999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhh
Q 002157 813 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (959)
Q Consensus 813 g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~ 889 (959)
+.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999987543221 11233456788999999999999999999999999999998 999998888777666554
Q ss_pred ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 890 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 890 ~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.......+..++..+++||.+||+.||.+||++.||++.|+
T Consensus 239 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 -QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33344456678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.05 Aligned_cols=251 Identities=30% Similarity=0.489 Sum_probs=216.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH---HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~---~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+.|++.+.||+|+||.||++.. ++..||||.+....... .....+.+|+.++++++||||+++++++..++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999975 67899999887543322 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||..| |+||||+|+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999998764 36888999999999999999999998 9999999999999999999999999987653321
Q ss_pred ccC---CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 831 LSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 831 ~~~---~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+................+|..++.++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23568889999999999989999999999999999999999998877665555554455566778889999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~ 929 (959)
||.+||..+|.+||++.+++.+
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.63 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=202.5
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~-IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||+||+|++ +++.||+|++...... ......+..|.. +++.++|+||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 5678999998754321 122334444444 56778999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|.+++.+. ..+.+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999764 36778888889999999999999999 99999999999999999999999999975433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....++..++..+.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999888777666553 23455667889999999999999999
Q ss_pred CCCCCHHHHH
Q 002157 918 SLRPSFAQLT 927 (959)
Q Consensus 918 ~kRPSa~EIL 927 (959)
.+|+++.+.+
T Consensus 236 ~~R~~~~~~~ 245 (325)
T cd05602 236 TKRLGAKDDF 245 (325)
T ss_pred HHCCCCCCCH
Confidence 9999876443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=337.04 Aligned_cols=251 Identities=34% Similarity=0.558 Sum_probs=214.6
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.++|++++.||+|+||.||++++.+ ..||||.+...... ...+.+|+.++++++||||+++++++.....+++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45689999999999999999998755 45999987654332 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+.+++|.+++.+....+++..++.++.||+.||.|||+.+ |+|+||||.|||++.++.+||+|||+++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999999775557899999999999999999999998 99999999999999999999999999876543321
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......++..|++||++.+..++.++|||||||++|+|++ |..||...+.......+. ...+...+...+..+++++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence 1122335678999999998889999999999999999998 999998877766655553 33344556678899999999
Q ss_pred HHhhcCCCCCCCHHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~L 930 (959)
+||+.+|.+||++.+|+..|
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHcCCCcccCCCHHHHHHhh
Confidence 99999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=364.28 Aligned_cols=264 Identities=32% Similarity=0.484 Sum_probs=219.1
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMG 740 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g 740 (959)
..++++.++|+++++||+|+||.||+|++. +..||||++.... .......+.+|+++|+++. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 456777889999999999999999999762 2369999886543 3334567899999999995 999999999
Q ss_pred eeecCCcEEEEEeccCCCCHHHHhhCCC----------------------------------------------------
Q 002157 741 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 768 (959)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------------------------------------------- 768 (959)
++.....++||||||++|+|.+++.+..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999885421
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC
Q 002157 769 -------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 805 (959)
Q Consensus 769 -------------------------------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPe 805 (959)
..+++..++.++.||+.||.|||..+ |+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 23677788899999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002157 806 NLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 882 (959)
Q Consensus 806 NILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ 882 (959)
|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999998653321 12233457788999999999999999999999999999996 99999876544
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 883 ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
...............+..++.++++||.+||+.||++||++.+|.+.|+++.+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 33322222334556677889999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.47 Aligned_cols=255 Identities=31% Similarity=0.542 Sum_probs=213.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|++.+.||+|+||.||+|.+. +..||||++..... .....++.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45578999999999999999999753 35699998754332 23445788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~---------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VK 816 (959)
...++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence 99999999999999999986432 23567788899999999999999998 99999999999999999999
Q ss_pred EEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc
Q 002157 817 VSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 893 (959)
Q Consensus 817 LiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~ 893 (959)
|+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999875433211 1122345778999999999889999999999999999998 789998887766655443 333
Q ss_pred ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 894 ~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
....+..++..+++||.+||+.||++||++.+++..|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 44567788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=362.96 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=215.6
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..++|++.+.||+|+||.||++++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 445668899999999999999999987 577899999865332 22334567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999999753 5888999999999999999999998 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--C
Q 002157 828 NTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--E 900 (959)
Q Consensus 828 ~~~-~~~~t~~GT~~YmAPEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~--~ 900 (959)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........+|. .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 322 2234577999999999997643 78899999999999999999999999887776666654444455555 4
Q ss_pred CcHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
++..+++||.+||..++.+ |+++.+++++
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 6899999999999865544 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.08 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=208.2
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+..++|++.++||+|+||.||++++ ++..+|+|++... ........+.+|++++++++|+||++++++|...+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4568899999999999999999987 4778999987654 234455678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999764 3688899999999999999999974 6 999999999999999999999999998765332
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--------------------
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------------- 889 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~-------------------- 889 (959)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......++...+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2234579999999999999889999999999999999999999997655433221110
Q ss_pred -----------------------ccccccCCC-CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 890 -----------------------FQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 890 -----------------------~~~~~~~iP-~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.......++ ..++.++++||.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 001111111 1357889999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=343.67 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=201.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeee-----c
Q 002157 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~-----~ 744 (959)
++|++.+.||+|+||.||+|++ .+..||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4689999999999999999976 357799998876543333334556777777766 6999999999875 3
Q ss_pred CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
...+++||||++ ++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 5899988653 345889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---c------
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---R------ 894 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~---~------ 894 (959)
+..... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..... +
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 865433 233456789999999999998999999999999999999999999998776555443321100 0
Q ss_pred ----------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 ----------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ----------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+...++..+++||.+||+.||++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0011346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.46 Aligned_cols=258 Identities=28% Similarity=0.500 Sum_probs=216.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+...+|++.+.||+|+||.||+|++ +++ .||||++... .......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 3456899999999999999999976 333 3899987643 2334556788999999999999999999998765
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..++|+||+++|+|.+++.+....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence 567999999999999999876667889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
...... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+....++...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 238 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 432221 122334678999999999999999999999999999997 999998877666544332 3334555677889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.+++.+||..+|.+||++.+|+..|..+.+
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=355.57 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=204.5
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
++||+|+||.||++++ +++.||||++...... ......+.+|+.++..+ +||||++++++|.+...++|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 5788999998765432 23455678899999998 799999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999988654 47999999999999999999999999 99999999999999999999999999875332223344578
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--------H-HHHhhhhccccccCCCCCCcHHHHHH
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--------M-QVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--------~-ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . .....+ ......+|..++.++.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999999999999999963211 1 122222 334566788899999999
Q ss_pred HHHHhhcCCCCCCC------HHHHHH
Q 002157 909 IWECWQTDPSLRPS------FAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPS------a~EIL~ 928 (959)
|.+||+.||.+|++ +.+++.
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 99999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=353.53 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=210.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||++++ +++.||||++.+.. ........+.+|+.++..++|+||+++++++.+.+.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999987 56789999986532 22233455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999875567899999999999999999999999 99999999999999999999999999976543322
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC---CCcH
Q 002157 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELDP 903 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~---~ls~ 903 (959)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+..+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2234579999999999876 4578899999999999999999999998887776666544443444443 4689
Q ss_pred HHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
++++||.+||..++.+ |+++++++.+
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999876544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.91 Aligned_cols=256 Identities=31% Similarity=0.572 Sum_probs=217.8
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|..++|+++++||+|+||.||+|.. +++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+.++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 356778999999999999999999976 6688999988755433 346889999999999999999999875 45789
Q ss_pred EEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++|||+.+++|.+++.+. ...+++..++.++.|++.||+|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999998643 346888999999999999999999998 99999999999999999999999999976552
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 829 TF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 829 ~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
.. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. .......+..++.+++
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 21 12223446778999999998889999999999999999998 999999887766665543 2334566777889999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+||.+||+.+|++||++++|+..|+.+
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.86 Aligned_cols=251 Identities=33% Similarity=0.589 Sum_probs=215.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee-ecCCcEEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSII 751 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~-~~~~~l~LV 751 (959)
+.+++|++.+.||+|+||.||++...+..||+|.+.... ....+.+|+.++++++|+||+++++++ .....+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 566789999999999999999999999999999875432 245688999999999999999999975 455678999
Q ss_pred EeccCCCCHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~-~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|||+++++|.+++.+... .+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999976433 4788999999999999999999998 9999999999999999999999999987543321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.. ......+..+++.+++||
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVM 232 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence 23345678999999999889999999999999999997 9999988777666655532 334456678899999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 910 WECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.+||+.+|.+||++.++++.|+.+
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.61 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=215.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~ 742 (959)
++++.++|++.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 5677789999999999999999999642 3679999886443 233455678899999999 899999999987
Q ss_pred ec-CCcEEEEEeccCCCCHHHHhhCCC-----------------------------------------------------
Q 002157 743 TR-PPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (959)
Q Consensus 743 ~~-~~~l~LVmEy~~gGsL~dlL~k~~----------------------------------------------------- 768 (959)
.. +..++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 456889999999999999885321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCC
Q 002157 769 -------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGT 839 (959)
Q Consensus 769 -------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT 839 (959)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788889999999999999999998 9999999999999999999999999998653221 112234567
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCC
Q 002157 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918 (959)
Q Consensus 840 ~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~ 918 (959)
..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............|...++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999997 99999875544333222223334556677889999999999999999
Q ss_pred CCCCHHHHHHHHHhhhh
Q 002157 919 LRPSFAQLTVALKPLQR 935 (959)
Q Consensus 919 kRPSa~EIL~~Le~l~k 935 (959)
+||++.+|+++|+.+.+
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999997754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.30 Aligned_cols=252 Identities=37% Similarity=0.624 Sum_probs=218.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+..++|++.+.||.|+||.||++...++.||||.+..... ....+.+|+.++++++|+||+++++++......++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567899999999999999999999999999999865532 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 753 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
||+++++|.+++.+.. ..+++..++.++.|++.||.|||.++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999997543 36899999999999999999999999 99999999999999999999999999986633211
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......+...+.. ......+..++.++.+||.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHHH
Confidence 2345668999999998889999999999999999997 9999988877666554432 2344566778999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHhh
Q 002157 911 ECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+||+.+|.+||++.+++..|+++
T Consensus 234 ~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 234 DCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHhccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=370.94 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=231.2
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-EEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~-l~LV 751 (959)
.++|..++++|+|+||.++++++ .+..|++|++......+........|+.++++++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46899999999999999999976 56789999998887777767788999999999999999999999999888 9999
Q ss_pred EeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|+||+||+|.+.|.+.+ ..+++..++.++.||+.|+.|||++. |+|||||+.|||++.++.|||+|||+++......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999987654 67899999999999999999999888 9999999999999999999999999999988775
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
....+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+...+...+... ...++|...+.+++.||+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-LYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-cCCCCCccccHHHHHHHH
Confidence 5667899999999999999999999999999999999999999999999998888777533 356788899999999999
Q ss_pred HHhhcCCCCCCCHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~ 929 (959)
.||+++|..||++.+|+.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999876
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.94 Aligned_cols=238 Identities=27% Similarity=0.405 Sum_probs=202.4
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~-IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
++||+|+||.||+|++ +++.||||++.+... .......+..|+. +++.++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578899999875432 2223344555554 57788999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|..++.+. ..+.+..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999988654 46888888999999999999999998 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|...+.++.++|.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988776666553 34567778889999999999999999
Q ss_pred CCCCCHH
Q 002157 918 SLRPSFA 924 (959)
Q Consensus 918 ~kRPSa~ 924 (959)
.+|++..
T Consensus 236 ~~R~~~~ 242 (321)
T cd05603 236 RRRLGAK 242 (321)
T ss_pred hhcCCCC
Confidence 9999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.84 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=215.5
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|+||.||++++ ++..||+|.+..... ......+.+|+.+++.++|+||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999987 678899998865432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999998864 3345789999999999999999999998 9999999999999999999999999997665443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+++||.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 45678999999999999889999999999999999999999999877766655543 23344566788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.||.+||++.+|+..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.08 Aligned_cols=251 Identities=33% Similarity=0.563 Sum_probs=213.9
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
...+|++.+.||+|+||.||++++. +..+|||++...... ...+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 3467899999999999999999874 457999987654332 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999999765557899999999999999999999999 999999999999999999999999998765432211
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 833 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 833 -~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...|...+.++.+|+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 111223457999999999999999999999999999998 899998877766665553 23345667778999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~L 930 (959)
+||+.+|++||++.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.90 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=210.3
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|++.++||+|+||.||++.+ +++.||||++....... .....+.+|+.++++++|+||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478999999999999999986 57899999987543322 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+.+++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cc
Confidence 99999999888543 346899999999999999999999998 999999999999999999999999999765432 22
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCCCCCcHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~--~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+. .......++..++..+++||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234578999999999999889999999999999999999999998865533221111 123344566778999999999
Q ss_pred HHhhcCCCCCC-----CHHHHHHH
Q 002157 911 ECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 911 kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
+||+.||.+|| ++++++.+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.89 Aligned_cols=260 Identities=32% Similarity=0.564 Sum_probs=216.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~ 749 (959)
|++|++.++||+|+||.||+|... +. .+++|.+... ........+.+|+.++.++ +||||+++++++.....++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 578999999999999999999763 33 4688876532 2333456788999999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 750 IITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996532 24788899999999999999999998 999999999999999999
Q ss_pred EEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc
Q 002157 815 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 893 (959)
Q Consensus 815 VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~ 893 (959)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. ..
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 235 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CC
Confidence 999999998643221 11122233557999999999889999999999999999997 9999998887766655532 23
Q ss_pred ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 894 ~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
....+..++.++++||.+||+.+|.+||++.+|++.|+.+.+....
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 4456778899999999999999999999999999999988775544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=362.14 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=194.6
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC------CceeEEeeeee
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAVT 743 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H------pNIVkL~g~~~ 743 (959)
.+..++|+++++||+|+||+||+|.+ .++.||||++.... .....+..|+.+++.++| .+|++++++|.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34567899999999999999999976 57789999986431 223345667777777654 45899999887
Q ss_pred cC-CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC--------
Q 002157 744 RP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW-------- 813 (959)
Q Consensus 744 ~~-~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g-------- 813 (959)
.. .+++||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||. .| ||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 65 4688999988 77899888664 478999999999999999999997 57 99999999999998665
Q ss_pred --------cEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 002157 814 --------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (959)
Q Consensus 814 --------~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~ 885 (959)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998864322 234578999999999999999999999999999999999999999887764433
Q ss_pred hhhhccccc--------------------------cCCCC--------------CCcHHHHHHHHHHhhcCCCCCCCHHH
Q 002157 886 GAVGFQNRR--------------------------LEIPK--------------ELDPLVARIIWECWQTDPSLRPSFAQ 925 (959)
Q Consensus 886 ~~i~~~~~~--------------------------~~iP~--------------~ls~eL~dLI~kCL~~DP~kRPSa~E 925 (959)
..+...... ...+. ..++.+++||.+||+.||.+||+++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 222110000 00000 11356789999999999999999999
Q ss_pred HHH
Q 002157 926 LTV 928 (959)
Q Consensus 926 IL~ 928 (959)
+++
T Consensus 435 ~L~ 437 (467)
T PTZ00284 435 MTT 437 (467)
T ss_pred Hhc
Confidence 987
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.43 Aligned_cols=261 Identities=31% Similarity=0.562 Sum_probs=221.0
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+++..++|++.+.||+|+||.||++.+.+ ..||+|++..... ......+.+|+.+++++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356777899999999999999999997632 5689998775433 33456788999999999 89999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~---------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeN 806 (959)
+...+.++++|||+++++|..++.+. ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998632 346888999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 002157 807 LLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 883 (959)
Q Consensus 807 ILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~q 883 (959)
||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999986543221 1122335668999999999999999999999999999997 999999888776
Q ss_pred HHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 884 l~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
....+.. ......+...+.++.+|+.+||..||.+||++.+|++.|+.+.
T Consensus 243 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 6655532 3344567788899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=342.09 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=203.5
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||+|+||+||++++ +++.||||++....... .....+..|+.+++.++|+||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 67899999987543322 2345677899999999999999999999999999999999999999
Q ss_pred HHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 761 FRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 761 ~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 988743 3346899999999999999999999998 99999999999999999999999999976544333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ......++..++.++.+|+.+||
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999765432 122222 22345567788999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 002157 914 QTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRP-----Sa~EIL~~ 929 (959)
+.||.+|| ++++++.+
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 67778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=360.05 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=215.2
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..++..++|++.+.||+|+||.||++++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3556678999999999999999999987 577899999865332 2233456788999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999999753 5788888999999999999999999 999999999999999999999999999865
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--C
Q 002157 827 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 899 (959)
Q Consensus 827 ~~~~-~~~~t~~GT~~YmAPEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~ 899 (959)
.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........+| .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4322 2234567999999999997643 7889999999999999999999999988777766665443334444 3
Q ss_pred CCcHHHHHHHHHHhhcCCCC--CCCHHHHHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSL--RPSFAQLTVAL 930 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~k--RPSa~EIL~~L 930 (959)
.++.++++||.+||..++.+ |+++.+|+++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 68999999999999844433 77999988853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=330.81 Aligned_cols=256 Identities=25% Similarity=0.471 Sum_probs=215.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||+|.. +++.||+|.+..... .......+.+|++++++++|+||+++++++...+.+++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6799999999999999999987 588999998875433 2334667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||+++++|..++.. ....+++..++.++.+|+.||.|||+.| |+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998853 2346889999999999999999999998 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhhccccccCCCC-CCcHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPK-ELDPLVA 906 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ql~~~i~~~~~~~~iP~-~ls~eL~ 906 (959)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+.. ......|. .++.+++
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 3333445689999999999998899999999999999999999999965432 223332221 22233444 6788999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
++|.+||..+|.+||++.+|++.|+.+.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.69 Aligned_cols=252 Identities=20% Similarity=0.342 Sum_probs=211.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.++||+|+||.||++++ .++.||+|++.+... .......+.+|+.++..++|+||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999987 467899999865322 2223445788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-c
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-L 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-~ 831 (959)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999875567899999999999999999999998 9999999999999999999999999987543221 2
Q ss_pred cCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC---CCCcH
Q 002157 832 SSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 903 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP---~~ls~ 903 (959)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999988877776665443334444 35789
Q ss_pred HHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
++++||.+||..++.+ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999765544 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=367.62 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=212.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--C-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
..|.+.+.||+|+||.||+|.. + +..||+|++.... ......+.+|+.+|+.++|||||+++++|...+.++|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3499999999999999999976 3 5678888764432 334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||+++|+|.+++.+ ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999998753 2346889999999999999999999998 999999999999999999999999999876433
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... ....+|..++.++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHH
Confidence 21 234567999999999999999999999999999999999999999988877766655433 233466788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~ 928 (959)
||.+||..||.+||++.+++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=351.66 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=210.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||++++ +++.||||++.+.. ........+.+|+.++..++|+||++++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 57889999987532 22334556888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999775667899999999999999999999999 99999999999999999999999999876543222
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC---CCCcH
Q 002157 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 903 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP---~~ls~ 903 (959)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223569999999999973 447889999999999999999999999887776665554333333333 34789
Q ss_pred HHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
++++||.+||..++.+ |+++.+++.+
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999998754443 7899998877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.24 Aligned_cols=246 Identities=34% Similarity=0.595 Sum_probs=216.0
Q ss_pred eEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
+.||+|+||.||+|... +..|+||++....... ....+.+|++++..++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 36899999999999874 7789999887654333 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 757 RGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 757 gGsL~dlL~k~--------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 467999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 ~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22344567889999999998889999999999999999998 6999999887777666653 44566778889999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+++.+||+.+|.+||++.+++..|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=354.20 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=203.2
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~-IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||+||+|++ +++.||||++..... .......+..|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999986 678999999875432 2233445556655 46678999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999988754 47899999999999999999999998 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+.. ....++...+..+.++|.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccCH
Confidence 99999999999999999999999999999999999999998887777665532 3445566789999999999999999
Q ss_pred CCCCCHHH
Q 002157 918 SLRPSFAQ 925 (959)
Q Consensus 918 ~kRPSa~E 925 (959)
.+||++.+
T Consensus 236 ~~R~~~~~ 243 (325)
T cd05604 236 QRRLGAKE 243 (325)
T ss_pred HhcCCCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.58 Aligned_cols=257 Identities=25% Similarity=0.461 Sum_probs=215.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||++++ ++..||||.+..... .......+.+|+.+++.++|+||+++++++...+.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788999999999999999985 788999998765433 3334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998853 2346889999999999999999999998 999999999999999999999999998766443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.... .....+.....+...+..++.++++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 33333457899999999999988999999999999999999999999765432 2222322222222233467889999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
||.+||+.||.+||++.+|++.++++.
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.42 Aligned_cols=246 Identities=28% Similarity=0.476 Sum_probs=210.7
Q ss_pred EeeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
+||+|+||.||+|.+ ++..||||++...........++.+|+.+++.+.|+||+++++++.. +.+++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 46789999887665555566789999999999999999999998864 5678999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc---CCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 835 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~---~~t 835 (959)
+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||.|||++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999654 36889999999999999999999998 999999999999999999999999999865433211 122
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
..++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.. ......|..++.++.+||.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHhc
Confidence 334678999999988889999999999999999997 9999998877766666543 34566788899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 002157 915 TDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 915 ~DP~kRPSa~EIL~~Le~l 933 (959)
.||.+||++.+|...|++.
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 237 YGVDERPGFAVVELRLRNY 255 (257)
T ss_pred cCchhCcCHHHHHHHHhcc
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.14 Aligned_cols=246 Identities=32% Similarity=0.566 Sum_probs=208.5
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGs 759 (959)
+.||+|+||.||+|++ +++.||+|.+... ........+.+|++++++++||||+++++++.....+++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3589999999999976 6888999987543 334455678999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC--CCCC
Q 002157 760 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTA 837 (959)
Q Consensus 760 L~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~--~t~~ 837 (959)
|.+++.+....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999766667899999999999999999999998 9999999999999999999999999987543321111 1112
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcC
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 916 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~D 916 (959)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+..++..+.+|+.+||+.+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999999889999999999999999997 889998777655544443 23345667788999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 002157 917 PSLRPSFAQLTVALK 931 (959)
Q Consensus 917 P~kRPSa~EIL~~Le 931 (959)
|++||++.+|++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.23 Aligned_cols=255 Identities=33% Similarity=0.578 Sum_probs=218.3
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++..++|++.+.||+|+||.||++.. .+..||||.+...... ..++.+|+.++++++|+||+++++++.....+++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 56778999999999999999999976 4467999988754433 3568899999999999999999999999899999
Q ss_pred EEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+|+||||+||+|+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999997643 46899999999999999999999998 999999999999999999999999998765432
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+. .......+...+.++++
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 1 11122335678999999999889999999999999999998 999998887766665553 23344556677899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
++.+||+.+|.+||++++|++.|+.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.95 Aligned_cols=253 Identities=28% Similarity=0.508 Sum_probs=214.1
Q ss_pred eeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-----
Q 002157 678 LVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 747 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~----- 747 (959)
|.+++.||+|+||.||+|.+. +..||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999763 2679999987665555566789999999999999999999998766554
Q ss_pred -EEEEEeccCCCCHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 748 -LSIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 748 -l~LVmEy~~gGsL~dlL~k~-----~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
.++||||+++++|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 78999999999999987432 236888999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 002157 822 LSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 822 lAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 9986543221 1112335678999999998889999999999999999999 899998888777665554 33455677
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
..++.++.++|.+||+.||.+||++.+|+..|+.+
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.94 Aligned_cols=265 Identities=31% Similarity=0.524 Sum_probs=222.9
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~ 739 (959)
.+++..++|.+.+.||+|+||.||++++. +..||+|++... ........+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 45677789999999999999999999741 236899987643 2334456788999999999 899999999
Q ss_pred eeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
+++.....+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999986532 24677888999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999986543221 1223345678999999999889999999999999999998 8899988877
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
.++...+. .......+..++.++++||.+||+.+|.+||++.+|++.|+++.....
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 77666553 333445667889999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=332.64 Aligned_cols=253 Identities=30% Similarity=0.508 Sum_probs=210.1
Q ss_pred eeEEeEeeccCcEEEEEEEECC--c--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 002157 678 LVLGERIGLGSYGEVYHADWNG--T--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g--~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~~ 747 (959)
|.+++.||+|+||.||+|++.. . .||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999998743 2 589998876555555677889999999999999999999976432 24
Q ss_pred EEEEEeccCCCCHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 748 LSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k-----~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
.+++|||+.+|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999988732 2235789999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCC
Q 002157 823 SRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (959)
Q Consensus 823 Ak~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~ 899 (959)
++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||.+....+....+... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCCC
Confidence 986543221 1223346778999999999999999999999999999999 88999888777666655432 3345566
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.++..++++|.+||+.||++||++.+|++.|+.+
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.67 Aligned_cols=254 Identities=34% Similarity=0.585 Sum_probs=215.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++..++|++.++||+|+||.||+|.+ .+..||+|.+...... ...+.+|+.++++++|+||+++++++.. ...++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI 77 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence 46678999999999999999999986 4567999988765443 2468899999999999999999998854 56789
Q ss_pred EEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+|||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999998653 345889999999999999999999998 999999999999999999999999999865432
Q ss_pred cc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. .......+...+..+++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHE 234 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHH
Confidence 21 1122345668999999998889999999999999999999 899998887766665553 23355567788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
|+.+||..+|.+||++.++...|+.
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.01 Aligned_cols=248 Identities=35% Similarity=0.520 Sum_probs=207.2
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|++++.||+|+||+||+++. +++.||+|++..............+|+.++++++|+||+++++++.+...+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999988 4567999999877655544445567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
++++|.+++.+ ...+++..++.++.||+.||.+||+++ |+||||||+|||++.++.++|+|||++............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999973 347899999999999999999999998 999999999999999999999999999764333334456
Q ss_pred CCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccccccCC--CCCCcHHHHHHH
Q 002157 836 TAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEI--PKELDPLVARII 909 (959)
Q Consensus 836 ~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~~~~~~i--P~~ls~eL~dLI 909 (959)
..++..|+|||++. +..++.++||||||+++|+|++|..||...... ............... ......++++||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 77899999999998 888999999999999999999999999987322 222222111111111 122348999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||+.||.+||++.++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=340.51 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=216.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+...+|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 44567888999999999999999763 3679999886443 333456788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 002157 746 PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~---------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd 810 (959)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 9999999999999999998421 134778888999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 002157 811 KNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (959)
Q Consensus 811 ~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~ 887 (959)
.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999876533211 1223456789999999988889999999999999999998 8889998887777666
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
+... ....++..++.++.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 239 i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5432 3445677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.54 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=203.4
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||.||++++ +++.||+|++.+... .......+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 577899999876533 233455677899998877 899999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999988664 47899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------h-HHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------P-MQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------~-~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... . ..+...+ ......+|..++.++.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999995311 1 1122222 334566888999999999
Q ss_pred HHHHhhcCCCCCCC------HHHHHHH
Q 002157 909 IWECWQTDPSLRPS------FAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPS------a~EIL~~ 929 (959)
|.+||+.||.+||+ +.+++.+
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999998 4566544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.37 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=206.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+++|.+.+.||+|+||.||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++..++.+++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 47899999999999999999976 5778999988754322 22345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++ +|.+++.+.+..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99975 888888766667889999999999999999999998 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------------cc
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------RR 894 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-----------------~~ 894 (959)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 344568999999999875 458999999999999999999999998876544332221000 00
Q ss_pred cC-----------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 LE-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ~~-----------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.. ....++.++++||.+||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 11246889999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.78 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=216.4
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
...+|++.+.||+|+||.||+|++. +..+|+|.+.... .......+.+|+.++++++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467999999999999999999762 2368999876433 344456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999999986543
Q ss_pred Cccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 829 TFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 829 ~~~~---~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.... .....++..|++||.+.+..++.++|+|+||+++|++++ |..||.+....+....+... .....+..++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHH
Confidence 2211 112223568999999999889999999999999999886 99999888776665555422 344555678899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+.+++.+||+.+|.+||++.++++.|+++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=327.92 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=213.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-~~~l~LVmE 753 (959)
+|++.+.||+|+||.||++.+ +++.||||++............+.+|+.++++++|+||+++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999976 56789999987665555566678899999999999999999998764 446889999
Q ss_pred ccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++++|.+++... ...+++.+++.++.+++.||+|||+.| |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999998653 345899999999999999999999998 999999999999999999999999999876543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+. .......+...+.++.+||.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999998877655544432 2223345677889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|+.||.+||++.+++.+
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 238 LSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hccCcccCCCHHHHhcC
Confidence 99999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=381.33 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=218.0
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-CC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeee-eec-
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGA-VTR- 744 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~-~~~- 744 (959)
.+++...+++|.+.|.+|||+.||+|+. .+ ..||+|++... .+.....+++|+.+|++|. |+|||.+++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 4556667889999999999999999987 33 89999998766 5777889999999999995 9999999993 211
Q ss_pred -----CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 002157 745 -----PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818 (959)
Q Consensus 745 -----~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLi 818 (959)
...++|+||||.||.|-++|.++ ...|++.++++|+.++++|+.+||...++|||||||-|||||+.+|++|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 13478999999999999999642 345999999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCcccC---------CCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh
Q 002157 819 DFGLSRLKHNTFLSS---------KSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 886 (959)
Q Consensus 819 DFGlAk~~~~~~~~~---------~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~ 886 (959)
|||.++......... -...-|+.|++||+|. |...++|+|||+|||+||-|++...||.+.....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--- 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--- 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---
Confidence 999987543221111 1123689999999984 7778999999999999999999999998764432
Q ss_pred hhhccccccCCCC--CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 887 AVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 887 ~i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
+.+....+|. ..+..+.+||+.||+.||.+||++-|++..+..+.....|
T Consensus 266 ---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 266 ---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 2344455554 6789999999999999999999999999999988665444
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=334.17 Aligned_cols=259 Identities=27% Similarity=0.482 Sum_probs=216.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+..++|++.+.||+|+||+||+|++ ++. .||||++.... .......+.+|+.+++.+.|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 3457899999999999999999986 343 48999876543 334456788999999999999999999998754
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..+++|||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 567999999999999999876667899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCH
Confidence 43211 1122335678999999999889999999999999999998 899998877665554443 2334455677899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
++.++|.+||+.||.+||++.++++.|+.+.+.
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 999999999999999999999999999877554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=337.81 Aligned_cols=259 Identities=33% Similarity=0.529 Sum_probs=218.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
++..+|.+.+.||+|+||.||+|++. +..+++|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45678999999999999999999752 3458888765432 33345788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd 810 (959)
..+++||||+++++|.+++.... ..+++..++.++.||+.||+|||.++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 99999999999999999986432 34788999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 002157 811 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (959)
Q Consensus 811 ~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~ 887 (959)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999997654321 11234557889999999999999999999999999999998 9999988777666555
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
+. .......+..++..+.+|+.+||+.+|.+||++.+|++.|+++.+.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 43 2333445567889999999999999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=369.57 Aligned_cols=269 Identities=32% Similarity=0.558 Sum_probs=240.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--C-C--ce-EEEEEeec-cCCCHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--N-G--TE-VAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~-g--~~-VAVK~i~~-~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~ 741 (959)
..+++..++..+.++||+|+||.||+|+. . + .. ||||.... .......+.+|.+|.++|++++|||||+|||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 45778888889999999999999999976 2 2 23 89998875 34667788999999999999999999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
......++||||+|+||+|.++|++.+..++..+++.++.+.+.||+|||+++ +|||||-.+|||++.++.+||+|||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999998777999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
+++.............-...|+|||.+....|+.++|||||||++||+++ |..||.+....++...+.....+...|..
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 99865421111112235679999999999999999999999999999998 78899999999999998788889999999
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
.+.++..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999999886665
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.26 Aligned_cols=263 Identities=31% Similarity=0.541 Sum_probs=220.8
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~ 739 (959)
.+.+.+++|.+++.||+|+||.||++++. ...||+|++.... .......+.+|+.+++++ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34567789999999999999999999752 3468999876443 344566788999999999 699999999
Q ss_pred eeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
+++...+.+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++| |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999986532 34788889999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~~~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432111 112234567999999999889999999999999999998 8999988877
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.+....+.. ......+..++.++++||.+||+.+|.+||++.+|++.|+++...
T Consensus 243 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 766665543 334456778889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=349.38 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=202.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
.++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 5789999998765444455667889999999999999999999986543
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999965 67776643 4788889999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 891 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~--------------- 891 (959)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 332 2233467899999999999999999999999999999999999999876643221111000
Q ss_pred -----cccc--------------------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 -----NRRL--------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 -----~~~~--------------------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.... ......+.++++||.+||+.||++||++.|++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0112246789999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.12 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=219.1
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|+||.||.++. ++..+++|.+............+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999998876 678899999877666666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+++++|.+++.+. ...+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 456899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.... ....+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHc
Confidence 45678999999999998888999999999999999999999999887777666554332 33445678899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.+|.+||++.+++.+
T Consensus 238 ~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 238 QQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccCcccCCCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=332.06 Aligned_cols=255 Identities=33% Similarity=0.575 Sum_probs=214.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++..++|++.++||+|+||.||+|++. ...||||++...... ...+.+|++++++++|+||+++++.+.. ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 456678999999999999999999874 357999988754432 3468899999999999999999998754 56789
Q ss_pred EEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.+. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999753 345788999999999999999999998 999999999999999999999999999765433
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. ......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHH
Confidence 221 123346678999999998889999999999999999999 8889988877666554432 2234456678899999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
||.+||+.||.+||++.++++.|+..
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.36 Aligned_cols=250 Identities=32% Similarity=0.534 Sum_probs=213.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||.|+||.||+|.+ +++.+++|++...... ....+.+|+.++++++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 47899999999999999999986 5678999998765332 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999776567999999999999999999999998 999999999999999999999999999876543333
Q ss_pred CCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---ccCCCCCCcHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---RLEIPKELDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~---~~~iP~~ls~eL~ 906 (959)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+.+....+..... ....+...+.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3456789999999999877 788999999999999999999999988776554433322211 1122334578899
Q ss_pred HHHHHHhhcCCCCCCCHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+||.+||..+|.+||++.+|+.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.33 Aligned_cols=251 Identities=29% Similarity=0.443 Sum_probs=207.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++||||+++++++...+.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999986 678899998865432 23346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999998754 46899999999999999999999998 999999999999999999999999999866433333
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc---CCCCCCcHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---EIPKELDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~---~iP~~ls~eL~ 906 (959)
.....|+..|+|||.+. ...++.++|||||||++|+|++|+.||....+.+....+....... ..+..++..++
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 34567899999999985 3447889999999999999999999997665543332221111111 11234678999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
+||.+||+.+|++||++.+|++.|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.87 Aligned_cols=258 Identities=32% Similarity=0.594 Sum_probs=214.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCce--EEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~--VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
+.+++|++.+.||+|+||.||+|.+ ++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 5678999999999999999999986 3443 567665432 2344556788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 002157 748 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~ 812 (959)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 999999999999999996432 25788899999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc
Q 002157 813 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (959)
Q Consensus 813 g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~ 891 (959)
+.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~- 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ- 238 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-
Confidence 99999999998643211 11222334668999999988889999999999999999998 9999988877666655432
Q ss_pred ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 892 ~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
......+..++.++.+||.+||+.+|.+||++.+++..|+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22344566788999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=335.12 Aligned_cols=257 Identities=26% Similarity=0.479 Sum_probs=214.3
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..++|++++.||+|+||+||+|.+ ++. .|++|++... .......++..|+.+++++.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 446899999999999999999987 444 4777776432 223345678889999999999999999998754 56
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
.++++||+++|+|.+++.+....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 78999999999999999876667899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 828 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 828 ~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
... .......++..|++||.+.+..++.++|||||||++|||++ |..||.+..+......+. .......+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHH
Confidence 321 11233456778999999998889999999999999999998 999999887765544442 33444556677889
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+.+++.+||..||.+||++.++++.|..+.+
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=335.83 Aligned_cols=260 Identities=30% Similarity=0.512 Sum_probs=215.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~ 743 (959)
+++..++|++.++||+|+||.||+|..+ +..||||.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3566789999999999999999999653 3479999875443 2233456788999999999999999999999
Q ss_pred cCCcEEEEEeccCCCCHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 744 RPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k~~---------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
.....++||||+++|+|.+++.+.. ..+....++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 9999999999999999999996421 23456778889999999999999998 999999999999999999
Q ss_pred EEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc
Q 002157 815 VKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (959)
Q Consensus 815 VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~ 891 (959)
+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875433211 1122345778999999999889999999999999999998 789998887776655543 2
Q ss_pred ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 892 ~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
......+..++..+++++.+||+.||.+||++.++++.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 3344556778899999999999999999999999998888653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=340.52 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=218.2
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+++.+++|.+.+.||+|+||.||++++ .+..||||++..... ......+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3556678899999999999999999974 234699998765432 33456788999999999 79999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
+...+.+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997533 34899999999999999999999998 999999999999999999999999
Q ss_pred CccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCC
Q 002157 821 GLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEI 897 (959)
Q Consensus 821 GlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~i 897 (959)
|+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...................
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99975533211 1223346788999999999999999999999999999998 99999887655444333333334455
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+...+.++.+|+.+||+.+|++||++.+|+..|+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 667889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=334.29 Aligned_cols=255 Identities=30% Similarity=0.483 Sum_probs=213.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++++++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45678999999999999999999874 3568888765432 334456788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEE
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVK 816 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g---~VK 816 (959)
...++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++ .+|
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 99999999999999999986543 25888999999999999999999998 99999999999998654 599
Q ss_pred EEecCccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc
Q 002157 817 VSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 893 (959)
Q Consensus 817 LiDFGlAk~~~~~~~~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~ 893 (959)
|+|||+++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999999865322111 112234568999999999889999999999999999996 999999877766655443 334
Q ss_pred ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 894 ~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
....|..++..+.+|+.+||+.+|++||++.+|+++|.
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 55667888999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=357.45 Aligned_cols=249 Identities=30% Similarity=0.468 Sum_probs=221.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LV 751 (959)
+.|++.+.||+|.||.||+++. +|+.+|+|++.+..... .....+.+|+.||+++. |||||+++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 5799999999999999999977 58899999998766533 24567899999999997 99999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC----CCcEEEEecCcccccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKH 827 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~----~g~VKLiDFGlAk~~~ 827 (959)
||+|.||.|++.+.+. .+++..+..++.||+.+++|||+.| |+||||||+|+|+.. ++.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999998765 3999999999999999999999999 999999999999953 3589999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLV 905 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~eL 905 (959)
. .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.........+....... .....++..+
T Consensus 191 ~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 191 P-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred C-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 6 455677899999999999999999999999999999999999999999999877777665544333 2335678999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++||+.||..||.+|+++.+++++
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhcC
Confidence 999999999999999999999983
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.11 Aligned_cols=243 Identities=22% Similarity=0.371 Sum_probs=204.3
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||.||+|+. +++.||||++...... ......+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999986 5678999998765332 33456688999999988 699999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988654 36899999999999999999999998 99999999999999999999999999875333223344577
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hH-HHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN------PM-QVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~------~~-ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... .. .....+ ......+|..++..+.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~ 235 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLSVKASHVLK 235 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999996421 11 222222 33456678889999999999
Q ss_pred HHhhcCCCCCCC------HHHHHHH
Q 002157 911 ECWQTDPSLRPS------FAQLTVA 929 (959)
Q Consensus 911 kCL~~DP~kRPS------a~EIL~~ 929 (959)
+||+.||.+|++ +.+++.+
T Consensus 236 ~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 236 GFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999997 4566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=331.04 Aligned_cols=255 Identities=32% Similarity=0.547 Sum_probs=216.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--C---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g---~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
..+|++.+.||+|+||.||+|.+. + ..||||++... .......+|..|+.++++++||||+++++++..+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 467899999999999999999763 2 35999987643 34555678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++++|.+++......+++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccc--CCC-C--CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 830 FLS--SKS-T--AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 830 ~~~--~~t-~--~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
... ... . ..+..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCH
Confidence 111 011 1 12457999999999899999999999999999886 999998887766665553 3334455677889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=336.62 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=212.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECC------------------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNG------------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g------------------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN 734 (959)
+.+++|+++++||+|+||.||+++... ..||+|++.... .......+.+|++++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCC
Confidence 356789999999999999999997532 458999876543 2345678899999999999999
Q ss_pred eeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~----------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
|+++++++..+..++++|||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLAT 158 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccch
Confidence 9999999999999999999999999999986543 26889999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 880 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt--G~~PF~g~~ 880 (959)
+|||++.++.++|+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ +..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999987643321 11233456788999999998889999999999999999997 778998776
Q ss_pred hHHHHhhhhcc------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 881 PMQVVGAVGFQ------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 881 ~~ql~~~i~~~------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
..+....+... ......+..++.++.+||.+||+.||.+||++.+|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 66554443211 1122334567789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.90 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=216.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCc---eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~---~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
|..++|+..+.||+|+||.||+|.. .+. .+|||++... ........+..|++++++++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 4456889999999999999999976 233 6899987543 233445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
.++||||+++++|.+++.+....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999776667899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCcccC---CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 828 NTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 828 ~~~~~~---~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
...... .....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.. ....+.+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCH
Confidence 322111 11223457999999998889999999999999999997 9999988777666665543 234445567889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
++.+|+.+||+.+|.+||++.+|++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.24 Aligned_cols=254 Identities=33% Similarity=0.539 Sum_probs=215.2
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
|.+.+|.+.++||+|+||.||+++. ++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 5678899999999999999999964 3457889976543 344556789999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~--------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~ 811 (959)
...+++|||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 99999999999999999986532 24788999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 002157 812 NWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 888 (959)
Q Consensus 812 ~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i 888 (959)
++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999987543221 11223345788999999999999999999999999999998 99999887776665554
Q ss_pred hccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 889 ~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
. .......+..+++.+.+||.+||+.||.+||++.+|++.|+
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 3 23345566788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=357.47 Aligned_cols=262 Identities=32% Similarity=0.489 Sum_probs=219.2
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~ 741 (959)
.+++..++|.++++||+|+||.||+|++.+ +.||||++..... ......+.+|+.+|.++. |||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 477888899999999999999999998643 5799999875432 233456889999999997 9999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-----------------------------------------------------
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~----------------------------------------------------- 768 (959)
+...+.+++||||+++|+|.+++++..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 769 --------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 769 --------------------------------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
..+++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp 267 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA 267 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence 12456677889999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
+|||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999998643221 12233457889999999999889999999999999999998 8899987665
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
.+..........+...|..++.++.+||.+||+.+|.+||++.+|+..|+.+.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 54433333334456677788999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.06 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=217.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g-----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
++..++|.+.++||+|+||.||+|.+.. ..||||...... .......+.+|+.+++++.|+||+++++++.+ .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3556789999999999999999997632 368899775432 24455678999999999999999999998876 4
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..++||||+++++|.+++.+....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 578999999999999999876667899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. ...+...+..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHH
Confidence 43321 1122334568999999998889999999999999999986 999998887766555443 33355667888999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+.+||.+||..+|.+||++.+++..|+.+..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=335.67 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=214.3
Q ss_pred CeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 677 DLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+|++.+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47788999999999999997632 458888776443 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 002157 750 IITEFLPRGSLFRILHRP-----------------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~-----------------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeN 806 (959)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999998532 124778889999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 002157 807 LLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 883 (959)
Q Consensus 807 ILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~q 883 (959)
||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999975432211 1223346778999999998889999999999999999998 999999888777
Q ss_pred HHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 884 l~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+...+.. ......+..++.++++|+.+||+.+|.+||++.+|+..|+++..
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 6655432 23445677889999999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=357.35 Aligned_cols=261 Identities=35% Similarity=0.525 Sum_probs=208.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-EEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~-l~LV 751 (959)
..++|.-..+||+|+||.||+|...+ +.||||++....... ..+|.+|+.+|.+++|||+|+|+|||.+.+. .+||
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 34677777889999999999998854 899999776544332 4569999999999999999999999999984 9999
Q ss_pred EeccCCCCHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC-CCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 752 TEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~-~lse~~~l~Ia~QIa~AL~yLHs~g-~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||+++|+|.++|+.... .++|..+++|+.++|+||+|||... ++|||||||+.|||||++++.||+|||+++.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999987665 8999999999999999999999954 47999999999999999999999999999765431
Q ss_pred cccCCCC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhh----hhc----cccccCC
Q 002157 830 FLSSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGA----VGF----QNRRLEI 897 (959)
Q Consensus 830 ~~~~~t~-~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---~~ql~~~----i~~----~~~~~~i 897 (959)
.....+. .||..|+|||.+..+..+.|+||||||++|.||++|+.+..... ...+..+ +.. ......+
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 1222222 89999999999999889999999999999999999998776432 1111211 100 0011111
Q ss_pred C-CCCc-----HHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 898 P-KELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 898 P-~~ls-----~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
. .... ..+..+..+|++.+|.+||++.||++.|+.+...
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 1 1222 2356778899999999999999999999666544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=360.81 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=200.3
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP----- 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~----- 745 (959)
....+|+++++||+|+||.||+|.+ +++.||||++.... ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3456899999999999999999987 67899999875432 1234799999999999999999876432
Q ss_pred ---CcEEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEE
Q 002157 746 ---PNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVS 818 (959)
Q Consensus 746 ---~~l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLi 818 (959)
..+++||||+++ +|.+++. +....+++..++.++.||+.||+|||+++ ||||||||+||||+.++ .+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 246799999975 6777664 33457899999999999999999999999 99999999999999664 79999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc------
Q 002157 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------ 891 (959)
Q Consensus 819 DFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~------ 891 (959)
|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+...
T Consensus 214 DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999865433 223456789999999998764 6899999999999999999999999987654433222110
Q ss_pred ---------------------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhh
Q 002157 892 ---------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPL 933 (959)
Q Consensus 892 ---------------------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l 933 (959)
.....+|...+.++++||.+||+.||.+||++.+++. +++.+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0011234567889999999999999999999999984 34443
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.63 Aligned_cols=254 Identities=33% Similarity=0.578 Sum_probs=213.1
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++..++|++.+.||+|+||.||++.+.+ ..+|+|++...... ...+.+|++++++++|+||+++++++.. +..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence 3455789999999999999999998744 57999987654322 3467889999999999999999998854 56889
Q ss_pred EEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||+.+++|.+++.+. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999999653 335788999999999999999999998 999999999999999999999999999765432
Q ss_pred cc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 FL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..++..+++
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHH
Confidence 21 1123346678999999998889999999999999999999 899999887766655543 22344566788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
|+.+||+.||.+||++++|++.|+.
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=325.63 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=215.7
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCcEEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIIT 752 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--~~~l~LVm 752 (959)
+|++.+.||.|+||.||++.+ ++..||+|++............+..|+.++++++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999976 67889999987766666667788999999999999999999998754 44588999
Q ss_pred eccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 753 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLH-----TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLH-----s~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
||+++++|.+++.+. ...+++..++.++.||+.||.||| ..+ |+||||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998643 457899999999999999999999 777 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.............++..|+|||++.+..++.++|+|+||+++|+|++|+.||...+...+...+.. .....++..++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccCHH
Confidence 765443323456789999999999998899999999999999999999999998876665555432 2334567788999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+.+|+.+||+.+|.+||++.+|+++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=352.42 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=205.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----cEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~-----~l~ 749 (959)
+|++++.||+|+||.||++.+ +++.||||++............+.+|+.+|+.++|+||+++++++.... .++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999986 6889999988654334445567889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 5788887654 46899999999999999999999998 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------
Q 002157 830 F-LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------- 891 (959)
Q Consensus 830 ~-~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~---------------- 891 (959)
. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.++.+....+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1 122345689999999999875 4789999999999999999999999887765443322100
Q ss_pred --------ccc------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 --------NRR------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 --------~~~------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
... ..+....+.++.+||.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 12234567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=347.46 Aligned_cols=262 Identities=31% Similarity=0.507 Sum_probs=213.7
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~ 742 (959)
++++.++|++++.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+|.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 456678999999999999999999974 35689999986543 233456788999999999 689999999987
Q ss_pred ecC-CcEEEEEeccCCCCHHHHhhCCC-----------------------------------------------------
Q 002157 743 TRP-PNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (959)
Q Consensus 743 ~~~-~~l~LVmEy~~gGsL~dlL~k~~----------------------------------------------------- 768 (959)
... ..+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46889999999999999986421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--ccC
Q 002157 769 -------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSS 833 (959)
Q Consensus 769 -------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~ 833 (959)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 13567788889999999999999998 9999999999999999999999999987643221 112
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................|...++++.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 23345678999999999899999999999999999996 89999876543333222233345566777889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHhhhh
Q 002157 913 WQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~Le~l~k 935 (959)
|+.||.+||++.+|+++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=334.08 Aligned_cols=256 Identities=31% Similarity=0.494 Sum_probs=215.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|++.+.||+|+||.||++.+ .+..||||++.... .......+.+|+.++++++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999976 35679999876432 344556788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH---------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~---------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
..+++||||+++++|.+++.... ..+++..++.++.||+.||.|||..+ ++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 99999999999999999986421 24678888999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
.|||++.++.+||+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987543221 11222345678999999999899999999999999999997 8889988887
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
.+....+.. ......+..++.++.+||.+||+.+|.+||++.||++.|++
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 776665542 22344567788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.61 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=218.6
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~- 744 (959)
.+..++|++.+.||+|+||.||+|.+. +..|++|++.. .........+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356789999999999999999999874 46788988753 3344556778899999999999999999998765
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~-------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKL 817 (959)
....++++||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 567899999999999999986532 35889999999999999999999998 999999999999999999999
Q ss_pred EecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccc
Q 002157 818 SDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR 894 (959)
Q Consensus 818 iDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~ 894 (959)
+|||+++....... ......++..|+|||++.+..++.++||||||+++|++++ |..||...++.++...+.. ...
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCC
Confidence 99999985432211 1122346778999999999889999999999999999998 9999998887776655432 233
Q ss_pred cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 895 ~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
...+..++.++++++.+||..||++||++.++++.|+.+.+.
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 444566789999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=332.38 Aligned_cols=250 Identities=27% Similarity=0.319 Sum_probs=204.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|+||.||+|++ ++..||||++............+.+|+.++++++||||+++++++..+..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 578899998875543333446778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 755 LPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 755 ~~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
+. ++|.+++.+.. ..+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 58888886432 56889999999999999999999998 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc--------------------
Q 002157 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------- 891 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-------------------- 891 (959)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3345678999999998764 4788999999999999999999999876543222111000
Q ss_pred -------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 -------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 -------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.........+++++++||.+||+.||.+||++.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123578899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.44 Aligned_cols=251 Identities=30% Similarity=0.471 Sum_probs=211.7
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+.+.|+++++||+|+||.||+|++ ++..|++|++... .......+.+|+.+++.++|+||+++++.+..+..+++|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 346799999999999999999987 5788999988654 244566788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++++|..++.+....+++..++.++.||+.+|.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999999999988765567899999999999999999999998 99999999999999999999999999876543333
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLV 905 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL 905 (959)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... .....+..++.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 3345668999999999853 346789999999999999999999998877655444332211 1223456778899
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||.+||..||++||++.++++
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhc
Confidence 99999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=334.52 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=198.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeeec-----CC
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR-----PP 746 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~~-----~~ 746 (959)
+|++.+.||+|+||+||+|++ +++.||||.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999987 578899998875433222223455677777665 79999999998764 34
Q ss_pred cEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+++||||+++ +|.+++.+.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58899999974 8888886533 35899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------c--c--
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------R--R-- 894 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-------~--~-- 894 (959)
.... .......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.... . .
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 5432 22234568999999999999889999999999999999999999998776554333221100 0 0
Q ss_pred --------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 --------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 --------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+...++.++++||.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111356788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.57 Aligned_cols=246 Identities=26% Similarity=0.463 Sum_probs=207.7
Q ss_pred EeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.||+|+||.||+|.+. +..||||++... ........+.+|+.++++++|+||+++++++.. ..+++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999763 446999987654 234455678999999999999999999998864 5789999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc---CCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 835 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~---~~t 835 (959)
+|.+++......+++..++.++.||+.||.|||.+| ++||||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999765567899999999999999999999998 999999999999999999999999999755332111 111
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+. ...+...|...+.++.+||.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 223578999999998889999999999999999996 999999887766655443 334566778889999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 002157 915 TDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 915 ~DP~kRPSa~EIL~~Le~l 933 (959)
.+|++||++.+|++.|+.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=347.00 Aligned_cols=252 Identities=25% Similarity=0.294 Sum_probs=214.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCcEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSI 750 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--~~~l~L 750 (959)
.++|+.+.+|++|+||.||+|++ +++.||+|+++......-....-+|||.+|.+++|||||.+.+++.. -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 47899999999999999999976 67889999998765444344566899999999999999999998754 356999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|||||+. +|..++.....++...+...++.|+++||+|||.+. |+|||||+.|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999975 899999888788999999999999999999999999 9999999999999999999999999999998887
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc----------------
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------------- 893 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~---------------- 893 (959)
...+..+-|.||.|||.+.|.+ |++++|+||+|||+.||+.+.+.|.|......+..|.....
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 7777788999999999999865 99999999999999999999999999877655444321000
Q ss_pred -------------ccCCCCC-CcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 -------------RLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 -------------~~~iP~~-ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+..++.. ++..-.+|+..+|..||.+|.|+.+.|.+
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0011111 56778999999999999999999998764
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.87 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=217.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||+|+||.||+++. +++.||||.+...........++.+|+.++++++|+||+++++++...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999976 678999999876555555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+.+++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999998653 345788999999999999999999998 9999999999999999999999999998665433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.. ......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHHHHh
Confidence 345688999999999998899999999999999999999999988777766655533 3344567788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.+|.+||++.+|+.+
T Consensus 238 ~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 238 KRNPRDRPSVNSILEK 253 (256)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.52 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=210.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECC----------------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNG----------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g----------------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI 735 (959)
+++..+|++.++||+|+||.||++++.+ ..||||++... ........+.+|++++++++|+||
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CCchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3566789999999999999999996532 24899987654 334455678999999999999999
Q ss_pred eEEeeeeecCCcEEEEEeccCCCCHHHHhhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~-----------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
+++++++......++||||+++++|.+++.... ..+.+..++.++.||+.||.|||+++ ++||||||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp 157 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLAT 157 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccCh
Confidence 999999999999999999999999999985432 13678888999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 880 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt--G~~PF~g~~ 880 (959)
+|||++.++.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ +..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999999987643321 11222345778999999998889999999999999999988 678898876
Q ss_pred hHHHHhhhhc------cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 881 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 881 ~~ql~~~i~~------~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
..+....+.. .......+..++..+++||.+||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6554433211 11123345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.02 Aligned_cols=247 Identities=30% Similarity=0.516 Sum_probs=209.1
Q ss_pred eEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
++||+|+||.||+|.+. +..||+|.+...... .....+.+|+++++.+.|+||+++++++. ...+++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999762 257999988765443 45567889999999999999999999876 456899999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc---C
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---S 833 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~---~ 833 (959)
+++|.+++.+.. .+++..++.++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997654 7899999999999999999999998 999999999999999999999999999865433211 1
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .......|..++..+++||.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 11223567999999999889999999999999999997 999998887766665553 3345567778899999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHhhh
Q 002157 913 WQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~Le~l~ 934 (959)
|+.+|.+||++.+|++.|+.+.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=377.55 Aligned_cols=264 Identities=32% Similarity=0.572 Sum_probs=231.0
Q ss_pred ccccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEee
Q 002157 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740 (959)
Q Consensus 668 ~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g 740 (959)
....+|+..+.++.+.||+|+||+||+|+.. ...||||.++... ..+...+|++|+.+|..|+|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3445678888999999999999999999752 3469999876543 4557889999999999999999999999
Q ss_pred eeecCCcEEEEEeccCCCCHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcE
Q 002157 741 AVTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 807 (959)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~k~-------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNI 807 (959)
+|..++.++||+|||..|+|.+||... ...++..+.+.||.||+.||.||-++. +|||||-.+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 999999999999999999999999521 123788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCccccccCC-ccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 002157 808 LVDKNWNVKVSDFGLSRLKHNT-FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQV 884 (959)
Q Consensus 808 LLd~~g~VKLiDFGlAk~~~~~-~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql 884 (959)
||.++..|||+|||+++.+-.. ++. .....-..+|||||.|..++|+.++||||+||+|||+++ |..||.+....++
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 9999999999999999864322 222 112334679999999999999999999999999999997 8899999999999
Q ss_pred HhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 885 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 885 ~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
...+..+.. +..|..++.++..|+..||+.+|.+||+|++|-..|+...+
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 988876655 89999999999999999999999999999999999987755
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=382.58 Aligned_cols=280 Identities=29% Similarity=0.501 Sum_probs=242.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE---CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW---NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~---~g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
++++..++.+.||+|.||.||.|.. .+. .||||.+.. ..+.+.+.+|.+|..+|+.++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 5578899999999999999999976 232 388887654 34567788999999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 002157 746 PNLSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiD 819 (959)
...+|++|||.+|+|..||++. ...+.....+.|+.||++|++||++++ +|||||-.+||||+....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999876 567889999999999999999999998 99999999999999999999999
Q ss_pred cCccccccC-CcccCCCC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccC
Q 002157 820 FGLSRLKHN-TFLSSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 896 (959)
Q Consensus 820 FGlAk~~~~-~~~~~~t~-~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~ 896 (959)
||+|+.+.. .++..... .-...|||||.+....++.|+|||||||++||+++ |..||.+.+..++......+. +++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence 999994332 22222222 23458999999999999999999999999999998 889999999988887555444 999
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCCCCCCCCCCC
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVN 956 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~~~~~~p~~~~~~ 956 (959)
.|..++..+.++|.+||+.+|++||+|..|++++..+.....+.+--+.+..++....+.
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~~~~~~~~ 984 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADYESVSIRP 984 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccccCcccccC
Confidence 999999999999999999999999999999999999988887777666666666544433
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.17 Aligned_cols=256 Identities=31% Similarity=0.567 Sum_probs=216.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+++..++|++.+.||+|+||.||++.+ .+..+|+|.+... ......+.+|+.++++++|+||+++++.+.+ ..++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 356778999999999999999999986 4567999987643 2234678899999999999999999999887 7789
Q ss_pred EEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++|||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999999753 446788889999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 829 TFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 829 ~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.......+. .......+...+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 221 1222345678999999998889999999999999999998 999999887766655443 2334455667889999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+++.+||+.+|.+||++.+++..|+.+
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=346.99 Aligned_cols=248 Identities=24% Similarity=0.313 Sum_probs=202.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~ 746 (959)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999976 578899999876554455566788999999999999999999988644 3
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999965 67777753 4788889999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 891 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~--------------- 891 (959)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 433 2234567999999999999999999999999999999999999999887643322111000
Q ss_pred ------c----c---------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 ------N----R---------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 ------~----~---------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. . ....+...+.++++||.+||+.||.+||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0 001112245678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.99 Aligned_cols=245 Identities=21% Similarity=0.287 Sum_probs=199.4
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||+|+||.||+++. +++.||+|++....... .....+..|++++++++||||+++++++.....+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 58899999986543322 2233456799999999999999999999999999999999999999
Q ss_pred HHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCC
Q 002157 761 FRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839 (959)
Q Consensus 761 ~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT 839 (959)
.+++... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9887543 345888999999999999999999998 9999999999999999999999999987654332 22345689
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCcHHHHHHHHHHhhc
Q 002157 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (959)
Q Consensus 840 ~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~ 915 (959)
..|+|||++.+..++.++|||||||++|+|++|+.||...... ++........ .......++.++++||.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-cccccccCCHHHHHHHHHHhcc
Confidence 9999999999988999999999999999999999999765432 2222221111 1112246789999999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 002157 916 DPSLRPSFAQLTVALKP 932 (959)
Q Consensus 916 DP~kRPSa~EIL~~Le~ 932 (959)
||.+||+++++++.+..
T Consensus 237 ~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 237 KPEDRLGSREKNDDPRK 253 (277)
T ss_pred CHhhCCCCccchhhhhc
Confidence 99999999776654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.07 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=203.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~ 746 (959)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999976 578899999876544444556788999999999999999999987543 3
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999965 77777753 4788889999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------- 893 (959)
... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 177 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 443 223446799999999999999999999999999999999999999988766543332211000
Q ss_pred -------c--------------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 -------R--------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 -------~--------------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. .......+.++++||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.66 Aligned_cols=240 Identities=25% Similarity=0.406 Sum_probs=201.3
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc---CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
||+|+||+||+|++ +++.||||++..... .......+..|..++.++ +||||+++++++.....+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 578999999865432 222334456677777765 699999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999998764 46899999999999999999999999 99999999999999999999999999876433333344577
Q ss_pred CCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC-CCcHHHHHHHHHHhhc
Q 002157 838 GTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARIIWECWQT 915 (959)
Q Consensus 838 GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~-~ls~eL~dLI~kCL~~ 915 (959)
||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.... ..+|. .++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCC
Confidence 99999999999765 47899999999999999999999999988777766664433 33343 5789999999999999
Q ss_pred CCCCCC----CHHHHHH
Q 002157 916 DPSLRP----SFAQLTV 928 (959)
Q Consensus 916 DP~kRP----Sa~EIL~ 928 (959)
||.+|| ++.++++
T Consensus 236 ~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 236 NPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHCCCCCCCHHHHhc
Confidence 999998 5677665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.19 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=210.2
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC------------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~------------------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN 734 (959)
+..++|++.+.||+|+||.||++++. +..||||++.... .......+.+|+.+++.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999998542 2358999876442 3445568899999999999999
Q ss_pred eeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~----------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
|+++++++...+..++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 9999999999999999999999999999986532 23667789999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 880 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt--G~~PF~g~~ 880 (959)
+|||++.++.++|+|||+++....... ......++..|++||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999976533211 1122344678999999988889999999999999999998 778998776
Q ss_pred hHHHHhhhhc------cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 881 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 881 ~~ql~~~i~~------~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
..+....... .......+..++..+++|+.+||+.||.+||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6554432210 111233455678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.76 Aligned_cols=265 Identities=31% Similarity=0.526 Sum_probs=221.5
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
.++++...+|++++.||+|+||.||+|++. ...||+|++... ........+.+|+.+++++ +|+||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 446667778999999999999999999752 236899977643 3344566888999999999 89999999
Q ss_pred eeeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 002157 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (959)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLK 803 (959)
++++...+.++++|||+++|+|.+++.+.. ..+.+..++.++.||+.||.|||.+| |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 999999999999999999999999986532 24677888999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002157 804 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (959)
Q Consensus 804 PeNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 880 (959)
|+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999976543221 1122334567999999999999999999999999999998 889999888
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 881 ~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
..+....+. .......+..++.++.+||.+||+.+|.+||++.+|+..|+.+....
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 777665553 23344566778899999999999999999999999999999887533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.14 Aligned_cols=251 Identities=33% Similarity=0.550 Sum_probs=214.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
...+|++.+.||+|+||.||++.+. +..+|||++...... ...+.+|++++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 3468999999999999999999874 788999987654433 246788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+.+++|.+++......+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999999999766567889999999999999999999998 99999999999999999999999999876543211
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... .....|...+.++.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHH
Confidence 1122335678999999998889999999999999999998 99999887776666555322 234456667899999999
Q ss_pred HHhhcCCCCCCCHHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~L 930 (959)
+||+.+|++||++.++++.|
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcccChhhCCCHHHHHHhh
Confidence 99999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.19 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=205.1
Q ss_pred eeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEE
Q 002157 678 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~ 749 (959)
|++.+.||+|+||+||++.+ .+..||+|.+.... .......+.+|+++|++++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48999999999999988753 46689999886543 233456788999999999999999999987654 3588
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++++|.+++.+. .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999999763 5899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--H------------Hhhhhccc
Q 002157 830 FLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--V------------VGAVGFQN 892 (959)
Q Consensus 830 ~~~---~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q--l------------~~~i~~~~ 892 (959)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... . ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 122345667999999998889999999999999999999999986533210 0 00011112
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
.....+..++.++++|+.+||+.+|.+||++++|++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 233456678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.00 Aligned_cols=246 Identities=32% Similarity=0.578 Sum_probs=209.0
Q ss_pred eEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 682 k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
+.||+|+||.||+|.. ++..||+|++.... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3589999999999976 56789999876443 344455788999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC-CCCCCC
Q 002157 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAGT 839 (959)
Q Consensus 761 ~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~-~t~~GT 839 (959)
.+++......+.+..++.++.|++.+|.|||.+| ++||||||+||+++.++.+||+|||++.......... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9999766567889999999999999999999998 9999999999999999999999999987544322211 122345
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCC
Q 002157 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918 (959)
Q Consensus 840 ~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~ 918 (959)
..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+. ...+...+..++..+.+|+.+||+.+|+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999998889999999999999999998 999998887766555443 2334456677899999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 002157 919 LRPSFAQLTVALK 931 (959)
Q Consensus 919 kRPSa~EIL~~Le 931 (959)
+||++.++++.|+
T Consensus 237 ~Rp~~~~l~~~l~ 249 (250)
T cd05085 237 NRPKFSELQKELA 249 (250)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.03 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=202.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||+|+||.||+|++ +|+.||+|++............+.+|+.++++++|+||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488999999999999999987 688999999875443333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+. ++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 5788887665567999999999999999999999998 99999999999999999999999999986544333334
Q ss_pred CCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhc------------------cccc
Q 002157 835 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGF------------------QNRR 894 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ql~~~i~~------------------~~~~ 894 (959)
...++..|+|||++.+.. ++.++|||||||++|+|++|..||.. .+..+....+.. ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456889999999987754 78999999999999999999888543 332222211100 0000
Q ss_pred ---------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 ---------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ---------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
......++.++++||.+||+.||.+|||+++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0112346789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.05 Aligned_cols=248 Identities=28% Similarity=0.437 Sum_probs=206.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC------C
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP------P 746 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~------~ 746 (959)
+.|++.+.||+|+||.||+|.+ .++.||||++..... ....+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5688889999999999999977 577899998865432 234678899999998 799999999998653 4
Q ss_pred cEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 588999999999999998763 346889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
............|+..|+|||++. +..++.++|||||||++|+|++|..||....+......+.........+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 544333344567999999999986 335788999999999999999999999876665444433322223334456
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++.++++||.+||..||.+||++.+++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 7889999999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.45 Aligned_cols=251 Identities=30% Similarity=0.472 Sum_probs=214.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||.|+||.||++.+ ++..||+|++... .......+.+|+.++++++|+||+++++++.....+++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 36799999999999999999987 5788999988643 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+.+..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999876667999999999999999999999999 999999999999999999999999998765444333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~ 906 (959)
.....++..|++||++. +..++.++|+||||+++|+|++|..||...+..+....+.... .....+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34567899999999985 3446789999999999999999999998887766554443221 12334567889999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+||.+||+.+|.+||++.+++..
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.53 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=209.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..++|++.+.||.|+||.||+|++ +++.||+|.+...... .....+.+|+.++++++|+||+++++++.....+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 357899999999999999999976 5788999988654322 1234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||++ ++|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99996 5899988776667889999999999999999999998 99999999999999999999999999976543333
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------------cc
Q 002157 832 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-----------------NR 893 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-----------------~~ 893 (959)
......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 33345678999999998764 4788999999999999999999999887654433221100 00
Q ss_pred ccCC-----------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhh
Q 002157 894 RLEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQ 934 (959)
Q Consensus 894 ~~~i-----------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~ 934 (959)
...+ ...++.++++||.+||+.||.+||++.+++. +++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0111 1356889999999999999999999999987 454443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.34 Aligned_cols=248 Identities=30% Similarity=0.498 Sum_probs=213.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||.|+||.||++.+. +..|++|.+..... ...+.+|++++++++|+||+++++++.....+++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 367999999999999999999874 68899998764421 568899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999999999776678999999999999999999999998 999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.+....+.. .......+..++.++.+||.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 3445688999999999999999999999999999999999999988766544333221 112233445678899999999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||+.||.+||++.+|+.
T Consensus 236 ~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 236 CLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhcChhhCcCHHHHhc
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.36 Aligned_cols=258 Identities=28% Similarity=0.506 Sum_probs=219.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+...+|++.+.||+|+||.||+|.+ ++. .||+|++..... ......+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 3457899999999999999999976 232 589997765433 4455678899999999999999999999887 7
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..++||||+++|+|.+++.+....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 889999999999999999876667999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
...... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+....++...+. .......|...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 432211 111223568999999988889999999999999999998 999999988777665554 3345566677889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+.+++.+||..||.+||++.++++.|+.+.+
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.82 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=209.1
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
|++.+.||+|+||+||++.+ +++.||+|++....... .....+.+|+++|++++|+||+++++++..++.+++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 77889999999999999987 57889999987654332 2344578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCC-Ccc
Confidence 9999999888643 346899999999999999999999998 999999999999999999999999998764322 222
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCCCCCcHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~--~~~~~~~iP~~ls~eL~dLI~k 911 (959)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+. .......++..++.++.+|+.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 34579999999999999899999999999999999999999998876543322221 1222344567788999999999
Q ss_pred HhhcCCCCCCC-----HHHHHHH
Q 002157 912 CWQTDPSLRPS-----FAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPS-----a~EIL~~ 929 (959)
||+.||.+||+ +.+++.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 99999999999 7777774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.63 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=205.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||++++ +++.||+|++............+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999987 57899999887543333334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|++++.|..++.+. ..+++..++.++.||+.+|.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99998888777553 46899999999999999999999998 9999999999999999999999999998765443233
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------------c
Q 002157 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------R 893 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-------------------~ 893 (959)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+.... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999999876 457889999999999999999999998876543332211000 0
Q ss_pred ccCC----------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 RLEI----------PKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 ~~~i----------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.... -..++..+.+||.+||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 1245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=321.85 Aligned_cols=246 Identities=32% Similarity=0.573 Sum_probs=209.9
Q ss_pred eEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
++||+|+||.||++.+. ++.||+|++...... .....+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999874 789999987665433 4556789999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC--CCCCC
Q 002157 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAG 838 (959)
Q Consensus 761 ~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~--~t~~G 838 (959)
.+++.+....+++..++.++.+++.+|.|||+++ |+||||||+|||++.++.+||+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999766567889999999999999999999998 9999999999999999999999999997654221111 12233
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 839 T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. ......+..++.++.+|+.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999998 8899988876655554432 23445667889999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002157 918 SLRPSFAQLTVALK 931 (959)
Q Consensus 918 ~kRPSa~EIL~~Le 931 (959)
.+||++.+|++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=329.97 Aligned_cols=250 Identities=30% Similarity=0.469 Sum_probs=207.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.+++.++||||+++++.+...+.+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788999999999999999987 578899998865432 23456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++...+ .+++..++.++.||+.||.|||.+| |+|+||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999987643 7899999999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-CC--CCCCcHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EI--PKELDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~-~i--P~~ls~eL~ 906 (959)
.....|+..|+|||++. ...++.++|+|||||++|+|++|..||....+.............. .. ...++..++
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34567999999999985 4557889999999999999999999997766544332221111111 11 124678899
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+||.+||..+|++||++.+|+++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.44 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=205.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--~~~ 747 (959)
.+|++.+.||+|+||.||++.+ ++..||||++.... ......+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999974 46789999876442 3445678899999999999999999998644 346
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999765557899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---------------Hhhhh
Q 002157 828 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV---------------VGAVG 889 (959)
Q Consensus 828 ~~~~~---~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql---------------~~~i~ 889 (959)
..... .....++..|+|||++.+..++.++||||||+++|||++|..++........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 32111 1112234569999999998899999999999999999998777543321100 00111
Q ss_pred ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 890 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 890 ~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
........+..++.++.+||.+||..+|++||++.+|+..|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 12223345567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.02 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=211.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||+|.. +++.||||.+....... .....+.+|++++++++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999987 47899999988765443 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002157 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~- 830 (959)
||+.+++|.+++.+. ...+++..++.++.||+.||.|||..| |+||||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998753 356899999999999999999999998 9999999999999999999999999987542211
Q ss_pred ----------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 002157 831 ----------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 882 (959)
Q Consensus 831 ----------------------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ 882 (959)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346899999999999988999999999999999999999999888776
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCC----HHHHHH
Q 002157 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS----FAQLTV 928 (959)
Q Consensus 883 ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPS----a~EIL~ 928 (959)
.....+............++.++++||.+||..||++||+ +.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 5555443222222222236899999999999999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.82 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=207.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-----CCcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-----~~~l 748 (959)
..|..++.||+|+||.|+.+.+ +|+.||||++..........++..+|+++|++++|+||+.+++.+.- -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455689999999999999976 78999999987655555567788999999999999999999998865 3459
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|+|+|+| +.+|..+++.+ ..+++.....+++||++||.|+|+.+ |+||||||.|+|++.+..+||||||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 66999999764 35999999999999999999999999 99999999999999999999999999998743
Q ss_pred --CcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---------------
Q 002157 829 --TFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 890 (959)
Q Consensus 829 --~~~~~~t~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~--------------- 890 (959)
.....+..+.|.||.|||++. ...|+.++||||+||||.||++|++-|.|.+....+..+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 122345678999999999875 56799999999999999999999999999765433322210
Q ss_pred ---------cccccC-----CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 891 ---------QNRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 891 ---------~~~~~~-----iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...... +-++.+++..+|+.+||..||.+|+|++|.+.+
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000111 113678999999999999999999999999875
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.13 Aligned_cols=249 Identities=26% Similarity=0.466 Sum_probs=215.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||+|+||.||++.. ++..||||.+............+.+|+.++++++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999976 678899999887665556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCccccccCCccc
Q 002157 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 755 ~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk~~~~~~~~ 832 (959)
+++++|.+++.+. ...+++..+..++.+++.+|+|||+++ |+||||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 345899999999999999999999998 9999999999999855 468999999998765432 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .....++..++.++++||.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHH
Confidence 2345688999999999988889999999999999999999999988877665554432 234456677899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|+.+|.+||++.+++.+
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.46 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=213.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||.|+||.||+|.+ +++.||+|++.... .......+.+|+++++.++|+||+++++++.++..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4688899999999999999986 57889999886543 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999764 7899999999999999999999998 9999999999999999999999999998765443334
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC-CcHHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWEC 912 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~-ls~eL~dLI~kC 912 (959)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...++.+....+... ....++.. ++.++.++|.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence 4567899999999999988999999999999999999999999887766555444322 23333444 788999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTV 928 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~ 928 (959)
|..+|.+||++++++.
T Consensus 235 l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 235 LNKDPKERPSAKELLK 250 (274)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.25 Aligned_cols=248 Identities=34% Similarity=0.585 Sum_probs=211.5
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
..++|++.+.||+|+||.||++...++.||+|++.... ....+.+|+.++++++||||+++++++... .+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 44679999999999999999999999999999875432 234678999999999999999999998765 4789999
Q ss_pred ccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++++|.+++.... ..+++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999997543 35889999999999999999999998 999999999999999999999999998764322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.. ......+..++..+++|+.+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHH
Confidence 122334678999999998889999999999999999997 9999998877666555432 23344556788999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHh
Q 002157 912 CWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~Le~ 932 (959)
||+.+|.+||++.+|+..|+.
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.02 Aligned_cols=246 Identities=32% Similarity=0.561 Sum_probs=211.0
Q ss_pred eEeeccCcEEEEEEEEC---Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 682 ERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~---g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
++||+|+||.||+|.+. ++ .||||.+...... .....+.+|+.++++++|+||+++++++.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 36899999999999863 22 5899988766544 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc---c
Q 002157 757 RGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---S 832 (959)
Q Consensus 757 gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~---~ 832 (959)
+++|.+++.+.. ..+++..++.++.|++.||+|||.++ ++||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997654 56899999999999999999999998 99999999999999999999999999987643211 1
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.+|+.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 123457788999999999899999999999999999998 9999988877776665544444555667788999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~Le 931 (959)
||+.+|.+||++.+|++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.22 Aligned_cols=245 Identities=22% Similarity=0.261 Sum_probs=198.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
.+...+|+++++||+|+||.||+|.+ +++.||||+.. ...+.+|+++|++++|||||+++++|......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 35567899999999999999999977 67889999642 224678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+|||++. ++|..++... ..+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9999995 6898888654 46889999999999999999999998 999999999999999999999999999754322
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhh------------
Q 002157 830 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVG------------ 889 (959)
Q Consensus 830 -~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-------~ql~~~i~------------ 889 (959)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1223356799999999999999999999999999999999999988754321 00000000
Q ss_pred --------------cc--ccccCCC-----CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 890 --------------FQ--NRRLEIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 890 --------------~~--~~~~~iP-----~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.. ......+ ..++.++.+||.+||+.||.+||+++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000001 134678999999999999999999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.38 Aligned_cols=248 Identities=30% Similarity=0.513 Sum_probs=210.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-------~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+|.+++.||+|+||.||+|.+ +++.||+|.+...... ......+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 5788999988654322 1233568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||+|+|||++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999764 46888899999999999999999998 9999999999999999999999999988664
Q ss_pred CCc------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 828 NTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 828 ~~~------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
... .......|+..|+|||.+.+..++.++|+|+|||++|+|++|+.||.+.+.......+. ......+|..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCccc
Confidence 211 11123458899999999999889999999999999999999999998876654443332 23345667788
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+..++++|.+||+.||.+||++.+|++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 999999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.26 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=209.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|++.+.||+|+||.||++.+ +++.||||.+...... ......+.+|+.++++++|+||+++++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999987 5789999988754332 2234557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999988543 345889999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhhccccccCCCCCCcHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---l~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ...... ......++..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 234579999999999999999999999999999999999999998754321 111111 1223345677899999999
Q ss_pred HHHhhcCCCCCCC-----HHHHHH--HHHh
Q 002157 910 WECWQTDPSLRPS-----FAQLTV--ALKP 932 (959)
Q Consensus 910 ~kCL~~DP~kRPS-----a~EIL~--~Le~ 932 (959)
.+||+.||.+||+ +++++. +++.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 889887 4443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.68 Aligned_cols=249 Identities=30% Similarity=0.514 Sum_probs=204.7
Q ss_pred eEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee-cCCcEEEEEecc
Q 002157 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLSIITEFL 755 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~-~~~~l~LVmEy~ 755 (959)
+.||+|+||.||+|.+. ...||||.+.... .......+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999752 3469999875322 2334567889999999999999999999765 455688999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc----c
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----L 831 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~----~ 831 (959)
.+++|.+++.+....+.+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999776556778888899999999999999998 9999999999999999999999999997543221 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......++..|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. .......+..++..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 11234467789999999988899999999999999999995 66787777665554442 33345556678899999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 911 ECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+||+.+|++||++.+|+..|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.08 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=216.1
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|++.+.||.|+||.||+|+.. ...|++|.+.... .......+.+|++++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34578999999999999999999852 3568999765432 233566789999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 002157 746 PNLSIITEFLPRGSLFRILHRPH--------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~--------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKL 817 (959)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 99999999999999999997543 15889999999999999999999998 999999999999999999999
Q ss_pred EecCccccccCC-cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccccc
Q 002157 818 SDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 895 (959)
Q Consensus 818 iDFGlAk~~~~~-~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~ 895 (959)
+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 999998754321 122234456778999999988888999999999999999998 889998877776666655444445
Q ss_pred CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 896 ~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
..+..++..+.++|.+||+.+|.+||++.+++..|.
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.81 Aligned_cols=243 Identities=28% Similarity=0.396 Sum_probs=203.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.++||+|+||.||+|.+ ++..||||++.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999976 67889999886543 33445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+++++|..+. .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999987653 4678888899999999999999999 999999999999999999999999999765433 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-------HHHhhhhccccccCC-CCCCcHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQNRRLEI-PKELDPLV 905 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-------ql~~~i~~~~~~~~i-P~~ls~eL 905 (959)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||...... .....+.. ...... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cCCCCCCCCcCCHHH
Confidence 3467999999999999999999999999999999999999999653321 12222111 112222 23578899
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++||.+||+.+|.+||++++++++
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=329.14 Aligned_cols=248 Identities=29% Similarity=0.453 Sum_probs=209.1
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|++.+.||+|+||.||++.+ ++..+++|.+.... ......+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 67889999999999999987 45678888875432 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
++++|..++.+....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 999999988765567899999999999999999999998 999999999999999999999999998765443333345
Q ss_pred CCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHH
Q 002157 836 TAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARII 909 (959)
Q Consensus 836 ~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~eL~dLI 909 (959)
..++..|+|||++. +..++.++|||||||++|+|++|..||...+..+....+... ......|..++.++++||
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 67899999999984 445788999999999999999999999887766554444222 122345567889999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||+.||.+||++.+++.+
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.22 Aligned_cols=245 Identities=26% Similarity=0.456 Sum_probs=214.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||++.+ +++.||||++..... .......+.+|++++++++||||+++++.+.....+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999987 578999999875433 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+.| |+||||+|.||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999765 47899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+. .....+|..++..++++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 234578999999999988888999999999999999999999998877665555543 335667888899999999999
Q ss_pred hhcCCCCCC-----CHHHHHH
Q 002157 913 WQTDPSLRP-----SFAQLTV 928 (959)
Q Consensus 913 L~~DP~kRP-----Sa~EIL~ 928 (959)
|..||.+|+ ++++++.
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHccCcccCCHHHHHc
Confidence 999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.67 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=211.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
..+|++.+.||+|+||.||++.. ++..||+|.+...... ....+.+|+.+++.++|+||+++++.|.....+++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 36899999999999999999976 6789999988765433 2456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. .+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999999999653 5788999999999999999999998 999999999999999999999999998765433222
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-ccccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~-~~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+. ........+..++..+.+||.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 334578999999999999889999999999999999999999998876643332221 1222334466788999999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||..+|++||++.+|+..
T Consensus 253 ~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 253 CLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HCcCCcccCcCHHHHhhC
Confidence 999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=323.05 Aligned_cols=249 Identities=31% Similarity=0.470 Sum_probs=209.5
Q ss_pred CeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCC----CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF----SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~----~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+|++.+.||+|+||.||+|.. +++.+|||.+..... .......+.+|+.++++++|+||+++++++.+...+++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 678899998765432 123345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC--
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 829 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~-- 829 (959)
|||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999764 36789999999999999999999998 999999999999999999999999998754211
Q ss_pred ----cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHH
Q 002157 830 ----FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPL 904 (959)
Q Consensus 830 ----~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~e 904 (959)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... .....++..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122456899999999999988999999999999999999999999876655433333222 2234567788999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+.+||.+||+.+|.+||++.+++.
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.61 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=207.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.++||+|+||.||++.+ ++..||+|.+... ........+.+|++++++++||||+++++.|..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4799999999999999999987 5677898887643 334456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++++|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999765 468899999999999999999997 57 9999999999999999999999999987654322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------------
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------------- 891 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~--------------------- 891 (959)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 23467899999999999888999999999999999999999999765543332221100
Q ss_pred --------------ccccCCCC-CCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 --------------NRRLEIPK-ELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 --------------~~~~~iP~-~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...+..|. .++.++++||.+||..+|++||++.+|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111221 367889999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.91 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=220.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+.|++-++||+|.|+.||++.+ +|+.+|+|++....+.....+++.+|++|.+.|+|||||+|.+.+......|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5688888999999999999965 78899999887777766677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlAk~~~~~~ 830 (959)
++.|++|..-|-++ ...++..+-.+++||+.+|.|+|.++ |||||+||+|+|+- ..--+||+|||++.... ..
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 99999997755433 46788888889999999999999999 99999999999994 44569999999999887 44
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~eL~dL 908 (959)
.....++|||.|||||++...+|++.+|||+-|+|||-|+.|++||.+.+...+++.|....... ..+.+++++.++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 56678899999999999999999999999999999999999999999988888888886544333 3446889999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|++||..||.+|.|+.|.|.
T Consensus 247 vrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHhccChhhhccHHHHhC
Confidence 99999999999999987653
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.00 Aligned_cols=248 Identities=34% Similarity=0.534 Sum_probs=213.5
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~---~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+|++.+.||+|+||.||+|.. ++..|++|.+..... .......+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 466778999999999999976 588999998865432 234566789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999765 36889999999999999999999998 9999999999999999999999999987654332
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......|+..|++||.+.... ++.++|+||||+++|+|++|..||......+....+........++..+++++++|+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 234566899999999998776 8999999999999999999999998877655544444334455677788999999999
Q ss_pred HHhhcCCCCCCCHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~ 928 (959)
+||+.+|.+||++.+++.
T Consensus 237 ~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 237 KCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhhcCcccCcCHHHHhc
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=331.63 Aligned_cols=260 Identities=28% Similarity=0.528 Sum_probs=215.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+..++|++.+.||+|+||.||+|.+ ++. .||+|.+.... ......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3457889999999999999999976 343 47888775433 233445788999999999999999999998754
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..++++||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 567999999999999999876667899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTI 238 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 43221 1223445778999999999999999999999999999997 999998876655544443 3334455667889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
.+.+++.+||..+|++||++.+++..|+.+.+..
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 9999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.13 Aligned_cols=249 Identities=38% Similarity=0.662 Sum_probs=211.8
Q ss_pred eeEEeEeeccCcEEEEEEEECC------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+++.+.||.|+||.||++++.. ..||+|++.... .......+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999998753 779999885443 222556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~-lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|||+++++|.+++...... +++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999765434 899999999999999999999998 9999999999999999999999999998665431
Q ss_pred ccC-CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 831 LSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~-~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
... ....++..|+|||.+.+..++.++|||+||+++|+|++ |..||...+.......+.. ......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHH
Confidence 111 12336789999999988889999999999999999998 8899988777666655543 33455667789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~L 930 (959)
+.+||+.||.+||++.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.20 Aligned_cols=249 Identities=30% Similarity=0.491 Sum_probs=208.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~---~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l 748 (959)
.+|++.+.||+|+||.||++.+ ++..||||++..... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999986 578899998764321 223456788999999999999999999998764 458
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+++|||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998754 35788889999999999999999998 99999999999999999999999999875432
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 ~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+........+|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 11 112335688999999999988899999999999999999999999988765555444443444555677888999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.++|.+||. +|.+||++.+|+.
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhc
Confidence 999999994 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=344.29 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=199.6
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
...+|++++.||+|+||.||++... +..||||.+.... .+.+|+++|++++|||||+++++|.....++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3467999999999999999999753 4679999875432 3458999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+|||++. ++|.+++.+ ...+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 163 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999995 689888844 357899999999999999999999998 999999999999999999999999999765433
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhh--cc-----------
Q 002157 830 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVG--FQ----------- 891 (959)
Q Consensus 830 ~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---l~~~i~--~~----------- 891 (959)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+. .+
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 21 2234679999999999999999999999999999999999999997754311 000000 00
Q ss_pred --------------ccccCCC-----CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 --------------NRRLEIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 --------------~~~~~iP-----~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
......| ..++.++++||.+||..||++||++.+++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001111 2346789999999999999999999999875
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.75 Aligned_cols=247 Identities=32% Similarity=0.585 Sum_probs=204.9
Q ss_pred EeeccCcEEEEEEEEC--Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 683 RIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~--g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
.||+|+||.||+|++. +. .+++|.+... ........+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999863 33 4678876532 2334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 758 GSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 758 GsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
++|.+++.+.. ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 99999986532 24778899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
+...... ........+..|+|||++.+..++.++||||||+++|||++ |..||.+.+.......+.. ......+..+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNC 236 (270)
T ss_pred ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcC
Confidence 8643211 11222334667999999998889999999999999999996 9999988777666555432 2344556678
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+.++.+|+.+||+.||.+||++.+++..|+.+.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=325.61 Aligned_cols=254 Identities=32% Similarity=0.519 Sum_probs=211.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--~~~ 747 (959)
++|++.+.||+|+||.||++++. +..||||++...... .....+.+|+++++.+.|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 56888899999999999999863 568999998755433 356688999999999999999999999877 557
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 89999999999999999876667999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HHhhhh
Q 002157 828 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VVGAVG 889 (959)
Q Consensus 828 ~~~~~---~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---------------l~~~i~ 889 (959)
..... .....++..|++||.+.+..++.++||||||+++|+|++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL- 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-
Confidence 32111 112335567999999998889999999999999999999999986532211 11111
Q ss_pred ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 890 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 890 ~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
........+..++.++.+|+.+||+.+|.+||++.+|++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 12233444567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=325.28 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=208.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|+.++++++|+||+++++++..+..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999986 678999999887655445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-cC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~-~~ 833 (959)
+ +++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999765567999999999999999999999998 99999999999999999999999999986644321 12
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----------------c-
Q 002157 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------R- 894 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-----------------~- 894 (959)
....|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+.........+..... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345689999999998764 468999999999999999999888877665433322210000 0
Q ss_pred ----------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 ----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ----------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..+....+.++++||.+||+.+|.+||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01113457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=325.67 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=206.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeee-----
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT----- 743 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~----- 743 (959)
....++|++.+.||+|+||.||++.+ +++.||+|++.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34568999999999999999999976 67889999875432 1234677899999999 7999999999873
Q ss_pred cCCcEEEEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 744 RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
.++.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 44568999999999999998752 2346888999999999999999999998 999999999999999999999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccc
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRR 894 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~ 894 (959)
|++..............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||............... ...
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 998865443333345579999999999853 44788999999999999999999999887654443332211 112
Q ss_pred cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...|..++.++++||.+||+.||++||++.+|++.
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 23455678899999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.96 Aligned_cols=249 Identities=28% Similarity=0.472 Sum_probs=213.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.+.+|++.+.||.|+||.||++.+ +++.||||.+...... ....+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 346799999999999999999975 6889999988654332 345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
+||+++++|..++.+. .+++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999999998753 5899999999999999999999999 99999999999999999999999999876544332
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-~~~~~~iP~~ls~eL~dLI~ 910 (959)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+.. .......+..++..+++||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 23345689999999999998899999999999999999999999988776544333321 22234456778999999999
Q ss_pred HHhhcCCCCCCCHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~ 928 (959)
+||..||.+||++.+|+.
T Consensus 251 ~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHhhcChhhCCCHHHHhh
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.72 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=201.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~ 746 (959)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|++++|+||++++++|... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36899999999999999999976 577899998875443333455677999999999999999999987543 3
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++++|++ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999988 7799988864 36899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 892 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~------------- 892 (959)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 432 235679999999999987 568999999999999999999999998766543332221000
Q ss_pred --------cccCC--------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 --------RRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 --------~~~~i--------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..... ....++.+.+||.+||+.||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001 12356778999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.65 Aligned_cols=253 Identities=31% Similarity=0.515 Sum_probs=207.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcE
Q 002157 677 DLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l 748 (959)
-|++.+.||+|+||.||++++ .+..||+|.+.... .......+.+|+.++++++|+||+++++++... ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478899999999999999974 46789999876443 234456789999999999999999999998775 568
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccccc
Confidence 8999999999999999766556899999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHhhhhc
Q 002157 829 TFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---------------MQVVGAVGF 890 (959)
Q Consensus 829 ~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---------------~ql~~~i~~ 890 (959)
... ......++..|+|||++.+..++.++||||||+++|+|++++.|+..... ......+ .
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL-E 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-H
Confidence 211 12234577789999999988899999999999999999998766432110 0111111 1
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.......+..++..+.+||.+||+.||.+||++.+++..|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2234455677899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.21 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=209.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||.||++.+ .+..||+|.+... ........+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4788999999999999999987 5889999988654 334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~--~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|+++++|..++.+. ...+++..+..++.||+.||.|||. ++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998763 2368999999999999999999996 57 999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCCCCCc
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELD 902 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~------~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~--~~~~~~~iP~~ls 902 (959)
......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+. .......++..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 223456888999999986543 4789999999999999999999997765544332221 1233455677799
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.++++||.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=323.17 Aligned_cols=249 Identities=29% Similarity=0.491 Sum_probs=208.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~---~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l 748 (959)
.+|++.+.||+|+||.||++.+ ++..||+|++...... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999976 5789999988654322 23445688999999999999999999988753 568
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+++|||+++++|.+++.+.. .+++...+.++.||+.||.|||.++ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999997643 5888999999999999999999998 99999999999999999999999999875432
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 ~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+.............+|..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 111234588899999999998899999999999999999999999988766555544444444566777889999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++|| +||..+|++||++++|+.
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhc
Confidence 9999 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.40 Aligned_cols=250 Identities=32% Similarity=0.476 Sum_probs=206.8
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC----
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP---- 746 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~---- 746 (959)
..++|++.+.||+|+||.||+|++ +++.|++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457899999999999999999987 567899998865432 345788999999999 7999999999997644
Q ss_pred --cEEEEEeccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 747 --NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 747 --~l~LVmEy~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
.+++||||+++++|.+++... +..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988642 357899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-ccc
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRL 895 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g~-----~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~ 895 (959)
++..............|+..|+|||++.+. .++.++||||||+++|+|++|..||...........+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 987655443334456789999999998643 46788999999999999999999998766554443332211 122
Q ss_pred CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+..++.++++||.+||..||.+||++.+|+.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 223346789999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=319.60 Aligned_cols=250 Identities=32% Similarity=0.473 Sum_probs=210.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||.|+||+||+|.+ ++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.....+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999976 67789999886554433 56778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 754 FLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 754 y~~gGsL~dlL~k~--~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|+++++|.+++... ...+++..+..++.||+.||.|||+.| |+||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999753 246899999999999999999999998 99999999999999999999999999876554322
Q ss_pred c----CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC-----CCC
Q 002157 832 S----SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-----KEL 901 (959)
Q Consensus 832 ~----~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP-----~~l 901 (959)
. .....|+..|++||++... .++.++|+||||+++|+|++|+.||...+..+........ ....++ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccc
Confidence 1 2345689999999998876 7899999999999999999999999887766544433222 111122 256
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+.++++|+.+||+.||.+||++.+|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.90 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=206.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+..+.+.....||+|+||.||+|++ ++..||+|.+.... ......+.+|+.++++++|+||+++++++..++.+++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3344454556899999999999976 56779999876443 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCcccccc
Q 002157 751 ITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKH 827 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~l--se~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~~~ 827 (959)
||||+++++|.+++......+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999997643445 78888899999999999999998 999999999999986 6799999999987654
Q ss_pred CCcccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~~~iP~~ls~e 904 (959)
..........|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... .............+|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 3323333456899999999987643 7889999999999999999999997654322 121222223345677889999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+++|+.+||+.+|.+||++.+|+.+
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.22 Aligned_cols=248 Identities=32% Similarity=0.529 Sum_probs=210.4
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||+|+||.||++.. ++..|+||++............+.+|+.++++++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999976 678899999887665555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC-
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS- 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~- 833 (959)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999764 35788899999999999999999998 9999999999999999999999999988764332211
Q ss_pred ---CCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCCCC--cHH
Q 002157 834 ---KSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKEL--DPL 904 (959)
Q Consensus 834 ---~t~~GT~~YmAPEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~~iP~~l--s~e 904 (959)
....++..|++||++.+.. ++.++|||+||+++|+|++|+.||...... .....+.. .....+|... +..
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHH
Confidence 1356788999999998766 789999999999999999999999766332 22222222 3344455544 899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+.+||.+||+.+|.+||++.+++.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=341.44 Aligned_cols=252 Identities=27% Similarity=0.335 Sum_probs=210.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCC-----
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPP----- 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN-IVkL~g~~~~~~----- 746 (959)
...|+.+++||+|+||+||+|+. +|+.||+|++....-.+-......+|+.+|+.++|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45577778899999999999975 7889999999865432223446689999999999999 999999998887
Q ss_pred -cEEEEEeccCCCCHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 747 -NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 747 -~l~LVmEy~~gGsL~dlL~k~~---~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
.+++||||++. +|..++.... ..++...+..+++||+.||+|||+++ |+||||||.||||++.|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 79999999954 9999997654 35777889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc---------
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------- 892 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~--------- 892 (959)
|+...-+.......++|.+|.|||++.|. .|+..+||||+|||++||++++..|.+....+....+-..-
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99776555556678899999999999987 68999999999999999999999999988765554431100
Q ss_pred -------cccCCC------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 -------RRLEIP------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 -------~~~~iP------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....++ +..+++..+++.+||+.+|.+|.+++..+.+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000111 1233578999999999999999999999876
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=371.81 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=209.2
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--C
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--P 746 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~ 746 (959)
.++..++|++++.||+|+||+||+|++ .+..||+|++............+..|+.+|++|+|||||+++++|... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 345668999999999999999999987 567899999887666666677889999999999999999999988543 4
Q ss_pred cEEEEEeccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCEEeeCCCCCcEEEcC-------
Q 002157 747 NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTST-----PTIVHRDLKSPNLLVDK------- 811 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g-----~~IIHRDLKPeNILLd~------- 811 (959)
.+||||||+++++|.++|.+. ...+++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999998642 346899999999999999999999854 34999999999999964
Q ss_pred ----------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002157 812 ----------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGM 879 (959)
Q Consensus 812 ----------~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~ 879 (959)
.+.+||+|||++....... .....+||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3459999999998654332 2334679999999999965 45889999999999999999999999876
Q ss_pred ChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 880 ~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+....+....... +.......+.++.+||.+||+.+|.+||++.|++.
T Consensus 247 ~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5543332221111 11112457899999999999999999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=330.53 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=211.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
..+|++.+.||+|+||.||++.. +++.||||.+...... ....+.+|+.+++.++|+||++++++|...+.+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36899999999999999999976 6889999988754432 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999999999653 5788899999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.++......+.. .......|..++..+++||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 3345789999999999998899999999999999999999999987665433222221 122333566788999999999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||+.+|.+||++.+|++
T Consensus 252 ~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 252 CLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=318.54 Aligned_cols=250 Identities=28% Similarity=0.490 Sum_probs=213.1
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|.+.+.||+|+||.||++.+ ++..||+|.+............+.+|+.++++++|+||+++++.+.....+++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999987 578899999876544444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccCCccc
Q 002157 755 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 755 ~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~~~~~ 832 (959)
+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999986543 35789999999999999999999998 99999999999999876 4699999999876543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. ......++..++.+++++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334568999999999988889999999999999999999999998877666554443 2233345567788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|+.+|++||++.+|+.+
T Consensus 238 l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 238 FKVSPRDRPSITSILKR 254 (257)
T ss_pred hccChhhCcCHHHHhhC
Confidence 99999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=325.51 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=205.5
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec------
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR------ 744 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~------ 744 (959)
..+.|++.+.||.|+||.||+|++ .++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346789999999999999999987 57889999875432 3345678899999998 79999999999853
Q ss_pred CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
...++++|||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45689999999999999998653 345788888999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
..............|+..|+|||++. +..++.++|||||||++|+|++|..||....+......+.........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 76543333344567999999999986 3457889999999999999999999998776554443332222222233
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++.++.+||.+||..||.+||++.+|+.
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 467899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.78 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=220.3
Q ss_pred CeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|.+.+.||.|+||.||++.+. +..|++|++............+.+|+++++.++|+|++++++.+.....+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999874 88999999887666556677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 755 LPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 755 ~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
+++++|.+++.+. ...+++..+..++.+|+.||.|||++| ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 367899999999999999999999998 99999999999999999999999999987654432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
......|++.|+|||.+.+..++.++|+|+||+++|+|++|..||...+..+...... ......+|..++.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3344578999999999999889999999999999999999999998887766665543 333556677889999999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||+.+|.+||++.+++..
T Consensus 238 ~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 238 LLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.47 Aligned_cols=249 Identities=31% Similarity=0.485 Sum_probs=214.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|++|.||++++ +++.|+||++...... .....+.+|+.++.+++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4689999999999999999987 4789999988765432 456678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++++|.+++.+. ..+++..++.++.||+.||.|||+ .+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999765 578999999999999999999999 88 999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhhccccccCCCCC-CcHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKE-LDPLVARI 908 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---~~ql~~~i~~~~~~~~iP~~-ls~eL~dL 908 (959)
.....++..|+|||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+. .......+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334568899999999999989999999999999999999999998774 334444433 3334445555 88999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||..+|.+||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=326.20 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=206.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||+|.+ .++.||+|++............+.+|+++++.++||||+++++++..+..+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4789999999999999999987 47889999876544433345568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|++++.|..+.... ..+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99998888877554 35899999999999999999999998 9999999999999999999999999988764443333
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 002157 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 893 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------------- 893 (959)
....++..|+|||++.+. .++.++||||||+++|+|++|..||......+....+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 446688999999998763 478899999999999999999999976654332221110000
Q ss_pred -c---------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 -R---------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 -~---------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. ......++..+++|+.+||+.+|.+||++.+|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 00123567889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.91 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=206.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|++++++++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4699999999999999999987 57789999887654444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-c
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~-~ 832 (959)
|++++.|..++.+. ..+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 99887676665443 46899999999999999999999998 99999999999999999999999999987654432 2
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------------c
Q 002157 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------N 892 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-------------------~ 892 (959)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+... .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3446788999999999888 7899999999999999999999999876543322111000 0
Q ss_pred -c----------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 -R----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 -~----------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ....+..++.++++||++||..+|++||++++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00123345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=334.98 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=201.5
Q ss_pred EEeEeecc--CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 680 LGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 680 I~k~LGkG--~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
++++||+| +|++||++++ +++.||||++............+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999976 6789999998766554555667788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc---
Q 002157 756 PRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 831 (959)
Q Consensus 756 ~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~--- 831 (959)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999998653 345889999999999999999999998 99999999999999999999999986543321110
Q ss_pred ----cCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------
Q 002157 832 ----SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 894 (959)
Q Consensus 832 ----~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~----------- 894 (959)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+..........+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356788999999976 45889999999999999999999999875543322111100000
Q ss_pred ---------------------------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhh
Q 002157 895 ---------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQ 934 (959)
Q Consensus 895 ---------------------------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~ 934 (959)
......+++++++||.+||+.||.+||++.++++ +++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0011235678999999999999999999999987 355543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=356.92 Aligned_cols=244 Identities=27% Similarity=0.327 Sum_probs=204.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C-----CceeEEeeeeecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-----PNVVLFMGAVTRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-H-----pNIVkL~g~~~~~~~l 748 (959)
+|+|.++||+|+||.|.+|.+ +++.||||+++... ....+...|++||..|+ | -|||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 799999999999999999976 68899999987653 34456678999999996 5 3899999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEecCcccc
Q 002157 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 825 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~ 825 (959)
|||+|.+ ..+|+++|+.++ ..++...++.|+.||+.||.+||+.+ |||+|||||||||.. ...|||+|||.++.
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999999 569999997653 46889999999999999999999999 999999999999964 35799999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---------------
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 890 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~--------------- 890 (959)
.....+ +++.++.|.|||+|.|.+|+.+.||||||||++||++|.+.|.|.+..+.+..|..
T Consensus 341 ~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 341 ESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 766544 68899999999999999999999999999999999999999999877554432210
Q ss_pred -----cc------------------------------cccCCC-----------CCCcHHHHHHHHHHhhcCCCCCCCHH
Q 002157 891 -----QN------------------------------RRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFA 924 (959)
Q Consensus 891 -----~~------------------------------~~~~iP-----------~~ls~eL~dLI~kCL~~DP~kRPSa~ 924 (959)
.. .....| ..-...+.+||++||..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 00 000112 01134589999999999999999999
Q ss_pred HHHHH
Q 002157 925 QLTVA 929 (959)
Q Consensus 925 EIL~~ 929 (959)
|.+++
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 88764
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.43 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=206.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~---~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+|++.+.||+|+||.||+|.+ +++.||||++...... ......+..|+.++++++|+||+++++++.+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478899999999999999986 5789999998765443 22344567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+ +++|.+++.+....+++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999999775557899999999999999999999999 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc------------------
Q 002157 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------ 892 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~------------------ 892 (959)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334567889999999865 457899999999999999999988888766544332221000
Q ss_pred ---ccc-----CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 ---RRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ---~~~-----~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
... ......+.++++||.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0113457889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.11 Aligned_cols=249 Identities=34% Similarity=0.553 Sum_probs=217.2
Q ss_pred CeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIIT 752 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~LVm 752 (959)
+|.+.+.||+|++|.||+|... ++.|++|++............+.+|+.++++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999874 88999999877665555677889999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+++++|.+++.+.. .+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999997654 7899999999999999999999998 99999999999999999999999999987655432
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 832 -~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
......++..|++||.+.+...+.++|||+||+++|+|++|..||.... .......+........+|..++.++++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334668999999999998889999999999999999999999998766 33333333333456677888899999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||..||.+||++.+++.
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhCcCChhhCCCHHHHhh
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.76 Aligned_cols=248 Identities=30% Similarity=0.491 Sum_probs=212.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
..|++.+.||.|+||.||+|.+ .+..||||++..... ......+.+|+.+++++.|+||+++++.+.+...+++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577788999999999999976 578899998875432 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999975 35888899999999999999999998 9999999999999999999999999997654433233
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+. ......++..++..+.+||.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 34568889999999998889999999999999999999999998877665544332 23344555678889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.+|.+||++.+++.+
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.62 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=206.6
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~ 749 (959)
..++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999987 588999999875543333334566899999999999999999998765 4689
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+. ++|.+++......+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999996 4888888765567899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---------------
Q 002157 830 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 893 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--------------- 893 (959)
........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222333456888999999876 4578999999999999999999999998877655443321000
Q ss_pred --ccCCC-----------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 --RLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 --~~~iP-----------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...++ ...++++.+||.+||+.||++||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011 1357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.84 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=212.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+|++.+.||.|+||.||++.+ +++.||+|++...... ......+.+|++++++++||||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488999999999999999987 4889999998765432 2456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||.++ |+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999765 47899999999999999999999998 9999999999999999999999999988664432 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ....... ......+|..++.++.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHH
Confidence 346688999999999988899999999999999999999999988763 3333322 21456677888999999999
Q ss_pred HHhhcCCCCCCCH--HHHH
Q 002157 911 ECWQTDPSLRPSF--AQLT 927 (959)
Q Consensus 911 kCL~~DP~kRPSa--~EIL 927 (959)
+||+.||.+||++ ++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHccCChhHcCCccHHHHh
Confidence 9999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.23 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=210.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||.|+||.||++.+ +++.||+|++..... ......+.+|+.++++++||||+++++.+.....+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 4678889999999999999987 478899998876533 3455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|+++++|.+++.+....+++..+..++.||+.||+|||+ .+ ++||||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999997654678999999999999999999999 88 99999999999999999999999999876543322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHhhhhccccccCCCCC-CcHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIPKE-LDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-----~~ql~~~i~~~~~~~~iP~~-ls~eL~ 906 (959)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+. .......+.. ++.+++
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 12678899999999999999999999999999999999999997652 222332222 2233344444 889999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+||.+||..||.+||++.+++.+
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhC
Confidence 99999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.18 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=198.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHH-HHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~I-L~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||++++ +++.||||++........ ...+..|+.+ ++.++||||+++++++..+..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4799999999999999999987 588999998876543332 3445556665 55668999999999999999999999
Q ss_pred eccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 753 Ey~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
||++ ++|.+++.. ....+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 578777643 334689999999999999999999987 7 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccccCCC-CCCc
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIP-KELD 902 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~~~iP-~~ls 902 (959)
.. ......|+..|+|||++.+ ..++.++|+|+|||++|+|++|+.||..... .+....+. ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 22 2233568899999999865 4468899999999999999999999975432 22222222 22223333 3578
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.++++||.+||..+|.+||++.+|+.
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=341.84 Aligned_cols=242 Identities=27% Similarity=0.374 Sum_probs=198.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----cEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~-----~l~ 749 (959)
.|.-.+++|.|+||.||+|.. .++.||||+...+..- -.+|+++|+.+.|||||+|..+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 467789999999999999976 5789999987755321 137999999999999999999885432 356
Q ss_pred EEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCcccc
Q 002157 750 IITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRL 825 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk~ 825 (959)
+||||++. +|.++++. .+..++...+.-+.+||++||.|||.+| |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999975 89998863 3457788888889999999999999998 9999999999999965 9999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc------------
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------ 892 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~------------ 892 (959)
+.... ...++..|+.|.|||.+.|. .|+.+.||||.||++.||+.|++-|.|.+....+..+..-.
T Consensus 176 L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 76553 34667789999999999885 59999999999999999999999999977654433221000
Q ss_pred -c--c---c---------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 -R--R---L---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 -~--~---~---------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. . + .+....++++.+|+.++|+.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 0 0 123457899999999999999999999998874
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.07 Aligned_cols=245 Identities=31% Similarity=0.529 Sum_probs=205.6
Q ss_pred EeeccCcEEEEEEEECC--------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 683 RIGLGSYGEVYHADWNG--------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~g--------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.||+|+||.||+|++.. ..||||.+.... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999997632 568999875432 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-----cEEEEecCcc
Q 002157 755 LPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLS 823 (959)
Q Consensus 755 ~~gGsL~dlL~k~------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-----~VKLiDFGlA 823 (959)
+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999998642 234788899999999999999999998 99999999999999877 8999999998
Q ss_pred ccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 824 RLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 824 k~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
+....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 75432211 1123345788999999999899999999999999999998 999998877766655543 2334556678
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
++..+.+||.+||+.+|.+||++.+|++.|+
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8999999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=325.83 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=210.3
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.|++.+.||+|+||.||+|.+ .+..||||++..... ......+.+|+.++++++|+||+++++++.....+++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466778899999999999976 577899998764432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++.. ..+.+..+..++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++...........
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999999999865 36888999999999999999999998 99999999999999999999999999976554333333
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
...|+..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+. ......++..++.++.+||.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568899999999999889999999999999999999999998766655444332 222344555678899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002157 915 TDPSLRPSFAQLTVA 929 (959)
Q Consensus 915 ~DP~kRPSa~EIL~~ 929 (959)
.+|.+||++.+++.+
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06642 239 KDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCcCHHHHHHh
Confidence 999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.61 Aligned_cols=253 Identities=29% Similarity=0.511 Sum_probs=210.0
Q ss_pred eeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 678 LVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
|.+.+.||+|+||.||+|.+ ++..||||++...........++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 3578999998766555666778899999999999999999999876532
Q ss_pred cEEEEEeccCCCCHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 747 NLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k-----~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
..++++||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 24788999999999988642 1235788889999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 002157 822 LSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 822 lAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
+++...... .......++..|++||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCcCCCC
Confidence 998654321 11223345678999999999889999999999999999998 8899988877665554432 2334455
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.97 Aligned_cols=244 Identities=27% Similarity=0.444 Sum_probs=195.1
Q ss_pred EeeccCcEEEEEEEE-C---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLGSYGEVYHADW-N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG~fG~VYka~~-~---g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
+||+|+||.||+|+. + ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+.....+++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999965 2 3468888765432 3444567889999999999999999999999999999999999999
Q ss_pred CHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--cc
Q 002157 759 SLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LS 832 (959)
Q Consensus 759 sL~dlL~k~~----~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~ 832 (959)
+|.+++.+.. ....+...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999986542 22457778889999999999999998 9999999999999999999999999986532221 11
Q ss_pred CCCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc----cccCCCCC
Q 002157 833 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKE 900 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-------~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~----~~~~iP~~ 900 (959)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+......... ....++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223446778999999753 346789999999999999998 788998877655444332211 12233456
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
++..+.+++..|| .||++||++++|++.|
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 7889999999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.34 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=207.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~LV 751 (959)
++|++.+.||.|+||.||+|++ +++.||||.+............+.+|+.++++++||||+++++++... ..+++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5789999999999999999987 478899999876544433445677899999999999999999998877 889999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||++ ++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99997 4899998765557899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------------
Q 002157 832 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 891 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~------------------- 891 (959)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 334456789999999987654 688999999999999999999999877655443322100
Q ss_pred ----------ccccCCCCC-CcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 ----------NRRLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 ----------~~~~~iP~~-ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.....++.. +++.+.+||.+||+.||++||++.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001112223 58889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.38 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=195.8
Q ss_pred eEeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||+|+||.||+|.+. +..+|+|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999763 34689998765432 33445788999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc--
Q 002157 758 GSLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 831 (959)
Q Consensus 758 GsL~dlL~k~~----~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~-- 831 (959)
|+|.+++.... ...++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999986422 24566777889999999999999998 99999999999999999999999999875433211
Q ss_pred cCCCCCCCCCccCcccccCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc-ccc---cCCCC
Q 002157 832 SSKSTAGTPEWMAPEVLRNE-------PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ-NRR---LEIPK 899 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~-------~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~-~~~---~~iP~ 899 (959)
......++..|+|||++.+. .++.++||||||+++|||++ |..||......+........ ... ..+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12234578899999998643 35789999999999999996 99999877665543322111 111 12223
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
..+..+.+++.+|| .+|++||++.+|+..|.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 56788999999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=326.30 Aligned_cols=251 Identities=29% Similarity=0.410 Sum_probs=209.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+..++|++.+.||+|+||+||++.+ +++.||+|++.... .......+.+|+++++.++||||+++++++.....+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3457899999999999999999987 48889999876543 33456678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.+. ..+++.....++.+++.+|.|||+ ++ |+||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999999998764 368899999999999999999997 57 999999999999999999999999998654322
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHhhhhccccccCCC
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGFQNRRLEIP 898 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-----------ql~~~i~~~~~~~~iP 898 (959)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ......++
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCC
Confidence 123457899999999998888999999999999999999999999865542 1122221 11122233
Q ss_pred C-CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 899 K-ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 899 ~-~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
. .++.++.+||.+||+.||.+||++.+++.+.
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 3 3778999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=326.22 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=209.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||++.+ .++.|+||.+...... ......+.+|+.+++.++||||+++++.+.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4789999999999999999987 5678999988755332 233457789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC---
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~--- 829 (959)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999765 46889999999999999999999998 999999999999999999999999988642110
Q ss_pred ------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccC
Q 002157 830 ------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLE 896 (959)
Q Consensus 830 ------------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-~~~ 896 (959)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0011234578899999999988899999999999999999999999998877766655433221 122
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+..++.++++||.+||+.||++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 22367899999999999999999999655555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=355.20 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=225.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
..|.+.+.||+|.|++|.++++ ++..||||.+.+..........+.+|+++|+.++|||||+++.+...+..+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 5689999999999999999987 78999999999888877777779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+.+|.+++++.+.+ ...+.....++.|++.|++|||.++ |||||||.+||||+.+.++||+|||++..+.. ....
T Consensus 136 ya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~l 211 (596)
T KOG0586|consen 136 YASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLML 211 (596)
T ss_pred eccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc-cccc
Confidence 999999999998876 5555888889999999999999999 99999999999999999999999999998863 3556
Q ss_pred CCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.++||++.|.|||++.|..| +..+|+|+||++||.|++|.+||.+.+...+....... ...+|..++.++.+||+++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--eecccceeechhHHHHHHh
Confidence 78999999999999999876 67899999999999999999999998887777666544 5566778999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|-.+|.+|+++.+|...
T Consensus 290 lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hccCccccCCHHHhhhh
Confidence 99999999999998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.76 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=186.3
Q ss_pred EeEeeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCcEEEEEec
Q 002157 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIITEF 754 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--~~~l~LVmEy 754 (959)
+++||+|+||+||+|++ .++.||||.+...... ..+.+|+++|++++||||+++++++.. +..+++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 45799999999999985 3467999988654432 346789999999999999999998854 4568899999
Q ss_pred cCCCCHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEecCc
Q 002157 755 LPRGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 822 (959)
Q Consensus 755 ~~gGsL~dlL~k~--------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL----d~~g~VKLiDFGl 822 (959)
+. ++|.+++... ...+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 95 5888877421 235888999999999999999999999 9999999999999 4568999999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHhhhh
Q 002157 823 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QVVGAVG 889 (959)
Q Consensus 823 Ak~~~~~~---~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---------ql~~~i~ 889 (959)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98754322 122346789999999999874 5899999999999999999999999753321 0000000
Q ss_pred -ccc-----------------------cc--c----------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 890 -FQN-----------------------RR--L----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 890 -~~~-----------------------~~--~----------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
... .. . ......+.++.+||.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00 0 000123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.61 Aligned_cols=247 Identities=31% Similarity=0.527 Sum_probs=211.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||+|++|.||++.+ +++.|++|++..... .....+.+|+.++++++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 578899999999999999987 478899999866543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++......+++..+..++.|++.+|.|||.++ ++||||+|+||+++.++.++|+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999776567899999999999999999999988 99999999999999999999999999987654322 34
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHH
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWEC 912 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~--~ls~eL~dLI~kC 912 (959)
...++..|++||.+.+..++.++|+|+||+++|+|++|+.||...+.......... ......+. .++.++.+||.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 56789999999999988899999999999999999999999988755444433322 22222222 3388999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~~ 929 (959)
|+.||.+||++.+++.+
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.79 Aligned_cols=248 Identities=31% Similarity=0.564 Sum_probs=217.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||+|++|.||++++ .++.|+||.+............+.+|++++.+++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588899999999999999976 567899999987766556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++.+. ..+++..++.++.|++.+|.|||+.| |+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999765 47899999999999999999999998 99999999999999999999999999987655433334
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
...++..|+|||.+.+..++.++|||+||+++|+|++|..||............. ......++..++.+++++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 5678999999999988888999999999999999999999998776554443333 234455677889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 002157 915 TDPSLRPSFAQLTV 928 (959)
Q Consensus 915 ~DP~kRPSa~EIL~ 928 (959)
.+|++||++.+++.
T Consensus 237 ~~p~~R~~~~~~l~ 250 (254)
T cd06627 237 KDPNLRPTAKQLLK 250 (254)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=378.49 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=226.6
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
...+...++|+|+++||+|+||.|.++++ +++.||+|++.+.. .......-|..|..+|..-+.+=|++++.+|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45567789999999999999999999987 56789999886632 2233455688999999988899999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.++||||||++||+|..+|.+.. ++++..++.++..|+.||.-||+.| +|||||||+|||||..|||||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHh
Confidence 99999999999999999999877 8999999999999999999999999 99999999999999999999999998876
Q ss_pred cc-CCcccCCCCCCCCCccCccccc----C-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC-
Q 002157 826 KH-NTFLSSKSTAGTPEWMAPEVLR----N-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP- 898 (959)
Q Consensus 826 ~~-~~~~~~~t~~GT~~YmAPEvl~----g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP- 898 (959)
.. +........+|||.|++||++. + +.|+..+|||||||++|||++|..||+.....+.+.+|......+.+|
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 65 4445566788999999999985 3 468999999999999999999999999999999999987777778888
Q ss_pred -CCCcHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 002157 899 -KELDPLVARIIWECWQTDPSLRPS---FAQLTVA 929 (959)
Q Consensus 899 -~~ls~eL~dLI~kCL~~DP~kRPS---a~EIL~~ 929 (959)
..+|.+.++||++++ .+|+.|.. +++|..+
T Consensus 305 ~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 568999999999988 67999988 8887654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.77 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=203.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++.+.+.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 678999998875544333445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+. ++|..++... ...+++..++.++.||+.||+|||..+ ++||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 96 5888888543 356889999999999999999999998 9999999999999999999999999987654433333
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 002157 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 893 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------------- 893 (959)
....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3456788999999987754 58899999999999999999999987665432221110000
Q ss_pred --------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 --------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 --------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
...+...++.++++||.+||+.||.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00112356788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.84 Aligned_cols=238 Identities=22% Similarity=0.371 Sum_probs=194.7
Q ss_pred eEeeccCcEEEEEEEEC--------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 682 ERIGLGSYGEVYHADWN--------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~--------------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+.||+|+||.||+|++. ...|++|++.... ......+.+|+.++..++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35899999999999752 2248888765432 3344578889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-------EEEEec
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VKVSDF 820 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~-------VKLiDF 820 (959)
.++||||+++++|..++.+....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998776667899999999999999999999998 999999999999987654 899999
Q ss_pred CccccccCCcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHhhhhccccccCCC
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELL-tG~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
|++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......+..... .......
T Consensus 157 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~ 229 (262)
T cd05077 157 GIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLV 229 (262)
T ss_pred CCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCC
Confidence 99865432 22356888999999987 566899999999999999998 588888776554332211 1122233
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
...+.++.+||.+||+.||.+||++.+|++.|
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 34567899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.23 Aligned_cols=236 Identities=25% Similarity=0.405 Sum_probs=194.5
Q ss_pred eEeeccCcEEEEEEEECCc------------eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 682 ERIGLGSYGEVYHADWNGT------------EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g~------------~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+.||+|+||.||+|.+.+. .|++|++..... ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999987432 377776544321 15678899999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-------cEEEEecCc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGL 822 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-------~VKLiDFGl 822 (959)
+||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999876557899999999999999999999998 99999999999999887 899999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCC
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~ 899 (959)
+..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||............. .....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCC
Confidence 986543 2234577889999999877 78999999999999999999 578887765443332221 1222233
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
.....+.+||.+||..+|.+||++.+|++.|
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3348899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.65 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=210.4
Q ss_pred CeeEEeEeeccCcEEEEEEEEC---CceEEEEEeeccC--------CCHHHHHHHHHHHHHHHH-cCCCceeEEeeeeec
Q 002157 677 DLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQD--------FSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR 744 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~---g~~VAVK~i~~~~--------~~~~~~~ef~~Ei~IL~~-L~HpNIVkL~g~~~~ 744 (959)
+|++.+.||+|+||.||++.+. ++.+|||.+.... .......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999874 4789999876432 223345567789988875 699999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 745 PPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
.+.+++||||+++++|.+++. .....+++..++.++.|++.+|.|||. .+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998873 234568999999999999999999996 56 999999999999999999999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
|++....... ......|+..|++||++.+..++.++|+||||+++|+|++|..||...+.......+............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9998755432 334566899999999999988999999999999999999999999887766555544333222222236
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+.++.+||.+||+.||.+||++.|+..+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.40 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=210.1
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||.|+||.||+++.. ++.||||++...... ......+.+|+.+++.++||||+++++.+.++..+++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999885 889999998765432 23456789999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCC
Q 002157 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (959)
Q Consensus 761 ~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~ 840 (959)
.+++.+. ..+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++....... ......|+.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 9999765 35889999999999999999999998 9999999999999999999999999998765432 233457899
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCC
Q 002157 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 918 (959)
Q Consensus 841 ~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~ 918 (959)
.|++||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+........+|...+.++++||.+||+.+|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998877 55555555444556777778899999999999999999
Q ss_pred CCCC-----HHHHHH
Q 002157 919 LRPS-----FAQLTV 928 (959)
Q Consensus 919 kRPS-----a~EIL~ 928 (959)
+||+ ++|+++
T Consensus 237 ~R~~~~~~~~~~l~~ 251 (262)
T cd05572 237 ERLGNLKGGIKDIKK 251 (262)
T ss_pred hCcCCcccCHHHHhc
Confidence 9999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.05 Aligned_cols=249 Identities=28% Similarity=0.509 Sum_probs=208.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC----HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~----~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+|++.+.||+|+||.||++.. +++.||+|++...... ......+.+|++++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 6889999988654321 2245678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| ++||||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999764 36889999999999999999999998 99999999999998776 5999999998765432
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccccccCCCCCCc
Q 002157 830 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELD 902 (959)
Q Consensus 830 ~~----~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~~~~~~iP~~ls 902 (959)
.. ......|+..|+|||++.+..++.++|+|+||+++|+|++|..||...... .....+........+|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 112346888999999999888999999999999999999999999754432 22222222334456677889
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+++++++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 99999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=353.63 Aligned_cols=277 Identities=23% Similarity=0.360 Sum_probs=239.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCce--EEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~--VAVK~i~~~~~~~~-~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
....+++++..||-|+||.|-+++.+++. +|+|++++....+. ....+..|.+||...+.|+||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44567888899999999999999887666 89998887655433 3456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
|+||-|-||.|+.+|++++ .+++.....++..+++|++|||.+| ||+|||||||+|++.+|.+||.|||+|+.+...
T Consensus 497 mLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999998765 6788888888889999999999999 999999999999999999999999999998766
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
..+.++|||++|.|||++.++..+.++|+|+|||++|||++|.+||.+.+++..+..|..+-....+|..+.+...+||
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 4456799999999999999999999999999999999999999999999999999999988889999999999999999
Q ss_pred HHHhhcCCCCCCC-----HHHHHHH--HHhh----hhhhCCCCCCCCCCCCCCCC
Q 002157 910 WECWQTDPSLRPS-----FAQLTVA--LKPL----QRLVIPSHPDQPSSALPQEI 953 (959)
Q Consensus 910 ~kCL~~DP~kRPS-----a~EIL~~--Le~l----~kl~~p~~p~~~~~~~p~~~ 953 (959)
+++++.+|.+|.. +.+|..+ ++.+ .+...-+-|..++...|+++
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~ 707 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDV 707 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccc
Confidence 9999999999986 4555432 3322 12222334666777777554
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=356.34 Aligned_cols=245 Identities=30% Similarity=0.443 Sum_probs=216.3
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeecc-CCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~-~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
|.-++.||.|+||.||.+++ +.+.||||++... ......+..++.|++.|++++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678899999999999976 6788999998754 33455678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
|- |+-.|++.-...++.+..+..|+.+.+.||.|||+++ .||||||..|||+.+.|.|||+|||.+..... ..
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 94 5888888666668999999999999999999999999 99999999999999999999999999976643 35
Q ss_pred CCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 835 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 835 t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
+++|||+|||||+|. .+.|+-++|||||||+..||...++|+..++.+..+..|..+..+..-...++..++.|+..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 799999999999985 45699999999999999999999999999999988877775554444445788999999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||++-|.+|||.++++.+
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999999999999987653
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.74 Aligned_cols=250 Identities=31% Similarity=0.500 Sum_probs=205.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC--------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~--------~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+|.+.+.||.|+||.||+|.. +++.||||.+...... ......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999975 6789999987542211 112346788999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.+||+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999775 47889999999999999999999998 999999999999999999999999999765
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC----
Q 002157 827 HNTF--LSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---- 898 (959)
Q Consensus 827 ~~~~--~~~~t~~GT~~YmAPEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP---- 898 (959)
.... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 1123356889999999987754 7889999999999999999999997766544333332222233333
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++++||.+||+.+|.+||++.+|+.+
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3458899999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=329.82 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=214.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC---C---HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---S---GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~---~---~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~ 746 (959)
+.|.-.+.||+|..+.|.++.+ ++..+|+|++..... . ....+...+|+.||+++ .||+|+++.+.|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566677899999999999965 688999998864322 1 22344567899999998 7999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++|+|.|+.|.|+|+|... -.++++..++|++|++.|++|||..+ ||||||||+|||++++.+|||+|||+++.+
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999764 47999999999999999999999999 999999999999999999999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-- 898 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP-- 898 (959)
... ......||||.|+|||.+.. ..|+..+|+|++|+|+|.|+.|.+||-....+-++..|..++..+.-|
T Consensus 174 ~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 655 45567899999999999853 357889999999999999999999998877766666665444444333
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+++.+.++||.+||+.||.+|.|++|.|.+
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 4678899999999999999999999999874
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.28 Aligned_cols=243 Identities=20% Similarity=0.292 Sum_probs=194.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
..+|++++.||+|+||.||+|++ +++.||+|+.... ....|+.++++++|+||+++++++......++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 35799999999999999999988 4568999974332 2346899999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. ++|.+++.+....+++..++.|+.||+.||.|||.+| ||||||||+|||++.++.+||+|||+++..... ..
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~ 212 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA 212 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-cc
Confidence 9995 6899888766668999999999999999999999998 999999999999999999999999999754322 22
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHhhhhc-cccccCCC--
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGF-QNRRLEIP-- 898 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-----------ql~~~i~~-~~~~~~iP-- 898 (959)
.....||..|+|||++.+..++.++|||||||++|||+++..++....+. .+...+.. ...+..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 33467999999999999999999999999999999999865554322110 01110000 00001111
Q ss_pred ----------------------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 ----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ----------------------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++.+||.+||+.||.+||++.|++.+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1346677889999999999999999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=322.27 Aligned_cols=237 Identities=22% Similarity=0.371 Sum_probs=197.5
Q ss_pred EeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 683 RIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.||+|+||.||+|.+. ...||+|.+.... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999999999763 2347888764332 2344578889999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--------EEEEecCcccc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRL 825 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~--------VKLiDFGlAk~ 825 (959)
|+++|+|.+++.+.+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++|+|||++..
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999876667899999999999999999999998 999999999999987654 69999998865
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
... .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||........... ......+|...+.
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAPKWT 230 (258)
T ss_pred cCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCCCcH
Confidence 432 233568889999999987 4578999999999999999998 467766655443322 2234556777788
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
++.+||.+||+.||.+||++++|++.|
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=356.62 Aligned_cols=250 Identities=29% Similarity=0.456 Sum_probs=219.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+-++|+..||-|+||+||++..+.. ..|.|++... .+..+..+.-|+.||..+.||+||+|++.|..++.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3467889999999999999976543 3566766433 35567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
||.||-+..++-.-++.+.+.++..+++|++.||.|||+.+ |||||||..|||+.-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998888889999999999999999999999999 9999999999999999999999999887655555556
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHH
Q 002157 834 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVAR 907 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~d 907 (959)
.+++|||+|||||++. ..+|++++|||||||+|.||..+.+|-...+++.++-.+.... ..+..|..++..+.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 7899999999999864 5679999999999999999999999999999998887765332 234567788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~ 929 (959)
|+++||.+||..||++.+|+.+
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhC
Confidence 9999999999999999998753
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=319.15 Aligned_cols=251 Identities=31% Similarity=0.466 Sum_probs=206.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC-----
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP----- 745 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~----- 745 (959)
..++|.+.+.||+|+||.||++.. +++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 357899999999999999999976 57889999875432 2234677899999999 899999999998654
Q ss_pred CcEEEEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 746 PNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
..+++||||+++++|.++++. ....+.+..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998853 3456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccC
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLE 896 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~~-----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~ 896 (959)
+..............|+..|+|||++.... ++.++|||||||++|+|++|+.||......+....+... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 886554333334467899999999986532 678999999999999999999999887765444333211 11223
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+...+.++.+||.+||+.+|++||++.+|+++
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 345677889999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.06 Aligned_cols=249 Identities=30% Similarity=0.491 Sum_probs=211.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC---CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~---~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l 748 (959)
.+|++.+.||+|+||.||++++ ++..||+|++.... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999976 67899999875432 2234456788999999999999999999998764 458
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+++|||+++++|.+++.... .+++...+.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999987643 5788999999999999999999998 99999999999999999999999999986532
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 ~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.. .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+.....+..+|..++.++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 112245689999999999998899999999999999999999999988776655555544445567888999999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.++|.+||+ +|.+||++.+++.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhc
Confidence 999999998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.83 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=200.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||.|+||.||+|+. +++.||||.+...... .....+.+|+.++++++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999976 5789999988654322 12234668999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+.+ +|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 899998776667899999999999999999999998 999999999999999999999999998754332222
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhc-------------------c
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGF-------------------Q 891 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~-------------------~ 891 (959)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+... .+....+.. .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233457889999999876 4578999999999999999999999976552 111111000 0
Q ss_pred cccc---------CCCCCCc--HHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 892 NRRL---------EIPKELD--PLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 892 ~~~~---------~iP~~ls--~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.... .....++ .++.+||.+||+.+|++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0001233 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.88 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=212.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
+.++-..|++++.||+||.+.||++.. +.+.||+|++.......+.+.-|.+|+..|.+| .|.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 456667899999999999999999987 456789888777777788888999999999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
||||||- ..+|..+|++.....+...++.+..||+.++.++|++| |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9999987 55999999887666665577788999999999999999 99999999999995 47999999999997764
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccc
Q 002157 829 TFL--SSKSTAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRR 894 (959)
Q Consensus 829 ~~~--~~~t~~GT~~YmAPEvl~g~~-----------~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~ 894 (959)
... ...+.+||+-||+||.+.... .+.++||||||||||+|+.|+.||..... ...+..|..-+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 422 245678999999999986433 35689999999999999999999976542 2233344333344
Q ss_pred cCCCCCCcHH-HHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 LEIPKELDPL-VARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ~~iP~~ls~e-L~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.++|..-+.. +.++++.||..||.+||++.+||++
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 5666554444 9999999999999999999999864
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=317.51 Aligned_cols=247 Identities=27% Similarity=0.484 Sum_probs=212.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
-|++.+.||.|+||.||+|.+ ++..||||++..... ......+.+|+.++.+++||||+++++++..+..+++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 367888999999999999976 578899998764432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||||.||+++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999998753 5889999999999999999999998 99999999999999999999999999876544322233
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568899999999998888999999999999999999999998877665554442 223444566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002157 915 TDPSLRPSFAQLTVA 929 (959)
Q Consensus 915 ~DP~kRPSa~EIL~~ 929 (959)
.+|.+||++.+++.+
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 239 KEPSFRPTAKELLKH 253 (277)
T ss_pred CChhhCcCHHHHHhC
Confidence 999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.88 Aligned_cols=250 Identities=24% Similarity=0.276 Sum_probs=200.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCc-----
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN----- 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~----- 747 (959)
++|++.+.||.|+||.||+|.+ +++.||||++............+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999987 5789999987654333333456788999999994 6999999999887666
Q ss_pred EEEEEeccCCCCHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCc
Q 002157 748 LSIITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGL 822 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~----~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGl 822 (959)
+++||||+++ +|.+++... ...+++..++.++.||+.||.|||.++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 788887542 235799999999999999999999998 999999999999998 89999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------- 893 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-------- 893 (959)
+..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8865433333334467889999998875 4578999999999999999999999988766543322210000
Q ss_pred --------------c----cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 --------------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 --------------~----~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ......++.++.+||.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0001347888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.35 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=202.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|++|.||+|++ +++.||||++............+.+|++++++++|+||+++++++.....+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999986 57889999886554433444567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCccccccCCcc
Q 002157 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 754 y~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~~~~~~~ 831 (959)
|++ ++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 996 5788877543 334678888899999999999999998 999999999999985 56799999999976543323
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----------------
Q 002157 832 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------------- 893 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~----------------- 893 (959)
......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...........+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 33345678999999998764 578999999999999999999999987765443322110000
Q ss_pred ---c-------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 ---R-------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 ---~-------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ......++.+++++|.+||+.+|++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0012356788999999999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=311.19 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=215.7
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|+||.||++++ +++.+|||++............+.+|+.++++++|+||+++++++.....+++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999976 577899999876655555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 755 LPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 755 ~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
+++++|.+++.+ ....+++..++.++.|++.||.|||+.| ++||||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999999865 2346888999999999999999999998 999999999999999999999999999876544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. .......+..++.+++++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2234568899999999999889999999999999999999999999888766555443 233344556788999999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||+.+|.+||++.+++..
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.51 Aligned_cols=237 Identities=22% Similarity=0.371 Sum_probs=194.6
Q ss_pred EeeccCcEEEEEEEEC--------------------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCcee
Q 002157 683 RIGLGSYGEVYHADWN--------------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~--------------------------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIV 736 (959)
+||+|+||.||+|.+. ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999999641 1247888765432 23345678899999999999999
Q ss_pred EEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---
Q 002157 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 813 (959)
Q Consensus 737 kL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g--- 813 (959)
++++++......++||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999776667899999999999999999999998 99999999999997643
Q ss_pred ----cEEEEecCccccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHhh
Q 002157 814 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGA 887 (959)
Q Consensus 814 ----~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELL-tG~~PF~g~~~~ql~~~ 887 (959)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999988643221 23457888999999876 56899999999999999985 68999987766544332
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
. .....+|....+++.+||.+||+.+|.+||++.+|++.|
T Consensus 234 ~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 Y---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2 123344555678899999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=319.23 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=198.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||+|.. ++..||||++..... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999976 588999999865432 2223356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+. ++|.+++......+.+..+..++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6777776554456788888899999999999999998 9999999999999999999999999987654332233
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhc--c--------------c---
Q 002157 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGF--Q--------------N--- 892 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~--~--------------~--- 892 (959)
....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.... +....+.. . .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 445678999999998764 4788999999999999999999999765532 11111000 0 0
Q ss_pred --cccCCC---------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 --RRLEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 --~~~~iP---------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....+ ...+.++.+|+.+||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 012568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.04 Aligned_cols=246 Identities=28% Similarity=0.477 Sum_probs=207.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCcEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~---HpNIVkL~g~~~~~~~l~LV 751 (959)
.|++.+.||.|+||.||+|.+ +++.||||.+.... .......+.+|+.++++++ ||||+++++++.....+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999986 67889999876542 2334567889999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++++|.+++... .+++..++.++.||+.||.|||+.| |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999998663 6889999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC-CCcHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 909 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~-~ls~eL~dLI 909 (959)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+... ....++. ..+.++.+|+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3445678999999999875 44688999999999999999999999887765544333211 2233333 3788999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||+.||.+||++.+++.
T Consensus 236 ~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 236 AACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHcCCCcccCcCHHHHhh
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.63 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=218.1
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECC--ceEEEEEeeccCCCH-HHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g--~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
.|...+|.++.+||+|+||+|.++..+| +.||||++++..... +.++--..|-++|... +-|++++++-.|+..+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5667899999999999999999998855 569999988764422 2222334677788766 57899999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|+||||+.||+|-.+|++-+ ++.+..+..++.+|+.||-+||++| ||+||||.+|||||.+|+|||+|||+++.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999999998764 7778888889999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
-....+.++|||+.|+|||++.-++|++.+|||++|+|||||+.|+.||.+.+..++++.|. .....+|+.++.+...
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVA 579 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHH
Confidence 55567789999999999999999999999999999999999999999999999999998884 4467889999999999
Q ss_pred HHHHHhhcCCCCCCC
Q 002157 908 IIWECWQTDPSLRPS 922 (959)
Q Consensus 908 LI~kCL~~DP~kRPS 922 (959)
+++..|.+.|.+|..
T Consensus 580 ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHhhcCCccccC
Confidence 999999999999963
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.21 Aligned_cols=250 Identities=30% Similarity=0.499 Sum_probs=212.8
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..+.|++.+.||+|+||.||++.+. +..|++|++..... ....+.+|+.++++++|+||+++++.+.....+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3466888999999999999999874 88899999875433 456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
+||+++++|.+++......+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999875457899999999999999999999998 99999999999999999999999998875543322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-~~~iP~~ls~eL~dLI~ 910 (959)
......++..|++||.+.+..++.++|+||||+++|+|++|..||...++......+..... ....+..++.++++||.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 23345688899999999988899999999999999999999999988776654444322211 22223347899999999
Q ss_pred HHhhcCCCCCCCHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~ 928 (959)
+||+.+|.+||++.+|+.
T Consensus 252 ~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=363.99 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=210.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.++||+|+||.||+|++ +++.||||++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999987 578999999875432 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 753 EFLPRGSLFRILHRP----------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~----------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
||++|++|.+++... ....+...++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999988531 123455677889999999999999998 99999999999999999999999999
Q ss_pred cccccCC------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002157 823 SRLKHNT------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884 (959)
Q Consensus 823 Ak~~~~~------------------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql 884 (959)
++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865210 0111235699999999999999999999999999999999999999987655433
Q ss_pred Hhhhhcccc-ccCCCCCCcHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHhhhh
Q 002157 885 VGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRP-SFAQLTVALKPLQR 935 (959)
Q Consensus 885 ~~~i~~~~~-~~~iP~~ls~eL~dLI~kCL~~DP~kRP-Sa~EIL~~Le~l~k 935 (959)
......... .......+++.+.+++.+||+.||.+|+ +++++++.|+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 322111110 1111136788999999999999999996 57888888877644
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=320.50 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=200.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
.++|++.+.||+|+||.||+|+. +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999987 5789999988755433333345668999999999999999999886654
Q ss_pred --cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 747 --NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 747 --~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
.+++||||+. ++|.+++.+....+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3599999996 5888888766557899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCcc----cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------
Q 002157 825 LKHNTFL----SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------ 893 (959)
Q Consensus 825 ~~~~~~~----~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------ 893 (959)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6543221 112345788999999987654 78899999999999999999999988765433222111000
Q ss_pred -----------ccCCC-------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 -----------RLEIP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 -----------~~~iP-------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...++ ...+..+++||.+||+.||.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00011 1235678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.45 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=203.6
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|++.+.||.|++|.||+|.+ ++..||||++............+.+|+.++++++|+||+++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999976 6889999998765444334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 756 PRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 756 ~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+ ++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999886543 46899999999999999999999998 99999999999999999999999999976543322333
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------------
Q 002157 835 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------------- 891 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~---------------------- 891 (959)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 44678899999988764 4688999999999999999999999877654322211100
Q ss_pred -----ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 -----NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 -----~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.........++..+.+||.+||+.||.+||++++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011224567899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.11 Aligned_cols=247 Identities=30% Similarity=0.432 Sum_probs=207.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.|++.+.||+|+||.||+|++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688999999999999999986 578999998865432 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. |+|.+++......+++..+..++.||+.||.|||..+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9996 5777777654457899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....++..|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........+..++.++++||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 3456889999999984 355788999999999999999999999888776554444333222223345788999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||+.+|.+||++.+|+.+
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=316.42 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=202.9
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|++.+.||.|++|.||+|++ +++.||||++...... .....+.+|+.++++++|+||+++++++...+.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 5788999988754322 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 755 LPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 755 ~~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8888876533 46899999999999999999999998 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------cccc
Q 002157 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------NRRL 895 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~----------------~~~~ 895 (959)
.....++..|++||++.+. .++.++|||+||+++|+|++|..||.+.+..+....+... ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3345678999999998764 5788999999999999999999999887655433322100 0000
Q ss_pred C-----------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 E-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ~-----------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. +...++.+++++|.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 11245788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.58 Aligned_cols=248 Identities=27% Similarity=0.459 Sum_probs=214.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LV 751 (959)
++|.+.+.||+|+||.||+++. ++..||+|++..... .......+.+|+.+++++. |+||+++++++.....+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 688999999876433 3344567889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~- 830 (959)
|||+.+++|.+++.+.+ .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999997653 7999999999999999999999999 9999999999999999999999999988654322
Q ss_pred -------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc
Q 002157 831 -------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891 (959)
Q Consensus 831 -------------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~ 891 (959)
.......++..|++||++.+..++.++|+|+||+++++|++|+.||...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 12234567899999999998889999999999999999999999999887655554442
Q ss_pred ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCH----HHHHH
Q 002157 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSF----AQLTV 928 (959)
Q Consensus 892 ~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa----~EIL~ 928 (959)
.....+|..+++.+.+||.+||+.+|.+||++ ++++.
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 34556777889999999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=346.13 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=197.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
...|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+++|++++|+|||++++++...+..+|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999987 467899995321 23568999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
|++. ++|..++.+....+++..++.|+.||+.||.|||.+| ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9994 6899988766567999999999999999999999998 99999999999999999999999999986543211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHhhhhccccc-cCCC---
Q 002157 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PMQVVGAVGFQNRR-LEIP--- 898 (959)
Q Consensus 832 -~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------~~ql~~~i~~~~~~-~~iP--- 898 (959)
......||..|+|||++.+..++.++|||||||++|||++|..|+.... ..++...+...... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234579999999999999999999999999999999999876553321 11222211110000 0000
Q ss_pred ----------------------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 ----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ----------------------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++.+||.+||+.||.+||++.|+|++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1345689999999999999999999999875
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=322.71 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=185.3
Q ss_pred EeEeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCcEEEEEec
Q 002157 681 GERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSIITEF 754 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~--~~~~l~LVmEy 754 (959)
+++||+|+||.||+|++. +..||+|.+...... ..+.+|+.+|++++||||+++++++. .+..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 467999999999999863 467999988654332 35678999999999999999999884 35568999999
Q ss_pred cCCCCHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEecCc
Q 002157 755 LPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 822 (959)
Q Consensus 755 ~~gGsL~dlL~k--------~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL----d~~g~VKLiDFGl 822 (959)
+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 96 478777642 1235788899999999999999999998 9999999999999 5678999999999
Q ss_pred cccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH----------HHHhhh
Q 002157 823 SRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM----------QVVGAV 888 (959)
Q Consensus 823 Ak~~~~~~~---~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----------ql~~~i 888 (959)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... +.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 987543321 22345689999999999774 5799999999999999999999999753321 000000
Q ss_pred hc-c----------------------cccc------------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 889 GF-Q----------------------NRRL------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 889 ~~-~----------------------~~~~------------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.. . .... ......+..+++||.+||+.||.+|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0 0000 001123566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.06 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=198.7
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecC--CcEEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP--PNLSIIT 752 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~--~~l~LVm 752 (959)
|++.+.||+|+||.||+++. +++.||+|++........ .....+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999976 678899998865432222 233457888999885 99999999999987 8899999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. ++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||+++. +.+||+|||+++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9996 5888888765557899999999999999999999998 999999999999999 9999999999987643322
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------cccc
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------NRRL 895 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~----------------~~~~ 895 (959)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 234568899999998754 55788999999999999999999999887665433222100 0011
Q ss_pred CC-----------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 EI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 ~i-----------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+ ...++.++++||.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11 12467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.69 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=206.8
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|++.+.||.|++|.||++.. +++.+++|++............+.+|+.++++++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999986 5788999988765544445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
++ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 888888775567899999999999999999999999 999999999999999999999999999876554322334
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--------------------
Q 002157 836 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-------------------- 894 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~-------------------- 894 (959)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999999876 6899999999999999999999999887654433222110000
Q ss_pred --------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 --------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 --------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
......++.++++||.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0112346788999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=340.70 Aligned_cols=277 Identities=23% Similarity=0.305 Sum_probs=226.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..+.|..-++||+|+||.||-++. +|+.||.|++.+...... .....++|..||+++..++||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 345567899999999999999998854 789999998866544332 23346789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
+++||..|.||+|.-+|...+ ..+++..++.++.+|+.||++||..+ ||+|||||+|||||+.|||+|.|+|+|..+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999999986543 46899999999999999999999998 999999999999999999999999999977
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCc
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELD 902 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ql~~~i~~~~~~~~iP~~ls 902 (959)
.... .....+||..|||||++.++.|+...|||+|||+||||+.|+-||...... ++...+ ......++..++
T Consensus 338 ~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS 414 (591)
T KOG0986|consen 338 PEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFS 414 (591)
T ss_pred CCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccC
Confidence 6543 334568999999999999999999999999999999999999999775432 233333 445677889999
Q ss_pred HHHHHHHHHHhhcCCCCCCCHH-----HHHHH--HHhh-----h-hhhCCCCCCCCCCCCCCC
Q 002157 903 PLVARIIWECWQTDPSLRPSFA-----QLTVA--LKPL-----Q-RLVIPSHPDQPSSALPQE 952 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~-----EIL~~--Le~l-----~-kl~~p~~p~~~~~~~p~~ 952 (959)
+++++|.+.+|++||.+|.... ++.++ ++.+ + ..+.|+.-+.|-.||.++
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakD 477 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKD 477 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhh
Confidence 9999999999999999998544 44432 2222 2 244454555555555544
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.08 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=201.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~ 746 (959)
.++|++.+.||+|+||.||+|.. +++.||||++............+.+|+.++++++|+||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 37799999999999999999976 688999998865444444556778899999999999999999988644 3
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+. ++|.+.+... +++..+..++.||+.||+|||.+| |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 5799999995 5888888643 888999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc----------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF---------------- 890 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~---------------- 890 (959)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 4432 23345689999999999999999999999999999999999999987654322211100
Q ss_pred -----cccc-------------cCC-------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 891 -----QNRR-------------LEI-------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 891 -----~~~~-------------~~i-------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.... ... +...+.++++||.+||+.||.+||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000 12346678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.99 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=209.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||.||++.. ++..||+|.+..... .....+.+|+.++++++||||+++++.+...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999975 678899998754332 23456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+. .+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999999763 4788899999999999999999998 999999999999999999999999988765443333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+.. .......+..++..+++||.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 3445688999999999888899999999999999999999999987765443322221 111222344578899999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||..+|.+||++.+++.+
T Consensus 252 ~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 252 CLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=323.64 Aligned_cols=247 Identities=29% Similarity=0.416 Sum_probs=206.9
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.|.....||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344456799999999999976 67889999875432 23455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 101 ~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9999999988653 5888999999999999999999998 99999999999999999999999999876543333334
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHHHHHh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~eL~dLI~kCL 913 (959)
...|+..|+|||.+.+..++.++||||||+++|||++|..||...........+... ..........+..+.+||.+||
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 456899999999999888999999999999999999999999887766554433211 1112222356889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
..||.+||+++++++.
T Consensus 257 ~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 257 VREPSQRATAQELLQH 272 (292)
T ss_pred cCChhHCcCHHHHhhC
Confidence 9999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.06 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=209.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
....++++++..||.|+.|.|+++++ .|...|||.+......+ ..++++..+.++..- .+|+||+.+|+|..+...
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34456778888999999999999987 45889999998776544 345666667766655 589999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+|.||.| ..-+..++.+-..+++|..+-++...++.||.||.++. +|||||+||.|||+|+.|+|||||||++..+.+
T Consensus 167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999998 44677777776778999999999999999999998643 499999999999999999999999999988876
Q ss_pred CcccCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCC--CCc
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPK--ELD 902 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~~iP~--~ls 902 (959)
.. ......|.+.|||||.+.-. .|+.++|||||||.++||.||+.||.+-+.. +++-.+. ++.++.+|. .++
T Consensus 245 Sk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 245 SK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGHMGFS 322 (391)
T ss_pred cc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCcccCcC
Confidence 63 34457899999999999744 5899999999999999999999999996654 3444443 455555553 489
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+++++|+..||++|+.+||.+.++++
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99999999999999999999998875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=351.44 Aligned_cols=242 Identities=31% Similarity=0.497 Sum_probs=212.3
Q ss_pred EeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 683 RIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
+||+|.||+||-|++. ....|||.+...+. ....-+..|+.+.++|+|.|||+++|.+.+++++-|.||.++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999874 45678998765432 2344578899999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccccccCCcccCCCCC
Q 002157 761 FRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 761 ~dlL~k~~~~l--se~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
..+|+..=+++ ++..+-.+..||++||.|||++. |||||||-+||||+ -.|.+||.|||-++.+..-...+.++.
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99998765566 78888999999999999999998 99999999999997 579999999999988766556677899
Q ss_pred CCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 838 GTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 838 GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
||..|||||+|..+ .|++++|||||||++.||.||++||......+ ..-++.+-...+++|..++.+++.||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 99999999999754 48999999999999999999999998865543 3344556677889999999999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 002157 915 TDPSLRPSFAQLTV 928 (959)
Q Consensus 915 ~DP~kRPSa~EIL~ 928 (959)
.||.+||++++++.
T Consensus 818 pd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcccCccHHHhcc
Confidence 99999999999975
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.32 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=211.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
..|.+.+.||+|+||.||++++ ++..||||++..... .......+.+|++++++++|+||+++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4578889999999999999986 578899998875432 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+.+ +|.+++......+++..+..++.||+.||.|||+++ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 99964 788887655567899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+.........+...+..+++||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23456889999999974 456788999999999999999999999887766555554433333344456788999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 910 WECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
.+||+.+|.+||++.+|+.++-.+
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhh
Confidence 999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.85 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=215.4
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
.+.|+-++|+|.++||.|||.-||+++. ++..||+|++.... .+..+...+|++..++++||||++++++...+..
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 4557778999999999999999999985 78889999987654 4556788999999999999999999998755444
Q ss_pred -----EEEEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 002157 748 -----LSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (959)
Q Consensus 748 -----l~LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiD 819 (959)
.||++.|...|+|.+.+++ .+..+++.++++|+.+|++||++||...++++||||||.|||+...+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 9999999999999998864 34579999999999999999999999998999999999999999999999999
Q ss_pred cCccccccCCcc---------cCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhh
Q 002157 820 FGLSRLKHNTFL---------SSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887 (959)
Q Consensus 820 FGlAk~~~~~~~---------~~~t~~GT~~YmAPEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~ 887 (959)
||.++...-... .......|..|.|||.+.-+ ..+.++|||||||+||+|++|.-||...-..-.--.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 999876432111 11123468899999998744 468899999999999999999999965332111112
Q ss_pred hhccccccCCCC--CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 888 VGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 888 i~~~~~~~~iP~--~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+...+....+|. -.+..+.+||+.||+.||.+||++.+++..++.+.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 223343444443 37899999999999999999999999999998764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=319.11 Aligned_cols=249 Identities=29% Similarity=0.399 Sum_probs=199.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++.+.||+|+||.||++.+ +++.||||++...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35677788999999999999987 5788999988754433 44567889999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHh---h-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 752 TEFLPRGSLFRIL---H-RPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 752 mEy~~gGsL~dlL---~-k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
|||+.. +|.++. . .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999854 555443 2 2235689999999999999999999974 7 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccC----CC
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLE----IP 898 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~~----iP 898 (959)
..... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... +....+. ...... .+
T Consensus 159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (288)
T cd06616 159 VDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE 236 (288)
T ss_pred ccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence 43322 2334689999999999876 6899999999999999999999999776531 1212211 111111 22
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++.+||.+||+.||.+||++.+|+.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3478899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.34 Aligned_cols=246 Identities=27% Similarity=0.453 Sum_probs=219.8
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|.|+++||+|+||.||++.+ .|..+|||.+... ..+.++..|+.||++++.|+||++||.|.....+|||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 66788999999999999965 6889999987543 45678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
..|++.++++-+...+.+.++..+++..+.||+|||... -||||||..|||++.+|+.||+|||.+..+.+......+
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 999999999877789999999999999999999999976 799999999999999999999999999998888777888
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHHHhh
Q 002157 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
..||+.|||||++..-.|+.++||||||++..||..|++||.+..++.....+.... ..+..|...+.++.+||++||.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 999999999999999999999999999999999999999999988876544443221 1223456678899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002157 915 TDPSLRPSFAQLTVA 929 (959)
Q Consensus 915 ~DP~kRPSa~EIL~~ 929 (959)
++|++|.|+.+++++
T Consensus 269 K~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 269 KKPEERKTALRLCEH 283 (502)
T ss_pred CCHHHHHHHHHHhhh
Confidence 999999999998875
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.18 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=208.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.|.....||+|+||.||++.. +++.||||++...... ....+.+|+.+++.++||||+++++.+..++.+++||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 345556799999999999976 6889999988654322 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999998865 35889999999999999999999998 99999999999999999999999999876544333334
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHHHHHh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~eL~dLI~kCL 913 (959)
...|+..|+|||++.+..++.++|||||||++|+|++|..||......+....+... ......+..++..+.++|.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 567899999999999988999999999999999999999999877765554443211 1122234467889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.+|.+||++.+|++.
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.67 Aligned_cols=243 Identities=27% Similarity=0.438 Sum_probs=206.3
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||.|+||.||++++ +++.|++|++..... .......+.+|++++++++|+||+++++.+.....+++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999987 488999999875533 223456788999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc--------c
Q 002157 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--------S 832 (959)
Q Consensus 761 ~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~--------~ 832 (959)
.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997654 7899999999999999999999998 99999999999999999999999999875433211 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCC--cHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL--DPLVARIIW 910 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~l--s~eL~dLI~ 910 (959)
.....++..|++||.+.+..++.++||||||+++|+|++|..||......+....+... ....+... +..+.+||.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcCCCccccCCHHHHHHHH
Confidence 23456888999999999888999999999999999999999999888877766655432 33344444 899999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~Le 931 (959)
+||+.+|.+||++..+.+.|+
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhc
Confidence 999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.26 Aligned_cols=246 Identities=30% Similarity=0.435 Sum_probs=207.3
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|...+.||+|++|.||++.+ +++.|++|++.... ......+.+|+.+++.++|+||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567899999999999976 57889999875432 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++.. ..+++..+..++.||+.||+|||++| |+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 46888999999999999999999998 99999999999999999999999998876543322333
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHHh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-~~~iP~~ls~eL~dLI~kCL 913 (959)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.||...++......+..... ....+..++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 45689999999999988899999999999999999999999988776655554432211 11223347889999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 002157 914 QTDPSLRPSFAQLTV 928 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~ 928 (959)
+.+|.+||++.++++
T Consensus 254 ~~~p~~Rpt~~~il~ 268 (285)
T cd06648 254 VRDPAQRATAAELLN 268 (285)
T ss_pred ccChhhCcCHHHHcc
Confidence 999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.48 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=204.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP---- 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~---- 746 (959)
...++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999987 5788999998765433334456778999999999999999999987655
Q ss_pred ------cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 747 ------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 747 ------~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
.+++|+||+++ +|..++......+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 787877765557899999999999999999999998 999999999999999999999999
Q ss_pred CccccccCCcc-cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---c-
Q 002157 821 GLSRLKHNTFL-SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---R- 894 (959)
Q Consensus 821 GlAk~~~~~~~-~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~---~- 894 (959)
|++........ ......++..|+|||++.+. .++.++|||+|||++|+|++|+.||...+..+....+..... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99986543321 11223567889999988754 478899999999999999999999987665443322211000 0
Q ss_pred ------------------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 ------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ------------------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
......++..+.+||.+||+.||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00122468899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=350.91 Aligned_cols=246 Identities=34% Similarity=0.504 Sum_probs=214.1
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC--CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc--EEEE
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--LSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~--~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~--l~LV 751 (959)
.++..+||+|+|-+||+|.+ .|-.||--.+...+ ..+.....|..|+.+|+.|+|||||+||..|.+..+ +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 45667899999999999966 56666643333222 234456789999999999999999999999988776 8899
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~~~~ 830 (959)
+|++..|+|..|+++. +..+...+..|++||+.||.|||++.|+|||||||.+||+|+ ..|.|||+|+|+|.......
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999999775 478999999999999999999999999999999999999997 56999999999999887654
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
. ...+|||.|||||++. +.|+..+||||||+++.||+|+.+||.. .++.+++.++..+.++-.+.+.-++++++||
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 3 3488999999999998 7799999999999999999999999966 6788999888777767667777789999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||.. ..+|+++.|||.
T Consensus 278 ekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhcC-chhccCHHHHhh
Confidence 999999 999999999985
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.86 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=202.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~LV 751 (959)
++|++.+.||.|++|.||++.+ +++.||+|.+..... ......+.+|++++++++||||++++++|... ..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4689999999999999999987 578899998875433 24556788999999999999999999988653 468999
Q ss_pred EeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 752 mEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||+++++|.+++.+ ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988642 3456888999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHhhhhccccccCCC-----
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIP----- 898 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-----~~ql~~~i~~~~~~~~iP----- 898 (959)
.. .....++..|+|||.+.+..++.++|||+||+++|+|++|..||.... ..+....+.. .....++
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGN 234 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCC
Confidence 22 123567889999999999999999999999999999999999997652 2233332221 1111111
Q ss_pred -CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 -KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 -~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
...++.+++||.+||..+|.+||++.||+.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 234678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.53 Aligned_cols=240 Identities=27% Similarity=0.361 Sum_probs=200.8
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||+|+||+||+|.+ +++.||+|++....... .....+.+|+.+|++++||||+++++++...+.+++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999976 58899999987543322 2344567899999999999999999999999999999999999999
Q ss_pred HHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCC
Q 002157 761 FRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839 (959)
Q Consensus 761 ~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT 839 (959)
.+++.+.. ..+++..++.++.|++.||.|||++| |+||||+|+|||++.++.+||+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99986543 36899999999999999999999998 999999999999999999999999998765432 223345688
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhc
Q 002157 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (959)
Q Consensus 840 ~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~ 915 (959)
..|+|||++.+..++.++||||||+++|+|++|+.||..... .++...+ ......++..+++.++++|.+||+.
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--LEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--ccccccCCccCCHHHHHHHHHHccC
Confidence 899999999988899999999999999999999999977554 2222221 2335566778899999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 002157 916 DPSLRP-----SFAQLTV 928 (959)
Q Consensus 916 DP~kRP-----Sa~EIL~ 928 (959)
||.+|| ++.+++.
T Consensus 236 ~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 236 DPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ChhHccCCCcccHHHHHh
Confidence 999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=310.17 Aligned_cols=245 Identities=22% Similarity=0.391 Sum_probs=193.6
Q ss_pred EeeccCcEEEEEEEE-CCc---eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLGSYGEVYHADW-NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG~fG~VYka~~-~g~---~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.||+|+||.||+++. ++. .+++|.+.... .......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999965 332 35566554332 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC--cccC
Q 002157 759 SLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSS 833 (959)
Q Consensus 759 sL~dlL~k~~---~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~--~~~~ 833 (959)
+|.+++.+.. ....+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999997532 24566778889999999999999998 999999999999999999999999998643211 1122
Q ss_pred CCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc----cccCCCCCC
Q 002157 834 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKEL 901 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g-------~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~----~~~~iP~~l 901 (959)
....++..|+|||++.. ..++.++||||||+++|||++ |..||......+....+.... .+..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34568899999999853 235778999999999999996 577888777665544432221 123344567
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
+..+.+++..|| .+|++||++.+|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 889999999999 67999999999988774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.58 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=197.3
Q ss_pred CeeEEeEeeccCcEEEEEEEE----CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~ 749 (959)
+|++.+.||+|+||.||+|.+ .+..||||.+..... .......+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488999999999999999987 468899999876331 112234567899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC----CCcEEEEecC
Q 002157 750 IITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFG 821 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k----~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~----~g~VKLiDFG 821 (959)
+||||+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999965 67776642 1236889999999999999999999998 999999999999999 9999999999
Q ss_pred ccccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------HHhhh
Q 002157 822 LSRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------VVGAV 888 (959)
Q Consensus 822 lAk~~~~~~~---~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---------l~~~i 888 (959)
++........ ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+..... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543322 23345688999999988764 57899999999999999999999998654321 00000
Q ss_pred ----h--------------------ccccccCCC-----------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 889 ----G--------------------FQNRRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 889 ----~--------------------~~~~~~~iP-----------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. .......++ ...+.++.++|.+||+.||++||++.+++.+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000011111 1566789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.90 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=198.6
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHH-HcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~-~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.||.|+||.||+|.+ +++.||||++...... ......+..|..++. ..+|+||+++++++...+.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999987 6789999998654332 222334455555544 45899999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.+||+|||++..... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999764 36889999999999999999999998 99999999999999999999999999875432 23456
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCCCCCCcHHHHHHHHHHhhc
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARIIWECWQT 915 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--~~~iP~~ls~eL~dLI~kCL~~ 915 (959)
|+..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... ....+..++.++.++|.+||+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88999999999988889999999999999999999999988877766554432221 2223346789999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 002157 916 DPSLRPSFAQLTVAL 930 (959)
Q Consensus 916 DP~kRPSa~EIL~~L 930 (959)
+|++||++.++.+.|
T Consensus 235 ~p~~R~~~~~~~~~l 249 (260)
T cd05611 235 DPAKRLGANGYQEIK 249 (260)
T ss_pred CHHHccCCCcHHHHH
Confidence 999999765554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.61 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=204.8
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~ 746 (959)
.+.+..++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.++.++ .|+||+++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34567789999999999999999999885 889999998755432 2345566777777666 5999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+++||||+. +.|..++......+++..+..++.||+.||+|||+ ++ |+||||+|+||+++.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999985 57888776645578999999999999999999997 57 99999999999999999999999999876
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccccCCC--
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIP-- 898 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~~~iP-- 898 (959)
...... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+... .....+
T Consensus 165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (296)
T cd06618 165 LVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPN 242 (296)
T ss_pred ccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCC
Confidence 543322 22345788999999997654 78899999999999999999999976433 2333332222 122222
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++++||.+||+.||.+||++.+++.+
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3468899999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.91 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=205.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~l 748 (959)
.+|.+.+.||+|+||+||++++ +++.||||.+............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999986 678999998875433333455677899999999999999999988654 348
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999995 6899988764 47899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-----------------
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF----------------- 890 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~----------------- 890 (959)
.........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3223344568999999998865 4588999999999999999999999987653221111100
Q ss_pred ----------c--ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHhh
Q 002157 891 ----------Q--NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 933 (959)
Q Consensus 891 ----------~--~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~l 933 (959)
. .........+++++++||.+||+.+|.+||++++++.+ ++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00001124578899999999999999999999999987 6544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=338.79 Aligned_cols=262 Identities=27% Similarity=0.502 Sum_probs=229.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC----Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN----GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~----g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~ 742 (959)
.++++..+.....+.||.|-||.||+|.+. |+ .||||.-+.+. ..+..+.|..|..+|++++|||||+|+|+|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 456677778888999999999999999762 33 38888765544 445578899999999999999999999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
.+ ...|||||+++-|.|..||+++...++......+++||..||.|||+.. +|||||-.+|||+....-|||+|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 86 4789999999999999999998889999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 823 SRLKHNTFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 823 Ak~~~~~~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
++...+..+. .....-...|||||-++-..++.++|||.||+++||++. |..||.+....++...+ .++.+++.|+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCC
Confidence 9987765332 333334567999999999999999999999999999874 89999998887776655 36678999999
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+++.+..|+.+||..+|.+||.|.+|...|..+.+
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988865
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=308.47 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=203.0
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcEEEEEe
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIITE 753 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l~LVmE 753 (959)
|++.+.||.|+||.||+|++ +++.||||++............+.+|+.++++++|+||+++++++... +.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 468899999886643333445678999999999999999999999888 88999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-c
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 832 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~-~ 832 (959)
|+++ +|..++.+....+++..++.++.||+.||+|||..+ ++|+||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9974 899988766567899999999999999999999998 99999999999999999999999999986654321 1
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------------
Q 002157 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------- 894 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~----------------- 894 (959)
.....++..|+|||.+.+. .++.++|||+||+++|+|++|+.||...+.......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2234578899999988754 5789999999999999999999999887765443322110000
Q ss_pred ------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 ------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+...++..+.++|.+||+.+|.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011123788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.83 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=199.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------- 745 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------- 745 (959)
.++|++.++||.|+||.||+|++ +++.||||++............+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999987 578899998875443332334567899999999999999999987543
Q ss_pred -CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 746 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 746 -~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
..+++||||+.+ +|...+......+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999964 788777665567999999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCccc-----------CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc
Q 002157 825 LKHNTFLS-----------SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 825 ~~~~~~~~-----------~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~ 892 (959)
........ .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 65432111 1233578889999998764 57899999999999999999999998877654333221000
Q ss_pred c---------------------ccCCC-------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 R---------------------RLEIP-------KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 ~---------------------~~~iP-------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ....+ ..+.+++.+||.+||+.||.+||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00000 234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.48 Aligned_cols=240 Identities=24% Similarity=0.341 Sum_probs=195.6
Q ss_pred EeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHH---HHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREV---KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 683 ~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-~~~ef~~Ei---~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
.||+|+||.||++.+ +++.||||++........ ....+..|. ++++...||||+++++++...+.+++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 578999999876543221 112233343 34445579999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~ 836 (959)
+++|.+++.+. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 99999998654 46899999999999999999999998 999999999999999999999999998755432 22345
Q ss_pred CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 837 AGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 837 ~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.|+..|+|||++.+. .++.++||||||+++|+|++|+.||..... ....... ......+|..++.++.++|.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHH
Confidence 799999999999754 688999999999999999999999987632 2222211 2335567777899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 002157 913 WQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 913 L~~DP~kRP-----Sa~EIL~~ 929 (959)
|..+|.+|| ++.+++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhC
Confidence 999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=314.31 Aligned_cols=252 Identities=17% Similarity=0.208 Sum_probs=189.7
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECC-----ceEEEEEeeccCCCH--H-H------HHHHHHHHHHHHHcCCCceeE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSG--A-A------LLEFKREVKIMRRLRHPNVVL 737 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g-----~~VAVK~i~~~~~~~--~-~------~~ef~~Ei~IL~~L~HpNIVk 737 (959)
++..++|++.++||+|+||+||+|.+.+ ..+|+|+........ . . ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3555789999999999999999998743 356777543222111 0 0 011223344555678999999
Q ss_pred EeeeeecCC----cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 002157 738 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 738 L~g~~~~~~----~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g 813 (959)
+++++.... ..++++|++. .++.+++... ...++..++.|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998765443 3467888874 4677776543 34678888999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 002157 814 NVKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVV 885 (959)
Q Consensus 814 ~VKLiDFGlAk~~~~~~-------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~ 885 (959)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999998653211 112235699999999999999999999999999999999999999987732 2211
Q ss_pred --------hhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 886 --------GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 886 --------~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
..+. .... .+..+++++.+++..||+.+|++||++.+|++.|
T Consensus 244 ~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLH--EGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhh--hhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111 1111 2346689999999999999999999999999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.22 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=208.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----cEE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~-----~l~ 749 (959)
+|++.+.||.|+||.||+|++ .++.||||++............+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999987 4789999988765433445567889999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||++ ++|.+++.+.. .+++..++.++.||+.||+|||++| |+||||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 58999987654 7999999999999999999999998 999999999999999999999999999876543
Q ss_pred c---ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------------
Q 002157 830 F---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 893 (959)
Q Consensus 830 ~---~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------ 893 (959)
. .......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 123345689999999999888 789999999999999999999999988776543332211000
Q ss_pred -----------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHh
Q 002157 894 -----------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKP 932 (959)
Q Consensus 894 -----------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~ 932 (959)
...+...++.++.+||.+||+.+|.+||++.+++.+ |+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000123467889999999999999999999999874 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=311.79 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=196.2
Q ss_pred EeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHHHHHH---HcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMR---RLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 683 ~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-~~~ef~~Ei~IL~---~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
.||+|+||.||++.. +++.||||.+........ ....+.+|..+++ ..+|+||+.+++++..++.+++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999976 578999998876543222 1223344444443 3479999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~ 836 (959)
+++|.+++.+. ..+++..+..++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 99999998764 36899999999999999999999999 999999999999999999999999998755432 12335
Q ss_pred CCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 837 AGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 837 ~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q--l~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
.|+..|+|||.+. +..++.++|||||||++|+|++|..||....... ..... .......+|..++.++++||.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 4568999999999999999999999997643321 11111 122345567788999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH--HHh
Q 002157 914 QTDPSLRP-----SFAQLTVA--LKP 932 (959)
Q Consensus 914 ~~DP~kRP-----Sa~EIL~~--Le~ 932 (959)
+.||.+|| ++++++++ ++.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999999 59999885 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.92 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=200.0
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeeecCCc-----
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPN----- 747 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~~~~~----- 747 (959)
|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999987 478999999875433333334566788877766 59999999999988777
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++++|||+.+ +|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999974 8988886543 36899999999999999999999998 999999999999999999999999998776
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------- 893 (959)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4332 22334578899999999999899999999999999999999999988776554433211000
Q ss_pred --------c----cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 --------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 --------~----~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ......++..+.+||.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0001234677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.06 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=201.6
Q ss_pred eeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.+++.+|.|+++.||+++.+++.||||++............+.+|+.++++++|+||+++++++...+.++++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34566677777888888877899999999987655566677899999999999999999999999999999999999999
Q ss_pred CCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc------
Q 002157 758 GSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------ 830 (959)
Q Consensus 758 GsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~------ 830 (959)
++|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999753 346889999999999999999999998 9999999999999999999999999886543211
Q ss_pred -ccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc---------------
Q 002157 831 -LSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 892 (959)
Q Consensus 831 -~~~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~--------------- 892 (959)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 112334577889999999763 57889999999999999999999998765443221110000
Q ss_pred -----------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 -----------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 -----------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.....+..++.++.+||.+||+.||.+||++++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0011112345678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.24 Aligned_cols=237 Identities=28% Similarity=0.433 Sum_probs=206.8
Q ss_pred eeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCH
Q 002157 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (959)
Q Consensus 684 LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (959)
||+|+||.||++.+ .++.||+|++...... ......+.+|+.++++++|+||+++++.+.....+++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999987 4789999998765432 23566788999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCC
Q 002157 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (959)
Q Consensus 761 ~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~ 840 (959)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99997653 6899999999999999999999988 99999999999999999999999999987654323344567899
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCC
Q 002157 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 920 (959)
Q Consensus 841 ~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kR 920 (959)
.|++||.+.+...+.++|+|+||+++|+|++|..||...+..+....+.. ....+|..++..+.++|.+||..||++|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999988889999999999999999999999988776655555533 4567788889999999999999999999
Q ss_pred CCHHH
Q 002157 921 PSFAQ 925 (959)
Q Consensus 921 PSa~E 925 (959)
|++.+
T Consensus 236 ~~~~~ 240 (250)
T cd05123 236 LGSGG 240 (250)
T ss_pred CCccc
Confidence 99944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.84 Aligned_cols=245 Identities=29% Similarity=0.439 Sum_probs=205.7
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
|...+.||+|+||+||+|++ +++.|+||++..... .......+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999986 678899998875433 333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+. ++|.+++......+++..++.++.||+.+|.|||++| |+||||||+||+++.++.+||+|||++.... ...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~ 175 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PAN 175 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC----CCC
Confidence 96 5788887665567899999999999999999999998 9999999999999999999999999886432 223
Q ss_pred CCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 835 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 835 t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
...|+..|+|||++. +..++.++||||||+++|+|++|..||...+.......+............++..+++||.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 467899999999984 35578899999999999999999999988876655554433333333334567889999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||+.+|.+||++.+++..
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=321.56 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=201.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~~l~ 749 (959)
++|++.+.||+|+||.||+|.. +++.||+|++............+.+|+.+|++++||||++++++|.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999976 68899999987643333345667789999999999999999998763 34689
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 68999986643 5899999999999999999999998 999999999999999999999999999765432
Q ss_pred ccc----CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------
Q 002157 830 FLS----SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 890 (959)
Q Consensus 830 ~~~----~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-------------- 890 (959)
... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 124578999999999866 4588999999999999999999999987654332211100
Q ss_pred ----------cccccCC-----CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 891 ----------QNRRLEI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 891 ----------~~~~~~i-----P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....... ....+.++++||.+||+.+|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000111 13468899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.60 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=203.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~--~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
+|++.+.||.|+||.||+++. ++..||+|++...... ......+.+|+++++++ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478999999999999999975 5788999998754321 12345678899999999 689999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999999764 36888999999999999999999998 99999999999999999999999999976543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCC
Q 002157 829 TF-LSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 829 ~~-~~~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~~~iP~~l 901 (959)
.. .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+ ......+|..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 21 122345689999999998753 467899999999999999999999964332 2222222 22244567788
Q ss_pred cHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
++.+.+|+.+||+.||.+|| ++.+++.+
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=305.43 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=206.7
Q ss_pred CeeEEeEeeccCcEEEEEEEEC--CceEEEEEeec---cCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~---~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+|.+.+.||+|+||.||++++. +..+++|+++. ..........+.+|+.++++++||||+++++++.+...+++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999774 34466665543 223333445677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 752 mEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||+++++|.+++.+ ....+++..++.++.|++.||.|||+.| ++|+||||+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998853 3356899999999999999999999998 999999999999975 5699999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333445668899999999988888999999999999999999999998776655544442 233444566788999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.+|++||++.+++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.52 Aligned_cols=239 Identities=19% Similarity=0.344 Sum_probs=194.5
Q ss_pred CCeeEEeEe--eccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEE
Q 002157 676 EDLVLGERI--GLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 676 ~dy~I~k~L--GkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~L 750 (959)
++|++.+.+ |.|+||.||+++. ++..+|+|++........ |+.....+ +|+||++++++|...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 355565555 9999999999976 678899998865433221 22222222 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~~ 829 (959)
||||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999997654 7899999999999999999999999 99999999999999988 9999999998765432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HhhhhccccccCCCCCCcHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql--~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
....|+..|+|||++.+..++.++||||||+++|+|++|..||........ .............+..+++.+++
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 235689999999999998899999999999999999999999986543221 11111123344556678999999
Q ss_pred HHHHHhhcCCCCCCC-HHHHHH
Q 002157 908 IIWECWQTDPSLRPS-FAQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPS-a~EIL~ 928 (959)
||.+||+.+|.+||+ ++++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhccChhhCCchHHHHhc
Confidence 999999999999995 688874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=343.12 Aligned_cols=252 Identities=17% Similarity=0.221 Sum_probs=188.2
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC---CceEEEEEe--------------ec-cCCCHHHHHHHHHHHHHHHHcCCCcee
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKF--------------LD-QDFSGAALLEFKREVKIMRRLRHPNVV 736 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~---g~~VAVK~i--------------~~-~~~~~~~~~ef~~Ei~IL~~L~HpNIV 736 (959)
.++|+++++||+|+||+||+|.++ +..+++|.+ .+ ..........+.+|+.+|++++|+|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998652 222222211 10 111122345678999999999999999
Q ss_pred EEeeeeecCCcEEEEEeccCCCCHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 002157 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (959)
Q Consensus 737 kL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~----~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~ 812 (959)
++++++...+..|+|+|++. ++|..++.... .......++.|+.||+.||.|||++| ||||||||+||||+.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 99999999999999999995 57777764321 12335667789999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCC--h-HHHHhh
Q 002157 813 WNVKVSDFGLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMN--P-MQVVGA 887 (959)
Q Consensus 813 g~VKLiDFGlAk~~~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~P-F~g~~--~-~ql~~~ 887 (959)
+.+||+|||+++...... ......+||..|+|||++.+..++.++|||||||++|||++|..+ |.... + .++...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998764432 223346799999999999999999999999999999999998764 43322 1 111111
Q ss_pred hhccc-ccc-----------------------CC-----CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 888 VGFQN-RRL-----------------------EI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 888 i~~~~-~~~-----------------------~i-----P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+.... ... .+ ...++.++.++|.+||+.||.+||++.|++.+
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 10000 000 00 01345678889999999999999999999864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.48 Aligned_cols=249 Identities=28% Similarity=0.409 Sum_probs=207.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.|...+.||+|+||.||+|++ ++..||||.+..... .......+.+|+++++.++|+||+++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788999999999999987 577899998865322 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. |+|.+++......+++..+..++.|++.||.|||+++ ++||||||.|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9996 5888877554556899999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....|+..|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+++||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 3456889999999985 345788999999999999999999999887665544444333323333456889999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+||+.+|.+||++.+++...-
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 9999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=370.38 Aligned_cols=246 Identities=31% Similarity=0.460 Sum_probs=213.2
Q ss_pred EEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
-+..||.|.||.||.|.. +|...|||-++...........+.+|+.+|..|+|||+|+++|+-.+.+..+|.||||.+
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 356799999999999975 788899998877766655667789999999999999999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc----ccC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LSS 833 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~----~~~ 833 (959)
|+|.++++. ++..++.....+..|++.|+.|||++| ||||||||+||||+.+|.||++|||.|..+.... ...
T Consensus 1319 GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1319 GSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred CcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999999965 346777777788889999999999999 9999999999999999999999999998776542 123
Q ss_pred CCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....||+-|||||+|.|.. ...++|||||||++.||+||+.||...+.. ++...+. ....+++|..++.+-++||
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHHHHH
Confidence 4677999999999998644 567899999999999999999999876654 3444443 4567889999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||..||++|.++.||+++
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHh
Confidence 99999999999998888764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=319.40 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=201.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC--CcEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~--~~l~ 749 (959)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++++ +|+||++++++|... ..++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 36789999999999999999976 578899998865433333445677899999999 999999999988654 3589
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||++ ++|..++.+. .+.+..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999988764 6788889999999999999999998 999999999999999999999999999865432
Q ss_pred c-----ccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------
Q 002157 830 F-----LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 892 (959)
Q Consensus 830 ~-----~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~----------- 892 (959)
. .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 1 12234568999999998865 457889999999999999999999998765443322211000
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 ------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ------------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
........++.++.+||.+||+.||.+||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0001113368899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.55 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=199.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~l 748 (959)
++|++.++||+|+||.||+|.+ +++.||||++..... ......+.+|+.++++++|+||+++++++... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6799999999999999999976 678999998854322 23345677899999999999999999886544 348
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++|+||+. ++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 99999996 588888865 36899999999999999999999999 99999999999999999999999999876533
Q ss_pred Ccc---cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh---------------
Q 002157 829 TFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--------------- 889 (959)
Q Consensus 829 ~~~---~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~--------------- 889 (959)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 211 1233568999999998765 568999999999999999999999997755432211110
Q ss_pred cc---------ccccC-----CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHhh
Q 002157 890 FQ---------NRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 933 (959)
Q Consensus 890 ~~---------~~~~~-----iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~l 933 (959)
.. ..... .....+.++.+||.+||+.+|.+||++.+++.+ |+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 00000 112457889999999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.84 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=204.6
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|++.+.||.|+||.||+|+. +++.||+|++............+.+|+.++++++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999987 4789999998765433344566788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
+ ++|.+++.+....+++..++.++.|++.||.|||+++ |+||||+|+||+++.++.+||+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5899999876457999999999999999999999998 999999999999999999999999999876544333334
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc----------------ccc---
Q 002157 836 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRL--- 895 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~----------------~~~--- 895 (959)
..++..|+|||.+.+. .++.++|||+||+++|+|++|..||.+.........+.... ...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5567889999998776 78899999999999999999999998876543332211000 000
Q ss_pred --------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 --------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 --------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....++..+.++|.+||..||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011234778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=327.06 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=221.3
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
-.+++.+.+.++++||+|-||.|.+|+..+ .+||||+++.... .....+|.+|+++|.+|+|||||.++++|..++.+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 346778889999999999999999998866 8999999876543 34467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~l-se~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+||+||+.+|+|.+|+.+...+. .......|+.||+.||+||.+.+ +|||||-+.|||++.++++||+|||.++-+-
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999998764333 45566779999999999999999 9999999999999999999999999998442
Q ss_pred C--CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH--hCCCCCCCCChHHHHhhhhc------cccccCC
Q 002157 828 N--TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA--TLKLPWIGMNPMQVVGAVGF------QNRRLEI 897 (959)
Q Consensus 828 ~--~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELL--tG~~PF~g~~~~ql~~~i~~------~~~~~~i 897 (959)
. .+......+-..+|||||.|..++++.++|+|+||+++||++ |...||......++...... ....+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 2 222223345567999999999999999999999999999975 57899999888877655421 1123456
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
|.-++..+.+||.+||+.|-.+||+|++|...|..
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 77889999999999999999999999999988864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=315.67 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=203.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
.++|++.+.||+|+||.||++.. ++..||||++............+.+|+.+|++++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46799999999999999999976 6788999988654434444557889999999999999999999987654
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 7799988865 36889999999999999999999998 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 892 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~------------- 892 (959)
... .....+++.|++||++.+ ..++.++|+||||+++|+|++|..||.+.+.......+....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 234567899999999876 457899999999999999999999998766433222111000
Q ss_pred ----------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHH--HHHHhh
Q 002157 893 ----------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT--VALKPL 933 (959)
Q Consensus 893 ----------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL--~~Le~l 933 (959)
....+...+++++.++|.+||+.||.+||++.+++ .+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00012245778899999999999999999999998 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.27 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=206.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~--~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
+|++.+.||+|+||.||++++ +++.||||++...... ......+.+|+.++.++ +|+||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999974 4678999988754321 22345678999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+. ..+++..+..++.|++.+|.|||..+ ++||||||.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998754 36888999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCC
Q 002157 829 TFL-SSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 829 ~~~-~~~t~~GT~~YmAPEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~~~iP~~l 901 (959)
... ......|+..|++||.+.+.. .+.++|||+||+++|+|++|..||..... ......+ .......|..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 221 122356899999999987765 78899999999999999999999964322 2222222 12234567778
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
+.++.+||.+||+.||++||++.++.+.|+.
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999999999999999999998877776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=343.63 Aligned_cols=266 Identities=32% Similarity=0.504 Sum_probs=236.3
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
-+|......|.++||.|.||.||+|+. +...||||.++. ...+....+|+.|..||-++.||||++|.|++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 357778899999999999999999976 234699998754 45667788999999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
...+||+|||++|.|..||+++..++...++.-+++.|+.||+||-+.+ +|||||-.+||||+.+...|+.|||+++.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999999999999999889999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCcccCCCCC---CCCCccCcccccCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTFLSSKSTA---GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~~~~~t~~---GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELL-tG~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
+.+......+.. -..+|.|||.|...+++.++||||+||++||.+ .|..||=++...+....+. +..+++-|.++
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCC
Confidence 865543322222 246899999999999999999999999999976 5899999998888877764 56788889999
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~ 940 (959)
+..+.+|+..||++|-.+||.|.||+..|+++.+.....
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 999999999999999999999999999999987654433
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.87 Aligned_cols=243 Identities=29% Similarity=0.432 Sum_probs=204.3
Q ss_pred EeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
..+||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 46799999999999976 67899999875432 234556889999999999999999999999999999999999999
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~G 838 (959)
+|.+++... .+++..++.++.|++.+|+|||+.| |+||||+|+||+++.++.++|+|||++..............|
T Consensus 103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 999988653 5788999999999999999999998 999999999999999999999999988765433222334568
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHHHHHhhcCC
Q 002157 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 839 T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
+..|++||.+.+..++.++|+||||+++|+|++|..||.+....+....+... .........++..+.++|.+||+.+|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 99999999998888899999999999999999999999887665544433211 11222334678899999999999999
Q ss_pred CCCCCHHHHHHH
Q 002157 918 SLRPSFAQLTVA 929 (959)
Q Consensus 918 ~kRPSa~EIL~~ 929 (959)
.+||++.+++.+
T Consensus 259 ~~R~~~~~ll~~ 270 (292)
T cd06657 259 AQRATAAELLKH 270 (292)
T ss_pred ccCcCHHHHhcC
Confidence 999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.23 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=202.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------~ 747 (959)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999976 6889999988754433334456789999999999999999999986543 4
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++|+||+. .+|..++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 689999995 47777663 35888999999999999999999998 9999999999999999999999999987643
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 892 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-------------- 892 (959)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 AE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 22 234568899999999876 458899999999999999999999998876543332211100
Q ss_pred -------cccC--------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHhhhh
Q 002157 893 -------RRLE--------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQR 935 (959)
Q Consensus 893 -------~~~~--------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~l~k 935 (959)
.... .....+.++++||.+||+.||.+||++.+++.+ ++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 012467789999999999999999999999954 777654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.35 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=199.0
Q ss_pred Eeecc--CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG--~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.||+| +||+||++++ .++.||||++..........+.+.+|+.+++.++||||++++++|...+.+++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 7899999998766555556678899999999999999999999999999999999999999
Q ss_pred CHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc-----
Q 002157 759 SLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS----- 832 (959)
Q Consensus 759 sL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~----- 832 (959)
+|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999987542 35888999999999999999999998 999999999999999999999999865332111100
Q ss_pred --CCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc----------------
Q 002157 833 --SKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------------- 892 (959)
Q Consensus 833 --~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~---------------- 892 (959)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 1112356679999999764 47899999999999999999999998765433321111000
Q ss_pred -----------------------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhhhh
Q 002157 893 -----------------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQRL 936 (959)
Q Consensus 893 -----------------------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~kl 936 (959)
.....+..++..+++||.+||+.||.+|||+.+++. +++.+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 011112345678999999999999999999999974 55555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.66 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=199.3
Q ss_pred CCee-EEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH------------HHHHHHHHHHHHHHcCCCceeEEee
Q 002157 676 EDLV-LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVLFMG 740 (959)
Q Consensus 676 ~dy~-I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~------------~~~ef~~Ei~IL~~L~HpNIVkL~g 740 (959)
++|. +.+.||.|+||+||+|.+ .++.||||++........ ....+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 567899999999999976 578999998865432210 0124678999999999999999999
Q ss_pred eeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
++...+..++||||+. ++|.+++... ..+++.....++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 5899988654 46889999999999999999999998 999999999999999999999999
Q ss_pred CccccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 002157 821 GLSRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (959)
Q Consensus 821 GlAk~~~~~--------------~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~ 885 (959)
|++...... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998765411 1112234568899999999764 4689999999999999999999999887765544
Q ss_pred hhhhcccc--------------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 886 GAVGFQNR--------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 886 ~~i~~~~~--------------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+..... ........+.++.+||.+||+.+|.+||++.+++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 32211000 00011345788999999999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=302.78 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=199.0
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEec
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
|++.+.||.|+||.||+|.. +++.|+||++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 5678999988654332 12234457899999998 99999999999999999999999
Q ss_pred cCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+ +++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||+|.||+++.++.++|+|||++....... ..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence 9 789999886643 46899999999999999999999998 9999999999999999999999999998664332 22
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------------ccc-
Q 002157 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-----------------NRR- 894 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-----------------~~~- 894 (959)
....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34568899999998854 45789999999999999999999999876654332211100 000
Q ss_pred ----------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 ----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ----------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.......+.++++||.+||+.||.+||+++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00111236789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=329.34 Aligned_cols=258 Identities=35% Similarity=0.610 Sum_probs=226.3
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
.|+....++.+..+||-|.||.||.|.|+ .-.||||.++.+ ...+.+|+.|..+|+.++|||+|+|+|+|..+..
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 45556667888899999999999999885 567999987543 2347799999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~-~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
+|||+|||..|+|.+||++..+ .++...+++++.||..||+||..++ +|||||-.+||||.++..||++|||++++.
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999987543 4677788999999999999999998 999999999999999999999999999987
Q ss_pred cCCccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
....+. .....-...|.|||-+.-..++.|+|||+||+||||+.| |--||.+.+..+++..+ ....+..-|..|++.
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCPpk 494 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCPPK 494 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCCHH
Confidence 654332 223334567999999999999999999999999999987 67899999988887765 466788899999999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+.+|+..||+..|.+||+|.+|-+.|+.+
T Consensus 495 VYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 495 VYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 99999999999999999999999999866
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=313.81 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=200.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~ 746 (959)
.++|.+.+.||+|+||.||++.. +++.||||++............+.+|+.++++++|+||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999975 678999998875433333455678899999999999999999987543 3
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..+++++++ +++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 477888887 78999888653 5889999999999999999999998 999999999999999999999999998765
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 893 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------ 893 (959)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 171 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 332 234568999999999876 5688899999999999999999999987665433222110000
Q ss_pred ---------ccCC--------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ---------RLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ---------~~~i--------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...+ ....++++++||.+||+.||.+||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0001 12357889999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=316.16 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=203.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-----
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 747 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~----- 747 (959)
.++|++.+.||+|+||.||+|++ ++..||||++............+.+|+.++++++|+||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999987 57889999886543333445667889999999999999999998876654
Q ss_pred -EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 -l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799999875 36899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 893 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------ 893 (959)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+....+..+.....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 234568899999999876 3678999999999999999999999988766544332211000
Q ss_pred --------------c---cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 --------------R---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 --------------~---~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. ......++.++.+||.+||+.||.+||++.+|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 01112458899999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.81 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=200.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-~~~l~LV 751 (959)
.++|++.+.||.|+||.||+++. +++.||||++............+.+|+.++++++||||++++++|.. ...+++|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 36799999999999999999976 67889999886544333445667889999999999999999999865 5578999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+ +++|..++... .+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||++......
T Consensus 89 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 89 TELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred eehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 9998 56899888653 5788888899999999999999998 999999999999999999999999998754322
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------------
Q 002157 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------- 890 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-------------------- 890 (959)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 234567889999999876 5689999999999999999999999987665322111100
Q ss_pred ----cccccC-----CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 891 ----QNRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 891 ----~~~~~~-----iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...... ....++.+++++|.+||+.+|++||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011 113567899999999999999999999998665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.33 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=197.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-------- 745 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-------- 745 (959)
.+|.+.+.||.|+||.||+|.. ++..||+|++..... .....+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999977 578999998866543 3345678899999999999999999876544
Q ss_pred ------CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEE
Q 002157 746 ------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVS 818 (959)
Q Consensus 746 ------~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLi 818 (959)
..+++||||++ ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 589988865 35889999999999999999999998 99999999999997 45679999
Q ss_pred ecCccccccCCcc---cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---
Q 002157 819 DFGLSRLKHNTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--- 891 (959)
Q Consensus 819 DFGlAk~~~~~~~---~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~--- 891 (959)
|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.++......+...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999976532211 1122457889999998754 56788999999999999999999999877654433221100
Q ss_pred --------------------cccc-----CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 892 --------------------NRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 892 --------------------~~~~-----~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.... .+...++.++++||.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 112357889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=335.35 Aligned_cols=257 Identities=32% Similarity=0.566 Sum_probs=225.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC---Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~---g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~ 743 (959)
..+-|..+++.+.++||+|.||.|++|.|+ |+ .||||+++...... ....|++|+.+|.+|+|+|+++|||++.
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 345577778888999999999999999984 33 48999998766543 6778999999999999999999999998
Q ss_pred cCCcEEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 744 RPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
+ ..+.||||++++|+|.+.|++ ....|....+..|+.||+.||.||..++ +|||||-.+||||-..-.|||+|||+
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccc
Confidence 8 678899999999999999987 4456777888899999999999999998 99999999999999999999999999
Q ss_pred cccccCCccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 002157 823 SRLKHNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 823 Ak~~~~~~~~---~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
.+.+...... .....-...|+|||.+...+++.++|||++|++||||++ |..||.|....++++.+. ...++..|
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRP 337 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRP 337 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCC
Confidence 9976543221 111223557999999999999999999999999999997 689999999999999887 77789999
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
+.++.++.++++.||..+|.+||+|..|.+.+
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 99999999999999999999999999997544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=339.83 Aligned_cols=147 Identities=28% Similarity=0.447 Sum_probs=133.2
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+++|.++++||+|+||+||+|.+. ++.||||++..... .......+.+|+.+++.++|+||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999884 88999999876433 344556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
|||+.+++|.+++... ..+.+..++.|+.||+.||.|||.++ ||||||||+||||+.++++||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 36888999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=328.67 Aligned_cols=243 Identities=27% Similarity=0.377 Sum_probs=207.3
Q ss_pred EeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.++||.|.||+||-|++ +|+.||||++.+..+.......+++|+.||++++||.||.|...|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36799999999999966 7999999999988877666688999999999999999999999999999999999999766
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCccccccCCcccCCC
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
-|.-+|.....++++.....++.||+.||.|||-++ |+|+||||||||+.. --.+||||||+|+.+++. ....+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhh
Confidence 666667777778999998889999999999999999 999999999999964 357999999999998765 33467
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HhhhhccccccCCCCCCcHHHHHHHHHHhh
Q 002157 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV-VGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql-~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~ 914 (959)
.+||+.|+|||++..+.|...-|+||+|+|+|--+.|.+||........ .+... -..+..-+..++++..+||..+|+
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCCCchhhcCHHHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999976543221 11111 112333346789999999999999
Q ss_pred cCCCCCCCHHHHH
Q 002157 915 TDPSLRPSFAQLT 927 (959)
Q Consensus 915 ~DP~kRPSa~EIL 927 (959)
..-++|.+..+-+
T Consensus 805 Vkm~kRysvdk~l 817 (888)
T KOG4236|consen 805 VKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHhcchHhhc
Confidence 9999999887544
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.03 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=195.9
Q ss_pred CeeEEeEeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----CCc
Q 002157 677 DLVLGERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 747 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~----~~~ 747 (959)
+|++.+.||+|+||.||++++. +..||||++............+.+|+.+++++ +|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999874 56899998865433333455678899999999 59999999986532 245
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++++||+. ++|.+++... ..+++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788999985 6899988653 47899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcc----cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc------------
Q 002157 828 NTFL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------ 890 (959)
Q Consensus 828 ~~~~----~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~------------ 890 (959)
.... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 2211 1234578999999998766 4689999999999999999999999987654322211100
Q ss_pred --------------ccccc---CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 891 --------------QNRRL---EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 891 --------------~~~~~---~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..... ......+..+++||.+||+.||.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 1112357889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.29 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=201.6
Q ss_pred CCeeE-EeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----CCc
Q 002157 676 EDLVL-GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 747 (959)
Q Consensus 676 ~dy~I-~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~----~~~ 747 (959)
++|.| -++||-|-.|+|..+.+ +++++|+|++.... ..++|+++.-.. .|||||.++++|+. ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56666 36899999999999966 78899999875432 356788776655 79999999998754 345
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCcc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLS 823 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlA 823 (959)
+.+|||.++||.|+..++.++ ..++|.++..|+.||..|+.|||+.+ |.||||||||+|.. .+..+||+|||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 889999999999999997654 46999999999999999999999999 99999999999996 4567999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCC-
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIP- 898 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ql~~~i~~~~~~~~iP- 898 (959)
+..... ....+.|-|++|.|||++..++|++..|+||||+++|-|+||.+||+..... .+..+|..+...++-|
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 976543 4456788999999999999999999999999999999999999999875432 2334443333222222
Q ss_pred -CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 -~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.+.+++|+++|+.+|.+|.|+++++++
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 3578999999999999999999999999765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.93 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=205.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
....-|..++.||-|+||.|.+++. +...||+|.+++.+ +....+..++.|..||.....+-||+||..|++.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3345588999999999999999975 45679999988754 45556677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||++||++-.+|-+.+ .+.|..++.++.++.+|+++.|..| +|||||||+|||||.+|||||+||||+.-+.-.
T Consensus 706 FVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999987764 6777777777779999999999999 999999999999999999999999998632100
Q ss_pred ------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHH
Q 002157 830 ------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 867 (959)
Q Consensus 830 ------------------------------------------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLy 867 (959)
.......+||+-|+|||++....|+.-+|||+.|+|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00112456999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHHhhcCCCCCC
Q 002157 868 ELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRP 921 (959)
Q Consensus 868 ELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dLI~kCL~~DP~kRP 921 (959)
||+.|+.||....+.+...++.-....+.+| .++++++.+||.+++ .+++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999999988877666654333444454 478999999999877 5677776
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=313.81 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=208.5
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 745 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~ 745 (959)
...++..++++-+..||.|+||+|++..+ .|+..|||.++.... +..+.+++.|.....+- ++||||+|||++..+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34456667777788899999999999987 588999999987655 44566778888776665 799999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhh----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 746 PNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~----k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
+.+||.||+|+ .+|..+.. .....++|..+-.|....+.||.||...- .|||||+||.||||+..|.|||||||
T Consensus 136 GdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeeccc
Confidence 99999999994 56766542 23457999999999999999999997642 49999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc-CC
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-EI 897 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~-~i 897 (959)
++..+.+... .+...|...|||||.+.. ..|+.++|+|||||+|||+.+|.+||.+++.. +.+..+..+..+. ..
T Consensus 214 IcGqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 214 ICGQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred chHhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 9988876643 345789999999999974 35899999999999999999999999998763 2333333222222 22
Q ss_pred CC---CCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 898 PK---ELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 898 P~---~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+. +.+..++++|.-||.+|-..||.+.+++.+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 368899999999999999999999998653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.08 Aligned_cols=241 Identities=27% Similarity=0.408 Sum_probs=202.5
Q ss_pred EeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCC
Q 002157 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
.+.||+|+|+.|-.+.. ++..||||++.+.. ......+.+|+.++.+. .|+||++|++||+++.++|||||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35699999999999864 89999999987763 34567888999999999 699999999999999999999999999
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecCccccccCC-----
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNT----- 829 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~---g~VKLiDFGlAk~~~~~----- 829 (959)
|.|..+|+++. .+++.++.++..+|+.||.|||.+| |.||||||+|||.... .-||||||.++......
T Consensus 161 GplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99999998753 6899999999999999999999999 9999999999999654 45899999987643321
Q ss_pred --cccCCCCCCCCCccCccccc---C--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHhh
Q 002157 830 --FLSSKSTAGTPEWMAPEVLR---N--EPSNEKCDVYSFGVILWELATLKLPWIGMNP---------------MQVVGA 887 (959)
Q Consensus 830 --~~~~~t~~GT~~YmAPEvl~---g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---------------~ql~~~ 887 (959)
.....+.+|+.+|||||+.. + ..|+++.|.||||+|+|-||.|++||.|.-. ..++..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 12234678999999999863 3 3589999999999999999999999977321 233444
Q ss_pred hhccccccCCCC----CCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 888 VGFQNRRLEIPK----ELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 888 i~~~~~~~~iP~----~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
| +....++|. .++.+.++||..+|..|+.+|.++.+++.
T Consensus 318 I--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 I--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred H--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 4 556677774 57899999999999999999999988875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=331.18 Aligned_cols=261 Identities=33% Similarity=0.580 Sum_probs=224.9
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~ 739 (959)
.+++..+++.+.+.||.|.||.|++|... ...||||.++..... .....+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 67888888999999999999999999642 346999987765544 6677899999999999 699999999
Q ss_pred eeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
|++...+.+++|+||+..|+|..++++.+ ..+.....+.++.||+.||+||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998765 34888999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCC-cccCCCCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~-~~~~~t~~G--T~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 880 (959)
+||||.++..+||+|||+++..... .+......| ...|||||.+....|+.++||||+||+|||+++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999854432 222122233 335999999999999999999999999999998 789999866
Q ss_pred -hHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 881 -PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 881 -~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
..++.. ....+.+...|..++.++.++++.||+.+|++||+|.++.+.|+...
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 445544 44567788999999999999999999999999999999999999853
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=304.70 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=212.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~-~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
-+..++|.++++||+|+|.+|.++++ +.+.||+|+++++-..++ .+.-+..|..+..+. +||++|-+..+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35568999999999999999999976 567899999887654332 344456777888876 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++|.||++||+|--++++. +++++..++.+..+|..||+|||+.| ||+||||.+|||||..|+|||+|+|.++.-.
T Consensus 326 lffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999988764 58999999999999999999999999 9999999999999999999999999998766
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-------CChHH-HHhhhhccccccCCCC
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-------MNPMQ-VVGAVGFQNRRLEIPK 899 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-------~~~~q-l~~~i~~~~~~~~iP~ 899 (959)
.+...+.++||||.|+|||++.|..|+..+|||+||++++||+.|+.||.- .+... +++.+ .++...+|.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--lekqiripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--LEKQIRIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--hhhcccccc
Confidence 666677899999999999999999999999999999999999999999953 22222 22222 456778899
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCC
Q 002157 900 ELDPLVARIIWECWQTDPSLRPS 922 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPS 922 (959)
.++-....+++..|++||.+|..
T Consensus 481 slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcC
Confidence 99999999999999999999963
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=342.18 Aligned_cols=243 Identities=31% Similarity=0.465 Sum_probs=195.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec---------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--------- 744 (959)
.+|+.++.||+||||.||+++. +|+.||||++.... .......+.+|+.+|.+|+|||||+++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5788899999999999999976 89999999998776 56667788999999999999999998753310
Q ss_pred --------------------------------------------------------------------------------
Q 002157 745 -------------------------------------------------------------------------------- 744 (959)
Q Consensus 745 -------------------------------------------------------------------------------- 744 (959)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 002157 745 ----------------------P--------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794 (959)
Q Consensus 745 ----------------------~--------~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g 794 (959)
+ -.+||-||||+...|.+++.++...-.....|+++++|+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1367889999998888888876543357888999999999999999999
Q ss_pred CCEEeeCCCCCcEEEcCCCcEEEEecCcccccc------------------CCcccCCCCCCCCCccCcccccCCC---C
Q 002157 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH------------------NTFLSSKSTAGTPEWMAPEVLRNEP---S 853 (959)
Q Consensus 795 ~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~------------------~~~~~~~t~~GT~~YmAPEvl~g~~---~ 853 (959)
||||||||.||+|++++.|||+|||+++... ......+..+||.-|+|||++.+.. |
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998611 0111345678999999999998654 9
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCC------CcHHHHHHHHHHhhcCCCCCCCHHHH
Q 002157 854 NEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQL 926 (959)
Q Consensus 854 s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ql~~~i~~~~~~~~iP~~------ls~eL~dLI~kCL~~DP~kRPSa~EI 926 (959)
+.|+|+|||||+|+||+. ||.. +....++..+. ...+|.. --+.-..+|.+||+.||.+|||+.|+
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR----~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR----KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc----cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 999999999999999985 5543 23333444443 3333322 12456799999999999999999999
Q ss_pred HH
Q 002157 927 TV 928 (959)
Q Consensus 927 L~ 928 (959)
|.
T Consensus 869 L~ 870 (1351)
T KOG1035|consen 869 LN 870 (1351)
T ss_pred hh
Confidence 74
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=326.64 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=201.8
Q ss_pred eEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------cEEE
Q 002157 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------NLSI 750 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------~l~L 750 (959)
...+.||+|+||.||++++ .|+.||||.+..... ....+...+|+++|++|+|+|||++++.-+... ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456799999999999985 799999999877543 234566789999999999999999998765543 4679
Q ss_pred EEeccCCCCHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCC--cEEEEecCccc
Q 002157 751 ITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNW--NVKVSDFGLSR 824 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k--~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd--~~g--~VKLiDFGlAk 824 (959)
|||||.||+|+.+|++ +...+++.+.+.++.++..||.|||++| ||||||||+||++- .+| ..||+|||.|+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999999976 3467999999999999999999999999 99999999999994 333 47999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHhhhhc---------
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGF--------- 890 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q----l~~~i~~--------- 890 (959)
-..+.. ...+.+||+.|++||++.. +.|+..+|.|||||++|+++||.+||....... +...+..
T Consensus 173 el~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 173 ELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred cCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 886653 5678899999999999994 889999999999999999999999996643321 2111110
Q ss_pred ----cc------cccCCCCCCcHH----HHHHHHHHhhcCCCCCC--CHHHHHHHHHhhhhh
Q 002157 891 ----QN------RRLEIPKELDPL----VARIIWECWQTDPSLRP--SFAQLTVALKPLQRL 936 (959)
Q Consensus 891 ----~~------~~~~iP~~ls~e----L~dLI~kCL~~DP~kRP--Sa~EIL~~Le~l~kl 936 (959)
.+ ..+++|-.++.. +-..+..+|..+|++|- .+.+....+..|.+.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11 122344455544 45667778889999999 777777777766543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=326.71 Aligned_cols=252 Identities=29% Similarity=0.454 Sum_probs=216.7
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR---- 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~---- 744 (959)
....+-|+|.++||+|.+|.||+++. +++.+|||++... .+..+++..|.+||+.+ .|||++.++++|..
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34456799999999999999999964 7899999986543 23345777889999988 79999999999853
Q ss_pred -CCcEEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 745 -PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 745 -~~~l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
++.+|||||||.+|+.-|+++. .+.++.|..+.+|++.++.||.+||.+. +||||||=.|||++.+|.|||+|||.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeee
Confidence 5679999999999999999863 2568999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-cC
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LE 896 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~~-----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~-~~ 896 (959)
+...........+++||+.|||||++.... |+.++|+|||||+..||--|.+|+.++.++..+-.|..+..+ +.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 999888777788999999999999997543 677899999999999999999999999998776655432221 12
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
-|+..+.++.+||..||.+|-++||+..++++
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 35677899999999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.56 Aligned_cols=218 Identities=21% Similarity=0.266 Sum_probs=183.1
Q ss_pred cCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCHHHHh
Q 002157 687 GSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 764 (959)
Q Consensus 687 G~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL 764 (959)
|.||.||++++ +++.||+|++.... .+.+|...+....||||+++++++......++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999977 67889999986542 2334555556667999999999999999999999999999999998
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccC
Q 002157 765 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844 (959)
Q Consensus 765 ~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmA 844 (959)
.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 764 35899999999999999999999998 999999999999999999999999987655432 223456778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCH
Q 002157 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 923 (959)
Q Consensus 845 PEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa 923 (959)
||.+.+..++.++|+||||+++|+|++|..||..... ... ......+|..++..+++||.+||+.||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS-GIN-----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-hcc-----cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9999888899999999999999999999988754321 111 122345677889999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=322.88 Aligned_cols=238 Identities=23% Similarity=0.332 Sum_probs=201.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++...+|.|+|+.|..+.+ +++.++||++.+... +..+|+.++... .||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 46788888899999999999976 678899999876521 223567666665 799999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE-cCCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-DKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL-d~~g~VKLiDFGlAk~~~~~~ 830 (959)
||++.|+.|.+.+.... .....+..|+.+|+.|+.|||.+| ||||||||+|||+ +..|+++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999988886643 333777789999999999999998 9999999999999 69999999999999987654
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
..+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... ++...+. ...+...+|.+.++||
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKFSECVSDEAKDLL 543 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCccccccCHHHHHHH
Confidence 44567899999999999999999999999999999999999999775544 4444432 3334478999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||+.||.+|+++.++..+
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHhccCChhhCcChhhhccC
Confidence 99999999999999999764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.81 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=207.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|.-.++||+|.||+||+++. +++.||+|.++..+-.+-......+|+-+|+.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 345567899999999999975 577899999887665555556778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
|.. +|..+.....+.++....+.++.|+++||.++|+++ +.||||||.|+||+.+|++||+|||+++.++-+..-..
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 965 899988777778999999999999999999999999 99999999999999999999999999998876654444
Q ss_pred CCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc------c------------
Q 002157 835 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR------R------------ 894 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~------~------------ 894 (959)
..+-|.+|.+|.++.|.+ |+...|+||.|||+.|+.. |++.|.+.+..+.+.++-.... .
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 566899999999999876 8999999999999999986 6777888776554443321110 0
Q ss_pred cCCC---------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 LEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ~~iP---------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+.+| +.++..-++|+.++|..+|.+|.++++.+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0011 1234456899999999999999999987653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=271.58 Aligned_cols=236 Identities=31% Similarity=0.492 Sum_probs=197.8
Q ss_pred CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCHHHHhh
Q 002157 688 SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 765 (959)
Q Consensus 688 ~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~ 765 (959)
+||.||+|.+ +++.||+|++........ ...+.+|++++++++|+||+++++++......++++||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 5899999987 468999999876543322 5688899999999999999999999999899999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCc
Q 002157 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845 (959)
Q Consensus 766 k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAP 845 (959)
... .+++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 643 3889999999999999999999998 9999999999999999999999999998765432 33456688999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCC-CcHHHHHHHHHHhhcCCCCCCCH
Q 002157 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWECWQTDPSLRPSF 923 (959)
Q Consensus 846 Evl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ql~~~i~~~~~~~~iP~~-ls~eL~dLI~kCL~~DP~kRPSa 923 (959)
|.+.+..++.++|||+||+++|+|++|..||.. .+.......+............ ++.++.+++.+||..+|.+||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988889999999999999999999999987 4444444433222111111111 78899999999999999999999
Q ss_pred HHHHH
Q 002157 924 AQLTV 928 (959)
Q Consensus 924 ~EIL~ 928 (959)
.++++
T Consensus 236 ~~~~~ 240 (244)
T smart00220 236 EEALQ 240 (244)
T ss_pred HHHhh
Confidence 99986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=305.98 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=204.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeecc-CCCHH----HHHHHHHHHHHHHHcCCCceeEEeeeeecC-C
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGA----ALLEFKREVKIMRRLRHPNVVLFMGAVTRP-P 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~-~~~~~----~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-~ 746 (959)
.++|-++.+||+|||+.||++.+ ..+.||||+-... ++.++ ..+...+|.+|.+.|.||.||++|++|.-+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 36788999999999999999965 5677999965432 33222 234467899999999999999999999644 5
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCcc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLS 823 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlA 823 (959)
.+|-|+|||+|.+|..||+.+ ..++++.++.|+.||+.||.||.+..++|||-||||.||||- ..|.|||+|||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 688999999999999999765 478999999999999999999999999999999999999994 4689999999999
Q ss_pred ccccCCccc-------CCCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhh-c
Q 002157 824 RLKHNTFLS-------SKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVG-F 890 (959)
Q Consensus 824 k~~~~~~~~-------~~t~~GT~~YmAPEvl~g~----~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~-~ 890 (959)
+...+..+. +....||.||++||.+.-. +.+.|+||||+|+|+|.++.|+.||...... +++.... .
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 987654322 3456799999999987532 3678999999999999999999999765433 2332211 1
Q ss_pred cccccCCC--CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 891 QNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 891 ~~~~~~iP--~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
......+| +.++.+.++||++||+.--++|.+..++..
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22233444 468999999999999999999999888754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=297.22 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=196.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-~~~l 748 (959)
..|++++.||+|+||.||+|... ...+|||+|+.+.-..-.-....+|+.+++.++||||+.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56889999999999999999541 2369999987652211122356799999999999999999999877 7789
Q ss_pred EEEEeccCCCCHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC----CcEEEEec
Q 002157 749 SIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDF 820 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k----~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~----g~VKLiDF 820 (959)
+|++||.+. +|+.+|+- ....++...+..|++||+.|++|||++- |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999975 89988852 2346888999999999999999999999 9999999999999765 99999999
Q ss_pred CccccccCCcc---cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHH--Hhh
Q 002157 821 GLSRLKHNTFL---SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP-------MQV--VGA 887 (959)
Q Consensus 821 GlAk~~~~~~~---~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~-------~ql--~~~ 887 (959)
|+++.+.++.. .....+-|.+|.|||.+.|.+ |+.+.|||++|||+.||++-.+.|.+... .+. +.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998876533 334566799999999999865 89999999999999999998887766322 111 111
Q ss_pred hhc-cc-----ccc---CCC--------------------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 888 VGF-QN-----RRL---EIP--------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 888 i~~-~~-----~~~---~iP--------------------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
|.. .. ..+ .+| +.-++...+|+.+||+.||.+|.|+++.++..
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 100 00 000 011 11244578999999999999999999987754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=337.05 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=192.2
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.|...++||+|+||.||+|++ ++..||||++...... ...|++++++++|||||++++++.+....++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456677899999999999986 6789999987643221 13468899999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
+++|+|.+++++ +++..+..|+.||+.||+|||.. .++|+||||||+|||++.++..++. ||....... .
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~ 835 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D 835 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence 999999999953 78899999999999999999943 2349999999999999998888875 665543321 1
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhh--cccc------ccC------C
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVG--FQNR------RLE------I 897 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ql~~~i~--~~~~------~~~------i 897 (959)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .... ... .
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 2346899999999999999999999999999999999999998542110 1111000 0000 001 1
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
+.....++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 1112235788999999999999999999999999876633
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=302.16 Aligned_cols=262 Identities=32% Similarity=0.493 Sum_probs=212.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeecCC----cEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~--L~HpNIVkL~g~~~~~~----~l~ 749 (959)
..+++.++||+|.||.||+|+.+++.||||+|.. +....|.+|.+|... ++|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4456778899999999999999999999999753 456678889988885 48999999999876665 799
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-------TPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-------g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
||+||.+.|+|.++|..+ .++|....+|+.-+++||+|||+. +++|+|||||..||||..++...|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999874 699999999999999999999983 35699999999999999999999999999
Q ss_pred cccccCCc--ccCCCCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHhCC------------CCCCC----
Q 002157 823 SRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATLK------------LPWIG---- 878 (959)
Q Consensus 823 Ak~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~------s~ksDIWSLGiLLyELLtG~------------~PF~g---- 878 (959)
|..+.... ......+||.+|||||++.|.-. -++.||||+|.+||||+... .||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98765332 22334789999999999987542 24689999999999999754 33331
Q ss_pred -CChHHHHhhhhccccccCCCCCC-----cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCC
Q 002157 879 -MNPMQVVGAVGFQNRRLEIPKEL-----DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 944 (959)
Q Consensus 879 -~~~~ql~~~i~~~~~~~~iP~~l-----s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~ 944 (959)
..-.++...+.....++.+|... -.-+++.+..||..|++.|.|+.=+.+++..+..+..-+.++.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s 514 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGES 514 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCcc
Confidence 12234555556666777777543 3458999999999999999999999999988877665433333
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=295.14 Aligned_cols=253 Identities=36% Similarity=0.645 Sum_probs=206.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeecCC----cEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~--L~HpNIVkL~g~~~~~~----~l~ 749 (959)
.+..+.+.||+|.||.||+|.|+|+.||||+|...+ ...+.+|.+|++. |+|+||+.|++.-..+. ++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 457889999999999999999999999999987654 2356788888886 49999999998765443 489
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~------g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
||++|.+.|+|+|||.+ ..++....++++.-++.||+|||.. .|.|.|||||..||||.++|.-.|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999988 4688999999999999999999972 256999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhC----------CCCCCCCCh--
Q 002157 824 RLKHNT----FLSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGMNP-- 881 (959)
Q Consensus 824 k~~~~~----~~~~~t~~GT~~YmAPEvl~g~~------~s~ksDIWSLGiLLyELLtG----------~~PF~g~~~-- 881 (959)
...... ....+..+||.+|||||++...- .-+.+||||||.++||+... ++||.+.-+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 765432 12345678999999999986542 23479999999999999852 588877533
Q ss_pred ---HHHHhhhhccccccCCCCCCc-----HHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 882 ---MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 882 ---~ql~~~i~~~~~~~~iP~~ls-----~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.++..-+..+..++.+|.... ..+.+|++.||..||..|.++-.|...|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 344555556666777775432 347788999999999999999999988887764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=296.14 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=199.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C-C----ceeEEeeeeec
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-P----NVVLFMGAVTR 744 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-H-p----NIVkL~g~~~~ 744 (959)
+-..+|+|.+.||+|.||.|.++.+ .+..||||+++.- .......+-|+++|+++. + | -+|++.+||..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3357899999999999999999966 4678999987642 122334567899999993 2 3 38999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC------------
Q 002157 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK------------ 811 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~------------ 811 (959)
.++.+||+|.+ |-+++++|..+ ..+++...++.|++||+.+++|||+.+ ++|.||||||||+-.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999988 67999999874 457889999999999999999999999 999999999999931
Q ss_pred --------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002157 812 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (959)
Q Consensus 812 --------~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q 883 (959)
+-.|||+|||.|....... .+.+.|..|.|||++.|-.|+.++||||+||||+||++|...|++.+..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3469999999998765442 46788999999999999999999999999999999999999998877544
Q ss_pred HH---hhhh----------------ccccccCCCC-------------------------CCcHHHHHHHHHHhhcCCCC
Q 002157 884 VV---GAVG----------------FQNRRLEIPK-------------------------ELDPLVARIIWECWQTDPSL 919 (959)
Q Consensus 884 l~---~~i~----------------~~~~~~~iP~-------------------------~ls~eL~dLI~kCL~~DP~k 919 (959)
.+ +.+. +...++..|. .-..++.+||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 22 1111 0000111110 01135899999999999999
Q ss_pred CCCHHHHHHH
Q 002157 920 RPSFAQLTVA 929 (959)
Q Consensus 920 RPSa~EIL~~ 929 (959)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-33 Score=289.30 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=201.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--------C
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------P 745 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--------~ 745 (959)
..|+-..+||+|.||.||+|+. .+++||+|++..+...+-......+|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4567778899999999999976 57789998766544333334566799999999999999999998743 2
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..+|+||.+|.. +|+-+|.....+++...+.+++.+++.||.|+|... |+|||+|++|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999965 899999887778999999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCc----ccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--ccccc---
Q 002157 826 KHNTF----LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRL--- 895 (959)
Q Consensus 826 ~~~~~----~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~--~~~~~--- 895 (959)
+.... ...+..+-|.+|.+||.+.|.+ |+++.|||..|||+.||+++.+-|.+....+.+..|.. +....
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54221 1122345699999999999864 89999999999999999999999988776655543321 00000
Q ss_pred ---------------CCC-------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 ---------------EIP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 ---------------~iP-------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++| ..-+++..+|+.++|..||.+|+++.+++.+
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 011 1234578999999999999999999998865
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=309.22 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=218.7
Q ss_pred eeEEeEeeccCcEEEEEEEE--CC----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADW--NG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
++-.++||.|+||+||+|.| .+ -+||||++.... ......++.+|+-+|.+++|||+++|++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 45568999999999999987 33 468999876543 3445678999999999999999999999998765 7899
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
++|++.|.|.++++.++..+..+..+.|..||++||.|||.+. +|||||-.+||||..-.++||+|||+++.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999888888999999999999999999999988 99999999999999999999999999998764432
Q ss_pred c--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 832 S--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 832 ~--~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
. .....-.+.|||-|.+....|+.++||||||+++||++| |..|+.+....++...+.... ++..|+.++.++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCCCCccHHHHHH
Confidence 2 222334567999999999999999999999999999987 999999999888877766544 588999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 909 IWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+.+||..|+..||+|+++...+.+.
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHH
Confidence 9999999999999999998877755
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=306.21 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=170.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--C----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeee----
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA---- 741 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~---- 741 (959)
.+..++|++.++||+|+||.||+|++ + +..||||++......+ .+..| .++...+.+++.++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 34568999999999999999999987 3 6789999875432111 11111 1122222233322222
Q ss_pred --eecCCcEEEEEeccCCCCHHHHhhCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 002157 742 --VTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------------VDEKRRIKMALDVARGMNCLHTSTPTIVHR 800 (959)
Q Consensus 742 --~~~~~~l~LVmEy~~gGsL~dlL~k~~~~-------------------lse~~~l~Ia~QIa~AL~yLHs~g~~IIHR 800 (959)
......++|||||+.+++|.+++...... ..+..+..|+.||+.||.|||+++ ||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 24566799999999999999998654321 112345678999999999999998 9999
Q ss_pred CCCCCcEEEcC-CCcEEEEecCccccccCC-cccCCCCCCCCCccCcccccCC----------------------CCCch
Q 002157 801 DLKSPNLLVDK-NWNVKVSDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNE----------------------PSNEK 856 (959)
Q Consensus 801 DLKPeNILLd~-~g~VKLiDFGlAk~~~~~-~~~~~t~~GT~~YmAPEvl~g~----------------------~~s~k 856 (959)
||||+||||+. ++.+||+|||+++..... .......++++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 689999999999865322 2233467899999999976432 23456
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------c------cCCCCCCcHHHHHHHHHHhhcCC
Q 002157 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------R------LEIPKELDPLVARIIWECWQTDP 917 (959)
Q Consensus 857 sDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-------------~------~~iP~~ls~eL~dLI~kCL~~DP 917 (959)
+|||||||+||||+++.+++.... .+....+..... . ..+.........+||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 799999999999999877654321 111111100000 0 00111123345689999999999
Q ss_pred CCCCCHHHHHHH
Q 002157 918 SLRPSFAQLTVA 929 (959)
Q Consensus 918 ~kRPSa~EIL~~ 929 (959)
.+||++.+++++
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=293.64 Aligned_cols=256 Identities=19% Similarity=0.185 Sum_probs=184.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE------------------CCceEEEEEeeccCCCH--H----------HHHHHH
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW------------------NGTEVAVKKFLDQDFSG--A----------ALLEFK 721 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~------------------~g~~VAVK~i~~~~~~~--~----------~~~ef~ 721 (959)
++..++|++.++||+|+||+||+|.+ .++.||||++....... + ......
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 46778999999999999999999953 34579999986432110 0 011234
Q ss_pred HHHHHHHHcCCCce-----eEEeeeeec--------CCcEEEEEeccCCCCHHHHhhCCC--------------------
Q 002157 722 REVKIMRRLRHPNV-----VLFMGAVTR--------PPNLSIITEFLPRGSLFRILHRPH-------------------- 768 (959)
Q Consensus 722 ~Ei~IL~~L~HpNI-----VkL~g~~~~--------~~~l~LVmEy~~gGsL~dlL~k~~-------------------- 768 (959)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888876654 667777643 356899999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-cCCCCCCCCCccC
Q 002157 769 ---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SSKSTAGTPEWMA 844 (959)
Q Consensus 769 ---~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~-~~~t~~GT~~YmA 844 (959)
..+++..++.++.||+.+|.|||..+ |+||||||+|||++.++.+||+|||++........ ......+++.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12355678889999999999999998 99999999999999999999999999975433211 1122335889999
Q ss_pred cccccCCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCChHHH-----------Hhhhhc
Q 002157 845 PEVLRNEP--------------------S--NEKCDVYSFGVILWELATLKL-PWIGMNPMQV-----------VGAVGF 890 (959)
Q Consensus 845 PEvl~g~~--------------------~--s~ksDIWSLGiLLyELLtG~~-PF~g~~~~ql-----------~~~i~~ 890 (959)
||++.... + ..+.||||+||++|+|++|.+ ||.+...... ......
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99986432 1 124799999999999999986 7754321110 011111
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCC---CCCCCHHHHHHH
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDP---SLRPSFAQLTVA 929 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP---~kRPSa~EIL~~ 929 (959)
...........+...++|+.+||..+| .+|+++.|++.+
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 112223335678899999999999866 689999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=245.96 Aligned_cols=210 Identities=38% Similarity=0.632 Sum_probs=186.0
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCHH
Q 002157 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (959)
Q Consensus 684 LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~ 761 (959)
||.|.+|.||+++.. ++.++||++....... ....+.+|+++++.+.|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 8899999987654322 3467889999999999999999999999999999999999999999
Q ss_pred HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCccccccCCcccCCCCCCCC
Q 002157 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (959)
Q Consensus 762 dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~~~~~~~~~~t~~GT~ 840 (959)
+++......+++..++.++.+++.+|.+||..+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999765446889999999999999999999998 999999999999999 89999999999987654422233456888
Q ss_pred CccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCC
Q 002157 841 EWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 919 (959)
Q Consensus 841 ~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~k 919 (959)
.|++||.+... .++.+.|+|+||+++++| ..+.+++.+||+.+|.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 788999999999999999 77899999999999999
Q ss_pred CCCHHHHHHH
Q 002157 920 RPSFAQLTVA 929 (959)
Q Consensus 920 RPSa~EIL~~ 929 (959)
||++.+++..
T Consensus 205 R~~~~~l~~~ 214 (215)
T cd00180 205 RPSAKEILEH 214 (215)
T ss_pred CcCHHHHhhC
Confidence 9999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=265.11 Aligned_cols=214 Identities=29% Similarity=0.455 Sum_probs=180.5
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
+++.-+++.-+..||+|+||.|-+.++ +|+..|+|.+...-. .+.+++.++|+.+..+. .+|++|.|||.+.++..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 667777888889999999999988876 899999999876644 44566778888887765 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
.+|.||.|. .+|..+.. +.+..++|..+-+|+..++.||.|||++- .|||||+||.||||+..|+||+||||++.
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999994 57776643 45678999999999999999999999863 59999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhh
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAV 888 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i 888 (959)
.+.+... .+...|...|||||.+.. ..|+.++||||||+++.||.++++||..+.. .+.+..+
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 8776643 233678899999999864 3588999999999999999999999988654 4444444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=288.16 Aligned_cols=207 Identities=22% Similarity=0.280 Sum_probs=177.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC------CceeEEeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAV 742 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H------pNIVkL~g~~ 742 (959)
.++.-.+|.+....|+|-|++|..|.+ .|..||||+|..... ..+.=+.|+.||++|.. -|+++|+..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 344457899999999999999999976 577999999987643 33455789999999952 3799999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEe
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSD 819 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~~~--~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiD 819 (959)
...+++|||||-+ ..+|.++|++.+. .+....+..++.|++.||..|..+| |+|.||||.||||++. ..+||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 9999999999988 5699999987553 4777889999999999999999999 9999999999999865 5789999
Q ss_pred cCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 002157 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (959)
Q Consensus 820 FGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~ 885 (959)
||.|........ +.++-+..|.|||+|.|..|+...|+||+||+||||++|+..|.|....+++
T Consensus 581 fGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 581 FGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred Cccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 999987765433 2355678999999999999999999999999999999999999997776555
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=260.65 Aligned_cols=243 Identities=20% Similarity=0.349 Sum_probs=195.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCC--cEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~--~l~ 749 (959)
.++|++.+++|+|.|+.||.|.. ++++++||+++. ...+.+.+|++||+.|. ||||++|++.+.++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 36899999999999999999974 788999998653 34668899999999995 999999999998764 377
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~~~~ 828 (959)
||+||+.+.+...+.. .+....++.++.+++.||.|||+.| |+|||+||.|++||. .-.++|+|+|+|.+.+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999888877764 4777888999999999999999999 999999999999985 56799999999998876
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCh-HHHHhhhhc----------ccccc
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIG-MNP-MQVVGAVGF----------QNRRL 895 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~-~ql~~~i~~----------~~~~~ 895 (959)
.. .....+.+..|.-||.+.. ..|+..-|+|||||+|..|++.+.||.. .+. .+++.-... .....
T Consensus 186 ~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred Cc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 53 3345678899999999876 4589999999999999999999988754 322 222211000 00000
Q ss_pred C--------------------CC----CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 E--------------------IP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 ~--------------------iP----~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. ++ .-.++++.||+.++|+.|-.+|+|++|.+.+
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 00 1236899999999999999999999998753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=287.82 Aligned_cols=199 Identities=27% Similarity=0.407 Sum_probs=173.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHH------HHHHHHHHHHHHHcC---CCceeEEeeeee
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA------LLEFKREVKIMRRLR---HPNVVLFMGAVT 743 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~------~~ef~~Ei~IL~~L~---HpNIVkL~g~~~ 743 (959)
..+|..++.||.|+||.|++|.+ +...|+||.+.+...-.+. +-.+--|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 46799999999999999999987 4567999988775432222 224567999999997 999999999999
Q ss_pred cCCcEEEEEec-cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 744 RPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 744 ~~~~l~LVmEy-~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
+++++||+||- -++.+|+++|... ..++|.+...|+.|++.|+++||+.| |||||||-|||.++.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 99999999996 4577999999764 47999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIG 878 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g 878 (959)
+...... ....++||..|.|||++.|.+| ++.-|||+||++||.++....||+.
T Consensus 717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9876543 2346899999999999999886 7789999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=297.11 Aligned_cols=238 Identities=29% Similarity=0.454 Sum_probs=188.3
Q ss_pred EeEeeccCcEE-EEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 681 GERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 681 ~k~LGkG~fG~-VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.+.+|.|+-|+ ||+|.+.++.||||.+.... ..-+.+|+.+|+.- .|||||++++.-++....||..|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 35689999875 89999999999999875433 33567999999988 799999999999999999999999965
Q ss_pred CHHHHhhCC--CCCC-CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---C--CcEEEEecCccccccCC-
Q 002157 759 SLFRILHRP--HCQV-DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---N--WNVKVSDFGLSRLKHNT- 829 (959)
Q Consensus 759 sL~dlL~k~--~~~l-se~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~--g~VKLiDFGlAk~~~~~- 829 (959)
+|.+++... .... .....+.+..|++.||++||+.+ ||||||||.||||.. + ..++|.|||+++.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999999763 1111 11344677889999999999998 999999999999975 3 56899999999976543
Q ss_pred --cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccC-CCCCCcHHH
Q 002157 830 --FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLE-IPKELDPLV 905 (959)
Q Consensus 830 --~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~-iP~~ls~eL 905 (959)
.....+..||..|+|||++.......++|||||||++|+.++| ..||...-..+. .|...+..+. +-...+.+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 2234566799999999999999888999999999999999886 789976543322 2222222221 111222389
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++||.+||+.+|..||++.+|+.
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhC
Confidence 99999999999999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=273.83 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=197.2
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----cEEEEEec
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLSIITEF 754 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~-----~l~LVmEy 754 (959)
+.||-|+||.||-+++ +|+.||+|++..-...-..-+.+.+|+++|..++|.|++..++..+-.. .+|+++|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999986 7999999998765444455678899999999999999999988765443 36788999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-ccC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSS 833 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-~~~ 833 (959)
+. .+|..+|-.. ..++...+.-+.+||++||.|||+.+ |.||||||.|+|++.+..+||||||+++...... ...
T Consensus 139 mQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 85 4888888654 36888888889999999999999999 9999999999999999999999999999765432 223
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 002157 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 893 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------------- 893 (959)
+..+-|.+|.|||++.|. .|+.++||||.|||+.||+..+..|...++.+.++.|.....
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 445578899999999885 489999999999999999999999998888765544321110
Q ss_pred -----ccCC--------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 894 -----RLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 894 -----~~~i--------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
.+.+ +.....+...++.++|..||++|.+..+.+.++
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111 113345678999999999999999988877654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=263.91 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=220.6
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEe
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~ 739 (959)
......+...+++...++-+|.||.||.|.|.. +.|.||.++ +..++-.+..+..|-.++..+.|||+....
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 344556667778888899999999999996632 346666543 333455567788999999999999999999
Q ss_pred eeeec-CCcEEEEEeccCCCCHHHHhh-----C--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 002157 740 GAVTR-PPNLSIITEFLPRGSLFRILH-----R--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (959)
Q Consensus 740 g~~~~-~~~l~LVmEy~~gGsL~dlL~-----k--~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~ 811 (959)
++..+ ....+.++.++.-|+|..||. + .-+.+...+...++.|++.|++|||.++ |||.||-.+|++||+
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 98744 456888899999999999997 2 1234666788889999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccCCcccC--CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 002157 812 NWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 888 (959)
Q Consensus 812 ~g~VKLiDFGlAk~~~~~~~~~--~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i 888 (959)
...|||+|=.+++-+-...+.+ ...-....||+||.+....|+.++|+||||+++|||++ |+.|+...++.++...+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 9999999999998654333321 11223557999999999999999999999999999987 89999999999988777
Q ss_pred hccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 889 ~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
+ .+.++..|.+++.++..++..||...|++||+++|+...|......
T Consensus 512 k-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 K-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred h-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 5 5678889999999999999999999999999999999999877554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=239.13 Aligned_cols=208 Identities=34% Similarity=0.550 Sum_probs=177.4
Q ss_pred eeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|.+.+.||.|++|.||++... ++.+|||.+...... .....+.+|+..+++++|+||+++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999874 688999998765433 24567889999999999999999999999989999999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-ccCC
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSK 834 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-~~~~ 834 (959)
++++|.+++......+++..++.++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999765433889999999999999999999998 9999999999999999999999999998765432 1223
Q ss_pred CCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChH-HHHhhh
Q 002157 835 STAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPM-QVVGAV 888 (959)
Q Consensus 835 t~~GT~~YmAPEvl-~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~-ql~~~i 888 (959)
...++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+.. .+.+.+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 45688899999999 666778899999999999999999999977 4444 455544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=289.91 Aligned_cols=250 Identities=30% Similarity=0.491 Sum_probs=215.9
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
+.++|+.+.++|.|+||.||++++ +++..|||+++...- +...-+..|+-+++..+|||||.+++.+.....++|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457899999999999999999976 788999998875432 2344567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
||||.+|+|.+..+-. ..+.+.++.+.+++.+++|+|||+.| =+|||||-.|||+++.|.+||.|||.+..+.....
T Consensus 91 MEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999988765 48999999999999999999999998 89999999999999999999999999988877777
Q ss_pred cCCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---cccccCCCCCCcHHH
Q 002157 832 SSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF---QNRRLEIPKELDPLV 905 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~---~~~~~~iP~~ls~eL 905 (959)
....+.||++|||||+-. ...|...+|||++|+...|+-.-+.|.....+++....... +...+.-+...++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 778899999999999864 45689999999999999999988999888887766544432 222223334567889
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
-+|++.+|.++|.+||+++.+|.
T Consensus 248 h~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHhcCCCccCCChhhhee
Confidence 99999999999999999988765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=265.20 Aligned_cols=246 Identities=24% Similarity=0.301 Sum_probs=198.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------~ 747 (959)
.+|.-++.+|.|.- .|..+-+ .+++||+|++..............+|..++..+.|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999998 6666644 7899999988765444455667889999999999999999999985443 4
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
.|+||||+. .+|...+. ..++-..+.+|.+|+++|++|||+.| |+||||||+||++..++.+||+|||+++...
T Consensus 96 ~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccC
Confidence 889999995 58998886 35788889999999999999999999 9999999999999999999999999998766
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 893 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-------------- 893 (959)
.. ...+.++.|+.|.|||++.|..|...+||||+||++.||+.|...|.|.+......++.....
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 54 345667899999999999999999999999999999999999999988655332221110000
Q ss_pred ---------------ccCCCC-----------CCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ---------------RLEIPK-----------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ---------------~~~iP~-----------~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...+|. .-...+++|+.+||-.||++|.+++++|.+
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000111 112348999999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-26 Score=255.70 Aligned_cols=131 Identities=21% Similarity=0.300 Sum_probs=109.3
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----C---CceeEEeeeee
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----H---PNVVLFMGAVT 743 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-----H---pNIVkL~g~~~ 743 (959)
.-.+|.+.++||.|-|++||+|.+ ..+.||+|+.+... ...+....||++|++++ | ..||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 347899999999999999999977 56789999976542 23345678999999983 2 36999999996
Q ss_pred cC----CcEEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 002157 744 RP----PNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (959)
Q Consensus 744 ~~----~~l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL 809 (959)
.. .+++||+|++ |.+|..+|.+ ..+.++...+.+|++||+.||.|||..- +|||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 54 4699999999 7788888764 4567999999999999999999999752 59999999999999
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=222.07 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=204.8
Q ss_pred eeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCC-ceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~-~~~ef~~Ei~IL~~L~Hp-NIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778899999999999999888 8899998876654433 567889999999999988 7999999998877789999999
Q ss_pred CCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccCCcc-
Q 002157 756 PRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 756 ~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~~~~- 831 (959)
.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+|||++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999998876654 26888999999999999999999999 99999999999999988 799999999985544321
Q ss_pred -----cCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccc-cC--
Q 002157 832 -----SSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRR-LE-- 896 (959)
Q Consensus 832 -----~~~t~~GT~~YmAPEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~-~~-- 896 (959)
......|+..|++||.+.+ ..+....|+|++|+++++++.|..||..... ......+...... ..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999988 5788999999999999999999999887763 3343333322222 11
Q ss_pred CCCCC----cHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 897 IPKEL----DPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 897 iP~~l----s~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..... ...+.+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=243.81 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=190.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEee-eeecCCcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG-AVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g-~~~~~~~l~LV 751 (959)
+.|.|.+.||+|.||.+.+++++ .+.+++|.+..... .+.+|.+|...--.| .|.||+.-|+ +|+..+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 56999999999999999999985 56799998766543 466888888766566 5899998776 57888889999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEecCccccccCC
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd--~~g~VKLiDFGlAk~~~~~ 829 (959)
+||++.|+|..-+... .+.|.....++.|++.||.|+|+.+ +||||||.+||||- +...|||||||+....+..
T Consensus 101 qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999998764 4888889999999999999999999 99999999999994 3357999999999866543
Q ss_pred cccCCCCCCCCCccCcccccCC---C--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHhhhhc-cccccCCCC--
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNE---P--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGF-QNRRLEIPK-- 899 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~---~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q--l~~~i~~-~~~~~~iP~-- 899 (959)
... .--+..|.+||+.... . ..+..|+|.||||+|.+++|++||.....+. ....... +......|+
T Consensus 177 V~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 177 VKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred ehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 221 1235578999986532 2 3667899999999999999999998533221 1111111 122233443
Q ss_pred -CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 900 -ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 900 -~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
-+++.+.++.++-|..++++|-...+...+.+..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 4678899999999999999997666665555433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=280.27 Aligned_cols=195 Identities=21% Similarity=0.201 Sum_probs=143.8
Q ss_pred HcCC-CceeEEeeee-------ecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 002157 729 RLRH-PNVVLFMGAV-------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800 (959)
Q Consensus 729 ~L~H-pNIVkL~g~~-------~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHR 800 (959)
.++| .||++++++| .....++++|||+ +++|.++|......+++..++.|+.||+.||.|||++| ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 3445 5788888877 3334678889988 66999999876667999999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCC-------------------cEEEEecCccccccCCc----------------ccCCCCCCCCCccCc
Q 002157 801 DLKSPNLLVDKNW-------------------NVKVSDFGLSRLKHNTF----------------LSSKSTAGTPEWMAP 845 (959)
Q Consensus 801 DLKPeNILLd~~g-------------------~VKLiDFGlAk~~~~~~----------------~~~~t~~GT~~YmAP 845 (959)
||||+||||+..| .+||+|||+++...... ......+||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 45555666554321100 001124689999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHH
Q 002157 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 925 (959)
Q Consensus 846 Evl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~E 925 (959)
|++.+..++.++|||||||+||||++|..||..... ....+.....+.... ...+...+++.+||+.+|.+||++.|
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999888764321 111111111111111 12455679999999999999999999
Q ss_pred HHHH
Q 002157 926 LTVA 929 (959)
Q Consensus 926 IL~~ 929 (959)
|+++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=220.70 Aligned_cols=163 Identities=23% Similarity=0.286 Sum_probs=131.6
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCC
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~ 837 (959)
|+|.+++.+.+..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876667999999999999999999999976 999999999999999 9999875432 236
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc-----CCCCCCcH--HHHHHH
Q 002157 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-----EIPKELDP--LVARII 909 (959)
Q Consensus 838 GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~-----~iP~~ls~--eL~dLI 909 (959)
||+.|||||++.+..++.++|||||||++|||++|+.||...... .....+....... ..+..++. ++++||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11223333 699999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 910 WECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+||+.||.+||++.+++.++..+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999999877644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=233.83 Aligned_cols=253 Identities=17% Similarity=0.254 Sum_probs=212.0
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|+|+++||.|.||.+++|+. +++.||||........ -++..|.+.++.| ..++|.+.|.+..++.+-.||||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 589999999999999999975 8999999975543322 3567788888888 57999999999999989999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-----CcEEEEecCccccccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFGLSRLKHN 828 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-----g~VKLiDFGlAk~~~~ 828 (959)
++ |-+|.|++.-+++.++.+.+..+|.|++.-++|+|.+. +|+|||||+|+||... ..|.|+|||+|+...+
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 98 88999999888899999999999999999999999999 9999999999999743 4599999999997654
Q ss_pred C-------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccC--
Q 002157 829 T-------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLE-- 896 (959)
Q Consensus 829 ~-------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ql~~~i~~~~~~~~-- 896 (959)
+ +....+..||.+||+--...|.+.+.+.|+-+||-+++++|-|.+||.|... .+.+++|........
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 3 2334567799999999999999999999999999999999999999998654 445555543322222
Q ss_pred -CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 897 -IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 897 -iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
+-..++.++..-+...-+.+-.+-|+++-+...+..+...
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 2246788898988888899999999999888888777543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=235.39 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=201.3
Q ss_pred CeeEEeEeeccCcEEEEEEEECC---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC----CCceeEEeeee-ecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR----HPNVVLFMGAV-TRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~g---~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~----HpNIVkL~g~~-~~~~~l 748 (959)
+|.+.+.||+|+||.||++.... ..+|+|+......... ..+..|+.++..+. ..++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998744 3689997765422211 15667888888886 26899999999 577789
Q ss_pred EEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-----CcEEEEecCc
Q 002157 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFGL 822 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-----g~VKLiDFGl 822 (959)
+|||+.+ |.+|.++..... ..++....+.|+.|++.+|++||+.| +|||||||.|+++... ..+.|+|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999988 889999886544 78999999999999999999999999 9999999999999854 4699999999
Q ss_pred cc--cccCCc-------cc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc
Q 002157 823 SR--LKHNTF-------LS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 823 Ak--~~~~~~-------~~-~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~ 892 (959)
++ ...... .. ...+.||..|+++.+..+...+.+.|+|||+.++.+|+.|.+||.+..............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321111 11 234669999999999999999999999999999999999999998766432222221111
Q ss_pred cccC---CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 893 RRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 893 ~~~~---iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
.... .....+.++.++...+-..+...+|++..+...|+.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111 23445678888888888899999999999999988775543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=239.39 Aligned_cols=244 Identities=21% Similarity=0.321 Sum_probs=190.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
.+.|.++.+||.|.|++||++.. .++.||+|.+..... ...+.+|+++|..+ .+.||+++.+++...+..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 46788999999999999999954 457899998765432 34688999999999 689999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~ 827 (959)
.+||||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||.|+|.+ ..+.-.|+|||++....
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999998854 667888899999999999999999 99999999999998 46889999999987100
Q ss_pred -C---------------C-------------------c---------ccCCCCCCCCCccCcccccCC-CCCchhHHHHH
Q 002157 828 -N---------------T-------------------F---------LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSF 862 (959)
Q Consensus 828 -~---------------~-------------------~---------~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSL 862 (959)
. . . .......||+.|.|||++..- ..+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 0 0 001134599999999998764 46889999999
Q ss_pred HHHHHHHHhCCCCCCCCChH-----HHH---------hh-hhccc-------------------ccc-------------
Q 002157 863 GVILWELATLKLPWIGMNPM-----QVV---------GA-VGFQN-------------------RRL------------- 895 (959)
Q Consensus 863 GiLLyELLtG~~PF~g~~~~-----ql~---------~~-i~~~~-------------------~~~------------- 895 (959)
|+|+..++++++||...... ++. .. ...+. ...
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999998542210 110 00 00000 000
Q ss_pred ---CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 ---EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ---~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..-...+..+.+|+.+||..||.+|.++++.|.
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001223457899999999999999999998875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=213.31 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=209.1
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H-pNIVkL~g~~~~~~~l~ 749 (959)
|-...|.++++||.|+||.+|+|.. .|+.||||+-....-.+ ++..|.++.+.|++ ..|..+..++.+..+-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4457899999999999999999976 89999999866543322 46788999999964 78888888888888899
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCccccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLK 826 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlAk~~ 826 (959)
+|||++ |.+|.+++.-..+.++.+..+.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+++..
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999988 88999998776778999999999999999999999999 999999999999963 356999999999865
Q ss_pred cCC-------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccccccC
Q 002157 827 HNT-------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLE 896 (959)
Q Consensus 827 ~~~-------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~~~~~~ 896 (959)
-+. ........||.+|.+--...|...+.+.|+-|+|.+|..+.-|.+||.+.... +.+..|.. ....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E--kK~s 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE--KKMS 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH--hhcC
Confidence 432 23345567999999988888888899999999999999999999999997654 33333422 2222
Q ss_pred C-----CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 897 I-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 897 i-----P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
. -+.++.|+...+..|-..--++-|+..-|.+.++.+-+
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 2 25788999999999999999999998887777776533
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=222.36 Aligned_cols=257 Identities=29% Similarity=0.616 Sum_probs=217.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
|...++.++-+|...-.|..|+|+|.|..+++|++.........-..|..|.-.|+-+.||||+.++++|..+.++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 55566777888999999999999999999999998877776666678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 753 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
.|++.|+|+.+|+... ...+..+..+++.+|++|++|||+..+-|----|....|+||++.+.+|. .+-.++. .
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs----f 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS----F 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee----e
Confidence 9999999999998643 34677889999999999999999988444444689999999998877663 1112111 1
Q ss_pred cCCCCCCCCCccCcccccCCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s---~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
......-.+.||+||.+..++.+ .++|+|||++++|||.|...||....+++.-.++.....+..+|+.+++.+.+|
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 11233457899999999876643 479999999999999999999999999998888888899999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 909 IWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+.-|++-||.+||.|..|+-.|++.+
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999988653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=228.26 Aligned_cols=166 Identities=18% Similarity=0.172 Sum_probs=129.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeE-EeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVL-FMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~---~~~~~~ef~~Ei~IL~~L~HpNIVk-L~g~~~~~ 745 (959)
.-.++|.+.+.||+|+||+||+|++ +++.||||++..... .......+.+|+++|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 4457899999999999999999976 466789998653311 2334566899999999999999985 5442
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC-CCCcEEEcCCCcEEEEecCccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDL-KPeNILLd~~g~VKLiDFGlAk 824 (959)
+..+|||||++|++|... ... . ...++.+++.+|.|||++| |+|||| ||+|||++.++.+||+|||+++
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 457999999999999732 211 1 1457789999999999998 999999 9999999999999999999998
Q ss_pred cccCCcc--------cCCCCCCCCCccCcccccCCC
Q 002157 825 LKHNTFL--------SSKSTAGTPEWMAPEVLRNEP 852 (959)
Q Consensus 825 ~~~~~~~--------~~~t~~GT~~YmAPEvl~g~~ 852 (959)
....... .-....++..|+|||.+....
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 6543321 112456888899999986543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-24 Score=251.82 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=191.2
Q ss_pred eEEeEeeccCcEEEEEEEE--CCceEEEEEeec---cCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLD---QDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~---~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
....++|.|++|.|+.+.. ..+.++.|.+.. ....+ .....+..|+-+-..|.|+||+..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999998887755 334455554431 11122 22222667888888899999999888887777766679
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
|||++ +|+.++.+. .++....+..++.||+.|++|||..| |.|||||++|+++..+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999765 36788888889999999999999999 99999999999999999999999999987654432
Q ss_pred ---cCCCCCCCCCccCcccccCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCChHHHH--hhhh-----ccccccCCCCC
Q 002157 832 ---SSKSTAGTPEWMAPEVLRNEPSNE-KCDVYSFGVILWELATLKLPWIGMNPMQVV--GAVG-----FQNRRLEIPKE 900 (959)
Q Consensus 832 ---~~~t~~GT~~YmAPEvl~g~~~s~-ksDIWSLGiLLyELLtG~~PF~g~~~~ql~--~~i~-----~~~~~~~iP~~ 900 (959)
.....+|+..|+|||++.+..|+. .+||||.|++++.|++|+.||......+.. .... .......+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 245678999999999999998865 689999999999999999999765443221 1111 11112223345
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++.+.+.+|.+||+.||.+|.++++|++
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhh
Confidence 7888999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-24 Score=245.09 Aligned_cols=226 Identities=28% Similarity=0.399 Sum_probs=188.9
Q ss_pred EeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEeccC
Q 002157 683 RIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 683 ~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
++|+|+||.|++++. .+..+|+|+..+.............|..++..++ ||++|++..+|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998843 4667899987765432222225567889999996 9999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~ 836 (959)
+|+|+..+.+.. .+.+.....+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++....... .
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----A 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----c
Confidence 999999987754 4555555556669999999999999 99999999999999999999999999987654432 2
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcC
Q 002157 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 916 (959)
Q Consensus 837 ~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~D 916 (959)
|||..|||||+++ .....+|+|+||++.++|++|..||.+ ++...| ....+.+|..++..+++++.+++..+
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhC
Confidence 8999999999999 457889999999999999999999988 333333 33467889999999999999999999
Q ss_pred CCCCCCH
Q 002157 917 PSLRPSF 923 (959)
Q Consensus 917 P~kRPSa 923 (959)
|..|...
T Consensus 226 p~nrLg~ 232 (612)
T KOG0603|consen 226 PENRLGA 232 (612)
T ss_pred HHHHhcc
Confidence 9999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-21 Score=229.78 Aligned_cols=204 Identities=30% Similarity=0.436 Sum_probs=155.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|+.++.|..|+||.||+++++ .+++|+|+ .++.+. .+ .|+.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-------lR--nilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-------LR--NILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-------hh--ccccccCCccee-----------------
Confidence 67899999999999999999875 77899954 333211 11 133333444444
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC----
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 829 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~---- 829 (959)
|+-..+++.. ..++. +++.+++|||..| |+|||+||+|+||..-|++||+|||+++.....
T Consensus 136 ----gDc~tllk~~-g~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccC-CCCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3333444322 23332 2377999999999 999999999999999999999999998742110
Q ss_pred -----------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCC
Q 002157 830 -----------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEI 897 (959)
Q Consensus 830 -----------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-~~~~~~i 897 (959)
....+..+||+.|+|||++..+.|++.+|||++|+|+||.+.|+.||.+..+.+++..+.. ....++-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 1123456899999999999999999999999999999999999999999999998876532 2223333
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCC
Q 002157 898 PKELDPLVARIIWECWQTDPSLRP 921 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRP 921 (959)
...+.++++++|.++|+.+|..|.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 456789999999999999999996
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=200.71 Aligned_cols=232 Identities=22% Similarity=0.272 Sum_probs=152.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCC----------CceeEEeeee-
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRH----------PNVVLFMGAV- 742 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~H----------pNIVkL~g~~- 742 (959)
.+..++.||.|+++.||.+++ +++.+|||++.... ......+++++|......+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 356789999999999999998 56999999887544 233356677777655554322 1222222221
Q ss_pred --------ecC---C-----cEEEEEeccCCCCHHHHhh---CCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 002157 743 --------TRP---P-----NLSIITEFLPRGSLFRILH---RPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800 (959)
Q Consensus 743 --------~~~---~-----~l~LVmEy~~gGsL~dlL~---k~~---~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHR 800 (959)
... . +.+++|+-+ .++|.+++. ... ..+....++.+..|+++.+++||..| |||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 111 1 246778877 568888753 111 12344566677789999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC--------CCCchhHHHHHHHHHHHHHhC
Q 002157 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE--------PSNEKCDVYSFGVILWELATL 872 (959)
Q Consensus 801 DLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~--------~~s~ksDIWSLGiLLyELLtG 872 (959)
||||+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999887765543221 2345789999987442 368899999999999999999
Q ss_pred CCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCC
Q 002157 873 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 920 (959)
Q Consensus 873 ~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kR 920 (959)
..||........... . ..... .++..++.||.++|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~-~----f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-D----FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-G----GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-c----chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999987654322211 1 11222 778899999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.7e-21 Score=228.79 Aligned_cols=247 Identities=19% Similarity=0.188 Sum_probs=184.5
Q ss_pred CeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~--~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+|...+.||.+.|=+|.+|+++...|+||++.+++. .-....+...|++ ...++|||++.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 678889999999999999999777799999987652 3233344445555 5567999999999998888889999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc--CCccc
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLS 832 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~--~~~~~ 832 (959)
+. .+|+|.|..+ ..+...+...|+.||+.||..+|..| |+|||||.|||||+.-.-+.|+||..-+..- .....
T Consensus 103 vk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 95 4999999765 36788888899999999999999999 9999999999999998899999998665321 11110
Q ss_pred -----CCCCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccccc
Q 002157 833 -----SKSTAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 895 (959)
Q Consensus 833 -----~~t~~GT~~YmAPEvl~g~~-----------~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~ 895 (959)
..+......|+|||.+.... .+++.||||+||+++||++ |++||.- .+++....-.....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSGNADDP 255 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhccCccCH
Confidence 11222344699999985421 4678999999999999987 5777742 12221111000000
Q ss_pred --CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 896 --EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 896 --~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+.+--+..+++||..|++.||.+|.++++.|+..+
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 000112447899999999999999999999998744
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=196.33 Aligned_cols=173 Identities=13% Similarity=0.101 Sum_probs=135.1
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHH-HHHH------HHHHHHHHHHcCCCceeEEeeeeecC-
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLE------FKREVKIMRRLRHPNVVLFMGAVTRP- 745 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~-~~~e------f~~Ei~IL~~L~HpNIVkL~g~~~~~- 745 (959)
-..+|++.++||.|+||.||++..++..+|||++.......+ .... +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 357899999999999999999877888999999876543322 2222 57999999999999999988876533
Q ss_pred -------CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 002157 746 -------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818 (959)
Q Consensus 746 -------~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLi 818 (959)
...+|||||++|.+|.++.. +++. ...+++.+|..||..| |+||||||.||+++.+| ++|+
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999988742 2332 3459999999999999 99999999999999988 9999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH
Q 002157 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 870 (959)
Q Consensus 819 DFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELL 870 (959)
|||........... ...+....++.++|+|+||+++.-+.
T Consensus 177 Dfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988654322110 01334445678999999999887664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=190.86 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=107.1
Q ss_pred EeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHH------------------------HHHHHHHHHHHHHcCCCce
Q 002157 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA------------------------LLEFKREVKIMRRLRHPNV 735 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~------------------------~~ef~~Ei~IL~~L~HpNI 735 (959)
.+.||+|+||.||+|.+ +|+.||||+++........ .....+|+++|.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35699999999999987 6899999998754221100 1123459999999987766
Q ss_pred eEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yL-Hs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
.....+.. ...+|||||+++++|...+.+. ..+++.....++.|++.+|.|| |..| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43322222 2237999999988776553332 4688899999999999999999 6888 99999999999998 478
Q ss_pred EEEEecCccccc
Q 002157 815 VKVSDFGLSRLK 826 (959)
Q Consensus 815 VKLiDFGlAk~~ 826 (959)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=186.88 Aligned_cols=186 Identities=16% Similarity=0.171 Sum_probs=142.1
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCCCH--HHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEeccC
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~--~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
+...|++|+||+||++...+.+++.+.+....... -....+.+|+++|++|. |++|++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45789999999999998888898887765543311 12235789999999995 5889999886 34689999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC-CCCcEEEcCCCcEEEEecCccccccCCcc----
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 831 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDL-KPeNILLd~~g~VKLiDFGlAk~~~~~~~---- 831 (959)
|.+|...+... ...++.|++.+|.++|.+| |+|||| ||+|||++.+|.++|+|||++........
T Consensus 82 G~~L~~~~~~~--------~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPRG--------DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhhh--------hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 99987654221 1346779999999999999 999999 79999999999999999999985443221
Q ss_pred -c--------CCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002157 832 -S--------SKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGM 879 (959)
Q Consensus 832 -~--------~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~ 879 (959)
. ..-...++.|+.|+...-- ..-...+|++.|+-+|.++|+..++-+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0011267888888865432 2235789999999999999999886543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=198.00 Aligned_cols=189 Identities=24% Similarity=0.399 Sum_probs=143.9
Q ss_pred CCCceeEEeeeeec---------------------------CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHH
Q 002157 731 RHPNVVLFMGAVTR---------------------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783 (959)
Q Consensus 731 ~HpNIVkL~g~~~~---------------------------~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QI 783 (959)
+|||||++.++|.+ ...+|+||..++. +|..++-.+. .+....+.|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999887753 2348899998865 8999986643 4445555677899
Q ss_pred HHHHHHHHhCCCCEEeeCCCCCcEEEc--CC--CcEEEEecCccccccC-----Cccc-CCCCCCCCCccCcccccCCC-
Q 002157 784 ARGMNCLHTSTPTIVHRDLKSPNLLVD--KN--WNVKVSDFGLSRLKHN-----TFLS-SKSTAGTPEWMAPEVLRNEP- 852 (959)
Q Consensus 784 a~AL~yLHs~g~~IIHRDLKPeNILLd--~~--g~VKLiDFGlAk~~~~-----~~~~-~~t~~GT~~YmAPEvl~g~~- 852 (959)
++|+.|||++| |.|||||.+||||. ++ -.+.|+|||++-.... ++.. ....-|...-||||+.+..+
T Consensus 351 LEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 351 LEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 99999999999993 33 3589999998753222 1111 12334788899999987433
Q ss_pred -----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHH
Q 002157 853 -----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFA 924 (959)
Q Consensus 853 -----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~ 924 (959)
.-.|+|.|+.|.|-||++....||++...+.+...-..+..-+.+|..+++.+++|+..+|+.||.+|++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 235899999999999999999999985544332222223345678889999999999999999999998754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=182.45 Aligned_cols=140 Identities=21% Similarity=0.253 Sum_probs=109.4
Q ss_pred EeEeeccCcEEEEEEEE-CCceEEEEEeeccCCC----------------------HH--HHHHHHHHHHHHHHcCCCce
Q 002157 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------------GA--ALLEFKREVKIMRRLRHPNV 735 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~----------------------~~--~~~ef~~Ei~IL~~L~HpNI 735 (959)
.+.||+|+||.||+|++ +|+.||||++...... .. ....+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 5999999998764211 00 01224679999999999887
Q ss_pred eEEeeeeecCCcEEEEEeccCCCCHHHH-hhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC
Q 002157 736 VLFMGAVTRPPNLSIITEFLPRGSLFRI-LHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~dl-L~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g 813 (959)
.....+... ..+|||||++|+.+... +.. ..++......++.|++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 544333332 24799999988755443 433 357788888999999999999999 88 99999999999999 89
Q ss_pred cEEEEecCcccccc
Q 002157 814 NVKVSDFGLSRLKH 827 (959)
Q Consensus 814 ~VKLiDFGlAk~~~ 827 (959)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=216.21 Aligned_cols=250 Identities=21% Similarity=0.245 Sum_probs=186.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeec
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTR 744 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~---HpNIVkL~g~~~~ 744 (959)
..+++..+.|.|.+.||+|+||+||+|.. +++.||||+-+.....+- .=-.+++.+|+ -+-|..+..++..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34556668899999999999999999976 688999998766544321 11234444554 2345666666677
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-------CCcEEE
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKV 817 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-------~g~VKL 817 (959)
.+..+||+||.+.|+|.++++. ...+++.....|+.|++.-+++||.++ |||+||||+|+||.. .--++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 7788899999999999999984 457899999999999999999999999 999999999999942 345999
Q ss_pred EecCcccccc--CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc
Q 002157 818 SDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 895 (959)
Q Consensus 818 iDFGlAk~~~--~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~ 895 (959)
+|||.+.-+. .........++|-.+-.+|+..|..|++.+|.|.|+.++|-||+|++- +....- ......
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q~~~g~-~~~~~~ 914 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------EVKNGS-SWMVKT 914 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------HhcCCc-ceeccc
Confidence 9999886321 122334557789999999999999999999999999999999999752 100000 000111
Q ss_pred CCCCCCcHH-HHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 896 EIPKELDPL-VARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 896 ~iP~~ls~e-L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
.++..+..+ +-+|+..+|+.|-..=|.+.+|...|+.+.
T Consensus 915 ~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 915 NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred cchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 123333333 567888899966666688888888887653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=171.25 Aligned_cols=136 Identities=23% Similarity=0.410 Sum_probs=115.2
Q ss_pred eEeeccCcEEEEEEEECCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~------~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
+.||+|++|.||+|.+.+..|+||+......... ....+.+|+.++..+.|++|+....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5699999999999999999999998765433211 2245778999999999999877777776777889999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+|++|.+++.... . ....++.+++.+|.+||..+ ++||||+|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986532 2 77789999999999999999 99999999999999 78999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=173.92 Aligned_cols=134 Identities=19% Similarity=0.245 Sum_probs=103.8
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-----CCCceeEEeeeeecCC---c-EEEE
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-----RHPNVVLFMGAVTRPP---N-LSII 751 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-----~HpNIVkL~g~~~~~~---~-l~LV 751 (959)
.+.||+|+||.||.-..++.. +||++...... ....+.+|+.+++.+ .||||++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356999999999963234444 68887654322 345789999999999 5799999999998874 3 3378
Q ss_pred Eec--cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCEEeeCCCCCcEEEcC----CCcEEEEecCcc
Q 002157 752 TEF--LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM-NCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLS 823 (959)
Q Consensus 752 mEy--~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL-~yLHs~g~~IIHRDLKPeNILLd~----~g~VKLiDFGlA 823 (959)
||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999763 35555 24567888777 9999999 999999999999974 347999995444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=170.01 Aligned_cols=133 Identities=22% Similarity=0.365 Sum_probs=108.8
Q ss_pred EeeccCcEEEEEEEECCceEEEEEeeccCCCH------HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 683 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~------~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
.||+|+||.||++.+.+..|+||+........ .....+.+|++++..++|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999866543221 123567889999999988776544444555667789999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
|++|.+++..... .++.+++.+|.+||..| ++|||++|.|||++ ++.++|+|||++...
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998855321 67889999999999998 99999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.8e-18 Score=194.46 Aligned_cols=209 Identities=32% Similarity=0.516 Sum_probs=167.7
Q ss_pred HHHcCCCceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 002157 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (959)
Q Consensus 727 L~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeN 806 (959)
|+.+.|.|+.+|+|.+.++..+++|.+||..|+|.+.+......+++.....+.++|+.||+|||.--. ..|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence 356789999999999999999999999999999999998877889999999999999999999998752 3999999999
Q ss_pred EEEcCCCcEEEEecCccccccC--CcccCCCCCCCCCccCcccccCCC-------CCchhHHHHHHHHHHHHHhCCCCCC
Q 002157 807 LLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWMAPEVLRNEP-------SNEKCDVYSFGVILWELATLKLPWI 877 (959)
Q Consensus 807 ILLd~~g~VKLiDFGlAk~~~~--~~~~~~t~~GT~~YmAPEvl~g~~-------~s~ksDIWSLGiLLyELLtG~~PF~ 877 (959)
+++|..+.+||+|||+...... .........-...|.|||.+.+.. .+.+.|+||||++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 9999999999999999877642 111111122345799999998742 3567999999999999999999997
Q ss_pred CCC----hHHHHhhhhccccccCCCC-----CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 878 GMN----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 878 g~~----~~ql~~~i~~~~~~~~iP~-----~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
... +.++...+.........|. .+.+++..++..||.-+|.+||++++|...++.+.+.
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 632 2344444433122222221 3455799999999999999999999999999887664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=172.79 Aligned_cols=144 Identities=24% Similarity=0.230 Sum_probs=111.3
Q ss_pred CeeEEeEeeccCcEEEEEEE---ECCceEEEEEeeccCCCH----------------------HHHHHHHHHHHHHHHcC
Q 002157 677 DLVLGERIGLGSYGEVYHAD---WNGTEVAVKKFLDQDFSG----------------------AALLEFKREVKIMRRLR 731 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~---~~g~~VAVK~i~~~~~~~----------------------~~~~ef~~Ei~IL~~L~ 731 (959)
-|.+.+.||+|+||.||+|. .+|+.||||++....... .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37888999999999999998 378999999987543110 01234578999999997
Q ss_pred CC--ceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 002157 732 HP--NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (959)
Q Consensus 732 Hp--NIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL 809 (959)
+. .+.+++++ ...+|||||+++++|...+... ..+.......++.||+.+|.+||.+| +|+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 53 34455543 2347999999998887665332 24556667789999999999999986 59999999999999
Q ss_pred cCCCcEEEEecCcccccc
Q 002157 810 DKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 810 d~~g~VKLiDFGlAk~~~ 827 (959)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=189.19 Aligned_cols=137 Identities=20% Similarity=0.335 Sum_probs=114.4
Q ss_pred eeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCH------HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~------~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
|...+.||+|+||+||++.+.+..+++|+........ .....+.+|+++++.++|++|+..+.++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4567889999999999999988777777544332211 1235678999999999999998887777777788999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
|||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999885 34578899999999999999 9999999999999 6789999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=162.26 Aligned_cols=137 Identities=21% Similarity=0.227 Sum_probs=107.2
Q ss_pred eeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCH--------------------HHHHHHHHHHHHHHHcCCC--c
Q 002157 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG--------------------AALLEFKREVKIMRRLRHP--N 734 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~--------------------~~~~ef~~Ei~IL~~L~Hp--N 734 (959)
|.+.+.||+|+||.||++.+ +++.||||++....... .....+.+|+.++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67778899999999999987 68999999876432100 0112367899999999777 4
Q ss_pred eeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
+++.++. ...++||||+++++|..+... .....++.+|+.++.++|..| |+||||||+||+|++++.
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 4444442 345899999999998776431 234567889999999999998 999999999999999999
Q ss_pred EEEEecCcccccc
Q 002157 815 VKVSDFGLSRLKH 827 (959)
Q Consensus 815 VKLiDFGlAk~~~ 827 (959)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-16 Score=180.42 Aligned_cols=167 Identities=25% Similarity=0.356 Sum_probs=129.0
Q ss_pred CcEEEEEeccCCCCHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 746 PNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k--~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
.++||.|++|...+|.++|.+ .....+......++.|++.|+.| ++ .+|||+||.||++..+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 458899999999999999954 34556778888999999999999 56 999999999999999999999999998
Q ss_pred ccccCCc------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccC
Q 002157 824 RLKHNTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLE 896 (959)
Q Consensus 824 k~~~~~~------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~ 896 (959)
....... ......+||.+||+||.|.|..|+.++|||+||+||+||+.. ...|... .....+ +...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~----r~g~ 476 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDI----RDGI 476 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh----hcCC
Confidence 7654332 234567899999999999999999999999999999999972 2222211 111112 2333
Q ss_pred CCCC---CcHHHHHHHHHHhhcCCCCCCCHH
Q 002157 897 IPKE---LDPLVARIIWECWQTDPSLRPSFA 924 (959)
Q Consensus 897 iP~~---ls~eL~dLI~kCL~~DP~kRPSa~ 924 (959)
+|+. -.++-..|+.+||.+.|.+||++.
T Consensus 477 ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 477 IPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred CChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 3321 124456999999999999999443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-15 Score=142.73 Aligned_cols=134 Identities=19% Similarity=0.186 Sum_probs=113.0
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCCcEEEEEeccCC
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H--pNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.+.||.|.++.||++...+..++||.+..... ...+.+|+.+++.++| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457799999999999999888999998765432 4568899999999976 5899999998888889999999988
Q ss_pred CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 758 GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g-~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.+..+ +......++.+++.+|.+||... .+++|+||+|+|||+++.+.++|+|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 44556677889999999999852 2499999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-17 Score=196.58 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=195.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LV 751 (959)
..|.+.+.||+|+|+.|-.... ....+|+|.+............+..|..+-+.+. |.|++++++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4567777899999999998865 3344666655544433444556667888888886 99999999999999999999
Q ss_pred EeccCCCCHHHHh-hCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccC
Q 002157 752 TEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 828 (959)
Q Consensus 752 mEy~~gGsL~dlL-~k~~~~lse~~~l~Ia~QIa~AL~yLH-s~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~ 828 (959)
++|..++++++.+ .......+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ .+++.|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999998 443324555556667889999999999 888 99999999999999999 999999999987654
Q ss_pred -C--cccCCCCCC-CCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh--hhhcc-ccccCCCCC
Q 002157 829 -T--FLSSKSTAG-TPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG--AVGFQ-NRRLEIPKE 900 (959)
Q Consensus 829 -~--~~~~~t~~G-T~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~--~i~~~-~~~~~iP~~ 900 (959)
. .......+| ++.|+|||...+. ......|+||.|+++..+++|..||.......... ..... ......+..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2 223445678 9999999999985 55788999999999999999999997655433211 11111 112344567
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLT 927 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL 927 (959)
++....+++.++|..+|..|.+.+++.
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred CChhhhhcccccccCCchhcccccccc
Confidence 888999999999999999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=152.39 Aligned_cols=137 Identities=23% Similarity=0.215 Sum_probs=97.9
Q ss_pred EeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHH----------------------HHHHHHHHHHcCCC--ce
Q 002157 681 GERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLE----------------------FKREVKIMRRLRHP--NV 735 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~e----------------------f~~Ei~IL~~L~Hp--NI 735 (959)
++.||+|+||+||+|.+. ++.||||++............ ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999874 899999998754322111111 13566667666443 24
Q ss_pred eEEeeeeecCCcEEEEEeccCCCCHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC
Q 002157 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~d-lL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g 813 (959)
.+.++. ...++||||++++.+.. .+.... .. .....++.+++.++.++|. ++ |+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 444443 23589999999854332 121111 11 5567789999999999999 88 99999999999999 89
Q ss_pred cEEEEecCcccccc
Q 002157 814 NVKVSDFGLSRLKH 827 (959)
Q Consensus 814 ~VKLiDFGlAk~~~ 827 (959)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=156.09 Aligned_cols=136 Identities=16% Similarity=0.263 Sum_probs=106.3
Q ss_pred eEee-ccCcEEEEEEEECCceEEEEEeeccCC-----------CHHHHHHHHHHHHHHHHcCCCce--eEEeeeeecCCc
Q 002157 682 ERIG-LGSYGEVYHADWNGTEVAVKKFLDQDF-----------SGAALLEFKREVKIMRRLRHPNV--VLFMGAVTRPPN 747 (959)
Q Consensus 682 k~LG-kG~fG~VYka~~~g~~VAVK~i~~~~~-----------~~~~~~ef~~Ei~IL~~L~HpNI--VkL~g~~~~~~~ 747 (959)
..|| .|+.|+||.++..+..++||.+..... .......+.+|+.++.+|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 888899999988899999998854221 11233567889999999988775 667766433222
Q ss_pred ----EEEEEeccCC-CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCc
Q 002157 748 ----LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (959)
Q Consensus 748 ----l~LVmEy~~g-GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGl 822 (959)
.+|||||++| .+|.+++.+. .+++.. +.+|+.+|.+||.+| |+||||||+|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2599999997 6899988653 345443 468999999999999 99999999999999999999999998
Q ss_pred ccc
Q 002157 823 SRL 825 (959)
Q Consensus 823 Ak~ 825 (959)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4e-13 Score=156.48 Aligned_cols=244 Identities=24% Similarity=0.195 Sum_probs=186.9
Q ss_pred CeeEEeEeec--cCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEE
Q 002157 677 DLVLGERIGL--GSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 677 dy~I~k~LGk--G~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~ 749 (959)
.+.+.+.+|. |.+|.||.+.. .+..+|+|+-+...........=.+|+...+.+ .|+|.++.+..|...+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778999 99999999865 567789986332221111222224566666666 4999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR 824 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~----AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk 824 (959)
+-+|+| +.+|..+.+.....+++..++.+..+..+ ||.++|..+ |+|-|+||.||++..+ ...+++|||+..
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 999999 57999998887777899999999999999 999999998 9999999999999998 889999999998
Q ss_pred cccCCcccCC-----CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHhhhhccccccC
Q 002157 825 LKHNTFLSSK-----STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLE 896 (959)
Q Consensus 825 ~~~~~~~~~~-----t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~---~~~ql~~~i~~~~~~~~ 896 (959)
.+........ ...|...|++||.+++. ++...|+|+||.++.+..++..++... .+.++-. ...+.+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----~~ip~e 346 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----GYIPLE 346 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----ccCchh
Confidence 8765542222 22688899999998776 678999999999999998886554332 1111110 112333
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+-...+.++...+.+|++.+|..|++++.++.
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 33456777888999999999999998877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.6e-13 Score=163.63 Aligned_cols=251 Identities=21% Similarity=0.243 Sum_probs=194.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeecc-CCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~-~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+....+.+.+.+-+-.|.++.++.++- .+...++|+.... .+.......+..+-.++...++|.++....-+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 567788999999999999999999865 3333455543322 1112223344555666656677888887777777788
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++|+++|+.+++|...|+..+ ..+....+.+...+.++++|||... ++|||++|.|+|+..+|+.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999998765 3444445556668999999999987 8999999999999999999999998433211
Q ss_pred CC-------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002157 828 NT-------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876 (959)
Q Consensus 828 ~~-------------------------------~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF 876 (959)
.. ........||+.|.+||.+.+......+|||++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 01123456999999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHH
Q 002157 877 IGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFA 924 (959)
Q Consensus 877 ~g~~~~ql~~~i~~~~~-~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~ 924 (959)
....+.++++.+..... ....|...+.+.++++..+|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999998877753322 2334567889999999999999999998776
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.7e-12 Score=126.37 Aligned_cols=129 Identities=16% Similarity=0.117 Sum_probs=96.2
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCcEEEEEeccCCCC
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGS 759 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~~gGs 759 (959)
++.|+.|.++.||+++..+..|+||+...... ....+.+|+.+++.+.+.++ .+++.+.. ...++||||++|..
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46789999999999999999999998654321 12345788999998865444 34554433 34579999999987
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 760 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP---TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 760 L~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~---~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
+.... .....++.+++.+|..||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 1112356789999999999861 259999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-11 Score=143.65 Aligned_cols=164 Identities=19% Similarity=0.248 Sum_probs=125.3
Q ss_pred CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHH
Q 002157 698 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777 (959)
Q Consensus 698 ~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l 777 (959)
++.+|.|+++....- .....+.+-++-|+.++||||+++++.++.++.+|||+|.+. -|..++.+. ......
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 677888887765433 334456788899999999999999999999999999999984 577777653 356666
Q ss_pred HHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchh
Q 002157 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857 (959)
Q Consensus 778 ~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ks 857 (959)
..+.||+.||.|||..+ .++|++|.-.-|+|+..|+.||++|.++..............---.|..|+.+.... -..
T Consensus 108 ~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 78899999999998543 499999999999999999999999988765432221111112222466666654443 457
Q ss_pred HHHHHHHHHHHHHhC
Q 002157 858 DVYSFGVILWELATL 872 (959)
Q Consensus 858 DIWSLGiLLyELLtG 872 (959)
|.|.|||++++++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.1e-12 Score=144.65 Aligned_cols=141 Identities=24% Similarity=0.249 Sum_probs=97.4
Q ss_pred eEeeccCcEEEEEEEE-CCceEEEEEeeccCCCH----------------------------HH----------HHHHHH
Q 002157 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------------------AA----------LLEFKR 722 (959)
Q Consensus 682 k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~----------------------------~~----------~~ef~~ 722 (959)
+.||.|++|.||+|+. +|+.||||+.+..-... .. ...+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999987 79999999875431000 00 012455
Q ss_pred HHHHHHHcC-----CCceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 002157 723 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR-GMNCLHTSTPT 796 (959)
Q Consensus 723 Ei~IL~~L~-----HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~-AL~yLHs~g~~ 796 (959)
|.+.+.+++ +++|.-..-++......+|||||++|++|.++......... ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 666666662 33332111122223456899999999999887643211222 3345556665 467889988
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 797 IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++|+|+||.||+++.+|.++|+|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.9e-11 Score=133.95 Aligned_cols=199 Identities=23% Similarity=0.348 Sum_probs=140.6
Q ss_pred HHHHHcCCCceeEEeeeeecCC-----cEEEEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 002157 725 KIMRRLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPT 796 (959)
Q Consensus 725 ~IL~~L~HpNIVkL~g~~~~~~-----~l~LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~ 796 (959)
..|-++-|.|||+++.||.+.. ...++.||+..|+|..+|++ ++..+..+...+|+.||+.||.|||+..+.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3444567999999999986543 37899999999999999864 455688888899999999999999999999
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh
Q 002157 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871 (959)
Q Consensus 797 IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-----~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt 871 (959)
|+|++|..+-|++..+|-||+.--... ..+... .......+-+.|.+||.=.....+.++|||+||+...+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998887422111 111111 11122346778999997666666778999999999999987
Q ss_pred CCCC-CCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 872 LKLP-WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 872 G~~P-F~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+..- -.+.........+ .....-. -...=+++|.+||+..|..||+++.++.+
T Consensus 278 lEiq~tnseS~~~~ee~i--a~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENI--ANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhh--hhheeec---cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 6532 1111111111111 0001111 11223688999999999999999988754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-11 Score=143.77 Aligned_cols=249 Identities=20% Similarity=0.189 Sum_probs=184.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
....+|..+..||.|.|+.|+.+.. ++..|++|...+..........-..|+.+...+ -|.+++.++..|....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4456788999999999999999854 467899997665544433333335677777666 589999988888888888
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk~~~ 827 (959)
|+-.|||.++++...+. ....+++..++.+..|++.++.++|+.. ++|+|+||.||++..+ +.-++.|||++..+.
T Consensus 342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccc
Confidence 89999999998877662 2245778888899999999999999998 9999999999999875 888999999987422
Q ss_pred CCcccCCCCCCCCCcc--CcccccCCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 828 NTFLSSKSTAGTPEWM--APEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 828 ~~~~~~~t~~GT~~Ym--APEvl~g~~~s~ksDIWSLGiLLyELLtG~~-PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.. .....+.-+++ +++......+..++|+++||.-+.+.+++.. ++.+.... ...............+
T Consensus 419 ~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~------~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL------TIRSGDTPNLPGLKLQ 489 (524)
T ss_pred ee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce------eeecccccCCCchHHh
Confidence 11 11223333444 5555566778899999999999999998864 33332221 1122233333444588
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+..+.+.++..++..||.+.++..+.+..
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999998887665543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.6e-11 Score=142.47 Aligned_cols=142 Identities=17% Similarity=0.186 Sum_probs=90.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE-C-CceEEEEEeeccCC---------------------------CH-----HHHH---
Q 002157 676 EDLVLGERIGLGSYGEVYHADW-N-GTEVAVKKFLDQDF---------------------------SG-----AALL--- 718 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~-~-g~~VAVK~i~~~~~---------------------------~~-----~~~~--- 718 (959)
.+|+. +.||.|++|.||+|+. + |+.||||+.+..-. .. +...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45555 7899999999999987 3 89999999874310 00 0111
Q ss_pred ---HHHHHHHHHHHcC----CCceeEEeeee-ecCCcEEEEEeccCCCCHHHH--hhCCCC---CCCHHHHHHHHHHHHH
Q 002157 719 ---EFKREVKIMRRLR----HPNVVLFMGAV-TRPPNLSIITEFLPRGSLFRI--LHRPHC---QVDEKRRIKMALDVAR 785 (959)
Q Consensus 719 ---ef~~Ei~IL~~L~----HpNIVkL~g~~-~~~~~l~LVmEy~~gGsL~dl--L~k~~~---~lse~~~l~Ia~QIa~ 785 (959)
.+.+|...+.+++ +.+.+.+-.++ .....-+|||||+.|+.|.++ +.+.+. .+.+.....++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2344555555442 32222222222 123446799999999999875 333221 12233333334443
Q ss_pred HHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecCcccccc
Q 002157 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKH 827 (959)
Q Consensus 786 AL~yLHs~g~~IIHRDLKPeNILLd~~g----~VKLiDFGlAk~~~ 827 (959)
+..| ++|+|+||.||+++.+| .++++|||+.....
T Consensus 277 -----f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3467 99999999999999888 99999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-10 Score=119.48 Aligned_cols=137 Identities=20% Similarity=0.188 Sum_probs=97.8
Q ss_pred eEeeccCcEEEEEEEEC--------CceEEEEEeeccC--CC------------------HHHHHHH----HHHHHHHHH
Q 002157 682 ERIGLGSYGEVYHADWN--------GTEVAVKKFLDQD--FS------------------GAALLEF----KREVKIMRR 729 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~--------g~~VAVK~i~~~~--~~------------------~~~~~ef----~~Ei~IL~~ 729 (959)
..||.|.-+.||.|... +..+|||+++... +. ......+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999653 3689999775311 00 0112223 489999999
Q ss_pred cC--CCceeEEeeeeecCCcEEEEEeccCCCCHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeeCCCCC
Q 002157 730 LR--HPNVVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSP 805 (959)
Q Consensus 730 L~--HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~d-lL~k~~~~lse~~~l~Ia~QIa~AL~yL-Hs~g~~IIHRDLKPe 805 (959)
+. .-++.+.+++ ..-+|||||+.++.+.. .+.. ..+++.....+..+++.+|..| |..| |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 84 3456666654 34579999997654432 2322 2344555667788999999999 8888 999999999
Q ss_pred cEEEcCCCcEEEEecCcccccc
Q 002157 806 NLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 806 NILLd~~g~VKLiDFGlAk~~~ 827 (959)
|||+. ++.++|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4789999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-09 Score=122.96 Aligned_cols=248 Identities=17% Similarity=0.228 Sum_probs=166.2
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee------e-ecCCcEEEE
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA------V-TRPPNLSII 751 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~------~-~~~~~l~LV 751 (959)
.++.||+|+-+.+|..-.-+..|| |++.......+. ..+..|... .||-+-.-+.| . ..+....++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhchhh-eeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 356799999999997754444454 777655432211 122334433 45543321211 1 122337788
Q ss_pred EeccCCCCH-HHHhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 752 TEFLPRGSL-FRILH-----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 752 mEy~~gGsL-~dlL~-----k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
|..+.+..- ..++. +......|...++.++.|+.+.+.||.+| .+-+|+.++|+|+.+++.|.|+|-..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence 888876532 23322 12234778999999999999999999999 99999999999999999999998764433
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCh-------HH--HHh----
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATL-KLPWIGMNP-------MQ--VVG---- 886 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~-------~q--l~~---- 886 (959)
- .........+|..+|.+||.-+ |...+...|.|.||+++++++.| +.||.|... .+ +..
T Consensus 167 ~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 N-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred c-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2 2223344677999999999754 44557789999999999999987 899977321 11 110
Q ss_pred -h----hhccccccCCC-CCCcHHHHHHHHHHhhc--CCCCCCCHHHHHHHHHhhhhh
Q 002157 887 -A----VGFQNRRLEIP-KELDPLVARIIWECWQT--DPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 887 -~----i~~~~~~~~iP-~~ls~eL~dLI~kCL~~--DP~kRPSa~EIL~~Le~l~kl 936 (959)
. ......+..+| .-+++.+..|..+|+.. ++.-||+++.++..|..+...
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0 00011111222 24688999999999974 467999999999999877554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.8e-10 Score=115.75 Aligned_cols=132 Identities=26% Similarity=0.383 Sum_probs=102.5
Q ss_pred EeeccCcEEEEEEEECCceEEEEEeeccCCCHHHH------HHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 683 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL------LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~------~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
.+.+|+-..+|.+.+.|.++.+|.=..+.+....+ ....+|.+++.+++--.|.--+=++.+.....|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999999988888888544444433222 345789999999865555444444556677789999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
|..|.+++... ...++..+-..+.-||..| |||+||.+.||++...+ +.++|||++..
T Consensus 83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999898764 2456677888888899999 99999999999997765 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=5e-10 Score=115.17 Aligned_cols=141 Identities=21% Similarity=0.262 Sum_probs=107.5
Q ss_pred eEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecC---CcEEEEEecc
Q 002157 682 ERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRP---PNLSIITEFL 755 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H--pNIVkL~g~~~~~---~~l~LVmEy~ 755 (959)
+.|+.|.++.||+++..+ +.++||+....... .....+.+|..+++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 89999986543321 124467899999999965 3456777776553 3568999999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST----------------------------------------- 794 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g----------------------------------------- 794 (959)
+|.+|.+.+.. ..+++.....++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888776532 24677777778888888888888521
Q ss_pred -------------CCEEeeCCCCCcEEEcC--CCcEEEEecCcccc
Q 002157 795 -------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 825 (959)
Q Consensus 795 -------------~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~ 825 (959)
..+||+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23899999999999998 67789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-09 Score=110.90 Aligned_cols=145 Identities=19% Similarity=0.244 Sum_probs=107.2
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHH------HHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA------LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~------~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.+..|-+|+-+.|+++.+.|+.+.||.-....+.... ....++|.++|.+++--.|.--.=+|.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567899999999999999999999865544443332 2356789999998864444433334445555678999
Q ss_pred ccCC-CCHHHHhhCCCCCCC-HHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEEecCccccc
Q 002157 754 FLPR-GSLFRILHRPHCQVD-EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLK 826 (959)
Q Consensus 754 y~~g-GsL~dlL~k~~~~ls-e~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g---~VKLiDFGlAk~~ 826 (959)
|++| .++.+++........ ......++.+|-+.+.-||..+ |||+||..+||+|..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9976 478888754332333 3333788999999999999999 99999999999996543 4689999998643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.2e-08 Score=109.68 Aligned_cols=139 Identities=19% Similarity=0.121 Sum_probs=98.7
Q ss_pred eeccCcEEEEEEEECCceEEEEEeeccCCCH---------HHHHHHHHHHHHHHHcCCCc--eeEEeeeeec-----CCc
Q 002157 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSG---------AALLEFKREVKIMRRLRHPN--VVLFMGAVTR-----PPN 747 (959)
Q Consensus 684 LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~---------~~~~ef~~Ei~IL~~L~HpN--IVkL~g~~~~-----~~~ 747 (959)
+-......|+++++.|+.|.||........+ .....+.+|.+.+.+|..-+ .+..++++.. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 3333334467788889999999764433211 01114778999998884333 2334444432 234
Q ss_pred EEEEEeccCCC-CHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-------CCcEEEE
Q 002157 748 LSIITEFLPRG-SLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKVS 818 (959)
Q Consensus 748 l~LVmEy~~gG-sL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-------~g~VKLi 818 (959)
.+||||++++. +|.+++... ...........++.+++..+.-||..| |+|+||++.||||+. ++.+.|+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEE
Confidence 77999999876 799988531 234556677789999999999999999 999999999999975 4789999
Q ss_pred ecCccc
Q 002157 819 DFGLSR 824 (959)
Q Consensus 819 DFGlAk 824 (959)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999775
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-07 Score=108.92 Aligned_cols=212 Identities=16% Similarity=0.193 Sum_probs=151.3
Q ss_pred CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCcEEEEEeccCC-CCH
Q 002157 688 SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLPR-GSL 760 (959)
Q Consensus 688 ~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~~l~LVmEy~~g-GsL 760 (959)
--.+.|++.. +|..|.+|++...... .....-.-+++++++.|+|||+|.++|.. +..+++|++|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3457888865 7889999998432211 11112244678999999999999999873 3458899999874 477
Q ss_pred HHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 761 FRILHR--------------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 761 ~dlL~k--------------~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++... .+.+.+|..+|.++.||..||.++|+.| +..+=|.+.+||++.+..|+|...|+....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence 775421 2345778999999999999999999999 888999999999999889999877776655
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHH-HhhhhccccccCCCCCCcHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQV-VGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~P-F~g~~~~ql-~~~i~~~~~~~~iP~~ls~e 904 (959)
.... -|.+.+ -.+-|.=.||.|++.|.+|..- |.....++. ... +-...+.+
T Consensus 444 ~~d~--------------~~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D 497 (655)
T KOG3741|consen 444 QEDP--------------TEPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTD 497 (655)
T ss_pred cCCC--------------CcchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHH
Confidence 4331 012222 3467999999999999999643 333333222 221 22467888
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~L 930 (959)
++++|..+...++++ -++.+++.++
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 999999888888886 5666665443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-07 Score=98.86 Aligned_cols=127 Identities=28% Similarity=0.318 Sum_probs=81.0
Q ss_pred EEEEEEE-CCceEEEEEeecc--CCCH----------------------HHHHHHHHHHHHHHHcCCC--ceeEEeeeee
Q 002157 691 EVYHADW-NGTEVAVKKFLDQ--DFSG----------------------AALLEFKREVKIMRRLRHP--NVVLFMGAVT 743 (959)
Q Consensus 691 ~VYka~~-~g~~VAVK~i~~~--~~~~----------------------~~~~ef~~Ei~IL~~L~Hp--NIVkL~g~~~ 743 (959)
.||.|.. ++..+|||+.+.. .+.. .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899976 7889999977542 1111 1123467899999999755 466666543
Q ss_pred cCCcEEEEEeccC--CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 744 RPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC-LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 744 ~~~~l~LVmEy~~--gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~y-LHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
.-.|||||++ |..+..+.... +.......++.+++..+.. +|..| |||+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 2369999998 65555544321 1123344566677775555 47888 9999999999999887 9999999
Q ss_pred Ccccccc
Q 002157 821 GLSRLKH 827 (959)
Q Consensus 821 GlAk~~~ 827 (959)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-07 Score=98.61 Aligned_cols=105 Identities=30% Similarity=0.333 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHHcCCCc--eeEEeeeeecC----CcEEEEEeccCCC-CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 002157 718 LEFKREVKIMRRLRHPN--VVLFMGAVTRP----PNLSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790 (959)
Q Consensus 718 ~ef~~Ei~IL~~L~HpN--IVkL~g~~~~~----~~l~LVmEy~~gG-sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yL 790 (959)
....+|...+..|..-. +++.+++.... ...+||+|++++. +|.+++.... ..+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence 35678888888774322 34445544432 2357999999874 7999987533 266677788999999999999
Q ss_pred HhCCCCEEeeCCCCCcEEEcCCC---cEEEEecCcccc
Q 002157 791 HTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 825 (959)
Q Consensus 791 Hs~g~~IIHRDLKPeNILLd~~g---~VKLiDFGlAk~ 825 (959)
|..| |+|+|+++.||||+.++ .+.|+||+-++.
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-08 Score=118.77 Aligned_cols=145 Identities=19% Similarity=0.284 Sum_probs=107.3
Q ss_pred HHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc------c---CCCCCCCCCccCcccccCCC
Q 002157 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL------S---SKSTAGTPEWMAPEVLRNEP 852 (959)
Q Consensus 782 QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~------~---~~t~~GT~~YmAPEvl~g~~ 852 (959)
+++.||.|+|..- ++||++|.|++|.++.+|.+||+.|+++........ . .....-...|.|||.+.+..
T Consensus 107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 5559999999874 699999999999999999999999998865433111 0 01112456799999999988
Q ss_pred CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH--HhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHH
Q 002157 853 SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQV--VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 927 (959)
Q Consensus 853 ~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql--~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL 927 (959)
.+.++|+||||+++|.+.. |+.-+...+.... ......+.....++..++.++++=|.++|..++.-||++.++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 8999999999999999994 4444443322111 1111222334445578999999999999999999999776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.6e-07 Score=98.74 Aligned_cols=135 Identities=25% Similarity=0.299 Sum_probs=94.6
Q ss_pred eeEEeEeeccCcEEEEEEEE-CCceEEEEEeecc--CC----------------C--HHHHHHHHHHHHHHHHcCCC--c
Q 002157 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQ--DF----------------S--GAALLEFKREVKIMRRLRHP--N 734 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~--~~----------------~--~~~~~ef~~Ei~IL~~L~Hp--N 734 (959)
..++..||-|.-+.||.|.. +|.++|||.=+.- .+ + ........+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35678999999999999987 6999999932210 00 0 11234567899999999654 6
Q ss_pred eeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
|.+-+++- .-.+||||+.|..|...-- +....-.++..|++-+..+-..| |||+|+.+-|||++++|.
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCccccc----cceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 77766643 4479999999877765431 11222233444444444444567 999999999999999999
Q ss_pred EEEEecCccc
Q 002157 815 VKVSDFGLSR 824 (959)
Q Consensus 815 VKLiDFGlAk 824 (959)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.9e-06 Score=86.43 Aligned_cols=141 Identities=18% Similarity=0.226 Sum_probs=84.0
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeEEeeee---ecCCcEEEEEecc
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV---TRPPNLSIITEFL 755 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp--NIVkL~g~~---~~~~~l~LVmEy~ 755 (959)
++.|+.|..+.||++...+..+++|..... .....+.+|..+++.+... -+.+++.+. ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999998889999985443 3455677888888888422 345555533 2333478999999
Q ss_pred CCCCHHH----------------Hh---hCC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 002157 756 PRGSLFR----------------IL---HRP---HCQVDEKR---------RIKM------------ALDVAR-GMNCLH 791 (959)
Q Consensus 756 ~gGsL~d----------------lL---~k~---~~~lse~~---------~l~I------------a~QIa~-AL~yLH 791 (959)
+|..+.. .+ ++. ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 11 111 01111100 0000 011222 233333
Q ss_pred h-----CCCCEEeeCCCCCcEEEc-CCCcEEEEecCcccc
Q 002157 792 T-----STPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRL 825 (959)
Q Consensus 792 s-----~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~ 825 (959)
. ....++|+|+.|.|||++ .++.|.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 223599999999999999 667778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.8e-06 Score=89.28 Aligned_cols=139 Identities=17% Similarity=0.100 Sum_probs=101.7
Q ss_pred eeccCcEEEEEEEECCceEEEEEeeccC---CC-HHHHHHHHHHHHHHHHcCC--CceeEEeeee--ecC--CcEEEEEe
Q 002157 684 IGLGSYGEVYHADWNGTEVAVKKFLDQD---FS-GAALLEFKREVKIMRRLRH--PNVVLFMGAV--TRP--PNLSIITE 753 (959)
Q Consensus 684 LGkG~fG~VYka~~~g~~VAVK~i~~~~---~~-~~~~~ef~~Ei~IL~~L~H--pNIVkL~g~~--~~~--~~l~LVmE 753 (959)
-|+||-+.|+.....|..+-||.-.... .. +.-...|.+|+..|.+|.. -.+.+.+.+. ... -.-+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 3779999999999888888888643110 01 2234678999999999843 2244444221 111 22668999
Q ss_pred ccCC-CCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--EEEEecCccc
Q 002157 754 FLPR-GSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSR 824 (959)
Q Consensus 754 y~~g-GsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~--VKLiDFGlAk 824 (959)
-+.+ .+|.+++.... .+.+...+..++.+|+..+.-||..| +.|+|+.+.|||++.+|. ++|+||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 7753 48888875432 35677878889999999999999999 999999999999986667 9999997665
|
|
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.9e-07 Score=78.27 Aligned_cols=54 Identities=30% Similarity=0.248 Sum_probs=46.6
Q ss_pred eccccchhhHHHHHHHhhccCCceEEeeccccC---------CCCCCeeEEEEecCcceeeeec
Q 002157 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYT---------GVEDDAVNIIKLEEEREFLVDL 316 (959)
Q Consensus 262 i~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~---------~~~~~a~~~v~~~~~~~~~~Dl 316 (959)
-+.|.|.++|.||..|+..+||||++|.|..-. ....|+|++|.+ +++||.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~-~~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYL-EGGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEE-CCCeEEEeC
Confidence 467999999999999999999999999994322 245699999999 699999994
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.6e-06 Score=88.49 Aligned_cols=135 Identities=21% Similarity=0.210 Sum_probs=83.9
Q ss_pred eEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeeeeecCCcEEEEEeccCCCC
Q 002157 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIITEFLPRGS 759 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN--IVkL~g~~~~~~~l~LVmEy~~gGs 759 (959)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 35677888765432 1234678999999885433 4667777777778889999998863
Q ss_pred -HHHH---------------------hhCC---CCCCCHHHHHHHHH----------HHHH-HHHHHH--hCCCCEEeeC
Q 002157 760 -LFRI---------------------LHRP---HCQVDEKRRIKMAL----------DVAR-GMNCLH--TSTPTIVHRD 801 (959)
Q Consensus 760 -L~dl---------------------L~k~---~~~lse~~~l~Ia~----------QIa~-AL~yLH--s~g~~IIHRD 801 (959)
+... |+.. ...+... ...+.. .+.. ...+|. .....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 1111 1111 1111100 000000 0111 112222 2233589999
Q ss_pred CCCCcEEEcCCCcEEEEecCccc
Q 002157 802 LKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 802 LKPeNILLd~~g~VKLiDFGlAk 824 (959)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=6e-06 Score=88.21 Aligned_cols=140 Identities=17% Similarity=0.189 Sum_probs=96.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHH-HH------HHHHHHHHHHHcCC---CceeEEeee-
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA-LL------EFKREVKIMRRLRH---PNVVLFMGA- 741 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~-~~------ef~~Ei~IL~~L~H---pNIVkL~g~- 741 (959)
|.-.+|.+.+++-......|.+...+++.+.+|..+......+. .. ...+++..+.+++. ..++.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34468899999988888999999999999999987665432221 11 12344444444432 222222222
Q ss_pred ----eecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 002157 742 ----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (959)
Q Consensus 742 ----~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKL 817 (959)
+......+|+|||++|..|.++.. +++ .++..|++++.-||.+| ++|+|..|.|+++..++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEE
Confidence 222344678999999988877642 222 24456778899999999 99999999999998655 999
Q ss_pred EecCccc
Q 002157 818 SDFGLSR 824 (959)
Q Consensus 818 iDFGlAk 824 (959)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.1e-07 Score=103.45 Aligned_cols=53 Identities=28% Similarity=0.557 Sum_probs=45.8
Q ss_pred ccccchhhHHHHHHHhhccCCceEEeeccccCCCC---------CCeeEEEEecCcceeeeeccc
Q 002157 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVE---------DDAVNIIKLEEEREFLVDLMA 318 (959)
Q Consensus 263 ~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~~~~---------~~a~~~v~~~~~~~~~~Dlm~ 318 (959)
-.+||..||.|||.||..+||||.+|+| |-+.. +||||+|++ |++||+||.--
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIeg--f~k~~~~~~~~~~iNHaWN~Vki-D~~yy~VDtTw 269 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEG--FLKSPIYYTRDININHAWNIVKI-DNEYYLVDTTW 269 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEee--cccccccccCCccccceeeEEEE-CCeEEEEeeec
Confidence 4589999999999999999999999999 53333 499999999 55999999754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-05 Score=85.55 Aligned_cols=136 Identities=21% Similarity=0.224 Sum_probs=84.0
Q ss_pred eeccCc-EEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEeccCCCCHH
Q 002157 684 IGLGSY-GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (959)
Q Consensus 684 LGkG~f-G~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~ 761 (959)
|-.|.. ..||++...+..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|..|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 445555 7899998777788888764432 234667888888883 444667788777767788999999987765
Q ss_pred HHh-------------------hCC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh-----
Q 002157 762 RIL-------------------HRP---HCQVDEK--RRIKMAL--------------------DVARGMNCLHT----- 792 (959)
Q Consensus 762 dlL-------------------~k~---~~~lse~--~~l~Ia~--------------------QIa~AL~yLHs----- 792 (959)
... +.- ...+... ..+.... .+...+..|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 111 0011100 0000000 01111222211
Q ss_pred CCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 793 ~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12349999999999999998888999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-06 Score=81.51 Aligned_cols=53 Identities=25% Similarity=0.270 Sum_probs=43.7
Q ss_pred ccccchhhHHHHHHHhhccCCceEEeeccccC----------CCCCCeeEEEEecCcceeeee
Q 002157 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYT----------GVEDDAVNIIKLEEEREFLVD 315 (959)
Q Consensus 263 ~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~----------~~~~~a~~~v~~~~~~~~~~D 315 (959)
++|.|.++|.||..||..+||||++|.|.... +...|+|++|.+.+++|+.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 46999999999999999999999999994332 123399999999889999998
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.5e-06 Score=96.42 Aligned_cols=142 Identities=22% Similarity=0.228 Sum_probs=91.6
Q ss_pred eEeeccCcEEEEEEEEC-CceEEEEEeeccCCC---------------------------HH-HH----------HHHHH
Q 002157 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFS---------------------------GA-AL----------LEFKR 722 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~---------------------------~~-~~----------~ef~~ 722 (959)
.-|+.++-|.||+|+.. |+.||||+.+..-.. .. .. ..+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46899999999999984 999999987542100 00 00 12455
Q ss_pred HHHHHHHcC-----CCceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 002157 723 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797 (959)
Q Consensus 723 Ei~IL~~L~-----HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~I 797 (959)
|...+.+++ .++|.--.=+++....-.|+|||++|.-+.++..-.....+.+.+.....++. +..+-..| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg--f 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG--F 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC--c
Confidence 666666653 24432222233334556799999999999888422223455433333222222 12222356 9
Q ss_pred EeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 798 IHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|.|..|.||+++.+|.+-+.|||+...+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999999999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.4e-05 Score=82.75 Aligned_cols=138 Identities=21% Similarity=0.168 Sum_probs=91.7
Q ss_pred EeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHH--------------------HH--HHHHHHHHHHHcC--CCce
Q 002157 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA--------------------LL--EFKREVKIMRRLR--HPNV 735 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~--------------------~~--ef~~Ei~IL~~L~--HpNI 735 (959)
...|..|.-..||+|.. ++..||||+++........ +. =..+|...|.++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34677888889999975 6889999988753211110 00 1246777777773 3344
Q ss_pred eEEeeeeecCCcEEEEEeccCCC-CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC
Q 002157 736 VLFMGAVTRPPNLSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gG-sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g 813 (959)
.+-+.+.. -.|||||+... .-.-.|..- .+.......+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 55555443 36999998543 111122221 22233555667788888888866 66 99999999999999 88
Q ss_pred cEEEEecCcccccc
Q 002157 814 NVKVSDFGLSRLKH 827 (959)
Q Consensus 814 ~VKLiDFGlAk~~~ 827 (959)
.+.|+|||-+....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999886544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1e-06 Score=104.32 Aligned_cols=184 Identities=21% Similarity=0.212 Sum_probs=136.8
Q ss_pred eeEEeEeeccCcEEEEEEEECCce-EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g~~-VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN-IVkL~g~~~~~~~l~LVmEy~ 755 (959)
+.....+++|+++++++.+-..++ ...+.+... ....-++++|.+++||| .+..++-++.+...+++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 444456899999999998764333 223433222 34556889999999999 777788788888899999999
Q ss_pred CCC-CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 756 PRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 756 ~gG-sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
.++ +-...+......+.+.+..++.+.-.++|++||+.. =+||| |||..+ +..|+.||+....+.... ...
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~ 388 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR 388 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence 877 333333222334555666677778888999999863 38998 777655 789999999988776543 566
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF 876 (959)
+..+++.++|||++....+....|.|++|.--.+|.-|-+|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 788999999999999999999999999997666666665553
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.9e-05 Score=79.30 Aligned_cols=127 Identities=29% Similarity=0.414 Sum_probs=92.5
Q ss_pred CCeeEEeEeeccCc-EEEEEEEECCceEEEEEeeccC----------CCH---------HHHHHHHHHHHHHHHcC---C
Q 002157 676 EDLVLGERIGLGSY-GEVYHADWNGTEVAVKKFLDQD----------FSG---------AALLEFKREVKIMRRLR---H 732 (959)
Q Consensus 676 ~dy~I~k~LGkG~f-G~VYka~~~g~~VAVK~i~~~~----------~~~---------~~~~ef~~Ei~IL~~L~---H 732 (959)
.+++.++.||.|.- |.||+++.+|..||||++..-. +.. ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 9999999999999999943211 000 11224778888888884 4
Q ss_pred Cce--eEEeeeeecC------------------CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 002157 733 PNV--VLFMGAVTRP------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792 (959)
Q Consensus 733 pNI--VkL~g~~~~~------------------~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs 792 (959)
.++ |+++||+.-. ....||.||++... .+.. .-+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 566 8999987221 11457888876543 1222 234578888889999
Q ss_pred CCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 793 ~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
.| |+-+|+++.|.. .-||+|||.+
T Consensus 183 ~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CC--eeeccCcccccc-----CCEEEecccC
Confidence 99 999999999986 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00015 Score=91.16 Aligned_cols=78 Identities=17% Similarity=0.198 Sum_probs=56.1
Q ss_pred EeEeeccCcEEEEEEEECC----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCce--eEEeeeeecC---CcEEE
Q 002157 681 GERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV--VLFMGAVTRP---PNLSI 750 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNI--VkL~g~~~~~---~~l~L 750 (959)
++.|+.|.++.+|+.+..+ ..+++|+....... .....+.+|.++|+.+. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5678999999999997754 46777765432211 12346789999999995 6665 7777777664 46789
Q ss_pred EEeccCCCC
Q 002157 751 ITEFLPRGS 759 (959)
Q Consensus 751 VmEy~~gGs 759 (959)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998764
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.3e-05 Score=77.98 Aligned_cols=131 Identities=22% Similarity=0.236 Sum_probs=93.0
Q ss_pred eeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCcee-EEeeeeecCCcEEEEEeccC
Q 002157 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIV-kL~g~~~~~~~l~LVmEy~~ 756 (959)
.++.+.|++|.+|.||++.|.+..+|+|+-+.+.. ...+..|.++|..+...++. ++|.|-.+ ++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 45567899999999999999999999998654433 44678899999988776654 44444333 35699999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC-CCcEEEcCCCcEEEEecCccccc
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLK-PeNILLd~~g~VKLiDFGlAk~~ 826 (959)
|-.|.+.... .+..+++ .++..---|...| |-|+-|. |..++|-.++.+.|+||..|+..
T Consensus 96 G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhc----ccHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8888776532 1223333 4444444455667 9999987 66555656669999999988744
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00026 Score=73.89 Aligned_cols=101 Identities=21% Similarity=0.271 Sum_probs=80.5
Q ss_pred HHHHHHHHHcCC-CceeEEeeeeecCCcEEEEEeccCCCCHHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 002157 721 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCLHTSTP- 795 (959)
Q Consensus 721 ~~Ei~IL~~L~H-pNIVkL~g~~~~~~~l~LVmEy~~gGsL~dl---L~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~- 795 (959)
..|.-+|+.+++ +++++++|+|-+ ++|.||...+.+... +.+ -...+|..+.+|+.+++..+.+|+..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888976 699999999854 578999987766532 111 1247899999999999999999987311
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 796 ~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+...|++++|+-|+++|++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 3899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00017 Score=76.70 Aligned_cols=73 Identities=15% Similarity=0.149 Sum_probs=45.4
Q ss_pred eEeeccCcE-EEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC---ceeEEeeeeecC---CcEEEEEec
Q 002157 682 ERIGLGSYG-EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVTRP---PNLSIITEF 754 (959)
Q Consensus 682 k~LGkG~fG-~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp---NIVkL~g~~~~~---~~l~LVmEy 754 (959)
+.|+.|+.. .||+. +..+++|...... ....+.+|.++|..+... -+.+.++..... ...+++||+
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777776 48976 3467778644321 234678899999887421 344444443332 235789999
Q ss_pred cCCCCHH
Q 002157 755 LPRGSLF 761 (959)
Q Consensus 755 ~~gGsL~ 761 (959)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9887663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00027 Score=74.64 Aligned_cols=73 Identities=18% Similarity=0.260 Sum_probs=48.1
Q ss_pred EeEeeccCcEEEEEEEEC---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC-ceeEEeeeeecCCcEEEEEeccC
Q 002157 681 GERIGLGSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~---g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp-NIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
++.|..|-...+|++... +..|++|+...... ......+|+.+++.+... -.+++++.+.. .+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 456888889999999865 57888997653211 112335788888888433 34455544332 37999998
Q ss_pred CCCH
Q 002157 757 RGSL 760 (959)
Q Consensus 757 gGsL 760 (959)
|..+
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00065 Score=75.62 Aligned_cols=77 Identities=14% Similarity=-0.026 Sum_probs=56.0
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC---CceeEEeeeeec---CCcEEEEEe
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVLFMGAVTR---PPNLSIITE 753 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H---pNIVkL~g~~~~---~~~l~LVmE 753 (959)
-.+.||.|..+.||.....+..+.+|..+. .. ....+.+|...|+.|.- -.+.+.++++.. .+..+||||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 356799999999999987666777787432 11 12367889999988842 357778877654 366899999
Q ss_pred ccCCCCH
Q 002157 754 FLPRGSL 760 (959)
Q Consensus 754 y~~gGsL 760 (959)
+++++.+
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9988654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00076 Score=71.25 Aligned_cols=130 Identities=18% Similarity=0.249 Sum_probs=90.2
Q ss_pred eEeeccCcEEEEEEEECCceEEEEEeeccC--------------CCHHHHHHHHHHHHHHHHcC------CCceeEEeee
Q 002157 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQD--------------FSGAALLEFKREVKIMRRLR------HPNVVLFMGA 741 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g~~VAVK~i~~~~--------------~~~~~~~ef~~Ei~IL~~L~------HpNIVkL~g~ 741 (959)
..||+|+.-.||.--.+ ....||+..... .......+..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 35899999999865433 334567776554 11112345667777777665 7889999999
Q ss_pred eecCCcEEEEEeccC------CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC--C
Q 002157 742 VTRPPNLSIITEFLP------RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN--W 813 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~------gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~--g 813 (959)
.+++..+.+|+|.+. .-+|.+++.+. .+++ .... .+-+-..||-.++ |+.+||+|.||++... +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALDEFKRYLLDHH--IVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHHHHHHHHHHcC--CeecCCCcccEEEEecCCC
Confidence 999999999999864 23788888653 3555 3333 3334456777777 9999999999999532 2
Q ss_pred --cEEEEec
Q 002157 814 --NVKVSDF 820 (959)
Q Consensus 814 --~VKLiDF 820 (959)
.+.|+|-
T Consensus 158 ~~~lvlIDG 166 (199)
T PF10707_consen 158 EFRLVLIDG 166 (199)
T ss_pred ceEEEEEeC
Confidence 5778874
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00055 Score=86.37 Aligned_cols=233 Identities=15% Similarity=0.124 Sum_probs=154.8
Q ss_pred eeccCcEEEEEEEECC------ceEEEEEee-ccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc----EEEEE
Q 002157 684 IGLGSYGEVYHADWNG------TEVAVKKFL-DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIIT 752 (959)
Q Consensus 684 LGkG~fG~VYka~~~g------~~VAVK~i~-~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~----l~LVm 752 (959)
|..-.+|++++.+|.- .++-++.-. .....+........|...+..+.|+|++.++.|-..... +.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 5666777888886621 122222100 011112234445667888888999999999988655433 23456
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC---cEEEcCCCcEEEE--ecCcccccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP---NLLVDKNWNVKVS--DFGLSRLKH 827 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPe---NILLd~~g~VKLi--DFGlAk~~~ 827 (959)
|+|...++...++.- ...+....+.+..++..||.|+|... ..|.-|... +..++..+.+.+. ||+..+...
T Consensus 266 ~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred hhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCC
Confidence 788888888888654 36777888888999999999999986 555555444 4444566777777 999888765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCch--hHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~k--sDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
+... .....-...|.++|......+..+ .|+|.+|.++..+..|..+-..... . ....+.....++
T Consensus 343 d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~--~---------~~~l~~~~~~~~ 410 (1351)
T KOG1035|consen 343 DNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV--P---------VSLLDVLSTSEL 410 (1351)
T ss_pred Cccc-chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc--h---------hhhhccccchhh
Confidence 5432 233445667888888877665544 7999999999999987654211110 0 111111222278
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+++.+|+.-+.++|+...+++...-
T Consensus 411 ~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhhhcchhhhhccchhhhhhchh
Confidence 89999999999999999999987653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0003 Score=75.81 Aligned_cols=135 Identities=16% Similarity=0.122 Sum_probs=77.7
Q ss_pred eeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCcEEEEEeccCCCCHHH
Q 002157 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGSLFR 762 (959)
Q Consensus 684 LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~~gGsL~d 762 (959)
+..|-.+.+|+...++..+++|....... .......+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 56788889999988888899987543211 100134678888888853322 33444332 268999998865431
Q ss_pred --------------Hh---hCC---CCCCCHHH-HHHHHHH---------HHHHHHHHHhC------CCCEEeeCCCCCc
Q 002157 763 --------------IL---HRP---HCQVDEKR-RIKMALD---------VARGMNCLHTS------TPTIVHRDLKSPN 806 (959)
Q Consensus 763 --------------lL---~k~---~~~lse~~-~l~Ia~Q---------Ia~AL~yLHs~------g~~IIHRDLKPeN 806 (959)
.+ +.. ...++... +..+..+ +...+..+-.. ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 111 11112111 1111111 11112222111 1248999999999
Q ss_pred EEEcCCCcEEEEecCcccc
Q 002157 807 LLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 807 ILLd~~g~VKLiDFGlAk~ 825 (959)
||+++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 79999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=1.5e-05 Score=101.30 Aligned_cols=202 Identities=15% Similarity=0.102 Sum_probs=137.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC---CceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~---g~~VAVK~i~~~~~---~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~--~~~~ 747 (959)
+.+++.=-+|.|.+ ++++|- -.-+-+|+++.-++ .+...+....|+.-++...|+++.....-.. ....
T Consensus 1229 e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 45555444555544 355542 22345566554333 3333444556766677778998877655442 2334
Q ss_pred EEEEEeccCCCCHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 748 LSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~---~~lse~~~l~Ia~QIa~AL~yLHs~---g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
.+.+++|+.+|.++..|-+.- ..++.........+.+.+..-+|.. |-..+|++||+-|.+|..+..+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 678999999999999885421 2233333333333435666665542 2247999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~ 880 (959)
+.+............++++.|+.|+..+.-.++.+.|+|.+|+.+|++..|..+|....
T Consensus 1386 LdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~fl 1444 (2724)
T KOG1826|consen 1386 LDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFL 1444 (2724)
T ss_pred cccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHH
Confidence 99955544444556778999999999999899999999999999999998888775433
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00037 Score=83.21 Aligned_cols=138 Identities=19% Similarity=0.208 Sum_probs=87.2
Q ss_pred eEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHH------------------------------------HHHHHHHH
Q 002157 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA------------------------------------LLEFKREV 724 (959)
Q Consensus 682 k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~------------------------------------~~ef~~Ei 724 (959)
+.||.-+.|.||+|+. +|+.||||+-+..- .+.. ...|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5699999999999986 78889999754321 1100 01244555
Q ss_pred HHHHHc----CCCc------eeEEeeeeecCCcEEEEEeccCCCCHHHH--hhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 002157 725 KIMRRL----RHPN------VVLFMGAVTRPPNLSIITEFLPRGSLFRI--LHRPHCQVDEKRRIKMALDVARGMNCLHT 792 (959)
Q Consensus 725 ~IL~~L----~HpN------IVkL~g~~~~~~~l~LVmEy~~gGsL~dl--L~k~~~~lse~~~l~Ia~QIa~AL~yLHs 792 (959)
+...++ +|-+ |.+++- .....-.|+||||+|.-+.++ |.+. .++...+..-+.++..-+- =.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qI--f~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQI--FK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHH--Hh
Confidence 555444 3444 333332 222356799999999877765 4443 3555443333323222221 23
Q ss_pred CCCCEEeeCCCCCcEEEcC----CCcEEEEecCccccccC
Q 002157 793 STPTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 793 ~g~~IIHRDLKPeNILLd~----~g~VKLiDFGlAk~~~~ 828 (959)
.| ++|+|=.|.|||+.. ++.+.|.|||+...+..
T Consensus 320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 46 999999999999983 67899999999876543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0015 Score=71.91 Aligned_cols=74 Identities=23% Similarity=0.331 Sum_probs=47.8
Q ss_pred EeEeeccCcEEEEEEEEC--------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCcEEEE
Q 002157 681 GERIGLGSYGEVYHADWN--------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSII 751 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~--------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN-IVkL~g~~~~~~~l~LV 751 (959)
++.|..|-...||+++.. ++.|++|+..... .......+|.+++..+.... ..++++.+.. .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 355777878899999764 3789999865432 12234568888888884322 3455555532 368
Q ss_pred EeccCCCCHH
Q 002157 752 TEFLPRGSLF 761 (959)
Q Consensus 752 mEy~~gGsL~ 761 (959)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9998876653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0021 Score=71.30 Aligned_cols=144 Identities=17% Similarity=0.155 Sum_probs=84.2
Q ss_pred CeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeEEeee------eecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA------VTRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp--NIVkL~g~------~~~~~~l 748 (959)
....++.++.|....+|+++.++..+++|+..... . ...+..|.+++..|... .+.+++.. ....+..
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 34456778888888999998767788899765421 1 22345667777777322 23444332 1224567
Q ss_pred EEEEeccCCCCHH-----------HH---hhC--CCC--------CC-CHHHHH------------HHHHHHHHHHHHHH
Q 002157 749 SIITEFLPRGSLF-----------RI---LHR--PHC--------QV-DEKRRI------------KMALDVARGMNCLH 791 (959)
Q Consensus 749 ~LVmEy~~gGsL~-----------dl---L~k--~~~--------~l-se~~~l------------~Ia~QIa~AL~yLH 791 (959)
+++|||++|..+. .. +++ .+. .. .+.... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999875431 11 111 000 00 000000 00112333455553
Q ss_pred h-----CCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 792 T-----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 792 s-----~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
. ...++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 12359999999999999988877999999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0046 Score=68.67 Aligned_cols=140 Identities=16% Similarity=0.109 Sum_probs=76.9
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----CCceeEEee---eeecCCcEEEEE
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFMG---AVTRPPNLSIIT 752 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-----HpNIVkL~g---~~~~~~~l~LVm 752 (959)
.+.|+.|....+|+.+.++..+++|++. .... ..+..|+.+++.|. .|.++.-.+ +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4567788888999998777789999875 2222 23334555555552 333332110 122345678999
Q ss_pred eccCCCCHH-----------HHh---hCC--C--------CCCCH-HHHHH------------HHHH-HHHHHHHHHh--
Q 002157 753 EFLPRGSLF-----------RIL---HRP--H--------CQVDE-KRRIK------------MALD-VARGMNCLHT-- 792 (959)
Q Consensus 753 Ey~~gGsL~-----------dlL---~k~--~--------~~lse-~~~l~------------Ia~Q-Ia~AL~yLHs-- 792 (959)
||++|..+. ..+ +.. . ..+.+ ..... ...+ +...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999886431 111 110 0 00111 11000 1111 1112223321
Q ss_pred ---CCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 793 ---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 793 ---~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
...++||+|+.+.|||++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 122599999999999998665568999998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0041 Score=68.07 Aligned_cols=139 Identities=19% Similarity=0.140 Sum_probs=84.1
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeEEeee------eecCCcEEEEE
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA------VTRPPNLSIIT 752 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp--NIVkL~g~------~~~~~~l~LVm 752 (959)
.+.|..|....+|+....+..+++|++.. . . ...+..|++++..+.+. .+.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-V-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-C-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45688888889999987777899998754 1 1 23466778888877432 24444432 23345678999
Q ss_pred eccCCCCHHH-----------Hh---hC---C-C------CCCCHHHHH----------HHHHHHHHHHHHHHh-----C
Q 002157 753 EFLPRGSLFR-----------IL---HR---P-H------CQVDEKRRI----------KMALDVARGMNCLHT-----S 793 (959)
Q Consensus 753 Ey~~gGsL~d-----------lL---~k---~-~------~~lse~~~l----------~Ia~QIa~AL~yLHs-----~ 793 (959)
+|++|..+.. .+ +. . . ....+.... .....+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998866421 11 11 0 0 000111000 011112334444443 1
Q ss_pred CCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 794 g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...+||+|+.|.|||++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 1249999999999999998778999998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF04473 DUF553: Transglutaminase-like domain; InterPro: IPR007562 This entry represents a transglutaminase-like domain found in a family of uncharacterised archaeal proteins that had previously been called DUF553 and UPF0252 | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0013 Score=66.75 Aligned_cols=115 Identities=13% Similarity=0.185 Sum_probs=72.4
Q ss_pred HHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHH---HHhHHHHHHHHHHhhCC---ceeEee--eeccccchhhHH
Q 002157 201 QCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIM---LARWMERSTELRRSLQT---SVLPIG--SINIGLSRHRAL 272 (959)
Q Consensus 201 ~~l~~~l~~~~~~~~v~~LA~lV~~~mgg~~~~~~~~---~~~~~~~~~~l~~~~~s---~v~plg--~i~~g~~~~~a~ 272 (959)
..++..|.-.+..+-+..|...+.+.|.=-...+... ..-|.....+...-.+. .--|.. ..++|+|+.+|+
T Consensus 4 ~~l~~~lkg~~~~e~~~nIl~W~~~NI~Yd~~Ka~~~~~~i~~~~~~~~~~~~~~~~~~~i~tp~etl~~k~GiC~DYA~ 83 (153)
T PF04473_consen 4 KNLAEELKGNDIKETIWNILEWEDENIEYDYEKAESPEPFIYIWSTYRTEVYEDYKNSTYIQTPYETLKYKKGICGDYAI 83 (153)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHhccccchhhccCCCceeEeeeccceeeeccccccccccCHHHHHHcCCeeeHHHHH
Confidence 3455555566677777888888887765322221111 11232211111111000 012322 346899999999
Q ss_pred HHHHHhhccCCceEEeeccccCCCCCCeeEEEEecCcceeeeec
Q 002157 273 LFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFLVDL 316 (959)
Q Consensus 273 lfk~l~d~~~~~~~lv~G~~~~~~~~~a~~~v~~~~~~~~~~Dl 316 (959)
|...|.-.+|+.-.-|-+-.+.+..+|||++|++ ||++|++|-
T Consensus 84 Lta~lLl~~g~~~~yi~~~~~~~~~~Haa~aV~i-ng~~yvlDq 126 (153)
T PF04473_consen 84 LTAALLLNMGYSPVYILHIEFDNDPGHAAVAVKI-NGKYYVLDQ 126 (153)
T ss_pred HHHHHHHHCCCCceEEEEEecCCCCCeEEEEEEE-CCEEEEEeC
Confidence 9999999999877555566677766999999999 999999993
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.022 Score=66.38 Aligned_cols=76 Identities=17% Similarity=0.035 Sum_probs=51.8
Q ss_pred EeEeeccCcEEEEEEEECC--ceEEEEEeeccCC-----CHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCcEEE
Q 002157 681 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQDF-----SGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g--~~VAVK~i~~~~~-----~~~~~~ef~~Ei~IL~~L~---HpNIVkL~g~~~~~~~l~L 750 (959)
.+.||.|.+..||++...+ +.|+||.-..... .......+..|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999998754 3899997432110 0123456677888888762 2456777766 3355789
Q ss_pred EEeccCCC
Q 002157 751 ITEFLPRG 758 (959)
Q Consensus 751 VmEy~~gG 758 (959)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0019 Score=72.66 Aligned_cols=133 Identities=20% Similarity=0.249 Sum_probs=89.6
Q ss_pred eeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccC--C-----CH-------------HHHHHHHHHHHHHHHcC-CC-c
Q 002157 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQD--F-----SG-------------AALLEFKREVKIMRRLR-HP-N 734 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~--~-----~~-------------~~~~ef~~Ei~IL~~L~-Hp-N 734 (959)
+.++..||-|.-+-||.+-+ .|++.++|.=+.-. + .. -......+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56789999999999999976 58888888321100 0 00 01123467888888884 32 2
Q ss_pred eeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 002157 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~ 814 (959)
|.+.+++ +..++|||++.|-.|...-+- .+... +...++.-+--|-.+| +||+|..--||+|.+++.
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEecCCC
Confidence 4444443 345789999988777655322 12222 3334444555666788 999999999999999999
Q ss_pred EEEEecCcc
Q 002157 815 VKVSDFGLS 823 (959)
Q Consensus 815 VKLiDFGlA 823 (959)
++++||--.
T Consensus 241 i~vIDFPQm 249 (465)
T KOG2268|consen 241 IVVIDFPQM 249 (465)
T ss_pred EEEeechHh
Confidence 999999643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.012 Score=66.89 Aligned_cols=141 Identities=16% Similarity=0.270 Sum_probs=79.6
Q ss_pred CeeEEeEeeccCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCcEE
Q 002157 677 DLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLS 749 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-VkL~g~~~~~~~l~ 749 (959)
.+.+ +.|-.|-...+|++... ++.|.+|+..... . ......+|..+++.+..-++ .++++.+...
T Consensus 38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3444 45555888899999752 3578888765432 1 12223678888888853333 3455655432
Q ss_pred EEEeccCCCCHHHH-----------------hhCCC---CC-C-CHHHHHHHHHH-----------------HHHHHHHH
Q 002157 750 IITEFLPRGSLFRI-----------------LHRPH---CQ-V-DEKRRIKMALD-----------------VARGMNCL 790 (959)
Q Consensus 750 LVmEy~~gGsL~dl-----------------L~k~~---~~-l-se~~~l~Ia~Q-----------------Ia~AL~yL 790 (959)
.|+||+++..|... +++.. .. . ....+.++..+ +...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 57899877665311 11111 01 1 11222222211 11111112
Q ss_pred ----Hh--CCCCEEeeCCCCCcEEEcC-CCcEEEEecCcccc
Q 002157 791 ----HT--STPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 825 (959)
Q Consensus 791 ----Hs--~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~ 825 (959)
.. ....++|+||++.|||+++ ++.++|+||..+..
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 1224999999999999986 47899999987753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.017 Score=65.34 Aligned_cols=143 Identities=20% Similarity=0.250 Sum_probs=84.4
Q ss_pred CeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCC--cEEEEE
Q 002157 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPP--NLSIIT 752 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H--pNIVkL~g~~~~~~--~l~LVm 752 (959)
...+++.+-.|-.-.+|.....+++++|. ...............+|..+|+.+.- --+...++.|.++. ..++||
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455555455555566666668888888 33222222334456788888888743 22344555565554 678999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHH-HHHH----------------------------------------------
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVAR---------------------------------------------- 785 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~-QIa~---------------------------------------------- 785 (959)
+|+.|..+...+.... .. .+++. .++.
T Consensus 105 ~~veGe~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 105 EWVEGEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEecceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 9998743322211100 00 01111 2222
Q ss_pred ----HHHHHHhCCC------CEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 786 ----GMNCLHTSTP------TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 786 ----AL~yLHs~g~------~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
-..+|+.+-+ .++|+|+.+.||+|+..+-+=++||+++.+-
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2344443322 4999999999999999888999999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0066 Score=69.39 Aligned_cols=140 Identities=22% Similarity=0.277 Sum_probs=91.2
Q ss_pred eEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCC----------------------CHHH-HH-HHHHHHHHHHHcCCC
Q 002157 679 VLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF----------------------SGAA-LL-EFKREVKIMRRLRHP 733 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~----------------------~~~~-~~-ef~~Ei~IL~~L~Hp 733 (959)
.|-..|..|.-..||.+.. +|..+|||+++-.-+ .+.. +. =...|++.|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456789999999999975 788999997643110 0011 11 135688888888655
Q ss_pred ceeEEeeeeecCCcEEEEEeccCCCCHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcC
Q 002157 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDK 811 (959)
Q Consensus 734 NIVkL~g~~~~~~~l~LVmEy~~gGsL~-dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~ 811 (959)
.|..---.... .-.|||+|+.+.... -.|+. ..+....+..+-.+++.-|.-|-+ ++ +||.||.--|+|+.
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-
Confidence 54322222211 235899999532211 12322 345556666677788888877754 55 99999999999995
Q ss_pred CCcEEEEecCcccc
Q 002157 812 NWNVKVSDFGLSRL 825 (959)
Q Consensus 812 ~g~VKLiDFGlAk~ 825 (959)
+|.+.|+|-+-+.-
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 47899999986653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.023 Score=64.31 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=78.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g-----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-VkL~g~~~~~~~l~ 749 (959)
+++++. .|..|-...+|++...+ ..|.+|+..... . ....-.+|..+++.+..-++ .++++++..+
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G---- 86 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG---- 86 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----
Confidence 344444 44457788899987543 378888765421 1 12234578888888854444 4556555322
Q ss_pred EEEeccCCCCHHH--------------H---hhCCCCC----C-CHHHHHHHHHH----------------------H--
Q 002157 750 IITEFLPRGSLFR--------------I---LHRPHCQ----V-DEKRRIKMALD----------------------V-- 783 (959)
Q Consensus 750 LVmEy~~gGsL~d--------------l---L~k~~~~----l-se~~~l~Ia~Q----------------------I-- 783 (959)
+|.+|+++..|.. . ++..... . -+..+..+..+ +
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5889987665421 1 1111100 1 11222112111 1
Q ss_pred -HHHHHHHH-hCC--CCEEeeCCCCCcEEEcC-CCcEEEEecCcccc
Q 002157 784 -ARGMNCLH-TST--PTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 825 (959)
Q Consensus 784 -a~AL~yLH-s~g--~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~ 825 (959)
+..+..+. ..+ ..++|+||.+.|||+++ ++.++|+||..+..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111111 111 24899999999999975 57899999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.02 Score=63.30 Aligned_cols=30 Identities=23% Similarity=0.491 Sum_probs=25.3
Q ss_pred CEEeeCCCCCcEEEcCCCc-EEEEecCcccc
Q 002157 796 TIVHRDLKSPNLLVDKNWN-VKVSDFGLSRL 825 (959)
Q Consensus 796 ~IIHRDLKPeNILLd~~g~-VKLiDFGlAk~ 825 (959)
.+||+|+++.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG1305 Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0037 Score=68.15 Aligned_cols=51 Identities=29% Similarity=0.360 Sum_probs=42.8
Q ss_pred cccchhhHHHHHHHhhccCCceEEeeccccCCCC--------------CCeeEEEEecCcceeeeec
Q 002157 264 IGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVE--------------DDAVNIIKLEEEREFLVDL 316 (959)
Q Consensus 264 ~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~~~~--------------~~a~~~v~~~~~~~~~~Dl 316 (959)
.|+|+|.|-||=.||..+|||||+|.| |.... .|+|.+|.+....|+-+|-
T Consensus 194 ~G~C~d~a~l~val~Ra~GIpAR~V~G--y~~~~~~~~~~~~~~~~~~~Haw~ev~~~~~gW~~~Dp 258 (319)
T COG1305 194 RGVCRDFAHLLVALLRAAGIPARYVSG--YLGAEVEPLSGRPLVRNDDAHAWAEVYLPGRGWVPLDP 258 (319)
T ss_pred CcccccHHHHHHHHHHHcCCcceeeec--cccCCCCcccccccccCcccceeeeeecCCCccEeecC
Confidence 899999999999999999999999999 43333 1999999994335888873
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.037 Score=61.61 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=27.5
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 796 ~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
++||+|+.+.|||++.++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.039 Score=60.65 Aligned_cols=28 Identities=29% Similarity=0.406 Sum_probs=25.0
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 796 ~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
++||+|+.+.|||++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 5999999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.033 Score=63.85 Aligned_cols=106 Identities=18% Similarity=0.206 Sum_probs=69.6
Q ss_pred cCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 744 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
+..+.|++|++- |+.|...- .....+...|+++.+.-+.-+... .+.-||||...||||+ +|+|.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~ik-----~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIK-----ADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeeee-----cccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeee
Confidence 334567788865 55554322 234677778888888777666553 3689999999999999 999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHH
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG 863 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLG 863 (959)
++-..... +-....--|-.+.|.. +..-+||-+-
T Consensus 369 Rl~~~q~~-----isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 369 RLSYSQGI-----ISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred ecccCCce-----eeccccCchhhhcCcc-ceeeeHHHHH
Confidence 85433221 1112233455556543 5666777643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.078 Score=59.25 Aligned_cols=75 Identities=21% Similarity=0.178 Sum_probs=48.6
Q ss_pred eEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCcEEEEEecc
Q 002157 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~---HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
+-.+.|+.|....+|+.+.+++.+.||+-.... ...|..|..-|+.|. .-.+.+.+++....+..+|||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345778999999999999889999999865322 235677888888873 345778888887777779999998
Q ss_pred CCC
Q 002157 756 PRG 758 (959)
Q Consensus 756 ~gG 758 (959)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.1 Score=61.13 Aligned_cols=76 Identities=14% Similarity=-0.012 Sum_probs=51.0
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCC--CH---HHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCcEEEE
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SG---AALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~--~~---~~~~ef~~Ei~IL~~L~---HpNIVkL~g~~~~~~~l~LV 751 (959)
..+.||-|....||+....+..|+||.-..... .. .....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357789999999999988777899996542111 00 12333445566776653 247788888777 345788
Q ss_pred EeccCC
Q 002157 752 TEFLPR 757 (959)
Q Consensus 752 mEy~~g 757 (959)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.026 Score=59.10 Aligned_cols=30 Identities=33% Similarity=0.572 Sum_probs=21.4
Q ss_pred CEEeeCCCCCcEEE-cCCCcEEEEecCcccc
Q 002157 796 TIVHRDLKSPNLLV-DKNWNVKVSDFGLSRL 825 (959)
Q Consensus 796 ~IIHRDLKPeNILL-d~~g~VKLiDFGlAk~ 825 (959)
.++|+||.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 49999999999999 8899999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.083 Score=60.18 Aligned_cols=137 Identities=18% Similarity=0.280 Sum_probs=79.3
Q ss_pred EeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc------eeEEee----eeecCCcEEEEE
Q 002157 683 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMG----AVTRPPNLSIIT 752 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN------IVkL~g----~~~~~~~l~LVm 752 (959)
.|.. .-..||+.+..+..+++|+.... .. ..++..|+..|..|.-.. |..+-| .+....+.+-|+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 55679999887777799987665 33 235566777887773222 222222 222223677899
Q ss_pred eccCCCCHHH------------Hh---h---CCC--------CCCCHHH----H---------HHHHHHHHHHHHHHHhC
Q 002157 753 EFLPRGSLFR------------IL---H---RPH--------CQVDEKR----R---------IKMALDVARGMNCLHTS 793 (959)
Q Consensus 753 Ey~~gGsL~d------------lL---~---k~~--------~~lse~~----~---------l~Ia~QIa~AL~yLHs~ 793 (959)
+|++|..+.. ++ + +.. ....+.. . .....++...+..+...
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999887762 11 1 000 0111210 0 01112333333333331
Q ss_pred ------C--CCEEeeCCCCCcEEEcCCCc-EEEEecCccc
Q 002157 794 ------T--PTIVHRDLKSPNLLVDKNWN-VKVSDFGLSR 824 (959)
Q Consensus 794 ------g--~~IIHRDLKPeNILLd~~g~-VKLiDFGlAk 824 (959)
. ..+||+|+.|.|||++.+.. +-++|||.++
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 12999999999999998875 8999999775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.088 Score=57.02 Aligned_cols=116 Identities=11% Similarity=0.041 Sum_probs=71.9
Q ss_pred cEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCC
Q 002157 689 YGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768 (959)
Q Consensus 689 fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~ 768 (959)
-.+.-.++.+=.+..+|+++.-...- ...-|..+.+++++++ .|+++..- ....+.+++|+|-...
T Consensus 75 NsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~--------- 140 (308)
T PF07387_consen 75 NSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK--------- 140 (308)
T ss_pred ceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc---------
Confidence 33333333322344556665433321 1234577888888875 47777732 4445789999984210
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 769 ~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
... ..++..=+.+|.-.|+.....+|+|-.|+||+-|..|.+||.|=+..
T Consensus 141 -i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 -INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 11222224567778965557999999999999999999999997654
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.13 Score=59.25 Aligned_cols=73 Identities=19% Similarity=0.083 Sum_probs=45.5
Q ss_pred EeeccCcEEEEEEEECC--ceEEEEEeeccC-----CCHHHHHHHHHHHHHHHHcC--CC-ceeEEeeeeecCCcEEEEE
Q 002157 683 RIGLGSYGEVYHADWNG--TEVAVKKFLDQD-----FSGAALLEFKREVKIMRRLR--HP-NVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 683 ~LGkG~fG~VYka~~~g--~~VAVK~i~~~~-----~~~~~~~ef~~Ei~IL~~L~--Hp-NIVkL~g~~~~~~~l~LVm 752 (959)
.||-|....||++...+ +.|+||.-.... ..+-...+...|...|+... .| .+++++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 47999999999998754 479999543210 11223344556777777663 34 3444443 3445566999
Q ss_pred eccCC
Q 002157 753 EFLPR 757 (959)
Q Consensus 753 Ey~~g 757 (959)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.25 Score=57.41 Aligned_cols=78 Identities=17% Similarity=0.201 Sum_probs=46.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEECC---ce-----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC-ceeEEeeeeecCC
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNG---TE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP-NVVLFMGAVTRPP 746 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g---~~-----VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp-NIVkL~g~~~~~~ 746 (959)
+++++ +.|..|-...+|++...+ .. |.++... . .......-.+|+++++.+... .-.++++.+..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-T--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEecc-C--CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 34444 455568889999997532 23 3333221 1 111122335789999998544 44566666653
Q ss_pred cEEEEEeccCCCCHH
Q 002157 747 NLSIITEFLPRGSLF 761 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~ 761 (959)
++|.||++|..|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 5899999887653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 959 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-101 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-99 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-41 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-40 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-40 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-40 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-38 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-38 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-38 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-38 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-38 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-38 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-38 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-38 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-38 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-37 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-37 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-37 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-37 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-37 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-36 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-36 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-36 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-36 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-36 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-36 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-34 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-32 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-32 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-32 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-32 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-32 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-32 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-31 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-31 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-31 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-31 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-31 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-31 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-31 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-31 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-31 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-31 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-31 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-31 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-31 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-31 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-31 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-31 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-31 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-31 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-31 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-31 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-31 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-31 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-30 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-30 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-30 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-30 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-30 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-30 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-30 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-30 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-30 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-30 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-30 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-30 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-30 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-29 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-29 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-29 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-29 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-29 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-29 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-29 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-29 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-29 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-29 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-29 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-29 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-28 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-28 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-28 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-28 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-28 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-28 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-28 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-28 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-28 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-28 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-28 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-28 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-28 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-28 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-28 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-28 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-28 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-28 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-28 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-28 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-28 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-28 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-28 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-28 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-28 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-28 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-27 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-27 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-27 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-27 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-27 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-27 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-27 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-27 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-27 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-27 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-26 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-26 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-26 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-26 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-26 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-26 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-26 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-26 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-26 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-26 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-26 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-25 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-25 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-25 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-25 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-25 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-25 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-25 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-25 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-25 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-25 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-25 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-25 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-25 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-25 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-25 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-25 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-25 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-25 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-25 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-25 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-25 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-25 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-24 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-24 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-24 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-24 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-24 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-24 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-24 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-24 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-23 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-23 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-23 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-23 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-23 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-23 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-23 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-23 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-22 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-21 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-21 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-21 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-21 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-21 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-20 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-20 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-20 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-20 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-20 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-20 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-19 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-19 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-19 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-19 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-19 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-19 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-18 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-18 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-165
Identities = 181/302 (59%), Positives = 224/302 (74%), Gaps = 3/302 (0%)
Query: 641 LKLRDLESPSSSVDSSTSKVDQIFD-DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG 699
+K P S D T++ D + +IPW DL + E+IG GS+G V+ A+W+G
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 700 TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759
++VAVK ++QDF + EF REV IM+RLRHPN+VLFMGAVT+PPNLSI+TE+L RGS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 760 LFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817
L+R+LH+ Q+DE+RR+ MA DVA+GMN LH P IVHR+LKSPNLLVDK + VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 818 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877
DFGLSRLK +TFLSSKS AGTPEWMAPEVLR+EPSNEK DVYSFGVILWELATL+ PW
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 878 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937
+NP QVV AVGF+ +RLEIP+ L+P VA II CW +P RPSFA + L+PL +
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 938 IP 939
+P
Sbjct: 301 VP 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 433 bits (1117), Expect = e-146
Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 11/270 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++ L ++ GE++ W G ++ VK +D+S +F E +R
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 732 HPNVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMN 788
HPNV+ +GA PP + ++IT ++P GSL+ +LH VD+ + +K ALD+ARGM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
LHT P I L S ++++D++ ++S + S P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180
Query: 849 RNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ +P + D++SF V+LWEL T ++P+ ++ M++ V + R IP + P V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
++++ C DP+ RP F + L+ +Q
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-144
Identities = 98/273 (35%), Positives = 147/273 (53%), Gaps = 15/273 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRR 729
EI + +L L E IG+G +G+VY A W G EVAVK + + ++E K+
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
L+HPN++ G + PNL ++ EF G L R+L ++ + A+ +ARGMN
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 790 LHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840
LH I+HRDLKS N+L+ + N +K++DFGL+R H T + S AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
WMAPEV+R ++ DV+S+GV+LWEL T ++P+ G++ + V V L IP
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
A+++ +CW DP RPSF + L +
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-143
Identities = 93/314 (29%), Positives = 150/314 (47%), Gaps = 22/314 (7%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 703
+L S+ + IF E +IP+E L +GE IG G +G+VYH W+G EVA
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQ---EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVA 59
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
++ + + L FKREV R+ RH NVVLFMGA PP+L+IIT +L+ +
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
+ +D + ++A ++ +GM LH I+H+DLKS N+ D N V ++DFGL
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 824 RLKHNTFLSSKST-----AGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWEL 869
+ + G +APE++R P ++ DV++ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929
+ P+ ++ +G + + ++ I+ CW + RP+F +L
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 930 LKPLQRLVI-PSHP 942
L+ L + SHP
Sbjct: 297 LEKLPKRNRRLSHP 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-142
Identities = 100/279 (35%), Positives = 156/279 (55%), Gaps = 13/279 (4%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
D + EIP + +G+RIG GS+G VY W+G +VAVK + L FK EV
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
++R+ RH N++LFMG T P L+I+T++ SL+ LH + + K+ I +A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 843
GM+ LH +I+HRDLKS N+ + ++ VK+ DFGL+ K S + G+ WM
Sbjct: 132 GMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 844 APEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR---LE 896
APEV+R + SN + DVY+FG++L+EL T +LP+ +N Q++ VG + +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ + R++ EC + RPSF ++ ++ L R
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-138
Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 21/278 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALL-----EFKREV 724
+ ++ ++IG G +G V+ + + VA+K + D G + EF+REV
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
IM L HPN+V G + PP ++ EF+P G L+ L + ++++ LD+A
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKHNTFLSSKSTAGT 839
G+ + P IVHRDL+SPN+ + KV+DFGLS+ ++ G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189
Query: 840 PEWMAPEVL--RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRL 895
+WMAPE + E EK D YSF +IL+ + T + P+ + ++ + + + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
IP++ P + +I CW DP RP F+ + L L
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 412 bits (1060), Expect = e-137
Identities = 90/292 (30%), Positives = 128/292 (43%), Gaps = 17/292 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
DL+ GE +G G +G+ T + F F +EVK+MR
Sbjct: 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
L HPNV+ F+G + + L+ ITE++ G+L I+ Q +R+ A D+A GM
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--------------KHNTFLSSKS 835
LH+ I+HRDL S N LV +N NV V+DFGL+RL K +
Sbjct: 124 LHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRR 894
G P WMAPE++ +EK DV+SFG++L E+ P + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPS 946
P P I C DP RPSF +L L+ L+ + P P
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 402 bits (1034), Expect = e-133
Identities = 82/281 (29%), Positives = 135/281 (48%), Gaps = 14/281 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++++ + E +G G++G V A W +VA+K+ + F E++ + R+
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK----AFIVELRQLSRVN 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNC 789
HPN+V GA P + ++ E+ GSL+ +LH P + L ++G+
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 790 LHTSTPT-IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH+ P ++HRDLK PNLL+ V K+ DFG + ++K G+ WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVA 906
+EKCDV+S+G+ILWE+ T + P+ + P + R + K L +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 907 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947
++ CW DPS RPS ++ + L R +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 365 bits (939), Expect = e-119
Identities = 91/341 (26%), Positives = 146/341 (42%), Gaps = 58/341 (17%)
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
G +L+ +S SS S + Q + + + ++IG G YGEV+
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQ---------RTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTRP----PNLSI 750
W G +VAVK F + + + RE +I +RH N++ F+ A + L +
Sbjct: 58 WRGEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112
Query: 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKS 804
IT++ GSL+ L +D K +K+A G+ LHT P I HRDLKS
Sbjct: 113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 805 PNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVL------RNEPSN 854
N+LV KN ++D GL+ + + + GT +M PEVL + S
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 855 EKCDVYSFGVILWELAT----------LKLPWIGMNPMQ-----VVGAVGFQNRRLEIPK 899
D+YSFG+ILWE+A +LP+ + P + V + R P
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 900 -----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
E + +++ ECW +P+ R + ++ L +
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-118
Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHP 733
D+ L E +G G YGEV+ W G VAVK F +D + RE ++ LRH
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-----SWFRETELYNTVMLRHE 62
Query: 734 NVVLFMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
N++ F+ + L +IT + GSL+ L +D +++ L +A G+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120
Query: 790 LHT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LSSKSTAGT 839
LH P I HRDLKS N+LV KN ++D GL+ + + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 840 PEWMAPEVLRNEP------SNEKCDVYSFGVILWELAT----------LKLPWIGMNP-- 881
+MAPEVL S ++ D+++FG++LWE+A K P+ + P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 882 ---MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ V +R IP +A+++ ECW +PS R + ++ L +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-112
Identities = 97/340 (28%), Positives = 151/340 (44%), Gaps = 58/340 (17%)
Query: 638 GTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW 697
GT LK + +S S + Q +VL E IG G +GEV+ W
Sbjct: 13 GTTLKDLIYDMTTSGSGSGLPLLVQ---------RTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 698 NGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTR----PPNLSII 751
G EVAVK F ++ + RE +I LRH N++ F+ A + L ++
Sbjct: 64 RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118
Query: 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKSP 805
+++ GSLF L+R V + IK+AL A G+ LH P I HRDLKS
Sbjct: 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 806 NLLVDKNWNVKVSDFGLSRLKHNT----FLSSKSTAGTPEWMAPEVLRNE------PSNE 855
N+LV KN ++D GL+ + ++ GT +MAPEVL + S +
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 856 KCDVYSFGVILWELATL----------KLPWIGMNPM-----QVVGAVGFQNRRLEIPK- 899
+ D+Y+ G++ WE+A +LP+ + P ++ V Q R IP
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296
Query: 900 ----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
E ++A+I+ ECW + + R + ++ L L +
Sbjct: 297 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-109
Identities = 85/330 (25%), Positives = 126/330 (38%), Gaps = 56/330 (16%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 706
SS VD T L L E G +G V+ A VAVK
Sbjct: 6 HHHSSGVDLGTE-----------NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI 54
Query: 707 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIITEFLPRGSLFR 762
F QD + + EV + ++H N++ F+GA R + L +IT F +GSL
Sbjct: 55 FPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111
Query: 763 ILHRPHCQVDEKRRIKMALDVARGMNCLHT--------STPTIVHRDLKSPNLLVDKNWN 814
L V +A +ARG+ LH P I HRD+KS N+L+ N
Sbjct: 112 FLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 815 VKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILW 867
++DFGL+ + + GT +MAPEVL + + D+Y+ G++LW
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 868 ELATLKLPWIGMNP----------------MQVVGAVGFQNRRLEIPKELDP-----LVA 906
ELA+ G + V + +R + ++
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289
Query: 907 RIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
I ECW D R S + + +QRL
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-103
Identities = 84/331 (25%), Positives = 126/331 (38%), Gaps = 60/331 (18%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR- 728
E + ++L L E IG G YG VY + VAVK F + F E I R
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-----NFINEKNIYRV 61
Query: 729 -RLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
+ H N+ F+ R ++ E+ P GSL + L D ++A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHS 119
Query: 783 VARGMNCLHTST-------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 831
V RG+ LHT P I HRDL S N+LV + +SDFGLS L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 832 ----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELA---TLKLPWI 877
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ T P
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 878 GMNPMQV---------------VGAVGFQNRRLEIPKELDP------LVARIIWECWQTD 916
+ Q+ V + +R + P+ + I +CW D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 917 PSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947
R + + L + + P++
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-72
Identities = 78/255 (30%), Positives = 122/255 (47%), Gaps = 12/255 (4%)
Query: 680 LGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+ VY D EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 738 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 794 TPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
TP I+HRDLK N+ + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK- 205
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQNRRLEIPKELDPLVARIIWE 911
+E DVY+FG+ + E+AT + P+ + V + K P V II
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 912 CWQTDPSLRPSFAQL 926
C + + R S L
Sbjct: 266 CIRQNKDERYSIKDL 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 8e-70
Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 9/271 (3%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ + EDLVLGE+IG G++GEV+ T VAVK + +F +E +I+
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARIL 166
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
++ HPN+V +G T+ + I+ E + G L ++ K ++M D A GM
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAP 845
L + +HRDL + N LV + +K+SDFG+SR + + ++ P +W AP
Sbjct: 227 EYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E L + + DV+SFG++LWE +L P+ ++ Q V + RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
V R++ +CW +P RPSF+ + L+ +++
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 9e-68
Identities = 90/285 (31%), Positives = 145/285 (50%), Gaps = 18/285 (6%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG 714
S + D+ + + ++L L + IG G +G+V D+ G +VAVK +
Sbjct: 3 GSVAAQDEFYRS---GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----D 55
Query: 715 AALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILH-RPHCQVD 772
A F E +M +LRH N+V +G + L I+TE++ +GSL L R +
Sbjct: 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 773 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832
+K +LDV M L VHRDL + N+LV ++ KVSDFGL++ +T +
Sbjct: 116 GDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 833 SKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
K P +W APE LR + + K DV+SFG++LWE+ + ++P+ + VV V
Sbjct: 174 GK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE- 228
Query: 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ +++ P P V ++ CW D ++RPSF QL L+ ++
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-67
Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 25/312 (8%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAV 704
+ + + + + I L+LG+ +G G +G V + +VAV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 705 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNLSIITEFLPRGS 759
K + S + EF E M+ HPNV+ +G P +I F+ G
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 760 LFRIL--HRPHCQVDE---KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814
L L R + +K +D+A GM L S +HRDL + N ++ +
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMT 185
Query: 815 VKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL 872
V V+DFGLS+ ++ + P +W+A E L + K DV++FGV +WE+AT
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 873 -KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
P+ G+ ++ + RL+ P++ + I++ CW+TDP RP+F+ L + L+
Sbjct: 246 GMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 932 PLQRLVIPSHPD 943
L + S PD
Sbjct: 305 KL----LESLPD 312
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 1e-67
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 9/267 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
I +L + IG G +G V+ W +VA+K + + +F E ++M +L
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEE--DFIEEAEVMMKL 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP +V G + ++TEF+ G L L + + M LDV GM L
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
++HRDL + N LV +N +KVSDFG++R + +S + P +W +PEV
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 237
Query: 909 IWECWQTDPSLRPSFAQLTVALKPLQR 935
+ CW+ P RP+F++L L +
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-67
Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 22/294 (7%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ IP + LG +G G +G V A +VAVK + + + EF RE
Sbjct: 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 725 KIMRRLRHPNVVLFMGAVTR------PPNLSIITEFLPRGSLFRIL--HRPH---CQVDE 773
M+ HP+V +G R P +I F+ G L L R +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833
+ ++ +D+A GM L S+ +HRDL + N ++ ++ V V+DFGLSR ++
Sbjct: 137 QTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 834 KSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
+ A P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ +
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253
Query: 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 944
RL+ P E V ++++CW DP RPSF L + L+ + + Q
Sbjct: 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-67
Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 9/267 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E+ E++ L + +G G +G V W G +VAVK + + EF +E + M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSED--EFFQEAQTMMKL 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP +V F G ++ + I+TE++ G L L ++ + ++M DV GM L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
+ +HRDL + N LVD++ VKVSDFG++R + S P +W APEV
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV++FG+++WE+ +L K+P+ +VV V Q RL P + +I
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI 237
Query: 909 IWECWQTDPSLRPSFAQLTVALKPLQR 935
++ CW P RP+F QL +++PL+
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 7e-67
Identities = 82/273 (30%), Positives = 125/273 (45%), Gaps = 12/273 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ I ED+VL +G G +GEVY + VAVK +D + +F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSEA 64
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
IM+ L HP++V +G + P II E P G L L R + + +L +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 843
+ M L + VHRD+ N+LV VK+ DFGLSR + S P +WM
Sbjct: 124 KAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+PE + DV+ F V +WE+ + K P+ + V+G + + RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
P++ ++ CW DPS RP F +L +L + +
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 8e-67
Identities = 90/287 (31%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFK 721
++D E E+P E L L ER+G G +GEV+ +NG T+VAVK L Q F
Sbjct: 3 WWED---EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPD--AFL 56
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMA 780
E +M++L+H +V VT+ P IITE++ GSL L ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840
+A GM + +HRDL++ N+LV + K++DFGL+RL + +++ A P
Sbjct: 116 AQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 841 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 898
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 945
+ +++ CW+ P RP+F L L+ + QP
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 8e-67
Identities = 81/267 (30%), Positives = 125/267 (46%), Gaps = 9/267 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EI +DL + +G G +G V + W G +VA+K + + EF E K+M L
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSED--EFIEEAKVMMNL 76
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
+ +HRDL + N LV+ VKVSDFGLSR + +S + P W PEVL
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI 253
Query: 909 IWECWQTDPSLRPSFAQLTVALKPLQR 935
++ CW RP+F L + +
Sbjct: 254 MYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-66
Identities = 90/304 (29%), Positives = 150/304 (49%), Gaps = 27/304 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 79
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQVDEKRR------ 776
+M+ +VV +G V++ +I E + RG L + RP +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 777 -IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 140 MIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G P WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 256
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ----RLVIPSHPDQPSSA 948
L+ P ++ ++ CWQ +P +RPSF ++ ++K R V + ++
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLP 316
Query: 949 LPQE 952
P+E
Sbjct: 317 EPEE 320
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-66
Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 14/274 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+M + +P+V +G + +IT+ +P G L + + + + + +A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 842
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
V I+ +CW D RP F +L + + R
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-66
Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 18/293 (6%)
Query: 667 DVCECEIP--WEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLE 719
+V + IP IG G +G VYH ++ + A+K L + +
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEA 68
Query: 720 FKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F RE +MR L HPNV+ +G + P ++ ++ G L + + P K I
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKST 836
L VARGM L + VHRDL + N ++D+++ VKV+DFGL+R + + +
Sbjct: 129 FGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 837 AGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 893
P +W A E L+ K DV+SFGV+LWEL T P+ ++P + + Q R
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGR 245
Query: 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH-PDQP 945
RL P+ + +++ +CW+ DP++RP+F L ++ + ++ H P
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-66
Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 30/295 (10%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALL 718
+ I D+VL +G G++G+V+ A+ VAVK +D + AA
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARK 62
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR 776
+F+RE +++ L+H ++V F G L ++ E++ G L + L H P + +
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 777 -------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
+ +A +A GM L ++ VHRDL + N LV N VK+ DFG+S
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 824 RLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMN 880
R ++T P WM PE + + DV+SFGVILWE+ T K PW ++
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+V+ + Q R LE P+ V ++ CWQ +P R + ++ L L +
Sbjct: 241 NTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-65
Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 28/300 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 84
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 835
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 145 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 952
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP E
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPIE 316
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-65
Identities = 87/271 (32%), Positives = 125/271 (46%), Gaps = 13/271 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALL-EFKRE 723
C I +DL L E++G GS+G V +W+ VAVK S + +F RE
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
V M L H N++ G V PP + ++TE P GSL L + + A+ V
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 840
A GM L + +HRDL + NLL+ VK+ DFGL R P
Sbjct: 131 AEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 899
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930
+ + ++ +CW P RP+F L L
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 8e-65
Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 15/300 (5%)
Query: 653 VDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKF 707
+D S + + + E IG G +G VYH AVK
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS- 60
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHR 766
L++ + +F E IM+ HPNV+ +G R + ++ ++ G L +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFGL+R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 827 HNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNP 881
++ + T P +WMA E L+ + K DV+SFGV+LWEL T P+ +N
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 941
+ + Q RRL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 239 FDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 9e-65
Identities = 97/324 (29%), Positives = 150/324 (46%), Gaps = 30/324 (9%)
Query: 636 FMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA 695
MG+ L E S + + Q F D C I D+VL +G G++G+V+ A
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA-CVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 696 DWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
+ + VAVK ++ S +A +F+RE +++ L+H ++V F G T L
Sbjct: 61 ECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 749 SIITEFLPRGSLFRIL--HRPHCQVDEKRR------------IKMALDVARGMNCLHTST 794
++ E++ G L R L H P ++ + +A VA GM L +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AG 176
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEP 852
VHRDL + N LV + VK+ DFG+SR ++T P WM PE +
Sbjct: 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ DV+SFGV+LWE+ T K PW ++ + + + Q R LE P+ P V I+
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRG 295
Query: 912 CWQTDPSLRPSFAQLTVALKPLQR 935
CWQ +P R S + L+ L +
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQ 319
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-64
Identities = 96/270 (35%), Positives = 144/270 (53%), Gaps = 13/270 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 63
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 785
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 122
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 844
M L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W A
Sbjct: 123 AMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239
Query: 904 LVARIIWECWQTDPSLRPSFAQLTVALKPL 933
V ++ CWQ +PS RPSFA++ A + +
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-64
Identities = 82/273 (30%), Positives = 124/273 (45%), Gaps = 12/273 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 67
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 843
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WM
Sbjct: 127 TALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE + DV+ FGV +WE+ P+ G+ V+G + RL +P
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
P + ++ +CW DPS RP F +L L +
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-64
Identities = 84/288 (29%), Positives = 123/288 (42%), Gaps = 29/288 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
EI + E +G +G+VY G VA+K L G EF+ E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHEA 63
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 776
+ RL+HPNVV +G VT+ LS+I + G L L PH V
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 777 -------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829
+ + +A GM L S+ +VH+DL + N+LV NVK+SD GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 830 FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVG 886
P WMAPE + + D++S+GV+LWE+ + P+ G + VV
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
+ + L P + V ++ ECW PS RP F + L+
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-64
Identities = 85/302 (28%), Positives = 135/302 (44%), Gaps = 28/302 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 125
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 835
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 186 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 952
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP E
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPIE 357
Query: 953 IS 954
Sbjct: 358 YG 359
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-64
Identities = 69/295 (23%), Positives = 127/295 (43%), Gaps = 19/295 (6%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+L + +G G +G V+ W V +K ++ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+ L H ++V +G L ++T++LP GSL + + + + + + +A
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EW 842
+GM L +VHR+L + N+L+ V+V+DFG++ L + TP +W
Sbjct: 126 KGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E + + DV+S+GV +WEL T P+ G+ +V + + RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQ 951
V ++ +CW D ++RP+F +L + R LVI + P+
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPE 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 8e-64
Identities = 84/294 (28%), Positives = 141/294 (47%), Gaps = 19/294 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 725
EI + + IG G +GEVY VA+K L ++ ++F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 98
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 842
GM L + VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+G P W
Sbjct: 159 GMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
APE + DV+SFG+++WE+ T + P+ ++ +V+ A+ RL P +
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 275
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALP 950
+ +++ +CWQ + + RP FA + L L R + + S LP
Sbjct: 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLP 329
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 9e-64
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 18/295 (6%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+M + +P+V +G + +IT+ +P G L + + + + + +A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 842
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPL----QRLVIPSHPDQPSSALPQE 952
V I+ +CW D RP F +L + + QR ++ ++ P +
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 299
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 37/310 (11%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQD 711
++ + + + E P ++ IG G++G V+ A G T VAVK L ++
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEE 88
Query: 712 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC 769
S +F+RE +M +PN+V +G + ++ E++ G L L PH
Sbjct: 89 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 770 QVDEKRR---------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808
+ +A VA GM L S VHRDL + N L
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCL 206
Query: 809 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVIL 866
V +N VK++DFGLSR ++ P WM PE + + DV+++GV+L
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 867 WELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 925
WE+ + P+ GM +V+ V L P+ + ++ CW P+ RPSF
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 926 LTVALKPLQR 935
+ L+ +
Sbjct: 326 IHRILQRMCE 335
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-63
Identities = 88/272 (32%), Positives = 140/272 (51%), Gaps = 19/272 (6%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK--KFLDQDFSGAALLEFKREVKIM 727
+ ++L L + IG G +G+V D+ G +VAVK K + A F E +M
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDATAQAFLAEASVM 240
Query: 728 RRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVAR 785
+LRH N+V +G + L I+TE++ +GSL L R + +K +LDV
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 844
M L VHRDL + N+LV ++ KVSDFGL++ +T + K P +W A
Sbjct: 301 AMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTA 354
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE LR + + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413
Query: 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
V ++ CW D + RP+F QL L+ ++
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-63
Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 15/305 (4%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEV 702
+ + +D S + + + E IG G +G VYH
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 703 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLF 761
AVK L++ + +F E IM+ HPNV+ +G R + ++ ++ G L
Sbjct: 121 AVKS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFG
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 822 LSRLKHNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPW 876
L+R ++ T P +WMA E L+ + K DV+SFGV+LWEL T P+
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
+N + + Q RRL P+ + ++ +CW +RPSF++L + +
Sbjct: 298 PDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
Query: 937 VIPSH 941
I H
Sbjct: 357 FIGEH 361
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-63
Identities = 87/294 (29%), Positives = 148/294 (50%), Gaps = 13/294 (4%)
Query: 656 STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSG 714
+SK + ++ D EIP E L L +++G G +GEV+ A +N T+VAVK
Sbjct: 170 MSSKPQKPWEKD--AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GS 224
Query: 715 AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDE 773
++ F E +M+ L+H +V VT+ P IITEF+ +GSL L +
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833
+ I + +A GM + +HRDL++ N+LV + K++DFGL+R+ + ++
Sbjct: 284 PKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 834 KSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 891
+ A P +W APE + K DV+SFG++L E+ T ++P+ GM+ +V+ A+ +
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-R 400
Query: 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 945
R+ P+ + I+ CW+ P RP+F + L + + P
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-63
Identities = 95/316 (30%), Positives = 160/316 (50%), Gaps = 35/316 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G++G+V A+ G T+VAVK L D + L +
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 123
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + H
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 827 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H+ K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 943
+ + + R++ P + ++ +CW PS RP+F QL ++ L R+V +
Sbjct: 302 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIVALTSNQ 357
Query: 944 QPSSALPQEISVNSTP 959
+ P
Sbjct: 358 EMGYYHHHHHHDYDIP 373
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-63
Identities = 89/290 (30%), Positives = 148/290 (51%), Gaps = 32/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E P + L LG+ +G G++G+V A+ G VAVK L D + L +
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVS 89
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC---------- 769
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L RP
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 770 ---QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
Q+ K + +ARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 827 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
+N K+T G P +WMAPE L + + DV+SFGV++WE+ TL P+ G+ +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + + R++ P + ++ +CW PS RP+F QL L +
Sbjct: 268 LFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-63
Identities = 92/285 (32%), Positives = 143/285 (50%), Gaps = 15/285 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 234
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 786
+LRH +V V+ P I+TE++ +GSL L + + + MA +A G
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 292
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 845
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 293 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 949
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 452
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 724
E + + L L ++ +G G++G V + VAVK ++ A E E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+M++L +P +V +G + ++ E G L + L + + V +K I++ V+
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVS 127
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 841
GM L VHRDL + N+L+ K+SDFGLS+ K+ P +
Sbjct: 128 MGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
+ ++ CW D RP FA + + L+
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-62
Identities = 88/295 (29%), Positives = 143/295 (48%), Gaps = 37/295 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P ++LVLG+ +G G +G+V A T VAVK L ++ S + L + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEF 77
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 776
+++++ HP+V+ GA ++ L +I E+ GSL L R
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 777 ---------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
I A +++GM L + +VHRDL + N+LV + +K+SDFG
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 822 LSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 878
LSR + K + G P +WMA E L + + DV+SFGV+LWE+ TL P+ G
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ P ++ + R+E P + R++ +CW+ +P RP FA ++ L+ +
Sbjct: 256 IPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-62
Identities = 88/273 (32%), Positives = 130/273 (47%), Gaps = 13/273 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 726
EI + + + IG G GEV + VA+K L ++ +F E I
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEASI 103
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M + HPN++ G VTR I+TE++ GSL L Q + + M V G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 843
M L S VHRDL + N+LVD N KVSDFGLSR+ + ++ +T G P W
Sbjct: 164 MRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE + + DV+SFGV++WE+ + P+ M V+ +V + RL P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP 280
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ +++ +CW D + RP F+Q+ L L R
Sbjct: 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-62
Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 32/293 (10%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
+ L +++G G++G V ++ VAVKK L + L +F+RE
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDFERE 61
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLS--IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
++I++ L+H N+V + G + +I E+LP GSL L + ++D + ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 839
+ +GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPM 882
P W APE L + DV+SFGV+L+EL T M
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
++ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-62
Identities = 95/330 (28%), Positives = 159/330 (48%), Gaps = 40/330 (12%)
Query: 637 MGTNLKLRDLESPSSSVDS-----STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGE 691
M +N L + + SS S+ + D E P + L LG+ +G G +G+
Sbjct: 40 MNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW---EFPRDKLTLGKPLGEGCFGQ 96
Query: 692 VYHADWNG---------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741
V A+ G VAVK L D + L + E+++M+ + +H N++ +GA
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 742 VTRPPNLSIITEFLPRGSL--FRILHRPHC-------------QVDEKRRIKMALDVARG 786
T+ L +I E+ +G+L + RP Q+ K + +ARG
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMA 844
M L ++ +HRDL + N+LV +N +K++DFGL+R +N K+T G P +WMA
Sbjct: 216 MEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE L + + DV+SFGV++WE+ TL P+ G+ ++ + + R++ P
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTN 332
Query: 904 LVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ ++ +CW PS RP+F QL L +
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-62
Identities = 89/302 (29%), Positives = 148/302 (49%), Gaps = 18/302 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 726
E+ ++ + + +G G +GEV VA+K L ++ +F E I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEASI 99
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M + HPN++ G VT+ + I+TE++ GSL L + Q + + M +A G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 843
M L S VHRDL + N+L++ N KVSDFGL R+ + ++ +T G P W
Sbjct: 160 MKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+PE + DV+S+G++LWE+ + + P+ M+ V+ AV + RL P +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQEISVNS 957
+ +++ +CWQ D + RP F Q+ L L R +I S +PS+ L + +V+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDI 336
Query: 958 TP 959
T
Sbjct: 337 TT 338
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-62
Identities = 93/272 (34%), Positives = 144/272 (52%), Gaps = 13/272 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 270
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 785
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 329
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 844
M L +HR+L + N LV +N VKV+DFGLSR + +T+ + +W A
Sbjct: 330 AMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446
Query: 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
V ++ CWQ +PS RPSFA++ A + + +
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 5e-62
Identities = 89/285 (31%), Positives = 138/285 (48%), Gaps = 30/285 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 79
Query: 728 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR-------- 776
+L HPN++ +GA L + E+ P G+L L R
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 777 -----IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831
+ A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR +
Sbjct: 140 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-- 195
Query: 832 SSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 888
K T G P WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 255 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 5e-62
Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 30/290 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVK 725
L +G G +G+V + G +VAVK L + G + + K+E++
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIE 75
Query: 726 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
I+R L H N+V + G T + +I EFLP GSL L + +++ K+++K A+ +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 840
+GM+ L + VHRDL + N+LV+ VK+ DFGL++ P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQVV 885
W APE L DV+SFGV L EL T M ++V
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ + +RL P V +++ +CW+ PS R SF L + L +
Sbjct: 254 NTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-62
Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 32/291 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 725
+ L +++G G++G V ++ VAVKK Q + L +F+RE++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94
Query: 726 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
I++ L+H N+V + G L +I E+LP GSL L + ++D + ++ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-TP- 840
+GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +P
Sbjct: 155 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPMQV 884
W APE L + DV+SFGV+L+EL T M +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 885 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 273 IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-61
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 14/269 (5%)
Query: 672 EIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKI 726
+ ++L++ + +G G++G V + +VA+K L Q A E RE +I
Sbjct: 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQI 63
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M +L +P +V +G + ++ E G L + L ++ ++ V+ G
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 843
M L VHRDL + N+L+ K+SDFGLS+ + + P +W
Sbjct: 123 MKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 239
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVALK 931
P + ++ +CW RP F + ++
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 89/325 (27%), Positives = 140/325 (43%), Gaps = 37/325 (11%)
Query: 642 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-- 699
+L+ ++ SS + + ++ D+ + E P E+L G+ +G G++G+V +A G
Sbjct: 12 QLQMVQVTGSSDNEYFYVDFREYEYDL-KWEFPRENLEFGKVLGSGAFGKVMNATAYGIS 70
Query: 700 -----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753
+VAVK L + + E+K+M +L H N+V +GA T + +I E
Sbjct: 71 KTGVSIQVAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129
Query: 754 FLPRGSLFRIL--HRPHCQVDEKRR--------------------IKMALDVARGMNCLH 791
+ G L L R DE + A VA+GM L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 188
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLR 849
+ VHRDL + N+LV VK+ DFGL+R + P +WMAPE L
Sbjct: 189 -EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
K DV+S+G++LWE+ +L P+ G+ + +++ P + I
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 307
Query: 909 IWECWQTDPSLRPSFAQLTVALKPL 933
+ CW D RPSF LT L
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-61
Identities = 86/290 (29%), Positives = 139/290 (47%), Gaps = 32/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P + L LG+ +G G++G+V AD G VAVK L + + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSEL 81
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL--HRPHC----------- 769
KI+ + H NVV +GA T+P L +I EF G+L L R
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 770 --QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
+ + I + VA+GM L ++ +HRDL + N+L+ + VK+ DFGL+R +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 828 NTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM-NPMQ 883
+ P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 260 FCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-61
Identities = 80/290 (27%), Positives = 123/290 (42%), Gaps = 31/290 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P L G+ +G G++G+V A G VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPH------------- 768
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 769 --CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
+D + + + VA+GM L ++ +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 827 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
N P +WMAPE + N + DV+S+G+ LWEL +L P+ GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + R+ P+ + I+ CW DP RP+F Q+ ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-61
Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
+I EDL+ E +G G++ +++ TEV +K LD+ F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKA-HRNYSESFFE 61
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
+M +L H ++VL G ++ EF+ GSL L + ++ ++++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRLKHNTFLSSK 834
+A M+ L T++H ++ + N+L+ + + +K+SD G+S + K
Sbjct: 122 LAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPK 174
Query: 835 STAGTP-EWMAPEVLRNEPS-NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 891
W+ PE + N + N D +SFG LWE+ + P ++ + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-D 233
Query: 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
+L PK +A +I C +P RPSF + L L
Sbjct: 234 RHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 8e-61
Identities = 82/271 (30%), Positives = 123/271 (45%), Gaps = 12/271 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 726
EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALT 444
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 845
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WMAP
Sbjct: 504 LAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 620
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ ++ +CW DPS RP F +L L +
Sbjct: 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-60
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 32/292 (10%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
L +G G +G+V ++ VAVK L D +K+E
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQE 83
Query: 724 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
+ I+R L H +++ + G +L ++ E++P GSL L R + + + A
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQ 141
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 839
+ GM LH +HRDL + N+L+D + VK+ DFGL++ + G +
Sbjct: 142 QICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQ 883
P W APE L+ DV+SFGV L+EL T + M ++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ + + RL P + V ++ CW+T+ S RP+F L LK +
Sbjct: 260 LTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-60
Identities = 92/285 (32%), Positives = 143/285 (50%), Gaps = 15/285 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 317
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 786
+LRH +V V+ P I+TE++ +GSL L + + + MA +A G
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 375
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 845
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 376 MAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 949
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 535
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-60
Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 29/287 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P +L G+ +G G++G+V A G +VAVK L E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSEL 100
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR----- 776
KIM L +H N+V +GA T + +ITE+ G L L + D
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 777 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830
+ + VA+GM L ++ +HRD+ + N+L+ K+ DFGL+R N
Sbjct: 161 ASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 831 LSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG-MNPMQVVG 886
P +WMAPE + + + DV+S+G++LWE+ +L P+ G + +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
V ++ P + I+ CW +P+ RP+F Q+ L+
Sbjct: 279 LVK-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-59
Identities = 78/313 (24%), Positives = 132/313 (42%), Gaps = 36/313 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
L ++G G++G V ++ VAVK+ Q +F+RE
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQRE 74
Query: 724 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
++I++ L +V + G P +L ++ E+LP G L L R ++D R + +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGT 839
+ +GM L + VHRDL + N+LV+ +VK++DFGL++L + + +
Sbjct: 135 QICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF------- 890
P W APE L + + + DV+SFGV+L+EL T +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 891 ------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL-------KPLQRLV 937
+ +RL P V ++ CW P RPSF+ L L + +
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 938 IPSHPDQPSSALP 950
+HP+ +L
Sbjct: 313 FTAHPEGKHHSLS 325
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 199 bits (506), Expect = 2e-54
Identities = 67/271 (24%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 670 ECEIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 724
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 387
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+IM +L +P +V +G + ++ E G L + L ++ ++ V+
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 841
GM L VHR+L + N+L+ K+SDFGLS+ + + P +
Sbjct: 447 MGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
P + ++ +CW RP F + ++
Sbjct: 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-54
Identities = 61/254 (24%), Positives = 128/254 (50%), Gaps = 6/254 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E V ++IG GS+G+ +G + +K+ S E +REV ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHT 792
N+V + + +L I+ ++ G LF+ + + E + + + + + +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
I+HRD+KS N+ + K+ V++ DFG++R+ ++T +++ GTP +++PE+ N+P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
N K D+++ G +L+EL TLK + + +V + + + ++ +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQL 260
Query: 913 WQTDPSLRPSFAQL 926
++ +P RPS +
Sbjct: 261 FKRNPRDRPSVNSI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 11/261 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMN 788
N+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 789 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 244
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
II RPS ++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEI 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 19/292 (6%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTE 701
+ + D+ + + E + R+G GS+GEV+ D G +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
AVKK + F E+ L P +V GAV P ++I E L GSL
Sbjct: 86 CAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDF 820
+++ + + E R + G+ LHT I+H D+K+ N+L+ + + DF
Sbjct: 139 QLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDF 195
Query: 821 GLSR-----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
G + + L+ GT MAPEV+ +P + K D++S ++ + P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
Query: 876 WIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
W + + + EIP PL A+ I E + +P R S +L
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-53
Identities = 66/260 (25%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 732
+ + ++IG G + EVY A +G VA+KK + A + +E+ ++++L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNC 789
PNV+ + + L+I+ E G L R++ + + E+ K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
+H+ ++HRD+K N+ + VK+ D GL R + ++ S GTP +M+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LDPLVA 906
N K D++S G +L+E+A L+ P+ G MN + + Q +P + +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDHYSEELR 268
Query: 907 RIIWECWQTDPSLRPSFAQL 926
+++ C DP RP +
Sbjct: 269 QLVNMCINPDPEKRPDVTYV 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-52
Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 14/281 (4%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDF 712
S S + + D+ E + +++ +G G+YG VY D N +A+K+ ++D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 713 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH--CQ 770
+ L E+ + + L+H N+V ++G+ + + I E +P GSL +L +
Sbjct: 61 RYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 771 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNT 829
+E+ + G+ LH + IVHRD+K N+L++ + +K+SDFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 830 FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFG-VILWELATLKLPWIGM-NPMQVV 885
+++ GT ++MAPE++ P + D++S G I+ E+AT K P+ + P +
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAM 235
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
VG EIP+ + I +C++ DP R L
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-50
Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 43/285 (15%)
Query: 676 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D +G G++G+V A + A+KK + L EV ++ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 734 NVVLFMGAVTRPPNLS-------------IITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
VV + A N I E+ G+L+ ++H + ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--- 837
+ ++ +H+ I+HRDLK N+ +D++ NVK+ DFGL++ H + K +
Sbjct: 123 RQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 838 -----------GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
GT ++A EVL NEK D+YS G+I +E+ + GM + ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNIL 238
Query: 886 GAVGFQNRRLEIPKELD----PLVARIIWECWQTDPSLRPSFAQL 926
+ ++ +E P + D + +II DP+ RP L
Sbjct: 239 KKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-50
Identities = 55/264 (20%), Positives = 109/264 (41%), Gaps = 22/264 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E L L + +D R ++ ++ +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 128
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 854 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
+ ++ C + DP R S +L
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-50
Identities = 55/264 (20%), Positives = 109/264 (41%), Gaps = 22/264 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E L L + +D R ++ ++ +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 147
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 854 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
+ ++ C + DP R S +L
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 7e-49
Identities = 60/272 (22%), Positives = 120/272 (44%), Gaps = 38/272 (13%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 732
D E IG G +G+V+ A +G +K+ + + + +REVK + +L H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDH 63
Query: 733 PNVVLFMGA----------------VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR 775
N+V + G ++ L I EF +G+L + + R ++D+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSK 834
+++ + +G++ +H+ +++RDLK N+ + VK+ DFGL LK++
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 894
+ GT +M+PE + ++ ++ D+Y+ G+IL EL + + R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF-TDLRD 233
Query: 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
I D ++ + P RP+ +++
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-48
Identities = 54/264 (20%), Positives = 108/264 (40%), Gaps = 22/264 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E L L + +D R ++ ++ +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 175
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
IVH DLK N L+ +K+ DFG++ T + S G +M PE +++ S+
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 855 -----------EKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 902
K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
+ ++ C + DP R S +L
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 73/288 (25%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
++G G +G+VY +G +VA+K+ + S + EF+ E++ + RHP+
Sbjct: 43 HKFLIGH----GVFGKVYKGVLRDGAKVALKR-RTPE-SSQGIEEFETEIETLSFCRHPH 96
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH 791
+V +G + +I +++ G+L R L+ P + ++R+++ + ARG++ LH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 849
T I+HRD+KS N+L+D+N+ K++DFG+S+ + ST GT ++ PE
Sbjct: 157 T--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------RRLEIPKE 900
EK DVYSFGV+L+E+ + + N ++ +
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLC------ARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 901 LDPL------------VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
+DP +C RPS + L+ RL
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 29/324 (8%)
Query: 609 NSKDENPKNVE--DHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD 666
+ + V+ + + + R L+SP S Q F
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQ- 60
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREV 724
R+G GSYGEV+ +G AVK+ + EV
Sbjct: 61 -------------RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
++ +HP V A L + TE SL + + E + D
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 843
+ LH+ +VH D+K N+ + K+ DFGL + T + + G P +M
Sbjct: 167 LLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYM 223
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELD 902
APE+L DV+S G+ + E+A G Q + Q E L
Sbjct: 224 APELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLS 278
Query: 903 PLVARIIWECWQTDPSLRPSFAQL 926
+ ++ + DP LR + L
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEAL 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-46
Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 44/281 (15%)
Query: 684 IGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G G +G+VY +GT VAVK+ L ++ + L+F+ EV+++ H N++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 743 TRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIV 798
P ++ ++ GS+ L +D +R ++AL ARG+ LH P I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
HRD+K+ N+L+D+ + V DFGL++L +T +++ GT +APE L S+EK
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 215
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------FQNRRLEIPKEL-D 902
DV+ +GV+L EL T G + + ++LE L D
Sbjct: 216 TDVFGYGVMLLELIT------GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---ALVD 266
Query: 903 PL---------VARIIW---ECWQTDPSLRPSFAQLTVALK 931
V ++I C Q+ P RP +++ L+
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-46
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 23/287 (8%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFS 713
SS S D++ + + +G G+ G + + ++ +VAVK+ L + FS
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS 62
Query: 714 GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD 772
A REV+++R HPNV+ + I E +L + +
Sbjct: 63 FA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 773 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRL-- 825
I + G+ LH+ IVHRDLK N+L+ +SDFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATL-KLPWIGMN 880
++F GT W+APE+L + D++S G + + + + P+
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 881 PMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
Q +G L K D + +I + DP RPS +
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-46
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 32/294 (10%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + +++G G + V +G A+K+ L + E +RE + R HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHP 86
Query: 734 NVVLFMGAVTRPPN----LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARG 786
N++ + R ++ F RG+L+ + + E + + + L + RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--------- 837
+ +H HRDLK N+L+ + D G S+
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 838 GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLP--WIGMNPMQVVGAVGFQN 892
T + APE+ + +E+ DV+S G +L+ + + P + V AV
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---Q 261
Query: 893 RRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 944
+L IP+ + +++ DP RP L L+ LQ H Q
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-45
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKR 722
D+ + P E + E++G GSYG VY A G VA+K+ ++ D E +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIK 73
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E+ IM++ P+VV + G+ + +L I+ E+ GS+ I+ + + E +
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKST 836
+G+ LH +HRD+K+ N+L++ + K++DFG++ K NT +
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----- 186
Query: 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RL 895
GTP WMAPEV++ N D++S G+ E+A K P+ ++PM+ + +
Sbjct: 187 -GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF 245
Query: 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
P+ + +C P R + QL
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-45
Identities = 67/296 (22%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 737 -LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCL 790
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 71 KLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 791 HTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 845
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P
Sbjct: 129 REN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 846 EVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-------------- 883
++ + D++S GV + AT LP+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 884 ---VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-45
Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 22/280 (7%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+ ER+G G +G V G +VA+K+ Q+ S + E++IM++L HPNVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 737 -LF-----MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMN 788
+ + + E+ G L + L++ C + E + D++ +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 844
LH + I+HRDLK N+++ K+ D G ++ L GT +++A
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLA 191
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
PE+L + D +SFG + +E T P++ + + E D L
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDL 250
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 944
+ + P+ L+ + ++ H Q
Sbjct: 251 TGAVKFSSVLPTPNHLSGILA--GKLERWLQCMLMWHQRQ 288
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 57/273 (20%), Positives = 98/273 (35%), Gaps = 38/273 (13%)
Query: 681 GERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
E+IG G +G V+ +G A+K+ REV L +H +VV
Sbjct: 16 LEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ A ++ I E+ GSL + +R E + L V RG+ +H+
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 794 TPTIVHRDLKSPNLLVDKN-------------------WNVKVSDFGLSRLKHNTFLSSK 834
+ +VH D+K N+ + + K+ D G + +
Sbjct: 135 S--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----Q 188
Query: 835 STAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893
G ++A EVL+ N K D+++ + + A + + + Q R
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQGR 244
Query: 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
IP+ L ++ DP RPS L
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 44/273 (16%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P E E+IG GS+GEV+ + VA+K +D + + + + ++E+ ++ +
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCD 78
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH 136
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAP 845
+ +HRD+K+ N+L+ ++ VK++DFG++ ++K NTF GTP WMAP
Sbjct: 137 SEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAP 188
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP-- 903
EV++ + K D++S G+ ELA + P ++PM+V+ IPK P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTL 239
Query: 904 ----------LVARIIWECWQTDPSLRPSFAQL 926
V C +PS RP+ +L
Sbjct: 240 EGNYSKPLKEFVEA----CLNKEPSFRPTAKEL 268
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 68/327 (20%), Positives = 130/327 (39%), Gaps = 50/327 (15%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTE 701
+ LE + +++ E+ +D +G G+ G V+ +G
Sbjct: 2 KKLEELELD-EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
+A K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 61 MARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
++L + ++ E+ K+++ V +G+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 120 QVLKKAG-RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881
+S ++ + S GT +M+PE L+ + + D++S G+ L E+A + P +
Sbjct: 178 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 882 MQVVGAVGFQNRRLE---------------------------------IPKELDPLVARI 908
++ G Q I E P +
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 909 IW---------ECWQTDPSLRPSFAQL 926
++ +C +P+ R QL
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERADLKQL 322
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 26/275 (9%)
Query: 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVV 736
+GE G +G VY N T VAVKK + +F +E+K+M + +H N+V
Sbjct: 38 KMGE----GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 794
+G + +L ++ ++P GSL L R K+A A G+N LH
Sbjct: 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-- 151
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLRNEP 852
+HRD+KS N+L+D+ + K+SDFGL+R + ++ GT +MAPE LR E
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE- 210
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPL------ 904
K D+YSFGV+L E+ T Q + ++ I +D
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 905 -----VARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
+ + +C + RP ++ L+ +
Sbjct: 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-44
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 31/298 (10%)
Query: 645 DLESPSSSVDSSTSKV--DQIFD--DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWN 698
++ + ++ + V +Q V + P L +IG GS G V A +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 699 GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755
G +VAVK Q EV IMR +H NVV + L ++ EFL
Sbjct: 70 GRQVAVKMMDLRKQQRRE-----LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815
G+L I+ +++E++ + V + + LH ++HRD+KS ++L+ + V
Sbjct: 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRV 180
Query: 816 KVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
K+SDFG K + GTP WMAPEV+ + D++S G+++ E+
Sbjct: 181 KLSDFGFCAQISKDVPKRKSL------VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ P+ +P+Q + + +L+ ++ P++ + DP R + +L
Sbjct: 235 VDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 37/309 (11%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVV 736
+ + G + VY A +G E A+K+ L + +EV M++L HPN+V
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNIV 89
Query: 737 LFMGAVTRPPNLS-------IITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGM 787
F A + S ++ L +G L L + +K+ R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---------- 837
+H P I+HRDLK NLL+ +K+ DFG + + S S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 838 --GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892
TP + PE++ N P EK D+++ G IL+ L + P+ +++V N
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------N 263
Query: 893 RRLEIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 950
+ IP + +I Q +P R S A++ L+ + + + L
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLE 323
Query: 951 QEISVNSTP 959
Q S
Sbjct: 324 QNGGYGSAT 332
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 41/296 (13%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 63
Query: 734 NVVLFMGA------------VTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKM 779
+V + A + L I + + +L ++ + + + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-- 837
L +A + LH+ ++HRDLK N+ + VKV DFGL
Sbjct: 124 FLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 838 ----------GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887
GT +M+PE + + K D++S G+IL+EL M ++ +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239
Query: 888 VGFQNRRLEIPKELD---PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940
V R L+ P P ++ + P RP + + + L P
Sbjct: 240 V----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI-IENAVFEDLDFPG 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 65/253 (25%), Positives = 115/253 (45%), Gaps = 10/253 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
PN++ G + +I E+ P G+++R L + + DE+R ++A ++ H+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHS 127
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRD+K NLL+ +K++DFG S H GT +++ PE++
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 241
Query: 913 WQTDPSLRPSFAQ 925
+ +PS RP +
Sbjct: 242 LKHNPSQRPMLRE 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 70/270 (25%), Positives = 130/270 (48%), Gaps = 23/270 (8%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKRE 723
+ P + E+IG G+ G VY A G EVA+++ L Q E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINE 67
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
+ +MR ++PN+V ++ + L ++ E+L GSL ++ +DE + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCREC 125
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 837
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + K +T
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------V 177
Query: 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLE 896
GTP WMAPEV+ + K D++S G++ E+ + P++ NP++ + + L+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 897 IPKELDPLVARIIWECWQTDPSLRPSFAQL 926
P++L + + C + D R S +L
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 55/298 (18%), Positives = 121/298 (40%), Gaps = 43/298 (14%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVK---------------KFLDQDFSGAALLEFKREV 724
+ + G + ++ + + A+K D+ + +FK E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+I+ +++ + G +T + II E++ S+ + +D+ + + V
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVI 153
Query: 785 R--------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836
+ + +H + I HRD+K N+L+DKN VK+SDFG S + + K +
Sbjct: 154 KCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGS 210
Query: 837 AGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNR 893
GT E+M PE NE + K D++S G+ L+ + +P + ++ +++ + + +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI--RTK 268
Query: 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIP---SHP 942
+E P + + + + + + + L P +R+ H
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK--NPAERITSEDALKHE 324
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 4e-43
Identities = 67/307 (21%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV- 736
L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 737 LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLH 791
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 72 LF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 792 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P+
Sbjct: 130 EN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPD 185
Query: 847 VLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------- 883
+ + D++S GV + AT LP+ +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 884 --VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 932 PLQRLVI 938
+ ++
Sbjct: 306 DILHRMV 312
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 32/279 (11%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKRE 723
+ V P E + +G G++G+VY A G A K ++ S L ++ E
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVE 66
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
++I+ HP +V +GA L I+ EF P G++ I+ + E + + +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 837
+N LH+ I+HRDLK+ N+L+ +++++DFG+S K ++F+
Sbjct: 127 LEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------ 178
Query: 838 GTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-- 890
GTP WMAPEV+ E + K D++S G+ L E+A ++ P +NPM+V+
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKI 234
Query: 891 -QNR--RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
++ L P + + +P RPS AQL
Sbjct: 235 AKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 62/253 (24%), Positives = 115/253 (45%), Gaps = 10/253 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+D +G +G G +G VY A N +A+K + +RE++I LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
PN++ + ++ EF PRG L++ L + H + DE+R ++A ++ H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHE 132
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRD+K NLL+ +K++DFG S + ++ GT +++ PE++ +
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGKT 188
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+EK D++ GV+ +E P+ + + + N L+ P L +I +
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLISKL 246
Query: 913 WQTDPSLRPSFAQ 925
+ P R
Sbjct: 247 LRYHPPQRLPLKG 259
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 46/287 (16%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
I +D L E IG G+ V A +VA+K+ ++ + ++ E +E++ M +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQC 70
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMAL-DV 783
HPN+V + + L ++ + L GS+ I+ + + K I L +V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-----------RLKHNTFLS 832
G+ LH + +HRD+K+ N+L+ ++ +V+++DFG+S TF
Sbjct: 131 LEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-- 186
Query: 833 SKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF- 890
GTP WMAPEV+ + + K D++SFG+ ELAT P+ PM+V+
Sbjct: 187 ----VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----ML 238
Query: 891 --QNR--RLEIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 926
QN LE + ++ + +I C Q DP RP+ A+L
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 8e-42
Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 35/297 (11%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAV 704
+ ++ + P + IG GS+G VY A N VA+
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAI 84
Query: 705 KKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
KK S + +EV+ +++LRHPN + + G R ++ E+ GS +
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDL 143
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
L + E + +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG +
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA 201
Query: 824 --RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIG 878
N+F GTP WMAPEV+ + K DV+S G+ ELA K P
Sbjct: 202 SIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 926
MN M + I + P + W C Q P RP+ L
Sbjct: 256 MNAMSAL---------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 50/302 (16%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDF 712
+S S + + D+ P L E +G G+YG+VY G A+K D
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV---MDV 59
Query: 713 SGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTRPPNLSIITEFLPRGSLFRILH 765
+G E K+E+ ++++ H N+ + GA L ++ EF GS+ ++
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 766 RPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS- 823
++ I ++ RG++ LH ++HRD+K N+L+ +N VK+ DFG+S
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 824 -----RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLK 873
+ NTF GTP WMAPEV+ + + + K D++S G+ E+A
Sbjct: 178 QLDRTVGRRNTF------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 874 LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSFA 924
P M+PM+ + F IP+ P + W C + S RP+
Sbjct: 232 PPLCDMHPMRAL----FL-----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATE 282
Query: 925 QL 926
QL
Sbjct: 283 QL 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 26/259 (10%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
G +G G + + + A K + + E+ I R L H +V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
V F G + ++ E R SL + KRR + AR G
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGC 128
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEV
Sbjct: 129 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
L + + + DV+S G I++ L K P+ + + + IPK ++P+ A
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAAS 244
Query: 908 IIWECWQTDPSLRPSFAQL 926
+I + QTDP+ RP+ +L
Sbjct: 245 LIQKMLQTDPTARPTINEL 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 45/284 (15%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEF----------- 720
L + IG GSYG V A + + T A+K K + Q
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 721 --------KREVKIMRRLRHPNVV-LF--MGAVTRPPNLSIITEFLPRGSLFRILHRPHC 769
+E+ I+++L HPNVV L + +L ++ E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPL 134
Query: 770 QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KH 827
D+ R D+ +G+ LH I+HRD+K NLLV ++ ++K++DFG+S
Sbjct: 135 SEDQARFY--FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ L +T GTP +MAPE L + DV++ GV L+ + P++ M +
Sbjct: 191 DALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 885 VGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQL 926
+ +++ LE P ++ + +I +P R ++
Sbjct: 249 HSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 43/280 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 728
E+ +DL +G G+YG V +G +AVK+ + + ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVAR 785
+ P V F GA+ R ++ I E + SL + + + + E K+A+ + +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTP 840
+ LH S +++HRD+K N+L++ VK+ DFG+S + + AG
Sbjct: 121 ALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCK 173
Query: 841 EWMAPEVLRNEPS----NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRL 895
+MAPE + E + + K D++S G+ + ELA L+ P+ P Q +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ-------- 225
Query: 896 EIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 926
+ +E P + + +C + + RP++ +L
Sbjct: 226 -VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 81/341 (23%), Positives = 134/341 (39%), Gaps = 74/341 (21%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEF 720
D + E P + L LG+ +G G++G+V AD G K L + + +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72
Query: 721 KREVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRP----------- 767
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 768 -----------HCQVDEKRRIKM-----------ALDVARGMNCLHTSTPTIVHRDLKSP 805
VD KRR+ ++ + P +++D +
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192
Query: 806 NLLVDKNWNV------------------------------KVSDFGLSR-LKHNTFLSSK 834
L+ ++ V K+ DFGL+R + + K
Sbjct: 193 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 835 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 61/309 (19%), Positives = 111/309 (35%), Gaps = 26/309 (8%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLG--SYGEVYHA--DWNGTEVAVKKFLDQDFSGAA 716
+ ++ + L IG G V A G V V++ + S
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 717 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 776
+ + E+ + + HPN+V + L ++T F+ GS ++ +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 777 IKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNT 829
I L V + ++ +H VHR +K+ ++L+ + V +S + +
Sbjct: 130 IAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 830 -FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 886
K + W++PEVL+ + K D+YS G+ ELA +P+ M Q++
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML- 246
Query: 887 AVGFQNRRLEIPKELDP-LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 945
LE P L+ + S S A ++ PS+ D P
Sbjct: 247 --------LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 946 SSALPQEIS 954
S + S
Sbjct: 299 SHPYHRTFS 307
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-39
Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 26/259 (10%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
G +G G + + + A K + + E+ I R L H +V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
V F G + ++ E R SL + KRR + AR G
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGC 154
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEV
Sbjct: 155 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
L + + + DV+S G I++ L K P+ + + + IPK ++P+ A
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAAS 270
Query: 908 IIWECWQTDPSLRPSFAQL 926
+I + QTDP+ RP+ +L
Sbjct: 271 LIQKMLQTDPTARPTINEL 289
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 736
+G +G GS+ VY A G EVA+K + A +++ + EVKI +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E G + R L E + GM LH+
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I+HRDL NLL+ +N N+K++DFGL+ + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 916
DV+S G + + L + P+ + V E+P L +I + + +
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIHQLLRRN 250
Query: 917 PSLRPSFAQL 926
P+ R S + +
Sbjct: 251 PADRLSLSSV 260
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 13/252 (5%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L + IG G++ +V A G EVA+K + +L + REV+IM+ L HPN+V
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L +I E+ G +F ++ + E R + + H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--FRQIVSAVQYCHQKR-- 134
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN- 854
IVHRDLK+ NLL+D + N+K++DFG S L + G P + APE+ + + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYDG 192
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ DV+S GVIL+ L + LP+ G N ++ V + IP + ++
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFLV 250
Query: 915 TDPSLRPSFAQL 926
+P R + Q+
Sbjct: 251 LNPIKRGTLEQI 262
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 43/274 (15%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR----- 785
H NVV F G + E+ G LF RI I M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQ 113
Query: 786 ---GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 838
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L G
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCG 169
Query: 839 TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQN 892
T ++APE+L+ E DV+S G++L + +LPW + Q + N
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+I L+ +I+ +PS R + +
Sbjct: 230 PWKKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 22/257 (8%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 736
LG+ +G+G++G+V G +VAVK Q ++ KRE++ ++ RHP+++
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCLH 791
++ P + ++ E++ G LF I + E RR I A+D H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD------YCH 128
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRN 850
+VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 129 RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISG 184
Query: 851 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ + D++S GVIL+ L LP+ + + + + IP+ L+ VA ++
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATLL 242
Query: 910 WECWQTDPSLRPSFAQL 926
Q DP R + +
Sbjct: 243 MHMLQVDPLKRATIKDI 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 728
+ EDL IG G+YG V +G +AVK+ + + ++ + MR
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMR 76
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----VDEKRRIKMALDVA 784
P +V F GA+ R + I E + S + + + E+ K+ L
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ +N L I+HRD+K N+L+D++ N+K+ DFG+S ++ ++ AG +MA
Sbjct: 136 KALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMA 193
Query: 845 PEVLRNEPSNE----KCDVYSFGVILWELATLKLPWIGMNPM-----QVVGAVGFQNRRL 895
PE + S + + DV+S G+ L+ELAT + P+ N + QVV +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV--------KG 245
Query: 896 EIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 926
+ P+ + + C D S RP + +L
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-39
Identities = 57/285 (20%), Positives = 113/285 (39%), Gaps = 15/285 (5%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLD 709
S SS + + + DL +G G+ G+V+ G +AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQ-RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MR 59
Query: 710 QDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
+ + ++ + ++ P +V G ++ I E + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
+ E+ KM + + + + L ++HRD+K N+L+D+ +K+ DFG+S +
Sbjct: 120 P-IPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 829 TFLSSKSTAGTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNP-M 882
+ +AG +MAPE + + + DV+S G+ L ELAT + P+
Sbjct: 178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236
Query: 883 QVVGA-VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+V+ + + L + +C D RP + +L
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
++ ++ + + G LF I+ R E + + H++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN--G 125
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 183
Query: 853 SNEKCDVYSFGVIL 866
++ D+++ GVIL
Sbjct: 184 YSKPVDIWACGVIL 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 60/273 (21%), Positives = 115/273 (42%), Gaps = 44/273 (16%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHP 733
++G+ +G GSYG+V AVK L + K+E++++RRLRH
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 734 NVV-LF--MGAVTRPPNLSIITEFLPRGS--LF-RILHRPHCQVDEKRRIKMALDVAR-- 785
NV+ L + + ++ E+ G + + + + + A
Sbjct: 67 NVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPVCQAHGY 114
Query: 786 ------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKS 835
G+ LH+ IVH+D+K NLL+ +K+S G++ + ++
Sbjct: 115 FCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RT 170
Query: 836 TAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893
+ G+P + PE+ S K D++S GV L+ + T P+ G N ++ +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKG 228
Query: 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
IP + P ++ ++ + +P+ R S Q+
Sbjct: 229 SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 14/193 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
E +G G++ EV+ T A+K + LE E+ ++++++H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVT 70
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ + + G LF RIL R EK + V + LH +
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG-- 126
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
IVHRDLK NLL ++N + ++DFGLS+++ N + + GTP ++APEVL +P
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKPY 184
Query: 854 NEKCDVYSFGVIL 866
++ D +S GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 43/274 (15%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR----- 785
H NVV F G + E+ G LF RI I M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQ 113
Query: 786 ---GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 838
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L G
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCG 169
Query: 839 TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQN 892
T ++APE+L+ E DV+S G++L + +LPW + Q + N
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+I L+ +I+ +PS R + +
Sbjct: 230 PWKKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + G + E +REV I+R++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
NV+ ++ +I E + G LF + + + E+ + G+N LHT
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G GS+GEV T E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH--N 141
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 853 SNEKCDVYSFGVIL 866
+EKCDV+S GVIL
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 44/283 (15%)
Query: 679 VLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
V + +G GS G V + G VAVK+ L A E+K++ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVI 72
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHR-----PHCQVDEKRRIKMALDVARGMNCL 790
+ + T L I E +L + + E I + +A G+ L
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 791 HTSTPTIVHRDLKSPNLLVD-------------KNWNVKVSDFGLSRL----KHNTFLSS 833
H+ I+HRDLK N+LV +N + +SDFGL + + + +
Sbjct: 132 HSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 834 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ-- 883
+ +GT W APE+L D++S G + + + + K P+ +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 884 -VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 925
+ G + + L +I + DP RP+ +
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + L G + E +REV I+R +RHP
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ ++ +I E + G LF + + + E + + G++ LH+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS 126
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ N +K+ DFG++ ++ K+ GTPE++APE+
Sbjct: 127 KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
GE +G G + V G + A K + G + + +REV I++ ++HP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
NV+ ++ +I E + G LF + + + E+ + + G+ LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHS 132
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ +K+ DFGL+ + K+ GTPE++APE+
Sbjct: 133 LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
++ ++ + + G LF I+ R E + + H++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN--G 148
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 206
Query: 853 SNEKCDVYSFGVIL 866
++ D+++ GVIL
Sbjct: 207 YSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-37
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L E +G G++ V E A + S + +RE +I R L+HPN+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+++ + +I + + G LF I+ R + E + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM--G 130
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+VHR+LK NLL+ K VK++DFGL+ + AGTP +++PEVLR +P
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 854 NEKCDVYSFGVIL 866
+ D+++ GVIL
Sbjct: 191 GKPVDLWACGVIL 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 58/260 (22%), Positives = 103/260 (39%), Gaps = 26/260 (10%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFL-DQDFSGAALLEFKREVKIMRRL 730
+G G++G V+ A EV VK K L D L + E+ I+ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGS-LF-RILHRPHCQVDEKRRIKMALDVARGMN 788
H N++ + ++ E G LF I P I + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI--FRQLVSAVG 144
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 847
L I+HRD+K N+++ +++ +K+ DFG + + + GT E+ APEV
Sbjct: 145 YLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEV 200
Query: 848 LRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
L P + +++S GV L+ L + P+ + + V A + P + +
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYLVSKELM 252
Query: 907 RIIWECWQTDPSLRPSFAQL 926
++ Q P R + +L
Sbjct: 253 SLVSGLLQPVPERRTTLEKL 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + G E +REV I+R++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ ++ +I E + G LF + + + E+ + G+N LHT
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-36
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 625 YHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI 684
+H + NL + + S ++S T+ + + D + + + +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 685 GLGSYGEVYHADWNGT--EVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
G G+ VY GT A+K K +D+ + E+ ++ RL HPN++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-------IVRTEIGVLLRLSHPNIIKLK 114
Query: 740 GAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
P +S++ E + G LF RI+ + + E+ + + LH + IV
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG--IV 170
Query: 799 HRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
HRDLK NLL + +K++DFGLS+ ++H + K+ GTP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYG 228
Query: 855 EKCDVYSFGVIL 866
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
L E IG G + V G + AVK G + + KRE I L+HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVD--EKRRIKMALDVARGMNCLH 791
+V + + L ++ EF+ L I+ R E + + H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 792 TSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
+ I+HRD+K +L+ + + VK+ FG++ + L + GTP +MAPEV+
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 849 RNEPSNEKCDVYSFGVIL 866
+ EP + DV+ GVIL
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 31/261 (11%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ E +G GS+G+V A +VA+K D +RE+ ++ LRH
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM----RVEREISYLKLLRH 68
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGM 787
P+++ +T P ++ ++ E+ G LF I+ + DE RR I A++
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIE----- 122
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPE 846
H IVHRDLK NLL+D N NVK++DFGLS + FL K++ G+P + APE
Sbjct: 123 -YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPE 177
Query: 847 VLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
V+ + + + DV+S G++L+ + +LP+ + V + +P L P
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGA 235
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
+I DP R + ++
Sbjct: 236 QSLIRRMIVADPMQRITIQEI 256
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 32/288 (11%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+G +G G +G VY + VA+K + EV +++++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 733 --PNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 788
V+ + RP + +I E P LF I R Q + R V +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVR 163
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H ++HRD+K N+L+D N +K+ DFG L +T GT + PE
Sbjct: 164 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEW 219
Query: 848 LRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
+R V+S G++L+++ +P+ +++ ++ + +
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSECQ 271
Query: 907 RIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIPSHPDQPSSA 948
+I C PS RP+F + + L P + I H P +
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNV 735
+ + +G G + V G E A K + E E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+ + +I E+ G +F L V E I++ + G+ LH +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 795 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 850
IVH DLK N+L+ ++K+ DFG+SR + H L + GTPE++APE+L
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNY 207
Query: 851 EPSNEKCDVYSFGVIL 866
+P D+++ G+I
Sbjct: 208 DPITTATDMWNIGIIA 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK-------KFLDQDFSGAALLEFKREVKIMRRL 730
E +G G V E AVK + +EV I+R++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 731 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 788
HPN++ ++ + + +G LF + + + EK K+ + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVIC 138
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
LH IVHRDLK N+L+D + N+K++DFG S L L + GTP ++APE+
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEI 194
Query: 848 LRNEPS------NEKCDVYSFGVIL 866
+ + ++ D++S GVI+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 49/320 (15%), Positives = 101/320 (31%), Gaps = 51/320 (15%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRL 730
LV G +G A G V + A+ + K EV +R L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 731 R----------------------HPNVVLFMGAVTRPPNLSIITEFLPR-------GSLF 761
R P + ++ +++ F +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 762 RILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818
+L H + R+++ L V R + LH +VH L+ ++++D+ V ++
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253
Query: 819 DFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEK-----CDVYSFGVILWELATL 872
F + +S PE A +L + D ++ G+ ++ +
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 873 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL--TVAL 930
LP + + F++ + IP+ + L+ + + R Q T
Sbjct: 314 DLPNTDDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQAMETPEY 367
Query: 931 KPLQRLVIPSHPDQPSSALP 950
+ L+ + + P + P
Sbjct: 368 EQLRTELSAALPLYQTDGEP 387
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 49/301 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 705
+P + S + +++ +++G G+YGEV T E A+K
Sbjct: 23 TPGMFITSKKGHLSEMYQ--------------RVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 706 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RIL 764
S ++ + EV +++ L HPN++ N ++ E G LF I+
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 765 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFG 821
HR +E + V G+ LH IVHRDLK NLL+ +K+ +K+ DFG
Sbjct: 129 HRMK--FNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 822 LSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
LS + ++ + + GT ++APEVLR + +EKCDV+S GVIL+ L P+ G
Sbjct: 185 LSAVFENQKKMKER--LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
Query: 881 PMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSLRPSFAQLTVAL 930
+++ V + + + L+ +++ Q D R S Q AL
Sbjct: 242 DQEILRKV----EKGKYTFDSPEWKNVSEGAKDLIKQML----QFDSQRRISAQQ---AL 290
Query: 931 K 931
+
Sbjct: 291 E 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 60/285 (21%), Positives = 122/285 (42%), Gaps = 22/285 (7%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 735
+ +++G G VY A D +VA+K + L F+REV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V + ++ E++ +L + H + I + G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
IVHRD+K N+L+D N +K+ DFG+++ L + + GT ++ +PE + E ++
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-------ELDPLVAR 907
E D+YS G++L+E+ + P+ G + + ++ + +P ++ ++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 952
+I + D + R Q L ++ + ++ L +
Sbjct: 247 VILRATEKDKANRYKTIQ--EMKDDLSSVLHENRANEDVYELDKM 289
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-35
Identities = 76/288 (26%), Positives = 139/288 (48%), Gaps = 27/288 (9%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNV 735
LG+ +G+G++G+V + G +VAVK L++ S + + +RE++ ++ RHP++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 790
+ ++ P ++ ++ E++ G LF I E RR I +D
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD------YC 132
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLR 849
H +VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 133 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 188
Query: 850 NEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + D++S GVIL+ L LP+ + + + + P+ L+P V +
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISL 246
Query: 909 IWECWQTDPSLRPSFAQLTV---ALKPLQRLVIPSHPDQPSSALPQEI 953
+ Q DP R + + + L + + P P S+ + E
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 16/194 (8%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L IG GS+GEV A A KK K+E++IM+ L HPN++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF--KQEIEIMKSLDHPNIIR 70
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
++ ++ E G LF R++H+ E ++ DV + H
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL--N 126
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+ HRDLK N L + +K+ DFGL+ K + ++ GTP +++P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG-L 183
Query: 853 SNEKCDVYSFGVIL 866
+CD +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 731
+ + +G G+ GEV A +VA+K + F+ + E + E++I+++L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP ++ + I+ E + G LF +++ + + + + L
Sbjct: 74 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--FYQMLLAVQYL 130
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 131 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 186
Query: 847 VLRNEPS---NEKCDVYSFGVIL 866
VL + + N D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-35
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ E +G G++G V+ T K LD+ K E+ IM +L H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-------TVKNEISIMNQLHH 107
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P ++ A + +I EFL G LF RI + ++ E I G+ +H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH 166
Query: 792 TSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 848
+ IVH D+K N++ K +VK+ DFGL+ L + + K T T E+ APE++
Sbjct: 167 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIV 222
Query: 849 RNEPSNEKCDVYSFGVIL 866
EP D+++ GV+
Sbjct: 223 DREPVGFYTDMWAIGVLG 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
L IG GSYG V A A+K K + + + K EV++M++L HPN
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ + ++ E G L ++ + + + C +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 794 TPT------------------------------------IVHRDLKSPNLLV--DKNWNV 815
I HRD+K N L +K++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 816 KVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWEL 869
K+ DFGLS+ + + + AGTP ++APEVL NE KCD +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV---AR-IIWECWQTDPSLRPSFAQ 925
+P+ G+N + V N++L ++ AR ++ + R +
Sbjct: 270 LMGAVPFPGVNDADTISQV--LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 65/301 (21%), Positives = 111/301 (36%), Gaps = 42/301 (13%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLR- 731
LG +G G +G V+ + +VA+K + + + EV ++ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 732 ---HPNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARG 786
HP V+ + ++ E LP LF I + R V
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF--FGQVVAA 151
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
+ H+ +VHRD+K N+L+D + K+ DFG L H+ GT + P
Sbjct: 152 IQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPP 207
Query: 846 EVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------LEIP 898
E + V+S G++L+++ V G + F+ + L P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAELHFP 253
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 958
+ P +I C PS RPS + + L P + P PS P ++ +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEE--ILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
Query: 959 P 959
P
Sbjct: 312 P 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
+ + +GLG G+V G + A+K D + ++EV + P++
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHI 84
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
V + L II E + G LF RI R E+ ++ D+ + L
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H+ I HRD+K NLL +K+ +K++DFG ++ L ++ TP ++APEV
Sbjct: 145 HSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEV 200
Query: 848 LRNEPSNEKCDVYSFGVIL 866
L E ++ CD++S GVI+
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 45/197 (22%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ E +G G +G V+ + K K DQ K+E+ I+ RH
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARHR 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ + L +I EF+ +F RI +++E+ + V + LH+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 793 STPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 849
I H D++ N++ ++ +K+ +FG +R LK + PE+ APEV +
Sbjct: 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQ 176
Query: 850 NEPSNEKCDVYSFGVIL 866
++ + D++S G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 731
+ + +G G+ GEV A +VA++ + F+ + E + E++I+++L
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP ++ + I+ E + G LF +++ + E + + L
Sbjct: 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYL 255
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 256 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 311
Query: 847 VLRNEPS---NEKCDVYSFGVIL 866
VL + + N D +S GVIL
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 43/321 (13%), Positives = 84/321 (26%), Gaps = 60/321 (18%)
Query: 677 DLVLGERIGLGSYGEVYHA-DWN-GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 733
L L E + +G V+ D + A+K F + + S + L RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 734 NVVLFMG--------AVTRPPNLSIITEFLPRGSLFRILHR----PHCQVD--------- 772
+ + + P + + + P VD
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 773 ----------EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822
+ + R L + +VH NL + + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 823 SRLKHNTFLSSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
+ P AP + + G+ ++ + L LP+ +
Sbjct: 241 LWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 880 NP-------MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK- 931
P + G + L V +I D R + A++
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE---AMET 353
Query: 932 -PLQRLVIPSHPDQPSSALPQ 951
+L ++ SS+L
Sbjct: 354 PEFLQL-----QNEISSSLST 369
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 28/263 (10%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+ ++G G++G+V+ + +G E +K +++D S + + + E+++++ L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTS 793
N+ I+ E G L RI+ E ++ + + H+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 794 TPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 849
+VH+DLK N+L + +K+ DFGL+ K + + AGT +MAPEV +
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFK 199
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP------ 903
KCD++S GV+++ L T LP+ G + +V + E P
Sbjct: 200 -RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRPLTPQAV 256
Query: 904 -LVARIIWECWQTDPSLRPSFAQ 925
L+ +++ DP RPS AQ
Sbjct: 257 DLLKQML----TKDPERRPSAAQ 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR 731
+ IG G V G E AVK + L + +RE I+R++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 732 -HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 789
HP+++ + + + ++ + + +G LF + + + EK + + ++
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSF 215
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 848
LH + IVHRDLK N+L+D N +++SDFG S L+ L + GTP ++APE+L
Sbjct: 216 LHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEIL 271
Query: 849 RNEPS------NEKCDVYSFGVIL 866
+ ++ D+++ GVIL
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRR 729
+ E +G G +G+V+ + T ++A K D++ E K E+ +M +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMNQ 142
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 788
L H N++ A ++ ++ E++ G LF RI+ + + E I + G+
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIR 201
Query: 789 CLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 845
+H I+H DLK N+L V+++ +K+ DFGL+R K L K GTPE++AP
Sbjct: 202 HMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAP 257
Query: 846 EVLRNEPSNEKCDVYSFGVIL 866
EV+ + + D++S GVI
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 40/267 (14%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
+ IG G++G VAVK ++++ A ++ +RE+ R LRHPN+
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVK-YIERG----AAIDENVQREIINHRSLRHPNI 78
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 790
V F + P +L+II E+ G L+ RI + DE R + + M
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ-- 136
Query: 791 HTSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 847
I HRDLK N L+D + +K+ DFG S+ ++ KST GTP ++APEV
Sbjct: 137 ------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEV 188
Query: 848 LRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQN-RRLEIP 898
L + + + DV+S GV L+ + P+ Q + +V + + I
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQ 925
E L++RI DP+ R S +
Sbjct: 249 PECCHLISRIF----VADPATRISIPE 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-34
Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 27/265 (10%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G GS+GEV E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH--N 141
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-----GAVGFQNRR-LEIPKELDPLVA 906
+EKCDV+S GVIL+ L + P+ G N ++ G F + I + L+
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 907 RIIWECWQTDPSLRPSFAQLTVALK 931
+++ PSLR + Q L+
Sbjct: 259 KML----TFHPSLRITATQ---CLE 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-34
Identities = 41/240 (17%), Positives = 85/240 (35%), Gaps = 38/240 (15%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKR 722
E ++ + + + +G G++ +VY A N + +K A EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-----KPANPWEFYI 113
Query: 723 EVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKR 775
++M RL+ + F A ++ E G+L ++ P + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----------DKNWNVKVSDFGLSR 824
I A+ + + +H I+H D+K N ++ D + + + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 825 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
T ++K T + E+L N+P N + D + ++ + +
Sbjct: 232 DMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 42/298 (14%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK 705
+P V ST+ + +G GS+GEV G E AVK
Sbjct: 12 TPGMFVQHSTAIFSDRYK--------------GQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 706 KFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RI 763
+ E REV+++++L HPN++ ++ E G LF I
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDF 820
+ R E ++ V G+ +H + IVHRDLK NLL+ K+ N+++ DF
Sbjct: 118 ISRKR--FSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 821 GLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
GLS + + + K GT ++APEVL +EKCDV+S GVIL+ L + P+ G
Sbjct: 174 GLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA 230
Query: 880 NPMQVV-----GAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
N ++ G F+ + ++ + L+ +++ PS+R S AL
Sbjct: 231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML----TYVPSMRISARD---ALD 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 75/312 (24%), Positives = 125/312 (40%), Gaps = 60/312 (19%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 705
+P V K+ + + ++G G+YGEV E A+K
Sbjct: 22 NPGMYVRKKEGKIGESYF--------------KVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 706 -----------KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
D E E+ +++ L HPN++ ++TEF
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 755 LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---D 810
G LF +I++R DE + + G+ LH IVHRD+K N+L+ +
Sbjct: 128 YEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKN 183
Query: 811 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
N+K+ DFGLS + L + GT ++APEVL+ + NEKCDV+S GVI++ L
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDR--LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSL 919
P+ G N ++ V + + + + L+ ++ D +
Sbjct: 241 LCGYPPFGGQNDQDIIKKV----EKGKYYFDFNDWKNISDEAKELIKLML----TYDYNK 292
Query: 920 RPSFAQLTVALK 931
R + + AL
Sbjct: 293 RCTAEE---ALN 301
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 47/251 (18%), Positives = 91/251 (36%), Gaps = 25/251 (9%)
Query: 693 YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752
+ + + + + S + + +++ M N V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 753 EFLPRGSLF-RILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810
+ + +L + R + E + + +A + LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 811 KNWNVKVSDFGLSRLKHNTFLSSKSTA------------GTPEWMAPEVLRNEPSNEKCD 858
+ VKV DFGL GT +M+PE + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 859 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD---PLVARIIWECWQT 915
++S G+IL+EL M ++++ V R L+ P P ++ +
Sbjct: 259 IFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 916 DPSLRPSFAQL 926
P+ RP +
Sbjct: 313 SPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 64
Query: 734 NVV 736
+V
Sbjct: 65 GIV 67
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 42/308 (13%)
Query: 680 LGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 735
LGE +G G EV+ A +VAVK L D + + L F+RE + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 736 VLFMGAV--------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
V AV P I+ E++ +L I+H + KR I++ D + +
Sbjct: 75 V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMA 844
N H + I+HRD+K N+++ VKV DFG++R ++ S TA GT ++++
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--------VGAVGFQNRRLE 896
PE R + + + DVYS G +L+E+ T + P+ G +P+ V ++
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 245
Query: 897 IPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQRLVIPSHPDQPSSALPQ 951
+ +LD +V + +P R A L D ++L
Sbjct: 246 LSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLS 301
Query: 952 EISVNSTP 959
+ N +
Sbjct: 302 SAAGNLSG 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 48/327 (14%), Positives = 96/327 (29%), Gaps = 76/327 (23%)
Query: 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-- 731
LV G +G A G V + A+ + K EV +R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 732 -----------------------HPNVVLFMGAVTRPPNLSI-ITEFLPRGSLFRILH-- 765
++ LS + +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 766 ----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
H + R+++ L V R + LH +VH L+ ++++D+ V ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 822 LSRLKHNTFLSSKSTAGTPEWMAPEVL-----------RNEPSNEKCDVYSFGVILWELA 870
+ ++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 871 TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 930
LP + + F++ + IP+ + L+ + + R Q
Sbjct: 308 CADLPITKDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQ----- 356
Query: 931 KPLQRLVIPSHP------DQPSSALPQ 951
P + S+ALP
Sbjct: 357 -------AMETPEYEQLRTELSAALPL 376
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 117
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
V + L I+ E L G LF RI R E+ ++ + + L
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
H+ I HRD+K NLL N +K++DFG ++ + L + TP ++APE
Sbjct: 178 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPE 233
Query: 847 VLRNEPSNEKCDVYSFGVIL 866
VL E ++ CD++S GVI+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 16/195 (8%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV 735
+ + +G GS+ + AVK + + ++E+ ++ HPN+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPNI 68
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
V + ++ E L G LF RI + H E + + ++ +H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVG 126
Query: 795 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+VHRDLK NLL + N +K+ DFG +RLK K+ T + APE+L
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 852 PSNEKCDVYSFGVIL 866
+E CD++S GVIL
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-33
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 599 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 658
P L + + + + E G R K T + + V+
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQD 711
V +D + E +G G++G V+ T A K D++
Sbjct: 154 HVLDHYD--------------IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 712 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQ 770
++E++ M LRHP +V A + +I EF+ G LF ++ H +
Sbjct: 200 -------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNK 251
Query: 771 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LKH 827
+ E ++ V +G+ +H + VH DLK N++ K N +K+ DFGL+ L
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866
+ K T GT E+ APEV +P D++S GV+
Sbjct: 310 KQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
+ E IG+GSY E AVK + + E++I+ R +HPN++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNII 79
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ ++TE + G L +IL + E+ + + + + LH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQG- 136
Query: 796 TIVHRDLKSPNLLV----DKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 849
+VHRDLK N+L ++++ DFG ++ N L + T ++APEVL
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLE 193
Query: 850 NEPSNEKCDVYSFGVIL 866
+ + CD++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 38/291 (13%)
Query: 680 LGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRH 732
L +G G G+VY A + VA+K + + S +RE + RL+
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRER---IVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 733 PNVVLFMGAV----TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 788
P+VV + L + + L +L R + R + + + ++
Sbjct: 94 PHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALD 148
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEV 847
H + HRD+K N+LV + + DFG++ + L+ GT +MAPE
Sbjct: 149 AAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------NRRLEIPKEL 901
+ + D+Y+ +L+E T P+ G + + V+GA Q R IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 902 DPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 951
D ++AR +P R + L+ A + + D+ + L +
Sbjct: 266 DAVIAR----GMAKNPEDRYVTCGDLSAA---AHAALATADQDRATDILRR 309
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 38/234 (16%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLD 709
S DS + + + ++ + + +G G++ V E AVK
Sbjct: 2 STDSFSGRFEDVYQ-------------LQEDVLGEGAHARVQTCINLITSQEYAVKIIEK 48
Query: 710 QDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRP 767
Q + REV+++ + + H NV+ + ++ E + GS+ I R
Sbjct: 49 QPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 768 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR 824
H +E + DVA ++ LH I HRDLK N+L ++ VK+ DF L
Sbjct: 107 H--FNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
Query: 825 -LKHNTFLSSKST------AGTPEWMAPEVLRNEPS-----NEKCDVYSFGVIL 866
+K N S ST G+ E+MAPEV+ +++CD++S GVIL
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-31
Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 35/283 (12%)
Query: 680 LGERIGLGSYGEVYHA-DW--NGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
+ I G G +Y A D NG V +K + D + E + + + HP
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----AMAERQFLAEVVHP 139
Query: 734 NVVL-----FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 788
++V P I+ E++ SL R + + I L++ ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALS 196
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
LH+ +V+ DLK N+++ + +K+ D G S GTP + APE++
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPEIV 249
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
R P+ D+Y+ G L L G + V + + L+ L+ R
Sbjct: 250 RTGPT-VATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTYDSYGRLLRR- 303
Query: 909 IWECWQTDPSLRP-SFAQLTVALKPLQRLVIPSHPDQPSSALP 950
DP R + +++ L + R V+ P L
Sbjct: 304 ---AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 55/264 (20%), Positives = 110/264 (41%), Gaps = 38/264 (14%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFK------REVKI 726
ED G+ +G GS+ V E A+K +++ RE +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA-TSREYAIKIL-----EKRHIIKENKVPYVTRERDV 83
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMAL 781
M RL HP V L + G L + + + + R I AL
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GT 839
+ LH I+HRDLK N+L++++ +++++DFG +++ +++ + GT
Sbjct: 144 E------YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLE 896
++++PE+L + + + D+++ G I+++L P+ N + FQ +
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYD 250
Query: 897 IPKELDPLVARIIWECWQTDPSLR 920
P++ P ++ + D + R
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKR 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 42/199 (21%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 73
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
V + L I+ E L G LF RI R E+ ++ + + L
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H+ I HRD+K NLL N +K++DFG A E
Sbjct: 134 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170
Query: 848 LRNEPSNEKCDVYSFGVIL 866
E ++ CD++S GVI+
Sbjct: 171 TG-EKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 51/241 (21%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 735
IG G++GEV + A+K + +L+ F+ E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNC 789
A NL ++ ++ G L +L + ++ E+ + +A+D
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------S 190
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVL 848
+H VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L
Sbjct: 191 VHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 849 RNEPSNEK-----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
+ + CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 904 L 904
+
Sbjct: 309 V 309
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 61/300 (20%), Positives = 126/300 (42%), Gaps = 49/300 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPW----------EDLVLGERIGLGSYGEVYHADW 697
+ ++ S V + + W + + +G GS+G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 698 NGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMRRLRHPNVVLFMGAVTRPPNLS 749
+ A+K +++ K+ E +I++ + P +V + NL
Sbjct: 63 KESGNHYAMKIL-----DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 750 IITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDVARGMNCLHTSTPTIVHRDLKS 804
++ E++ G +F L R + R I + + LH+ +++RDLK
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLHSLD--LIYRDLKP 169
Query: 805 PNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG 863
NLL+D+ ++V+DFG + R+K T+ + GTPE +APE++ ++ N+ D ++ G
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 864 VILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWECWQTDPSLR 920
V+++E+A P+ P+Q+ ++ ++ P + ++ Q D + R
Sbjct: 226 VLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+IG GSYG V+ G VA+KKF +D AL RE++++++L+HPN+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLKHPNL 64
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 792
V + R L ++ E+ ++ L R V E K L + +N H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHK 120
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
+HRD+K N+L+ K+ +K+ DFG +RL L+ S E W +PE+
Sbjct: 121 HN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPEL 173
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
L + DV++ G + EL +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
E+IG G+YG V+ A VA+K+ LD D G AL RE+ +++ L+H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 63
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 792
V + L+++ EF + L + + +D K + L +G+ H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
++HRDLK NLL+++N +K+++FGL+R + E W P+V
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPDV 172
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLKLP 875
L + D++S G I ELA P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 48/238 (20%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 735
IG G++ EV T A+K + +L+ F+ E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTST 794
A L ++ E+ G L +L + ++ + R +A ++ ++ +H
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG 182
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
VHRD+K N+L+D+ +++++DFG +L+ + + S GTP++++PE+L+
Sbjct: 183 --YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 854 NEK-------CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
CD ++ GV +E+ + P+ + + G + L +P + +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
E++G G+YG VY A D G VA+K+ LD + G A+ RE+ +++ L HPN+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELHHPNIV 82
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 793
+ + L+++ EF+ + L ++L + + K + L RG+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH 138
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
I+HRDLK NLL++ + +K++DFGL+R + T E W AP+VL
Sbjct: 139 R--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVTLWYRAPDVL 191
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+ T K
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
E+IG G+YG VY A + G A+KK L+++ G + RE+ I++ L+H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKELKHSNIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 793
+ L ++ E L + L ++L ++ K + L G+ H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
++HRDLK NLL+++ +K++DFGL+R T E W AP+VL
Sbjct: 120 R--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDVL 172
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 740
IG G++GEV T A+K + + F E IM P VV
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNCLHTST 794
A L ++ E++P G L ++ V EK + +ALD +H+
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALD------AIHSMG 188
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+HRD+K N+L+DK+ ++K++DFG ++ + + GTP++++PEVL+++
Sbjct: 189 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 854 NEK----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+ CD +S GV L+E+ P+ + + + L P + D
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 71/316 (22%), Positives = 118/316 (37%), Gaps = 70/316 (22%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+G GSYG V G VA+KKF D A+ RE+K++++LRH N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLRHENL 86
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 792
V + + ++ EF+ ++ L +D ++ + + G+ H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHS 142
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
I+HRD+K N+LV ++ VK+ DFG +R L++ E W APE+
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVATRWYRAPEL 195
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK--LP----------------------WIGMNPM 882
L + + DV++ G ++ E+ + P N
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 883 QVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPS---------FAQLT 927
V V + PK L +V + +C DP RP F
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 928 VALKPLQRLVIPSHPD 943
A + Q L + D
Sbjct: 315 FAERFSQELQLKVQKD 330
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 61/265 (23%), Positives = 119/265 (44%), Gaps = 45/265 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVK---KFLDQDFSGAALLEFKR------EV 724
+D + +G GS+G V+ A+K K ++ K+ E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--------EIVVRLKQVEHTNDER 57
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKM 779
++ + HP ++ G + +I +++ G LF +L + + + + +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAG 838
AL+ LH+ I++RDLK N+L+DKN ++K++DFG + + T+ + G
Sbjct: 118 ALE------YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCG 165
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRL 895
TP+++APEV+ +P N+ D +SFG++++E+ P+ N M+ ++ L
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAEL 220
Query: 896 EIPKELDPLVARIIWECWQTDPSLR 920
P + V ++ D S R
Sbjct: 221 RFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 736
+++G G+Y VY T+ VA+K+ L+ + A+ REV +++ L+H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 793
+ +L+++ E+L + L + L ++ K + L RG+ H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR- 118
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
++HRDLK NLL+++ +K++DFGL+R K S + E W P++L
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRPPDIL 172
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ + D++ G I +E+AT +
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 736
E++G G+Y VY G VA+K+ LD + A+ RE+ +M+ L+H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIV 66
Query: 737 LFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
+ L+++ EF+ R K L +G+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 844
H + I+HRDLK NLL++K +K+ DFGL+R + E W A
Sbjct: 124 CHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVTLWYRA 176
Query: 845 PEVLRNEPS-NEKCDVYSFGVILWELATLK 873
P+VL + + D++S G IL E+ T K
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 21/249 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV T A KK + AL E K+ I+ ++ VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQ---ILEKVNSRFVV 247
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTP 795
A L ++ + G L ++ E R + A ++ G+ LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER- 306
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSN 854
IV+RDLK N+L+D + ++++SD GL+ H + GT +MAPEV++NE
Sbjct: 307 -IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 911
D ++ G +L+E+ + P+ V + E + P + +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVPEEYSERFSPQARSLCSQ 422
Query: 912 CWQTDPSLR 920
DP+ R
Sbjct: 423 LLCKDPAER 431
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFK---------REVKIMRRLR 731
I GSYG V D G VA+K+ + G + RE++++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 732 HPNVVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
HPN++ + ++TE + L +++H + + +
Sbjct: 88 HPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
G++ LH + +VHRDL N+L+ N ++ + DF L+R + + AP
Sbjct: 146 GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWYRAP 202
Query: 846 EVLRNEPS-NEKCDVYSFGVILWELATLK 873
E++ + D++S G ++ E+ K
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGA---ALLEFKREVKIMRRLRH 732
+ +G G + VY A VA+KK + G AL RE+K+++ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKLLQELSH 71
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNC 789
PN++ + A N+S++ +F+ L I+ + K + M L +G+
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEY 127
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 844
LH I+HRDLK NLL+D+N +K++DFGL++ S + A T + W A
Sbjct: 128 LHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVTRWYRA 180
Query: 845 PEVLRNEPS-NEKCDVYSFGVILWELATLK 873
PE+L D+++ G IL EL
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 60/246 (24%), Positives = 110/246 (44%), Gaps = 19/246 (7%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 212
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ L + E+ G LF L R E R ++ ++ LH S +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLH-SEKNV 270
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE++APEVL +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 858 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQ 914
D + GV+++E+ +LP+ + ++ F+ + P+ L P ++ +
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGPEAKSLLSGLLK 385
Query: 915 TDPSLR 920
DP R
Sbjct: 386 KDPKQR 391
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+IG G++GEV+ A G +VA+KK ++ + G AL RE+KI++ L+H NV
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLLKHENV 78
Query: 736 VLFMGAVT--------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
V + ++ ++ +F L +L + ++ + G+
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM 843
+H + I+HRD+K+ N+L+ ++ +K++DFGL+R + +S+ T W
Sbjct: 138 YYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAKNSQPNRYTNRVVTLWY 194
Query: 844 -APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
PE+L E D++ G I+ E+ T
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 42/289 (14%), Positives = 84/289 (29%), Gaps = 54/289 (18%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAA--LLEFKREVKIMRRLRHPNV 735
L G + + A D +VA+ F+D L E + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ V ++ E++ GSL + I+ +A + H +
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 855
+ + V + +V ++ +N
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANP 181
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------NRRLEIPKELDPLVA 906
+ D+ G L+ L + P + + +IP ++ + A
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 907 RIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPSHPDQPSSALPQ 951
R Q D +R + L + + + V+ + P SA P+
Sbjct: 242 R----SVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 61/250 (24%), Positives = 103/250 (41%), Gaps = 20/250 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV+ T A KK + A++E K+ I+ ++ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE-KK---ILAKVHSRFIV 248
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---DEKRRIKMALDVARGMNCLHTS 793
A +L ++ + G + ++ E R I + G+ LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I++RDLK N+L+D + NV++SD GL+ +K AGTP +MAPE+L E
Sbjct: 309 N--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIW 910
+ D ++ GV L+E+ + P+ + Q + + P + P
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFCE 425
Query: 911 ECWQTDPSLR 920
Q DP R
Sbjct: 426 ALLQKDPEKR 435
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 44/215 (20%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+ IG GS+G V+ A + EVA+KK D+ F RE++IMR ++HPNVV
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKHPNVVDLK 98
Query: 740 GAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VAR 785
+ L+++ E++P +++R K + M + + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQLLR 152
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPE--- 841
+ +H+ I HRD+K NLL+D +K+ DFG ++ +
Sbjct: 153 SLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSYICS 204
Query: 842 -WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+ APE++ + D++S G ++ EL +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 86
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 785
+ + T +L I+ E + +L +++ + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLC 138
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + AP
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 195
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLK 873
EV+ E D++S G I+ E+
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-22
Identities = 55/251 (21%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GS+G+V N T+ A+K K ++++ + +E++IM+ L HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN----EVRNVFKELQIMQGLEHPFLV 78
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ ++ + L G L L + +E ++ + ++ ++ L
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR-- 135
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-- 853
I+HRD+K N+L+D++ +V ++DF ++ L T +++ + GT +MAPE+ +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGAG 193
Query: 854 -NEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ D +S GV +EL + P+ + ++V F+ + P + ++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPSAWSQEMVSLL 251
Query: 910 WECWQTDPSLR 920
+ + +P R
Sbjct: 252 KKLLEPNPDQR 262
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G+YG V A G VA+KK F F+ L RE+KI++ +H N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENII 72
Query: 737 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVAR 785
+ RP + II E + L R++ H Q R
Sbjct: 73 TIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-------FIYQTLR 123
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 843
+ LH S ++HRDLK NLL++ N ++KV DFGL+R+ + + G M
Sbjct: 124 AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 844 --------APEVLRNEPS-NEKCDVYSFGVILWEL 869
APEV+ + DV+S G IL EL
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 34/211 (16%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
++G G+YGEVY A VA+K+ L+ + G A+ REV +++ L+H N+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKELQHRNI 95
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ + L +I E+ L + + + K + + G+N H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFCH-- 149
Query: 794 TPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 843
+ +HRDLK NLL+ + +K+ DFGL+R T E W
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWYR 204
Query: 844 APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
PE+L + D++S I E+
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 6e-22
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 679 VLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPN
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPN 79
Query: 735 VVLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA-------- 784
V+ + + + ++ L+ I+ K+ +++ +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN----VKVSDFGLSRLKHNTFLSSKSTAGTP 840
G++ LH + ++HRDLK N+LV VK++D G +RL ++ P
Sbjct: 139 DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDP 194
Query: 841 E----WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
W APE+L + D+++ G I EL T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 9e-22
Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 32/252 (12%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 69
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
A L + E+ G LF L R E+R ++ + LH+ +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRD--V 126
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRNE 851
V+RD+K NL++DK+ ++K++DFGL + TF GTPE++APEVL +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDN 180
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARI 908
D + GV+++E+ +LP+ + ++ F+ + P+ L P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSL 235
Query: 909 IWECWQTDPSLR 920
+ + DP R
Sbjct: 236 LAGLLKKDPKQR 247
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 67/250 (26%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 684 IGLGSYGEVY---HADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+G GS+G+V+ + V K L + K E I+ + HP
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR----DRVRTKMERDILVEVNHPF 87
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTS 793
+V A L +I +FL G LF L + E+ + +A ++A ++ LH+
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLA-ELALALDHLHSL 145
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I++RDLK N+L+D+ ++K++DFGLS+ + + S GT E+MAPEV+
Sbjct: 146 G--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIW 910
+ D +SFGV+++E+ T LP+ G + + +L +P+ L P ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLGMPQFLSPEAQSLLR 258
Query: 911 ECWQTDPSLR 920
++ +P+ R
Sbjct: 259 MLFKRNPANR 268
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR---HPNV 735
G G++G V G VA+KK D F RE++IM+ L HPN+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNI 81
Query: 736 V----LFMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD------ 782
V F R L+++ E++P +L R + +R++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVFL 135
Query: 783 --VARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGT 839
+ R + CLH + + HRD+K N+LV++ + +K+ DFG ++ S S
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPNV 189
Query: 840 PEWM-----APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APE++ D++S G I E+ +
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 682 ERIGLGSYGEVYHA-DWNGTE--VAVKKF-LDQDFSGA---ALLEFKREVKIMRRLR--- 731
IG G+YG+V+ A D VA+K+ + G + REV ++R L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRHLETFE 72
Query: 732 HPNVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDV 783
HPNVV + R L+++ E + + + + P + K + L
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL-- 130
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPE 841
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ T
Sbjct: 131 -RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSV 179
Query: 842 ----WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 873
W APEVL D++S G I E+ K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 4e-21
Identities = 61/248 (24%), Positives = 105/248 (42%), Gaps = 19/248 (7%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG G +GEVY T A+K + AL E + + ++ P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-RNEPSNE 855
+V+RDLK N+L+D++ +V++SD GL+ + ++ GT +MAPEVL + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
D +S G +L++L P+ ++ +E+P P + ++
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 428
Query: 913 WQTDPSLR 920
Q D + R
Sbjct: 429 LQRDVNRR 436
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-21
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 123
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 785
+ + T L ++ E + +L +++ + +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLC 175
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + AP
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 232
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLK 873
EV+ E D++S G I+ E+ K
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-21
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 41/214 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+ IG GS+G VY A +G VA+KK D+ F RE++IMR+L H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRL 112
Query: 739 MGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VA 784
L+++ +++P +++R+ + + + + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY-----SRAKQTLPVIYVKLYMYQLF 166
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR-LKHNTFLSSK-STAGTPE 841
R + +H+ I HRD+K NLL+D + +K+ DFG ++ L S +
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----R 220
Query: 842 WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+ APE++ DV+S G +L EL +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 44/214 (20%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+G G+YG V A +G +VA+KK F + F+ A RE+ +++ ++H NV
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENV 85
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 785
+ + T +L ++ F+ L +I+ Q + + +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQMLK 137
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 843
G+ +H++ +VHRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 138 GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTR 187
Query: 844 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APEV+ + N+ D++S G I+ E+ T K
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 36/215 (16%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK--REVKIMRRLR---HP 733
IG+G+YG VY A +G VA+K + G L REV ++RRL HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 734 NVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDVAR 785
NVV R ++++ E + + + P + K ++ L R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL---R 131
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPE-- 841
G++ LH + IVHRDLK N+LV VK++DFGL+R+ TP
Sbjct: 132 GLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVV 181
Query: 842 --WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 873
W APEVL D++S G I E+ K
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 35/254 (13%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIM--RR-----LR 731
+G GS+G+V+ A++ T A+KK +L M +R
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK--------DVVLMDDDVECTMVEKRVLSLAWE 76
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP + NL + E+L G L + H D R A ++ G+ LH
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 135
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 849
+ IV+RDLK N+L+DK+ ++K++DFG+ K N +K+ GTP+++APE+L
Sbjct: 136 SKG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVA 906
+ N D +SFGV+L+E+ + P+ G + ++ F P+ L+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAK 246
Query: 907 RIIWECWQTDPSLR 920
++ + + +P R
Sbjct: 247 DLLVKLFVREPEKR 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 42/259 (16%)
Query: 684 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 731
+G G YG+V+ T A+K A ++ ++ I+ ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL-----KKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCL 790
HP +V + A L +I E+L G LF L R E +A +++ + L
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLA-EISMALGHL 137
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMA 844
H I++RDLK N++++ +VK++DFGL + +TF GT E+MA
Sbjct: 138 HQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------GTIEYMA 189
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKEL 901
PE+L N D +S G +++++ T P+ G N + +L +P L
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCKLNLPPYL 244
Query: 902 DPLVARIIWECWQTDPSLR 920
++ + + + + R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 56/229 (24%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
IG GSYG VY A VA+KK F D L RE+ I+ RL+ +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDYI 87
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDV 783
+ + P +L I+ E L ++ P H + + ++
Sbjct: 88 IRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-------ILYNL 138
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------------LKHNTFL 831
G N +H S I+HRDLK N L++++ +VKV DFGL+R
Sbjct: 139 LLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 832 SSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 869
+ + APE++ + + + D++S G I EL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-20
Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 25/249 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GS+G+V A EV AVK L + + E R V +++ ++HP +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLV 102
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L + +++ G LF L R C E R A ++A + LH+
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLN-- 159
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 854
IV+RDLK N+L+D ++ ++DFGL K N +S ++ GTPE++APEVL +P +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWE 911
D + G +L+E+ P+ N ++ + N + L++ + ++
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITNSARHLLEG 272
Query: 912 CWQTDPSLR 920
Q D + R
Sbjct: 273 LLQKDRTKR 281
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ +G G+YG V A G +VA+KK F + F+ A RE+++++ +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENV 86
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 788
+ + T L ++ F+ L +++ + + RI+ + + +G+
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQMLKGLR 142
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 843
+H + I+HRDLK NL V+++ +K+ DFGL+R + T W
Sbjct: 143 YIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRWYR 192
Query: 844 APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APEV+ N + D++S G I+ E+ T K
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+G G+YG V A G VAVKK F + RE+++++ ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENV 90
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 788
+ + T +L ++T + L I+ CQ ++ + + RG+
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILRGLK 146
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW-MAPEV 847
+H++ I+HRDLK NL V+++ +K+ DFGL+R + +T W APE+
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT----RWYRAPEI 200
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
+ N N+ D++S G I+ EL T +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-19
Identities = 80/453 (17%), Positives = 166/453 (36%), Gaps = 33/453 (7%)
Query: 480 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 539
T + ++ + V R ++ + + ++ K + K
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 540 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ--L 597
+ + + I D SR+ GS S + +
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 598 NGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSST 657
+G + P E E R+K + + + + S +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 658 SKVDQIFDDDVCECEIPWEDL-VLGERIGLGSYGEVYHADWNGTE------VAVKKFLDQ 710
D++ D + L VLG+ GS+G+V ++ GT+ + K + Q
Sbjct: 333 GNRDRMKLTD-------FNFLMVLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQ 381
Query: 711 DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ 770
D + KR + + + P + L + E++ G L + + +
Sbjct: 382 DDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-R 438
Query: 771 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830
E + A ++A G+ L + I++RDLK N+++D ++K++DFG+ +
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF 890
+++K+ GTP+++APE++ +P + D ++FGV+L+E+ + P+ G + ++ F
Sbjct: 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----F 551
Query: 891 Q---NRRLEIPKELDPLVARIIWECWQTDPSLR 920
Q + PK + I P R
Sbjct: 552 QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A + N VA+KK F Q + L RE+KI+ R RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 739 MGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLH 791
+ R P + I+ + + L+++L Q I L + RG+ +H
Sbjct: 91 N-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIH 145
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-------- 843
++ ++HRDLK NLL++ ++K+ DFGL+R + ++
Sbjct: 146 SAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVATRW 196
Query: 844 --APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APE++ N + D++S G IL E+ + +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 47/217 (21%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 673 IPWE---DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D L ++G G Y EV+ A N +V VK + KRE+KI+
Sbjct: 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKIL 84
Query: 728 RRLR-HPNVVLFMGAVTRPP---NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMA 780
LR PN++ + + P +++ E + ++ + +
Sbjct: 85 ENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR----FYMYEI 139
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839
L + ++ H+ I+HRD+K N+++D ++ +++ D+GL+ H + A +
Sbjct: 140 L---KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-S 193
Query: 840 PEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLP 875
+ PE+L + + D++S G +L + K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 61/234 (26%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
IG GSYG V A VA+KK F D L RE+ I+ RL H +V
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHV 114
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDV 783
V + + P ++ ++ E ++ P H + + ++
Sbjct: 115 VKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-------LLYNL 165
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------------LK 826
G+ +H++ I+HRDLK N LV+++ +VKV DFGL+R
Sbjct: 166 LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 827 HNTFLSSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 869
++ T + APE++ + + E DV+S G I EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 42/220 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G G V+ A + VA+KK D AL RE+KI+RRL H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDHDNIVK 72
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRI----------LHRP-HCQVDEKRRIKMAL-DVAR 785
+ P + + L + L + ++ + + R
Sbjct: 73 VF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 843
G+ +H++ ++HRDLK NL ++ ++ +K+ DFGL+R +
Sbjct: 132 GLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSHKGHLS 182
Query: 844 ---------APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+P +L + + + D+++ G I E+ T K
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-19
Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 25/249 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A T AVK L D + E + + + HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRI-LSLARNHPFLT 87
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
P L + EF+ G L + + DE R A ++ + LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKG-- 144
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 854
I++RDLK N+L+D + K++DFG+ K + GTP+++APE+L+
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 911
D ++ GV+L+E+ P+ N + F+ N + P L I+
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGILKS 257
Query: 912 CWQTDPSLR 920
+P++R
Sbjct: 258 FMTKNPTMR 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 52/229 (22%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLR-HPN 734
+++G G+YG V+ + G VAVKK F + + RE+ I+ L H N
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70
Query: 735 VVLFMGAVTRPPNLS---IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARG 786
+V + V R N ++ +++ L ++ H Q + + +
Sbjct: 71 IVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQY-------VVYQLIKV 121
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------LKHNTFLSSKS 835
+ LH+ ++HRD+K N+L++ +VKV+DFGLSR + + ++++
Sbjct: 122 IKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 836 TAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+ APE+L + D++S G IL E+ K
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 60/257 (23%), Positives = 108/257 (42%), Gaps = 32/257 (12%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GSY +V T+ A+K D + E + V + HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 73
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + R + E+ + +++ +N LH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 130
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 184
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 903
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 904 LVARIIWECWQTDPSLR 920
A ++ DP R
Sbjct: 245 KAASVLKSFLNKDPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 56/253 (22%), Positives = 110/253 (43%), Gaps = 33/253 (13%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVV 736
+G GS+G+V ++ GT+ + K + QD E +++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFLT 84
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + + + E + A ++A G+ L +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG-- 141
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+++D ++K++DFG+ + TF GTP+++APE++
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAY 195
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVAR 907
+P + D ++FGV+L+E+ + P+ G + ++ FQ + PK +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVA 250
Query: 908 IIWECWQTDPSLR 920
I P R
Sbjct: 251 ICKGLMTKHPGKR 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 34/259 (13%)
Query: 684 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 731
+G G+YG+V+ + T A+K A +++ + +++ +R
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVL-----KKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 732 H-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNC 789
P +V A L +I +++ G LF L + + E +I + ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVG-EIVLALEH 174
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMAPE 846
LH I++RD+K N+L+D N +V ++DFGLS K ++ GT E+MAP+
Sbjct: 175 LHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPD 230
Query: 847 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKEL 901
++R S ++ D +S GV+++EL T P+ + + P+E+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEM 289
Query: 902 DPLVARIIWECWQTDPSLR 920
L +I DP R
Sbjct: 290 SALAKDLIQRLLMKDPKKR 308
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 61/257 (23%), Positives = 108/257 (42%), Gaps = 32/257 (12%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GSY +V T+ VKK D + E + V + HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 116
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + R + E+ + +++ +N LH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 173
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 227
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 903
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287
Query: 904 LVARIIWECWQTDPSLR 920
A ++ DP R
Sbjct: 288 KAASVLKSFLNKDPKER 304
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 77/248 (31%)
Query: 682 ERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVV-- 736
+ +G GS+G V G A+KK L QD +K RE+ IM+ L H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVL-QDPR------YKNRELDIMKVLDHVNIIKL 65
Query: 737 ------------------------------LFMGAVTRPPN------LSIITEFLPRGSL 760
+ + N L++I E++P +L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124
Query: 761 FRILHRPHCQVDEKRRIKMALD--------VARGMNCLHTSTPTIVHRDLKSPNLLVD-K 811
++L + + ++ + R + +H+ I HRD+K NLLV+ K
Sbjct: 125 HKVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSK 177
Query: 812 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRNEPS-NEKCDVYSFGVI 865
+ +K+ DFG ++ S + APE++ D++S G +
Sbjct: 178 DNTLKLCDFGSAK------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 866 LWELATLK 873
EL K
Sbjct: 232 FGELILGK 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 3e-13
Identities = 35/197 (17%), Positives = 55/197 (27%), Gaps = 48/197 (24%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK------FLDQDFSGAALLEFKREVKI 726
+P E L E+IG G +GEV+ + T VA+K L E E+ I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 727 MRRL---------RHPNVVLFMGA------------------------------VTRPPN 747
+ L R + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 807
L I+ EF G + + + I + + S HRDL N+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSI--LHQLTASLAVAEAS-LRFEHRDLHWGNV 193
Query: 808 LVDKNWNVKVSDFGLSR 824
L+ K K+ +
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 43/220 (19%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 682 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR-- 731
++G G + V+ A D N T VA+K + + + E+K+++R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---------EDEIKLLQRVNDA 75
Query: 732 ---------HPNVVLFMGAVT-RPPNLS---IITEFLPRGSLFRILHRPHCQVDEKRRIK 778
+++ + + PN ++ E L +L ++ + + +K
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 779 -MALDVARGMNCLHTSTPTIVHRDLKSPNLLVD------KNWNVKVSDFGLSRLKHNTFL 831
++ + G++ +H I+H D+K N+L++ +K++D G + +
Sbjct: 135 QISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+S T E+ +PEVL P D++S +++EL T
Sbjct: 194 NSIQT---REYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 60/233 (25%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
LG +IG GS+G++Y G EVA+K + + L E KI + ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQL--HIESKIYKMMQGGVGIP 68
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
+ V+ M G P+L LF R K +K
Sbjct: 69 TIRWCGAEGDYNVMVMELLG-----PSLE---------DLFNFCSR-------KFSLKTV 107
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 826
L +A M +H+ +HRD+K N L+ V + DFGL++ +
Sbjct: 108 LLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRHP 733
IG GS+G+V A VA+K FL+Q A +E V+++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIE----VRLLELMNKH 110
Query: 734 ------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARG 786
+V +L ++ E L +L+ +L + + + A +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 787 MNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTPE 841
+ L T +I+H DLK N+L+ K +K+ DFG S ++ S+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+ +PEVL P + D++S G IL E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 5e-10
Identities = 71/438 (16%), Positives = 123/438 (28%), Gaps = 161/438 (36%)
Query: 596 QLNGPPLVEDLSSNSKDENPKNV----E-DHEIGYHDRRKCTHDRFMGTNLKLRDLESPS 650
+ V++ + PK++ E DH I D T R T L
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLFWT---LLS--KQE 76
Query: 651 SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI---------GLGSYGEVYHADWNGTE 701
V Q F ++V + L I Y E +N +
Sbjct: 77 EMV--------QKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMR------RLR-HPNVVLF-MG---------AVTR 744
V K + R ++ LR NV++ + V
Sbjct: 125 VFAKYNV------------SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 745 PPNLSIITEFLPRGSLFRI--LHRPHCQVDEKRRIKMA-----LDVARGMNCLHTSTPTI 797
+ + + F+I L+ +C E + +D H+S +
Sbjct: 173 --SYKVQCKM-D----FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 798 VHRDLKS-----------PN-LLV-DKNWNVKVSD-FGL-------SRLKHNT-FLSSKS 835
+++ N LLV N K + F L +R K T FLS+ +
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 895
T + + + E+ +L L ++ P
Sbjct: 286 T------------THISLDHHSMTLTPD----EVKSLLLKYLDCRPQ------------- 316
Query: 896 EIPKE---LDPLVARII----------WECWQT-----------------DPS-LRPSFA 924
++P+E +P II W+ W+ +P+ R F
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
Query: 925 QLTV----ALKPLQRLVI 938
+L+V A P L +
Sbjct: 377 RLSVFPPSAHIPTILLSL 394
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 49/334 (14%), Positives = 93/334 (27%), Gaps = 63/334 (18%)
Query: 16 SNRTNETLASTTSCATDHNRTSSSSSNAAP-----PSPSASAATAASS--PAPVVS---- 64
+ T +R + + A P A PA V
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 65 --SGSRTDYMTSE--EEFQVQLAMA-----ISASSSN-PEDFSEKDQIRAATLLSLNNRR 114
SG + + ++VQ M ++ + N PE E Q + R
Sbjct: 159 LGSGKTW--VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 115 SDLG---RDKADVAAEVLSR--QYWEYN----VLD--YEERVVDGFYDIYG---LST--D 158
SD + + L R + Y VL + + F ++ L T
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NL-SCKILLTTRF 274
Query: 159 PSTQGKLPSLA--HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILV 216
L + H+ + + T D L++ C DLP +
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTL-------TPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 217 QQLADLVNGHMGGPVKDANIMLARWMERSTE-LRRSLQTSVLPIGSINIGLSRHRALLFK 275
++L+ ++ ++D W + + L +++S + + R
Sbjct: 328 RRLS-II----AESIRDGLATWDNWKHVNCDKLTTIIESS---LNVLEPAEYRKMFDRLS 379
Query: 276 VLADSIRLP----CRLVKGSHYTGVEDDAVNIIK 305
V S +P + + V + K
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 3e-06
Identities = 91/652 (13%), Positives = 163/652 (25%), Gaps = 223/652 (34%)
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
V+D +I+ EE +D I+ +KD + L + +
Sbjct: 38 VQDMPKSILSKEE-----ID-----------HIIMSKDAVSGTL--RL--FWTLLSKQEE 77
Query: 356 GAVYSKPKPLHAEGSSQNSTVDGSLPLNGG--STSEKAESL-PSFPSPSYEPGAASSGIS 412
V+ L +N + K E PS + Y I
Sbjct: 78 MV---------------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--------IE 114
Query: 413 SR-VTPNQSDYLSS---------STIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQED 462
R N + + + +L + R NV+ G
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-----------LRPAKNVLIDGV----- 158
Query: 463 SKSLFADLNPFQIKGAGKTSL------------------------HKNPTESKVEEFQS- 497
G+GKT + + N E+ +E Q
Sbjct: 159 -------------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 498 -HRINPVSGRPPIPMMRKNQHPYNEVPRKKEY----SYMEGIL-------PKINREPNNN 545
++I+P ++ + Y +L K N +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 546 ---LSTSASTSSTSENFNPHSFKPS-NDANISSKDSESRSALSGSGPSLASSTSQLNGPP 601
L T+ T + S + +++ E +S L L+ P
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----------KYLDCRP 315
Query: 602 LVEDLSSNSKDENP-------KNVEDHEIGYHDRRKCTHDRFMGTNL-KLRDLESPSSSV 653
+DL NP +++ D T D + N KL SS+
Sbjct: 316 --QDLPREVLTTNPRRLSIIAESIRDG--------LATWDNWKHVNCDKLT--TIIESSL 363
Query: 654 DSSTSKVDQ-------IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 706
+ + +F IP +L + W +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSA---HIPTI--LL----------SLI---WFDVIKSDVM 405
Query: 707 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
+ +L+E K+ + + SI E + LHR
Sbjct: 406 VVVNKLHKYSLVE-KQPKESTISI-P----------------SIYLELKVKLENEYALHR 447
Query: 767 -------PHCQVDEKRRIKMALD------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813
D I LD + H R + +D +
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----HLKNIEHPERMTLFRMVFLDFRF 502
Query: 814 -NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSF 862
K+ + N S +T ++ P + N+P E+ + F
Sbjct: 503 LEQKIRHDSTAW---NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 682 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH- 732
+ IG GS+G+V A D VA+K +F Q A E ++I+ LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEE----IRILEHLRKQ 153
Query: 733 -----PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARG 786
NV+ + T ++ + E L +L+ ++ + Q ++ A + +
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 787 MNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTPE 841
++ LH + I+H DLK N+L+ +KV DFG S +H T++ S+
Sbjct: 213 LDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------ 264
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+ APEV+ D++S G IL EL T
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 62/236 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
+G RIG GS+G ++ N +VA+K + S A L + E + + L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQL--RDEYRTYKLLAGCTGIP 69
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
NV VL + G P+L L + R K +K
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-----PSLE---------DLLDLCGR-------KFSVKTV 108
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLV----DKNWN-VKVSDFGLSRL------ 825
A+ M +H ++V+RD+K N L+ KN N + V DFG+ +
Sbjct: 109 AMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
+H + K+ +GT +M+ + + D+ + G + LPW G+
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 46/236 (19%), Positives = 86/236 (36%), Gaps = 62/236 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
+G++IG G++GE+ + VA+ K L E + ++L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAI-KLEPMKSRAPQL---HLEYRFYKQLGSGDGIP 68
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
V + + G P+L LF + R +K
Sbjct: 69 QVYYFGPCGKYNAMVLELLG-----PSLE---------DLFDLCDR-------TFSLKTV 107
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRL------ 825
L +A + +H+ +++RD+K N L+ + N + + DF L++
Sbjct: 108 LMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
KH + KS GT +M+ + + + D+ + G + LPW G+
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 60/234 (25%), Positives = 90/234 (38%), Gaps = 60/234 (25%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
LG +IG GS+GE+Y EVA+K + + L E KI R L+ P
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQL--LYESKIYRILQGGTGIP 66
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
NV VL M G P+L LF R K +K
Sbjct: 67 NVRWFGVEGDYNVLVMDLLG-----PSLE---------DLFNFCSR-------KLSLKTV 105
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 826
L +A M +H+ + +HRD+K N L+ V + DFGL++ +
Sbjct: 106 LMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 47/235 (20%), Positives = 81/235 (34%), Gaps = 44/235 (18%)
Query: 680 LGERIGLGSYGEVYHAD-WNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G IG G +G +Y AD + V + + S L E+K +R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQI 96
Query: 737 LFMGAVTRPPNLSIIT-----EFLPRGSLFRIL-----------HRPHCQVDEKRR--IK 778
+ L + G +R + +R K
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN----AKRFSRK 152
Query: 779 MALDVARGM----NCLHTSTPTIVHRDLKSPNLLVD-KNWN-VKVSDFGLSRL------- 825
L ++ + +H VH D+K+ NLL++ KN + V + D+GL+
Sbjct: 153 TVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 826 KHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
K + GT E+ + + PS + D+ G + + T LPW
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 47/236 (19%), Positives = 80/236 (33%), Gaps = 47/236 (19%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
VLG++IG G +G +Y A + A + ++ L E+K +R+ + +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLF--SELKFYQRVAKKDCI 96
Query: 737 LFMGAVTRPPNLSIIT-----EFLPRGSLFRILHRPHCQV------------DEKRR--I 777
+ L I +G +R + V +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM------VMERLGIDLQKISGQNGTFKK 150
Query: 778 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL------ 825
L + M +H + VH D+K+ NLL+ +V +D+GLS
Sbjct: 151 STVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 879
K K GT E+ + + + S + DV G + KLPW
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 47/253 (18%), Positives = 89/253 (35%), Gaps = 74/253 (29%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-----HPN- 734
+G G + V+ + VA+K + ++ A E+++++ +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSVRNSDPNDPNR 100
Query: 735 --VVLFMGAVT-RPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGM 787
VV + N + ++ E L L + + + + Q +K + V +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 788 NCLHTSTPTIVHRDLKSPNLLV-------------------------------------- 809
+ LHT I+H D+K N+L+
Sbjct: 160 DYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 810 -----------DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+ VK++D G + H F T ++ + EVL N D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT---RQYRSLEVLIGSGYNTPAD 275
Query: 859 VYSFGVILWELAT 871
++S + +ELAT
Sbjct: 276 IWSTACMAFELAT 288
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 53/235 (22%), Positives = 86/235 (36%), Gaps = 70/235 (29%)
Query: 682 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ +G G++G+V G VAVK ++ + A E ++++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA-----ARSE----IQVLEHLNT 70
Query: 733 P------NVVLFMGAVTRPPNLSIITEFLPRGSL--------FRILHRPHCQVDEKRRIK 778
V + ++ I+ E L S F H + K
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR-------K 122
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSD 819
MA + + +N LH++ + H DLK N L V N ++KV D
Sbjct: 123 MAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 820 FG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
FG H+T +S++ APEV+ ++ CDV+S G IL E
Sbjct: 181 FGSATYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 68/234 (29%)
Query: 682 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
+G G++G+V ++VA+K K+ + A LE + ++++++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA-----ARLE----INVLKKIKE 75
Query: 733 P------NVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKM 779
VL ++ I E L + + F+ PH + M
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-------HM 128
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSDF 820
A + + LH + + H DLK N L V+ KN +++V+DF
Sbjct: 129 AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 821 G---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
G H T ++++ PEV+ + CDV+S G IL+E
Sbjct: 187 GSATFDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 48/239 (20%), Positives = 89/239 (37%), Gaps = 74/239 (30%)
Query: 682 ERIGLGSYGEVYHADW---NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
++G G++G V N AVK K+ A +E I++++++
Sbjct: 41 RKMGDGTFGRVLLC-QHIDNKKYYAVKVVRNIKKYTRS-----AKIE----ADILKKIQN 90
Query: 733 -----PNVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMA 780
N+V + G ++ +I E L + + H +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK-------LYC 143
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------------KNWNV 815
+++ + +N L + + H DLK N LL D K+ +
Sbjct: 144 IEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 816 KVSDFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
K+ DFG H + ++++ + APEV+ N + D++SFG +L EL T
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 43/236 (18%), Positives = 76/236 (32%), Gaps = 44/236 (18%)
Query: 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHP 733
L + G +Y A T Q F + L+ K E +R P
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKF--SLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 734 NVVLFMGAVTRPPNLSI--ITEFLPRGSLFRIL-----------HRPHCQVDEKRR---I 777
V + P L+I F +R L +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP----KHVLSE 158
Query: 778 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL-----K 826
+ L VA + LH + VH ++ + N+ VD +V + +G + K
Sbjct: 159 RSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 827 HNTFLSSKSTA--GTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 879
H ++ + G E+++ ++ + PS + D+ S G + + LPW
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 29/162 (17%), Positives = 56/162 (34%), Gaps = 38/162 (23%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFKR 722
+G+ +G G V++ E VK D FS A+ +
Sbjct: 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153
Query: 723 EVKIMRRLRH---PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 779
E + +++L+ P V + G ++ E I + +V + ++
Sbjct: 154 EFRALQKLQGLAVPKVYAWEGNA-------VLMEL--------IDAKELYRVRVENPDEV 198
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ + + IVH DL N+LV + + + DF
Sbjct: 199 LDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 959 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.11 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 2q3z_A | 687 | Transglutaminase 2; transglutaminase 2, tissue tra | 95.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.81 | |
| 1vjj_A | 692 | Protein-glutamine glutamyltransferase E; transglut | 95.77 | |
| 1g0d_A | 695 | Protein-glutamine gamma-glutamyltransferase; tissu | 95.55 | |
| 1ex0_A | 731 | Coagulation factor XIII A chain; transglutaminase, | 94.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.02 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=484.75 Aligned_cols=252 Identities=24% Similarity=0.438 Sum_probs=222.8
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.+++|+++++||+|+||+||+|++ +++.||||++............+.+|+++|++|+|||||+++++|++++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999987 588999999988777777788899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+||+|.++|.+. ...+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999999643 446799999999999999999999999 9999999999999999999999999999775443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+... ....++..+++++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHH
Confidence 3344578999999999999999999999999999999999999999999988887776543 344567889999999999
Q ss_pred HHhhcCCCCCCCHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~ 928 (959)
+||++||.+||++.|+++
T Consensus 259 ~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=467.89 Aligned_cols=264 Identities=34% Similarity=0.573 Sum_probs=225.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
..++|..++|+++++||+|+||+||+|++++ .||||+++...........|.+|+.+|++++|||||++++++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3468899999999999999999999998765 59999988766677778899999999999999999999998865 568
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999877778999999999999999999999998 99999999999999999999999999987543
Q ss_pred C--cccCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-ccccc---cCCCC
Q 002157 829 T--FLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRR---LEIPK 899 (959)
Q Consensus 829 ~--~~~~~t~~GT~~YmAPEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~-~~~~~---~~iP~ 899 (959)
. .......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+.......+. ..... ..++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 2234567899999999999753 58999999999999999999999999877654443332 22222 24567
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.+++++.+||.+||+.||.+||++.||+..|+.++..
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 8899999999999999999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=471.85 Aligned_cols=249 Identities=21% Similarity=0.358 Sum_probs=223.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|+++++||+|+||+||+|++ +++.||||++.+... .......+.+|+++|++++|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999987 688999999976432 122356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC--
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 829 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~-- 829 (959)
||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999764 47999999999999999999999999 999999999999999999999999999976432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.. ....+|..+++++++||
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHHHH
Confidence 2334578999999999999999999999999999999999999999999998888877743 35678899999999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||++||.+||+++|++.
T Consensus 266 ~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTC
T ss_pred HHHccCCHhHCcChHHHcC
Confidence 9999999999999998743
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=465.01 Aligned_cols=260 Identities=30% Similarity=0.533 Sum_probs=229.7
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
+|..++|.+.+.||+|+||+||+|++. +..||||++... ......+|.+|+++|++++|||||+++++|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 467789999999999999999999863 567999998653 35567789999999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 002157 745 PPNLSIITEFLPRGSLFRILHRP------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~ 812 (959)
.+.++||||||++|+|.++|++. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999653 246999999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhh
Q 002157 813 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (959)
Q Consensus 813 g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~ 889 (959)
+.+||+|||+++....... ......||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543322 2334569999999999999999999999999999999998 899999999888877765
Q ss_pred ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 890 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 890 ~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
. ..++..|..+++++.+||.+||+.||.+||++.+|...|+++.+.
T Consensus 245 ~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 Q-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3 446678899999999999999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=465.07 Aligned_cols=261 Identities=33% Similarity=0.531 Sum_probs=225.2
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~ 743 (959)
.+|..++|.+.++||+|+||+||+|++. ++.||||++... ......+|.+|+++|++++|||||+++++|.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3466688999999999999999999863 578999998643 4556778999999999999999999999999
Q ss_pred cCCcEEEEEeccCCCCHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 002157 744 RPPNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k~~--------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL 809 (959)
+...++||||||++|+|.+++++.. ..+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 9999999999999999999997532 35899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHh
Q 002157 810 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 886 (959)
Q Consensus 810 d~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~ 886 (959)
+.++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+..++..
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998654332 22345679999999999999999999999999999999998 899999999888877
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 887 ~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.+. ...++..|..+++++.+||.+||+.||++||++.||+++|+.+.+.
T Consensus 272 ~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 665 3456788999999999999999999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=471.06 Aligned_cols=247 Identities=29% Similarity=0.416 Sum_probs=221.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+.|+++++||+|+||+||+|++ +|+.||||++....... ...+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999988 58899999997654322 3457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
||+||+|.+++.+ ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.........
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999999999976 36999999999999999999999999 9999999999999999999999999999876655556
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~dLI~kC 912 (959)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+.... .....+..+++++++||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999998888777664322 13344567899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTV 928 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~ 928 (959)
|++||.+||++.|+++
T Consensus 308 L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 308 LVRDPAQRATAAELLK 323 (346)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred cCCChhHCcCHHHHhc
Confidence 9999999999999976
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=462.05 Aligned_cols=259 Identities=30% Similarity=0.515 Sum_probs=228.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
+|..++++++++||+|+||+||+|++ +++.||||++.... ......+|.+|+.+|++++|||||+++|+|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 46678899999999999999999986 35689999986543 23345689999999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL 809 (959)
++.++||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 999999999999999999996432 35889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHh
Q 002157 810 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 886 (959)
Q Consensus 810 d~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~ 886 (959)
+.++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654322 23445689999999999999999999999999999999998 899999999888887
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 887 ~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
.+. ...+.+.|..++.++.+||.+||+.||.+||+|.+|++.|+.+.
T Consensus 259 ~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 259 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 765 34466788999999999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=466.83 Aligned_cols=267 Identities=27% Similarity=0.340 Sum_probs=228.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..+.|++.++||+|+||+||+|++ +|+.||||++...... .+|+.+|++++|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346799999999999999999987 5889999999865433 3799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~~~ 830 (959)
||||+||+|.++|++. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+++......
T Consensus 129 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999999765 47999999999999999999999999 99999999999999987 69999999998765321
Q ss_pred -----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-cCCCCCCcHH
Q 002157 831 -----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPL 904 (959)
Q Consensus 831 -----~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~-~~iP~~ls~e 904 (959)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.....+ ..+|..++++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1233468999999999999999999999999999999999999999988776666665443322 3578899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh-CCCCCCCCCCCCC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV-IPSHPDQPSSALP 950 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~-~p~~p~~~~~~~p 950 (959)
+++||.+||++||.+|||+.||+++|....... .-.+||.....-|
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 999999999999999999999999998776543 3456776554444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=470.84 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=216.3
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+..++|++++.||+|+||+||+|++ .++.||||++.+..........+.+|+++|++++|||||+++++|++++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 4457899999999999999999976 36789999987654333333467889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999999765 47999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 255 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQS 255 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHHHHH
Confidence 554555678999999999999999999999999999999999999999999998888877643 456788999999999
Q ss_pred HHHHHhhcCCCCCCC-----HHHHHH
Q 002157 908 IIWECWQTDPSLRPS-----FAQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPS-----a~EIL~ 928 (959)
||.+||++||.+||+ ++|+++
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999999999999998 467765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=451.28 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=205.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999987 68899999997654432 33567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||| +|+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+..... ..
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NF 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC-Cc
Confidence 999 67999998765 47999999999999999999999999 999999999999999999999999999876543 23
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
..+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKR 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 456789999999999999876 589999999999999999999999988887777664 34567788999999999999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||++||.+|||+.|+++
T Consensus 246 ~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HSCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHc
Confidence 99999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=452.86 Aligned_cols=247 Identities=31% Similarity=0.471 Sum_probs=215.9
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCcEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~~l~LV 751 (959)
|++.++||+|+||+||+|.+ ++..||||++............|.+|+++|++++|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 57889999999999999988 57789999998877777777889999999999999999999999865 3458999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999764 479999999999999999999999887899999999999997 5899999999999865433
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+... ..+...+.....+..++..+++++++||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 3346789999999999876 599999999999999999999999987554 4455555444445556778899999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||++||.+|||+.|+++
T Consensus 264 ~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=473.84 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=223.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.+.|+++++||+|+||+||+|++ +|+.||||++....... ...+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 46799999999999999999988 58899999997654322 345789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|||+||+|.+++... .+++..+..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++........
T Consensus 228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999999753 5999999999999999999999999 999999999999999999999999999987665555
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~dLI~k 911 (959)
..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+.... .....+..+++++++||.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999888777664332 2344556899999999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||++||.+||++.|++++
T Consensus 384 ~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HcCCChhHCcCHHHHhcC
Confidence 999999999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=462.46 Aligned_cols=270 Identities=31% Similarity=0.490 Sum_probs=232.5
Q ss_pred CCccccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeE
Q 002157 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVL 737 (959)
Q Consensus 666 ~~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H-pNIVk 737 (959)
.+...++|+.++|++++.||+|+||+||+|++.+ +.||||++.... .......|.+|+++|.++.| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3445688999999999999999999999998743 469999886543 34456789999999999965 99999
Q ss_pred EeeeeecC-CcEEEEEeccCCCCHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeC
Q 002157 738 FMGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801 (959)
Q Consensus 738 L~g~~~~~-~~l~LVmEy~~gGsL~dlL~k~---------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRD 801 (959)
++++|.+. ..++||||||++|+|.++|++. ...+++..++.|+.||+.||+|||+++ |||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD 210 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 210 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence 99998664 5689999999999999999642 235889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002157 802 LKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIG 878 (959)
Q Consensus 802 LKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g 878 (959)
|||+||||+.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++ |..||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654322 22345679999999999999999999999999999999998 8999998
Q ss_pred CChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 879 ~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
.+..+.+........++..|..+++++.+||.+||+.||.+|||+.+|+++|+.+.+...
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 776554444444566788899999999999999999999999999999999999877543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=430.35 Aligned_cols=256 Identities=33% Similarity=0.514 Sum_probs=204.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----cEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~----~l~LV 751 (959)
.+|.+.++||+|+||+||+|+++|+.||||++.... .....+..|+.++.+++|||||++++++.+++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999999999986542 12223345676777889999999999997654 58999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~------g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
||||++|+|.++|++. .+++..+++|+.|++.||+|||++ .++||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999764 589999999999999999999986 22499999999999999999999999999987
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhCCCCCCCCC---------------
Q 002157 826 KHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMN--------------- 880 (959)
Q Consensus 826 ~~~~~~----~~~t~~GT~~YmAPEvl~g~------~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------------- 880 (959)
...... .....+||+.|||||++.+. .++.++|||||||++|||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 644321 22346799999999999865 35779999999999999999976653221
Q ss_pred hHHHHhhhhccccccCCCCC-----CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 881 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 881 ~~ql~~~i~~~~~~~~iP~~-----ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
..++...+.....++.+|.. ....+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 12333333334445556543 335789999999999999999999999999988653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=442.23 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=213.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~------~~~ 747 (959)
++|+++++||+|+||+||+|++ +|+.||||++............+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999987 68899999998766666667788999999999999999999998753 467
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|||||||. |+|.+++.+. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 999999995 6899999765 47999999999999999999999999 9999999999999999999999999998654
Q ss_pred CC----cccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-------
Q 002157 828 NT----FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------- 895 (959)
Q Consensus 828 ~~----~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~------- 895 (959)
.. .....+.+||+.|||||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+......+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 2234568999999999999875 57999999999999999999999999988776665543211100
Q ss_pred ---------------C-------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 ---------------E-------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 ---------------~-------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. +...+++++++||.+||+.||.+|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 113568999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=430.53 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=192.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 746 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------- 746 (959)
++|++++.||+|+||+||+|++ +++.||||++.... .......+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999987 58899999987554 3445678899999999999999999999987544
Q ss_pred -----cEEEEEeccCCCCHHHHhhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 002157 747 -----NLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (959)
Q Consensus 747 -----~l~LVmEy~~gGsL~dlL~k~~~--~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiD 819 (959)
.+|||||||++|+|.+++.+... ...+..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37899999999999999976532 2455678889999999999999999 99999999999999999999999
Q ss_pred cCccccccCCc------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHh
Q 002157 820 FGLSRLKHNTF------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVG 886 (959)
Q Consensus 820 FGlAk~~~~~~------------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~ 886 (959)
||+|+...... ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+.... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99998764321 12235689999999999999999999999999999999996 78653221 2222
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 887 ~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.+. ....+..+...++.+++||.+||+.||.+||++.|+++
T Consensus 239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221 11111122344567899999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=414.89 Aligned_cols=273 Identities=64% Similarity=1.091 Sum_probs=232.7
Q ss_pred ccccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 668 ~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
...+++.+++|++.+.||+|+||+||+|+++++.||||++............+.+|+.+|++++||||+++++++.+...
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34566788999999999999999999999999999999998877777777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~--~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+++||||+++++|.+++.+... .+++..++.++.||+.||+|||++|++|+||||||+||||+.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999987542 38999999999999999999999876799999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........+|..+++++
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 65544445567899999999999999999999999999999999999999999998888777766677788899999999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~ 940 (959)
.+||.+||+.||.+||++.+|++.|+.+.+...|+
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999998766553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=449.80 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=221.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||+||+|++ +|+.||||++.... ......+.+|+++|+.++|||||+++++|.+...+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999987 68899999987653 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEecCccccccCCc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~~~~~~ 830 (959)
|||+||+|+++|.+....+++..+..|+.||+.||+|||+++ |+||||||+||||+. .+++||+|||+++.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 999999999999776668999999999999999999999999 999999999999985 489999999999987543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--~~iP~~ls~eL~dL 908 (959)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+...... ...+..+++++++|
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2334578999999999999999999999999999999999999999999988888776543322 22335789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|.+||+.||.+||++.|+++
T Consensus 391 i~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=454.47 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=213.9
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC----CHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF----SGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~----~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
..+..++|+++++||+|+||+||+|++ +|+.||||++.+... ..........++.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 456778999999999999999999987 688999999975432 12222233344666667799999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
.+.+|||||||+||+|.++|.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999999765 47999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCC
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ql~~~i~~~~~~~~iP~~ 900 (959)
..... ...+.+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+. .++...+ ......+|..
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~ 416 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDS 416 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTT
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCcc
Confidence 76543 345689999999999996 46799999999999999999999999976433 2333333 3346678899
Q ss_pred CcHHHHHHHHHHhhcCCCCCCC-----HHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPS-----FAQLTV 928 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPS-----a~EIL~ 928 (959)
+++++++||.+||++||.+|++ +.+|+.
T Consensus 417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 9999999999999999999998 688775
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=420.01 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=198.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~ 749 (959)
++|+++++||+|+||+||+|++ .++.||||++..... ...+.+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 6799999999999999999975 357899998865432 34578999999998 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk~~~~ 828 (959)
||||||++|+|.+++. .+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +++||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999994 4899999999999999999999999 9999999999999876 8999999999975433
Q ss_pred Cc----------------------------ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002157 829 TF----------------------------LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM 879 (959)
Q Consensus 829 ~~----------------------------~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~ 879 (959)
.. ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 21 112346799999999999876 5899999999999999999999999654
Q ss_pred C-hHHHHhhhhc----------------------------------------------------cccccCCCCCCcHHHH
Q 002157 880 N-PMQVVGAVGF----------------------------------------------------QNRRLEIPKELDPLVA 906 (959)
Q Consensus 880 ~-~~ql~~~i~~----------------------------------------------------~~~~~~iP~~ls~eL~ 906 (959)
. ..+.+..+.. ..........++++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3 2222211100 0001112345789999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+||.+||+.||.+|+|++|+++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=380.93 Aligned_cols=260 Identities=31% Similarity=0.604 Sum_probs=232.8
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CcE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~l 748 (959)
..+..++|++.+.||+|+||.||+|+++++.||||++............+.+|+.++++++||||+++++++.+. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 356678999999999999999999999999999999988777777778899999999999999999999999887 788
Q ss_pred EEEEeccCCCCHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~-~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++||||+++++|.+++.+... .+++..++.++.||+.||.|||+++..|+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999987779999999999999999999999999876532
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~---ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+....+....+........+|..++.+
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 23457899999999998866544 8999999999999999999999988887776666666677888899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+.+||.+||+.||.+||++.++++.|+.+.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=400.26 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=225.4
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..++|++++.||+|+||.||+|++ +++.||||++............+.+|+++|+.++||||+++++++.....+++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357899999999999999999987 788999999988777777778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++++||+|||++...... .
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence 9999999999999664 46999999999999999999999999 999999999999999999999999999866443 2
Q ss_pred cCCCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s-~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+.. ....+|..+++++.+||.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHH
Confidence 34567899999999999988865 799999999999999999999999988877776643 355678889999999999
Q ss_pred HHhhcCCCCCCCHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~ 929 (959)
+||+.||.+|||+.|++++
T Consensus 247 ~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTC
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=401.83 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=223.1
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+..++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|+.++||||++++++|.+.+.++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4567999999999999999999987 588999999875422 1223456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
|||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999999764 46899999999999999999999999 999999999999999999999999999865444
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++++||
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3445667899999999999999999999999999999999999999999888777766643 35667889999999999
Q ss_pred HHHhhcCCCCCC-----CHHHHHHH
Q 002157 910 WECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
.+||+.||.+|| ++.+|+++
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999 89999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=398.89 Aligned_cols=264 Identities=31% Similarity=0.532 Sum_probs=228.8
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEee
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g 740 (959)
+++..++|++++.||+|+||.||+|++. +..||||++... ........+.+|+.+|+++ +||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4456689999999999999999999862 346999998654 3455667899999999999 8999999999
Q ss_pred eeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC
Q 002157 741 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 805 (959)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPe 805 (959)
+|.+.+.+++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 9999999999999999999999997543 34788999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002157 806 NLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 882 (959)
Q Consensus 806 NILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ 882 (959)
||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654332 22334557889999999999999999999999999999999 99999998877
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 883 ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
++...+. .......|..++.++.+||.+||+.||.+||++.+|++.|+.+.....
T Consensus 313 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 7665553 334566788899999999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=377.59 Aligned_cols=260 Identities=31% Similarity=0.528 Sum_probs=230.5
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+.+..++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+|+.++++++||||+++++++.+...++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 556778999999999999999999988 67789999987655443 46889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999999877677999999999999999999999999 999999999999999999999999999865433
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.. ......|..++.++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQ 238 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccCCCCCcCCHHHHH
Confidence 2 22334567889999999999999999999999999999999 9999999888777766543 3455667788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
||.+||+.||.+||++.+++++|+.+.+.
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999999988653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=404.98 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=215.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
.+..++|+++++||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|+.+ +||||++++++|.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999987 578999999876432 222345678899999998 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999999764 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..++.++++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDATG 253 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence 444445677899999999999999999999999999999999999999999998888777743 456678889999999
Q ss_pred HHHHHhhcCCCCCCCH------HHHHH
Q 002157 908 IIWECWQTDPSLRPSF------AQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa------~EIL~ 928 (959)
||.+||+.||.+||++ .+|++
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 9999999999999998 77765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=375.62 Aligned_cols=258 Identities=38% Similarity=0.671 Sum_probs=216.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~--~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++..++|++.+.||+|+||.||+|++.++.||||++...... ......+.+|+.+++.++||||+++++++.+...++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999988654322 223467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEeeCCCCCcEEEcC--------CCcEEEEec
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDF 820 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~-~IIHRDLKPeNILLd~--------~g~VKLiDF 820 (959)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||++|. +|+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999965 468999999999999999999999874 3889999999999986 788999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
|+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+........++..
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9998654432 23467999999999999999999999999999999999999999998887777666666667778889
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
++.++.+||.+||+.||.+||++.+++++|+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=387.85 Aligned_cols=263 Identities=33% Similarity=0.495 Sum_probs=222.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+..++|+++++||+|+||+||+|++ +++.||||++... .......+.+|+.++++++||||+++++++.++..+++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4557899999999999999999987 4888999987543 45667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999876678999999999999999999999999 9999999999999999999999999998654332
Q ss_pred cc--------------CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhh-hhcccccc
Q 002157 831 LS--------------SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA-VGFQNRRL 895 (959)
Q Consensus 831 ~~--------------~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~-i~~~~~~~ 895 (959)
.. ....+||+.|+|||++.+..++.++||||||+++|+|++|..||........... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 1256799999999999999999999999999999999999999876443211100 00011123
Q ss_pred CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 896 ~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
..|..+++++.+||.+||+.||.+||++.+|++.|+.+......
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 45678889999999999999999999999999999999775543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=389.21 Aligned_cols=264 Identities=31% Similarity=0.479 Sum_probs=228.8
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
.++..++|++.+.||+|+||.||+|++. +..||||++... ........+.+|+.+|++++||||+++++++.+.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3466689999999999999999999872 345999998654 3455667899999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..++|||||+++++|.+++......+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999999877678999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. ......+..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCCCCCCCCc
Confidence 643321 1223446778999999999999999999999999999999 9999999888877766543 3456677889
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
+.++.+||.+||..||.+||++.+|++.|+.+.+...
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 9999999999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=384.85 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=219.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||+||+|.+ +++.||||++....... ...+.+|+.++++++||||++++++|...+.+++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999976 68899999987654332 356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+.+++|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999764 5899999999999999999999999 999999999999999999999999999877655445
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~-~~~~~~iP~~ls~eL~dLI~k 911 (959)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. .......+..++..+++||.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 5567899999999999999999999999999999999999999999887665544432 223445677899999999999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||+.||.+||++.++++
T Consensus 253 ~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HccCChhHCcCHHHHhh
Confidence 99999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=393.15 Aligned_cols=268 Identities=31% Similarity=0.497 Sum_probs=228.9
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
....+++..++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|++++.++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4456778889999999999999999999984 34689999986543 344567789999999999 79999999
Q ss_pred eeeeecCCc-EEEEEeccCCCCHHHHhhCCCC------------------------------------------------
Q 002157 739 MGAVTRPPN-LSIITEFLPRGSLFRILHRPHC------------------------------------------------ 769 (959)
Q Consensus 739 ~g~~~~~~~-l~LVmEy~~gGsL~dlL~k~~~------------------------------------------------ 769 (959)
++++.+.+. +++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887654 8999999999999999976432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002157 770 -----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (959)
Q Consensus 770 -----------------~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-- 830 (959)
.+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1889999999999999999999999 9999999999999999999999999998653321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............|..+++++.+||
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 22344568899999999999999999999999999999998 99999987765554444445556778888999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 910 WECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
.+||+.||.+||++.+|+++|+.+.+..
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=374.34 Aligned_cols=259 Identities=33% Similarity=0.584 Sum_probs=227.0
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+++..++|++.+.||+|+||.||+|++. +..||||++....... .++.+|+.++++++||||+++++++.+...++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 4566789999999999999999999885 4579999987655433 46889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999776557999999999999999999999999 999999999999999999999999999865443
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......|...+.++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22334556778999999999889999999999999999998 999999988877665554 33455667788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
||.+||+.||.+||++.+|++.|+.+.+
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=386.41 Aligned_cols=264 Identities=29% Similarity=0.472 Sum_probs=227.9
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~ 742 (959)
.+++..++|++++.||+|+||.||+|++.+ +.||||++.... .......+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345677899999999999999999998753 789999987543 445567899999999999999999999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~~-----------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIH 799 (959)
.+...+++||||+++++|.+++.+.. ..+++..++.|+.||+.||.|||++| |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 99999999999999999999997532 46899999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002157 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 876 (959)
Q Consensus 800 RDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF 876 (959)
|||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999998654322 22334568899999999999999999999999999999998 99999
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 877 ~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
.+....+....+.. .....+|..++.++.+||.+||+.||.+||++.+|++.|+++....
T Consensus 278 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 99888777665543 3445677889999999999999999999999999999999886543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.18 Aligned_cols=261 Identities=31% Similarity=0.507 Sum_probs=226.2
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+++..++|++++.||+|+||.||++++. +..||||++....... .++.+|++++++++||||+++++++.+...
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 345677889999999999999999999885 4579999987655443 468899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999875567999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 828 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......|..++..+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHH
Confidence 322 22334557888999999999999999999999999999998 999999988877766654 334556677889999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+||.+||+.||.+||++.++++.|+.+..
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.63 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=210.9
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH------------------------HHHHHHHHHHHHH
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKIM 727 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~------------------------~~~~ef~~Ei~IL 727 (959)
..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999987 57889999987654221 1235688999999
Q ss_pred HHcCCCceeEEeeeeec--CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC
Q 002157 728 RRLRHPNVVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 805 (959)
Q Consensus 728 ~~L~HpNIVkL~g~~~~--~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPe 805 (959)
++++||||+++++++.+ ...+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 99999999999999986 5679999999999999987654 46999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 002157 806 NLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM 882 (959)
Q Consensus 806 NILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ 882 (959)
||||+.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987654433344578999999999998765 378999999999999999999999988877
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 883 ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....+............++.++++||.+||+.||.+||++.+|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6666554433333344578999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=381.81 Aligned_cols=253 Identities=25% Similarity=0.307 Sum_probs=211.1
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
--.++|++++.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3458899999999999999999988 678999999876554444567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++ +|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 999974 898888877677999999999999999999999999 99999999999999999999999999987655444
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc----------------
Q 002157 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------------- 894 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~---------------- 894 (959)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 4455689999999999987 56899999999999999999999999887665444332110000
Q ss_pred ------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 ------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+...+++++++||.+||+.||.+||++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0112346789999999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=397.92 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=220.2
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 745 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~ 745 (959)
...+..++|++++.||+|+||+||+|++. ++.||||++.+... .......+.+|+.+|..+ +||||++++++|.+.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 34567789999999999999999999984 57899999876432 112345678899999988 899999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999999999764 36899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..++.++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA 248 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHH
Confidence 54443445678899999999999999999999999999999999999999999988887777643 3566788999999
Q ss_pred HHHHHHHhhcCCCCCCC-----HHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPS-----FAQLTVA 929 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPS-----a~EIL~~ 929 (959)
++||.+||+.||.+||+ +.+|+.+
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999995 5777654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=391.17 Aligned_cols=267 Identities=31% Similarity=0.531 Sum_probs=232.8
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
..+++..++|++++.||+|+||.||+|++. +..||||++... ........+.+|+++++++ +|||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 345677889999999999999999999862 246999998654 3455667889999999999 99999999
Q ss_pred eeeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 002157 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (959)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLK 803 (959)
++++...+.+++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||++| |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 999999999999999999999999997543 35899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002157 804 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (959)
Q Consensus 804 PeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 880 (959)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998664332 22334557889999999999999999999999999999999 999999988
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 881 ~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
..++...+. .......+..++.++.+||.+||+.||.+||++.+|++.|+.+......
T Consensus 299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 877766554 3446667788999999999999999999999999999999999776544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.06 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=210.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~--~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
++..++|++++.||+|+||.||++++ +++.||||++...... ......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 45568899999999999999999986 5788999998765432 2234567889999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
.+.++|||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999764 36889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ....+|..++.+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHH
Confidence 654433344567899999999999999999999999999999999999999999888777666543 355678889999
Q ss_pred HHHHHHHHhhcCCCCCC-----CHHHHHH
Q 002157 905 VARIIWECWQTDPSLRP-----SFAQLTV 928 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRP-----Sa~EIL~ 928 (959)
+++||.+||+.||.+|| ++.+++.
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99999999999999999 7888876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=388.73 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=219.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+..++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+++.++||||+++++++.+...++
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3457899999999999999999987 5889999998754221 122456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999999764 46899999999999999999999999 999999999999999999999999999875432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ....+|..++.++++||
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 234 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence 3457899999999999999999999999999999999999999999888777766643 34667889999999999
Q ss_pred HHHhhcCCCCCC-----CHHHHHH
Q 002157 910 WECWQTDPSLRP-----SFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRP-----Sa~EIL~ 928 (959)
.+||+.||.+|| ++++|+.
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhc
Confidence 999999999999 8888885
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=397.71 Aligned_cols=263 Identities=31% Similarity=0.544 Sum_probs=229.8
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
.+++..++|++++.||+|+||.||+|++ +++.||||++... ........+.+|+++|++++||||+++++++.....
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4567778999999999999999999998 5889999988644 344455678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++|||||+++|+|.+++.+.+..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999876667999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccC--CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 828 NTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 828 ~~~~~~--~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
...... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..++.+
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 332211 12235678999999998889999999999999999998 999999988776665543 34466778889999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
+.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=390.49 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=217.3
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
+..++|++++.||+|+||.||+|++ +++.||||++.+... .......+.+|+.+++++ +||||++++++|.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567899999999999999999987 478899999987644 344566788999999998 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999999764 36899999999999999999999999 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHhhhhccccccCCCC
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---------NPMQVVGAVGFQNRRLEIPK 899 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~---------~~~ql~~~i~~~~~~~~iP~ 899 (959)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ......+|.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCC
Confidence 334455678999999999999999999999999999999999999999752 222233333 234566788
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCH------HHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSF------AQLTV 928 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa------~EIL~ 928 (959)
.++.++++||.+||+.||.+||++ .+++.
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 999999999999999999999985 56654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.33 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=211.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999988 57889999998776666666788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9975 666666555567999999999999999999999999 9999999999999999999999999998776554445
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHhhhhcc--------------------
Q 002157 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQ-------------------- 891 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF-~g~~~~ql~~~i~~~-------------------- 891 (959)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+.......+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5678999999999998766 899999999999999999888774 554444433332110
Q ss_pred -------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 892 -------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 892 -------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.........++.++++||.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0011122357899999999999999999999999976
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=397.80 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=219.3
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~ 746 (959)
..+..++|++.+.||+|+||+||+|++ +++.||||++.+... .......+.+|+.++..+ +||||++++++|.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999987 578899999876421 112345677899999987 9999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999999764 36899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..++.+++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAK 246 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHH
Confidence 4333445678899999999999999999999999999999999999999999988887777643 35567888999999
Q ss_pred HHHHHHhhcCCCCCCCHH-HHH
Q 002157 907 RIIWECWQTDPSLRPSFA-QLT 927 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~-EIL 927 (959)
+||.+||+.||.+||++. +|+
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHhcCCHhHcCCChHHHH
Confidence 999999999999999997 665
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=376.96 Aligned_cols=263 Identities=31% Similarity=0.541 Sum_probs=228.4
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~ 741 (959)
..+++..++|++.+.||+|+||.||+|++ .+..||||++.... .......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 45567788999999999999999999976 23679999886543 45566788999999999999999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIV 798 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~-----------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~II 798 (959)
+.+.+.+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 999999999999999999999997532 24889999999999999999999999 99
Q ss_pred eeCCCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 002157 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 875 (959)
Q Consensus 799 HRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~P 875 (959)
||||||+||||+.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654322 12334557889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 876 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 876 F~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
|.+.....+...+. .......+..++.++.+||.+||+.||.+||++.+|++.|+++..
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 253 YPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp STTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99988776665553 334566778899999999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=368.00 Aligned_cols=260 Identities=32% Similarity=0.534 Sum_probs=228.7
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+.+..++|++.+.||+|+||.||++++ ++..||||++....... ..+.+|+.++++++||||+++++++.+.+.++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456678999999999999999999988 67789999987655433 46889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999876667899999999999999999999999 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 830 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 830 ~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.. ......|..++.++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHHHH
Confidence 1 22234567889999999999999999999999999999999 8999999888777666543 3345567788999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
||.+||+.||.+||++.++++.|+.+.+.
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.28 Aligned_cols=264 Identities=30% Similarity=0.420 Sum_probs=223.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+++..++|++++.||+|+||.||+|++ .+..||||++.... .......+.+|+.+|+++ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4677889999999999999999999986 34579999987542 233456788999999999 89999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPHC----------------------QVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~~----------------------~lse~~~l~Ia~QIa~AL~yLHs~g~~IIH 799 (959)
+...+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 9999999999999999999999976532 3788999999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002157 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 876 (959)
Q Consensus 800 RDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF 876 (959)
|||||+||||+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986543221 1234457889999999999999999999999999999998 99999
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 877 ~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.+...................|..++.++.+||.+||..||.+||++.+|+++|+.+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 887765544444444556667788999999999999999999999999999999987553
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=377.86 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=208.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
++|++++.||+|+||.||+|++ .++.||||++............+.+|+.++++++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999987 488999999876544333345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 999999876678999999999999999999999999 99999999999999999999999999987654433344
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------------------
Q 002157 835 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------------- 893 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-------------------- 893 (959)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 56799999999999764 589999999999999999999999998876554433211000
Q ss_pred -------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 -------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 -------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
...+...++.++++||.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00122457899999999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=390.90 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=220.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999987 57899999998877766677789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~---g~VKLiDFGlAk~~~~~~ 830 (959)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 99999999999764 46899999999999999999999999 9999999999999764 45999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dL 908 (959)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+.........+ ..+++++++|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23345789999999999999999999999999999999999999999988877776664433322222 4679999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+||++.+++++
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=372.09 Aligned_cols=256 Identities=32% Similarity=0.588 Sum_probs=219.1
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHH-----HHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAAL-----LEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~-----~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+..++|++.+.||+|+||.||+|++ +++.||||++.......... ..+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4558899999999999999999988 68899999987644322211 5788999999999999999999999765
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-----EEEEec
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDF 820 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~-----VKLiDF 820 (959)
. ++||||+++++|.+++.+....+++..++.++.||+.||+|||++|.+|+||||||+||||+.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 699999999999999987777899999999999999999999998766999999999999988776 999999
Q ss_pred CccccccCCcccCCCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HhhhhccccccC
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRLE 896 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl~--g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql--~~~i~~~~~~~~ 896 (959)
|+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||........ ...+........
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999855432 33567999999999994 45578999999999999999999999987654433 334444555667
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
++..+++++.+||.+||+.||.+||++.+|++.|+++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 8889999999999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=386.99 Aligned_cols=265 Identities=30% Similarity=0.390 Sum_probs=216.9
Q ss_pred CCccccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 666 ~~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
....++.+..++|+++++||+|+||+||+|++.++.||||++.... .....+.+|+.+|++++|||||++++++...
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 3445566788899999999999999999999999999999986542 3344566799999999999999999999875
Q ss_pred Cc----EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCEEeeCCCCCcEEEcC
Q 002157 746 PN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS----------TPTIVHRDLKSPNLLVDK 811 (959)
Q Consensus 746 ~~----l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~----------g~~IIHRDLKPeNILLd~ 811 (959)
.. +++||||+++|+|.+++.+. .+++..++.++.||+.||.|||+. + |+||||||+||||+.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKN 166 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECT
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECC
Confidence 43 79999999999999999764 589999999999999999999998 7 999999999999999
Q ss_pred CCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCh---
Q 002157 812 NWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNP--- 881 (959)
Q Consensus 812 ~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~-----~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--- 881 (959)
++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 99999999999986543322 23346799999999999874 356688999999999999999999976432
Q ss_pred -------------HHHHhhhhccccccCCCC-----CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 882 -------------MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 882 -------------~ql~~~i~~~~~~~~iP~-----~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
......+........++. ..+.++.+||.+||+.||.+||++.+|++.|+.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 122222222222333322 23456999999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.30 Aligned_cols=270 Identities=28% Similarity=0.483 Sum_probs=213.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~ 743 (959)
....+..++|++++.||+|+||.||+|++.. ..||||++............+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 4456777899999999999999999998632 27999998776555566788999999999999999999999998
Q ss_pred cCCcE------EEEEeccCCCCHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 002157 744 RPPNL------SIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (959)
Q Consensus 744 ~~~~l------~LVmEy~~gGsL~dlL~k~-----~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~ 812 (959)
..... ++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 77665 9999999999999998532 225899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhh
Q 002157 813 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (959)
Q Consensus 813 g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~ 889 (959)
+.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999999998654322 11223457789999999999999999999999999999999 999999988877766554
Q ss_pred ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCC
Q 002157 890 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 941 (959)
Q Consensus 890 ~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~ 941 (959)
.......+..++.++.+||.+||+.||.+||++.++++.|+.+....+-..
T Consensus 254 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 254 -GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 334566778899999999999999999999999999999999977555433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=391.65 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=217.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++||||++++++|.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 6799999999999999999987 58899999998654322 13467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecCcccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g----~VKLiDFGlAk~ 825 (959)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ ++||+|||+++.
T Consensus 92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999999764 47999999999999999999999999 99999999999998776 799999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~ 903 (959)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ..+..++.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 6543 23445789999999999999999999999999999999999999999988887776664332211 12357889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++++||.+||..||.+||++.++++
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.50 Aligned_cols=261 Identities=30% Similarity=0.512 Sum_probs=215.3
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
.+++..++|++++.||+|+||.||+|.+. +..||||++... ........+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 35667789999999999999999999873 346999987643 23455678899999999999999999999985
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
++.+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence 46789999999999999999876667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 002157 825 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (959)
Q Consensus 825 ~~~~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls 902 (959)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.. .....++..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~ 243 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CCCCCCCCCCC
Confidence 7644321 2233457789999999999999999999999999999996 9999998887776665543 33556778899
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+++.+||.+||..||.+||++.+|++.|+.+.+
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999998865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=376.25 Aligned_cols=264 Identities=29% Similarity=0.438 Sum_probs=226.9
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+++..++|++++.||+|+||.||+|++ .++.||||++.... .......+.+|+.+++++ +||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 4567778999999999999999999985 35689999987543 334567789999999999 99999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPHC-----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~~-----------------~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
+...+.+++||||+++|+|.+++.+... .+++..++.++.||+.||.|||++| |+||||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 173 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 9999999999999999999999975432 4899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
+||||+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999987654322 1234457889999999999999999999999999999998 9999988765
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
................+..++.++.+||.+||+.||.+||++.+|++.|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5444443334445566778999999999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=399.43 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=213.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
.+..++|+++++||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+|.++ +|||||+++++|.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45668999999999999999999987 5778999999875443 23345678899999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++|||||+++|+|..++.+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999999764 47999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHhhhhccccccCCC
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------PMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---------~~ql~~~i~~~~~~~~iP 898 (959)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ......+|
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCC
Confidence 44445567889999999999999999999999999999999999999996432 12233333 34466788
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSF 923 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa 923 (959)
..++.++++||.+||+.||.+||++
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 8999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=380.05 Aligned_cols=272 Identities=30% Similarity=0.510 Sum_probs=230.5
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
..+++..++|++++.||+|+||.||+|++. +..||||++.... .......+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 445677789999999999999999999863 4679999986543 445567889999999999 89999999
Q ss_pred eeeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 002157 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (959)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLK 803 (959)
++++.+.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+|||||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 999999999999999999999999997643 24889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002157 804 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (959)
Q Consensus 804 PeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 880 (959)
|+||||+.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999998654432 12234457889999999999889999999999999999999 999999988
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCC
Q 002157 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 944 (959)
Q Consensus 881 ~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~ 944 (959)
..++...+. .......+..++.++++||.+||+.||.+||++.+|++.|+.+...........
T Consensus 265 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~ 327 (334)
T 2pvf_A 265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327 (334)
T ss_dssp HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred HHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccC
Confidence 777665553 333556778899999999999999999999999999999999988766544333
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=402.33 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=221.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||.||+|.+ +++.||+|++............+.+|+.+|++++|||||++++++.+.+.+++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 68899999998877666667789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlAk~~~~~~ 830 (959)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++......
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999998765 46999999999999999999999999 99999999999998 56889999999998776554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dL 908 (959)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++++++|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 44556789999999999999999999999999999999999999999988887777765443333222 4789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+||++.|++++
T Consensus 248 i~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=374.16 Aligned_cols=263 Identities=36% Similarity=0.627 Sum_probs=212.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
...++..++|++.++||+|+||.||+|++.+ .||||++............+.+|+.+|++++||||+++++++ ....+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 3457788999999999999999999998765 599999987766777778899999999999999999999965 45678
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999976542
Q ss_pred C--cccCCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-hcccc---ccCCCC
Q 002157 829 T--FLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNR---RLEIPK 899 (959)
Q Consensus 829 ~--~~~~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i-~~~~~---~~~iP~ 899 (959)
. ........||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.......... ..... ....+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 1 12223457999999999997 566889999999999999999999999886654433222 21111 122345
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+++++++||.+||+.||.+||++.+|++.|+.+.+
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 788999999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=374.64 Aligned_cols=261 Identities=22% Similarity=0.352 Sum_probs=219.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++++.||+|+||.||+|++ .++.||||++.... ........+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 47899999999999999999987 57899999986543 3455667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~- 830 (959)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999999764 37899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---ccCCCCCCcHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---RLEIPKELDPLVAR 907 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~---~~~iP~~ls~eL~d 907 (959)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+............... ....+..++..+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 223446799999999999999999999999999999999999999999887655433322211 12345678999999
Q ss_pred HHHHHhhcCCCCCC-CHHHHHHHHHhhhhhhC
Q 002157 908 IIWECWQTDPSLRP-SFAQLTVALKPLQRLVI 938 (959)
Q Consensus 908 LI~kCL~~DP~kRP-Sa~EIL~~Le~l~kl~~ 938 (959)
+|.+||..||.+|| ++.++.+.|+.+.....
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 99999999999998 89999999987765443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=375.89 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=216.7
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~- 744 (959)
++..++|++++.||+|+||.||+|++ +++.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 45567899999999999999999984 5788999998644 34556788999999999999999999999854
Q ss_pred -CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 745 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 745 -~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
...+++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999876667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HH
Q 002157 824 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VV 885 (959)
Q Consensus 824 k~~~~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---------------l~ 885 (959)
+...... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 8764332 11233457778999999999999999999999999999999999986532210 01
Q ss_pred hhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 886 ~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
............|..++.++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111123445667888999999999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=399.67 Aligned_cols=259 Identities=32% Similarity=0.569 Sum_probs=226.4
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-c
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-N 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~-~ 747 (959)
..+++..++|++.+.||+|+||.||+|+++++.||||++.... ....+.+|+.+|++++|||||++++++.+.. .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 3467788999999999999999999999999999999987653 2357889999999999999999999987665 7
Q ss_pred EEEEEeccCCCCHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~-~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++|||||+++|+|.+++.+.+. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999976543 3789999999999999999999999 999999999999999999999999999854
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..+++++
T Consensus 340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 415 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 332 223467889999999999999999999999999999998 999999988776666554 344667888999999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999887643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=368.35 Aligned_cols=262 Identities=17% Similarity=0.240 Sum_probs=220.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~ 749 (959)
+..++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.+ +|+||+++++++.....++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 3447899999999999999999985 7889999998754332 2467899999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-----EEEEecCccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSR 824 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~-----VKLiDFGlAk 824 (959)
+||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|||+++
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999999 99999999876667999999999999999999999998 999999999999987776 9999999998
Q ss_pred cccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccc--
Q 002157 825 LKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQN-- 892 (959)
Q Consensus 825 ~~~~~~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ql~~~i~~~~-- 892 (959)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+... .+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654321 23456799999999999999999999999999999999999999988542 23332222111
Q ss_pred -cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCC
Q 002157 893 -RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 941 (959)
Q Consensus 893 -~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~ 941 (959)
........++.++.+||.+||+.||.+||++.+|++.|+.+.+......
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 1122334789999999999999999999999999999999987665533
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=383.21 Aligned_cols=249 Identities=18% Similarity=0.304 Sum_probs=217.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||.||+|++ +++.||+|++... ......+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 37899999999999999999987 5788999988643 234556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEecCccccccCCc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~~~~~~ 830 (959)
||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999876667999999999999999999999999 999999999999987 7899999999998764432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--CCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~--iP~~ls~eL~dL 908 (959)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ .+..++.++++|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 23346799999999999999899999999999999999999999999888777766543322211 124689999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||..||.+||++.|++++
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.30 Aligned_cols=264 Identities=31% Similarity=0.551 Sum_probs=225.8
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+++..++|++++.||+|+||.||+|++. +..||||++...... ...+.+|++++++++||||+++++++.. +.+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 46677789999999999999999999885 458999998765433 3568899999999999999999999874 568
Q ss_pred EEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999997532 26899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 828 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHHH
Confidence 4322 2234557889999999998889999999999999999999 999999988777666554 233455677899999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~ 940 (959)
.+||.+||..||.+||++.+|++.|+.+......+
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 99999999999999999999999999987765443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=396.21 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=211.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHH-HHHcCCCceeEEeeeeecCCcE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~I-L~~L~HpNIVkL~g~~~~~~~l 748 (959)
+..++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|..+ ++.++||||++++++|.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 4457899999999999999999988 5678999999876543 2334556677776 4668999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999764 36889999999999999999999999 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....++..++.++++|
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHL 269 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHHH
Confidence 44455678899999999999999999999999999999999999999999888887776643 3566788899999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|.+||+.||.+||++.+.+.
T Consensus 270 i~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHH
T ss_pred HHHHcccCHHhCCCCCCCHH
Confidence 99999999999999754333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=391.85 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=225.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
++..++|++++.||+|+||+||+|++ .+..||||++... ........+.+|+.++++++|||||++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 45668899999999999999999985 3457999998643 344556678899999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cE
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NV 815 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g---~V 815 (959)
....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999996432 35889999999999999999999999 99999999999999555 59
Q ss_pred EEEecCccccccCC--cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 002157 816 KVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 816 KLiDFGlAk~~~~~--~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~ 892 (959)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999999854322 122334568999999999999999999999999999999998 999999988887776654 33
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.....+..++.++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 45666788999999999999999999999999999999988663
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.40 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=220.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 37899999999999999999987 5789999999887777777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~---VKLiDFGlAk~~~~~ 829 (959)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999988654 46899999999999999999999999 999999999999986655 999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC--CCCCcHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVAR 907 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~i--P~~ls~eL~d 907 (959)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......... ...+++++++
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred -ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2334567999999999999999999999999999999999999999998887776665443333222 2478999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~ 928 (959)
||.+||+.||.+||++.++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=390.50 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=220.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
...++|++++.||+|+||.||+|++ +++.||||++.+.... ......+.+|+++|+.++||||+++++++.+...++
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4557899999999999999999987 5889999998754321 123456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999764 36899999999999999999999999 999999999999999999999999999876433
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+... ...+|..++.++++||
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 34578999999999999999999999999999999999999999999888877766433 5667889999999999
Q ss_pred HHHhhcCCCCCCC-----HHHHHH
Q 002157 910 WECWQTDPSLRPS-----FAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPS-----a~EIL~ 928 (959)
.+||+.||.+||+ +.+|+.
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhcCHHhccCCccCCHHHHHh
Confidence 9999999999998 888875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=367.41 Aligned_cols=262 Identities=25% Similarity=0.447 Sum_probs=227.1
Q ss_pred cCcCCCCeeEEe-EeeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k-~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+.+..++|.+.+ .||+|+||.||+|.+ ++..||||++... ........+.+|+.++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 456667888887 999999999999975 4677999998754 3445667899999999999999999999999 45
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceee
Confidence 6789999999999999999876677999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
..... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+. ......+|..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCc
Confidence 64321 11233457889999999998889999999999999999998 999999988777665554 33456678899
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
++++.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999986643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=392.79 Aligned_cols=261 Identities=30% Similarity=0.527 Sum_probs=216.6
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
++..++|++.+.||+|+||.||+|++. +..||||++... ........+.+|+.+|++++||||+++++++.+..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 455678999999999999999999763 567999998654 34556678999999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++|||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999887778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 002157 827 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (959)
Q Consensus 827 ~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls 902 (959)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. .......+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 43321 1222345778999999999999999999999999999997 999999988877766554 333455677899
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999998664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.56 Aligned_cols=265 Identities=31% Similarity=0.543 Sum_probs=224.6
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CC---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE-EE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL-SI 750 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g---~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l-~L 750 (959)
.|.+.++||+|+||.||+|++ ++ ..||||++... ........+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 467789999999999999986 22 26999987643 3345567889999999999999999999999876665 99
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+.+++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999887778999999999999999999999999 9999999999999999999999999998654321
Q ss_pred ----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 831 ----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 831 ----~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
.......+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+.......+. .......+..++.++
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 223345688999999999999999999999999999999995 55566666655554443 344566778899999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCCC
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 945 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~~ 945 (959)
.+||.+||+.||.+||++.++++.|+.+.......+..+.
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~l 297 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhhC
Confidence 9999999999999999999999999999888776655443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=401.80 Aligned_cols=251 Identities=23% Similarity=0.408 Sum_probs=211.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+..++|+++++||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 4457899999999999999999987 578999999875432 2334456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+ +| ||||||||+||||+.++++||+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999764 378999999999999999999998 88 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ....+|..+++++++|
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 379 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 379 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHH
Confidence 44445668899999999999999999999999999999999999999999888877766643 3556788899999999
Q ss_pred HHHHhhcCCCCCC-----CHHHHHH
Q 002157 909 IWECWQTDPSLRP-----SFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRP-----Sa~EIL~ 928 (959)
|.+||+.||.+|| ++.++++
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999999999999 9999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=387.82 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=216.5
Q ss_pred cCcCCCCeeEEeEeecc--CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 671 CEIPWEDLVLGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG--~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+....++|+++++||+| +||.||+|++ +++.||||++............+.+|+.++++++|||||+++++|.+.+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 33455789999999999 9999999988 5889999999887767777788899999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+++||||+++++|.+++... ...+++..++.|+.||+.||+|||++| |+||||||+||||+.++.+||+|||++..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999998653 356899999999999999999999999 99999999999999999999999998865
Q ss_pred ccCC-------cccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---
Q 002157 826 KHNT-------FLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 893 (959)
Q Consensus 826 ~~~~-------~~~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--- 893 (959)
.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 3221 112233579999999999988 5789999999999999999999999988665544332211100
Q ss_pred -----------------------------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--H
Q 002157 894 -----------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--L 930 (959)
Q Consensus 894 -----------------------------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--L 930 (959)
....+..+++++++||.+||+.||.+||++.|++++ |
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 112345678999999999999999999999999865 5
Q ss_pred Hhh
Q 002157 931 KPL 933 (959)
Q Consensus 931 e~l 933 (959)
+.+
T Consensus 338 ~~~ 340 (389)
T 3gni_B 338 KQI 340 (389)
T ss_dssp GGC
T ss_pred HHH
Confidence 444
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=371.58 Aligned_cols=260 Identities=30% Similarity=0.477 Sum_probs=217.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
.+...+|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34456799999999999999999984 57889999987543 223346788999999999999999999999877
Q ss_pred --CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 746 --PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 746 --~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
..+++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccccc
Confidence 6689999999999999999766667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHh
Q 002157 824 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------------PMQVVG 886 (959)
Q Consensus 824 k~~~~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------------~~ql~~ 886 (959)
....... .......||..|+|||++.+..++.++||||||+++|+|++|..||.... ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8765432 22345668889999999999999999999999999999999998764321 111112
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 887 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 887 ~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
...........+..+++++.+||.+||+.||.+||++.++++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222344466678889999999999999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=378.46 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=215.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999987 58899999987654321 13567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecCcccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g----~VKLiDFGlAk~ 825 (959)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999999764 47999999999999999999999999 99999999999998877 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~ 903 (959)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..++.
T Consensus 168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 6433 22345679999999999999999999999999999999999999999988776665553222111 12256789
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++++||.+||+.||.+||++.++++
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=399.34 Aligned_cols=265 Identities=30% Similarity=0.543 Sum_probs=230.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+++..++|++.+.||+|+||.||+|+++ +..||||++..... ....+.+|+.+|++++|||||++++++. ...
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 346788899999999999999999999984 67899999876443 2567899999999999999999999987 567
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++|||||+.+|+|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 899999999999999997542 35888999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. ...+...|..++.+
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43321 2234457789999999999999999999999999999999 999999998887776654 33456678899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~ 940 (959)
+.+||.+||+.||.+||++.+|+..|+.+.....++
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999887655443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=373.77 Aligned_cols=269 Identities=30% Similarity=0.498 Sum_probs=227.2
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
....+++..++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+.++.++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3445667788999999999999999999975 34789999986543 344566789999999999 79999999
Q ss_pred eeeeecCC-cEEEEEeccCCCCHHHHhhCCCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC
Q 002157 739 MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQ---------------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802 (959)
Q Consensus 739 ~g~~~~~~-~l~LVmEy~~gGsL~dlL~k~~~~---------------lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDL 802 (959)
++++...+ .+++||||+++++|.+++...... +++..++.++.||+.||.|||++| |+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence 99987755 499999999999999999765432 889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002157 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 879 (959)
Q Consensus 803 KPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~ 879 (959)
||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999998654321 12234557889999999999999999999999999999998 99999887
Q ss_pred ChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 880 ~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
..................+..+++++.+||.+||+.||.+||++.+|+++|+.+.+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 65444333333444566778899999999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=392.68 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=216.5
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++|||||+++++|.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 456678999999999999999999987 567899999875432 12234578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999999999864 47999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCCC
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ql~~~i~~~~~~~~iP~~l 901 (959)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .++...+ ......+|..+
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~ 243 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAW 243 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTS
T ss_pred CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcC
Confidence 43 33456789999999999974 4589999999999999999999999975433 3333333 33456778899
Q ss_pred cHHHHHHHHHHhhcCCCCCCC-HHHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPS-FAQLTV 928 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPS-a~EIL~ 928 (959)
+.++.+||.+||+.||.+||+ +.+|+.
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999999998 777765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=366.62 Aligned_cols=276 Identities=26% Similarity=0.369 Sum_probs=232.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
..++|++++.||+|+||.||++++ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 346899999999999999999988 477899999876543 34556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999998654 36899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..++.++.+||.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHH
Confidence 44455679999999999999999999999999999999999999999888776655553 3355677889999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCCCCCCCCCC
Q 002157 911 ECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 955 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~~~~~~p~~~~~ 955 (959)
+||+.||.+||++.+++++-- +.....|.....+....|..++.
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 291 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEF-FTSGYIPARLPITCLTIPPRFSI 291 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHH-HHTSCCCSCCCGGGGTSCCCCCS
T ss_pred HHcccChhhCcCHHHHhhChh-eecCCcCCCCCccCCCCCCCccc
Confidence 999999999999999987521 23344444444444444444433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=403.44 Aligned_cols=259 Identities=20% Similarity=0.328 Sum_probs=222.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
...++..++|+++++||+|+||+||+|++ +++.||||++.+.... ......+.+|+.++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 34567778999999999999999999988 4678999998653211 11122478899999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..++|||||+++|+|.+++.+....+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 9999999999999999999876668999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCc-ccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC
Q 002157 826 KHNTF-LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (959)
Q Consensus 826 ~~~~~-~~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~ 899 (959)
..... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+........+|.
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 54332 2234578999999999997 45689999999999999999999999999998888777654444455554
Q ss_pred ---CCcHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 900 ---ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 900 ---~ls~eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
.+++++++||++||..+|++ |+++++++++
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 48999999999999988888 9999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=386.74 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=210.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~---~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++|++.+.||+|+||+||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+.++|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999987 588999999864321 11134678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEecCccc
Q 002157 751 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 824 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~---VKLiDFGlAk 824 (959)
||||+++++|.+++.+ .+..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999988753 2345899999999999999999999999 999999999999986554 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCc
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 902 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls 902 (959)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... +....+....... .....++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCC
Confidence 776544444567899999999999999999999999999999999999999988543 3333332221111 1124688
Q ss_pred HHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 903 PLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.++++||.+||+.||.+||++.++++
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=371.26 Aligned_cols=268 Identities=28% Similarity=0.479 Sum_probs=220.3
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~ 741 (959)
......+..++|.+++.||+|+||.||+|++. +..||||++............+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 44556677889999999999999999999762 3479999988776666677889999999999999999999999
Q ss_pred eecCC-----cEEEEEeccCCCCHHHHhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 002157 742 VTRPP-----NLSIITEFLPRGSLFRILH-----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (959)
Q Consensus 742 ~~~~~-----~l~LVmEy~~gGsL~dlL~-----k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~ 811 (959)
+.... .+++||||+++++|.+++. .....+++..++.++.||+.||.|||++| |+||||||+||||+.
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~ 182 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRD 182 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECT
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcC
Confidence 97765 3599999999999999984 23356899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 002157 812 NWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 888 (959)
Q Consensus 812 ~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i 888 (959)
++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999999998654322 12233457889999999999999999999999999999999 89999988877666555
Q ss_pred hccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 889 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 889 ~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
. .......+..++.++.+||.+||..||.+||++.+|++.|+.+.+..
T Consensus 263 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 L-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp H-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred H-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3 33355677889999999999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=400.31 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=220.6
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..++..++|+++++||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+++.++|||||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 4556778999999999999999999988 5788999998653211 111234778999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+||||||+++|+|.+++.+. .+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 999999999999999999763 5899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--C
Q 002157 827 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 899 (959)
Q Consensus 827 ~~~~-~~~~t~~GT~~YmAPEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~ 899 (959)
.... ....+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+........+| .
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 5432 2345678999999999998765 7889999999999999999999999999888777765443344444 4
Q ss_pred CCcHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 929 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~k--RPSa~EIL~~ 929 (959)
.++.++++||.+||+.+|.+ ||++++|+++
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 78999999999999999988 9999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=366.09 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=221.6
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+.+..++|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.++++++||||+++++++.++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4566789999999999999999999863 2359999886543 345567899999999999999999999998754
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 568999999999999999876667999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 826 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 826 ~~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...........+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 54332 12234557889999999999999999999999999999998 999998877766655443 2345566778999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
.+.+||.+||..||.+||++.+|++.|+.+.+.
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.19 Aligned_cols=261 Identities=35% Similarity=0.600 Sum_probs=227.9
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..+++..++|++.+.||+|+||.||+|.+. +..||||++.... .....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345677789999999999999999999884 7889999986543 24567889999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+++||||+.+++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999999753 345899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 826 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 826 ~~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. .......+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCH
Confidence 65332 22233457889999999999999999999999999999999 999999888776665553 3345667788999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=375.42 Aligned_cols=261 Identities=30% Similarity=0.497 Sum_probs=221.5
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEECC------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~g------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
.++..++|++.+.||+|+||.||+|++.. ..||||++.... .......+.+|+.++++++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 35677899999999999999999997632 359999986543 44556678999999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...++|||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999999876668999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 825 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 825 ~~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+.. ......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-CCcCCCccc
Confidence 7643321 1223346788999999999999999999999999999998 9999999888777665543 335566778
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.++.+||.+||+.||.+||++.+|++.|+.+.+
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999998865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=375.16 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=214.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++++ +||||+++++++.....+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 36899999999999999999985 6889999998755432 2577899999999 999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-----EEEEecCccccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRLK 826 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~-----VKLiDFGlAk~~ 826 (959)
|||+ +++|.+++......+++..++.|+.||+.||+|||++| |+||||||+||||+.++. +||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 99999999866568999999999999999999999999 999999999999998887 999999999875
Q ss_pred cCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccccccC
Q 002157 827 HNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLE 896 (959)
Q Consensus 827 ~~~~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~~~~~~ 896 (959)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +....+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43321 124678999999999999999999999999999999999999999885433 22332211111111
Q ss_pred ---CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 897 ---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 897 ---iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
....++ ++.+||.+||..||.+||++.+|++.|+.+.+..
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 112355 9999999999999999999999999999886543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=375.71 Aligned_cols=263 Identities=28% Similarity=0.464 Sum_probs=225.4
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.+++..++|++++.||+|+||.||+|++.+ ..||||++.... .......+.+|+.+++++ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 467788999999999999999999998732 379999886543 344567789999999999 89999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEE
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~-------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNIL 808 (959)
+.+.+.+++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999998642 235789999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002157 809 VDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 885 (959)
Q Consensus 809 Ld~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~ 885 (959)
|+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986543221 2234457889999999999999999999999999999998 99999887665544
Q ss_pred hhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 886 ~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
..+.........|..++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 44444444566677889999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=370.02 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=208.2
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.....+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999988 4889999998777666666778889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999988654 46899999999999999999999999 999999999999999999999999999876544444
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------------c
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------N 892 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-------------------~ 892 (959)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 455679999999999987 56899999999999999999999999988765544322110 0
Q ss_pred cccCCC----------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 RRLEIP----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ~~~~iP----------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.....+ ..++.++.+||.+||+.||.+||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 011111 3578889999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=400.10 Aligned_cols=257 Identities=19% Similarity=0.322 Sum_probs=219.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..++..++|+++++||+|+||+||+|++ +++.||||++.+... .......+.+|+.++..++||||++++++|++.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4556778999999999999999999987 588999999875322 1112335788999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+||||||+++|+|.+++.+.+..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheec
Confidence 999999999999999999875557999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC
Q 002157 827 HNTFL-SSKSTAGTPEWMAPEVLR-------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 827 ~~~~~-~~~t~~GT~~YmAPEvl~-------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
..... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+........+|
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 54322 234578999999999997 3568999999999999999999999999998887777665433333333
Q ss_pred ---CCCcHHHHHHHHHHhhcCCCCC---CCHHHHHHH
Q 002157 899 ---KELDPLVARIIWECWQTDPSLR---PSFAQLTVA 929 (959)
Q Consensus 899 ---~~ls~eL~dLI~kCL~~DP~kR---PSa~EIL~~ 929 (959)
..+++++++||.+||. +|.+| |++++|+.+
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 5799999999999998 99998 589998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.29 Aligned_cols=250 Identities=33% Similarity=0.588 Sum_probs=204.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeec----CCcE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTR----PPNL 748 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~--L~HpNIVkL~g~~~~----~~~l 748 (959)
.++|++++.||+|+||+||+|+++++.||||++... ....+.+|.+++.. ++||||+++++++.. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 468999999999999999999999999999998643 23455667777777 799999999998644 3458
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLH--------s~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
++||||+++|+|.++++. ..+++..++.++.||+.||+||| +++ |+||||||+||||+.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999965 36999999999999999999999 777 999999999999999999999999
Q ss_pred CccccccCCcc----cCCCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhC----------CCCCCCCC
Q 002157 821 GLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATL----------KLPWIGMN 880 (959)
Q Consensus 821 GlAk~~~~~~~----~~~t~~GT~~YmAPEvl~g~------~~s~ksDIWSLGiLLyELLtG----------~~PF~g~~ 880 (959)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99976543321 12345799999999999887 345799999999999999999 88886643
Q ss_pred h-----HHHHhhhhccccccCCCC-----CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 881 P-----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 881 ~-----~ql~~~i~~~~~~~~iP~-----~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
. ......+........+|. ..+.++.+||.+||+.||.+||++.+|++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2 222222222333334442 3567899999999999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=367.34 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=221.5
Q ss_pred ccCcCCCCeeEEe-EeeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 670 ECEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 670 ~~ei~~~dy~I~k-~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
+..+..++|++.+ .||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3456667899998 999999999999965 357899999876655555677899999999999999999999999 5
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
.+.+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 67789999999999999999764 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 825 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 825 ~~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. ......+|..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 6543321 1223446789999999999889999999999999999999 999999988877666554 3345667788
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=379.25 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=215.3
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCce----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~----VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+..++|++.+.||+|+||+||+|++ +++. ||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 3457899999999999999999987 3443 5777765432 233456789999999999999999999999875
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
..++|+||+.+|+|.+++.+....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999876678999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43322 2233457889999999999999999999999999999999 999999888776655543 3345667788999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.+||.+||+.||.+||++.+|++.|+.+.+
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998854
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=379.56 Aligned_cols=258 Identities=25% Similarity=0.457 Sum_probs=217.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCce----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~----VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+..++|++++.||+|+||+||+|++ +++. ||+|++..... ......+.+|+.++++++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 4557899999999999999999987 3443 77777654321 122335678999999999999999999986 46
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+.+|+|.+++.+....+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 789999999999999999876667999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... ......|+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......|..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcH
Confidence 43321 2234568889999999999999999999999999999999 999999888776665553 3446667778899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.+||.+||+.||.+||++.+|++.|+.+.+
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=377.73 Aligned_cols=251 Identities=27% Similarity=0.342 Sum_probs=209.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||+||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 37899999999999999999987 5889999998654322 23356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC--c
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~--~ 830 (959)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..... .
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999999764 46999999999999999999999999 999999999999999999999999999865422 1
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..... .................++.++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345789999999999988775 779999999999999999999998765532 2222222222233335789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+||++.|++++
T Consensus 242 i~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=367.06 Aligned_cols=264 Identities=24% Similarity=0.445 Sum_probs=210.5
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
..++|++.+.||+|+||.||+|++ +++.||||++.... ........+.+|+.++++++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999986 68899999987643 345566788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 751 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999853 3456899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhhccccccCCCCCCcHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
..........|++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.........+..++.++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333445679999999999999999999999999999999999999997643 2233333332222333346789999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
++||.+||..||.+||++.+|++.|+++....-+
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999776544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=369.37 Aligned_cols=255 Identities=31% Similarity=0.604 Sum_probs=211.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+..++|++.+.||+|+||.||++++.++.||||++... .....+.+|+++|++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 45678999999999999999999999999999987543 245678899999999999999999999874 478999
Q ss_pred eccCCCCHHHHhhCCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCCEEeeCCCCCcEEEcCCCc-EEEEecCccccc
Q 002157 753 EFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHT---STPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLK 826 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~--~lse~~~l~Ia~QIa~AL~yLHs---~g~~IIHRDLKPeNILLd~~g~-VKLiDFGlAk~~ 826 (959)
||+++++|.+++..... .+++..++.++.||+.||.|||+ +| |+||||||+||||+.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999976542 47888999999999999999999 66 999999999999998886 799999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ql~~~i~~~~~~~~iP~~ls~e 904 (959)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+ ........+..++..
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHH
T ss_pred ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHH
Confidence 432 23456999999999999999999999999999999999999999865432 222222 233455666789999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
+.+||.+||+.||.+||++.+|++.|+.+.+....
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999999776543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=365.66 Aligned_cols=261 Identities=30% Similarity=0.476 Sum_probs=219.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee-ecCCcE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNL 748 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~g-----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~-~~~~~l 748 (959)
..+|++.+.||+|+||.||+|++.. ..||||++... ........+.+|+.++++++||||+++++++ ..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3569999999999999999998632 24888987643 3345567889999999999999999999985 556678
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 829 TF----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 829 ~~----~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
.. .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+. .......|..++.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCH
Confidence 22 12234557889999999999999999999999999999999 667787776665554443 3345566778899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
++.+||.+||+.||.+||++.+|++.|+.+......
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999998876544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=367.63 Aligned_cols=258 Identities=33% Similarity=0.577 Sum_probs=217.3
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-CcE
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNL 748 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-~~l 748 (959)
.+.+..++|++.+.||+|+||.||+++++++.||||++.... ....+.+|+.++++++||||+++++++.+. +.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 355677899999999999999999999999999999986543 345788999999999999999999986544 578
Q ss_pred EEEEeccCCCCHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~-~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++||||+++++|.+++.+... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999999975432 3788999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~ 906 (959)
.. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++++.
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 33 223467899999999999999999999999999999998 999999887766665553 3345667788999999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
+||.+||+.||.+||++.+|++.|+.++...
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=367.87 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=194.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.++++++||||+++++++.+...+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36899999999999999999987 6889999998654221 11245788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999999877668999999999999999999999999 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. ......|..++.++++||.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999998876555544432 22445677899999999999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||+.||.+||++.++++
T Consensus 246 ~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HSCSSGGGSCCHHHHTT
T ss_pred HcccCHhhCCCHHHHhc
Confidence 99999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=378.06 Aligned_cols=258 Identities=28% Similarity=0.508 Sum_probs=215.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCce----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~----VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
+..++|+++++||+|+||.||+|++ +++. ||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4557899999999999999999987 4444 5666664332 2234567889999999999999999999998754
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++|+||+.+|+|.+++.+....+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 78999999999999999876678999999999999999999999999 999999999999999999999999999875
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 827 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 4322 12233457889999999999999999999999999999999 999999988776665553 3445667788999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.+||.+||+.||.+||++.+|++.|+.+.+
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=366.43 Aligned_cols=251 Identities=25% Similarity=0.467 Sum_probs=216.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
++..++|++++.||+|+||.||+|++ ++..||||++....... .....+.+|+.++++++||||+++++++.+...+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45668999999999999999999987 46689999986543221 1245688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999998754 46899999999999999999999998 99999999999999999999999999865443
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..++.++++|
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999988777666553 33556778899999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+||++.+|+++
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=370.50 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=214.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC--C-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN--G-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~--g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~ 742 (959)
++..++|++.+.||+|+||+||+|++. + ..||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 355688999999999999999999763 3 469999986543 23456789999999999999999999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--------
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------- 814 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~-------- 814 (959)
.+.+..++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999876666999999999999999999999999 999999999999998877
Q ss_pred EEEEecCccccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccc
Q 002157 815 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 815 VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~ 892 (959)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| ..||............ .
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 999999999765332 22457889999999988 6789999999999999999995 5566665554443322 2
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
....++...+.++++||.+||+.||.+||++.++++.|+.+..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3455667778899999999999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=372.58 Aligned_cols=260 Identities=31% Similarity=0.527 Sum_probs=224.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~ 742 (959)
.+++..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 45667789999999999999999999754 5679999886543 344556789999999999999999999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~~---------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g 813 (959)
.+...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 99999999999999999999986421 35688999999999999999999999 99999999999999999
Q ss_pred cEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhc
Q 002157 814 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 890 (959)
Q Consensus 814 ~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~ 890 (959)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999998654322 12234457889999999999999999999999999999999 8999999887776665542
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
......+..++.++.+||.+||+.||.+||++.++++.|+.+
T Consensus 256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 334556788999999999999999999999999999999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=386.50 Aligned_cols=248 Identities=27% Similarity=0.457 Sum_probs=215.2
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|+.++||||+++++++.....+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999997 68899999986542211 1234688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+ +|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...... .
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-N 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-B
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCC-c
Confidence 9999 67999988654 36999999999999999999999999 999999999999999999999999999876543 2
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....+...+ ......+|..+++++++||.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHH
Confidence 3456789999999999998876 78999999999999999999999887665554433 33455678889999999999
Q ss_pred HHhhcCCCCCCCHHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~ 929 (959)
+||+.||.+||++.||+++
T Consensus 241 ~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhC
Confidence 9999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.32 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=196.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+|++++||||+++++++..++.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46899999999999999999976 588999999875432 222356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 753 EFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~-----~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
||++ ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 5999988532 245899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------- 893 (959)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 443444556799999999999874 689999999999999999999999998887655443321000
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 -------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 -------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....+..++.++++||.+||+.||.+||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 011223578899999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=370.99 Aligned_cols=247 Identities=28% Similarity=0.391 Sum_probs=215.8
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.|.+.+.||+|+||.||+|++ +++.||||++...... ....+.+|+.++++++||||+++++++.....+++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 478889999999999999987 5889999998754432 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++++|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999975 36899999999999999999999998 99999999999999999999999999987655444445
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHHh
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-~~~iP~~ls~eL~dLI~kCL 913 (959)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+....+..... ....+..+++++++||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 67899999999999999999999999999999999999999998887766655432221 22234468899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVA 929 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~ 929 (959)
+.||.+||++.+++++
T Consensus 280 ~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 280 VRDPQERATAQELLDH 295 (321)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=399.17 Aligned_cols=260 Identities=35% Similarity=0.601 Sum_probs=228.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..+++..++|++.+.||+|+||.||+|++. +..||||++...... ...|.+|+.+|++++|||||++++++.+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 346677889999999999999999999884 788999998765432 467899999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.++|||||+++|+|.+++.+. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999753 346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 826 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 826 ~~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+...|..++.
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 64332 22334456789999999999999999999999999999998 999999988777665543 3446677889999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
++.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=372.46 Aligned_cols=262 Identities=32% Similarity=0.586 Sum_probs=221.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCce--EEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~--VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~ 747 (959)
+.+++|++.+.||+|+||.||+|++ ++.. ||||++.... .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 5568999999999999999999976 5554 4899876432 233456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 002157 748 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~ 812 (959)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999997653 46899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc
Q 002157 813 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (959)
Q Consensus 813 g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~ 891 (959)
+.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-c
Confidence 99999999999754322 22234567889999999999889999999999999999998 999999988877766654 3
Q ss_pred ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 892 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 892 ~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
......+..++.++++||.+||+.||.+||++.++++.|+.+......
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 345566778999999999999999999999999999999988765443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.50 Aligned_cols=262 Identities=33% Similarity=0.539 Sum_probs=216.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC---Cc--eEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~---g~--~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
.+..++|++++.||+|+||.||+|++. ++ .||||++..... .......+.+|++++++++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 455678999999999999999999862 22 589998876543 234567889999999999999999999999876
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
. +++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 5 88999999999999999765567999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.........+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 643321 1234557889999999999889999999999999999999 999999998888777776555566777889
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
+.++++||.+||..||.+||++.+|++.|+.+...
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 99999999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=363.77 Aligned_cols=262 Identities=25% Similarity=0.439 Sum_probs=224.0
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+..++|++.+.||+|+||.||+|++ ++..||||++....... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 445668999999999999999999988 46789999986543211 123568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999999764 36899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+. .....+|..++.++++
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKD 241 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHH
Confidence 32 2345679999999999999999999999999999999999999999888776665553 3355677889999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHH--HHHhhhhhhCC
Q 002157 908 IIWECWQTDPSLRPSFAQLTV--ALKPLQRLVIP 939 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~--~Le~l~kl~~p 939 (959)
||.+||+.||.+||++.++++ +++...+...|
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p 275 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence 999999999999999999987 55544433333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=372.89 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=221.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|.+++.||+|+||.||++++ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999988 467899999876543 445567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+.+++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999998654 47899999999999999999999999 99999999999999999999999999987654434
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....+|..++.++.+||.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHHHH
Confidence 4455779999999999999999999999999999999999999999887766655543 23456778899999999999
Q ss_pred HhhcCCCCCCCHHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~~ 929 (959)
||+.||.+||++.+|+++
T Consensus 275 ~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 275 MLQTDPTARPTINELLND 292 (335)
T ss_dssp HTCSSGGGSCCGGGGGGS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=366.95 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=218.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCcEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSI 750 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~--~~~~l~L 750 (959)
.++|++++.||+|+||.||++++ +++.||||++............+.+|+.++++++||||+++++++. ....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999987 5789999999877766777788999999999999999999999874 4667999
Q ss_pred EEeccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 751 ITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g---~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998642 345899999999999999999999976 239999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.............|++.|+|||++.+..++.++||||||+++|+|++|..||...+..++...+.. .....++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 764432222345689999999999999999999999999999999999999999887766655543 2344677789999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
+.+||.+||+.||.+||++.+|++.+.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=375.33 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=212.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H--pNIVkL~g~~~~~~~l 748 (959)
.+..++|++++.||+|+||.||++.+ +++.||||++............+.+|+.+|++++| +||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45567899999999999999999977 67789999998777777777889999999999976 9999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+||||+ .+++|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999995 578999999764 47899999999999999999999999 99999999999997 67899999999987643
Q ss_pred Ccc--cCCCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccc
Q 002157 829 TFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRR 894 (959)
Q Consensus 829 ~~~--~~~t~~GT~~YmAPEvl~g-----------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~ 894 (959)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322 2335679999999999975 6689999999999999999999999987543 2333344344556
Q ss_pred cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..+|...+.++.+||.+||+.||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 67788889999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=371.01 Aligned_cols=262 Identities=28% Similarity=0.430 Sum_probs=219.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~--~~ 747 (959)
..|++++.||+|+||+||++.+ +++.||||++... ........+.+|+.+|++++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 4469999999999999999865 5778999998755 3445567889999999999999999999999874 56
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 89999999999999999764 4899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHhhhhc
Q 002157 828 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------VVGAVGF 890 (959)
Q Consensus 828 ~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q--------------l~~~i~~ 890 (959)
... .......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 12334568889999999999999999999999999999999999997543210 0111222
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCC
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 942 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p 942 (959)
.......+..++.++.+||.+||+.||.+||++.+|++.|+.+......+.|
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 3445667788999999999999999999999999999999999887765443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=392.48 Aligned_cols=265 Identities=33% Similarity=0.563 Sum_probs=224.2
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+++..++|++.+.||+|+||.||+|++++ ..||||++...... ...|.+|+.+|++++||||+++++++.+ +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 3466778899999999999999999999864 57999998765433 3578899999999999999999999876 67
Q ss_pred EEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++|||||+++|+|.+++.+. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 89999999999999999642 245899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..++.+
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43321 2233457789999999999999999999999999999999 999999998877776654 34456778899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~ 940 (959)
+.+||.+||+.||.+||++.+|++.|+.+.....|+
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 999999999999999999999999999887655543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=373.54 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=218.8
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--c
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--R 744 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~--~ 744 (959)
+..++|++++.||+|+||.||+|++ +++.||||++... .......+.+|++++++++||||+++++++. +
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4557899999999999999999984 5778999998654 3445667899999999999999999999886 4
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...+++||||+++++|.+++.+....+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 55689999999999999999765557999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------------HHHhh
Q 002157 825 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--------------QVVGA 887 (959)
Q Consensus 825 ~~~~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--------------ql~~~ 887 (959)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 754322 1233456888999999999999999999999999999999999998654332 11111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
..........+..+++++++||.+||+.||.+||++.+|++.|+.+.....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222344566778899999999999999999999999999999998865443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=415.41 Aligned_cols=254 Identities=20% Similarity=0.342 Sum_probs=221.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 745 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~ 745 (959)
...+..++|+++++||+|+||+||+|++ +++.||||++.+... .......+..|+.+|..+ +||||++++++|++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456778999999999999999999987 567899999875421 122345677899999987 799999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.+||||||+++|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999999999764 36999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA 569 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHH
Confidence 54444455678899999999999999999999999999999999999999999998888877753 4567888999999
Q ss_pred HHHHHHHhhcCCCCCCCH-----HHHHH
Q 002157 906 ARIIWECWQTDPSLRPSF-----AQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa-----~EIL~ 928 (959)
++||.+||+.||.+||++ ++|++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999999997 77765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=382.87 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=201.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCC--cEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~--~l~ 749 (959)
.++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+++. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999987 6889999998766555666778889999999997 999999999997554 689
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
|||||+. ++|..++.. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999997 589999876 36899999999999999999999999 999999999999999999999999999865321
Q ss_pred ---------------------cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhh
Q 002157 830 ---------------------FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887 (959)
Q Consensus 830 ---------------------~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~ 887 (959)
.......+||++|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112234689999999999987 6789999999999999999999999999887655544
Q ss_pred hhccccc---------------------------------------------cCCCCCCcHHHHHHHHHHhhcCCCCCCC
Q 002157 888 VGFQNRR---------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRPS 922 (959)
Q Consensus 888 i~~~~~~---------------------------------------------~~iP~~ls~eL~dLI~kCL~~DP~kRPS 922 (959)
+...... ...+..+++++++||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 3210000 0112267889999999999999999999
Q ss_pred HHHHHHH
Q 002157 923 FAQLTVA 929 (959)
Q Consensus 923 a~EIL~~ 929 (959)
+.|++++
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=380.76 Aligned_cols=267 Identities=18% Similarity=0.192 Sum_probs=212.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHH---------HHHHHHHHHHHHcCCCcee
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAAL---------LEFKREVKIMRRLRHPNVV 736 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~---------~ef~~Ei~IL~~L~HpNIV 736 (959)
+..++|++++.||+|+||.||+|.+. ++.||||++.......... ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45678999999999999999999873 4679999987653211000 1234566677778899999
Q ss_pred EEeeeeecC----CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--
Q 002157 737 LFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-- 810 (959)
Q Consensus 737 kL~g~~~~~----~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-- 810 (959)
++++++... ..++|||||+ +++|.+++......+++..++.|+.||+.||.|||++| |+||||||+||||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 999998765 4489999999 99999999876678999999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002157 811 KNWNVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (959)
Q Consensus 811 ~~g~VKLiDFGlAk~~~~~~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q 883 (959)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999986543211 1234569999999999999999999999999999999999999998643221
Q ss_pred H-Hhhhhcc--c------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCC
Q 002157 884 V-VGAVGFQ--N------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 942 (959)
Q Consensus 884 l-~~~i~~~--~------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p 942 (959)
. ....... . .....+..++.++.+||..||..||.+||++.+|++.|+.+.+......+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 1 1111000 0 00111256789999999999999999999999999999999876555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=374.79 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=217.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
+...++|++.+.||+|+||.||+|++ +++.||||++..... .....+.+|+.++++++||||+++++++.+.+.+++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34457899999999999999999987 478999998765532 345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 751 ITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~---~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999996543 35899999999999999999999998 9999999999999999999999999998644
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-------h--------c
Q 002157 828 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-------G--------F 890 (959)
Q Consensus 828 ~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i-------~--------~ 890 (959)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+..... . .
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 321 1223456899999999999999999999999999999999999999875443211100 0 0
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
......++...+..+.+|+.+||+.||.+||++.+|++.|+.+.+..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 00111223345678999999999999999999999999999887653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=369.45 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=210.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC--cEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 750 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~--~l~L 750 (959)
.++|++.++||+|+||+||+|++. ++.||||++...... .....+.+|+++|++++||||+++++++.... .++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999884 889999998754322 22456789999999999999999999987765 7899
Q ss_pred EEeccCCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEecCccc
Q 002157 751 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR 824 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL----d~~g~VKLiDFGlAk 824 (959)
||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999997643 23899999999999999999999999 9999999999999 788899999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccc
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQN 892 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~--------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ql~~~i~~~~ 892 (959)
...... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... +....+....
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 765442 334567999999999986 567899999999999999999999999754331 2222221110
Q ss_pred c-----------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 893 R-----------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 893 ~-----------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
. ...++..++..+.+||.+||+.||.+||++.|++++..+-.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0 01222345678999999999999999999999999887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=378.91 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=200.3
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
...++|++++.||+|+||+||++++ +++.||||++....... ..+.+|+.++++++||||+++++++.+...+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4457899999999999999999987 68899999987644322 457799999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--EEEEecCccccccC
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRLKHN 828 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~--VKLiDFGlAk~~~~ 828 (959)
||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999998654 36999999999999999999999999 999999999999987765 99999999975432
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCcH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEK-CDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~k-sDIWSLGiLLyELLtG~~PF~g~~~~----ql~~~i~~~~~~~~iP~~ls~ 903 (959)
. ......+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+.... .....+............+++
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 2 22345679999999999998887655 89999999999999999999875442 233333222222333346899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++++||.+||+.||.+||++.+++++
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 99999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=369.45 Aligned_cols=245 Identities=24% Similarity=0.265 Sum_probs=205.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++.++||+|+||+||+|++ +++.||||++............+..|+..+.++ +||||++++++|.+.+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999988 588999999876655555556666777777666 9999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+ +++|.+++...+..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccC-CC
Confidence 999 67999998776667999999999999999999999998 999999999999999999999999999876543 23
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kC 912 (959)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... ..+........++..++.++++||.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHHHHH
Confidence 345679999999999987 6899999999999999999997766553322 222222233345567899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 002157 913 WQTDPSLRPSFAQLTV 928 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~ 928 (959)
|+.||.+||++.++++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 289 LEPDPKLRATAEALLA 304 (311)
T ss_dssp SCSSTTTSCCHHHHHT
T ss_pred cCCChhhCcCHHHHHh
Confidence 9999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=383.98 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=217.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+|++++||||+++++++.+...+++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 6799999999999999999987 57889999886543 3345578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEecCccccccCCcc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~~~~~~~ 831 (959)
|+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+. .+.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999999876668999999999999999999999999 999999999999974 5789999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCCCCCCcHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARII 909 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--~~~iP~~ls~eL~dLI 909 (959)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++++++||
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 22345799999999999999999999999999999999999999999887776665543222 2233457899999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||+.||.+||++.+++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=371.07 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=210.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc----
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 747 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~---- 747 (959)
.++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 678999999876543 34556778999999999999999999999876654
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 49999999999999999754 36899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCc
Q 002157 828 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 902 (959)
Q Consensus 828 ~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls 902 (959)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+................. ..+..++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 321 22334569999999999999999999999999999999999999999988766554433221111 1234689
Q ss_pred HHHHHHHHHHhhcCCCCCCC-HHHHHHHHHhhhhhhC
Q 002157 903 PLVARIIWECWQTDPSLRPS-FAQLTVALKPLQRLVI 938 (959)
Q Consensus 903 ~eL~dLI~kCL~~DP~kRPS-a~EIL~~Le~l~kl~~ 938 (959)
.++.+||.+||+.||.+||+ ++++.+.+..+.....
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999996 5556666666554433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=362.14 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=198.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
+++..++|++++.||+|+||.||+|++ +++.||||++............+.++..+++.++||||+++++++.+.+.+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356678999999999999999999988 788999999876544444444455566667788999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 749 SIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ | |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999997 488777643 445799999999999999999999998 8 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCC
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPK 899 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl----~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ql~~~i~~~~~~~~iP~ 899 (959)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... .................+.
T Consensus 159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 765432 23345799999999996 55678999999999999999999999998743 3333333322333333345
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.++.++.+||.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 78999999999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=396.54 Aligned_cols=251 Identities=26% Similarity=0.505 Sum_probs=221.4
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+..++|.+++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|+.++||||+++++++.....+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34568999999999999999999987 58899999987543211 2345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999999764 47999999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+.. .....|..+++++++
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIFYTPQYLNPSVIS 245 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--TCCCCCTTCCHHHHH
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCcCCCccCCHHHHH
Confidence 3 23446789999999999998775 7899999999999999999999999887777766643 345677889999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~ 928 (959)
||.+||+.||.+||++.+|++
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.62 Aligned_cols=252 Identities=31% Similarity=0.446 Sum_probs=215.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CC
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PP 746 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~ 746 (959)
.....|++.+.||+|+||.||+|.+ ++..||+|++............+.+|+.++++++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 3345699999999999999999987 56789999998877777778889999999999999999999998865 35
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~ 825 (959)
.+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++.+|+||||||+||||+ .++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 589999999999999999764 468999999999999999999999876799999999999997 789999999999976
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccccCCCCCCcHH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ......+........++...+++
T Consensus 182 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 182 KRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp CCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 5433 2234679999999999875 489999999999999999999999988544 34444444333445556678899
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+.+||.+||+.||.+||++.++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCCCHHHHhh
Confidence 999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=357.32 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=213.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeee-eecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~-~~~~~~l~LVm 752 (959)
++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+.+ +.....+++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 6899999999999999999986 6889999998765433 257899999999988776655554 46677789999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~~~ 829 (959)
||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999 89999999865567999999999999999999999999 9999999999999 48899999999999876543
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhcc---ccccC
Q 002157 830 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NRRLE 896 (959)
Q Consensus 830 ~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~---~~~~~ 896 (959)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +....+... .....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 22 234567999999999999999999999999999999999999999874431 222222111 11112
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCC
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~ 940 (959)
++..+++++.+||.+||+.||.+||++.+|++.|+.+......+
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 33678999999999999999999999999999999997765543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=371.60 Aligned_cols=265 Identities=28% Similarity=0.406 Sum_probs=204.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHH--HHHcCCCceeEEeeeee-----
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVT----- 743 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~I--L~~L~HpNIVkL~g~~~----- 743 (959)
..+..++|++++.||+|+||.||+|+++++.||||++.... ...+..|..+ +..++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 35677899999999999999999999999999999986442 2233334444 44589999999997542
Q ss_pred cCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCEEeeCCCCCcEEEcCCCc
Q 002157 744 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS---------TPTIVHRDLKSPNLLVDKNWN 814 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~---------g~~IIHRDLKPeNILLd~~g~ 814 (959)
....++|||||+++|+|.+++... ..++..++.++.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 333578999999999999999764 458889999999999999999998 7 999999999999999999
Q ss_pred EEEEecCccccccCC--------cccCCCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002157 815 VKVSDFGLSRLKHNT--------FLSSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATLKLPWIGM 879 (959)
Q Consensus 815 VKLiDFGlAk~~~~~--------~~~~~t~~GT~~YmAPEvl~g-------~~~s~ksDIWSLGiLLyELLtG~~PF~g~ 879 (959)
+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999865432 112234579999999999987 34567899999999999999997766432
Q ss_pred Ch------------------HHHHhhhhccccccCCCCC------CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 880 NP------------------MQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 880 ~~------------------~ql~~~i~~~~~~~~iP~~------ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.. ......+.....+..+|.. +++++.+||.+||+.||.+||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21 1111112222333444443 44589999999999999999999999999999987
Q ss_pred hhCCCCCCC
Q 002157 936 LVIPSHPDQ 944 (959)
Q Consensus 936 l~~p~~p~~ 944 (959)
.+.-.....
T Consensus 319 ~~~~~~~~~ 327 (336)
T 3g2f_A 319 IWERNKSVS 327 (336)
T ss_dssp CCCC-----
T ss_pred HHHhcccCC
Confidence 666544443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=375.84 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=200.0
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..++|+++++||+|+||+||+|++ +++.||||++............+.+|+.+|++++||||+++++++.+...++||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999976 688999999876655555566788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE-----cCCCcEEEEecCccccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL-----d~~g~VKLiDFGlAk~~ 826 (959)
|||+. ++|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+|||| +..+.+||+|||+++..
T Consensus 112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99997 59999997653 6899999999999999999999999 9999999999999 45566999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc----------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------- 895 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~---------- 895 (959)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 5444444556789999999999875 48999999999999999999999999887765544432110000
Q ss_pred ------C------------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 ------E------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ------~------------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. ++..++.++++||.+||+.||.+||++.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 01126789999999999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=368.42 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=199.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 746 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------- 746 (959)
++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+.+|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999988 58899999987654 3345677899999999999999999999986543
Q ss_pred --------------------------------------------------cEEEEEeccCCCCHHHHhhCCCC--CCCHH
Q 002157 747 --------------------------------------------------NLSIITEFLPRGSLFRILHRPHC--QVDEK 774 (959)
Q Consensus 747 --------------------------------------------------~l~LVmEy~~gGsL~dlL~k~~~--~lse~ 774 (959)
.+++|||||++++|.+++.+... ...+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 28999999999999999976532 34566
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc------------ccCCCCCCCCCc
Q 002157 775 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------LSSKSTAGTPEW 842 (959)
Q Consensus 775 ~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~------------~~~~t~~GT~~Y 842 (959)
.++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...... ......+||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78899999999999999999 9999999999999999999999999998765431 223446799999
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCC
Q 002157 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 922 (959)
Q Consensus 843 mAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPS 922 (959)
+|||++.+..++.++|||||||++|+|++|..|+... ......+. .......+...++++++||.+||+.||.+||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 9999999999999999999999999999987765321 11121111 11111112345678899999999999999999
Q ss_pred HHHHHH
Q 002157 923 FAQLTV 928 (959)
Q Consensus 923 a~EIL~ 928 (959)
+.++++
T Consensus 320 ~~~~l~ 325 (332)
T 3qd2_B 320 ATDIIE 325 (332)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.00 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=215.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5699999999999999999987 57899999987654321 13567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecCcccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g----~VKLiDFGlAk~ 825 (959)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999764 47899999999999999999999999 99999999999999887 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--~~iP~~ls~ 903 (959)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...... ..++..++.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 6543 2234567999999999999999999999999999999999999999998877766655322211 112256889
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++++||.+||+.||.+||++.+++.
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=371.54 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=208.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC---CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~---~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
++|++++.||+|+||.||+|.+ ++..||||++.... ........+.+|+.++++++||||+++++++.+...+++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999987 57789999987542 233456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 002157 751 ITEFLPRGSLFRILHRP---------------------------------------HCQVDEKRRIKMALDVARGMNCLH 791 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~---------------------------------------~~~lse~~~l~Ia~QIa~AL~yLH 791 (959)
||||+++|+|.+++... ...+++..++.|+.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998520 112457788899999999999999
Q ss_pred hCCCCEEeeCCCCCcEEEcCCC--cEEEEecCccccccCCc----ccCCCCCCCCCccCcccccC--CCCCchhHHHHHH
Q 002157 792 TSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTF----LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFG 863 (959)
Q Consensus 792 s~g~~IIHRDLKPeNILLd~~g--~VKLiDFGlAk~~~~~~----~~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLG 863 (959)
+++ |+||||||+||||+.++ .+||+|||+++...... .......||+.|+|||++.+ ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 999 99999999999998766 89999999998653321 12345679999999999975 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 864 VILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 864 iLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
|++|+|++|+.||.+....+....+.........+ ..+++++++||.+||+.||.+||++.++++
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999988877766654433333332 247899999999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=375.18 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=209.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||+|.+ +++.||||++...... ..+|+.++.++ +||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999987 5789999998765432 34688888888 7999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-C---CcEEEEecCccccccC
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-N---WNVKVSDFGLSRLKHN 828 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~---g~VKLiDFGlAk~~~~ 828 (959)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||+.. + +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999765 46999999999999999999999999 999999999999843 2 3599999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHhhhhcccccc--CCCCCCcH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRL--EIPKELDP 903 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~---~~~ql~~~i~~~~~~~--~iP~~ls~ 903 (959)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...++...+....... ..+..++.
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 444455678999999999999888999999999999999999999999863 4445555553332222 23457899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++++||.+||..||.+||++.+++++
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=374.40 Aligned_cols=267 Identities=32% Similarity=0.544 Sum_probs=221.9
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
....+++..++|++++.||+|+||.||+|++.+ .||||++............+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345677889999999999999999999999866 5999998765443333456778999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999877667999999999999999999999999 99999999999998 689999999998754
Q ss_pred cCC-----cccCCCCCCCCCccCcccccC---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc
Q 002157 827 HNT-----FLSSKSTAGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 827 ~~~-----~~~~~t~~GT~~YmAPEvl~g---------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~ 892 (959)
... ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 122234568999999999875 457889999999999999999999999988877766655444
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
.....+..++.++.+||.+||..||.+||++.+|++.|+.+.+..
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 444444568899999999999999999999999999999887643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=375.27 Aligned_cols=247 Identities=29% Similarity=0.422 Sum_probs=215.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|++++||||+++++++.....++|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999986 688999999876543 3345567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. |+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9997 6888888655567999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
....||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.......+.....+...+..++..+++||
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3467999999999985 566899999999999999999999999998877666555444444455667899999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||+.||.+||++.+++++
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTC
T ss_pred HHHcccChhhCcCHHHHhhC
Confidence 99999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.51 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=205.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+++|++++.||+|+||.||+|++ +++.||||++..... ......+.+|+.+|++++||||+++++++.....+++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 36899999999999999999987 578899998865432 111223457999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+. ++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9997 5899998877677999999999999999999999999 999999999999999999999999999876544444
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------------
Q 002157 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------- 894 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~----------------- 894 (959)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 455678999999999987 56899999999999999999999999998876654443211000
Q ss_pred -----------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhh
Q 002157 895 -----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQ 934 (959)
Q Consensus 895 -----------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~ 934 (959)
...+..++.++++||.+||+.||.+||++.|+++ ++..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0112357889999999999999999999999987 454443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.72 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=212.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||+|.+ ++..||+|++...... ....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 5699999999999999999988 4568999998765432 24578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~~~~ 830 (959)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999999988654 46899999999999999999999999 9999999999999 78899999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC----CCcHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK----ELDPLVA 906 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~----~ls~eL~ 906 (959)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+... ....|. .+++++.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHH
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHH
Confidence 233456799999999998775 899999999999999999999999998887766655433 233332 6889999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+||.+||+.||.+||++.++++
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=365.85 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=205.0
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHc---CCCceeEEeeeeec
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRL---RHPNVVLFMGAVTR 744 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~---~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~~ 744 (959)
+..++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999985 6889999998753321 11123455677777766 59999999999987
Q ss_pred CC-----cEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 002157 745 PP-----NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818 (959)
Q Consensus 745 ~~-----~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLi 818 (959)
.. .+++||||+. ++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 65 4899999996 59999997654 34899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc---
Q 002157 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 895 (959)
Q Consensus 819 DFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--- 895 (959)
|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999876433 23345679999999999999999999999999999999999999999988766554432110000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 ----------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ----------------------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....++.++.+||.+||+.||.+||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 011357889999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=369.69 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=220.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
++..++|++++.||+|+||.||+|++ ++..||||++... ........+.+|+.++++++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 35568899999999999999999984 4567999998643 344556688999999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcE
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNV 815 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~V 815 (959)
...+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997543 35889999999999999999999999 999999999999984 4569
Q ss_pred EEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 002157 816 KVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 892 (959)
Q Consensus 816 KLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~ 892 (959)
||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 999999997543321 12234567899999999999999999999999999999998 999999888776665554 33
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 3556678899999999999999999999999999999998865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.84 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=209.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++..+ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 588999999987655555677888999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-----------------
Q 002157 753 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----------------- 812 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~----------------- 812 (959)
||+++++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999653 246899999999999999999999999 9999999999999844
Q ss_pred --CcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh
Q 002157 813 --WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 889 (959)
Q Consensus 813 --g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~ 889 (959)
+.+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++........ +.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~ 241 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IR 241 (289)
T ss_dssp -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH---HH
T ss_pred CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH---HH
Confidence 47999999999876543 235699999999999876 566899999999999999999887755433222 21
Q ss_pred ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 890 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 890 ~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
......+|..++.++++||.+||+.||.+||++.+++++
T Consensus 242 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 -QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 233456778899999999999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=380.24 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=212.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~--HpNIVkL~g~~~~~~~l~ 749 (959)
+...+|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+|++++ ||||+++++++.....++
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3445799999999999999999987 5788999999877666777788999999999996 599999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
|||| +.+++|.+++.+.. .+++..++.|+.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 55889999997654 7888899999999999999999999 99999999999995 589999999999876433
Q ss_pred cc--cCCCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhcccccc
Q 002157 830 FL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRL 895 (959)
Q Consensus 830 ~~--~~~t~~GT~~YmAPEvl~g-----------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~~ 895 (959)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 21 2345679999999999975 3688999999999999999999999987543 33444444444556
Q ss_pred CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 ~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+|...+.++++||.+||+.||.+||++.+++++
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 6778889999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.86 Aligned_cols=249 Identities=27% Similarity=0.483 Sum_probs=220.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+.|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999987 5789999998765432 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 9999999999975 36899999999999999999999999 9999999999999999999999999998766544444
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHh
Q 002157 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL 913 (959)
....|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+. ......++..++.++.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHHc
Confidence 56789999999999999999999999999999999999999999888776655543 23345567789999999999999
Q ss_pred hcCCCCCCCHHHHHHHH
Q 002157 914 QTDPSLRPSFAQLTVAL 930 (959)
Q Consensus 914 ~~DP~kRPSa~EIL~~L 930 (959)
+.||.+||++.+|+++.
T Consensus 256 ~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSGGGSCCHHHHTTCH
T ss_pred CCChhhCcCHHHHhhCh
Confidence 99999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.57 Aligned_cols=253 Identities=32% Similarity=0.577 Sum_probs=206.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc--CCCceeEEeeeeecC----CcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRP----PNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L--~HpNIVkL~g~~~~~----~~l~ 749 (959)
++|++++.||+|+||.||+|+++++.||||++.... ...+.+|..++..+ +||||+++++++... ..++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 679999999999999999999999999999986432 23344555565554 899999999999877 6799
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------TPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~--------g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
+||||+++|+|.+++.+. .+++..++.++.||+.||.|||++ + |+||||||+||||+.++.+||+|||
T Consensus 112 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEEeCC
Confidence 999999999999999764 589999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCccc----CCCCCCCCCccCcccccCCCCCch------hHHHHHHHHHHHHHhC----------CCCCCCCCh
Q 002157 822 LSRLKHNTFLS----SKSTAGTPEWMAPEVLRNEPSNEK------CDVYSFGVILWELATL----------KLPWIGMNP 881 (959)
Q Consensus 822 lAk~~~~~~~~----~~t~~GT~~YmAPEvl~g~~~s~k------sDIWSLGiLLyELLtG----------~~PF~g~~~ 881 (959)
+++........ .....||+.|+|||++.+..+..+ +|||||||++|||++| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 99765433211 235679999999999988776554 9999999999999999 777765422
Q ss_pred -----HHHHhhhhccccccCCCC-----CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 882 -----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 882 -----~ql~~~i~~~~~~~~iP~-----~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
......+........+|. .++.++.+||.+||+.||.+||++.+|++.|+.+.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 222222323333444443 55678999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=379.60 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=210.7
Q ss_pred eEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEeccC
Q 002157 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
...+.||+|+||.||+|++ +++.||||++.... ......+.+|+.+|++++||||+++++++.+.+.++|||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3467899999999999987 58899999987653 2445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE--cCCCcEEEEecCccccccCCcccCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL--d~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++...... ...
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~ 246 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccc
Confidence 99999998766567999999999999999999999999 9999999999999 567899999999998765432 234
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHHHHHH
Q 002157 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARIIWEC 912 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~eL~dLI~kC 912 (959)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .....+++++++||.+|
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 5679999999999999999999999999999999999999999988877666554322221 12246899999999999
Q ss_pred hhcCCCCCCCHHHHHH--HHHhh
Q 002157 913 WQTDPSLRPSFAQLTV--ALKPL 933 (959)
Q Consensus 913 L~~DP~kRPSa~EIL~--~Le~l 933 (959)
|+.||.+||++.++++ +|...
T Consensus 327 L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 327 LIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999997 55544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=356.49 Aligned_cols=257 Identities=21% Similarity=0.251 Sum_probs=209.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeee-eecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~-~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+.+ +......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6799999999999999999985 6889999987654332 247789999999988776665554 46777889999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~~~ 829 (959)
||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 89999999865667999999999999999999999999 9999999999999 78999999999999876443
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccc---cccC
Q 002157 830 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQN---RRLE 896 (959)
Q Consensus 830 ~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~~---~~~~ 896 (959)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +....+.... ....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 21 233567999999999999999999999999999999999999999875432 1111111111 1111
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
....++.++.+||.+||+.||.+||++.+|++.|+.+.+....
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 2256789999999999999999999999999999999876554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=392.19 Aligned_cols=249 Identities=30% Similarity=0.474 Sum_probs=215.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|+++++||+|+||+||+|++ +++.||||++............+.+|+.+|++++|||||++++++.+...+++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 5799999999999999999987 58899999987543323335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlAk~~~~~~ 830 (959)
|+.+++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 99999999988654 36899999999999999999999999 99999999999995 5678999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dL 908 (959)
......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..++...+.........| ..++.++++|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 233456799999999999874 8999999999999999999999999998888777665444333333 4689999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+||++.+++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=386.16 Aligned_cols=250 Identities=25% Similarity=0.301 Sum_probs=191.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-----CCcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-----~~~l 748 (959)
++|++++.||+|+||+||+|++ +++.||||++............+.+|+.+|++++|||||++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999976 57899999997765566667789999999999999999999999843 3569
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|+||||+ +++|.+++... ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++++||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 57999999764 47999999999999999999999999 99999999999999999999999999987542
Q ss_pred Cc---------------------------ccCCCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHh---------
Q 002157 829 TF---------------------------LSSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELAT--------- 871 (959)
Q Consensus 829 ~~---------------------------~~~~t~~GT~~YmAPEvl-~g~~~s~ksDIWSLGiLLyELLt--------- 871 (959)
.. ......+||++|+|||++ .+..++.++||||||||+|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 123456789999999986 46679999999999999999998
Q ss_pred --CCCCCCCCChH--------------------HHHhhhh------------------------c-----cccccCCCCC
Q 002157 872 --LKLPWIGMNPM--------------------QVVGAVG------------------------F-----QNRRLEIPKE 900 (959)
Q Consensus 872 --G~~PF~g~~~~--------------------ql~~~i~------------------------~-----~~~~~~iP~~ 900 (959)
|+++|.+.... ..+..+. . ..........
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 67777665421 0000000 0 0000111235
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+++++++||.+||..||.+|||++|++++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 68999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=375.28 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=212.3
Q ss_pred ccccCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 668 ~~~~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
....++..++|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++....
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 345567778999999999999999999976 5888999998754321 11235789999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 747 NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~---~~lse~~~l~Ia~QIa~AL~yLHs~---g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
..++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||++ | |+||||||+||||+.++.+||+||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccC
Confidence 9999999999999999997643 3489999999999999999999998 8 999999999999999999999999
Q ss_pred CccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----h---HHHHhhhh--
Q 002157 821 GLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----P---MQVVGAVG-- 889 (959)
Q Consensus 821 GlAk~~~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-----~---~ql~~~i~-- 889 (959)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... . ........
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9998764332 22334569999999999999889999999999999999999999995211 0 01111000
Q ss_pred -------ccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHh
Q 002157 890 -------FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 932 (959)
Q Consensus 890 -------~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~ 932 (959)
........+...+.++.+|+.+||+.||.+||++.+|+++|+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0011112223345789999999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=400.28 Aligned_cols=266 Identities=24% Similarity=0.433 Sum_probs=225.4
Q ss_pred cCcCCCCeeEEe-EeeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k-~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+.+..+++.+.+ .||+|+||.||+|.+ ++..||||++.... .......+.+|+++|++++|||||++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 345567777777 899999999999976 34569999987543 23345678999999999999999999999976
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.++|||||+.+|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 5699999999999999999877677999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+..+|..+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 564 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 564 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 643211 1223346789999999999999999999999999999998 999999988887776664 34467788899
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCC
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 941 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~ 941 (959)
++++.+||.+||+.||.+||++.+|++.|+.+........
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999999999877665533
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=380.74 Aligned_cols=268 Identities=30% Similarity=0.492 Sum_probs=216.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--C-C--ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee-cCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--N-G--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~-g--~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~-~~~~l~ 749 (959)
..|++.+.||+|+||.||+|++ + + ..||||++.... .......+.+|+.++++++||||+++++++. .++.++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 3588899999999999999976 2 2 358999876432 3345678999999999999999999999864 456789
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+++|+|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999887777999999999999999999999999 999999999999999999999999999865432
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 830 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 830 ~~----~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.. ......+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+. .......|..++.+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 11 1233457889999999999999999999999999999999 778888877665554443 33456667889999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCCCCCCCC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~p~~~~~ 947 (959)
+.+||.+||+.||.+||++.+|++.|+.+.......+-...+.
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~~~~ 367 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 367 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCCCT
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceeeccc
Confidence 9999999999999999999999999999988776655444433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.25 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=195.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+|+.+|++++||||++++++|.+...+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 36799999999999999999998 46789999987543 2346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlAk~~~~~ 829 (959)
||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999999764 46899999999999999999999999 999999999999975 899999999999876433
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccc--cCCCCCCcHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRR--LEIPKELDPLVA 906 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~--~~iP~~ls~eL~ 906 (959)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ ....+...... ......++.+++
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 22345679999999999999999999999999999999999999998766544 33333322211 122357899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+||.+||+.||.+||++.++++
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=355.89 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=216.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4699999999999999999988 47899999987654322 13567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecCcccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g----~VKLiDFGlAk~ 825 (959)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999999653 46899999999999999999999998 99999999999998876 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--~~iP~~ls~ 903 (959)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+...... ...+..++.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 64432 233467999999999999999999999999999999999999999998877666554322211 112256789
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTV--ALKPLQRL 936 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~kl 936 (959)
.+++||.+||..||.+||++.++++ +++.+.+.
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 9999999999999999999999997 56665543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.88 Aligned_cols=252 Identities=27% Similarity=0.494 Sum_probs=210.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+..++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++.....+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45568999999999999999999987 5889999998654221 12345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999999764 36899999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
.. ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+. .....+|..++.++.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHH
Confidence 32 2334678999999999998765 689999999999999999999999888776666553 2345567889999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~ 929 (959)
||.+||+.||.+||++.+|+++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=371.27 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=209.8
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
..++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 347899999999999999999988 478999999987766666677788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||++++.|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 103 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999998888887654 46999999999999999999999999 99999999999999999999999999987655444
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----------------
Q 002157 832 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------------- 893 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~----------------- 893 (959)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44567799999999999876 689999999999999999999999998876554433211000
Q ss_pred ccC------------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 RLE------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ~~~------------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
... ....++.++.+||.+||+.||.+||++.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 113578999999999999999999999998863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=371.47 Aligned_cols=252 Identities=24% Similarity=0.251 Sum_probs=207.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH---HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~---~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
.++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 47899999999999999999987 57899999987543221 12246789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
+||||+.+ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99999975 899999877667899999999999999999999999 999999999999999999999999999877554
Q ss_pred cccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-------------
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------- 895 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~------------- 895 (959)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 4445567899999999999764 58999999999999999999999999988766554432110000
Q ss_pred --------C-----CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 --------E-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 --------~-----iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. +...++.++++||.+||+.||.+||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 114567899999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.63 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=209.1
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec--
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR-- 744 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~-- 744 (959)
......++|++++.||+|+||.||+|++ +++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3444568899999999999999999998 7889999998754332 34678999999999 89999999999976
Q ss_pred ----CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 002157 745 ----PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (959)
Q Consensus 745 ----~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiD 819 (959)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEee
Confidence 46799999999999999999753 246899999999999999999999999 99999999999999999999999
Q ss_pred cCccccccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc
Q 002157 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 894 (959)
Q Consensus 820 FGlAk~~~~~~~~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~ 894 (959)
||++..............||+.|+|||++. +..++.++|||||||++|+|++|..||.+.........+......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 999987654433344567999999999997 556889999999999999999999999988877665555433334
Q ss_pred cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 ~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
...+..++..+++||.+||..||.+||++.++++
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 4445678999999999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=391.09 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=203.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++|||||+++++|....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 5889999999876556666778899999999999999999999996553
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+||||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++| |+||||||+||||+.++++||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 47999999975 57777754 4889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~------------ 894 (959)
... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 543 2344578999999999999999999999999999999999999999998765544433211000
Q ss_pred -------------cC----CCCC-----------CcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 -------------LE----IPKE-----------LDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 -------------~~----iP~~-----------ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.. +|.. .++++++||.+||+.||.+|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0111 15679999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=371.19 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=209.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-------
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------- 744 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~------- 744 (959)
..++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+|++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 347899999999999999999987 67899999987665444445567899999999999999999999877
Q ss_pred -CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 745 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 745 -~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
.+.+++||||+.+ +|.+.+......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999975 888888776668999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccC
Q 002157 824 RLKHNT----FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLE 896 (959)
Q Consensus 824 k~~~~~----~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--~~~ 896 (959)
+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 865421 122345678999999999987 4589999999999999999999999999877655444321111 111
Q ss_pred CCCC----------------------------CcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 897 IPKE----------------------------LDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 897 iP~~----------------------------ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.... .++++++||.+||+.||.+||++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1000 26789999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=397.28 Aligned_cols=264 Identities=33% Similarity=0.564 Sum_probs=229.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..+++..++|++.++||+|+||.||+|++++ ..||||++...... ...|.+|+++|++++|+|||++++++.+ ..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 4467888999999999999999999999864 67999998765433 3578899999999999999999999876 67
Q ss_pred EEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++|||||+.+|+|.+++.+. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 89999999999999999642 245899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...+..++.+
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4322 12234457889999999999999999999999999999999 999999988877776654 34456678899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
+.+||.+||+.||.+||++.+|++.|+.+.....+
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 99999999999999999999999999987655444
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=363.19 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=199.1
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeee---
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVT--- 743 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~--- 743 (959)
.+++...+|++.++||+|+||.||+|++ +++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3455567899999999999999999998 78899999886543 445667889999999995 999999999983
Q ss_pred -----cCCcEEEEEeccCCCCHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 002157 744 -----RPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816 (959)
Q Consensus 744 -----~~~~l~LVmEy~~gGsL~dlL~k--~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VK 816 (959)
....+++||||+. |+|.+++.+ ....+++..++.|+.||+.||.|||+++++|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3445899999995 689998854 34569999999999999999999999876799999999999999999999
Q ss_pred EEecCccccccCCcc------------cCCCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002157 817 VSDFGLSRLKHNTFL------------SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881 (959)
Q Consensus 817 LiDFGlAk~~~~~~~------------~~~t~~GT~~YmAPEvl---~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~ 881 (959)
|+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999987543211 11245699999999998 566789999999999999999999999987655
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
..... .......+...+..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus 259 ~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 LRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 44332 222334455677889999999999999999999999999999977544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=390.76 Aligned_cols=253 Identities=30% Similarity=0.417 Sum_probs=212.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|+++++||+|+||+||+|++ ++..||||++............+.+|+.+|+.++|||||+++++|.+...+++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4699999999999999999988 57889999998765444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlAk~~~~~~ 830 (959)
||.+|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++.....
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999999988654 46899999999999999999999999 999999999999975 456999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dL 908 (959)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....++...+.........+ ..++.++++|
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 23445789999999999874 58999999999999999999999999999888777665443333222 4689999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH--HHhh
Q 002157 909 IWECWQTDPSLRPSFAQLTVA--LKPL 933 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~--Le~l 933 (959)
|.+||+.||.+||++.+++++ |+..
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999864 5443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=398.69 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=218.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+..++|++.++||+|+||.||+|++ +++.||||++.+..... .....+.+|+.+|++++||||++++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35568899999999999999999987 58899999987543211 2245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 749 SIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~---~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
||||||++||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999998653 246899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~----~~ql~~~i~~~~~~~~iP~~l 901 (959)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..++...+. .....+|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence 6554444455789999999999999999999999999999999999999998753 234444442 3355678899
Q ss_pred cHHHHHHHHHHhhcCCCCCCCH-----HHHHH
Q 002157 902 DPLVARIIWECWQTDPSLRPSF-----AQLTV 928 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa-----~EIL~ 928 (959)
+.++++||.+||+.||.+||++ .+|+.
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999999999999975 66664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=369.24 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=209.7
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----CCceeEEeee
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFMGA 741 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-----HpNIVkL~g~ 741 (959)
....+..++|+++++||+|+||+||+|++ +++.||||++... ......+..|+.+++.+. ||||++++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33445568999999999999999999988 6788999998642 344556788999999996 9999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---------
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--------- 811 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--------- 811 (959)
+...+.+++||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+||||+.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccc
Confidence 99999999999999 899999987543 45899999999999999999999999 999999999999975
Q ss_pred ----------------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002157 812 ----------------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875 (959)
Q Consensus 812 ----------------~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~P 875 (959)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999865432 3456799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHhhhhcccc------------------------ccCCCC--------------------CCcHHHHHHHHH
Q 002157 876 WIGMNPMQVVGAVGFQNR------------------------RLEIPK--------------------ELDPLVARIIWE 911 (959)
Q Consensus 876 F~g~~~~ql~~~i~~~~~------------------------~~~iP~--------------------~ls~eL~dLI~k 911 (959)
|.+.+..+....+..... ....|. ..++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 998776654433321100 000111 123778899999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||+.||.+||++.|+++
T Consensus 339 ~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCSSGGGSCCHHHHTT
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=360.32 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=211.9
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
...++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.++++++||||+++++++.....+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4457899999999999999999988 488999999876532 3467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999755567999999999999999999999999 9999999999999999999999999998765544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~eL~dLI 909 (959)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+... ......+..++.++.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 4445677999999999999999999999999999999999999999988776554433222 122334566889999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||..||.+||++.++++
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHHh
Confidence 9999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=374.10 Aligned_cols=257 Identities=21% Similarity=0.249 Sum_probs=204.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCCCHH---------HHHHHHHHHHHHHHcCCCceeEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGA---------ALLEFKREVKIMRRLRHPNVVLF 738 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~~~~---------~~~ef~~Ei~IL~~L~HpNIVkL 738 (959)
+..++|++++.||+|+||.||+|++ .+..||||++........ ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 4457899999999999999999988 457899999876532111 11236678899999999999999
Q ss_pred eeeeec----CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-
Q 002157 739 MGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW- 813 (959)
Q Consensus 739 ~g~~~~----~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g- 813 (959)
++++.. ...+++||||+ +++|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+||||+.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 999887 67899999999 999999997654 7999999999999999999999998 99999999999998877
Q ss_pred -cEEEEecCccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 002157 814 -NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--NPMQ 883 (959)
Q Consensus 814 -~VKLiDFGlAk~~~~~~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~--~~~q 883 (959)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999986543211 114567999999999999999999999999999999999999999652 2222
Q ss_pred HHhhhhccccccCCC---------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 884 VVGAVGFQNRRLEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 884 l~~~i~~~~~~~~iP---------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
..... ......+| ..++.++++||.+||..||.+||++.+|++.|+.+..
T Consensus 270 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 21111 11112222 2788999999999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.83 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=210.9
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee----c
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT----R 744 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~----~ 744 (959)
+.+..++|++++.||+|+||.||++++ +++.||||++... .......+.+|+.+++.++||||+++++++. .
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 345667899999999999999999986 6889999988653 3455678899999999999999999999986 3
Q ss_pred CCcEEEEEeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 745 PPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
...+++||||+.+++|.+++.+ ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecC
Confidence 4468999999999999999864 3567999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc---------cCCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHhh
Q 002157 822 LSRLKHNTFL---------SSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGA 887 (959)
Q Consensus 822 lAk~~~~~~~---------~~~t~~GT~~YmAPEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ql~~~ 887 (959)
++........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 9876432111 011245799999999998664 68899999999999999999999954211 011111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 888 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 888 i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+. .......+..++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 260 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11 222344456789999999999999999999999999999987753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=379.67 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=197.0
Q ss_pred CCeeEE-eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHH-cCCCceeEEeeeeec----CCc
Q 002157 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR----PPN 747 (959)
Q Consensus 676 ~dy~I~-k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~-L~HpNIVkL~g~~~~----~~~ 747 (959)
++|.+. ++||+|+||+||+|.+ +++.||||++... ..+.+|+.++.+ .+||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 567776 7999999999999987 5788999998632 246688888755 489999999998875 567
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCcc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 823 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlA 823 (959)
+|||||||++|+|.+++.+.. ..+++..++.|+.||+.||.|||++| ||||||||+||||+. ++.+||+|||++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 899999999999999997653 46999999999999999999999999 999999999999987 789999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHhhhhccccccC--C
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGFQNRRLE--I 897 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q----l~~~i~~~~~~~~--i 897 (959)
+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+........ .
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 865433 23346789999999999999999999999999999999999999998765432 2222322222222 2
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...++.++++||.+||+.||.+||++.+|+++
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 25689999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=374.09 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=205.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------~ 747 (959)
++|++++.||+|+||.||+|.+ +++.||||++............+.+|+++|++++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 6799999999999999999987 6889999998766555666778899999999999999999999997763 4
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 69999999 8899999976 36899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 892 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-------------- 892 (959)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 345689999999999987 679999999999999999999999999887655443331100
Q ss_pred ---------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 ---------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ---------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....+....++++++||.+||+.||.+||++.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0112334678999999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=364.44 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=211.1
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999987 578899999876533 34455788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999764 36899999999999999999999999 9999999999999999999999999997654332
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHH
Q 002157 831 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARI 908 (959)
Q Consensus 831 -~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~dL 908 (959)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.....+...+.... .....+..++.++.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 22234679999999999999999999999999999999999999998877654443332211 1234567789999999
Q ss_pred HHHHhhcCCCCCC-CHHHHHHHHHhhhhhhC
Q 002157 909 IWECWQTDPSLRP-SFAQLTVALKPLQRLVI 938 (959)
Q Consensus 909 I~kCL~~DP~kRP-Sa~EIL~~Le~l~kl~~ 938 (959)
|.+||+.||.+|| +++++++.|+.+.....
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 9999999999999 99999999987755443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.64 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=206.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|.+.+.||+|+||.||++++ ++..||||++...... .....+.+|+++|++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999987 5789999998765422 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCcccccc
Q 002157 754 FLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 754 y~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~ 827 (959)
|+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998853 2357999999999999999999999999 9999999999999 456889999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC-CCCCcHHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELDPLVA 906 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~i-P~~ls~eL~ 906 (959)
.. .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+....+......... ...++++++
T Consensus 179 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Cc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 43 22345679999999999864 5889999999999999999999999998877766555433222221 234789999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+||.+||+.||.+||++.||++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=390.85 Aligned_cols=250 Identities=30% Similarity=0.432 Sum_probs=218.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++.++||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++||||+++++++.+...+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999987 6889999998765432 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCccccccC
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~~ 828 (959)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999998765 46999999999999999999999999 9999999999999 5678999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVA 906 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~ 906 (959)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........| ..++++++
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred cc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 32 2334579999999999987 58999999999999999999999999999888777765444333333 46899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+||.+||+.||.+||++.+++++
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHCCCChhHCcCHHHHhhC
Confidence 99999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=388.63 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=212.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-----------HHHHHHHHHHHHHHHcCCCceeEEeee
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-----------AALLEFKREVKIMRRLRHPNVVLFMGA 741 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-----------~~~~ef~~Ei~IL~~L~HpNIVkL~g~ 741 (959)
.++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 36899999999999999999987 57889999987654321 234678899999999999999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEE
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVS 818 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g---~VKLi 818 (959)
+.+...++||||||++|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999999998654 46999999999999999999999999 99999999999998775 69999
Q ss_pred ecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC-
Q 002157 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI- 897 (959)
Q Consensus 819 DFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~i- 897 (959)
|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........
T Consensus 192 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999876543 23445779999999999875 5899999999999999999999999999988877776543322221
Q ss_pred -CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 898 -PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 898 -P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+..+++++++||.+||+.||.+||++.|++++
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 25789999999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.74 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=210.7
Q ss_pred eeEEeEeeccCcEEEEEEEECCceEEEEEeeccC--CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEecc
Q 002157 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~--~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 755 (959)
|..++.||+|+||.||+|+++++.||||++.... ........+.+|+.++++++||||+++++++.+.+.+++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4456889999999999999999999999987542 23345677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--c
Q 002157 756 PRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 831 (959)
Q Consensus 756 ~gGsL~dlL~k~--~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~ 831 (959)
++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999998642 346899999999999999999999999 9999999999999999999999999998654321 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh----hc---------cccccCCC
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV----GF---------QNRRLEIP 898 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i----~~---------~~~~~~iP 898 (959)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+ .. .......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 23346799999999998764 788999999999999999999999875543221111 00 01112233
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
...+..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 4456789999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=370.20 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=214.0
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..++..++|++.+.||+|+||.||+|++. +..||+|++... ........+.+|+.++++++||||+++++++...+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 34566789999999999999999999884 889999998765 345566788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+. | |+||||||+||||+.++.+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999999999764 3689999999999999999999985 8 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh------------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------ 888 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i------------------ 888 (959)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 183 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 332 233467999999999999999999999999999999999999999887654432211
Q ss_pred ------------------------hccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 889 ------------------------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 889 ------------------------~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.........+..++.++++||.+||+.||.+||++.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11111111223578999999999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=351.46 Aligned_cols=249 Identities=28% Similarity=0.350 Sum_probs=210.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999987 5889999998755432 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--c
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 831 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~ 831 (959)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999754 47899999999999999999999999 9999999999999999999999999998653221 2
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
......|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... ..............+..++.++++||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345679999999999988765 779999999999999999999998765432 22222222222233357899999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||+.||.+||++.+|++
T Consensus 243 ~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 243 HKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCchhCCCHHHHhc
Confidence 9999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.00 Aligned_cols=242 Identities=23% Similarity=0.385 Sum_probs=185.5
Q ss_pred CeeEE---eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEE
Q 002157 677 DLVLG---ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 677 dy~I~---k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~L 750 (959)
+|++. +.||+|+||.||+|.+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+...++|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 45553 7899999999999988 5789999998653 2356778999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEEecCcccccc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKH 827 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g---~VKLiDFGlAk~~~ 827 (959)
||||+++++|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999999765 47999999999999999999999999 99999999999997665 89999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhhccccccCCC--
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGFQNRRLEIP-- 898 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-------~ql~~~i~~~~~~~~iP-- 898 (959)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+....+... ...++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 238 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFEGE 238 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCCCSH
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCCcc
Confidence 544444567799999999999999999999999999999999999999987543 2344444322 22222
Q ss_pred --CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 --KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 --~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+++++++||.+||+.||.+||++.+++.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 357899999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.94 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=209.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++||||+++++++...+.+++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 46899999999999999999988 478899998865432 23567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999999999998765567999999999999999999999998 999999999999999999999999998654332223
Q ss_pred CCCCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHH
Q 002157 833 SKSTAGTPEWMAPEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 906 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl-----~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-~~~iP~~ls~eL~ 906 (959)
.....||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.......+..... ....+..++.++.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 3456799999999998 466789999999999999999999999999887766554432222 2334567899999
Q ss_pred HHHHHHhhcCCCCCCCHHHHHH
Q 002157 907 RIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 907 dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+||.+||+.||.+||++.+|++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHcccChhhCCCHHHHhc
Confidence 9999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=365.03 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=212.7
Q ss_pred CCeeEE-eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEE
Q 002157 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~-k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LV 751 (959)
++|.+. +.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+ +||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 457776 8999999999999987 588999999987655555567789999999999 569999999999999999999
Q ss_pred EeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCcccccc
Q 002157 752 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKH 827 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlAk~~~ 827 (959)
|||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||||+. ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999998643 357899999999999999999999999 999999999999987 7899999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--cccCCCCCCcHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--RRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~--~~~~iP~~ls~eL 905 (959)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... .....+..++.++
T Consensus 186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 186 HA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Cc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 43 22345679999999999999999999999999999999999999999988776655543222 2233345789999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++||.+||+.||.+||++.+++++
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCC
Confidence 999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=376.81 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=201.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~l 748 (959)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+|++++||||+++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 7899999999999999999987 578899999976655566677899999999999999999999999776 569
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999996 5999999764 47999999999999999999999999 99999999999999999999999999987543
Q ss_pred Ccc----------------------cCCCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhC-----------CC
Q 002157 829 TFL----------------------SSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATL-----------KL 874 (959)
Q Consensus 829 ~~~----------------------~~~t~~GT~~YmAPEvl-~g~~~s~ksDIWSLGiLLyELLtG-----------~~ 874 (959)
... .....+||++|+|||++ .+..++.++|||||||++|||++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 211 13567899999999986 556699999999999999999984 44
Q ss_pred CCCCCCh-----------------HHHH------------------------hhhhccccccC-----CCCCCcHHHHHH
Q 002157 875 PWIGMNP-----------------MQVV------------------------GAVGFQNRRLE-----IPKELDPLVARI 908 (959)
Q Consensus 875 PF~g~~~-----------------~ql~------------------------~~i~~~~~~~~-----iP~~ls~eL~dL 908 (959)
+|.+.+. ...+ ..+........ ....+++++++|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 4444321 0000 00000000000 113578999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+||++.|++++
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=356.66 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=210.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeee--ecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~--~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~--~~~~~l~ 749 (959)
++|++++.||+|+||.||++.+ +++.||||++...... ......+.+|+.++++++||||+++++++ .+...++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 6899999999999999999987 5788999998754321 23456789999999999999999999998 4456799
Q ss_pred EEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+||||+.++ |.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 999999876 7666643 3457899999999999999999999999 99999999999999999999999999986542
Q ss_pred C--cccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 829 T--FLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 829 ~--~~~~~t~~GT~~YmAPEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
. ........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+....+.. ....++..++.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~ 239 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCGPP 239 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSCHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccCHH
Confidence 2 12233567999999999998754 37899999999999999999999999887777666532 355677889999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+.+||.+||+.||.+||++.+++++
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=364.04 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=218.6
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
.+..++|++++.||+|+||.||+|++ +++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34557899999999999999999984 5788999998654 234567889999999999999999999998765
Q ss_pred C--cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 746 P--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 746 ~--~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
+ .+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 789999999999999999876667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HH
Q 002157 824 RLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VV 885 (959)
Q Consensus 824 k~~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q---------------l~ 885 (959)
........ ......++..|+|||++.+..++.++||||||+++|+|++|..||....... ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87643321 1233457888999999999889999999999999999999999886431100 01
Q ss_pred hhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 886 ~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
............+..++.++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111122334566788999999999999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=358.54 Aligned_cols=246 Identities=23% Similarity=0.380 Sum_probs=211.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++.+.||+|+||.||++++ +++.||||++..... .....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999987 588999999875432 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~~~~ 830 (959)
|+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999998654 36899999999999999999999999 9999999999999 78899999999999765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--~~iP~~ls~eL~dL 908 (959)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+...... ...+..++.++++|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 122346899999999999999999999999999999999999999998877766655433222 23446789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|.+||+.||.+||++.++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.03 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=209.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~------~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
++|++++.||+|+||.||+|++ +++.||||++........ ....+.+|+.+|++++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6799999999999999999976 688999999986543221 23456789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gG-sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
+++||||+.+| +|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999998766 999999765 36999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......|..++.++
T Consensus 181 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKEL 251 (335)
T ss_dssp CTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHHH
T ss_pred CCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHHH
Confidence 543 22345679999999999998876 88999999999999999999999763221 122345567789999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
++||.+||+.||.+||++.+|+++
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=362.45 Aligned_cols=253 Identities=35% Similarity=0.598 Sum_probs=211.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeecCC----cEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~--L~HpNIVkL~g~~~~~~----~l~ 749 (959)
++|++.+.||+|+||.||+|+++++.||||++... ....+.+|++++.. ++||||+++++++.... .++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 57999999999999999999999999999998543 23467788999988 68999999999998876 799
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeeCCCCCcEEEcCCCcEEEEecC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLH--------s~g~~IIHRDLKPeNILLd~~g~VKLiDFG 821 (959)
+||||+++|+|.+++.+. .+++..++.++.||+.||.||| +++ |+||||||+||||+.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999763 5899999999999999999999 777 9999999999999999999999999
Q ss_pred ccccccCCcc----cCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhC----------CCCCCCCCh
Q 002157 822 LSRLKHNTFL----SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGMNP 881 (959)
Q Consensus 822 lAk~~~~~~~----~~~t~~GT~~YmAPEvl~g~~------~s~ksDIWSLGiLLyELLtG----------~~PF~g~~~ 881 (959)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9986554321 234567999999999998763 23689999999999999999 789876532
Q ss_pred -----HHHHhhhhccccccCCCC-----CCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 882 -----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 882 -----~ql~~~i~~~~~~~~iP~-----~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
..+...+.....+..++. .++..+.+||.+||+.||.+||++.+|+++|+.+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 233333333333444443 34468999999999999999999999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.90 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=214.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC---C----HHHHHHHHHHHHHHHHcC-CCceeEEeeeeec
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---S----GAALLEFKREVKIMRRLR-HPNVVLFMGAVTR 744 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~---~----~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~ 744 (959)
.++|++.+.||+|+||.||+|++ +++.||||++..... . ......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999988 578999999876431 1 123456789999999995 9999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999764 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP 898 (959)
..... .......|++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........+
T Consensus 173 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 76433 2334567999999999985 4567899999999999999999999999888776665554333332222
Q ss_pred --CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 --KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 --~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++.++++||.+||+.||.+||++.++++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 468899999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=398.44 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=217.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.+..++|+++++||+|+||.||+|++ +++.||||++.+.... ......+.+|+.+|++++|||||+++++|.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35668899999999999999999987 6889999998754321 12245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|||||++||+|.+++...+ ..+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999997643 34899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCCcH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .++...+ ......+|..+++
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCH
Confidence 432 23456899999999999999999999999999999999999999987642 3333333 2335667788999
Q ss_pred HHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
++++||.+||+.||.+|| ++.+|+++
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 999999999999999999 78888764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=355.37 Aligned_cols=253 Identities=27% Similarity=0.464 Sum_probs=209.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
.+..++|.....||+|+||.||+|++ ++..||||++.... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34445666667899999999999987 57889999987653 234567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCccccc
Q 002157 750 IITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLK 826 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~~ 826 (959)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999997542 34678889999999999999999998 999999999999987 899999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcH
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~~~iP~~ls~ 903 (959)
...........|++.|+|||++.+.. ++.++||||||+++|+|++|..||....... .............++..++.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 54333344567999999999997653 7899999999999999999999997654332 22222223345567888999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++.+||.+||+.||.+||++.+++.
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=366.36 Aligned_cols=258 Identities=17% Similarity=0.182 Sum_probs=213.7
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEE-------ECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeEE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 738 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~-------~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~---HpNIVkL 738 (959)
..+++..++|.+.+.||+|+||+||+|. ..++.||||++.... ..++.+|+++++.++ |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3455677889999999999999999993 267889999986542 346778888888887 8999999
Q ss_pred eeeeecCCcEEEEEeccCCCCHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---
Q 002157 739 MGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--- 811 (959)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~k----~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--- 811 (959)
++++...+..+|||||+++|+|.+++.+ ....+++..++.|+.||+.||+|||++| ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999964 3457999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEEecCcccccc--CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002157 812 --------NWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881 (959)
Q Consensus 812 --------~g~VKLiDFGlAk~~~--~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~ 881 (959)
++.+||+|||+++... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997543 122234567899999999999999999999999999999999999999965433
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCC-CCHHHHHHHHHhhhhhhCC
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kR-PSa~EIL~~Le~l~kl~~p 939 (959)
.... + . ........+..+.+++..||+.+|.+| |++.++.+.|+.+.....+
T Consensus 291 ~~~~--~--~--~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 291 GECK--P--E--GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp TEEE--E--C--SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred Ccee--e--c--hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 2110 0 0 111111347789999999999999999 6799999999988765543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=398.79 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=220.3
Q ss_pred cCCCCeeEE-eEeeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLG-ERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~-k~LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+....+.+. ++||+|+||.||+|.+ .++.||||++...........++.+|+++|++++|||||++++++.. +.
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 344455553 5899999999999965 35679999987765555556789999999999999999999999975 56
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++|||||+.+|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 88999999999999999764 47899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 828 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 828 ~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. .......|..++.
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 599 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 322 12233457789999999999999999999999999999998 999999998887776654 3446677889999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
++.+||.+||+.||.+||++.+|++.|+.+...+
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999886644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=351.88 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=210.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec---------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--------- 744 (959)
.+|++++.||+|+||.||+|++ +++.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5699999999999999999988 48899999987543 246789999999999999999998854
Q ss_pred -------CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 002157 745 -------PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816 (959)
Q Consensus 745 -------~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VK 816 (959)
...+++||||+++++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999643 346899999999999999999999998 99999999999999999999
Q ss_pred EEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC
Q 002157 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 896 (959)
Q Consensus 817 LiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~ 896 (959)
|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.... .....+. ...
T Consensus 163 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~----~~~ 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR----DGI 235 (284)
T ss_dssp ECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH----TTC
T ss_pred ECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh----ccc
Confidence 99999998765432 2345679999999999999999999999999999999999998875321 2222221 234
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
++..++.++++||.+||+.||.+||++.++++.|..+.+..
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 56778999999999999999999999999999999887643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=367.71 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=215.1
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCH---------------HHHHHHHHHHHHHHHcCCCcee
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG---------------AALLEFKREVKIMRRLRHPNVV 736 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~---------------~~~~ef~~Ei~IL~~L~HpNIV 736 (959)
.+..++|++++.||+|+||.||+|+++++.||||++....... .....+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456899999999999999999999999999999987542211 1126788999999999999999
Q ss_pred EEeeeeecCCcEEEEEeccCCCCHHHH------hhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEE
Q 002157 737 LFMGAVTRPPNLSIITEFLPRGSLFRI------LHRP-HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLL 808 (959)
Q Consensus 737 kL~g~~~~~~~l~LVmEy~~gGsL~dl------L~k~-~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNIL 808 (959)
++++++.+.+.+++||||+++++|.++ +.+. ...+++..++.++.||+.||.|||+ +| |+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 6542 4579999999999999999999999 88 999999999999
Q ss_pred EcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 002157 809 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNE-KCDVYSFGVILWELATLKLPWIGMNP-MQVV 885 (959)
Q Consensus 809 Ld~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~-ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~ 885 (959)
|+.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876443 23456799999999999987 5666 99999999999999999999988776 5555
Q ss_pred hhhhccccccCCC-------------------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 886 GAVGFQNRRLEIP-------------------KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 886 ~~i~~~~~~~~iP-------------------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+... ...+| ..++.++.+||.+||+.||.+||++.++++
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 554322 23333 568999999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=366.43 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=200.3
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
.++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37899999999999999999987 5889999999876556666778899999999999999999999997765
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999964 78888864 4889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~------------ 894 (959)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 433 2234567999999999999999999999999999999999999999998776554443211100
Q ss_pred --------cC--------------CCC------CCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 --------LE--------------IPK------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 --------~~--------------iP~------~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.. +|. ..+.++++||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 011 125689999999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.96 Aligned_cols=249 Identities=16% Similarity=0.152 Sum_probs=199.7
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHH---HHHHcCCCceeEEe-------e
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVK---IMRRLRHPNVVLFM-------G 740 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~---IL~~L~HpNIVkL~-------g 740 (959)
..++|++.+.||+|+||.||+|++ +++.||||++.... ........+.+|+. +|++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999985 58899999987543 23345678889994 55555899999998 5
Q ss_pred eeecCC-----------------cEEEEEeccCCCCHHHHhhCCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 002157 741 AVTRPP-----------------NLSIITEFLPRGSLFRILHRPHC------QVDEKRRIKMALDVARGMNCLHTSTPTI 797 (959)
Q Consensus 741 ~~~~~~-----------------~l~LVmEy~~gGsL~dlL~k~~~------~lse~~~l~Ia~QIa~AL~yLHs~g~~I 797 (959)
++...+ ..+|||||+ +|+|.+++.+.+. .+++..++.|+.||+.||+|||++| |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 555543 388999999 6799999975321 2335888889999999999999999 9
Q ss_pred EeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCC-----------CCCchhHHHHHHHHH
Q 002157 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----------PSNEKCDVYSFGVIL 866 (959)
Q Consensus 798 IHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~-----------~~s~ksDIWSLGiLL 866 (959)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986443 2335678 999999999987 899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhhh
Q 002157 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQR 935 (959)
Q Consensus 867 yELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~k 935 (959)
|||++|+.||.+.........+ ...+..+++++++||.+||+.||.+||++.++++ +++.+..
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 9999999999876654433322 2233678999999999999999999999999986 5555443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=360.40 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=200.6
Q ss_pred CCeeEE-eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEE
Q 002157 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~-k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LV 751 (959)
+.|++. +.||+|+||.||+|++ +++.||||++..... .....+.+|+.+|.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 568884 7899999999999986 688999999876532 2345788999999995 799999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEecCccccccC
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHN 828 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~---VKLiDFGlAk~~~~ 828 (959)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999999764 36899999999999999999999998 999999999999987766 99999999876532
Q ss_pred Cc-------ccCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 002157 829 TF-------LSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNP--------------- 881 (959)
Q Consensus 829 ~~-------~~~~t~~GT~~YmAPEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--------------- 881 (959)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 11234569999999999975 4578899999999999999999999987542
Q ss_pred HHHHhhhhccccccCCC----CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 882 MQVVGAVGFQNRRLEIP----KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP----~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+...+. .....+| ..++.++++||.+||+.||.+||++.++++
T Consensus 247 ~~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 12223332 1223333 357899999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.95 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=205.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-----
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----- 744 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----- 744 (959)
+...++|++++.||+|+||+||+|++ +++.||||++...... ..+|+.+|+.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34557899999999999999999987 6889999998754322 2379999999999999999999843
Q ss_pred ---------------------------------CCcEEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHH
Q 002157 745 ---------------------------------PPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMN 788 (959)
Q Consensus 745 ---------------------------------~~~l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~ 788 (959)
...+++||||++ ++|.+.+. +....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 334889999997 47777664 23457999999999999999999
Q ss_pred HHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHH
Q 002157 789 CLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVIL 866 (959)
Q Consensus 789 yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLL 866 (959)
|||++| |+||||||+||||+ .++.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999999 99999999999998 6899999999999876443 2344567899999999998754 89999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhcc---------------------------ccccCCCCCCcHHHHHHHHHHhhcCCCC
Q 002157 867 WELATLKLPWIGMNPMQVVGAVGFQ---------------------------NRRLEIPKELDPLVARIIWECWQTDPSL 919 (959)
Q Consensus 867 yELLtG~~PF~g~~~~ql~~~i~~~---------------------------~~~~~iP~~ls~eL~dLI~kCL~~DP~k 919 (959)
|+|++|+.||.+.+..+....+... .....++..++.++++||.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998776554433210 0011245668899999999999999999
Q ss_pred CCCHHHHHH--HHHhhhh
Q 002157 920 RPSFAQLTV--ALKPLQR 935 (959)
Q Consensus 920 RPSa~EIL~--~Le~l~k 935 (959)
||++.|+++ +++.+..
T Consensus 313 R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SCCHHHHHTSGGGHHHHH
T ss_pred CCCHHHHhcCHHHHHHHh
Confidence 999999984 4555443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.73 Aligned_cols=256 Identities=16% Similarity=0.173 Sum_probs=210.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC----------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeE------
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN----------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL------ 737 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~----------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVk------ 737 (959)
..++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3478999999999999999999873 678999998754 25779999999999999987
Q ss_pred ---------Eeeeeec-CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 002157 738 ---------FMGAVTR-PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (959)
Q Consensus 738 ---------L~g~~~~-~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeN 806 (959)
+++++.. ...++|||||+ +++|.+++.+. ...+++..++.|+.||+.||.|||++| |+||||||+|
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 5566655 67789999999 99999999764 357999999999999999999999998 9999999999
Q ss_pred EEEcCCC--cEEEEecCccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002157 807 LLVDKNW--NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (959)
Q Consensus 807 ILLd~~g--~VKLiDFGlAk~~~~~~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 877 (959)
|||+.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999986543211 1234579999999999999999999999999999999999999998
Q ss_pred CCC--hHHHHhhhh-ccccccCCC------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 878 GMN--PMQVVGAVG-FQNRRLEIP------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 878 g~~--~~ql~~~i~-~~~~~~~iP------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
+.. ...+..... .......++ ..++.++.+||.+||..||.+||++.+|++.|+.+.+....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 764 222222111 011111111 25689999999999999999999999999999999776554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=358.46 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=194.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
.+.+..++|++.+.||+|+||.||+|++ +++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3556778999999999999999999976 688999998765432 2335578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 748 LSIITEFLPRGSLFRILHR-------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k-------~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999863 2356899999999999999999999998 999999999999999999999999
Q ss_pred CccccccCCc-----ccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-
Q 002157 821 GLSRLKHNTF-----LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR- 893 (959)
Q Consensus 821 GlAk~~~~~~-----~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~- 893 (959)
|++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987654221 11234579999999999976 5689999999999999999999999988776554433221111
Q ss_pred -------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 -------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 -------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.......++.++++||.+||+.||.+||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 12233567899999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=365.45 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=213.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC--CH----HHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG----AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~--~~----~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~ 746 (959)
++|++.+.||+|+||.||+|++ +|+.||||++..... .. .....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999987 588999999876432 22 2245678999999999 8999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999999754 46899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC--C
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--P 898 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~i--P 898 (959)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......... +
T Consensus 251 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 543 23345789999999999864 35788999999999999999999999988877666555433222221 2
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++.++.+||.+||+.||.+||++.++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 467889999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=372.16 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=210.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR 744 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~--~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~ 744 (959)
+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+++|+++ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 4457899999999999999999987 678999999865321 111223566899999999 69999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...++|||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999764 36899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCC-cccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCC
Q 002157 825 LKHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEI 897 (959)
Q Consensus 825 ~~~~~-~~~~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~~~~~i 897 (959)
..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+...+ ......+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCC
Confidence 65332 2223456799999999999863 478999999999999999999999975432 2232222 2235567
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCC-----CHHHHHHHH
Q 002157 898 PKELDPLVARIIWECWQTDPSLRP-----SFAQLTVAL 930 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRP-----Sa~EIL~~L 930 (959)
|..++..+++||.+||..||.+|| ++.+++++.
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 788999999999999999999999 999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=376.08 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=210.5
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC--cEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 750 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~--~l~L 750 (959)
.++|++.++||+|+||.||+|++. ++.||||++...... .....+.+|+.+|++++||||+++++++.... .+++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467999999999999999999884 889999998754322 22456789999999999999999999998765 7899
Q ss_pred EEeccCCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEecCccc
Q 002157 751 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR 824 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL----d~~g~VKLiDFGlAk 824 (959)
||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+|||| +.++.+||+|||+++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999997643 23899999999999999999999999 9999999999999 788889999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccc
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRN--------EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQN 892 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g--------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ql~~~i~~~~ 892 (959)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+....
T Consensus 165 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 165 ELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp ECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred EccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 76543 23345779999999999875 4578899999999999999999999975332 22222221111
Q ss_pred c-----------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 893 R-----------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 893 ~-----------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
. ...++..++..+.+||.+||+.||++||++.++++.++.+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 0 011223456789999999999999999999999999988755
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=372.81 Aligned_cols=253 Identities=15% Similarity=0.083 Sum_probs=191.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc--CCCceeEEe-------eeee
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL--RHPNVVLFM-------GAVT 743 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L--~HpNIVkL~-------g~~~ 743 (959)
.+|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999987 578899999987655 334556677886655555 699988865 3333
Q ss_pred cC-----------------CcEEEEEeccCCCCHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCEEee
Q 002157 744 RP-----------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMALDVARGMNCLHTSTPTIVHR 800 (959)
Q Consensus 744 ~~-----------------~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~------l~Ia~QIa~AL~yLHs~g~~IIHR 800 (959)
.. ..++|||||++ ++|.+++...+..+.+..+ +.++.||+.||+|||++| ||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence 22 33899999998 8999999764444555556 778899999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002157 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIG 878 (959)
Q Consensus 801 DLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g 878 (959)
||||+||||+.+|.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998764332 13456799999999987 6799999999999999999999999988
Q ss_pred CChHHHH--hh---hhcc--ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhhh
Q 002157 879 MNPMQVV--GA---VGFQ--NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQ 934 (959)
Q Consensus 879 ~~~~ql~--~~---i~~~--~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l~ 934 (959)
..+.... .. .... ......+..+++++++||.+||+.||.+||++.++++ +++.+.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 7543211 00 1111 1122233578999999999999999999999999975 444443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.36 Aligned_cols=249 Identities=29% Similarity=0.391 Sum_probs=206.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeee-----c
Q 002157 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~-----~ 744 (959)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 6799999999999999999987 467899999875443222223455777777766 8999999999987 5
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlA 823 (959)
...+++||||+. ++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCccc
Confidence 567999999997 69999987543 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 892 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~----------- 892 (959)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 876433 23345679999999999999999999999999999999999999999887765544332100
Q ss_pred --------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 --------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 --------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
....++..++.++++||.+||..||.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011233568899999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.03 Aligned_cols=248 Identities=29% Similarity=0.470 Sum_probs=213.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5799999999999999999987 58899999987655444456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~---g~VKLiDFGlAk~~~~~~ 830 (959)
|+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999988654 36899999999999999999999999 9999999999999754 479999999998664332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP--~~ls~eL~dL 908 (959)
......|++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+ ..++.++++|
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred -ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22334588999999998875 8899999999999999999999999988877766654433333333 4689999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|.+||+.||.+||++.++++
T Consensus 257 i~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcccChhhCcCHHHHhc
Confidence 99999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.37 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=196.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~------~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36899999999999999999987 5789999998765321 1223357899999999999999999999865 4
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecCcc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLS 823 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~---g~VKLiDFGlA 823 (959)
.+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 588999999999999998765 47999999999999999999999999 9999999999999754 45999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhcccc--ccCC
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNR--RLEI 897 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~--~~~i 897 (959)
+..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+..... ....
T Consensus 290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 876543 23345789999999999864 567889999999999999999999998754432 2222211111 1112
Q ss_pred CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 898 PKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 898 P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+..++.++++||.+||+.||.+||++.++++
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2468899999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=356.40 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=200.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~------~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999987 5788999998754321 122345789999999999999999999997654
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEecCccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 824 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~---VKLiDFGlAk 824 (959)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999999764 47899999999999999999999999 999999999999987654 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccc--ccCCC
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNR--RLEIP 898 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~--~~~iP 898 (959)
...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .+...+..... ....+
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 764331 122356899999999974 466889999999999999999999999775443 22222211111 11122
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++.++++||.+||..||.+||++.++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 467899999999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=353.12 Aligned_cols=241 Identities=20% Similarity=0.321 Sum_probs=200.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeec--CCcEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLSI 750 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~--~~~l~L 750 (959)
++|++++.||+|+||.||+|++ +++.||||++.... ...+.+|+.+|++++ ||||+++++++.+ ...+++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6899999999999999999976 68899999986432 356889999999996 9999999999987 667899
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCccccccCC
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~~~~~ 829 (959)
||||+.+++|.+++. .+++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++.....
T Consensus 111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999985 3888999999999999999999999 99999999999999776 8999999999876543
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhh-------------ccc--
Q 002157 830 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVG-------------FQN-- 892 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~-------------~~~-- 892 (959)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+. ...
T Consensus 185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 23345679999999999987 6689999999999999999999999954322 11111100 000
Q ss_pred --------------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 --------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 --------------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....+..+++++++||.+||+.||.+||++.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122337899999999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=370.67 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=191.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~~ 747 (959)
++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999986 688999999876655556677889999999999999999999998654 56
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 7899999875 46999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~------------ 894 (959)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 335679999999999987 67899999999999999999999999998765544333210000
Q ss_pred ---------c--------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 ---------L--------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 ---------~--------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. ......++++++||.+||+.||.+||++.+++.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0113568899999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.70 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=211.8
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecCC
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPP 746 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~--HpNIVkL~g~~~~~~ 746 (959)
...+..++|++++.||+|+||.||++++ +++.||||++............+.+|+.++++++ |+||+++++++....
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3456667899999999999999999987 5788999999877666777788999999999996 599999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.+++||| +.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. +.+||+|||+++..
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999 5578999999765 47899999999999999999999998 999999999999964 89999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccc
Q 002157 827 HNTFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQN 892 (959)
Q Consensus 827 ~~~~~--~~~t~~GT~~YmAPEvl~g-----------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~ 892 (959)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 43321 1234579999999999976 4688899999999999999999999987543 23333333344
Q ss_pred cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....++...+.++.+||.+||+.||.+||++.++++.
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 4566777889999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.23 Aligned_cols=245 Identities=19% Similarity=0.225 Sum_probs=199.7
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--------CCceeEEeeeee-
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--------HPNVVLFMGAVT- 743 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~--------HpNIVkL~g~~~- 743 (959)
.++|+++++||+|+||+||+|++ +++.||||++... ......+.+|+.+|++++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999987 5788999998643 345567889999999985 788999999987
Q ss_pred ---cCCcEEEEEeccCCCCHHHHh-hCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCC-----
Q 002157 744 ---RPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW----- 813 (959)
Q Consensus 744 ---~~~~l~LVmEy~~gGsL~dlL-~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g----- 813 (959)
....++|||||+ +++|.+++ ......+++..++.|+.||+.||.|||++ | |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhh
Confidence 566799999999 55666655 44445799999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------cEEEEecCccccccCCcccCCCCCCCCCccCccccc
Q 002157 814 --------------------------------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849 (959)
Q Consensus 814 --------------------------------------------~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~ 849 (959)
.+||+|||+++..... ....+||+.|+|||++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhc
Confidence 7999999999876533 34567999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH------HHHhhhhc--cc-----------------------------
Q 002157 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM------QVVGAVGF--QN----------------------------- 892 (959)
Q Consensus 850 g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~------ql~~~i~~--~~----------------------------- 892 (959)
+..++.++|||||||++|+|++|+.||.+.+.. .....+.. ..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999865421 11111100 00
Q ss_pred ---------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 ---------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 ---------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....+...+.++++||.+||+.||.+||++.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001123344677999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=364.52 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=206.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE-----
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL----- 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l----- 748 (959)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 6899999999999999999987 588999999987666666678899999999999999999999999887765
Q ss_pred -EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 -SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 -~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999996 689888854 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~------------- 893 (959)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 33 345679999999999987 6789999999999999999999999998876554443321000
Q ss_pred ----------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ----------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ----------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
...++..+++++++||.+||+.||.+||++.|++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 001224578999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.81 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=194.7
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
..+.+..++|++++.||+|+||.||+|++ +++.||||++............+.++..+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 34556678999999999999999999988 5889999999876544444445555666788889999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.+++||||+ ++.+..++.+....+++..++.++.||+.||.|||+. | |+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 5666666655456799999999999999999999984 8 99999999999999999999999999976
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCC-
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP- 898 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ql~~~i~~~~~~~~iP- 898 (959)
.... .......||+.|+|||++. +..++.++||||||+++|+|++|+.||.... ..+....+. ......++
T Consensus 175 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 252 (318)
T 2dyl_A 175 LVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCS
T ss_pred ccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCc
Confidence 5433 2233467999999999995 4568899999999999999999999998743 333333332 22233333
Q ss_pred -CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 899 -KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 899 -~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..++.++.+||.+||+.||.+||++.+|++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 457999999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=361.89 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=206.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~l 748 (959)
++|++++.||+|+||.||+|++ ++..||||++.... .......+.+|+++|++++||||+++++++... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 5899999999999999999987 57889999986433 344557788999999999999999999998655 468
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+. ++|.+++... .+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999996 5999998763 5899999999999999999999999 99999999999999999999999999987643
Q ss_pred Ccc---cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----------
Q 002157 829 TFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 893 (959)
Q Consensus 829 ~~~---~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~----------- 893 (959)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 321 1244689999999998765 4589999999999999999999999998876554443321000
Q ss_pred -------------c-----cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 -------------R-----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 -------------~-----~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
. ..+...++.++++||.+||+.||.+||++.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 01124578999999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.15 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=202.5
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCC---------CHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------SGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~---------~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~ 741 (959)
....++|++++.||+|+||.||+|.+ +++.||||++..... .......+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 34457899999999999999999976 688999998865322 22334678999999999999999999999
Q ss_pred eec-----CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 002157 742 VTR-----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816 (959)
Q Consensus 742 ~~~-----~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VK 816 (959)
+.. ...+++||||+. |+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEE
Confidence 843 346899999997 6899988877668999999999999999999999999 99999999999999999999
Q ss_pred EEecCccccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--
Q 002157 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-- 893 (959)
Q Consensus 817 LiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-- 893 (959)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 175 l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999999865433 22345679999999999987 6789999999999999999999999998876554443321000
Q ss_pred ----------------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ----------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ----------------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....+..+++.+.+||.+||+.||.+||++.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 011224568899999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=358.19 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=205.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN------ 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~------ 747 (959)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6899999999999999999987 58899999997766666667788999999999999999999999987654
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999996 588888754 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 891 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~--------------- 891 (959)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 234678999999999987 67899999999999999999999999988765443332110
Q ss_pred --------------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 --------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 --------------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
......+..+++++++||.+||+.||.+||++.+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00112334678999999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.52 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=206.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC------ceeEEeeeee
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP------NVVLFMGAVT 743 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp------NIVkL~g~~~ 743 (959)
+..++|++++.||+|+||.||+|.+ +++.||||++... ......+.+|+.+++.++|+ +|+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3347899999999999999999976 5788999998643 34456788999999998765 4999999999
Q ss_pred cCCcEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----------
Q 002157 744 RPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----------- 811 (959)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~----------- 811 (959)
..+.+++||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+||||+.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999999 889999986543 36889999999999999999999999 999999999999987
Q ss_pred --------CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002157 812 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (959)
Q Consensus 812 --------~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q 883 (959)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999865432 345679999999999999999999999999999999999999999877655
Q ss_pred HHhhhhcccc------------------------------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCC
Q 002157 884 VVGAVGFQNR------------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRP 921 (959)
Q Consensus 884 l~~~i~~~~~------------------------------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRP 921 (959)
....+..... ....+...++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 4332211000 0111223467899999999999999999
Q ss_pred CHHHHHHH
Q 002157 922 SFAQLTVA 929 (959)
Q Consensus 922 Sa~EIL~~ 929 (959)
++.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=369.64 Aligned_cols=245 Identities=24% Similarity=0.270 Sum_probs=205.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc------CCCceeEEeeeeecCC
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL------RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L------~HpNIVkL~g~~~~~~ 746 (959)
..+|+++++||+|+||.||+|.+ +++.||||++... ......+.+|+++++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 36799999999999999999987 5788999998653 33455677889998887 5679999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--EEEEecCcc
Q 002157 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLS 823 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~--VKLiDFGlA 823 (959)
.++|||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++. +||+|||++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999999995 68999886543 45899999999999999999999999 999999999999999887 999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---------
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------- 894 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--------- 894 (959)
+..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 250 CYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred eecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 765433 34578999999999999999999999999999999999999999988765544322110000
Q ss_pred ------------------------------------------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHH
Q 002157 895 ------------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926 (959)
Q Consensus 895 ------------------------------------------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EI 926 (959)
..++...++++++||.+||+.||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 00112347889999999999999999999999
Q ss_pred HH
Q 002157 927 TV 928 (959)
Q Consensus 927 L~ 928 (959)
++
T Consensus 407 L~ 408 (429)
T 3kvw_A 407 LR 408 (429)
T ss_dssp HT
T ss_pred hC
Confidence 86
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=371.55 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=198.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~------~~ 747 (959)
.+|+++++||+|+||.||+|++ +++.||||++..... .+.+|+++|++++|||||+++++|... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999988 588999999875432 234799999999999999999988432 23
Q ss_pred EEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCcc
Q 002157 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLS 823 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlA 823 (959)
+++||||+++ +|.+++. +....+++..++.|+.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7799999975 6666553 33457999999999999999999999998 9999999999999954 67899999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------- 891 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~----------- 891 (959)
+..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 205 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876433 223457899999999999875 6899999999999999999999999998765443332110
Q ss_pred ----ccccC------------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 892 ----NRRLE------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 892 ----~~~~~------------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..... ++..+++++++||.+||..||.+||++.|++.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00111 23467899999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.29 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=204.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----Cc
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 747 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~ 747 (959)
.++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 37899999999999999999988 48899999986432 344566788999999999999999999987654 67
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999999996 589999876 36899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc----------cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---
Q 002157 828 NTFL----------SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 893 (959)
Q Consensus 828 ~~~~----------~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--- 893 (959)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 1224578999999998765 6789999999999999999999999998876543322210000
Q ss_pred ---------------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 894 ---------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 894 ---------------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
....+..+++++++||.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00112467899999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.78 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=197.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec---------
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--------- 744 (959)
++|++++.||+|+||.||+|++ +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4699999999999999999987 6889999998643 3456778999999999999999999998755
Q ss_pred ----CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 745 ----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 745 ----~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
...+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeC
Confidence 35689999999999999999866667888999999999999999999999 999999999999999999999999
Q ss_pred CccccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHH
Q 002157 821 GLSRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQV 884 (959)
Q Consensus 821 GlAk~~~~~--------------~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~-~~~ql 884 (959)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||... +....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999865422 1122346799999999999875 68999999999999999998 55432 22233
Q ss_pred Hhhhhcc--ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 885 VGAVGFQ--NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 885 ~~~i~~~--~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
...+... ..+..++...+..+++||.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 3332211 1223345567788999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=349.16 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=199.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee---------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--------- 743 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~--------- 743 (959)
.++|++++.||+|+||.||+|.+. ++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 368999999999999999999884 789999988754 3455678899999999999999999998873
Q ss_pred -----cCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEE
Q 002157 744 -----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKV 817 (959)
Q Consensus 744 -----~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKL 817 (959)
+...+++||||+. |+|.+++.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 699999975 46899999999999999999999999 99999999999997 5679999
Q ss_pred EecCccccccCCc---ccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc
Q 002157 818 SDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893 (959)
Q Consensus 818 iDFGlAk~~~~~~---~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~ 893 (959)
+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998754321 12234567999999999876 6789999999999999999999999998876554443321100
Q ss_pred ----------------------------ccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ----------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ----------------------------~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
....+..++.++++||.+||+.||.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 001224678999999999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=355.05 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=187.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHH-HHHHcCCCceeEEeeeeecC
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~-IL~~L~HpNIVkL~g~~~~~ 745 (959)
..+.+..++|++++.||+|+||.||+|.+ +++.||||++..... ......+.+|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 44567789999999999999999999988 488999999876543 334445556666 66677999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 746 PNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k----~~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
+.+++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. | |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 78777652 245789999999999999999999998 8 999999999999999999999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL 895 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl----~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ql~~~i~~~~~~~ 895 (959)
|+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.... +....+. .....
T Consensus 171 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~ 248 (327)
T 3aln_A 171 GISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDPP 248 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCCC
T ss_pred CCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCCC
Confidence 9998765432 22345799999999999 4566899999999999999999999999875432 2222221 22222
Q ss_pred CCC----CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 EIP----KELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ~iP----~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.++ ..++.++.+||.+||+.||.+||++.+|++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 222 468899999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=376.84 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=212.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H-pNIVkL~g~~~~~~~l~LV 751 (959)
.++|+++++||+|+||.||+|++ +++.||||++....... .+.+|+++++.++| ++|+.+..++......+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999987 58899999887554332 46789999999976 6666777777888889999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecCccccccC
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL---d~~g~VKLiDFGlAk~~~~ 828 (959)
|||+ +++|.+++......+++..++.|+.||+.||.|||++| ||||||||+|||| +.++.+||+|||+++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 89999999866668999999999999999999999999 9999999999999 6889999999999987654
Q ss_pred Ccc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhcc---cccc
Q 002157 829 TFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NRRL 895 (959)
Q Consensus 829 ~~~-------~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~---~~~~ 895 (959)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... +.+..+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 321 223677999999999999999999999999999999999999999886542 222222111 1111
Q ss_pred CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 896 ~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.++..++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2335788999999999999999999999999999998854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=389.80 Aligned_cols=260 Identities=30% Similarity=0.511 Sum_probs=222.2
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
+++..++|++++.||+|+||.||+|.+. +..||||++... ........+.+|+.+|++++||||+++++++. +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 4556688999999999999999999873 346999987543 34455678999999999999999999999985 4
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.+++||||+++|+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 6789999999999999999876667999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 826 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 826 ~~~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. .....+|..+++
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~ 619 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPP 619 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCCCCTTCCH
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCCccccH
Confidence 644321 2233457789999999999999999999999999999997 9999999888777666543 345667889999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.+||.+||..||.+||++.+|++.|+.+..
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.84 Aligned_cols=246 Identities=23% Similarity=0.257 Sum_probs=199.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------~ 747 (959)
..+|++++.||+|+||+||+|++ .+..||+|++...... ..+|+++|+.++||||++++++|.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35799999999999999999988 4566999988654321 237999999999999999999985443 3
Q ss_pred EEEEEeccCCCCHHHHh--hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccc
Q 002157 748 LSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 824 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL--~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk 824 (959)
+++||||++++.+..+. .+....+++..++.++.||+.||+|||++| |+||||||+||||+ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 88999999765433332 123457999999999999999999999999 99999999999999 79999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 892 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~----------- 892 (959)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 191 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 76443 233457799999999999775 58999999999999999999999999987654443321100
Q ss_pred ----cc------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 ----RR------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 ----~~------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.. ..++..+++++++||.+||+.||.+||++.+++.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 01234578999999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.23 Aligned_cols=246 Identities=21% Similarity=0.288 Sum_probs=202.0
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc------eeEEeeeeec
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMGAVTR 744 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g-~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN------IVkL~g~~~~ 744 (959)
..++|++++.||+|+||+||+|.+ ++ ..||||++... ......+.+|+.++++++|++ |+.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 357899999999999999999987 33 68999998643 344567888999999997655 9999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE--------------
Q 002157 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-------------- 809 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL-------------- 809 (959)
.+.++|||||+ +++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccc
Confidence 99999999999 56677766543 356999999999999999999999998 9999999999999
Q ss_pred -----cCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002157 810 -----DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884 (959)
Q Consensus 810 -----d~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql 884 (959)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865432 3456799999999999999999999999999999999999999998776544
Q ss_pred Hhhhhccccc------------------------------------------cCCCCCCcHHHHHHHHHHhhcCCCCCCC
Q 002157 885 VGAVGFQNRR------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRPS 922 (959)
Q Consensus 885 ~~~i~~~~~~------------------------------------------~~iP~~ls~eL~dLI~kCL~~DP~kRPS 922 (959)
...+...... .......+.++.+||.+||+.||.+||+
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 3322110000 0011123568999999999999999999
Q ss_pred HHHHHH
Q 002157 923 FAQLTV 928 (959)
Q Consensus 923 a~EIL~ 928 (959)
+.++++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.14 Aligned_cols=250 Identities=19% Similarity=0.238 Sum_probs=191.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc---
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--- 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~--- 747 (959)
...++|++.+.||+|+||.||+|++ +++.||||++...... ...+.+|++.+..++||||++++++|.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3347899999999999999999987 4789999988654322 1245677888889999999999999865433
Q ss_pred ----EEEEEeccCCCCHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEeeCCCCCcEEEcC-CCcEEE
Q 002157 748 ----LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH--TSTPTIVHRDLKSPNLLVDK-NWNVKV 817 (959)
Q Consensus 748 ----l~LVmEy~~gGsL~dlL~---k~~~~lse~~~l~Ia~QIa~AL~yLH--s~g~~IIHRDLKPeNILLd~-~g~VKL 817 (959)
+++||||+++ .|.+.+. .....+++..++.++.||+.||.||| ++| |+||||||+||||+. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 8899999976 5554432 34457899999999999999999999 777 999999999999996 899999
Q ss_pred EecCccccccCCcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc----
Q 002157 818 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---- 892 (959)
Q Consensus 818 iDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~---- 892 (959)
+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 174 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 174 CDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999999876543 2334567999999999997654 8999999999999999999999999987765544432100
Q ss_pred --------------------------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 893 --------------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 893 --------------------------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.....+...+.++++||.+||+.||.+||++.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011223367899999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=354.04 Aligned_cols=247 Identities=19% Similarity=0.292 Sum_probs=200.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----------CCceeEEe
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFM 739 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-----------HpNIVkL~ 739 (959)
+..++|++++.||+|+||.||+|++ +++.||||++... ......+.+|+.+++++. |+||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4557899999999999999999986 6889999998643 334566788999999886 89999999
Q ss_pred eeeecCC----cEEEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEc---
Q 002157 740 GAVTRPP----NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVD--- 810 (959)
Q Consensus 740 g~~~~~~----~l~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~-g~~IIHRDLKPeNILLd--- 810 (959)
+++...+ .+++||||+ +++|.+++.+. ...+++..++.++.||+.||.|||++ | |+||||||+||||+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9997654 689999999 88999998653 34589999999999999999999998 8 99999999999994
Q ss_pred ---CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----
Q 002157 811 ---KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----- 882 (959)
Q Consensus 811 ---~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----- 882 (959)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876533 23467999999999999999999999999999999999999999865421
Q ss_pred -HHHhhhhc----------------------------------------cccccCCCCCCcHHHHHHHHHHhhcCCCCCC
Q 002157 883 -QVVGAVGF----------------------------------------QNRRLEIPKELDPLVARIIWECWQTDPSLRP 921 (959)
Q Consensus 883 -ql~~~i~~----------------------------------------~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRP 921 (959)
.....+.. ......++..++.++++||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111100 0011234455678899999999999999999
Q ss_pred CHHHHHH
Q 002157 922 SFAQLTV 928 (959)
Q Consensus 922 Sa~EIL~ 928 (959)
++.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=357.05 Aligned_cols=249 Identities=23% Similarity=0.243 Sum_probs=203.5
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CC-----ceeEEeeeeec
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HP-----NVVLFMGAVTR 744 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-Hp-----NIVkL~g~~~~ 744 (959)
...++|++.+.||+|+||+||+|++ +++.||||++... .....++.+|+.+++.++ |+ +|+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3458999999999999999999987 5788999998643 344567788999998884 55 49999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEecC
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFG 821 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd--~~g~VKLiDFG 821 (959)
.+.++|||||+. ++|.+++.... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999996 59999987543 468999999999999999999996433499999999999994 57889999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc------
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------ 895 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~------ 895 (959)
+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876433 345789999999999999999999999999999999999999999887765544332110000
Q ss_pred ----------CCC------------------C----------------------------CCcHHHHHHHHHHhhcCCCC
Q 002157 896 ----------EIP------------------K----------------------------ELDPLVARIIWECWQTDPSL 919 (959)
Q Consensus 896 ----------~iP------------------~----------------------------~ls~eL~dLI~kCL~~DP~k 919 (959)
.+| . ...+++++||.+||+.||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 000 0 00147899999999999999
Q ss_pred CCCHHHHHH
Q 002157 920 RPSFAQLTV 928 (959)
Q Consensus 920 RPSa~EIL~ 928 (959)
|||+.|+++
T Consensus 364 Rpta~e~L~ 372 (382)
T 2vx3_A 364 RIQPYYALQ 372 (382)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=346.76 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=199.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHc----CCCceeEEeeee
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRL----RHPNVVLFMGAV 742 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L----~HpNIVkL~g~~ 742 (959)
...++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999987 67889999987654322 1223456799999998 899999999999
Q ss_pred ecCCcEEEEEec-cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEec
Q 002157 743 TRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDF 820 (959)
Q Consensus 743 ~~~~~l~LVmEy-~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDF 820 (959)
...+..++|||| +.+++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999 7899999999764 36899999999999999999999999 99999999999999 8899999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~ 899 (959)
|++....... .....|+..|+|||++.+..+ +.++||||||+++|+|++|+.||..... .. .....++.
T Consensus 185 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~------~~~~~~~~ 254 (312)
T 2iwi_A 185 GSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--IL------EAELHFPA 254 (312)
T ss_dssp SSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HTCCCCCT
T ss_pred chhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hh------hhccCCcc
Confidence 9998765432 345679999999999987766 4589999999999999999999975321 11 22455678
Q ss_pred CCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.++.++++||.+||+.||.+||++.+++++
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=361.73 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=182.5
Q ss_pred CeeE-EeEeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCcEE
Q 002157 677 DLVL-GERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLS 749 (959)
Q Consensus 677 dy~I-~k~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~--~~~~l~ 749 (959)
.|++ +++||+|+||+||+|++. ++.||||++....... .+.+|+.+|++++|||||+++++|. ....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4665 568999999999999863 6789999987654432 5778999999999999999999994 467899
Q ss_pred EEEeccCCCCHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEE
Q 002157 750 IITEFLPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKV 817 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k--------~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILL----d~~g~VKL 817 (959)
|||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999996 588887742 1234899999999999999999999999 9999999999999 67899999
Q ss_pred EecCccccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HH
Q 002157 818 SDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QV 884 (959)
Q Consensus 818 iDFGlAk~~~~~~---~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---------ql 884 (959)
+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999998764321 223456799999999999884 5899999999999999999999999765431 11
Q ss_pred Hhhhhc-cccc-------------------------c----------CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 885 VGAVGF-QNRR-------------------------L----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 885 ~~~i~~-~~~~-------------------------~----------~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+..+.. ...+ . ......+.++++||.+||+.||.+|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111100 0000 0 001122678899999999999999999999987
Q ss_pred H
Q 002157 929 A 929 (959)
Q Consensus 929 ~ 929 (959)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.81 Aligned_cols=244 Identities=22% Similarity=0.380 Sum_probs=206.9
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcC--CCceeEEeeeee
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVT 743 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~--HpNIVkL~g~~~ 743 (959)
+...++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457899999999999999999987 68899999987654321 11234668999999996 599999999999
Q ss_pred cCCcEEEEEeccCC-CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecC
Q 002157 744 RPPNLSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFG 821 (959)
Q Consensus 744 ~~~~l~LVmEy~~g-GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFG 821 (959)
..+.+++||||+.+ ++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 8999998764 47899999999999999999999999 99999999999999 78999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .. .....++..
T Consensus 196 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~------~~~~~~~~~ 265 (320)
T 3a99_A 196 SGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--II------RGQVFFRQR 265 (320)
T ss_dssp TCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HCCCCCSSC
T ss_pred ccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hh------ccccccccc
Confidence 998765432 334679999999999987765 6889999999999999999999976421 11 123446678
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++.++.+||.+||+.||.+||++.+|++
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.98 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=175.2
Q ss_pred CCeeEEe-EeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCcE
Q 002157 676 EDLVLGE-RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNL 748 (959)
Q Consensus 676 ~dy~I~k-~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~~l 748 (959)
++|++.+ .||+|+||.||+|++ +++.||||++... .... .+....++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6799855 699999999999988 4889999998653 1111 222334566799999999999876 4458
Q ss_pred EEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCccc
Q 002157 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSR 824 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlAk 824 (959)
+|||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999997653 46999999999999999999999999 999999999999975 4569999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHh----hhhccc--cccCCC
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG----AVGFQN--RRLEIP 898 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~----~i~~~~--~~~~iP 898 (959)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .+.... ......
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 65432 2335678999999999998889999999999999999999999998765543321 111111 112222
Q ss_pred CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 ~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++++||.+||+.||.+||++.+++++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 5789999999999999999999999999983
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.92 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=196.5
Q ss_pred cCcCCCCeeEEeEeeccCcEE-EEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcE
Q 002157 671 CEIPWEDLVLGERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~-VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l 748 (959)
+.+...+|.+.+.||+|+||+ ||++..+++.||||++...... .+.+|+++|+++ +|||||++++++.+...+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 445566799999999999998 5555678999999998654332 246899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----CCcEEEEecCcc
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLS 823 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-----~g~VKLiDFGlA 823 (959)
+||||||. |+|.+++......+.+..++.++.||+.||.|||++| ||||||||+||||+. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999996 5999999876656666667789999999999999999 999999999999953 336889999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccc-c
Q 002157 824 RLKHNTF---LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR-L 895 (959)
Q Consensus 824 k~~~~~~---~~~~t~~GT~~YmAPEvl~---g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~-~ 895 (959)
+...... ......+||+.|+|||++. +..++.++|||||||++|+|++ |..||...........+...... .
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8764321 2234567999999999998 4567889999999999999999 89999766554443322211111 1
Q ss_pred CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 896 ~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
..+...+..+++||.+||+.||.+||++.+|++
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 122345677899999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.89 Aligned_cols=232 Identities=15% Similarity=0.101 Sum_probs=192.7
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC--CceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~--g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
..++|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++.+++||||+++++++.+.+.+||
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3468999999999999999999884 789999998765443 4556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||+++++|.+++.+. .....+..|+.||+.||+|||++| |+||||||+||||+.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999642 355677889999999999999999 9999999999999999999998543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-hccccc----cCCCCCCcHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRR----LEIPKELDPLV 905 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i-~~~~~~----~~iP~~ls~eL 905 (959)
|++ .++.++|||||||++|+|++|+.||.+.+........ ...... ..++..+++++
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 233 2689999999999999999999999987654322100 000111 12335789999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
++||.+||+.||.+| ++.++++.|+.+.....
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 999999999999999 99999999999876544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=352.46 Aligned_cols=243 Identities=26% Similarity=0.353 Sum_probs=187.2
Q ss_pred CCeeEEeEeeccCcEEEEEE-EECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka-~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+.|.+.+.||+|+||+||.+ ..+++.||||++.... ...+.+|+.+|+++ +|||||++++++.+...++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 44667899999999999755 4589999999986532 34567899999986 89999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCC------CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-------------Cc
Q 002157 754 FLPRGSLFRILHRPHCQV------DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-------------WN 814 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~l------se~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-------------g~ 814 (959)
||. |+|.+++....... .+..++.++.||+.||+|||++| |+||||||+||||+.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 69999997643211 22235679999999999999999 9999999999999654 48
Q ss_pred EEEEecCccccccCCcc----cCCCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002157 815 VKVSDFGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 882 (959)
Q Consensus 815 VKLiDFGlAk~~~~~~~----~~~t~~GT~~YmAPEvl~g-------~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ 882 (959)
+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 1234579999999999976 568999999999999999999 99999776543
Q ss_pred HHHhhhhccccccC-----CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 883 QVVGAVGFQNRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 883 ql~~~i~~~~~~~~-----iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
... +........ .+..++.++++||.+||+.||.+||++.+|++
T Consensus 247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 321 111111111 11235688999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=349.95 Aligned_cols=241 Identities=17% Similarity=0.144 Sum_probs=186.9
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCC-Ccee-------------
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRH-PNVV------------- 736 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~~~~~~~ef~~Ei~IL~~L~H-pNIV------------- 736 (959)
....|.+.++||+|+||+||+|++ +++.||||++.... ........+.+|+.+++.++| .|+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688999999999999999997 48999999887432 222335678899999999977 3211
Q ss_pred --------EEeeeeec-----CCcEEEEEeccCCCCHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 002157 737 --------LFMGAVTR-----PPNLSIITEFLPRGSLFRILH------RPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797 (959)
Q Consensus 737 --------kL~g~~~~-----~~~l~LVmEy~~gGsL~dlL~------k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~I 797 (959)
.++.++.. ...++++|+++ +++|.+++. .....+++..++.|+.||+.||+|||++| |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 11111111 23467788876 679999984 33445788899999999999999999999 9
Q ss_pred EeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCCCCCccCcccc----------cCCCCCchhHHHHHHHHHH
Q 002157 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL----------RNEPSNEKCDVYSFGVILW 867 (959)
Q Consensus 798 IHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl----------~g~~~s~ksDIWSLGiLLy 867 (959)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999876543 345678 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHH
Q 002157 868 ELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 927 (959)
Q Consensus 868 ELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL 927 (959)
+|++|+.||.+.+..+....+ ......++.++++||.+||+.||.+||++.+++
T Consensus 309 elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999887655443332 122246789999999999999999999966554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.12 Aligned_cols=223 Identities=25% Similarity=0.403 Sum_probs=182.1
Q ss_pred CCeeEE-eEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHH-HHcCCCceeEEeeeeec----CCc
Q 002157 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIM-RRLRHPNVVLFMGAVTR----PPN 747 (959)
Q Consensus 676 ~dy~I~-k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL-~~L~HpNIVkL~g~~~~----~~~ 747 (959)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 567776 8899999999999987 6789999998642 2466888888 45599999999999876 677
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCcc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 823 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGlA 823 (959)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999997643 46999999999999999999999999 999999999999997 789999999998
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccCCC---
Q 002157 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP--- 898 (959)
Q Consensus 824 k~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~--~~~~~~iP--- 898 (959)
.... +..++.++|||||||++|+|++|..||.+............ ......++
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 6432 23467899999999999999999999987665443322211 11122233
Q ss_pred -CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 -~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..++.++++||.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 5689999999999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=348.50 Aligned_cols=240 Identities=18% Similarity=0.186 Sum_probs=188.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCC------CHHHHHHHHHHHHHHHHcC---------CCceeE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRLR---------HPNVVL 737 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~------~~~~~~ef~~Ei~IL~~L~---------HpNIVk 737 (959)
+..++|++++.||+|+||+||+|+++++.||||++..... .......+.+|+.+|+.++ |||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999986542 2223467889999999886 555555
Q ss_pred E-----------------eeeeec-------------CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHH
Q 002157 738 F-----------------MGAVTR-------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787 (959)
Q Consensus 738 L-----------------~g~~~~-------------~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL 787 (959)
+ +++|.+ ...++|||||+++|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 4 444443 7789999999999977777654 4689999999999999999
Q ss_pred HHHH-hCCCCEEeeCCCCCcEEEcCCC--------------------cEEEEecCccccccCCcccCCCCCCCCCccCcc
Q 002157 788 NCLH-TSTPTIVHRDLKSPNLLVDKNW--------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846 (959)
Q Consensus 788 ~yLH-s~g~~IIHRDLKPeNILLd~~g--------------------~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPE 846 (959)
+||| ++| ||||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 898 99999999999999887 9999999999876533 357999999999
Q ss_pred cccCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCChH-HHHhhhh----ccc-cccCCCCCCcHHHHHHHHHHhhcCCCC
Q 002157 847 VLRNEPSNEKCDVYSFGVI-LWELATLKLPWIGMNPM-QVVGAVG----FQN-RRLEIPKELDPLVARIIWECWQTDPSL 919 (959)
Q Consensus 847 vl~g~~~s~ksDIWSLGiL-LyELLtG~~PF~g~~~~-ql~~~i~----~~~-~~~~iP~~ls~eL~dLI~kCL~~DP~k 919 (959)
++.+.. +.++|||||+++ .++++.|..||.+.... .....+. ... .....+..+++++++||.+||+.|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 999877 899999998776 77888899998543211 1111111 110 011122357889999999999977
Q ss_pred CCCHHHHH
Q 002157 920 RPSFAQLT 927 (959)
Q Consensus 920 RPSa~EIL 927 (959)
|+.|++
T Consensus 324 --sa~e~l 329 (336)
T 2vuw_A 324 --SATDLL 329 (336)
T ss_dssp --SHHHHH
T ss_pred --CHHHHH
Confidence 888887
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=365.57 Aligned_cols=243 Identities=22% Similarity=0.274 Sum_probs=199.6
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc--
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-- 747 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~---~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~-- 747 (959)
+..++|++.+.||+|+||+||+|.+ +++.||||++.... .......+.+|+.+|++++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 3447899999999999999999987 47889999886532 34556678899999999999999999999987766
Q ss_pred ---EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 748 ---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 748 ---l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
+||||||+++++|.+++.. .+++..++.|+.||+.||.|||++| ||||||||+||||+.+ .+||+|||+++
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999998765 6899999999999999999999999 9999999999999885 99999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....+. ........++.
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------~~~~~~~~~~~ 296 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------EDDPVLKTYDS 296 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------TTCHHHHHCHH
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc--------ccccccccCHH
Confidence 76433 4567999999999998764 88999999999999999999888653211000 00000123578
Q ss_pred HHHHHHHHhhcCCCCCC-CHHHHHHHHHhhhh
Q 002157 905 VARIIWECWQTDPSLRP-SFAQLTVALKPLQR 935 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRP-Sa~EIL~~Le~l~k 935 (959)
+.+||.+||+.||.+|| +++++.+.|..+.+
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999 57778888877654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=361.50 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=204.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CC
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PP 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~------~~ 746 (959)
.++|++.+.||+|+||.||+|.+ +++.||||++... ........+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999976 6889999987654 345566789999999999999999999998765 67
Q ss_pred cEEEEEeccCCCCHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEecC
Q 002157 747 NLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFG 821 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~--~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~---VKLiDFG 821 (959)
..++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997643 35888999999999999999999999 999999999999997665 9999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhh----------h---
Q 002157 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA----------V--- 888 (959)
Q Consensus 822 lAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~----------i--- 888 (959)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... .
T Consensus 170 ~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 99876543 233457899999999999999999999999999999999999999976432211100 0
Q ss_pred ------hcc---ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHH-----HHHHHHhhhh
Q 002157 889 ------GFQ---NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQR 935 (959)
Q Consensus 889 ------~~~---~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~E-----IL~~Le~l~k 935 (959)
.+. ..+..++..++..+.+||.+||..||.+||++.+ ++..++.+..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 0011123346789999999999999999999987 5555555543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=305.59 Aligned_cols=185 Identities=16% Similarity=0.103 Sum_probs=133.8
Q ss_pred eEeeccCcEEEEEEEE--CCceEEEEEeeccCC--------CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCcEEE
Q 002157 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 682 k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~--------~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~~l~L 750 (959)
..++.|++|.+..++. .|+.||||++.+... .+....+|.+|+++|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467888887777643 799999999976532 123456799999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||++|++|.++|.+.+ .+++. +|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++......
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999998754 56654 47889999999999999 9999999999999999999999999998776554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 873 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~ 873 (959)
....+.+||+.|||||++.+. +..++|+|++|+++++|+++.
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 455667899999999999875 567899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-27 Score=273.42 Aligned_cols=185 Identities=15% Similarity=0.221 Sum_probs=148.1
Q ss_pred eEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~------~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
...+.||+|+||.||++++.+..+++|+......... ....+.+|+++|++++||||+++..++...+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3467899999999999998999999998765443322 2345899999999999999996666666777789999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+++++|.+++.+ ++.|+.||+.||.|||+++ |+||||||+||||+. ++||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999975 4578999999999999999 999999999999998 9999999999976543211
Q ss_pred -------CCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002157 833 -------SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPW 876 (959)
Q Consensus 833 -------~~t~~GT~~YmAPEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF 876 (959)
....+||+.|||||++.+ ..|+...|+|+..+-..+.+.++-+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 135679999999999987 56788899999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=219.23 Aligned_cols=145 Identities=19% Similarity=0.170 Sum_probs=116.3
Q ss_pred CeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCH----------------HHHHHHHHHHHHHHHcCCCceeEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------AALLEFKREVKIMRRLRHPNVVLFM 739 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~----------------~~~~ef~~Ei~IL~~L~HpNIVkL~ 739 (959)
.|.+++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 456679999999999999998 57899999986432111 23567889999999999 4 6666
Q ss_pred eeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 002157 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (959)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiD 819 (959)
+++.. +.+++||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65544 56699999999999998 532 123468999999999999999 99999999999999 99999999
Q ss_pred cCccccccCCcccCCCCCCCCCccCccccc
Q 002157 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849 (959)
Q Consensus 820 FGlAk~~~~~~~~~~t~~GT~~YmAPEvl~ 849 (959)
||+++. +..|+|||.+.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHH
T ss_pred CCCCeE-------------CCCCCHHHHHH
Confidence 999863 33578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6e-19 Score=187.12 Aligned_cols=137 Identities=20% Similarity=0.243 Sum_probs=106.6
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCce--EEEEEeeccCCC----------------------HHHHHHHHHHHHHHHHcC
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFS----------------------GAALLEFKREVKIMRRLR 731 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~--VAVK~i~~~~~~----------------------~~~~~ef~~Ei~IL~~L~ 731 (959)
|++.+.||+|+||.||+|.+ +|+. ||||++...... ......+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999987 8888 999987543211 011235789999999998
Q ss_pred CCce--eEEeeeeecCCcEEEEEeccCC-C----CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEeeCCC
Q 002157 732 HPNV--VLFMGAVTRPPNLSIITEFLPR-G----SLFRILHRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLK 803 (959)
Q Consensus 732 HpNI--VkL~g~~~~~~~l~LVmEy~~g-G----sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLH-s~g~~IIHRDLK 803 (959)
|++| +.++++ ...+|||||+.+ | .|.++... .++..+..++.||+.+|.||| .+| |||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence 7754 344432 356899999942 3 67776532 234456788999999999999 888 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccc
Q 002157 804 SPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 804 PeNILLd~~g~VKLiDFGlAk~~ 826 (959)
|+||||+. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-16 Score=179.49 Aligned_cols=135 Identities=15% Similarity=0.168 Sum_probs=98.3
Q ss_pred eeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCC---------------CHHH-----HHHHHHHHHHHHHcCCCcee
Q 002157 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------------SGAA-----LLEFKREVKIMRRLRHPNVV 736 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~---------------~~~~-----~~ef~~Ei~IL~~L~HpNIV 736 (959)
|+|++.||.|+||.||+|.. +|+.||||+++.... .... .....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999986 788999998753210 0000 11124567777777544432
Q ss_pred --EEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-
Q 002157 737 --LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW- 813 (959)
Q Consensus 737 --kL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g- 813 (959)
..+++ ...+|||||++|+.|.++... . ....++.||+.+|.|||.+| ||||||||.||||+++|
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 22221 123699999999888776432 1 23457789999999999999 99999999999998776
Q ss_pred ---------cEEEEecCcccc
Q 002157 814 ---------NVKVSDFGLSRL 825 (959)
Q Consensus 814 ---------~VKLiDFGlAk~ 825 (959)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=7.1e-12 Score=131.27 Aligned_cols=141 Identities=16% Similarity=0.040 Sum_probs=111.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEec
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+.|++...++.|+++.||++...++.+++|+....... ....+.+|+.+|+.+. +..+.++++++...+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46888899999999999999888899999987642111 1235788999999984 67788999999888899999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST---------------------------------------- 794 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g---------------------------------------- 794 (959)
++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999886421 1122367789999999999810
Q ss_pred -----------------CCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 795 -----------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 795 -----------------~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 249999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=119.79 Aligned_cols=136 Identities=18% Similarity=0.137 Sum_probs=100.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN--IVkL~g~~~~~~~l~LVm 752 (959)
..|.+....+.|..+.||++.. +|..++||+..... ...+.+|+.+++.+.+.+ +.++++++...+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 4566655445666799999976 46779999865431 134678999999885434 566888888888899999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-------------------------------------- 794 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g-------------------------------------- 794 (959)
||++|..|. ... .. ...++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998884 221 12 1245667888888888743
Q ss_pred ------------------CCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 795 ------------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 795 ------------------~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..++|+|++|.|||++.++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.2e-10 Score=124.71 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=107.6
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEee--ccCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecC---CcEEEEE
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRP---PNLSIIT 752 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~--~~~~~~~~~~ef~~Ei~IL~~L~--HpNIVkL~g~~~~~---~~l~LVm 752 (959)
..+.|+.|.++.||+++..+..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46779999999999999888889999765 2211 112346788999999996 45578888888776 4588999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------------------------------------- 793 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~--------------------------------------- 793 (959)
||++|..+.+... ..++......++.+++..|..||..
T Consensus 121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999887754221 2367778888999999999999973
Q ss_pred -----------------CCCEEeeCCCCCcEEEcCCCc--EEEEecCcccc
Q 002157 794 -----------------TPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 825 (959)
Q Consensus 794 -----------------g~~IIHRDLKPeNILLd~~g~--VKLiDFGlAk~ 825 (959)
...+||||+++.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997653 69999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.1e-09 Score=115.77 Aligned_cols=185 Identities=19% Similarity=0.170 Sum_probs=122.4
Q ss_pred eEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCc--eeEEeeeeecCC---cEEEEEecc
Q 002157 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN--VVLFMGAVTRPP---NLSIITEFL 755 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpN--IVkL~g~~~~~~---~l~LVmEy~ 755 (959)
+.++.|.+..||++. ..++||+... ......+.+|..+|+.+ .+.. +.+.+....... ..|+|||++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999874 6788997532 23456788999999988 3332 344554443333 347899999
Q ss_pred CCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 002157 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST----------------------------------------- 794 (959)
Q Consensus 756 ~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g----------------------------------------- 794 (959)
+|..|..... ..++...+..++.+++..|..||...
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875432 23667777778888888888888611
Q ss_pred ---------------CCEEeeCCCCCcEEEcC--CCcEEEEecCccccccCCcccCCCCCCCCCccCccccc----CCC-
Q 002157 795 ---------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR----NEP- 852 (959)
Q Consensus 795 ---------------~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~----g~~- 852 (959)
+.++|+|++|.|||++. .+.+.|+||+.+........- ........-..|+.+. ...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCHHHHHHHHHHcCC
Confidence 24899999999999998 566899999988754321110 0000000002333321 111
Q ss_pred C---------CchhHHHHHHHHHHHHHhCCCCCC
Q 002157 853 S---------NEKCDVYSFGVILWELATLKLPWI 877 (959)
Q Consensus 853 ~---------s~ksDIWSLGiLLyELLtG~~PF~ 877 (959)
. ....++|+|+.++|.+.+|..+|.
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 112689999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.3e-06 Score=92.80 Aligned_cols=136 Identities=18% Similarity=0.145 Sum_probs=94.7
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC---ceeEEeeeee-cCCcEEEEEeccC
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVT-RPPNLSIITEFLP 756 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~Hp---NIVkL~g~~~-~~~~l~LVmEy~~ 756 (959)
++.++.|....||+. +..++||+-. .......+.+|..+|+.+.+. .|.+.+.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 355899999999998 7889999742 233456788999999999642 2556666653 4556789999999
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------------------------------------------ 794 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g------------------------------------------ 794 (959)
|..|....-. .++......++.++...|..||...
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9888763211 2344444455555555555555421
Q ss_pred ----------------CCEEeeCCCCCcEEEcC---CCc-EEEEecCccccc
Q 002157 795 ----------------PTIVHRDLKSPNLLVDK---NWN-VKVSDFGLSRLK 826 (959)
Q Consensus 795 ----------------~~IIHRDLKPeNILLd~---~g~-VKLiDFGlAk~~ 826 (959)
+.++|+|+++.|||++. ++. +.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24799999999999987 455 489999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.7e-06 Score=88.02 Aligned_cols=133 Identities=18% Similarity=0.230 Sum_probs=94.2
Q ss_pred EeeccCcE-EEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLGSYG-EVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG~fG-~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.+..|..| .||+... .+..++||+-... ....+.+|..+|+.+. +--|.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556555 6898765 4567899975432 3456788999999884 333677888888888999999999998
Q ss_pred CHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 002157 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-------------------------------------------- 794 (959)
Q Consensus 759 sL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g-------------------------------------------- 794 (959)
.+.+..... ......++.+++..|..||...
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765321 1122234556666666666421
Q ss_pred ------------CCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 795 ------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 795 ------------~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1289999999999999877778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.8e-06 Score=92.89 Aligned_cols=83 Identities=6% Similarity=-0.039 Sum_probs=55.3
Q ss_pred eEEeEe-eccCcEEEEEEEEC--------CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcC-C--CceeEEeeeeecC
Q 002157 679 VLGERI-GLGSYGEVYHADWN--------GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTRP 745 (959)
Q Consensus 679 ~I~k~L-GkG~fG~VYka~~~--------g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~-H--pNIVkL~g~~~~~ 745 (959)
...+.| +.|....+|++... +..+++|+...... .......+.+|+.+|+.+. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999998764 67889997543220 0000124567888888773 2 3466777776655
Q ss_pred ---CcEEEEEeccCCCCHH
Q 002157 746 ---PNLSIITEFLPRGSLF 761 (959)
Q Consensus 746 ---~~l~LVmEy~~gGsL~ 761 (959)
+..++||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999886654
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.6e-06 Score=93.03 Aligned_cols=103 Identities=15% Similarity=0.097 Sum_probs=70.0
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHhhCCceeEeeeeccccchhhHHHHH
Q 002157 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (959)
Q Consensus 196 L~~~a~~l~~~l~~~~~~~~v~~LA~lV~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~g~~~~~a~lfk 275 (959)
|.+.|..+..+ .....+.++.|...|.+.+. ........... ...-| .-++|+|+++|.||-
T Consensus 128 i~~~A~~~~~~--~~~~~~~~~ai~~~v~~~~~-Y~~~~~~~~~~---a~~~l------------~~~~G~C~d~A~l~v 189 (293)
T 3isr_A 128 LQKLAYKEFGK--IENVYSKVLAITDWIYNNVE-YISGSTNSQTS---AFDTI------------TERAGVCRDFAHLGI 189 (293)
T ss_dssp SHHHHHHHHTT--CCSHHHHHHHHHHHHHHHSE-ECTTSCCTTCC---HHHHH------------HHCEECHHHHHHHHH
T ss_pred HHHHHHHHhcc--CCCHHHHHHHHHHHHHhhcE-EeccCCCCCCC---HHHhh------------cCCcEehHHHHHHHH
Confidence 55566666655 33556788999999988754 22111100011 11112 236899999999999
Q ss_pred HHhhccCCceEEeeccccCC--CCCCeeEEEEecCcceeeeecc
Q 002157 276 VLADSIRLPCRLVKGSHYTG--VEDDAVNIIKLEEEREFLVDLM 317 (959)
Q Consensus 276 ~l~d~~~~~~~lv~G~~~~~--~~~~a~~~v~~~~~~~~~~Dlm 317 (959)
.||..+|||||+|.|..... .+.|||++|.+ +|.|+.||-=
T Consensus 190 al~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl-~ggWv~~DpT 232 (293)
T 3isr_A 190 ALCRALSIPARYFTGYAFKLNPPDFHACFEAYI-GGNWIIFDAT 232 (293)
T ss_dssp HHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEE-TTEEEEECTT
T ss_pred HHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEE-CCcEEEEECC
Confidence 99999999999999943221 23499999999 5699999953
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=2e-05 Score=84.58 Aligned_cols=138 Identities=14% Similarity=0.059 Sum_probs=79.4
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeEEee------eeecCCcEEEEE
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMG------AVTRPPNLSIIT 752 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~--HpNIVkL~g------~~~~~~~l~LVm 752 (959)
.+.|+.|..+.||++...+..+++|+.... . ..+..|..+++.|. .-.+.+++. +....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777788999999887777999987642 1 22334555555552 112333332 123456788999
Q ss_pred eccCCCCHH-----------HH---hh---CCCC-C---------CCHHH------------------------------
Q 002157 753 EFLPRGSLF-----------RI---LH---RPHC-Q---------VDEKR------------------------------ 775 (959)
Q Consensus 753 Ey~~gGsL~-----------dl---L~---k~~~-~---------lse~~------------------------------ 775 (959)
||++|..+. .. ++ .... . ..+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986432 11 11 1000 0 11110
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 776 -RIKMALDVARGMNCLHT-----------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 776 -~l~Ia~QIa~AL~yLHs-----------~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...+..++..++.+|+. ....+||+|+++.|||++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 00111223345666653 22359999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.3e-05 Score=87.36 Aligned_cols=77 Identities=16% Similarity=0.107 Sum_probs=49.0
Q ss_pred EEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC--CH---HHHHHHHHHHHHHHHcCC--Cc-eeEEeeeeecCCcEE
Q 002157 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG---AALLEFKREVKIMRRLRH--PN-VVLFMGAVTRPPNLS 749 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~--~~---~~~~ef~~Ei~IL~~L~H--pN-IVkL~g~~~~~~~l~ 749 (959)
-.+.||.|.++.||+++. .++.|+||....... .+ .....+..|.++|+.+.. +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999954 567899997653211 00 112345778889888732 33 4455543 344568
Q ss_pred EEEeccCCC
Q 002157 750 IITEFLPRG 758 (959)
Q Consensus 750 LVmEy~~gG 758 (959)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00011 Score=80.61 Aligned_cols=76 Identities=20% Similarity=0.126 Sum_probs=61.1
Q ss_pred EEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCcEEEEEeccC
Q 002157 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLP 756 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~---HpNIVkL~g~~~~~~~l~LVmEy~~ 756 (959)
-.+.|+.|.+..+|+....+..++||+.... ....+.+|...|+.|. ...+++.+.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3577899999999999888889999986543 2456788999998883 3567888888887788999999999
Q ss_pred CCCH
Q 002157 757 RGSL 760 (959)
Q Consensus 757 gGsL 760 (959)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00018 Score=81.17 Aligned_cols=76 Identities=17% Similarity=0.162 Sum_probs=45.7
Q ss_pred CCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCCCCC--CCCccCcccccCCC---CCchhHHHHHHHHHHHH
Q 002157 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEWMAPEVLRNEP---SNEKCDVYSFGVILWEL 869 (959)
Q Consensus 795 ~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t~~G--T~~YmAPEvl~g~~---~s~ksDIWSLGiLLyEL 869 (959)
..++|+|+++.|||++.++ ++|+||+.+..-.....- ..... ...|++|+...... .....++..+...+|++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3599999999999998876 999999988753321100 00000 12355665543211 12234555777777777
Q ss_pred HhC
Q 002157 870 ATL 872 (959)
Q Consensus 870 LtG 872 (959)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=4.4e-05 Score=83.19 Aligned_cols=51 Identities=18% Similarity=0.182 Sum_probs=46.4
Q ss_pred eccccchhhHHHHHHHhhccCCceEEeeccccCCCCCCeeEEEEecC-cceeeeecc
Q 002157 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDLM 317 (959)
Q Consensus 262 i~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~~~~~~a~~~v~~~~-~~~~~~Dlm 317 (959)
-++|+|+++|.||-.||-.+|||||+|-| | +.|||++|.+.. ..|+-||--
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g~~gWv~~Dpt 189 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDAC 189 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEETT
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECCCCeEEEEeCC
Confidence 37899999999999999999999999999 5 689999999966 589999965
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00034 Score=75.11 Aligned_cols=145 Identities=12% Similarity=0.078 Sum_probs=81.4
Q ss_pred CeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeee------eecCCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGA------VTRPPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN--IVkL~g~------~~~~~~l 748 (959)
+..-.+.|+.|....+|++...+..+++|+..... ....+..|+.+++.+...+ +.+++.. ....+..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 44456778889999999998876789999876521 1124556777777763211 2333321 1223567
Q ss_pred EEEEeccCCCCHHH-----------H---hhC---C-CCC----CC---HHHHHH------------HHHHHHHHHHHHH
Q 002157 749 SIITEFLPRGSLFR-----------I---LHR---P-HCQ----VD---EKRRIK------------MALDVARGMNCLH 791 (959)
Q Consensus 749 ~LVmEy~~gGsL~d-----------l---L~k---~-~~~----ls---e~~~l~------------Ia~QIa~AL~yLH 791 (959)
+++|+|++|..+.. . ++. . ... .. +...+. +...+...+.+++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 89999998764311 0 111 0 000 11 111000 0011334455554
Q ss_pred hC-----CCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 792 TS-----TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 792 s~-----g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.. ...+||+|+.+.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 31 12499999999999998876668999997753
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0003 Score=82.15 Aligned_cols=104 Identities=13% Similarity=0.120 Sum_probs=68.6
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHhhCCceeEeeeeccccchhhHHHHH
Q 002157 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (959)
Q Consensus 196 L~~~a~~l~~~l~~~~~~~~v~~LA~lV~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~g~~~~~a~lfk 275 (959)
++++|..+..+ ..+..+.++.|-.+|.+.+.=.....+..-..-.....-|+.. .|.|...|+||.
T Consensus 230 i~~~a~~l~~~--~~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~~a~~vl~~~------------~G~C~d~a~Ll~ 295 (506)
T 3kd4_A 230 SKTFAQFLTDK--SGNEQEKVNIIRDHILNNLSTCPIPMAMTGYTVRDIDTVLRSA------------YGTPLEIAQLLN 295 (506)
T ss_dssp HHHHHHHHHSS--CSSHHHHHHHHHHHHHHHCEECCCCGGGGTTCCCCHHHHHHHT------------EECHHHHHHHHH
T ss_pred HHHHHHHHHhc--CCCHHHHHHHHHHHHHhccEecceecccCCCCCCCHHHHHHhC------------CcchHHHHHHHH
Confidence 44455566655 4456677788888887776311000000000000122233333 699999999999
Q ss_pred HHhhccCCceEEeeccccCCCC----------CCeeEEEEecCcceeeeec
Q 002157 276 VLADSIRLPCRLVKGSHYTGVE----------DDAVNIIKLEEEREFLVDL 316 (959)
Q Consensus 276 ~l~d~~~~~~~lv~G~~~~~~~----------~~a~~~v~~~~~~~~~~Dl 316 (959)
.||..+||||++|-+ |++.. +|+|+.|++ ||+||++|-
T Consensus 296 AllRa~GIpA~~v~~--~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 296 VMLNAAGIPSEVLAV--YPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp HHHHHTTCCEEEEEE--EETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred HHHHHCCCCcEEEEE--EcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 999999999999998 44422 599999998 999999997
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00087 Score=72.63 Aligned_cols=138 Identities=14% Similarity=0.110 Sum_probs=70.8
Q ss_pred eEeeccCcEE-EEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C-CceeEEeeeeecCCcEEEEEeccCC
Q 002157 682 ERIGLGSYGE-VYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-PNVVLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 682 k~LGkG~fG~-VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-H-pNIVkL~g~~~~~~~l~LVmEy~~g 757 (959)
+.|+.|.... +|+.... +..+++|....... ..+..|+.+++.+. + -.+.+++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 3466665554 6677764 77787776433210 22345677777663 2 23455665533333 689999977
Q ss_pred CCHHHHhh---------------------CC----CCCCCHHHHH-------H-H------------HHHHHHHHHHHH-
Q 002157 758 GSLFRILH---------------------RP----HCQVDEKRRI-------K-M------------ALDVARGMNCLH- 791 (959)
Q Consensus 758 GsL~dlL~---------------------k~----~~~lse~~~l-------~-I------------a~QIa~AL~yLH- 791 (959)
..+.+.+. .. ...+...... . + ...+...+..|.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654331 10 0011111100 0 0 001111222221
Q ss_pred ---hCCCCEEeeCCCCCcEEEcCC----CcEEEEecCccccc
Q 002157 792 ---TSTPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRLK 826 (959)
Q Consensus 792 ---s~g~~IIHRDLKPeNILLd~~----g~VKLiDFGlAk~~ 826 (959)
.....+||||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 122359999999999999874 68999999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0016 Score=68.46 Aligned_cols=141 Identities=18% Similarity=0.153 Sum_probs=97.5
Q ss_pred CCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCCC
Q 002157 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (959)
Q Consensus 757 gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLH-s~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~t 835 (959)
..+|.++|...+.++++.++|.++.|.+.+|.-+- ... -..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 34899999888889999999999999999987762 111 11233457999999999998864 1110
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhc
Q 002157 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (959)
Q Consensus 836 ~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~ 915 (959)
.....+.+||... ...+.+.-|||||++||..+--..| ..-+..+++.+.+||..|...
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhc
Confidence 1223566888763 3456889999999999999853332 122346899999999999866
Q ss_pred C-------------------------CCCCCCHHHHHHHHHh
Q 002157 916 D-------------------------PSLRPSFAQLTVALKP 932 (959)
Q Consensus 916 D-------------------------P~kRPSa~EIL~~Le~ 932 (959)
+ +..|.++++|++.=+.
T Consensus 157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp CC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 2 4688999999876654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00074 Score=72.36 Aligned_cols=135 Identities=16% Similarity=0.117 Sum_probs=74.4
Q ss_pred EeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCcEEEEEecc-CCC
Q 002157 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFL-PRG 758 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~-~gG 758 (959)
.+.|+.|....+|++ ..+++|+..... .......+|..+++.+...++ .++++++ .+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 577999999999999 678889765421 111123467777777632222 4555543 33346899999 654
Q ss_pred CHHH---------------H---hhCCCCCC----CH-HHHHHHHH--------------HHHHHHH----HHH--hCCC
Q 002157 759 SLFR---------------I---LHRPHCQV----DE-KRRIKMAL--------------DVARGMN----CLH--TSTP 795 (959)
Q Consensus 759 sL~d---------------l---L~k~~~~l----se-~~~l~Ia~--------------QIa~AL~----yLH--s~g~ 795 (959)
.|.. . ++.....+ .. ..+..+.. .+...+. .|. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 0 11111111 11 11111100 0111111 111 1123
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 796 ~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667889999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0013 Score=74.87 Aligned_cols=71 Identities=14% Similarity=0.228 Sum_probs=48.4
Q ss_pred EeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCcEEE
Q 002157 681 GERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSI 750 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN-IVkL~g~~~~~~~l~L 750 (959)
.+.|+.|....||++... +..+.+|+..... . ...+.+|..+++.|...+ ..++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 467888999999999864 4689999874321 1 124457888888884323 3567766543 38
Q ss_pred EEeccCCCC
Q 002157 751 ITEFLPRGS 759 (959)
Q Consensus 751 VmEy~~gGs 759 (959)
|+||++|..
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.003 Score=67.11 Aligned_cols=78 Identities=17% Similarity=0.158 Sum_probs=54.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C--CceeEEeeeeecCCcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-H--pNIVkL~g~~~~~~~l~LV 751 (959)
.+..-.+.+|.|..+.||+.+. +|+.|.||+....... ....|.+|...|+.|. . --+++.+++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3456678899999999999987 6889999976543221 1234678999999884 2 1244555542 23689
Q ss_pred EeccCCCC
Q 002157 752 TEFLPRGS 759 (959)
Q Consensus 752 mEy~~gGs 759 (959)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99987664
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0015 Score=71.96 Aligned_cols=72 Identities=13% Similarity=0.156 Sum_probs=43.2
Q ss_pred EeEeeccCcEEEEEEEECC----------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCcEE
Q 002157 681 GERIGLGSYGEVYHADWNG----------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLS 749 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g----------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN-IVkL~g~~~~~~~l~ 749 (959)
.+.|+.|....+|++...+ ..+++|+..... ........|..+++.+...+ +.++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4568888889999998754 678888764321 11112357888888774223 446665442 26
Q ss_pred EEEeccCCCC
Q 002157 750 IITEFLPRGS 759 (959)
Q Consensus 750 LVmEy~~gGs 759 (959)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.002 Score=74.34 Aligned_cols=73 Identities=18% Similarity=0.122 Sum_probs=47.8
Q ss_pred EeEeeccCcEEEEEEEECC--ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCcEEEEEeccCC
Q 002157 681 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPR 757 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~g--~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~~g 757 (959)
++.|+.|-...+|++...+ ..+++|+..... . ......+|..+++.|...++ .++++.+.. .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D--EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C--SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h--hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 4678889999999999876 789999864321 0 01112578999998864444 567776632 359999987
Q ss_pred CCH
Q 002157 758 GSL 760 (959)
Q Consensus 758 GsL 760 (959)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0014 Score=73.85 Aligned_cols=137 Identities=13% Similarity=0.159 Sum_probs=79.1
Q ss_pred eEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEE
Q 002157 682 ERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 682 k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LV 751 (959)
+.|..|-...+|++... +..|.+|+.... . .....+.+|.++++.|. +.-..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 46777888899999763 367899875321 1 12345568999998883 3333566766654 389
Q ss_pred EeccCCCCHHH--------------H---hhCCC----CCCC--HHHHHHHHHHHH-------------------HHHHH
Q 002157 752 TEFLPRGSLFR--------------I---LHRPH----CQVD--EKRRIKMALDVA-------------------RGMNC 789 (959)
Q Consensus 752 mEy~~gGsL~d--------------l---L~k~~----~~ls--e~~~l~Ia~QIa-------------------~AL~y 789 (959)
|||++|..|.. . |+... .... +.++.++..++- ..+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998755431 1 12211 1111 233333433321 12222
Q ss_pred H----HhC--CCCEEeeCCCCCcEEEcCC----CcEEEEecCcccc
Q 002157 790 L----HTS--TPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 825 (959)
Q Consensus 790 L----Hs~--g~~IIHRDLKPeNILLd~~----g~VKLiDFGlAk~ 825 (959)
| ... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 222 1259999999999999876 7899999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0063 Score=66.83 Aligned_cols=31 Identities=23% Similarity=0.408 Sum_probs=27.7
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 796 ~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5999999999999998888999999887653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0089 Score=64.17 Aligned_cols=138 Identities=12% Similarity=0.098 Sum_probs=78.1
Q ss_pred eEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeEEeee-----eecCCcEEEEEe
Q 002157 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGA-----VTRPPNLSIITE 753 (959)
Q Consensus 682 k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H--pNIVkL~g~-----~~~~~~l~LVmE 753 (959)
..|+ |....||++.. +|+.+++|+........ ..+..|..+++.+.. -.+++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3466 88889999876 45689999876433322 345668888877732 123444432 223455678999
Q ss_pred ccCCCCHH-----------HH---hh----CC----CCCCCHHHH----------------------HHHHHHHHHHHHH
Q 002157 754 FLPRGSLF-----------RI---LH----RP----HCQVDEKRR----------------------IKMALDVARGMNC 789 (959)
Q Consensus 754 y~~gGsL~-----------dl---L~----k~----~~~lse~~~----------------------l~Ia~QIa~AL~y 789 (959)
|++|..+. .. ++ .. ....+.... ...+.+++..+.-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875431 11 11 10 011121110 0111122222221
Q ss_pred HHh--CCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 790 LHT--STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 790 LHs--~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+-. ....+||+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111 223589999999999999 4 899999988754
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0026 Score=70.26 Aligned_cols=51 Identities=24% Similarity=0.124 Sum_probs=45.4
Q ss_pred ccccchhhHHHHHHHhhccCCceEEeeccccCCCCCCeeEEEEecC-cceeeeeccc
Q 002157 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDLMA 318 (959)
Q Consensus 263 ~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~~~~~~a~~~v~~~~-~~~~~~Dlm~ 318 (959)
+.|.|.|+|.||-.||-.+|||||+|-| ..+|+|++|.... ++|.=||-..
T Consensus 180 r~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~rWv~vDp~~ 231 (335)
T 1x3z_A 180 RKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVDSCE 231 (335)
T ss_dssp CEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEETTT
T ss_pred CCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCCCEEEECCCC
Confidence 4799999999999999999999999988 3589999999976 5799999654
|
| >2q3z_A Transglutaminase 2; transglutaminase 2, tissue transglutaminase, TG2, transferas; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1kv3_A 3ly6_A* | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0042 Score=74.56 Aligned_cols=54 Identities=15% Similarity=0.072 Sum_probs=44.3
Q ss_pred eccccchhhHHHHHHHhhccCCceEEeeccc--------------cC--C----------CCCCeeEEEEec------C-
Q 002157 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSH--------------YT--G----------VEDDAVNIIKLE------E- 308 (959)
Q Consensus 262 i~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~--------------~~--~----------~~~~a~~~v~~~------~- 308 (959)
.+.|+|+++|-+|-++|-.+|||||+|.|.. |. | ++-|||++|-+. .
T Consensus 272 ~k~G~C~dfA~~~~~llRalGIPAR~VsGy~~~~~~~~~l~~d~~~~~~g~~~~~~~d~~~~~HAW~Ev~~~rpDLp~g~ 351 (687)
T 2q3z_A 272 VKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGY 351 (687)
T ss_dssp EEEECHHHHHHHHHHHHHHHTCCEEEEEEEEEECC--CCHHHHHHHC---------CCCCBSEEEEEEEEECCTTSSTTC
T ss_pred cceeehHHHHHHHHHHHHhCCCCcEEEeecccccccccccccccccCCCCceeeecCCcccceeEEEEEEcccCCCCCCC
Confidence 7899999999999999999999999999943 11 2 123999999996 3
Q ss_pred cceeeee
Q 002157 309 EREFLVD 315 (959)
Q Consensus 309 ~~~~~~D 315 (959)
+-|..||
T Consensus 352 ~GW~~~D 358 (687)
T 2q3z_A 352 EGWQALD 358 (687)
T ss_dssp CEEEEEC
T ss_pred CCEEEEC
Confidence 5788887
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.01 Score=67.88 Aligned_cols=73 Identities=14% Similarity=0.147 Sum_probs=47.7
Q ss_pred EeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEE
Q 002157 681 GERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~L 750 (959)
++.|..|-...+|++... +..|++|+..... .......+|.++++.+. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456778888999999875 6789999854321 11112357888888874 322445555432 268
Q ss_pred EEeccCCCCH
Q 002157 751 ITEFLPRGSL 760 (959)
Q Consensus 751 VmEy~~gGsL 760 (959)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999988653
|
| >1vjj_A Protein-glutamine glutamyltransferase E; transglutaminase 3, X-RAY crystallography, metalloenzyme, calcium ION; HET: GDP; 1.90A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1sgx_A* 1l9m_A 1l9n_A* 1nud_A 1nuf_A 1nug_A 1rle_A* | Back alignment and structure |
|---|
Probab=95.77 E-value=0.004 Score=74.64 Aligned_cols=102 Identities=15% Similarity=0.130 Sum_probs=63.3
Q ss_pred chHHHHHHHHHHHHhhc-CCCCC-------ChhHHHHhHHHHHHHHHHhhCCceeEeeeeccccchhhHHHHHHHhhccC
Q 002157 211 DVGILVQQLADLVNGHM-GGPVK-------DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIR 282 (959)
Q Consensus 211 ~~~~~v~~LA~lV~~~m-gg~~~-------~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~g~~~~~a~lfk~l~d~~~ 282 (959)
+...++..|+..|...- .|.+. ..+..-..|.-....|++-+.+.+.| +|.|+|+|+|-+|-+|+-.+|
T Consensus 211 dpv~v~r~lsa~vn~~~d~gvl~g~w~~~y~~g~~P~~~~gs~~il~~~~~~~~~P---V~~G~C~~fA~~~~~~lR~lG 287 (692)
T 1vjj_A 211 DPKYVGRVLSAMINSNDDNGVLAGNWSGTYTGGRDPRSWNGSVEILKNWKKSGLSP---VRYGQCWVFAGTLNTALRSLG 287 (692)
T ss_dssp CHHHHHHHHHHHTBCTTTTCSEEECCSSCCTTSCCGGGCCBSHHHHHHHHHTTSCC---EEEECHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhhccCccceeecccccccCCCcCCcccCChHHHHHHHHHcCCCc---ccceeeHHHHHHHHHHHHhCC
Confidence 44556677777775431 11110 11112233432223333333334444 578999999999999999999
Q ss_pred CceEEeecc--------------ccCC-------C-----CCCeeEEEEecC-------cceeeee
Q 002157 283 LPCRLVKGS--------------HYTG-------V-----EDDAVNIIKLEE-------EREFLVD 315 (959)
Q Consensus 283 ~~~~lv~G~--------------~~~~-------~-----~~~a~~~v~~~~-------~~~~~~D 315 (959)
||||+|.|. ||+. . +=|||+++-+.. +.|+.||
T Consensus 288 IPaR~Vtgy~s~~d~~~nL~~d~~~~~~g~~~~~~~dsIW~~HaW~E~w~~rpDLp~~~~gW~~~D 353 (692)
T 1vjj_A 288 IPSRVITNFNSAHDTDRNLSVDVYYDPMGNPLDKGSDSVWNFHVWNEGWFVRSDLGPSYGGWQVLD 353 (692)
T ss_dssp CCEEEEEEEEEEECSSSSSEEEEEECTTSCBCCCCSCEEEEEEEEEEEEECCTTTCGGGCEEEEEC
T ss_pred CCeeEEcccccccCCCCCcccceeeccCCcccccccccccceeEEEEEeccccCCCCCCCCEEEEC
Confidence 999999995 2221 1 139999999853 6788888
|
| >1g0d_A Protein-glutamine gamma-glutamyltransferase; tissue transglutaminase,acyltransferase; 2.50A {Pagrus major} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 | Back alignment and structure |
|---|
Probab=95.55 E-value=0.0079 Score=72.02 Aligned_cols=103 Identities=14% Similarity=0.137 Sum_probs=64.2
Q ss_pred CchHHHHHHHHHHHHhhc-CCCCC-------ChhHHHHhHHHHHHHHHHhhCCceeEeeeeccccchhhHHHHHHHhhcc
Q 002157 210 TDVGILVQQLADLVNGHM-GGPVK-------DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSI 281 (959)
Q Consensus 210 ~~~~~~v~~LA~lV~~~m-gg~~~-------~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~g~~~~~a~lfk~l~d~~ 281 (959)
.+...++..|+..|...- .|.+. ..+..-..|.-....|++-+.+.+.| +|.|.|.|+|-+|-+++-.+
T Consensus 210 ~dpv~v~r~lsa~vn~~dD~gvl~g~W~~~y~~g~~P~~w~gs~~il~~~~~~~~~P---V~~G~C~~fA~v~~t~lR~l 286 (695)
T 1g0d_A 210 SDPVYVGRTITAMVNSNGDRGVLTGRWEEPYTDGVAPYRWTGSVPILQQWSKAGVRP---VKYGQCWVFAAVACTVLRCL 286 (695)
T ss_dssp TCHHHHHHHHHHHHTTCTTTCSEEECCSSCCTTSCCGGGCSBSHHHHHHHHHTTSCC---EEEECHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhhccCcCceeecccccccCCCcCCcccCChHHHHHHHHHcCCCc---ccceeeHHHHHHHHHHHHhC
Confidence 345566788888886542 11111 11112233433333333333334444 58899999999999999999
Q ss_pred CCceEEeeccccC-----------------------CCC-----CCeeEEEEecC-------cceeeee
Q 002157 282 RLPCRLVKGSHYT-----------------------GVE-----DDAVNIIKLEE-------EREFLVD 315 (959)
Q Consensus 282 ~~~~~lv~G~~~~-----------------------~~~-----~~a~~~v~~~~-------~~~~~~D 315 (959)
|||||+|.|..+. ... =|+|+++-+.. +-|..||
T Consensus 287 GIPaR~Vtgy~sa~d~~~nL~id~~~~~~g~~~~~~~~~dsiw~~HaW~E~w~~rpDLp~~~~gWq~~D 355 (695)
T 1g0d_A 287 GIPTRPITNFASAHDVDGNLSVDFLLNERLESLDSRQRSDSSWNFHCWVESWMSREDLPEGNDGWQVLD 355 (695)
T ss_dssp TCCEEEEEEEEETTTTTTCSEEEEEECTTSCBSCTTCCBCSSEEEEEEEEEEECCTTSCTTCCEEEEEE
T ss_pred CCCeeEEccccccCCCCCccceeeeecccCceecccccCCcceeeEEEEEeecccCCCCCCCCCeEEEc
Confidence 9999999994211 111 28999999853 5688888
|
| >1ex0_A Coagulation factor XIII A chain; transglutaminase, blood coagulation, mutant, W279F, oxyanion, transferase; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1evu_A 1fie_A 1f13_A 1ggt_A 1ggu_A 1ggy_A 1qrk_A | Back alignment and structure |
|---|
Probab=94.97 E-value=0.015 Score=70.07 Aligned_cols=31 Identities=19% Similarity=0.343 Sum_probs=29.0
Q ss_pred eeccccchhhHHHHHHHhhccCCceEEeecc
Q 002157 261 SINIGLSRHRALLFKVLADSIRLPCRLVKGS 291 (959)
Q Consensus 261 ~i~~g~~~~~a~lfk~l~d~~~~~~~lv~G~ 291 (959)
.+|.|.|.|+|-+|-+++-.+|||||+|.|.
T Consensus 308 PV~~G~C~~fA~v~~~~lR~lGIPaRvVtgy 338 (731)
T 1ex0_A 308 PVRYGQCWVFAGVFNTFLRCLGIPARIVTNY 338 (731)
T ss_dssp CEEEECHHHHHHHHHHHHHHHTCCEEEEEEE
T ss_pred ccceeeehhHHHHHHHHHHhCCCCeeEEccc
Confidence 3688999999999999999999999999993
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.16 E-value=0.12 Score=58.05 Aligned_cols=29 Identities=24% Similarity=0.425 Sum_probs=25.2
Q ss_pred EEeeCCCCCcEEE------cCCCcEEEEecCcccc
Q 002157 797 IVHRDLKSPNLLV------DKNWNVKVSDFGLSRL 825 (959)
Q Consensus 797 IIHRDLKPeNILL------d~~g~VKLiDFGlAk~ 825 (959)
++|+|+.+.|||+ +++..++|+||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.02 E-value=3.8 Score=42.77 Aligned_cols=116 Identities=11% Similarity=0.096 Sum_probs=79.4
Q ss_pred CCCceeEEeeeeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 002157 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (959)
Q Consensus 731 ~HpNIVkL~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd 810 (959)
.||+++.. .+-..++.+.|.++.-+.+.=+..++ .++...+++++.+|+....+++. -+|-=|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEc
Confidence 68888866 56666677766666544332233343 47788899999999988865554 37888999999999
Q ss_pred CCCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002157 811 KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (959)
Q Consensus 811 ~~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 877 (959)
.++.+++.=-|+-.. ++|. ..+...=+-.+=|++..++.++..|.
T Consensus 114 ~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999976664322 2222 12333444567788889999888773
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 959 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-82 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-76 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-72 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-72 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-71 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-71 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-70 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-70 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-70 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-69 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-68 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-67 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-66 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-66 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-65 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-63 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-60 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (678), Expect = 2e-82
Identities = 93/273 (34%), Positives = 151/273 (55%), Gaps = 13/273 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
EIP + +G+RIG GS+G VY W+G VAVK + L FK EV ++R+ R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
H N++LFMG T P L+I+T++ SL+ LH + + + I +A A+GM+ LH
Sbjct: 63 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 849
+I+HRDLKS N+ + ++ VK+ DFGL+ +K S + +G+ WMAPEV+R
Sbjct: 122 A--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 850 NE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----EIPKELD 902
+ P + + DVY+FG++L+EL T +LP+ +N + + + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ R++ EC + RP F Q+ +++ L R
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (633), Expect = 3e-76
Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 13/267 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+ ++L L + IG G +G+V D+ G +VAVK + A F E +M +LR
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 732 HPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 789
H N+V +G + L I+TE++ +GSL L R + +K +LDV M
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
L VHRDL + N+LV ++ KVSDFGL++ +T + +W APE LR
Sbjct: 119 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P V +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEV 232
Query: 909 IWECWQTDPSLRPSFAQLTVALKPLQR 935
+ CW D ++RPSF QL L+ ++
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 2e-72
Identities = 80/257 (31%), Positives = 122/257 (47%), Gaps = 9/257 (3%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I +DL + +G G +G V + W +VA+K + S EF E K+M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 850
+ +HRDL + N LV+ VKVSDFGLSR + + + SS + W PEVL
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 851 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 910 WECWQTDPSLRPSFAQL 926
+ CW RP+F L
Sbjct: 235 YSCWHEKADERPTFKIL 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 238 bits (609), Expect = 3e-72
Identities = 87/287 (30%), Positives = 135/287 (47%), Gaps = 20/287 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 726
EI + + + IG G +GEV VA+K L ++ +F E I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASI 80
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M + HPNV+ G VT+ + IITEF+ GSL L + Q + + M +A G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPE 841
M L VHRDL + N+LV+ N KVSDFGLSR T+ S+
Sbjct: 141 MKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE ++ DV+S+G+++WE+ + + P+ M V+ A+ Q+ RL P +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947
+ +++ +CWQ D + RP F Q+ L + R +P+ +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR-----NPNSLKA 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 3e-72
Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 9/265 (3%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I +L + IG G +G V+ W N +VA+K + S +F E ++M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP +V G + ++ EF+ G L L + + M LDV GM L
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 850
++HRDL + N LV +N +KVSDFG++R + + + SS T +W +PEV
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 851 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 910 WECWQTDPSLRPSFAQLTVALKPLQ 934
CW+ P RP+F++L L +
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 5e-72
Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 11/261 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMN 788
N+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 789 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 906 ARIIWECWQTDPSLRPSFAQL 926
II RPS ++
Sbjct: 243 NEIITRMLNLKDYHRPSVEEI 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-71
Identities = 84/275 (30%), Positives = 142/275 (51%), Gaps = 14/275 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFK 721
++D+ E+P E L L ER+G G +GEV+ +N T+VAVK S F
Sbjct: 3 WWEDEW---EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFL 56
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMA 780
E +M++L+H +V VT+ P + IITE++ GSL L P ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
+A GM + +HRDL++ N+LV + K++DFGL+R ++ N + + +
Sbjct: 116 AQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 898
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 899 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ +++ CW+ P RP+F L L+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 3e-71
Identities = 87/274 (31%), Positives = 129/274 (47%), Gaps = 13/274 (4%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLE-FKREV 724
C I +DL L E++G GS+G V +W+ VAVK S ++ F REV
Sbjct: 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
M L H N++ G V PP + ++TE P GSL L + + A+ VA
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 841
GM L + +HRDL + NLL+ VK+ DFGL R + ++ +
Sbjct: 122 EGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934
+ ++ +CW P RP+F L L Q
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 1e-70
Identities = 91/282 (32%), Positives = 142/282 (50%), Gaps = 13/282 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT VA+K S F +E ++M++L
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 69
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 789
RH +V V+ P + I+TE++ +GSL L + + + MA +A GM
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVL 848
+ VHRDL++ N+LV +N KV+DFGL+RL + N + + + +W APE
Sbjct: 129 VER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 245
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 949
++ +CW+ +P RP+F L L+ QP L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-70
Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREV 724
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+IM +L +P +V +G V + L ++ E G L + L ++ ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 841
GM L VHRDL + N+L+ K+SDFGLS+ + + + + +
Sbjct: 120 MGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
P + ++ +CW RP F + ++
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 8e-70
Identities = 81/269 (30%), Positives = 126/269 (46%), Gaps = 12/269 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKI 726
EI E + LG IG G +G+V+ + E VA+K S + +F +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALT 61
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
MR+ HP++V +G +T + II E G L L +D I A ++
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 845
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ +T+ + +WMAP
Sbjct: 121 LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237
Query: 905 VARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ ++ +CW DPS RP F +L L +
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 8e-70
Identities = 79/255 (30%), Positives = 121/255 (47%), Gaps = 12/255 (4%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+ VY EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 738 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 794 TPTIVHRDLKSPN-LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
TP I+HRDLK N + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEKY 189
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
E DVY+FG+ + E+AT + P+ N Q+ V + K P V II
Sbjct: 190 D-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248
Query: 912 CWQTDPSLRPSFAQL 926
C + + R S L
Sbjct: 249 CIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 3e-69
Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 14/269 (5%)
Query: 673 IPWEDLVLGER-IGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ + L L ++ +G G++G V + VAVK ++ A E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
++L +P +V +G + + ++ E G L + L + + V +K I++ V+ GM
Sbjct: 63 QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMA 844
L S VHRDL + N+L+ K+SDFGLS+ N + + +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
Query: 904 LVARIIWECWQTDPSLRPSFAQLTVALKP 932
+ ++ CW D RP FA + + L+
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 229 bits (585), Expect = 5e-69
Identities = 89/268 (33%), Positives = 137/268 (51%), Gaps = 9/268 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ D+ + ++G G YGEVY W VAVK + EF +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 69
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMN 788
++HPN+V +G TR P IITEF+ G+L L +V + MA ++ M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
L +HRDL + N LV +N VKV+DFGLSR + +T+ + +W APE
Sbjct: 130 YLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
L + K DV++FGV+LWE+AT + + V + ++ R+E P+ V
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPLQR 935
++ CWQ +PS RPSFA++ A + + +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-68
Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT----EVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 728 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---------------V 771
+L HPN++ +GA L + E+ P G+L L + +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 772 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831
++ + A DVARGM+ L +HRDL + N+LV +N+ K++DFGLSR ++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 4e-68
Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-------EVAVKKFLDQDFSGAALLEFKREV 724
E P E+L G+ +G G++G+V +A G +VAVK L + + E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 91
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------------- 770
K+M +L H N+V +GA T + +I E+ G L L +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 771 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ + + A VA+GM L + VHRDL + N+LV VK+ DFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 822 LSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 878
L+R + ++ + +WMAPE L K DV+S+G++LWE+ +L P+ G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
+ + +++ P + I+ CW D RPSF LT L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 2e-67
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 19/279 (6%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P + + +G G++G+VY A A K + ++ E+ I+
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+V + A NL I+ EF G++ ++ + E + + +N LH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL--- 848
+ I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 128 DN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 849 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLV 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ + L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 906 ARIIWECWQTDPSLRPSFAQL-------TVALKPLQRLV 937
+ +C + + R + +QL + KP++ L+
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 4e-67
Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 19/286 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVK 725
EI + + IG G +GEVY + VA+K L ++ ++F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 61
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEW 842
GM L VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+ W
Sbjct: 122 GMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKEL 901
APE + DV+SFG+++WE+ T ++ +V+ A+ RL P +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 947
+ +++ +CWQ + + RP FA + L L R PD +
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-----APDSLKT 279
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 9e-67
Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 10/254 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
PN++ G + +I E+ P G+++R L + DE+R ++A ++ H+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 124
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRD+K NLL+ +K++DFG S ++ + GT +++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 913 WQTDPSLRPSFAQL 926
+ +PS RP ++
Sbjct: 239 LKHNPSQRPMLREV 252
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-66
Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 17/288 (5%)
Query: 667 DVCECEIPWEDLVL--GERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLE 719
V I L++ E IG G +G VYH D AVK L++ + +
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 720 FKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F E IM+ HPNV+ +G R ++ ++ G L + K I
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----NTFLSSK 834
L VA+GM L + VHRDL + N ++D+ + VKV+DFGL+R + ++ +
Sbjct: 135 FGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 893
+WMA E L+ + K DV+SFGV+LWEL T P+ +N + + Q R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 251
Query: 894 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 941
RL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 223 bits (568), Expect = 2e-66
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 37/295 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 724
E P ++ IG G++G V+ A T VAVK L ++ S +F+RE
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREA 67
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------- 770
+M +PN+V +G + ++ E++ G L L
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 771 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ ++ +A VA GM L VHRDL + N LV +N VK++DFG
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 822 LSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIG 878
LSR + + + + + A WM PE + + DV+++GV+LWE+ + L P+ G
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
M +V+ V L P+ + ++ CW P+ RPSF + L+ +
Sbjct: 246 MAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-65
Identities = 83/279 (29%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY D T VA+K +++ S +EF E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 74
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---------DEKR 775
+M+ +VV +G V++ +I E + RG L L + +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 135 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 836 TA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 251
Query: 893 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 9e-65
Identities = 86/300 (28%), Positives = 132/300 (44%), Gaps = 45/300 (15%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+VL E IG G +GEV+ W G EVAVK F ++ + E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENI 59
Query: 736 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+ F+ A + L +++++ GSLF L+R V + IK+AL A G+ LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 792 T------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPE 841
P I HRDLKS N+LV KN ++D GL+ ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 842 WMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------------ 883
+MAPEVL + S ++ D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 884 ---VVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935
+ V Q R IP E ++A+I+ ECW + + R + ++ L L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 9e-65
Identities = 67/263 (25%), Positives = 124/263 (47%), Gaps = 9/263 (3%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
+ P + E+IG G+ G VY A G EVA+++ Q E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINEI 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+MR ++PN+V ++ + L ++ E+L GSL ++ DE + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECL 126
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDP 903
PEV+ + K D++S G++ E+ + P++ NP++ + + L+ P++L
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 904 LVARIIWECWQTDPSLRPSFAQL 926
+ + C D R S +L
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (553), Expect = 3e-64
Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 19/272 (6%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAAL 717
+ F DD P + IG GS+G VY A N VA+KK S
Sbjct: 6 ELFFKDD------PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 718 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
+ +EV+ +++LRHPN + + G R ++ E+ + + + E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIA 118
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837
+ +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG + + S
Sbjct: 119 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFV 172
Query: 838 GTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 894
GTP WMAPEV+ + K DV+S G+ ELA K P MN M + +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ C Q P RP+ L
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-64
Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 34/297 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 724
E P L G+ +G G++G+V A VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----------------- 766
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL- 825
+D + + + VA+GM L + +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQ 883
+ ++ + +WMAPE + N + DV+S+G+ LWEL +L GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 940
+ + R+ P+ + I+ CW DP RP+F Q+ ++ +++ + S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI---VQLIEKQISES 309
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-63
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 12/291 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRL 730
+ + +G G++G VY W G +V + K L + S A E E +M +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
+P+V +G + +IT+ +P G L + + + + + +A+GMN L
Sbjct: 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVL 848
+VHRDL + N+LV +VK++DFGL++L ++ +WMA E +
Sbjct: 128 ED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+ + DV+S+GV +WEL T P+ G+ ++ + + RL P V
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYM 244
Query: 908 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 958
I+ +CW D RP F +L + + R Q + +S
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-63
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 13/283 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ +D +G G+ G V+ +G +A K + + A + RE++++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHE 60
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
P +V F GA +SI E + GSL ++L + ++ E+ K+++ V +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 176
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ + D++S G+ L E+A + P + ++ + F + E P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG 234
Query: 910 WECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 952
RP A + L +V P PS E
Sbjct: 235 RPLSSYGMDSRPPMA----IFELLDYIVNEPPPKLPSGVFSLE 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-62
Identities = 89/294 (30%), Positives = 152/294 (51%), Gaps = 35/294 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G++G+V A+ T+VAVK L D + L +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 67
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH---------------R 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 827 H--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H + + + + +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937
+ + + R++ P + ++ +CW PS RP+F QL ++ L R+V
Sbjct: 246 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIV 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-61
Identities = 72/257 (28%), Positives = 114/257 (44%), Gaps = 10/257 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED L + +G G+YGEV A VAVK +D + K+E+ I + L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
NVV F G + E+ G LF + + E + + G+ LH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNE 851
I HRD+K NLL+D+ N+K+SDFGL+ + +N GT ++APE+L+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 852 P-SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 909
E DV+S G++L + +LPW + Q + L K++D ++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 910 WECWQTDPSLRPSFAQL 926
+ +PS R + +
Sbjct: 241 HKILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-61
Identities = 55/272 (20%), Positives = 112/272 (41%), Gaps = 16/272 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
ED G+ +G GS+ V A E A+K + RE +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P V L + G L + + + DE ++ + LH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 126
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRN 850
I+HRDLK N+L++++ +++++DFG +++ + + S GT ++++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
+ + + D+++ G I+++L P+ N + + + P++ P ++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 911 ECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 942
+ D + R ++ + +HP
Sbjct: 243 KLLVLDATKRLGCEEM------EGYGPLKAHP 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 4e-60
Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 30/294 (10%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLE 719
D + E P + L LG+ +G G++G+V AD VAVK L + + +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRA 62
Query: 720 FKREVKIMRR-LRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQ------- 770
E+KI+ H NVV +GA T+P L +I EF G+L L +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 771 --------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822
+ + I + VA+GM L + +HRDL + N+L+ + VK+ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 823 SRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879
+R K ++ +WMAPE + + + DV+SFGV+LWE+ +L P+ G+
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 204 bits (520), Expect = 3e-59
Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 17/283 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + E +G G++G V+ G A K + S ++E++ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRHP 83
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V A + +I EF+ G LF + H ++ E ++ V +G+ +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 794 TPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
VH DLK N++ ++ +K+ DFGL+ + S K T GT E+ APEV +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARII 909
P D++S GV+ + L + P+ G N + + V N + I
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 910 WECWQTDPSLRPSFAQL------TVALKPLQRLVIPSHPDQPS 946
+ DP+ R + Q T P + IPS
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-58
Identities = 47/258 (18%), Positives = 107/258 (41%), Gaps = 12/258 (4%)
Query: 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
+E ++ E +G G +G V+ + K G + K+E+ I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ + L +I EF+ +F ++ +++E+ + V + LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 793 STPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
+ I H D++ N++ ++ +K+ +FG +R + + PE+ APEV ++
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQH 177
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908
+ + D++S G +++ L + P++ Q++ + E KE+
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 909 IWECWQTDPSLRPSFAQL 926
+ + R + ++
Sbjct: 238 VDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 198 bits (505), Expect = 4e-57
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 11/257 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + E +G G++G V+ G K K E+ IM +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 86
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
++ A + +I EFL G LF + ++ E I G+ +H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 794 TPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+IVH D+K N++ + K +VK+ DFGL+ + + +T T E+ APE++ E
Sbjct: 147 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDRE 203
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARII 909
P D+++ GV+ + L + P+ G + ++ + V + + + P I
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 910 WECWQTDPSLRPSFAQL 926
Q +P R +
Sbjct: 264 KNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 5e-57
Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G++ EV A+ VA+K + + + E+ ++ +++HPN+V
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+L +I + + G LF + E+ ++ V + LH I
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD--LGI 128
Query: 798 VHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
VHRDLK NLL D++ + +SDFGLS+++ + S + GTP ++APEVL +P +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPYS 187
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWEC 912
+ D +S GVI + L P+ N ++ + + P ++ I
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 913 WQTDPSLRPSFAQL 926
+ DP R + Q
Sbjct: 248 MEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-57
Identities = 63/254 (24%), Positives = 121/254 (47%), Gaps = 9/254 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRR-LR 731
ED +L + +G GS+G+V+ A++ A+K +E E +++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP + NL + E+L G L + H + D R A ++ G+ LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+ IV+RDLK N+L+DK+ ++K++DFG+ + + + GTP+++APE+L +
Sbjct: 121 S--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
N D +SFGV+L+E+ + P+ G + ++ ++ + P+ L+ ++ +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 912 CWQTDPSLRPSFAQ 925
+ +P R
Sbjct: 237 LFVREPEKRLGVRG 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (495), Expect = 4e-56
Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 11/257 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+D + +G GS+G V+ NG A+K + +E E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P ++ G + +I +++ G L R + A +V + LH+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
I++RDLK N+L+DKN ++K++DFG ++ + + GTP+++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
N+ D +SFG++++E+ P+ N M+ + N L P + V ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 913 WQTDPSLRPSFAQLTVA 929
D S R Q
Sbjct: 236 ITRDLSQRLGNLQNGTE 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 190 bits (483), Expect = 5e-55
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 22/270 (8%)
Query: 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-------FKREVK 725
+E+ E +G G V E AVK + E +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 726 IMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
I+R++ HPN++ ++ + + +G LF L + EK K+ +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 120
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ LH IVHRDLK N+L+D + N+K++DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLA 177
Query: 845 PEVLRNEPS------NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
PE++ + ++ D++S GVI++ L P+ M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 899 --KELDPLVARIIWECWQTDPSLRPSFAQL 926
+ V ++ P R + +
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-54
Identities = 59/257 (22%), Positives = 113/257 (43%), Gaps = 8/257 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
D + +G G++G+V G A+K + + + E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P + A L + E+ G LF L R E+R ++ + LH+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++APEVL +
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
D + GV+++E+ +LP+ + ++ + + P+ L P ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGL 239
Query: 913 WQTDPSLRPSFAQLTVA 929
+ DP R
Sbjct: 240 LKKDPKQRLGGGPSDAK 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 7e-54
Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 16/259 (6%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKF----LDQDFSGAALLEFKREVKIMRRLRHP 733
GE +G G + V G + A K G + + +REV I++ ++HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
NV+ ++ +I E + G LF L + E+ + + G+ LH+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS- 131
Query: 794 TPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
I H DLK N+++ +K+ DFGL+ K+ GTPE++APE++
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVN 189
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 907
EP + D++S GVI + L + P++G + + V N E L
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 908 IIWECWQTDPSLRPSFAQL 926
I DP R +
Sbjct: 250 FIRRLLVKDPKKRMTIQDS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 185 bits (470), Expect = 2e-53
Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 17/273 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
+ LGE +G G EV+ A +VAVK D + L F+RE + L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 733 PNVVLFMGAVTRPPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 788
P +V I+ E++ +L I+H + KR I++ D + +N
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALN 125
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAP 845
H I+HRD+K N+++ VKV DFG++R N+ + + GT ++++P
Sbjct: 126 FSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903
E R + + + DVYS G +L+E+ T + P+ G +P+ V ++ + L
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936
+ ++ + +P R A L R+
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAE--MRADLVRV 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 22/257 (8%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE----FKREVKIMRRLR-- 731
+G +G G +G VY + VA+K S L EV +++++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
V+ + RP + +I E + E+ V + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 792 TSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
++HRD+K N+L+D N +K+ DFG L +T + GT + PE +R
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIRY 183
Query: 851 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
V+S G++L+++ +P+ + ++ + + +I
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLI 235
Query: 910 WECWQTDPSLRPSFAQL 926
C PS RP+F ++
Sbjct: 236 RWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-50
Identities = 62/265 (23%), Positives = 114/265 (43%), Gaps = 27/265 (10%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 67
Query: 736 V----LFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCL 790
V ++ L I+ E L G LF + R E+ ++ + + L
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H+ I HRD+K NLL +K++DFG ++ + S + TP ++APEV
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEV 184
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------PKEL 901
L E ++ CD++S GVI++ L P+ + + + + + R + E+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 902 DPLVARIIWECWQTDPSLRPSFAQL 926
V +I +T+P+ R + +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (453), Expect = 5e-50
Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 13/262 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRR 729
D + IG G +GEVY G A+K + L + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
P +V A P LS I + + G L L + H E A ++ G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEH 122
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 848
+H +V+RDLK N+L+D++ +V++SD GL+ ++ GT +MAPEVL
Sbjct: 123 MH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVAR 907
+ + D +S G +L++L P+ + +E+P P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 908 IIWECWQTDPSLRPSFAQLTVA 929
++ Q D + R
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 4e-49
Identities = 52/276 (18%), Positives = 100/276 (36%), Gaps = 25/276 (9%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
LG +IG GS+G++Y G EVA+K + + E KI + ++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ + +++ L SL + + + K + +A + + +H+
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NF 124
Query: 798 VHRDLKSPNLLV---DKNWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAPEV 847
+HRD+K N L+ K V + DFGL++ +H + +K+ GT + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------GFQNRRLEIPKEL 901
+ + D+ S G +L LPW G+ + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 902 DPLVARIIWECWQTDPSLRPSFAQLTVALK-PLQRL 936
A + C +P ++ L + R
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-49
Identities = 63/281 (22%), Positives = 110/281 (39%), Gaps = 32/281 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E+ E+IG G+YG VY A G VA+KK + RE+ +++ L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V + + L ++ EFL + + + + +G+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP- 852
+ ++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV----------------GAVGFQNRRLE 896
+ D++S G I E+ T + + G + + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 897 IPK-----------ELDPLVARIIWECWQTDPSLRPSFAQL 926
PK LD ++ + DP+ R S
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 169 bits (429), Expect = 1e-47
Identities = 45/274 (16%), Positives = 95/274 (34%), Gaps = 26/274 (9%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G RIG GS+G ++ N +VA+K + + + + E + + L +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 64
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ + +++ L SL +L + K A + + +H + +
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--L 122
Query: 798 VHRDLKSPNLLVDK-----NWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAP 845
V+RD+K N L+ + + V DFG+ + +H + K+ +GT +M+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPK 899
+ + D+ + G + LPW G+ +G E+
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 900 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933
+ + P + L +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 1e-47
Identities = 58/257 (22%), Positives = 114/257 (44%), Gaps = 11/257 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+ + +G GS+G V +G A+K Q +E E +I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P +V + NL ++ E++ G +F L R + E A + LH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+++RDLK NLL+D+ ++V+DFG ++ + GTPE +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKG 214
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
N+ D ++ GV+++E+A P+ P+Q+ + + ++ P + ++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 913 WQTDPSLRPSFAQLTVA 929
Q D + R + V
Sbjct: 273 LQVDLTKRFGNLKNGVN 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 168 bits (427), Expect = 2e-47
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 32/280 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
E E+IG G+YG VY A + G A+KK + RE+ I++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L ++ E L L ++L ++ L + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--D 118
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
++HRDLK NLL+++ +K++DFGL+R T + AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------------- 888
+ D++S G I E+ + G++ + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 889 --GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
K LD ++ + + DP+ R + Q
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 39/287 (13%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-- 730
+ IG G+YG+V+ G VA+K+ Q L REV ++R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 731 -RHPNVVLFMGAVTRPPN-----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
HPNVV T L+++ E + + + P V + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ ++ ++ S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV---------------- 888
PEVL D++S G I E+ K + G + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 889 ---------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ ++D L ++ +C +P+ R S
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-46
Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 42/303 (13%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
+ +G G + VY A VA+KK S A RE+K+++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ A N+S++ +F+ L I+ + L +G+ LH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HW 120
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 855
I+HRDLK NLL+D+N +K++DFGL++ + + T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-------------------------GF 890
D+++ G IL EL G + + + + F
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 891 QNRRL-EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD-QPSSA 948
L I + +I + +P R + Q L+ + P P
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRPGPTPGCQ 294
Query: 949 LPQ 951
LP+
Sbjct: 295 LPR 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 16/267 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAA--LLEFKREVKIMR 728
E+ L + +G G+YG+V+ G A+K A + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 729 RLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+R P +V A L +I +++ G LF L + + E ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPE 846
LH I++RD+K N+L+D N +V ++DFGLS + + GT E+MAP+
Sbjct: 143 EHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 847 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELD 902
++R S ++ D +S GV+++EL T P+ + P+E+
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 903 PLVARIIWECWQTDPSLRPSFAQLTVA 929
L +I DP R
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-45
Identities = 70/318 (22%), Positives = 126/318 (39%), Gaps = 51/318 (16%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G+YG V A N VA+KK + RE+KI+ R RH N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 738 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ P + L L+++L H + + RG+ +H++
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSA 128
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEVLRN 850
++HRDLK NLL++ ++K+ DFGL+R+ H+ T + APE++ N
Sbjct: 129 N--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 851 E-PSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRL---------- 895
+ D++S G IL E+ + + + G + + ++G +G ++
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 896 ---------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK-P-LQRLVI 938
+ D ++ + +P R Q AL P L++
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ---ALAHPYLEQYYD 303
Query: 939 PSHPDQPSSALPQEISVN 956
PS D+P + P + +
Sbjct: 304 PS--DEPIAEAPFKFDME 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 7e-43
Identities = 60/304 (19%), Positives = 116/304 (38%), Gaps = 52/304 (17%)
Query: 672 EIPWEDLV----LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK 725
E P+ D V +IG G++GEV+ A G +VA+KK L ++ + RE+K
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 726 IMRRLRHPNVVLFMGAVTRPP--------NLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
I++ L+H NVV + ++ ++ +F + + + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK- 120
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSS 833
++ + G+ +H I+HRD+K+ N+L+ ++ +K++DFGL+R K++
Sbjct: 121 RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 834 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV---- 888
+ T + PE+L E D++ G I+ E+ T G + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 889 --------------------------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 922
+ + DP +I + DP+ R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 923 FAQL 926
Sbjct: 299 SDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 55/282 (19%), Positives = 105/282 (37%), Gaps = 34/282 (12%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ E+IG G+YG V+ A VA+K+ D RE+ +++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V + L+++ EF + D + + +G+ H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCH-- 118
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+ ++HRDLK NLL+++N +K+++FGL+R + T + P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 854 -NEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAV----------------------- 888
+ D++S G I ELA P G + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 889 ----GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
+ + +L+ ++ + +P R S +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-39
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 42/283 (14%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G+YG V A G +VA+KK S RE+++++ +RH NV+
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 738 FMGAVTRPPNLSIITEFL----PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ T L T+F G+ L + H ++ E R + + +G+ +H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EP 852
I+HRDLK NL V+++ +K+ DFGL+R + T + APEV+ N
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMR 195
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 895
+ D++S G I+ E+ T K + G + + + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 896 ------------EIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
I PL ++ + D R + +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 2e-37
Identities = 59/256 (23%), Positives = 106/256 (41%), Gaps = 21/256 (8%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G+ G V A VA+KK + RE+ +M+ + H N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 738 FMGAVTRPP------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+ T ++ ++ E + I D +R + + G+ LH
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH 136
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGM 193
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
E D++S G I+ E+ K+ + G + + N+ +E P + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW------NKVIEQLGTPCPEFMKKLQP 247
Query: 912 CWQTDPSLRPSFAQLT 927
+ RP +A LT
Sbjct: 248 TVRNYVENRPKYAGLT 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-37
Identities = 51/281 (18%), Positives = 89/281 (31%), Gaps = 46/281 (16%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
IG GS+G VY A +G VA+KK L RE++IMR+L H N+V
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 81
Query: 742 VTRP------PNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTS 793
L+++ +++P H R + + R + +H+
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 794 TPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
I HRD+K LL +K+ DFG ++ + +
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------------ 888
DV+S G +L EL + + G + + + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 889 ---GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 926
P + + P+ R + +
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 45/292 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+P E +G G+YG V A G VAVKK S RE+++++
Sbjct: 15 EVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 73
Query: 730 LRHPNVVLFMGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
++H NV+ + T +L + L L I+ D + + +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI--YQIL 131
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
RG+ +H + I+HRDLK NL V+++ +K+ DFGL+R + T + A
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRA 186
Query: 845 PEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV------------------ 885
PE+ L N+ D++S G I+ EL T + + G + + +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 886 ---GAVGFQNRRLEIPK--------ELDPLVARIIWECWQTDPSLRPSFAQL 926
A + ++PK +PL ++ + D R + AQ
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 7e-35
Identities = 58/319 (18%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 654 DSSTSKVDQIFDDDVCECEIPW---EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFL 708
D +T + + +D + + W +D L ++G G Y EV+ A N +V VK
Sbjct: 12 DVNTHRPREYWDYE--SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 709 DQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH 765
+ KRE+KI+ LR PN++ V P + +++ E + ++
Sbjct: 70 PVKKK-----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 824
+ + ++ + ++ H+ I+HRD+K N+++D ++ +++ D+GL+
Sbjct: 125 T----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-- 881
H + + PE+L + + D++S G +L + K P+ +
Sbjct: 179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 882 ------MQVVGAVGFQNRRLEIPKELDPLVARI--------------------------- 908
+V+G + + ELDP I
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 909 -IWECWQTDPSLRPSFAQL 926
+ + + D R + +
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 5e-28
Identities = 49/287 (17%), Positives = 103/287 (35%), Gaps = 30/287 (10%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+L ++G G + V+ A N T VA+K + E+K+++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 737 L---------------FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
F ++ ++ E L L I H + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKHNTFLSSKS 835
+ G++ +H I+H D+K N+L++ +K++D G + + +
Sbjct: 133 QLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 188
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 895
+ T E+ +PEVL P D++S +++EL T + + +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 896 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 942
E+ EL + R S + PL+ ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 1e-21
Identities = 31/193 (16%), Positives = 60/193 (31%), Gaps = 45/193 (23%)
Query: 679 VLGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFK 721
+G+ +G G V++ E VK D FS A+ +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
E + +++L+ V +++ E + + +V + ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELID--------AKELYRVRVENPDEVLD 110
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
+ + + IVH DL N+LV + + DF S E
Sbjct: 111 MILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGE 154
Query: 842 WMAPEVLRNEPSN 854
E+L + N
Sbjct: 155 EGWREILERDVRN 167
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 959 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.18 | |
| d2q3za4 | 316 | Transglutaminase catalytic domain {Human (Homo sap | 94.59 | |
| d1x3za1 | 320 | Peptide:N-glycanase 1, PNG1 {Baker's yeast(Sacchar | 84.43 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=448.11 Aligned_cols=263 Identities=35% Similarity=0.604 Sum_probs=223.3
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+++|+.++|+++++||+|+||+||+|++++ .||||++............|.+|+.+|++++|||||++++++.+ ..++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 367888999999999999999999998765 59999998776666677889999999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||||++|+|.+++.+....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999877678999999999999999999999998 999999999999999999999999999876432
Q ss_pred c--ccCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc----cccCCCCC
Q 002157 830 F--LSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----RRLEIPKE 900 (959)
Q Consensus 830 ~--~~~~t~~GT~~YmAPEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~----~~~~iP~~ 900 (959)
. .......||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+............ ....++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 1 223456799999999999753 47899999999999999999999999877654433332222 12245678
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
+++++++||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 899999999999999999999999999999988764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=445.61 Aligned_cols=249 Identities=25% Similarity=0.470 Sum_probs=222.7
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~-~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
+..++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+++|++++|||||++++++.+++.++
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 4568999999999999999999987 57889999987543221 23457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||||++|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++.....
T Consensus 83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999999764 47999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 2345689999999999999999999999999999999999999999998888777664 345678889999999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||+.||.+|||++|+++
T Consensus 236 ~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHHc
Confidence 9999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=444.15 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=211.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCcEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~--~~~l~LV 751 (959)
++|++++.||+|+||+||+|++ +|+.||||++......+.....+.+|+++|++++|||||++++++.+ ...+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999987 58899999998877777777889999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 752 mEy~~gGsL~dlL~k---~~~~lse~~~l~Ia~QIa~AL~yLHs~g---~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
||||++|+|.+++.+ ....+++..++.++.||+.||+|||+.+ .+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999853 2457999999999999999999999864 2499999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
...........+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..++...+... ....+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHH
Confidence 765544455688999999999999999999999999999999999999999999888877766433 3446788899999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++||.+||+.||.+||++.||++
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=435.59 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=218.2
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
|+.++|++++.||+|+||+||+|++ +++.||||++...... ..+|.+|++++++++|||||++++++..++.++||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 4567899999999999999999988 5678999998765443 35789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+++|+|.+++......+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999999999877778999999999999999999999999 99999999999999999999999999987654322
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 832 -~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+. ...+...|..+++++.+||
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHH
Confidence 2334679999999999999999999999999999999999 567777777777766654 3456677889999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 910 WECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+||+.||.+||++++|++.|+++.+
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=444.11 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=221.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||+||+|++ +|+.||||++....... ...+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 45799999999999999999986 58999999987654332 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|||++|+|.+++.+. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++........
T Consensus 97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999999998763 5999999999999999999999999 999999999999999999999999999987655455
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHHHH
Q 002157 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-~~~~~iP~~ls~eL~dLI~k 911 (959)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ......|..++.++++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 56778999999999999999999999999999999999999999998877665544322 23455678899999999999
Q ss_pred HhhcCCCCCCCHHHHHH
Q 002157 912 CWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRPSa~EIL~ 928 (959)
||+.||.+||++.|+++
T Consensus 253 ~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=442.95 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=219.4
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+.|++++.||+|+||+||+|++ +++.||||++..... .....+.+|+++|++++|||||+++++|.+++.++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4699999999999999999987 578899999876532 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
||++|+|.+++.+....+++..+..|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998765667999999999999999999999999 9999999999999999999999999998765443344
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHH
Q 002157 834 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVAR 907 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-~~~~iP~~ls~eL~d 907 (959)
.+.+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+....+.... .....|..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 4558899999999999999999999999988887776654332 234556789999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHH
Q 002157 908 IIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~ 928 (959)
||.+||+.||.+|||+.|+++
T Consensus 248 li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-51 Score=439.76 Aligned_cols=260 Identities=35% Similarity=0.611 Sum_probs=226.0
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
.++|..++|++.++||+|+||+||+|++ +++.||||++...... ..+|.+|+++|++++|||||+++++|.+.+.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4678889999999999999999999988 4788999998755433 4578999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k-~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++||||||++|+|.+++.+ ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999864 4457899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~~-~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~P-F~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
..... ......|++.|+|||++.+..++.++|||||||++|||++|..| |.+.+..++...+ ....++.+|..++++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHH
Confidence 54322 23344589999999999999999999999999999999997655 5555555554444 345567888899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
+++||.+||+.||.+|||+.+|++.|+.+.+
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=443.94 Aligned_cols=251 Identities=21% Similarity=0.359 Sum_probs=219.5
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
..++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+++|++++|||||+++++|.+++.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 347899999999999999999987 588999999875432 12234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 829 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~- 829 (959)
|||||++|+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.....
T Consensus 86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999998764 47999999999999999999999999 999999999999999999999999999876432
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 830 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 830 -~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
.....+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++|
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDL 240 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHH
Confidence 223345789999999999999999999999999999999999999999998888877764 33567888999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+|||++|++..
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHccCCHhHCcCHHHHcCC
Confidence 999999999999999987554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-50 Score=438.10 Aligned_cols=260 Identities=33% Similarity=0.552 Sum_probs=219.0
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC--Cc---eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN--GT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~--g~---~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~ 746 (959)
++..++|++.++||+|+||+||+|++. ++ .||||++... ........|.+|+++|++++|||||++++++.+.+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456688999999999999999999873 22 4888877543 34556678999999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++||||||++|+|.+++.+....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-----cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 827 HNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 827 ~~~~~-----~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
..... ......||+.|||||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 53321 1223457899999999999999999999999999999997 899999999888777664 3456677889
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++.++.+||.+||+.||.+||++.||++.|+++.+
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=436.63 Aligned_cols=250 Identities=28% Similarity=0.344 Sum_probs=210.8
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|+++++||+|+||+||+|++ +++.||||++...... .....+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 36899999999999999999987 5889999998765432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC--c
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~--~ 830 (959)
|||++|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+++..... .
T Consensus 83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999764 47999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
......+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ..............+..+++++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23456789999999999998876 578999999999999999999997765432 2222222222333346789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|.+||+.||.+|||++|+++
T Consensus 240 i~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=448.65 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=226.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
|..++|++++.||+|+||.||+|++ +++.||||++.+... .......+.+|+.+|++++|||||+++++|++.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 5678999999999999999999987 688999999976432 1223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
||||||++|+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.....
T Consensus 82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999999765 47899999999999999999999999 999999999999999999999999999976555
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 830 ~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++++||
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHH
Confidence 4555678899999999999999999999999999999999999999999998888776643 45778899999999999
Q ss_pred HHHhhcCCCCCCC-----HHHHHHH
Q 002157 910 WECWQTDPSLRPS-----FAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPS-----a~EIL~~ 929 (959)
.+||++||.+|++ +.+|+++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhccCCchhhcccccccHHHHHcC
Confidence 9999999999994 8888763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=442.89 Aligned_cols=259 Identities=31% Similarity=0.453 Sum_probs=223.0
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~g-------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.++|+.++|+++++||+|+||+||+|++.+ ..||||++.... .......+.+|+.+|.++ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 467888999999999999999999998732 258999876543 233445788999999998 89999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~----------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIH 799 (959)
|.+.+.++||||||++|+|.++|++.. ..+++..++.|+.||+.||+|||+++ |||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 999999999999999999999997543 24788999999999999999999998 999
Q ss_pred eCCCCCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002157 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 876 (959)
Q Consensus 800 RDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF 876 (959)
|||||+|||++.++++||+|||+++....... ...+..||+.|||||++.+..++.++|||||||++|||++ |..||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987544322 2234568999999999999999999999999999999997 89999
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 002157 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 931 (959)
Q Consensus 877 ~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le 931 (959)
.+.+..+....+.....++..|..+++++++||.+||+.||++|||++||+++|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9877766665555566678889999999999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=428.78 Aligned_cols=259 Identities=32% Similarity=0.566 Sum_probs=224.3
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..++|+.++|++++.||+|+||+||+|+++ ++.||||++...... ...|.+|+.+|++++|||||++++++.+ +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 356788899999999999999999999985 578999998765433 3568999999999999999999998765 56
Q ss_pred EEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
++|||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 799999999999999876432 35899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 827 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 827 ~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.... .......||+.|+|||++.+..++.++|||||||++|||++| .+||......++...+. ...+...|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 5432 233456799999999999999999999999999999999995 55666666666666554 44567788899999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+.+||.+||+.||++|||+.+|++.|+.+-
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=426.80 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=228.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.++|+++++||+|+||+||+|+++ +..||||++....... .+|.+|+.++++++|||||+++++|.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 4578999999999999999999984 5689999998765543 47899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
||+.+|+|.+++......+++..+++|+.||++||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999998777678999999999999999999999998 99999999999999999999999999986554322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+...|..+++++++||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHH
Confidence 2334679999999999999999999999999999999998 899999999888877765 34567788999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHhh
Q 002157 911 ECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
+||+.||.+|||+.+|+.+|.+|
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=430.03 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=226.7
Q ss_pred cCCCCeeEEeE-eeccCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 673 IPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 673 i~~~dy~I~k~-LGkG~fG~VYka~~----~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
+..++|.+.+. ||+|+||+||+|.+ ++..||||++... .......+|.+|+++|++++|||||++++++.. +.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 55678889885 99999999999976 2447999998654 345567789999999999999999999999875 56
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccc
Confidence 89999999999999998776678999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 828 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 828 ~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...++.+|..+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 322 22334568999999999999999999999999999999998 899999988877776664 4456788899999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999877553
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=429.11 Aligned_cols=247 Identities=31% Similarity=0.471 Sum_probs=214.6
Q ss_pred eeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCcEEEE
Q 002157 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSII 751 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~----~~~l~LV 751 (959)
|++.++||+|+||+||+|++ ++..||||++............+.+|+++|++++|||||+++++|.+ ...++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 57888999999999999988 47789999998877777777889999999999999999999999865 3458999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecCccccccCCc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd-~~g~VKLiDFGlAk~~~~~~ 830 (959)
||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++++||||||||+||||+ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999764 478999999999999999999999887799999999999996 5899999999999865433
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccccCCCCCCcHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARII 909 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ql~~~i~~~~~~~~iP~~ls~eL~dLI 909 (959)
.....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+... .++...+.....+..++...++++++||
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 2345789999999999976 489999999999999999999999987654 4444555444445556677899999999
Q ss_pred HHHhhcCCCCCCCHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~ 928 (959)
.+||+.||++|||+.||++
T Consensus 247 ~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHhC
Confidence 9999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=427.36 Aligned_cols=262 Identities=29% Similarity=0.516 Sum_probs=221.1
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEECC------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~g------~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~ 744 (959)
.||..++|++.++||+|+||.||+|.+++ ..||||++... ........|.+|+++|++++|||||++++++.+
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 36778899999999999999999998632 36999998644 344556679999999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
.+.+++||||+.+++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999999988776678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCC
Q 002157 825 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (959)
Q Consensus 825 ~~~~~~~---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~~~~~~~iP~~ 900 (959)
....... ......||+.|||||++.+..++.++|||||||++|||++| .+||.+....++...+. ...++..|..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~ 237 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchh
Confidence 7643321 22345689999999999999999999999999999999995 45566666666665554 4456778889
Q ss_pred CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 901 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 901 ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
++.++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999999999987663
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=442.76 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=214.2
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++.-++|++++.||+|+||+||+|++ +++.||||++.... .......+.+|+.+|++++|||||+++++|.++..++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45567899999999999999999987 58899999987643 3445578899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+ +| ||||||||+||||+.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999999764 369999999999999999999997 58 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-------------------
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------------------- 889 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~------------------- 889 (959)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+......
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 2346789999999999999999999999999999999999999998765432211000
Q ss_pred ----------------------ccccccCCC-CCCcHHHHHHHHHHhhcCCCCCCCHHHHHH--HHHhh
Q 002157 890 ----------------------FQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPL 933 (959)
Q Consensus 890 ----------------------~~~~~~~iP-~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~--~Le~l 933 (959)
....+..++ ..++.++++||.+||+.||.+|||++|+++ +|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 001111122 236889999999999999999999999988 35543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=425.62 Aligned_cols=260 Identities=30% Similarity=0.516 Sum_probs=218.0
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~-----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
++|+.++|++++.||+|+||.||+|++. +..||||++... ........+.+|+.+|++++|||||++++++. +
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 6788899999999999999999999873 235888876433 34556678999999999999999999999996 4
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
+.++|||||+++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhee
Confidence 6789999999999999998776678999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 002157 826 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (959)
Q Consensus 826 ~~~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~ 903 (959)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+. ...+..+|..+++
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54332 23345668999999999999999999999999999999998 899999999888877665 3445678899999
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
++++||.+||..||.+|||+.+|++.|+.+.+
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-50 Score=436.83 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=203.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
+.|++++.||+|+||+||+|++ +++.||||++....... ....+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6699999999999999999987 57889999997654432 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCccccccCCc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlAk~~~~~~ 830 (959)
||+||+|.+++.+. ..+++..+..|+.||+.||+|||++| ||||||||+|||+. +++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 99999999999764 47999999999999999999999999 99999999999994 5789999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~eL~dL 908 (959)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+....++...+....... ..+..+++++++|
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 23345789999999999999999999999999999999999999999998887777665443333 3446789999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+|||+.|++++
T Consensus 244 i~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-49 Score=441.41 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=220.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|+++++||+|+||+||+|++ +|+.||||++.... ......+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999987 58899999986543 344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEecCccccccCCc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd--~~g~VKLiDFGlAk~~~~~~ 830 (959)
|||++|+|.+++.+....+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+++.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 999999999999766668999999999999999999999999 99999999999995 4689999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~eL~dL 908 (959)
....+..||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....... ..+..+++++++|
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23345789999999999999999999999999999999999999999998888777665433222 2235689999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~ 929 (959)
|.+||+.||.+|||+.|++++
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-50 Score=435.87 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=221.3
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEE
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~L 750 (959)
..++|+++++||+|+||+||+|++ +|+.||||++.+.... ......+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 457899999999999999999987 5889999998754321 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|||||.||+|..++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.....
T Consensus 82 vmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999999999998764 46888888899999999999999999 999999999999999999999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
..+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.. ....+|..+++++++||.
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999998888777643 356778899999999999
Q ss_pred HHhhcCCCCCC-----CHHHHHHH
Q 002157 911 ECWQTDPSLRP-----SFAQLTVA 929 (959)
Q Consensus 911 kCL~~DP~kRP-----Sa~EIL~~ 929 (959)
+||.+||.+|+ ++++|+++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccchhhHHHHHcC
Confidence 99999999996 89999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=424.52 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=215.1
Q ss_pred eeEE-eEeeccCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 678 LVLG-ERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 678 y~I~-k~LGkG~fG~VYka~~~----g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+.+. ++||+|+||+||+|.+. ++.||||++...........+|.+|+++|++++|||||+++++|.. +.++|||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 3443 57999999999999762 3579999987665555566789999999999999999999999965 4678999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~-- 830 (959)
|||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 87 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp ECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999999999764 47999999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 002157 831 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (959)
Q Consensus 831 -~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dL 908 (959)
.......||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++.+|..+++++++|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDL 242 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHH
Confidence 12234579999999999999999999999999999999997 899999998887776664 345678889999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 909 IWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
|.+||+.||.+||++.+|+..|+.+.
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 99999999999999999999888764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-49 Score=439.14 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=221.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
++|++++.||+|+||+||+|++ +|+.||||++.... ......+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 58899999987653 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEecCccccccCCcc
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd--~~g~VKLiDFGlAk~~~~~~~ 831 (959)
||++|+|.+++.+.+..+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+++..... .
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC-C
Confidence 99999999998877778999999999999999999999999 99999999999998 6789999999999877543 2
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCCCCCCcHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARII 909 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~--~~~iP~~ls~eL~dLI 909 (959)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..... +...+..+++++++||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 33456799999999999999999999999999999999999999999988887766643332 2234467899999999
Q ss_pred HHHhhcCCCCCCCHHHHHHH
Q 002157 910 WECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 910 ~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+||+.||.+|||+.|++++
T Consensus 264 ~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=426.02 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=218.8
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~ 749 (959)
++|++++.||+|+||+||+|++ +|+.||||++.+..... .....+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999987 58899999997654322 23567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecCcccc
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g----~VKLiDFGlAk~ 825 (959)
||||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+++.
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999999764 37999999999999999999999999 99999999999998766 599999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--~~iP~~ls~ 903 (959)
.... ....+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... ...+..++.
T Consensus 167 ~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 6544 2345678999999999999999999999999999999999999999999888877666433222 223367899
Q ss_pred HHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 904 LVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
++++||.+||+.||.+||+++|+++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=433.45 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=217.1
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999987 5788999999876543 3455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
||.+|+|..++... ..+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.... .
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence 99999987766543 47999999999999999999999999 99999999999999999999999999986543 2
Q ss_pred CCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 834 KSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
...+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+.....+...+..+++++++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 35789999999999965 358899999999999999999999999988887776665555555556678999999999
Q ss_pred HHhhcCCCCCCCHHHHHH
Q 002157 911 ECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 911 kCL~~DP~kRPSa~EIL~ 928 (959)
+||+.||.+|||+.|+++
T Consensus 249 ~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHCcCChhHCcCHHHHHh
Confidence 999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=424.62 Aligned_cols=268 Identities=31% Similarity=0.500 Sum_probs=218.7
Q ss_pred CccccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 667 ~~~~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
+...++|++++|+++++||+|+||.||+|++. ++.||||++.... .......+.+|..++.++ +|+|||.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 44567888899999999999999999999862 3579999986543 344456778888888887 78999999
Q ss_pred eeeeecC-CcEEEEEeccCCCCHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC
Q 002157 739 MGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802 (959)
Q Consensus 739 ~g~~~~~-~~l~LVmEy~~gGsL~dlL~k~---------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDL 802 (959)
++++... ..+++|||||++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987654 4689999999999999998643 235889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCC
Q 002157 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879 (959)
Q Consensus 803 KPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~ 879 (959)
||+||||+.++++||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..||.+.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654332 223456799999999999999999999999999999999986 5688887
Q ss_pred ChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhh
Q 002157 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 937 (959)
Q Consensus 880 ~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~ 937 (959)
...+..........++.+|..+++++++||.+||+.||.+|||+.||+++|+++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 6555544444455677888999999999999999999999999999999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=421.13 Aligned_cols=255 Identities=33% Similarity=0.593 Sum_probs=219.4
Q ss_pred cCcCCCCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCcEE
Q 002157 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLS 749 (959)
Q Consensus 671 ~ei~~~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-~~~l~ 749 (959)
++|+.++|++++.||+|+||.||+|+++|+.||||++.... ..+.+.+|+++|++++|||||++++++.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 67888999999999999999999999999999999986543 23568899999999999999999998854 56789
Q ss_pred EEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.+|++||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999996532 35899999999999999999999998 99999999999999999999999999987543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
. .....++..|+|||++.+..++.++|||||||++|||++ |++||...+..++...+. ...++++|..+++++++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 234578999999999999999999999999999999998 789999888877777664 45677888999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
||.+||..||.+||++.+|+++|+.++.
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-49 Score=423.16 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=227.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~ 742 (959)
.++++.++|++++.||+|+||+||+|++. ++.||||++... .......+|.+|+.+|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 35677889999999999999999999874 367999998654 3455667899999999999999999999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~~-----------------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIH 799 (959)
...+.+++||||+.+|+|.+++.... ..+++..++.|+.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999985321 24788899999999999999999999 999
Q ss_pred eCCCCCcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCC
Q 002157 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPW 876 (959)
Q Consensus 800 RDLKPeNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF 876 (959)
|||||+||||+.++++||+|||+++...... ....+..|++.|+|||++.+..++.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654332 2234567899999999999999999999999999999999985 689
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 877 ~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
.+.+..++...+.. .....+|..+++++.+||.+||+.||.+|||+.||++.|+++.
T Consensus 244 ~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99988888777654 3466788899999999999999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=422.10 Aligned_cols=260 Identities=33% Similarity=0.543 Sum_probs=218.4
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEEC---C--ceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADWN---G--TEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~~---g--~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~ 745 (959)
-|..++|++.+.||+|+||.||+|+++ + ..||||++..... .......|.+|+.+|++++|||||++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 356688999999999999999999863 2 3689998876543 33456789999999999999999999999976
Q ss_pred CcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhh
Confidence 4678999999999999988766667999999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 002157 826 KHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (959)
Q Consensus 826 ~~~~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~l 901 (959)
..... .......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.....+++.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 64432 12334568889999999999999999999999999999997 899999999998888887777778888999
Q ss_pred cHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhh
Q 002157 902 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 934 (959)
Q Consensus 902 s~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~ 934 (959)
+.++++||.+||+.||++|||+.+|++.|++.+
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 999999999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=421.96 Aligned_cols=263 Identities=33% Similarity=0.558 Sum_probs=219.4
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.++|..++|++++.||+|+||+||+|+++ ++.||||++...... ...|.+|+.+|++++|||||++++++.+ +.+
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 45677899999999999999999999884 457999998765443 3578999999999999999999999865 568
Q ss_pred EEEEeccCCCCHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 749 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~-~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
++||||+++|+|..++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhcc
Confidence 8999999999999988542 346899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 828 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~-~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
... .......||+.|+|||++.+..++.++|||||||++|||++|. +||.+....++...+. ...+.+++..+++++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l 243 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHHH
Confidence 332 2233467999999999999999999999999999999999964 5566666666666554 344667889999999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
++||.+||+.||++||++.+|+..|+.+.....|
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 9999999999999999999999999887655444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-49 Score=434.69 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=220.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LV 751 (959)
.++|++++.||+|+||+||+|++ +|+.||||++.+.... ......+.+|+++|++++|||||+++++|.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999987 5889999998754321 12345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~ 831 (959)
|||+.+|+|..++.+.+ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999997653 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 002157 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (959)
Q Consensus 832 ~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~k 911 (959)
..+.+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+...+...+.. ....+|..+++++.+||.+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999988887777643 3566788999999999999
Q ss_pred HhhcCCCCCC-----CHHHHHH
Q 002157 912 CWQTDPSLRP-----SFAQLTV 928 (959)
Q Consensus 912 CL~~DP~kRP-----Sa~EIL~ 928 (959)
||+.||.+|+ ++++|++
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhhhCHHhccccccccHHHHHc
Confidence 9999999994 8999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-48 Score=413.92 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=215.0
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc----E
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----L 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~----l 748 (959)
++|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+++|++++|||||++++++...+. +
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999987 588999999987644 34556789999999999999999999999876543 8
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
|||||||+|++|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++.++|+|||+++....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 8999999999999998664 47999999999999999999999999 99999999999999999999999999875533
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 002157 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903 (959)
Q Consensus 829 ~~---~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~--~~iP~~ls~ 903 (959)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...... ...+..+++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 21 2344567999999999999999999999999999999999999999998887766554433222 234467899
Q ss_pred HHHHHHHHHhhcCCCCCC-CHHHHHHHHHhhh
Q 002157 904 LVARIIWECWQTDPSLRP-SFAQLTVALKPLQ 934 (959)
Q Consensus 904 eL~dLI~kCL~~DP~kRP-Sa~EIL~~Le~l~ 934 (959)
++++||.+||+.||.+|| +++++++.|.++.
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 999999999999999999 8999999988764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=423.53 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=217.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEEC--Cc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADWN--GT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~~--g~----~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l 748 (959)
.++|+++++||+|+||+||+|++. |+ +||||++.... .....++|.+|+.+|++++|||||+++++|.++ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 357999999999999999999873 33 58888876432 233456799999999999999999999999874 56
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
+++|||+.+++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 7889999999999998877778999999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 002157 829 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (959)
Q Consensus 829 ~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL 905 (959)
... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...++..|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 322 2334568999999999999999999999999999999998 899999988777665553 445677888999999
Q ss_pred HHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 906 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+||.+||+.||.+||++.+|+..|..+.+
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=430.22 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=220.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHH-HcCCCceeEEeeeeecCCcEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~-~~~~~~ef~~Ei~IL~-~L~HpNIVkL~g~~~~~~~l~L 750 (959)
.++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.++. .++|||||++++++.+.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 37899999999999999999988 688999999975422 1222345667777665 6899999999999999999999
Q ss_pred EEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002157 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 751 VmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~ 830 (959)
|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++++||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999999764 47899999999999999999999999 9999999999999999999999999998766554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~ 910 (959)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++++||.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHH
Confidence 55566789999999999999999999999999999999999999999999888877764 3466788999999999999
Q ss_pred HHhhcCCCCCCCHH-HHHH
Q 002157 911 ECWQTDPSLRPSFA-QLTV 928 (959)
Q Consensus 911 kCL~~DP~kRPSa~-EIL~ 928 (959)
+||+.||.+||++. +|++
T Consensus 236 ~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGG
T ss_pred HhcccCCCCCcCHHHHHHh
Confidence 99999999999995 6764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=423.03 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=218.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
.++|++++.||+|+||+||+|.+ +++.||||++.... .....+.+|+++|++++|||||+++++|++++.+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999987 57889999987653 23456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEecCccccccCCc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~--~g~VKLiDFGlAk~~~~~~ 830 (959)
|||+||+|.+++.+.+..+++..++.|+.||+.||+|||++| |+||||||+||||+. .+.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999999877668999999999999999999999999 999999999999984 458999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 002157 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (959)
Q Consensus 831 ~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~iP~~ls~eL~dL 908 (959)
.......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..++...+....... ..+..+++++++|
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 22345679999999999999999999999999999999999999999999888777664332221 1224689999999
Q ss_pred HHHHhhcCCCCCCCHHHHHH
Q 002157 909 IWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 909 I~kCL~~DP~kRPSa~EIL~ 928 (959)
|.+||..||.+||++.|+++
T Consensus 238 i~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=418.29 Aligned_cols=260 Identities=32% Similarity=0.605 Sum_probs=222.8
Q ss_pred CcCCCCeeEEeEeeccCcEEEEEEEE--CCc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 002157 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (959)
Q Consensus 672 ei~~~dy~I~k~LGkG~fG~VYka~~--~g~--~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~~~ 746 (959)
.|++++|++.++||+|+||.||+|++ ++. .||||++.... .......|.+|+++|.++ +|||||++++++.+.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 36779999999999999999999987 344 47778765432 233456789999999999 7999999999999999
Q ss_pred cEEEEEeccCCCCHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 002157 747 NLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~---------------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~ 811 (959)
.++|||||+++|+|.++|++. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999754 357899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHhhhhc
Q 002157 812 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGF 890 (959)
Q Consensus 812 ~g~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF~g~~~~ql~~~i~~ 890 (959)
++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..++...+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 999999999999865443 2334567999999999999999999999999999999999965 6798888888877764
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
...++.+|..+++++++||.+||+.||++||++.+|++.|+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3456778889999999999999999999999999999999988653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=414.95 Aligned_cols=264 Identities=32% Similarity=0.546 Sum_probs=227.0
Q ss_pred cccCcCCCCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002157 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (959)
Q Consensus 669 ~~~ei~~~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL 738 (959)
.+++|+.++|++++.||+|+||.||+|++. +..||||++.... ......++.+|..++.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 347788899999999999999999999752 2469999886543 455567888999999988 89999999
Q ss_pred eeeeecCCcEEEEEeccCCCCHHHHhhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 002157 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (959)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~k~~---------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLK 803 (959)
+++|.+++.+++|||||.+|+|.++|.... ..+++..++.++.||+.||+|||+++ |||||||
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiK 162 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 162 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeec
Confidence 999999999999999999999999996543 35899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002157 804 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (959)
Q Consensus 804 PeNILLd~~g~VKLiDFGlAk~~~~~~~--~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 880 (959)
|+|||++.++.+||+|||+++....... ......|++.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999999987654322 2345678999999999999999999999999999999997 799999988
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhh
Q 002157 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 936 (959)
Q Consensus 881 ~~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl 936 (959)
..++...+. ...++..|..+++++++||.+||+.||.+|||+.||++.|+++..+
T Consensus 243 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 243 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 887776654 4567788899999999999999999999999999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-47 Score=411.05 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=218.0
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC-------HHHHHHHHHHHHHHHHcC-CCceeEEeeeeec
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-------GAALLEFKREVKIMRRLR-HPNVVLFMGAVTR 744 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~-------~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~ 744 (959)
.++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 37899999999999999999987 6789999999865432 123346889999999996 9999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
++.+|||||||++|+|.+++..+ ..+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999764 47999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE-- 896 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~-- 896 (959)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 159 ~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 77554 23455789999999999863 3468899999999999999999999999988877766654433322
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+..+++++++||.+||+.||.+||++.||+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 334789999999999999999999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-48 Score=427.75 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=211.2
Q ss_pred CCCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCC----HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 002157 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (959)
Q Consensus 674 ~~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~----~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~ 747 (959)
..++|+++++||+|+||+||+|++ +|+.||||++.+.... ........+|+.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 568999999999999999999987 5889999998654321 1112223345667777789999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|||||||++|+|.++|.+. ..+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999999764 47889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-hccccccCCCCCCcHHH
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDPLV 905 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i-~~~~~~~~iP~~ls~eL 905 (959)
.. .....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.......... ........+|..+++++
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 234578999999999997 456899999999999999999999999876543322211 12344667788999999
Q ss_pred HHHHHHHhhcCCCCCCC-----HHHHHHH
Q 002157 906 ARIIWECWQTDPSLRPS-----FAQLTVA 929 (959)
Q Consensus 906 ~dLI~kCL~~DP~kRPS-----a~EIL~~ 929 (959)
++||.+||+.||.+||+ +++|+++
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 6888763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=414.30 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=210.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+++|+++++||+|+||+||+|++ +++.||||++......+.....+.+|+++|++++|||||+++++|.+.+.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 37899999999999999999987 5889999999765544444567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
||+.++.+..+.......+++..++.|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+++........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999765444444555567999999999999999999999999 999999999999999999999999999887665555
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------cccc
Q 002157 833 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------NRRL 895 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~----------------~~~~ 895 (959)
.....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+... ....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 66678999999999987765 588999999999999999999999988766544332110 0000
Q ss_pred CC-----------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 896 EI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 896 ~i-----------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.+ ...+++++++||.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 01 12567899999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=414.57 Aligned_cols=263 Identities=29% Similarity=0.451 Sum_probs=228.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~-------~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~ 741 (959)
.++|+.++|+++++||+|+||.||+|++ .++.||||++.... .......+.+|+.+++++ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 5678889999999999999999999986 23579999987654 344566889999999999 69999999999
Q ss_pred eecCCcEEEEEeccCCCCHHHHhhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 002157 742 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (959)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~k~~-----------------~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKP 804 (959)
+.+...++||||||++|+|.+++++.. ..+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999986432 25889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002157 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (959)
Q Consensus 805 eNILLd~~g~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 881 (959)
+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765432 22345678999999999999999999999999999999998 6667777766
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 882 ~ql~~~i~~~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
...+..+.....+...|..++.++.+||.+||+.||.+||++.+|++.|+++..
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 555555555666778888999999999999999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=411.49 Aligned_cols=246 Identities=24% Similarity=0.252 Sum_probs=203.5
Q ss_pred EEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH---HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEec
Q 002157 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 680 I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~---~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
.+++||+|+||+||+|++ +++.||||++....... .....+.+|+.+|++++|||||+++++|.+++.++|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999987 58899999986543322 1234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccCC
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~~ 834 (959)
+.++.+..++. ....+++..+..|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 98876666554 4457899999999999999999999999 99999999999999999999999999987766555556
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-------------------
Q 002157 835 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------- 894 (959)
Q Consensus 835 t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~------------------- 894 (959)
..+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+....+......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 67899999999998754 5799999999999999999999999998877655443211000
Q ss_pred --c-----CCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 895 --L-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 895 --~-----~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. .+...+++++++||.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 011356889999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=412.60 Aligned_cols=260 Identities=32% Similarity=0.538 Sum_probs=228.5
Q ss_pred ccCcCCCCeeEEeEeeccCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 002157 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (959)
Q Consensus 670 ~~ei~~~dy~I~k~LGkG~fG~VYka~~~-------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~ 742 (959)
.++|++++|++++.||+|+||.||+|.++ ++.||||++.... .......|.+|+.++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 47888999999999999999999999764 4679999986543 445566789999999999999999999999
Q ss_pred ecCCcEEEEEeccCCCCHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 002157 743 TRPPNLSIITEFLPRGSLFRILHRP---------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (959)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~k~---------~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g 813 (959)
..+..+++||||+++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 9999999999999999999988531 234788999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhc
Q 002157 814 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890 (959)
Q Consensus 814 ~VKLiDFGlAk~~~~~~--~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ql~~~i~~ 890 (959)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++| ..||.+.+..+....+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999998664432 223345689999999999999999999999999999999998 58899999888877665
Q ss_pred cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhh
Q 002157 891 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 933 (959)
Q Consensus 891 ~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l 933 (959)
...++.+|..+++.+.+||.+||+.||.+||++.+|++.|++.
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4456778889999999999999999999999999999998765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4e-47 Score=405.61 Aligned_cols=251 Identities=24% Similarity=0.279 Sum_probs=208.9
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEEe
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVmE 753 (959)
.++|+++++||+|+||+||+|++ +++.||||++......+.....+.+|+.+|++++|||||+++++|..++..+++||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 37899999999999999999987 57899999997665444456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcccC
Q 002157 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (959)
Q Consensus 754 y~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~~ 833 (959)
|+.++.+..+... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..........
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9977666665544 468999999999999999999999998 9999999999999999999999999998876554555
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------------
Q 002157 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------- 892 (959)
Q Consensus 834 ~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~-------------------- 892 (959)
....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 566799999999999765 46899999999999999999999999887665543321000
Q ss_pred -------cccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 893 -------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 893 -------~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.....+..+++++++||++||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001234567899999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=407.07 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=208.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeeec-----
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR----- 744 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~---g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L---~HpNIVkL~g~~~~----- 744 (959)
++|+++++||+|+||+||+|++. ++.||||++............+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999872 55799999876543333333456777777665 79999999999853
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...++++|||+.++.+..........+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35689999999888777666666678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------
Q 002157 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 891 (959)
Q Consensus 825 ~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~------------- 891 (959)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65443 3345678999999999999999999999999999999999999999998876655443210
Q ss_pred ------------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 ------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 ------------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.....++..+++++++||.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00112345678999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=416.78 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=203.9
Q ss_pred CCCeeEEe-EeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----CC
Q 002157 675 WEDLVLGE-RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PP 746 (959)
Q Consensus 675 ~~dy~I~k-~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L-~HpNIVkL~g~~~~----~~ 746 (959)
.++|+|.+ .||+|+||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|++ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 36898875 699999999999987 5789999998643 3467899987665 89999999999875 45
Q ss_pred cEEEEEeccCCCCHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecCc
Q 002157 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGL 822 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~-~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~---~g~VKLiDFGl 822 (959)
.+|||||||+||+|.++|.+.+ ..+++..++.|+.||+.||+|||++| |+||||||+|||++. .+.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 6899999999999999997653 46999999999999999999999999 999999999999975 56799999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCC--
Q 002157 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIP-- 898 (959)
Q Consensus 823 Ak~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~--~~~~~~~iP-- 898 (959)
++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+. .......+|
T Consensus 161 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 9876544 33456789999999999999999999999999999999999999998876544333221 112223333
Q ss_pred --CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 899 --KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 899 --~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
..+++++++||.+||+.||.+||++.|++++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3578999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=405.44 Aligned_cols=259 Identities=31% Similarity=0.493 Sum_probs=218.6
Q ss_pred eEEeEeeccCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCcEEEEE
Q 002157 679 VLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIIT 752 (959)
Q Consensus 679 ~I~k~LGkG~fG~VYka~~~g-----~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-~~~l~LVm 752 (959)
.+.++||+|+||+||+|++.. ..||||++... .......+|.+|+++|++++|||||++++++.+ +..+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 347899999999999998732 25899988643 345567889999999999999999999999765 56799999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCcc-
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~- 831 (959)
|||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999999887778889999999999999999999999 99999999999999999999999999987543321
Q ss_pred ---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhhccccccCCCCCCcHHHHH
Q 002157 832 ---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (959)
Q Consensus 832 ---~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~-~~~ql~~~i~~~~~~~~iP~~ls~eL~d 907 (959)
......||+.|+|||.+.+..++.++||||||+++|||++|..||... +..++...+. ...++..|..+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHH
Confidence 223456899999999999999999999999999999999987776554 3333444433 44577788899999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCCCC
Q 002157 908 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 941 (959)
Q Consensus 908 LI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p~~ 941 (959)
||.+||+.||++||++.||+++|+.+.+.+....
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 9999999999999999999999999988765543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=404.36 Aligned_cols=240 Identities=22% Similarity=0.391 Sum_probs=205.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcC--CCceeEEeeeeecCCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~----~~~~ef~~Ei~IL~~L~--HpNIVkL~g~~~~~~~ 747 (959)
++|+++++||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|++++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999987 58899999987643321 11234668999999996 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecCcccc
Q 002157 748 LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 825 (959)
Q Consensus 748 l~LVmEy~~g-GsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-~g~VKLiDFGlAk~ 825 (959)
+++||||+.+ +++.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999975 5788887654 47999999999999999999999999 999999999999985 57999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~~iP~~ls~e 904 (959)
.... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ++. .....++..++++
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~------~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQRVSSE 230 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSSCCCHH
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHh------hcccCCCCCCCHH
Confidence 6443 2346789999999999987765 678999999999999999999997632 111 2245677889999
Q ss_pred HHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 905 VARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 905 L~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
+++||.+||+.||.+|||++|+++
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=386.18 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=214.1
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCcEEEEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~~l~LVm 752 (959)
+++|+++++||+|+||+||+|++ +++.||||++............+.+|+.+|++++|||||+++++|.+...+++|+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 36899999999999999999987 6788999999877666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~~~~ 832 (959)
|++.++.|..++... ..+++..++.++.|++.||+|||++| ||||||||+||||+.++.+||+|||+++........
T Consensus 81 ~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999998888887654 57889999999999999999999999 999999999999999999999999999987665555
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhc--------------------
Q 002157 833 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGF-------------------- 890 (959)
Q Consensus 833 ~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ql~~~i~~-------------------- 890 (959)
.....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.. .+..+....+..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 55667889999999998765 68999999999999999999998644 343333332210
Q ss_pred -------cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 891 -------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 891 -------~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
.......+..+++++++||.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112233467899999999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=396.65 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=207.4
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~------ 746 (959)
.++|++++.||+|+||+||+|++ +++.||||++............+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 37899999999999999999987 5889999999876666667788999999999999999999999997665
Q ss_pred cEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccc
Q 002157 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (959)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~ 826 (959)
.++|||||+ +.+|..+++. ..+++..++.|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 479999999 6688888765 36999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---------------
Q 002157 827 HNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 890 (959)
Q Consensus 827 ~~~~~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~--------------- 890 (959)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 543 3457899999999999864 578999999999999999999999998776544322110
Q ss_pred --------------cccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHhh
Q 002157 891 --------------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 933 (959)
Q Consensus 891 --------------~~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~l 933 (959)
......+...+++++++||.+||..||.+|||+.|++++ |+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 001112335678999999999999999999999999985 5443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=392.53 Aligned_cols=258 Identities=33% Similarity=0.508 Sum_probs=203.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----cEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 751 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~----~l~LV 751 (959)
.+|.+.++||+|+||.||+|+++|+.||||++.... ........|+..+.+++|||||++++++.+.+ .++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 468899999999999999999999999999986432 12222334555666789999999999997654 58999
Q ss_pred EeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 752 mEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~------g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
||||++|+|.+++++. .+++..++.++.|++.||+|||.. ..+||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999874 589999999999999999999974 12499999999999999999999999999987
Q ss_pred ccCCc----ccCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCCCC---------------
Q 002157 826 KHNTF----LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMN--------------- 880 (959)
Q Consensus 826 ~~~~~----~~~~t~~GT~~YmAPEvl~g~~------~s~ksDIWSLGiLLyELLtG~~PF~g~~--------------- 880 (959)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 64432 1234567999999999997653 5678999999999999999988764321
Q ss_pred hHHHHhhhhccccccCCCCC-----CcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhC
Q 002157 881 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 938 (959)
Q Consensus 881 ~~ql~~~i~~~~~~~~iP~~-----ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~ 938 (959)
.......+.....++.+|.. ....+.+|+.+||+.||.+|||+.||++.|+++.+...
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 11222223233334444433 23468999999999999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=389.10 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=202.6
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--------
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-------- 744 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~-------- 744 (959)
.++|+++++||+|+||+||+|++ +|+.||||++......+.....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999987 58899999987665555556678899999999999999999998755
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...+++||||+.++.+. .+......+.+..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999776555 44444567899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCc----ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CC
Q 002157 825 LKHNTF----LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EI 897 (959)
Q Consensus 825 ~~~~~~----~~~~t~~GT~~YmAPEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~~--~i 897 (959)
...... ....+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 654321 223456799999999999875 68999999999999999999999999887766544332111000 00
Q ss_pred -------------------C---------CCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 898 -------------------P---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 898 -------------------P---------~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
+ ...++++++||.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0136678999999999999999999999854
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-43 Score=379.72 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=205.6
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpN-IVkL~g~~~~~~~l~LVm 752 (959)
++|++++.||+|+||.||+|++ +++.||||++...... .++.+|+++++.++|+| |+.+.+++.+....++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4699999999999999999987 5889999988764332 24678999999997665 556666678888899999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEecCccccccCC
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd---~~g~VKLiDFGlAk~~~~~ 829 (959)
||+ +++|.+.+......+++..++.++.||+.||+|||++| ||||||||+|||++ .+..+||+|||+++.....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 56777777666678999999999999999999999999 99999999999986 4567999999999876543
Q ss_pred c-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh------ccccccC
Q 002157 830 F-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------FQNRRLE 896 (959)
Q Consensus 830 ~-------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~------~~~~~~~ 896 (959)
. ......+||+.|||||++.+..++.++|||||||++|||++|..||.+.........+. .......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2 22345689999999999999999999999999999999999999998866543322111 0111122
Q ss_pred CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhh
Q 002157 897 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 935 (959)
Q Consensus 897 iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~k 935 (959)
.+..+++++.+||.+||+.||.+||++.+|.+.|+.+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 346789999999999999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=392.44 Aligned_cols=249 Identities=23% Similarity=0.272 Sum_probs=201.3
Q ss_pred CeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CCcE
Q 002157 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPNL 748 (959)
Q Consensus 677 dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~------~~~l 748 (959)
+|+.+++||+|+||+||+|++ +++.||||++...... +.+|+++|++++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999998 5889999998765322 2479999999999999999999853 3347
Q ss_pred EEEEeccCCCCHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecCcccc
Q 002157 749 SIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRL 825 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~--k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g-~VKLiDFGlAk~ 825 (959)
+||||||+++.+..+.. +....+++..++.|+.||+.||+|||++| ||||||||+||||+.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 89999997654333322 33457999999999999999999999999 99999999999999775 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------
Q 002157 826 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 891 (959)
Q Consensus 826 ~~~~~~~~~t~~GT~~YmAPEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~------------- 891 (959)
.... ....+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...
T Consensus 173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 6543 23445789999999999876 46899999999999999999999999887765544332110
Q ss_pred --ccc------------cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH--HHhhh
Q 002157 892 --NRR------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 934 (959)
Q Consensus 892 --~~~------------~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~--Le~l~ 934 (959)
... ......+++++++||.+||+.||.+|||+.|++++ |+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 01123578999999999999999999999999863 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=391.49 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=201.2
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----cEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLS 749 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~~----~l~ 749 (959)
++|++++.||+|+||+||+|++ +++.||||++.+.. .......+.+|+.+|++++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4699999999999999999987 58999999987544 3455667899999999999999999999986543 234
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~~ 829 (959)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 445566699999999764 5899999999999999999999999 999999999999999999999999999865433
Q ss_pred c---ccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc--------------
Q 002157 830 F---LSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------- 891 (959)
Q Consensus 830 ~---~~~~t~~GT~~YmAPEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~-------------- 891 (959)
. ......+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+...........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1234567999999999985 456789999999999999999999999887654333221100
Q ss_pred ----------ccc-----cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 892 ----------NRR-----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 892 ----------~~~-----~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
... ......++.++++||.+||+.||.+||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 01124678899999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=398.83 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=214.4
Q ss_pred cCCCCeeEEeEeeccCcEEEEEEEE-----CCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHcCC-CceeEEeeeeec
Q 002157 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTR 744 (959)
Q Consensus 673 i~~~dy~I~k~LGkG~fG~VYka~~-----~g~~VAVK~i~~~~~--~~~~~~ef~~Ei~IL~~L~H-pNIVkL~g~~~~ 744 (959)
+..++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 4458899999999999999999976 467899998865332 11223467799999999966 899999999999
Q ss_pred CCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccc
Q 002157 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (959)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk 824 (959)
...++++|||+.+|+|.+++...+ .+.+..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999999997653 6778889999999999999999999 9999999999999999999999999998
Q ss_pred cccCC-cccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccCCCC
Q 002157 825 LKHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPK 899 (959)
Q Consensus 825 ~~~~~-~~~~~t~~GT~~YmAPEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~--~~~~~~iP~ 899 (959)
..... .....+..|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+.+.......+.. ......+|.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 65432 2234556799999999999765 468899999999999999999999988765433332221 233566778
Q ss_pred CCcHHHHHHHHHHhhcCCCCCC-----CHHHHHH--HHHhhh
Q 002157 900 ELDPLVARIIWECWQTDPSLRP-----SFAQLTV--ALKPLQ 934 (959)
Q Consensus 900 ~ls~eL~dLI~kCL~~DP~kRP-----Sa~EIL~--~Le~l~ 934 (959)
.+++++++||.+||..||.+|| +++|+++ +++.+.
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 9999999999999999999999 5889986 355544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-43 Score=378.54 Aligned_cols=257 Identities=18% Similarity=0.243 Sum_probs=214.7
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCcEEEEE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIIT 752 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H-pNIVkL~g~~~~~~~l~LVm 752 (959)
++|+++++||+|+||+||+|++ +++.||||++...... ..+.+|+++++.+.| +||+.+++++.+....++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 6899999999999999999987 5889999988654322 246788899999965 89999999999999999999
Q ss_pred eccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----CCcEEEEecCcccccc
Q 002157 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKH 827 (959)
Q Consensus 753 Ey~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~-----~g~VKLiDFGlAk~~~ 827 (959)
||+ +++|.+++...+..+++..++.++.|++.||+|||++| ||||||||+||||+. .+.+||+|||+++...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999 78999999877778999999999999999999999999 999999999999964 5789999999998754
Q ss_pred CCc-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhcc---ccc
Q 002157 828 NTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NRR 894 (959)
Q Consensus 828 ~~~-------~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ql~~~i~~~---~~~ 894 (959)
... ......+||+.|||||++.+..++.++|||||||++|||++|..||.+.... .....+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 321 2234567999999999999999999999999999999999999999875432 222222111 111
Q ss_pred cCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHHHHhhhhhhCC
Q 002157 895 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 939 (959)
Q Consensus 895 ~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~Le~l~kl~~p 939 (959)
..++..+++++.+|+..|+..+|++||+++.|.+.|+.+.+....
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 223467889999999999999999999999999999987654433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.5e-43 Score=381.16 Aligned_cols=242 Identities=20% Similarity=0.302 Sum_probs=199.2
Q ss_pred CCCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeec--CCcEE
Q 002157 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLS 749 (959)
Q Consensus 675 ~~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~--~~~l~ 749 (959)
.++|+++++||+|+||+||+|++ +++.||||++.... ...+.+|+.+|+++. ||||++++++|.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36799999999999999999987 58899999986532 346789999999995 9999999999874 45699
Q ss_pred EEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecCccccccC
Q 002157 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHN 828 (959)
Q Consensus 750 LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~-g~VKLiDFGlAk~~~~ 828 (959)
+|||||.+++|..+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999998765 35899999999999999999999999 9999999999999865 4699999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhh----------------c
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVG----------------F 890 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-l~~~i~----------------~ 890 (959)
. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ....+. .
T Consensus 183 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 G-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp T-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 3 2345678999999999988754 7999999999999999999999997654321 110000 0
Q ss_pred c-------------------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 002157 891 Q-------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 928 (959)
Q Consensus 891 ~-------------------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~ 928 (959)
. .........+++++++||++||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0001112347899999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=389.18 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=205.1
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----CcE
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~~-----~~l 748 (959)
++|+++++||+|+||+||+|++ +|+.||||++............+.+|+++|++++|||||+++++|... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 7899999999999999999987 588999999987766666777889999999999999999999998643 334
Q ss_pred EEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCccccccC
Q 002157 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (959)
Q Consensus 749 ~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~~ 828 (959)
++||||+.+|+|.+++... .+++..++.|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCc
Confidence 5667777899999999653 6999999999999999999999999 99999999999999999999999999976543
Q ss_pred CcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-------------
Q 002157 829 TFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 894 (959)
Q Consensus 829 ~~~~~~t~~GT~~YmAPEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~~------------- 894 (959)
. ..+..|++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 174 ~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp G---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred c---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 3 34577999999999977754 689999999999999999999999988765544333211000
Q ss_pred --------cC--------CCCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 895 --------LE--------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 895 --------~~--------iP~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.. ....+++++++||.+||+.||.+|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 113578999999999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=387.84 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=196.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNIVkL~g~~~~------~~~ 747 (959)
++|+++++||+|+||+||+|++ +|+.||||++............+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999987 58999999998877777777789999999999999999999999964 367
Q ss_pred EEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecCcccccc
Q 002157 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (959)
Q Consensus 748 l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~~~ 827 (959)
+|+|||||.+ ++.+.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccch-HHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhccc
Confidence 8999999966 45555543 5899999999999999999999999 9999999999999999999999999988765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------------
Q 002157 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 893 (959)
Q Consensus 828 ~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ql~~~i~~~~~-------------- 893 (959)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 43 334556799999999999999999999999999999999999999988775543322210000
Q ss_pred ------cc--------------CC------CCCCcHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 002157 894 ------RL--------------EI------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 929 (959)
Q Consensus 894 ------~~--------------~i------P~~ls~eL~dLI~kCL~~DP~kRPSa~EIL~~ 929 (959)
.. .. +...++++++||++||..||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 01246789999999999999999999999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-38 Score=344.78 Aligned_cols=246 Identities=19% Similarity=0.291 Sum_probs=188.3
Q ss_pred CCeeEEeEeeccCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----------CCceeEEeeee
Q 002157 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFMGAV 742 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-----------HpNIVkL~g~~ 742 (959)
.+|+++++||+|+||+||+|++ +|+.||||++.+.. .....+.+|+++++.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 68999999987542 23456778999888875 57899999887
Q ss_pred ecC--CcEEEEEeccCCCCHHH--HhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC----
Q 002157 743 TRP--PNLSIITEFLPRGSLFR--ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW---- 813 (959)
Q Consensus 743 ~~~--~~l~LVmEy~~gGsL~d--lL~k~~~~lse~~~l~Ia~QIa~AL~yLHs-~g~~IIHRDLKPeNILLd~~g---- 813 (959)
... ...+++|+++..+.... ........+.+..+..++.||+.||+|||+ +| |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 543 45666777665443332 233445678999999999999999999997 77 99999999999998665
Q ss_pred --cEEEEecCccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-------H
Q 002157 814 --NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-------V 884 (959)
Q Consensus 814 --~VKLiDFGlAk~~~~~~~~~~t~~GT~~YmAPEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~q-------l 884 (959)
.+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||....... +
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999865433 345789999999999999999999999999999999999999997543210 0
Q ss_pred Hhhhhc-c--------------------------------------ccccCCCCCCcHHHHHHHHHHhhcCCCCCCCHHH
Q 002157 885 VGAVGF-Q--------------------------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 925 (959)
Q Consensus 885 ~~~i~~-~--------------------------------------~~~~~iP~~ls~eL~dLI~kCL~~DP~kRPSa~E 925 (959)
...+.. + ......+...++++++||.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000 0 0011122345678999999999999999999999
Q ss_pred HHHH
Q 002157 926 LTVA 929 (959)
Q Consensus 926 IL~~ 929 (959)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.8e-23 Score=205.93 Aligned_cols=165 Identities=18% Similarity=0.135 Sum_probs=119.8
Q ss_pred eeEEeEeeccCcEEEEEEEE-CCceEEEEEeeccCCC----------------HHHHHHHHHHHHHHHHcCCCceeEEee
Q 002157 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------GAALLEFKREVKIMRRLRHPNVVLFMG 740 (959)
Q Consensus 678 y~I~k~LGkG~fG~VYka~~-~g~~VAVK~i~~~~~~----------------~~~~~ef~~Ei~IL~~L~HpNIVkL~g 740 (959)
+.++++||+|+||+||+|++ +|+.||||+++..... ......+.+|..++.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45889999999999999986 7889999987532110 111234567899999999999998886
Q ss_pred eeecCCcEEEEEeccCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 002157 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (959)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g~~IIHRDLKPeNILLd~~g~VKLiDF 820 (959)
+.. .+++|||+++..+.++ .+.....++.||+.+|.|||++| |+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 643 3799999987655442 23335578899999999999999 9999999999999965 4999999
Q ss_pred CccccccCCcccCCCCCCCCCccCcc-----cccCCCCCchhHHHHHHHH
Q 002157 821 GLSRLKHNTFLSSKSTAGTPEWMAPE-----VLRNEPSNEKCDVYSFGVI 865 (959)
Q Consensus 821 GlAk~~~~~~~~~~t~~GT~~YmAPE-----vl~g~~~s~ksDIWSLGiL 865 (959)
|+++....+.. ..|.... .+..+.|..++|+||+.--
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99976543211 1122110 0123557888999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=3.6e-07 Score=92.75 Aligned_cols=142 Identities=15% Similarity=0.020 Sum_probs=97.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCcEEEEEec
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~~~l~LVmEy 754 (959)
+.|++.+..+-++...||+...++..+.||+....... ....+.+|..+++.+. +--+.+++.++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 45666666555556799999888888999987543221 1224668888888773 33356777788888889999999
Q ss_pred cCCCCHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 002157 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST---------------------------------------- 794 (959)
Q Consensus 755 ~~gGsL~dlL~k~~~~lse~~~l~Ia~QIa~AL~yLHs~g---------------------------------------- 794 (959)
++|..+....... .. ...++.+++..|..||+..
T Consensus 92 l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9998876654221 11 1223445555555555421
Q ss_pred -----------------CCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 795 -----------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 795 -----------------~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1289999999999999876677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.86 E-value=3.1e-05 Score=77.66 Aligned_cols=74 Identities=16% Similarity=0.158 Sum_probs=51.0
Q ss_pred EeeccCc-EEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecCCcEEEEEeccCCC
Q 002157 683 RIGLGSY-GEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 683 ~LGkG~f-G~VYka~~~-g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~--HpNIVkL~g~~~~~~~l~LVmEy~~gG 758 (959)
.+..|.. ..||+...+ +..+.+|....... ..+.+|...|+.+. .-.+.+++.+..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3455554 689999875 44578887554332 23567888887773 233667788888888899999999876
Q ss_pred CHH
Q 002157 759 SLF 761 (959)
Q Consensus 759 sL~ 761 (959)
.+.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.00021 Score=77.68 Aligned_cols=77 Identities=16% Similarity=0.083 Sum_probs=47.5
Q ss_pred EeEeeccCcEEEEEEEE--CCceEEEEEeeccC-C----CHHHHHHHHHHHHHHHHc-CC--CceeEEeeeeecCCcEEE
Q 002157 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-F----SGAALLEFKREVKIMRRL-RH--PNVVLFMGAVTRPPNLSI 750 (959)
Q Consensus 681 ~k~LGkG~fG~VYka~~--~g~~VAVK~i~~~~-~----~~~~~~ef~~Ei~IL~~L-~H--pNIVkL~g~~~~~~~l~L 750 (959)
.+.||.|....||+++. .++.|+||.-.... . .+....+...|...|+.+ .+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999975 46678898643210 0 011123445688888766 23 345555544 3445678
Q ss_pred EEeccCCCC
Q 002157 751 ITEFLPRGS 759 (959)
Q Consensus 751 VmEy~~gGs 759 (959)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.76 E-value=0.00053 Score=72.05 Aligned_cols=51 Identities=18% Similarity=0.189 Sum_probs=45.7
Q ss_pred eeccccchhhHHHHHHHhhccCCceEEeeccccCCCCCCeeEEEEecC-cceeeeec
Q 002157 261 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDL 316 (959)
Q Consensus 261 ~i~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~~~~~~a~~~v~~~~-~~~~~~Dl 316 (959)
.-|+|.|.++|.+|-.+|-.+|||||+|.| | .+|+|++|...+ ++|.-||-
T Consensus 137 ~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~--~---~~H~W~Ev~~~~~~rWv~vDp 188 (287)
T d2f4ma1 137 ETRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDA 188 (287)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEET
T ss_pred HhcCccHHHHHHHHHHHHHHcCCCeEEEec--C---CcceeEEEEecCCCcEEEecC
Confidence 457899999999999999999999999999 3 379999999976 46999996
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.59 E-value=0.0036 Score=67.39 Aligned_cols=76 Identities=17% Similarity=0.270 Sum_probs=50.5
Q ss_pred CCeeEEeEeeccCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecC
Q 002157 676 EDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP 745 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~---------g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~-HpNIVkL~g~~~~~ 745 (959)
++++| +.|+.|-.-.+|+++.. ...|.+++.-... . .....+|..+++.+. +.-..++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 44555 57888999999999763 2457777654221 1 234568889998884 4334577777754
Q ss_pred CcEEEEEeccCCCCH
Q 002157 746 PNLSIITEFLPRGSL 760 (959)
Q Consensus 746 ~~l~LVmEy~~gGsL 760 (959)
++|+||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999986543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.53 E-value=0.0037 Score=64.58 Aligned_cols=146 Identities=12% Similarity=0.031 Sum_probs=77.9
Q ss_pred CCeeEEeEeeccCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-----CceeEEee---eeecCCc
Q 002157 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-----PNVVLFMG---AVTRPPN 747 (959)
Q Consensus 676 ~dy~I~k~LGkG~fG~VYka~~~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~H-----pNIVkL~g---~~~~~~~ 747 (959)
..+.-.+.|..|---+.|+.+.++..+++|++.... ...++..|+.+|..|.. |..+...+ +......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 445555667788889999999888889999875432 12245566777777632 22222111 1222344
Q ss_pred EEEEEeccCCCCHHH-----------H---hh---C-C----CCCCC------------------HHHHHHHHHHHHHHH
Q 002157 748 LSIITEFLPRGSLFR-----------I---LH---R-P----HCQVD------------------EKRRIKMALDVARGM 787 (959)
Q Consensus 748 l~LVmEy~~gGsL~d-----------l---L~---k-~----~~~ls------------------e~~~l~Ia~QIa~AL 787 (959)
...++.++.+..... . ++ . . ..... .......+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 556666665432211 0 00 0 0 00000 011112222333333
Q ss_pred HHHHhCC--CCEEeeCCCCCcEEEcCCCcEEEEecCcccc
Q 002157 788 NCLHTST--PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (959)
Q Consensus 788 ~yLHs~g--~~IIHRDLKPeNILLd~~g~VKLiDFGlAk~ 825 (959)
...+..+ .++||+|+.+.|||++.+...-|+||+.++.
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3333221 2599999999999999887778999998853
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.18 E-value=0.0098 Score=62.20 Aligned_cols=67 Identities=13% Similarity=0.090 Sum_probs=43.7
Q ss_pred cEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-----eEEe--eeeecCCcEEEEEeccCCC
Q 002157 689 YGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-----VLFM--GAVTRPPNLSIITEFLPRG 758 (959)
Q Consensus 689 fG~VYka~~-~g~~VAVK~i~~~~~~~~~~~ef~~Ei~IL~~L~HpNI-----VkL~--g~~~~~~~l~LVmEy~~gG 758 (959)
--.||+++. +|+.|++|+.+....+ ..++..|...+..|....| +..- ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999976 6888999987765443 3456678888887742222 1111 1234556688899998754
|
| >d2q3za4 d.3.1.4 (A:146-461) Transglutaminase catalytic domain {Human (Homo sapiens), tissue isozyme [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Transglutaminase catalytic domain species: Human (Homo sapiens), tissue isozyme [TaxId: 9606]
Probab=94.59 E-value=0.0061 Score=63.82 Aligned_cols=51 Identities=18% Similarity=0.234 Sum_probs=43.1
Q ss_pred HHHhHHHHHHHHHHhhCCceeEeeeeccccchhhHHHHHHHhhccCCceEEeec
Q 002157 237 MLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKG 290 (959)
Q Consensus 237 ~~~~~~~~~~~l~~~~~s~v~plg~i~~g~~~~~a~lfk~l~d~~~~~~~lv~G 290 (959)
.-..|.-....|++=+.+.+.| +|.|-|-|+|-.+-+++-.+|||||+|.|
T Consensus 105 ~P~~W~GSv~IL~q~~~~~~~p---VkyGqCwvFA~v~~tvlR~lGIPaRvVT~ 155 (316)
T d2q3za4 105 SPMSWIGSVDILRRWKNHGCQR---VKYGQCWVFAAVACTVLRCLGIPTRVVTN 155 (316)
T ss_dssp CTTTCCBSHHHHHHHHHTTTCC---EEEECHHHHHHHHHHHHHHHTCCEEEEEE
T ss_pred CCCCCCCcHHHHHHHHHcCCcc---cccchhHHHHHHHHHHHHhcCCCceEecc
Confidence 3345666667777777777766 79999999999999999999999999999
|
| >d1x3za1 d.3.1.4 (A:8-327) Peptide:N-glycanase 1, PNG1 {Baker's yeast(Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Baker's yeast(Saccharomyces cerevisiae) [TaxId: 4932]
Probab=84.43 E-value=0.47 Score=49.61 Aligned_cols=58 Identities=21% Similarity=0.103 Sum_probs=48.7
Q ss_pred ceeEeeeeccccchhhHHHHHHHhhccCCceEEeeccccCCCCCCeeEEEEecC-cceeeeecc
Q 002157 255 SVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDLM 317 (959)
Q Consensus 255 ~v~plg~i~~g~~~~~a~lfk~l~d~~~~~~~lv~G~~~~~~~~~a~~~v~~~~-~~~~~~Dlm 317 (959)
++.-|=+-|.|=|-..|.+|-.+|..+|++||.|.- ..||.|++|.... ++|-=||..
T Consensus 172 ~p~~LL~tR~GRcgEwan~F~~~~ra~g~~aR~V~~-----~~DhvW~EVys~~~kRWIhvDpc 230 (320)
T d1x3za1 172 DPIKLLETRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVDSC 230 (320)
T ss_dssp CHHHHHHHCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEETT
T ss_pred CHHHHHhhcCcchHHHHHHHHHHHHHcCCceEEEEE-----CCCceEEEEeecccCeEEEEcCC
Confidence 344455778999999999999999999999999976 3489999999976 468889973
|